phenotype1;phenotype2;cosOriginal;cosTuned;cosOriginalTrans;cosTunedTrans;lin;deltaOriginal;deltaTuned;deltaOriginalTrans;deltaTunedTrans
Temporomandibular joint ankylosis;Dyslexia;1.007255476899445;0.8805999;0.497690489710774;0.5380971118859956;0.9999511492611326;0.007304327638312458;-0.11935123327983987;-0.5022606595503586;-0.46185403737513697
Temporomandibular joint ankylosis;Stippling of the epiphysis of the proximal phalanx of the 4th toe;0.8140445053577423;0.7659119;0.5595380272668038;0.5752104269046647;0.7973657807105512;0.016678724647191112;-0.03145390355524724;-0.2378277534437474;-0.22215535380588647
Temporomandibular joint ankylosis;Ankle joint effusion;0.7939617186784744;0.56284094;0.5660571433244672;0.6440153227012925;0.7973657807105512;-0.003404062032076771;-0.23452484214243596;-0.23130863738608398;-0.15335045800925873
Temporomandibular joint ankylosis;Reduced C-peptide level;1.0382218286395073;0.9029308;0.4878306497980708;0.5309468118786714;0.9999536937290383;0.03826813491046899;-0.09702289758264548;-0.5121230439309675;-0.4690068818503669
Temporomandibular joint ankylosis;Loss of voice;0.9164937362074852;0.8826361;0.526611859380572;0.5374443891283627;0.9999536937290383;-0.08345995752155311;-0.11731762347757346;-0.47334183434846633;-0.46250930460067563
Temporomandibular joint ankylosis;Elevated circulating growth hormone concentration;0.986403176560998;0.84560364;0.5043281366880232;0.5493432695523368;0.9999515360511232;-0.013548359490125228;-0.15434789120325332;-0.49562339936309996;-0.4506082664987864
Temporomandibular joint ankylosis;Visual acuity no light perception;1.0150191588327289;0.8818609;0.49521907350686767;0.5376928654599227;0.9999090677057578;0.015110091126971037;-0.11804815585959694;-0.5046899941988902;-0.46221620224583515
Temporomandibular joint ankylosis;Spinal hypomyelination;1.0178999584168196;0.84571236;0.49430196196270526;0.5493082435610162;0.9999090677057578;0.017990890711061747;-0.15419670398581764;-0.5056071057430526;-0.4506008241447417
Temporomandibular joint ankylosis;Bladder polyp;1.0328451693058014;0.8867116;0.4895431771758625;0.5361383935665673;0.9999574798349273;0.03288768947087406;-0.11324588239230038;-0.5104143026590648;-0.46381908626836
Temporomandibular joint ankylosis;Aberrant melanosome maturation;1.0514475852251053;0.8955682;0.48361649211603874;0.5333024048467544;0.9999574798349273;0.051490105390177954;-0.10438928782976986;-0.5163409877188886;-0.46665507498817294
Temporomandibular joint ankylosis;Vertebral artery tortuosity;0.8493822067975998;0.63626266;0.5481262792519936;0.6184994299129825;0.9999574798349273;-0.15057527303732754;-0.3636948245767486;-0.4518312005829337;-0.3814580499219449
Temporomandibular joint ankylosis;Warm reactive autoantibody positivity;0.9313274621963501;0.7791336;0.5218763652451026;0.5708884714991198;0.9999090677057578;-0.06858160550940773;-0.22077544982779762;-0.4780327024606552;-0.429020596206638
Temporomandibular joint ankylosis;Right aortic arch with retroesophageal left subclavian artery;0.8980986997485161;0.7116318;0.5324925907842057;0.5931127080523375;0.9999090677057578;-0.10181036795724174;-0.2882772928034141;-0.4674164769215521;-0.4067963596534203
Temporomandibular joint ankylosis;Elevated urine suberic acid level;1.1133554354310036;0.9084556;0.46384012132057373;0.5291803337363419;0.9999574798349273;0.11339795559607624;-0.09150186955965878;-0.5361173585143536;-0.47077714609858545
Temporomandibular joint ankylosis;Burkitt lymphoma;0.9631349630653858;0.82333326;0.5117371652636966;0.5565314901334046;0.9999545338528789;-0.036819570787493094;-0.17662127045566212;-0.4882173685891823;-0.4434230437194743
Temporomandibular joint ankylosis;Snail-like ilia;1.0255841426551342;0.8978789;0.4918554257955594;0.5325629244478087;0.9052477392617277;0.12033640339340645;-0.007368853992562707;-0.41339231346616834;-0.372684814813919
Temporomandibular joint ankylosis;Indurated nodule;0.8742015957832336;0.7517976;0.5401492496866629;0.579839799804913;0.9999090677057578;-0.12570747192252418;-0.24811145122397682;-0.45975981801909493;-0.42006926790084487
Temporomandibular joint ankylosis;Absent leukocyte alkaline phosphatase;1.011829194612801;0.8317865;0.4962345625894925;0.553799797860233;0.9999574798349273;0.011871714777873743;-0.16817096650637509;-0.5037229172454348;-0.4461576819746943
Temporomandibular joint ankylosis;Hippocampal sclerosis;1.0072439378127456;0.8441032;0.4976941628126752;0.5498267149079534;0.9999090677057578;0.007334870106987745;-0.15580585058081886;-0.5022149048930826;-0.4500823527978044
Temporomandibular joint ankylosis;Decreased sensitivity to hypoxemia;1.0565954484045506;0.8891963;0.4819754782879385;0.5353424859469795;0.9999574798349273;0.05663796856962322;-0.11076120317019345;-0.5179820015469888;-0.4646149938879478
Temporomandibular joint ankylosis;Decreased level of tissue plasminogen activator;0.9691423289477825;0.78479385;0.5098238612213476;0.5690423429365179;0.9999090677057578;-0.03076673875797531;-0.2151152139459922;-0.49008520648441023;-0.43086672476923993
Temporomandibular joint ankylosis;Submandibular lymph node enlargement;0.6895099878311157;0.79078543;0.6004931298452683;0.5670907009223505;0.9999574798349273;-0.3104474920038116;-0.2091720479730499;-0.3994643499896591;-0.43286677891257686
Temporomandibular joint ankylosis;Hepatic hemangioma;1.0305037777870893;0.82786757;0.4902888395596835;0.5550657021592065;0.9999556674707869;0.030548110316302446;-0.17208809993157181;-0.5096668279111034;-0.4448899653115804
Temporomandibular joint ankylosis;Triangular epiphysis of the distal phalanx of the 2nd finger;0.7904898375272751;0.77554435;0.567186933706703;0.5720603883044251;0.7973657807105512;-0.006875943183276112;-0.021821435331675465;-0.23017884700384816;-0.22530539240612613
Temporomandibular joint ankylosis;Acne inversa;0.7938812673091888;0.727349;0.5660833135218925;0.5879004382254471;0.9999515360511232;-0.20607026874193435;-0.2726025527633119;-0.43386822252923074;-0.41205109782567606
Temporomandibular joint ankylosis;Dentin dysplasia;0.6101109385490417;0.71132016;0.6274866481010285;0.5932163131119678;0.7938909578598223;-0.18378001931078058;-0.08257079604036432;-0.16640430975879383;-0.20067464474785457
Temporomandibular joint ankylosis;Aplasia of the inner ear;0.8422545790672302;0.6576803;0.5504225363382802;0.611212597448539;0.9999574798349273;-0.1577029007676971;-0.34227720677889706;-0.44953494349664713;-0.3887448823863884
Temporomandibular joint ankylosis;Polycystic liver disease;1.1342635452747345;0.85621893;0.4571331308470783;0.5459261147377887;0.9999536937290383;0.1343098515456962;-0.14373475966989524;-0.54282056288196;-0.45402757899124957
Temporomandibular joint ankylosis;Subungual hyperkeratosis;0.9038085043430328;0.92216665;0.5306661198729034;0.5248002070121809;0.9999524555142131;-0.09614395117118024;-0.07778580998732709;-0.4692863356413097;-0.4751522485020322
Temporomandibular joint ankylosis;Broad humeral epiphyses;0.8807734102010727;0.79054403;0.5380414944087062;0.5671692815892175;0.7973657807105512;0.0834076294905215;-0.006821747660014088;-0.259324286301845;-0.23019649912133366
Temporomandibular joint ankylosis;Autoimmune thrombocytopenia;0.9598847515881062;0.62061465;0.5127725073765013;0.6238645286390052;0.9999469426585951;-0.04006219107048892;-0.37933229479329966;-0.4871744352820938;-0.37608241401958986
Temporomandibular joint ankylosis;Adenomyosis;0.9318784102797508;0.77853954;0.5217005813667042;0.5710823842741057;0.9999574798349273;-0.06807906955517651;-0.22141794145144345;-0.47825689846822317;-0.4288750955608216
Temporomandibular joint ankylosis;Elevated leukocyte alkaline phosphatase;1.0059679839760065;0.82413197;0.49810032042297525;0.5562731968032066;0.9999574798349273;0.006010504141079176;-0.1758255141977203;-0.5018571594119521;-0.4436842830317207
Temporomandibular joint ankylosis;Clasp-knife sign;1.0184027906507254;1.0246934;0.4941418791162606;0.49213904892276583;0.8656029960338777;0.15279979461684767;0.1590903738315398;-0.3714611169176171;-0.37346394711111186
Temporomandibular joint ankylosis;Keratosis pilaris;0.9790515378117561;0.8959035;0.5066685904140789;0.5331950720505612;0.9999466809608285;-0.02089514314907237;-0.10404315322416469;-0.49327809054674965;-0.46675160891026735
Temporomandibular joint ankylosis;Lamina lucida cleavage;0.9836221262812614;0.87604016;0.5052134722094603;0.5395593988496205;0.9999515360511232;-0.016329409769861747;-0.12391137539514785;-0.49473806384166286;-0.46039213720150274
Temporomandibular joint ankylosis;Abnormal central response of multifocal electroretinogram;1.0088710766285658;0.87191266;0.4971762115703984;0.5408837884539386;0.9999090677057578;0.008962008922807962;-0.12799640949118873;-0.5027328561353595;-0.45902527925181924
Temporomandibular joint ankylosis;Atypical or prolonged hepatitis;1.02798025123775;0.7601792;0.49109244687619946;0.5770886773495689;0.9999574798349273;0.02802277140282272;-0.2397782582048309;-0.5088650329587279;-0.4228688024853584
Temporomandibular joint ankylosis;Cubitus varus;0.9243603944778442;0.8599575;0.5240998522019931;0.544723914492641;0.7973657807105512;0.12699461376729304;0.0625917354828387;-0.27326592850855813;-0.2526418662179102
Temporomandibular joint ankylosis;Nasal regurgitation;0.752298891544342;0.66013366;0.5796750956773962;0.6103818389021438;0.9999556674707869;-0.24765677592644486;-0.3398220076311568;-0.42028057179339073;-0.3895738285686431
Temporomandibular joint ankylosis;Moon facies;0.9627855718135834;0.91748863;0.5118484563224897;0.5262940695106586;0.899514961016858;0.06327061079672536;0.017973673569476212;-0.38766650469436836;-0.3732208915061994
Temporomandibular joint ankylosis;Intestinal pseudo-obstruction;0.9468888007104397;0.749925;0.5169137778947517;0.5804552739733508;0.9999504758588345;-0.05306167514839477;-0.2500254585019619;-0.4830366979640828;-0.4194952018854836
Temporomandibular joint ankylosis;Bilateral renal atrophy;0.996749646961689;0.689383;0.5010346213274477;0.6005356638251891;0.9999574798349273;-0.0032078328732383365;-0.31057450950182797;-0.49892285850747964;-0.39942181600973825
Temporomandibular joint ankylosis;Fractured left clavicle;0.9376826137304306;0.7981787;0.5198491014824116;0.5646860307408241;0.7356548868117849;0.20202772691864568;0.06252378597874242;-0.21580578532937333;-0.1709688560709608
Temporomandibular joint ankylosis;Positive urine norcotinine test;1.0260273031890392;0.9277318;0.4917143164226099;0.5230237494208134;0.9999090677057578;0.026118235483281405;-0.07217725570548317;-0.508194751283148;-0.4768853182849444
Temporomandibular joint ankylosis;Long fibula;0.7864364087581635;0.72092485;0.5685070555465401;0.5900278472258818;0.8968107519695712;-0.11037434321140771;-0.1758858976910067;-0.32830369642303103;-0.3067829047436894
Temporomandibular joint ankylosis;Fragmentation of the epiphysis of the distal phalanx of the hallux;0.7364016771316528;0.73764634;0.5849093418972893;0.5844987091342008;0.7973657807105512;-0.060964103578898365;-0.05971943938669866;-0.21245643881326193;-0.21286707157635043
Temporomandibular joint ankylosis;Type II cryptotia;1.1217985600233078;0.92221487;0.4611338112662169;0.5247848090050378;0.9999090677057578;0.12188949231754997;-0.07769420202124855;-0.5387752564395409;-0.47512425870072006
Temporomandibular joint ankylosis;Increased variability in muscle fiber diameter;0.9372908845543861;0.79636407;0.5199740371100057;0.5652758806795672;0.9153376606986002;0.02195322385578591;-0.11897359171361488;-0.39536362358859456;-0.350061780019033
Temporomandibular joint ankylosis;Widened proximal tibial metaphyses;0.8140435367822647;0.7189031;0.5595383410468819;0.59069822543633;0.9052477392617277;-0.09120420247946304;-0.18634461492929977;-0.3457093982148458;-0.31454951382539775
Temporomandibular joint ankylosis;Wide anterior fontanel;0.9161336496472359;0.81663;0.5267268819754006;0.5587006399534702;0.8018962303507605;0.11423741929647535;0.014733775485726297;-0.2751693483753599;-0.24319559039729033
Temporomandibular joint ankylosis;Increased circulating oleate level;1.012450609356165;0.81448793;0.4960367455526753;0.5593943704085309;0.9999090677057578;0.012541541650407106;-0.185421133593209;-0.5038723221530825;-0.4405146972972269
Temporomandibular joint ankylosis;Lozenge-shaped umbilicus;0.9893717635422945;0.85749936;0.5033831364320747;0.5455143062140082;0.9999556674707869;-0.0105839039284924;-0.1424563064325789;-0.49657253103871224;-0.4544413612567787
Temporomandibular joint ankylosis;Anti-myelin-associated glycoprotein antibody positivity;0.9167683571577072;0.7770224;0.5265241394417788;0.5715776719838945;0.9999090677057578;-0.08314071054805061;-0.22288664634574196;-0.47338492826397904;-0.4283313957218633
Temporomandibular joint ankylosis;Fractured radius;0.8313651531934738;0.70326877;0.5539358647256911;0.595896548846623;0.9052477392617277;-0.07388258606825393;-0.2019789728585295;-0.35131187453603663;-0.3093511904151047
Temporomandibular joint ankylosis;Abnormal manual kinetic perimetry test;0.9807337895035744;0.7797497;0.5061330047253555;0.5706874131251687;0.9999090677057578;-0.019175278202183454;-0.22015937621939918;-0.49377606298040233;-0.42922165458058914
Temporomandibular joint ankylosis;Small radial epiphyses;1.004550613462925;0.9010389;0.49855148974720886;0.5315519349268552;0.7973657807105512;0.20718483275237376;0.10367310440602595;-0.29881429096334233;-0.26581384578369605
Temporomandibular joint ankylosis;Generalized keratosis follicularis;0.93654865026474;0.8788627;0.520210769089215;0.5386541468295158;0.9999574798349273;-0.06340882957018734;-0.12109480083025814;-0.4797467107457123;-0.4613033330054115
Temporomandibular joint ankylosis;Hypoplasia of the calcaneus;0.8343187719583511;0.79422194;0.5529822814838243;0.5659724943928681;0.9012090531633711;-0.06689028120501994;-0.10698711550696849;-0.34822677167954674;-0.33523655877050296
Temporomandibular joint ankylosis;2-hydroxyadipic aciduria;1.0441919714212418;0.82265574;0.48592867601725453;0.5567506037088533;0.9999090677057578;0.044282903715483934;-0.1772533303057029;-0.5139803916885033;-0.4431584639969045
Temporomandibular joint ankylosis;Potter facies;1.0449723079800606;1.0386219;0.4856800399563429;0.4877032082412094;0.891127884050195;0.15384442392986553;0.14749401841562526;-0.40544784409385215;-0.40342467580898567
Temporomandibular joint ankylosis;Increased heart rate variability;0.9597600549459457;0.7619012;0.512812231625672;0.5765242062988881;0.9999574798349273;-0.04019742488898159;-0.23805628001726986;-0.4871452482092553;-0.4234332735360392
Temporomandibular joint ankylosis;Aplastic zygomatic arch;0.5469472408294678;0.66887915;0.6496650842049376;0.6074267808839826;0.7555979181251512;-0.20865067729568343;-0.08671876678085189;-0.10593283392021358;-0.1481711372411686
Temporomandibular joint ankylosis;Testicular torsion;0.9082106947898865;0.717233;0.5292586271361996;0.5912523190466221;0.9999574798349273;-0.09174678504504086;-0.2827244776491058;-0.4706988526987277;-0.4087051607883052
Temporomandibular joint ankylosis;Abolished vibration sense;0.9219603687524796;0.8460823;0.5248660696531638;0.5491890560011925;0.9999556674707869;-0.07799529871830735;-0.15387333772072587;-0.47508959781762305;-0.4507666114695944
Temporomandibular joint ankylosis;Fractured metatarsal bone of digit 5;0.7781969159841537;0.79980147;0.5711942160948871;0.5641587060439273;0.7973657807105512;-0.01916886472639745;0.0024356881386309315;-0.22617156461566412;-0.23320707466662394
Temporomandibular joint ankylosis;Prolonged G2 phase of cell cycle;1.0255411341786385;0.9117243;0.49186912029387453;0.5281356366392249;0.9999536937290383;0.025587440449600152;-0.08822936473428733;-0.5080845734351638;-0.4718180570898134
Temporomandibular joint ankylosis;Single naris;1.086921140551567;1.075836;0.47229718289998146;0.47583746916794023;0.8950412366415926;0.19187990390997445;0.18079470658045327;-0.42274405374161117;-0.4192037674736524
Temporomandibular joint ankylosis;Perifoveal ring of hyperautofluorescence surrounded by normal autofluorescence;1.0168637055903673;0.7967396;0.49463186133642456;0.5651538039645689;0.9999090677057578;0.01695463788460949;-0.2031694894586875;-0.5052772063693333;-0.4347552637411889
Temporomandibular joint ankylosis;Asymmetry of the thorax;0.8846004754304886;0.67256665;0.5368148307934771;0.6061836987957687;0.865385157817563;0.01921531761292561;-0.19281850551958934;-0.32857032702408584;-0.25920145902179426
Temporomandibular joint ankylosis;Type 2 muscle fiber predominance;0.9548703692853451;0.8994745;0.5143700883212109;0.5320523917629558;0.9297297346545392;0.025140634630805847;-0.030255233044736984;-0.41535964633332834;-0.3976773428915834
Temporomandibular joint ankylosis;Dependency on parenteral nutrition;1.0732958987355232;0.93823403;0.4766482501774961;0.5196732363111574;0.9999556674707869;0.07334023126473632;-0.061721636270377966;-0.5233074172932908;-0.48028243115962954
Temporomandibular joint ankylosis;Limited shoulder flexion;0.7906286865472794;0.66440505;0.5671417342271166;0.6089373373761451;0.8100986279188489;-0.019469941371569544;-0.14569358002532473;-0.24295689369173235;-0.20116129054270382
Temporomandibular joint ankylosis;Paroxysmal vertigo;0.8813063576817513;0.7259848;0.5378706387141068;0.5883518578581224;0.9999556674707869;-0.11864930978903565;-0.27397085568795;-0.4620850287566801;-0.4116038096126645
Temporomandibular joint ankylosis;Long hallux;0.7284759283065796;0.71224284;0.5875276563312384;0.5929096093738759;0.8862381141603949;-0.1577621858538153;-0.17399527243981383;-0.2987104578291565;-0.29332850478651895
Temporomandibular joint ankylosis;Broad medial eyebrow;0.8814500570297241;0.9000153;0.5378245725412094;0.5318793922669204;0.9036229035260553;-0.022172846496331222;-0.003607608974205978;-0.36579833098484593;-0.37174351125913496
Temporomandibular joint ankylosis;Myxoid subcutaneous tumors;0.9748665541410446;0.92637753;0.508001066807368;0.523455985500646;0.9999574798349273;-0.025090925693882715;-0.07357994496859432;-0.4919564130275593;-0.47650149433428135
Temporomandibular joint ankylosis;Bulbous tips of toes;0.9761628992855549;0.87250614;0.5075883035527609;0.5406933199259081;0.9012090531633711;0.07495384612218381;-0.02870291150077342;-0.3936207496106102;-0.360515733237463
Temporomandibular joint ankylosis;Absent internal genitalia;0.8824521452188492;0.84315455;0.5375033519053442;0.550132455768753;0.9999090677057578;-0.11745692248690864;-0.15675451810706398;-0.4624057158004137;-0.4497766119370048
Temporomandibular joint ankylosis;Hyperphalangy of the 2nd finger;0.808800458908081;0.7496536;0.561237757331701;0.5805445242799098;0.9052477392617277;-0.09644728035364669;-0.15559416145716232;-0.34400998193002674;-0.324703214981818
Temporomandibular joint ankylosis;Renal interstitial hemosiderin;1.0730516016483307;0.83461976;0.47672622138030385;0.5528851288513685;0.9999090677057578;0.07314253394257286;-0.16528930719245216;-0.523182846325454;-0.4470239388543893
Temporomandibular joint ankylosis;Abnormality of depressor anguli oris muscle;0.623104065656662;0.6597592;0.6230085651198016;0.610508578622197;0.7938909578598223;-0.17078689220316035;-0.1341317343986712;-0.1708823927400207;-0.18338237923762535
Temporomandibular joint ankylosis;Paroxysmal dyspnea;0.9364466667175293;0.7329472;0.5202432971121841;0.5860498222548177;0.9999090677057578;-0.06346240098822853;-0.2669618969713523;-0.47966577059357374;-0.4138592454509401
Temporomandibular joint ankylosis;Phenylpyruvic acidemia;1.1249617412686348;0.89325625;0.46011918669916496;0.5340424497027445;0.9999574798349273;0.12500426143370746;-0.10670123279131771;-0.5398382931357624;-0.46591503013218283
Temporomandibular joint ankylosis;Lateral ventricle dilatation;0.9858625307679176;0.7669789;0.5045002461399075;0.5748611161071235;0.9999445600944175;-0.014082029326499823;-0.23296564058834446;-0.49544431395450994;-0.4250834439872939
Temporomandibular joint ankylosis;Neonatal unconjugated hyperbilirubinemia;1.076039932668209;0.85869294;0.4757723516582014;0.5451304833133626;0.9999574798349273;0.07608245283328174;-0.14126453578509213;-0.5241851281767259;-0.4548269965215648
Temporomandibular joint ankylosis;High maternal circulating alpha-fetoprotein concentration;1.0161016397178173;0.8078738;0.49487446740112084;0.5615382984379715;0.9999090677057578;0.01619257201205948;-0.19203528220999977;-0.505034600304637;-0.4383707692677863
Temporomandibular joint ankylosis;Prominent nasolabial fold;0.5782469511032104;0.7566722;0.6385850797695891;0.5782390782820914;0.8892738924086724;-0.31102694130546193;-0.13260168886787038;-0.25068881263908327;-0.31103481412658096
Temporomandibular joint ankylosis;Abnormality of inferior alveolar nerve;0.4265941381454468;0.6160153;0.6943781666495037;0.6254484698157032;0.9999090677057578;-0.573314929560311;-0.38389375264991066;-0.30553090105625413;-0.3744605978900546
Temporomandibular joint ankylosis;Unilateral conductive hearing impairment;0.9266158416867256;0.8156108;0.5233799195799886;0.5590306777882885;0.9999574798349273;-0.07334163814820172;-0.18434665381945492;-0.4765775602549387;-0.4409268020466388
Temporomandibular joint ankylosis;Macular hypopigmented whorls, streaks, and patches;0.9806340634822845;0.86637646;0.5061647544274843;0.542661301637575;0.9999574798349273;-0.019323416352642786;-0.13358102023638607;-0.493792725407443;-0.45729617819735235
Temporomandibular joint ankylosis;Delayed ossification of pubic rami;0.6415325403213501;0.62022537;0.6167005959419773;0.6239984634837819;0.9012090531633711;-0.259676512842021;-0.28098368323310374;-0.28450845722139373;-0.2772105896795892
Temporomandibular joint ankylosis;Hyperphenylalaninemia;1.1087555885314941;0.8132969;0.4653134128998111;0.5597802298259094;0.9999530203863651;0.10880256814512901;-0.18665610628571816;-0.534639607486554;-0.4401727905604558
Temporomandibular joint ankylosis;Ureteropelvic junction obstruction;0.9794962592422962;0.7112678;0.5065270007702825;0.5932337021620087;0.9999491674684583;-0.02045290822616208;-0.2886813385271131;-0.49342216669817585;-0.40671546530644964
Temporomandibular joint ankylosis;Cone-shaped epiphysis of the proximal phalanx of the 2nd toe;0.8503085821866989;0.8308203;0.5478280233276274;0.5541118131645068;0.7973657807105512;0.052942801476147716;0.03345454132619197;-0.24953775738292383;-0.24325396754604445
Temporomandibular joint ankylosis;Difficulty walking;1.0144938183948398;0.8699566;0.4953863127732818;0.5415116591901044;0.9132464539952869;0.10124736439955284;-0.043289841408311824;-0.4178601412220051;-0.37173479480518257
Temporomandibular joint ankylosis;Bilobate gallbladder;1.0369015783071518;0.830529;0.488251195336481;0.5542059107041848;0.9999556674707869;0.03694591083636489;-0.16942669293770585;-0.5117044721343059;-0.4457497567666021
Temporomandibular joint ankylosis;Histidinuria;1.0352575108408928;0.83565825;0.488774859270234;0.5525499855666268;0.9999545338528789;0.03530297698801388;-0.16429628161365162;-0.5111796745826449;-0.4474045482862521
Temporomandibular joint ankylosis;Widened interpedicular distance;0.7758816480636597;0.67766416;0.5719502195125103;0.6044680406282721;0.7356548868117849;0.04022676125187474;-0.057990726083330335;-0.16370466729927458;-0.13118684618351284
Dyslexia;Stippling of the epiphysis of the proximal phalanx of the 4th toe;1.0068656615912914;0.88740504;0.49781457487089364;0.5359162551471452;0.9998944404568447;0.0069712211344467034;-0.11248940257690088;-0.5020798655859511;-0.4639781853096995
Dyslexia;Ankle joint effusion;1.1624735742807388;0.9588909;0.4480527745371098;0.5130891083268614;0.9998944404568447;0.1625791338238941;-0.04100352553985254;-0.5518416659197349;-0.48680533212998334
Dyslexia;Reduced C-peptide level;0.9279669523239136;0.83370185;0.522948706349821;0.5531814262947382;0.9999501780647019;-0.0719832257407883;-0.16624832908093723;-0.47700147171488083;-0.44676875176996367
Dyslexia;Loss of voice;0.7449028491973877;0.7803703;0.5821074548143728;0.5704849151283995;0.9999501780647019;-0.2550473288673142;-0.21957988301694187;-0.4178427232503291;-0.4294652629363024
Dyslexia;Elevated circulating growth hormone concentration;0.9827837198972702;0.888909;0.5054803829139382;0.5354345050625688;0.9179484122564726;0.06483530764079759;-0.02903942997955611;-0.41246802934253446;-0.38251390719390377
Dyslexia;Visual acuity no light perception;0.7687430381774902;0.7267405;0.5742838090869455;0.5881017764835312;0.9998944404568447;-0.2311514022793545;-0.2731539609875454;-0.4256106313698992;-0.4117926639733135
Dyslexia;Spinal hypomyelination;0.6178161799907684;0.5322359;0.6248278847544764;0.6549403095459784;0.8344817810370084;-0.21666560104624;-0.3022458606077787;-0.20965389628253206;-0.17954147149103006
Dyslexia;Bladder polyp;0.9385042451322079;0.87182724;0.519587065478485;0.5409111880161255;0.9999545338528789;-0.06145028872067104;-0.12812728909427296;-0.4803674683743939;-0.45904334583675344
Dyslexia;Aberrant melanosome maturation;0.7628630697727203;0.6819837;0.5762090058209959;0.6030166716250573;0.9999545338528789;-0.23709146408015858;-0.31797082451755176;-0.42374552803188303;-0.39693786222782157
Dyslexia;Vertebral artery tortuosity;0.8560138642787933;0.70366;0.5459920720441609;0.5957661464647319;0.9999545338528789;-0.14394066957408558;-0.296294522561375;-0.453962461808718;-0.404188387388147
Dyslexia;Warm reactive autoantibody positivity;1.1026362925767899;1.0476246;0.46727222074696206;0.4848349030726936;0.9998944404568447;0.10274185211994513;0.04773014755585059;-0.5326222197098827;-0.5150595373841511
Dyslexia;Right aortic arch with retroesophageal left subclavian artery;0.9096980541944504;0.86717623;0.5287832113544885;0.5424044308116024;0.9998944404568447;-0.09019638626239435;-0.13271820573470727;-0.47111122910235625;-0.45749000964524233
Dyslexia;Elevated urine suberic acid level;0.9568469785153866;0.88132966;0.5137403001022496;0.5378631771199334;0.9999545338528789;-0.04310755533749233;-0.11862487820560108;-0.48621423375062933;-0.46209135673294555
Dyslexia;Burkitt lymphoma;0.9120892584323883;0.84463537;0.5280190273848206;0.5496552368073081;0.9999511492611326;-0.0878618908287443;-0.15531578186763895;-0.47193212187631195;-0.4502959124538245
Dyslexia;Snail-like ilia;0.9577319547533989;0.8676174;0.5134583461212361;0.5422627385339268;0.9999545338528789;-0.04222257909948002;-0.13233710555011402;-0.4864961877316428;-0.4576917953189521
Dyslexia;Indurated nodule;0.9816856943070889;0.8840465;0.5058299504992583;0.5369923600205802;0.9998944404568447;-0.018208746149755872;-0.11584794549605981;-0.49406448995758645;-0.4629020804362646
Dyslexia;Absent leukocyte alkaline phosphatase;0.9964686557650566;0.88997906;0.5011240641177622;0.5350917959510362;0.9999545338528789;-0.003485878087822303;-0.10997546938830982;-0.4988304697351167;-0.46486273790184274
Dyslexia;Hippocampal sclerosis;0.7205682396888733;0.7003658;0.5901460740283007;0.5968646474629681;0.8344817810370084;-0.11391354134813514;-0.1341159992529508;-0.24433570700870777;-0.23761713357404035
Dyslexia;Decreased sensitivity to hypoxemia;0.8260104060173035;0.6998435;0.5556659116248766;0.5970388975601929;0.9999545338528789;-0.17394412783557545;-0.30011100796634327;-0.44428862222800236;-0.402915636292686
Dyslexia;Decreased level of tissue plasminogen activator;0.968752596527338;0.89118487;0.5099479767587903;0.5347056468751042;0.9998944404568447;-0.031141843929506696;-0.10870957402846948;-0.4899464636980544;-0.4651887935817405
Dyslexia;Submandibular lymph node enlargement;0.9330447763204575;0.89184254;0.5213284658429369;0.5344950658271573;0.9999545338528789;-0.06690975753242145;-0.10811198977405201;-0.478626068009942;-0.4654594680257216
Dyslexia;Hepatic hemangioma;0.9714313950389624;0.87263834;0.5090949068375134;0.540650882932496;0.9999524555142131;-0.028521060475250715;-0.1273141107495036;-0.49085754867669973;-0.4593015725817171
Dyslexia;Triangular epiphysis of the distal phalanx of the 2nd finger;0.852657675743103;0.69557554;0.5470718979112623;0.598464120466788;0.9998944404568447;-0.1472367647137417;-0.3043189051594509;-0.4528225425455824;-0.40143031999005674
Dyslexia;Acne inversa;0.958015151321888;0.8631501;0.5133681217601305;0.5436977999586292;0.9999476714516888;-0.041932520129800865;-0.1367975516701947;-0.48657954969155837;-0.4562498714930596
Dyslexia;Dentin dysplasia;0.7961151301860809;0.6171748;0.5653568232143837;0.6250488441751819;0.9998944404568447;-0.2037793102707638;-0.3827196362461819;-0.434537617242461;-0.3748455962816628
Dyslexia;Aplasia of the inner ear;0.7560253739356995;0.73009896;0.5784513634567101;0.5869909794591641;0.9999545338528789;-0.24392915991717945;-0.26985557106906544;-0.4215031703961688;-0.4129635543937148
Dyslexia;Polycystic liver disease;0.9427905008196831;0.76204884;0.5182202973548435;0.5764758103708216;0.9999501780647019;-0.0571596772450188;-0.23790133754193576;-0.48172988070985834;-0.42347436769388025
Dyslexia;Subungual hyperkeratosis;0.930047832429409;0.9165362;0.5222846660395025;0.5265982820418303;0.9999487417813083;-0.0699009093518993;-0.08341252981384006;-0.4776640757418058;-0.473350459739478
Dyslexia;Broad humeral epiphyses;1.0134860184043646;0.88589203;0.4957071368841659;0.5364009715843807;0.9998944404568447;0.013591577947519862;-0.11400240687987939;-0.5041873035726788;-0.463493468872464
Dyslexia;Autoimmune thrombocytopenia;0.9760687798261642;0.83340764;0.5076182712559825;0.5532763957932194;0.9999422754987515;-0.02387349567258723;-0.16653463504159816;-0.492324004242769;-0.44666587970553207
Dyslexia;Adenomyosis;0.9963320512324572;0.8575067;0.5011675469727345;0.5455119341299242;0.9999545338528789;-0.003622482620421752;-0.14244784144336353;-0.49878698688014445;-0.45444259972295475
Dyslexia;Elevated leukocyte alkaline phosphatase;1.0625793635845184;0.9640503;0.48006734546882246;0.5114456145930848;0.9999545338528789;0.06262482973163952;-0.03590424088412891;-0.5198871883840565;-0.4885089192597941
Dyslexia;Clasp-knife sign;0.9608922675251961;0.9516886;0.51245155318091;0.5153839967864753;0.801972397045473;0.1589198704797231;0.1497161906200849;-0.289520843864563;-0.2865884002589977
Dyslexia;Keratosis pilaris;0.9075945317745209;0.8570206;0.5294555950313791;0.5456682575235158;0.9999419656013786;-0.09234743382685773;-0.14292134907000653;-0.47048637056999953;-0.4542737080778628
Dyslexia;Lamina lucida cleavage;0.9399614296853542;0.8537111;0.519122370416401;0.546732900130761;0.9999476714516888;-0.0599862417663346;-0.14623654321682555;-0.48082530103528787;-0.4532147713209278
Dyslexia;Abnormal central response of multifocal electroretinogram;0.8098366260528564;0.74734664;0.560901770368408;0.5813032130275713;0.9998944404568447;-0.19005781440398828;-0.252547800823666;-0.4389926700884367;-0.41859122742927346
Dyslexia;Atypical or prolonged hepatitis;0.9507372602820396;0.8234133;0.5156871664227056;0.5565055979100932;0.9999545338528789;-0.04921727357083927;-0.17654122141772877;-0.4842673674301733;-0.44344893594278567
Dyslexia;Cubitus varus;0.9796253778040409;0.8757427;0.5064858924679587;0.5396548200828113;0.9998944404568447;-0.020269062652803815;-0.12415176658294336;-0.493408547988886;-0.46023962037403343
Dyslexia;Nasal regurgitation;0.9345029890537262;0.9000397;0.520863281024198;0.5318715981091025;0.9999524555142131;-0.06544946646048688;-0.09991278266265058;-0.4790891744900151;-0.46808085740511063
Dyslexia;Moon facies;0.9650768749415874;0.96406287;0.511118636837967;0.5114416075682913;0.9999524555142131;-0.03487558057262563;-0.03588958596541547;-0.4888338186762461;-0.4885108479459218
Dyslexia;Intestinal pseudo-obstruction;0.9091914892196655;0.75580937;0.5289451212128895;0.578522270047538;0.9999464332748575;-0.09075494405519202;-0.2441370665718241;-0.47100131206196805;-0.42142416322731957
Dyslexia;Bilateral renal atrophy;0.8996424376964569;0.7473899;0.5319986714957059;0.5812889770329305;0.9999545338528789;-0.100312096156422;-0.25256462124759327;-0.467955862357173;-0.41866555681994844
Dyslexia;Fractured left clavicle;1.0497787594795227;0.8874199;0.48414837761204177;0.5359115030900724;0.9998944404568447;0.04988431902267798;-0.1124745610203518;-0.515746062844803;-0.4639829373667723
Dyslexia;Positive urine norcotinine test;0.9447364285588264;0.91757363;0.5175999074354354;0.5262669218979821;0.9998944404568447;-0.05515801189801828;-0.08232080964706079;-0.48229453302140934;-0.47362751855886265
Dyslexia;Long fibula;1.1514114439487457;0.98006976;0.4516181630055983;0.5063444052982722;0.9999501780647019;0.15146126588404385;-0.019880421556828343;-0.5483320150591036;-0.4936057727664297
Dyslexia;Fragmentation of the epiphysis of the distal phalanx of the hallux;0.9666060656309128;0.75591135;0.5106315960522643;0.5784887996065661;0.9998944404568447;-0.03328837482593194;-0.24398309020660058;-0.48926284440458045;-0.42140564085027865
Dyslexia;Type II cryptotia;0.8756138607859612;0.7319436;0.5396961527086725;0.5863813629942627;0.9998944404568447;-0.12428057967088357;-0.26795083312652246;-0.4601982877481722;-0.41351307746258203
Dyslexia;Increased variability in muscle fiber diameter;1.0084250271320343;0.8293151;0.4973181988456774;0.5545980129132004;0.9999372395362296;0.008487787595804708;-0.17062211359399937;-0.5026190406905522;-0.44533922662302916
Dyslexia;Widened proximal tibial metaphyses;1.1344121545553207;0.99234116;0.4570853943405401;0.5024379021472212;0.9999545338528789;0.13445762070244183;-0.007613373078647956;-0.5428691395123388;-0.49751663170565774
Dyslexia;Wide anterior fontanel;0.8857647106051445;0.9752264;0.5364417760501232;0.5078864855349592;0.9999377423921926;-0.11417303178704807;-0.02471134010947773;-0.46349596634206935;-0.4920512568572334
Dyslexia;Increased circulating oleate level;1.0403170734643936;0.9626766;0.48716319769949545;0.5118831673631872;0.9998944404568447;0.04042263300754889;-0.03721785573623315;-0.5127312427573493;-0.48801127309365755
Dyslexia;Lozenge-shaped umbilicus;0.9313986822962761;0.88829494;0.5218536415941306;0.5356312008024604;0.9999524555142131;-0.06855377321793699;-0.11165752028777265;-0.47809881392008247;-0.4643212547117527
Dyslexia;Anti-myelin-associated glycoprotein antibody positivity;0.9077387452125549;0.8713701;0.5294094935296291;0.5410579379756445;0.9998944404568447;-0.09215569524428979;-0.128524363323666;-0.47048494692721565;-0.4588365024812002
Dyslexia;Fractured radius;0.95468370616436;0.7973;0.5144295658884924;0.564971629839721;0.9999545338528789;-0.045270827688518867;-0.20265455273563038;-0.4855249679643865;-0.43498290401315787
Dyslexia;Abnormal manual kinetic perimetry test;0.6860350668430328;0.6296307;0.6016574392540152;0.6207688650159904;0.9998944404568447;-0.3138593736138119;-0.3702637556042446;-0.39823700120282957;-0.37912557544085435
Dyslexia;Small radial epiphyses;0.8733431398868561;0.7482257;0.5404247080019113;0.5810140744981371;0.9998944404568447;-0.12655130056998865;-0.25166875152251855;-0.4594697324549334;-0.4188803659587076
Dyslexia;Generalized keratosis follicularis;0.9559717699885368;0.85684013;0.5140191526935997;0.5457262993582961;0.9999545338528789;-0.04398276386434208;-0.14311440018588673;-0.48593538115927926;-0.4542282344945828
Dyslexia;Hypoplasia of the calcaneus;1.0175272822380066;0.8542119;0.49442060709069435;0.5465717635431837;0.9999524555142131;0.017574826723793513;-0.14574052905394697;-0.5055318484235187;-0.45338069197102937
Dyslexia;2-hydroxyadipic aciduria;0.7947821021080017;0.6404396;0.565790304878284;0.6170733296029196;0.9998944404568447;-0.20511233834884302;-0.3594548109020962;-0.43410413557856076;-0.3828211108539251
Dyslexia;Potter facies;0.9394681267440319;0.9531681;0.5192796797365751;0.5149125107240263;0.9999481737645268;-0.06048004702049492;-0.04678007960635422;-0.48066849402795175;-0.4850356630405005
Dyslexia;Increased heart rate variability;1.0851234793663025;0.98353827;0.47287152527263543;0.5052401716507329;0.9999545338528789;0.08516894551342358;-0.016416263856235846;-0.5270830085802435;-0.49471436220214604
Dyslexia;Aplastic zygomatic arch;0.822069525718689;0.7988866;0.5569402162810972;0.5644559741529491;0.9999524555142131;-0.17788292979552411;-0.20106585835768842;-0.44301223923311583;-0.43549648136126395
Dyslexia;Testicular torsion;0.978814085945487;0.8182231;0.5067441904692956;0.558184852826036;0.9999545338528789;-0.02114044790739189;-0.18173141507083546;-0.49321034338358327;-0.4417696810268429
Dyslexia;Abolished vibration sense;0.8834137916564941;0.82490623;0.5371951310026151;0.5560228706812603;0.9108074905152194;-0.027393698858725224;-0.08590126054238001;-0.3736123595126043;-0.35478461983395904
Dyslexia;Fractured metatarsal bone of digit 5;0.9861666411161423;0.8299043;0.5044034353410409;0.5544076888675541;0.9998944404568447;-0.013727799340702451;-0.16999012260100976;-0.4954910051158038;-0.44548675158929063
Dyslexia;Prolonged G2 phase of cell cycle;0.9961786568164825;0.90042424;0.501216374274211;0.531748557828423;0.9999501780647019;-0.003771521248219334;-0.09952593604504856;-0.4987338037904909;-0.46820162023627887
Dyslexia;Single naris;0.8588800877332687;0.95413846;0.5450703106484935;0.5146033068561353;0.9999501780647019;-0.14107009033143314;-0.04581172028958591;-0.45487986741620834;-0.48534687120856657
Dyslexia;Perifoveal ring of hyperautofluorescence surrounded by normal autofluorescence;0.9024373590946198;0.8301229;0.5311046315999937;0.5543370834964436;0.9998944404568447;-0.09745708136222497;-0.1697715523686184;-0.46878980885685106;-0.4455573569604011
Dyslexia;Asymmetry of the thorax;0.9213794469833374;0.8262154;0.5250515526987584;0.5555996453316114;0.9999501780647019;-0.07857073108136448;-0.17373479167401584;-0.4748986253659435;-0.44435053273309044
Dyslexia;Type 2 muscle fiber predominance;1.0301163662225008;0.8619638;0.4904122131762094;0.5440790326031919;0.9999487417813083;0.030167624441192475;-0.13798493324477878;-0.5095365286050989;-0.4558697091781164
Dyslexia;Dependency on parenteral nutrition;0.9216715022921562;0.85480964;0.5249583010292842;0.54637945387715;0.9999524555142131;-0.07828095322205686;-0.14514281367613935;-0.4749941544849289;-0.45357300163706304
Dyslexia;Limited shoulder flexion;0.9727496467530727;0.80041766;0.5086751307321109;0.5639585354702641;0.9998944404568447;-0.027144793703771986;-0.1994767787899746;-0.4912193097247338;-0.43593590498658064
Dyslexia;Paroxysmal vertigo;0.7107394635677338;0.7194301;0.5934093922328278;0.5905234539614661;0.9999524555142131;-0.2892129919464793;-0.28052236651732587;-0.40654306328138523;-0.409429001552747
Dyslexia;Long hallux;1.0472358614206314;0.92718506;0.48495876138534333;0.5231982437905801;0.9999446427564167;0.04729121866421471;-0.0727595841626667;-0.5149858813710734;-0.4767463989658366
Dyslexia;Broad medial eyebrow;1.0244237389415503;1.002585;0.49222490930839347;0.49917713797223273;0.9999545338528789;0.024469205088671342;0.0026305195910297785;-0.5077296245444854;-0.5007773958806462
Dyslexia;Myxoid subcutaneous tumors;0.9835249595344067;0.8917795;0.5052444055192304;0.5345152503556323;0.9999545338528789;-0.01642957431847225;-0.10817505148822437;-0.49471012833364847;-0.4654392834972466
Dyslexia;Bulbous tips of toes;0.9502237066626549;0.89329964;0.5158508364161771;0.5340285582065998;0.9999524555142131;-0.0497287488515582;-0.10665281628920698;-0.48410161909803595;-0.4659238973076133
Dyslexia;Absent internal genitalia;0.8981779962778091;0.8344383;0.5324672179400265;0.5529436939785487;0.9998944404568447;-0.10171644417903558;-0.16545611648223535;-0.46742722251681823;-0.446950746478296
Dyslexia;Hyperphalangy of the 2nd finger;0.8688017725944519;0.7329522;0.5418824376225012;0.5860481684833039;0.9999545338528789;-0.131152761258427;-0.26700235632831226;-0.4580720962303777;-0.41390636536957504
Dyslexia;Renal interstitial hemosiderin;0.9943236550316215;0.8863369;0.5018068464239471;0.5362584316125631;0.9998944404568447;-0.005570785425223268;-0.11355751781127588;-0.4980875940328976;-0.4636360088442816
Dyslexia;Abnormality of depressor anguli oris muscle;0.828251451253891;0.687215;0.5549416608718898;0.6012619328409912;0.9998944404568447;-0.17164298920295373;-0.31267946986816064;-0.44495277958495494;-0.39863250761585356
Dyslexia;Paroxysmal dyspnea;0.8178950548171997;0.66449213;0.5582910609869813;0.6089079222443685;0.9998944404568447;-0.18199938563964502;-0.3354023101773037;-0.4416033794698634;-0.3909865182124762
Dyslexia;Phenylpyruvic acidemia;0.8747701346874237;0.79613334;0.539966835568587;0.5653509026898136;0.9999545338528789;-0.1251843991654552;-0.2038211944478191;-0.45998769828429187;-0.43460363116306533
Dyslexia;Lateral ventricle dilatation;0.8210789561271667;0.7307525;0.5572606665339959;0.5867749554697941;0.9050479411786477;-0.08396898505148098;-0.1742954134648721;-0.34778727464465187;-0.31827298570885365
Dyslexia;Neonatal unconjugated hyperbilirubinemia;0.8494080603122711;0.793014;0.5481179548751646;0.5663654608505275;0.9999545338528789;-0.1505464735406078;-0.2069405439274944;-0.45183657897771434;-0.4335890730023514
Dyslexia;High maternal circulating alpha-fetoprotein concentration;1.0456474609673023;1.0129658;0.48546491114006185;0.49587273424703526;0.9998944404568447;0.0457530205104576;0.013071357921145998;-0.5144295293167829;-0.5040217062098095
Dyslexia;Prominent nasolabial fold;0.8885851502418518;0.91494346;0.5355382326725588;0.5271070812569777;0.9999472202284223;-0.1113620699865705;-0.08500376357864203;-0.46440898755586346;-0.4728401389714446
Dyslexia;Abnormality of inferior alveolar nerve;0.8540816903114319;0.807089;0.5466136671033317;0.5617928748945447;0.8344817810370084;0.019599909274423455;-0.02739280989900794;-0.28786811393367673;-0.27268890614246377
Dyslexia;Unilateral conductive hearing impairment;0.6885064244270325;0.66915643;0.6008292408917937;0.6073332579113593;0.9999545338528789;-0.31144810942584644;-0.3307981017010845;-0.39912529296108523;-0.39262127594151963
Dyslexia;Macular hypopigmented whorls, streaks, and patches;0.8197504580020905;0.71600884;0.5576905291885825;0.5916586371745727;0.9999545338528789;-0.18020407585078846;-0.28394569186145435;-0.4422640046642964;-0.40829589667830624
Dyslexia;Delayed ossification of pubic rami;0.9895294094458222;0.8373596;0.5033329533898971;0.5520010412356948;0.9999524555142131;-0.01042304606839084;-0.16259284829451703;-0.49661950212431594;-0.44795141427851826
Dyslexia;Hyperphenylalaninemia;0.864260196685791;0.8322045;0.5433411183026569;0.5536648234850097;0.9999493977362748;-0.13568920105048377;-0.16774487703391272;-0.4566082794336179;-0.4462845742512651
Dyslexia;Ureteropelvic junction obstruction;0.9995381012558937;0.8576559;0.500147026941893;0.5454639706563091;0.9999448992541466;-0.00040679799825293905;-0.14228901641875846;-0.4997978723122537;-0.4544809285978375
Dyslexia;Cone-shaped epiphysis of the proximal phalanx of the 2nd toe;0.9482297003269196;0.7704484;0.5164863681582443;0.5737259710858609;0.9998944404568447;-0.05166474012992517;-0.2294460537876858;-0.4834080722986004;-0.42616846937098385
Dyslexia;Difficulty walking;0.8318497240543365;0.7628925;0.5537793865218146;0.5761993727770849;0.8790687609298627;-0.0472190368755262;-0.11617627626494575;-0.32528937440804817;-0.30286938815277786
Dyslexia;Bilobate gallbladder;0.9493064843118191;0.8223917;0.5161431664557113;0.5568360087803323;0.9999524555142131;-0.050645971202394;-0.17756076669051313;-0.48380928905850173;-0.44311644673388073
Dyslexia;Histidinuria;0.8504905998706818;0.74999607;0.5477694258750989;0.5804319165238356;0.9999511492611326;-0.14946054939045084;-0.24995508316768777;-0.4521817233860337;-0.41951923273729697
Dyslexia;Widened interpedicular distance;1.0449245758354664;0.91443485;0.48569524894145644;0.5272695847411792;0.9998944404568447;0.04503013537862166;-0.08545959024093286;-0.5141991915153883;-0.4726248557156655
Stippling of the epiphysis of the proximal phalanx of the 4th toe;Ankle joint effusion;0.6510120630264282;0.68800765;0.6134745850782802;0.6009963315644974;1.0;-0.3489879369735718;-0.311992347240448;-0.38652541492171977;-0.3990036684355026
Stippling of the epiphysis of the proximal phalanx of the 4th toe;Reduced C-peptide level;0.9014372080564499;0.79437006;0.5314245314182914;0.5659243216480925;0.9999056439461368;-0.0984684358896869;-0.20553558874746736;-0.4684811125278454;-0.4339813222980443
Stippling of the epiphysis of the proximal phalanx of the 4th toe;Loss of voice;1.075136013329029;0.9807772;0.4760609036379079;0.50611919178567;0.9999056439461368;0.07523036938289229;-0.019128439909424144;-0.5238447403082289;-0.4937864521604668
Stippling of the epiphysis of the proximal phalanx of the 4th toe;Elevated circulating growth hormone concentration;0.8648156523704529;0.7088513;0.5431626663896847;0.5940374492196958;0.9998962300503706;-0.13508057767991777;-0.2910449522221541;-0.45673356366068596;-0.40585878083067484
Stippling of the epiphysis of the proximal phalanx of the 4th toe;Visual acuity no light perception;0.9474323764443398;0.8712832;0.5167405103116973;0.5410858177761897;1.0;-0.05256762355566025;-0.1287168264389038;-0.4832594896883027;-0.4589141822238103
Stippling of the epiphysis of the proximal phalanx of the 4th toe;Spinal hypomyelination;0.9570271708071232;0.84285545;0.5136828898583723;0.5502288468377793;1.0;-0.042972829192876816;-0.15714454650878906;-0.4863171101416277;-0.4497711531622207
Stippling of the epiphysis of the proximal phalanx of the 4th toe;Bladder polyp;0.9549971967935562;0.87983596;0.5143296768134655;0.5383420490953599;0.9999201345566091;-0.044922937763052895;-0.12008417130740257;-0.4855904577431436;-0.46157808546124923
Stippling of the epiphysis of the proximal phalanx of the 4th toe;Aberrant melanosome maturation;0.8577396273612976;0.8090892;0.5454370302940932;0.5611441382993271;0.9999201345566091;-0.1421805071953115;-0.19083095074923606;-0.4544831042625159;-0.43877599625728203
Stippling of the epiphysis of the proximal phalanx of the 4th toe;Vertebral artery tortuosity;0.8916901871562004;0.8081713;0.5345438491200818;0.5614418155508041;0.9999201345566091;-0.1082299474004087;-0.19174886227877708;-0.4653762854365273;-0.43847831900580503
Stippling of the epiphysis of the proximal phalanx of the 4th toe;Warm reactive autoantibody positivity;0.9607802182435989;0.9143851;0.5124872469590614;0.5272854686713792;1.0;-0.03921978175640106;-0.08561491966247559;-0.48751275304093855;-0.47271453132862085
Stippling of the epiphysis of the proximal phalanx of the 4th toe;Right aortic arch with retroesophageal left subclavian artery;0.9451637417078018;0.81694543;0.5174636828641379;0.5585985074126791;1.0;-0.05483625829219818;-0.18305456638336182;-0.4825363171358621;-0.44140149258732087
Stippling of the epiphysis of the proximal phalanx of the 4th toe;Elevated urine suberic acid level;0.8918115645647049;0.78984094;0.5345049851182723;0.5673981836072391;0.9999201345566091;-0.10810856999190421;-0.2100791978958425;-0.46541514943833684;-0.43252195094936996
Stippling of the epiphysis of the proximal phalanx of the 4th toe;Burkitt lymphoma;1.0252995863556862;0.979361;0.4919460322081459;0.5065700614186179;0.9999090677057578;0.025390518649928362;-0.02054807002890846;-0.5079630354976119;-0.4933390062871399
Stippling of the epiphysis of the proximal phalanx of the 4th toe;Snail-like ilia;0.9467349536716938;0.9126675;0.5169628183444601;0.5278342573565147;0.683723727808895;0.2630112258627988;0.22894378508478175;-0.1667609094644349;-0.15588947045238033
Stippling of the epiphysis of the proximal phalanx of the 4th toe;Indurated nodule;0.8862241208553314;0.82892156;0.5362945815320903;0.5547251649184237;1.0;-0.11377587914466858;-0.17107844352722168;-0.4637054184679097;-0.4452748350815763
Stippling of the epiphysis of the proximal phalanx of the 4th toe;Absent leukocyte alkaline phosphatase;0.7531846761703491;0.72113323;0.5793841063337453;0.5899587961114758;0.9999201345566091;-0.24673545838626;-0.2787869024399099;-0.42053602822286384;-0.40996133844513327
Stippling of the epiphysis of the proximal phalanx of the 4th toe;Hippocampal sclerosis;0.9030423387885094;0.76955694;0.530911143249803;0.5740175442208542;1.0;-0.09695766121149063;-0.2304430603981018;-0.46908885675019696;-0.42598245577914584
Stippling of the epiphysis of the proximal phalanx of the 4th toe;Decreased sensitivity to hypoxemia;0.8775680363178253;0.8297075;0.5390693276909654;0.5544712644124745;0.9999201345566091;-0.12235209823878379;-0.1702126312378225;-0.4608508068656437;-0.4454488701441346
Stippling of the epiphysis of the proximal phalanx of the 4th toe;Decreased level of tissue plasminogen activator;0.8281653225421906;0.7887991;0.5549694902226026;0.5677374321732231;1.0;-0.17183467745780945;-0.21120089292526245;-0.44503050977739744;-0.43226256782677686
Stippling of the epiphysis of the proximal phalanx of the 4th toe;Submandibular lymph node enlargement;0.9944888651371002;0.8771639;0.501754257591259;0.539198950808128;0.9999201345566091;-0.005431269419508888;-0.12275624753268333;-0.4981658769653501;-0.46072118374848114
Stippling of the epiphysis of the proximal phalanx of the 4th toe;Hepatic hemangioma;1.0305571928620338;0.885784;0.49027182908358513;0.536435607478262;0.9999134918687169;0.030643700993316925;-0.11412952151272937;-0.5096416627851318;-0.4634778843904549
Stippling of the epiphysis of the proximal phalanx of the 4th toe;Triangular epiphysis of the distal phalanx of the 2nd finger;0.24421334266662598;0.3547272;0.7727452983378813;0.7232562861740223;1.0;-0.755786657333374;-0.6452727913856506;-0.2272547016621187;-0.27674371382597773
Stippling of the epiphysis of the proximal phalanx of the 4th toe;Acne inversa;0.9354358240962029;0.9583855;0.5205657205420549;0.5132501219749304;0.9998962300503706;-0.0644604059541678;-0.041510702916429;-0.4793305095083158;-0.4866461080754403
Stippling of the epiphysis of the proximal phalanx of the 4th toe;Dentin dysplasia;0.7900751382112503;0.75829124;0.5673219388415857;0.5777078483430418;1.0;-0.2099248617887497;-0.24170875549316406;-0.43267806115841434;-0.4222921516569582
Stippling of the epiphysis of the proximal phalanx of the 4th toe;Aplasia of the inner ear;0.9574660137295723;0.7043737;0.5135430739766005;0.5955283200117863;0.9999201345566091;-0.04245412082703681;-0.2955464172485647;-0.4863770605800086;-0.40439181454482276
Stippling of the epiphysis of the proximal phalanx of the 4th toe;Polycystic liver disease;1.0207318980246782;0.84438765;0.49340035907477153;0.5497350679632961;0.9999056439461368;0.02082625407854144;-0.15551799345632966;-0.5065052848713653;-0.4501705759828407
Stippling of the epiphysis of the proximal phalanx of the 4th toe;Subungual hyperkeratosis;0.6129008829593658;0.60396343;0.6265228776996796;0.6296146537633606;0.9999003561294039;-0.386999473170038;-0.39593692143320636;-0.37337747842972424;-0.3702857023660433
Stippling of the epiphysis of the proximal phalanx of the 4th toe;Broad humeral epiphyses;0.5400495529174805;0.556026;0.652132833277612;0.6464317522708298;1.0;-0.45995044708251953;-0.44397401809692383;-0.34786716672238804;-0.35356824772917017
Stippling of the epiphysis of the proximal phalanx of the 4th toe;Autoimmune thrombocytopenia;0.8891520947217941;0.7581269;0.5353566438256896;0.5777617703929411;0.9998726169824932;-0.11072052226069906;-0.241745702481303;-0.4645159731568036;-0.4221108465895521
Stippling of the epiphysis of the proximal phalanx of the 4th toe;Adenomyosis;1.0032569877803326;0.92400575;0.4989632667573958;0.5242130754221108;0.9999201345566091;0.003336853223723457;-0.07591438771517844;-0.5009568677992133;-0.4757070591344983
Stippling of the epiphysis of the proximal phalanx of the 4th toe;Elevated leukocyte alkaline phosphatase;0.7185689806938171;0.6523806;0.5908090610447194;0.6130098812829409;0.9999201345566091;-0.28135115386279197;-0.3475395488861379;-0.4091110735118897;-0.38691025327366824
Stippling of the epiphysis of the proximal phalanx of the 4th toe;Clasp-knife sign;0.830158531665802;0.82162297;0.5543255656769215;0.5570846613580176;1.0;-0.169841468334198;-0.17837703227996826;-0.4456744343230785;-0.4429153386419824
Stippling of the epiphysis of the proximal phalanx of the 4th toe;Keratosis pilaris;0.703734278678894;0.62303364;0.5957413949295558;0.6230327562407751;0.9998710980331391;-0.2961368193542451;-0.37683745526427925;-0.4041297031035833;-0.376838341792364
Stippling of the epiphysis of the proximal phalanx of the 4th toe;Lamina lucida cleavage;0.9994296096265316;0.93970656;0.500181560904704;0.5192036486881237;0.9998962300503706;-0.0004666204238390481;-0.06018966610078569;-0.49971466914566665;-0.4806925813622469
Stippling of the epiphysis of the proximal phalanx of the 4th toe;Abnormal central response of multifocal electroretinogram;0.9920154009014368;0.8631324;0.5025416038369348;0.5437034836013221;1.0;-0.007984599098563194;-0.13686758279800415;-0.4974583961630652;-0.45629651639867785
Stippling of the epiphysis of the proximal phalanx of the 4th toe;Atypical or prolonged hepatitis;1.0678624138236046;0.9190885;0.4783821082385006;0.5257831252092717;0.9999201345566091;0.06794227926699548;-0.08083165169985862;-0.5215380263181085;-0.4741370093473374
Stippling of the epiphysis of the proximal phalanx of the 4th toe;Cubitus varus;0.7951654493808746;0.84809387;0.5656656331850092;0.548541134437226;1.0;-0.20483455061912537;-0.15190613269805908;-0.4343343668149908;-0.45145886556277404
Stippling of the epiphysis of the proximal phalanx of the 4th toe;Nasal regurgitation;1.0036777257919312;0.9281139;0.4988293408827542;0.5229018145905264;0.9999134918687169;0.003764233923214233;-0.07179961409543201;-0.5010841509859627;-0.4770116772781905
Stippling of the epiphysis of the proximal phalanx of the 4th toe;Moon facies;0.9774887189269066;0.93206614;0.507166168655101;0.5216406808192597;0.9999134918687169;-0.022424772941810334;-0.0678473493096654;-0.4927473232136159;-0.4782728110494572
Stippling of the epiphysis of the proximal phalanx of the 4th toe;Intestinal pseudo-obstruction;0.9449177756905556;0.8168294;0.5175420947911783;0.5586360826770811;0.9998912449978579;-0.05497346930730229;-0.18306186162459737;-0.48234915020667957;-0.4412551623207768
Stippling of the epiphysis of the proximal phalanx of the 4th toe;Bilateral renal atrophy;0.8547680377960205;0.783517;0.5463928435192247;0.569458579317524;0.9999201345566091;-0.1451520967605886;-0.2164031314972219;-0.45352729103738443;-0.43046155523908514
Stippling of the epiphysis of the proximal phalanx of the 4th toe;Fractured left clavicle;0.6015831828117371;0.6101655;0.6304402406608194;0.627467796362546;1.0;-0.39841681718826294;-0.38983452320098877;-0.3695597593391806;-0.372532203637454
Stippling of the epiphysis of the proximal phalanx of the 4th toe;Positive urine norcotinine test;0.9246777147054672;0.85211235;0.5239985570657472;0.5472474022496847;1.0;-0.07532228529453278;-0.14788764715194702;-0.47600144293425284;-0.4527525977503153
Stippling of the epiphysis of the proximal phalanx of the 4th toe;Long fibula;0.5924992263317108;0.69700456;0.6335996316940462;0.5979866974900414;0.6109530888848884;-0.018453862553177602;0.08605146777099537;0.022646542809157788;-0.01296639139484701
Stippling of the epiphysis of the proximal phalanx of the 4th toe;Fragmentation of the epiphysis of the distal phalanx of the hallux;0.1793050765991211;0.34313333;0.8064134381618508;0.7281185707795121;1.0;-0.8206949234008789;-0.6568666696548462;-0.19358656183814915;-0.27188142922048786
Stippling of the epiphysis of the proximal phalanx of the 4th toe;Type II cryptotia;0.9751641284674406;0.9158508;0.5079063163792548;0.526817222264147;1.0;-0.024835871532559395;-0.08414918184280396;-0.49209368362074524;-0.47318277773585304
Stippling of the epiphysis of the proximal phalanx of the 4th toe;Increased variability in muscle fiber diameter;0.9108551442623138;0.8131254;0.5284134066000887;0.559835821285301;0.7712186293488323;0.1396365149134815;0.04190674258415106;-0.2428052227487436;-0.21138280806353138
Stippling of the epiphysis of the proximal phalanx of the 4th toe;Widened proximal tibial metaphyses;0.3660616874694824;0.42358738;0.7185626972063012;0.695547882475934;0.4693866352828394;-0.103324947813357;-0.04579925344308722;0.24917606192346176;0.2261612471930946
Stippling of the epiphysis of the proximal phalanx of the 4th toe;Wide anterior fontanel;1.0387500002980232;0.88659036;0.48766240288865614;0.5361772344557805;0.6617971500655027;0.37695285023252056;0.22479321152965115;-0.17413474717684652;-0.1256199156097222
Stippling of the epiphysis of the proximal phalanx of the 4th toe;Increased circulating oleate level;0.9435697197914124;0.8121376;0.517971862886751;0.5601558919953584;1.0;-0.056430280208587646;-0.18786239624023438;-0.482028137113249;-0.4398441080046416
Stippling of the epiphysis of the proximal phalanx of the 4th toe;Lozenge-shaped umbilicus;0.9180919229984283;0.89327985;0.5261013917526307;0.5340348909461707;0.9999134918687169;-0.08182156887028857;-0.10663364138577625;-0.4738121001160862;-0.4658786009225462
Stippling of the epiphysis of the proximal phalanx of the 4th toe;Anti-myelin-associated glycoprotein antibody positivity;0.9835310727357864;0.88120645;0.5052424593627556;0.537902661228487;1.0;-0.016468927264213562;-0.1187935471534729;-0.4947575406372444;-0.46209733877151304
Stippling of the epiphysis of the proximal phalanx of the 4th toe;Fractured radius;0.5256814360618591;0.5606664;0.6573055059149022;0.6447853947530318;0.4693866352828394;0.056294800779019716;0.09127974702993524;0.1879188706320628;0.17539875947019234
Stippling of the epiphysis of the proximal phalanx of the 4th toe;Abnormal manual kinetic perimetry test;0.8671801090240479;0.75197524;0.5424031865588363;0.5797814360371651;1.0;-0.13281989097595215;-0.24802476167678833;-0.45759681344116365;-0.42021856396283486
Stippling of the epiphysis of the proximal phalanx of the 4th toe;Small radial epiphyses;0.5131015181541443;0.5654132;0.66187183789473;0.643105587220763;1.0;-0.4868984818458557;-0.4345868229866028;-0.33812816210526997;-0.35689441277923695
Stippling of the epiphysis of the proximal phalanx of the 4th toe;Generalized keratosis follicularis;0.8320502191781998;0.79906017;0.553714646235585;0.5643995789913978;0.9999201345566091;-0.16786991537840934;-0.2008599686744985;-0.44620548832102414;-0.4355205555652113
Stippling of the epiphysis of the proximal phalanx of the 4th toe;Hypoplasia of the calcaneus;0.44603395462036133;0.56086797;0.6868862669422082;0.6447139702846172;0.5863259809806012;-0.14029202636023985;-0.02545801575919615;0.10056028596160704;0.05838798930401601
Stippling of the epiphysis of the proximal phalanx of the 4th toe;2-hydroxyadipic aciduria;0.9114543348550797;0.8494184;0.5282219210668389;0.5481146347295076;1.0;-0.08854566514492035;-0.15058159828186035;-0.47177807893316115;-0.4518853652704924
Stippling of the epiphysis of the proximal phalanx of the 4th toe;Potter facies;0.8999656438827515;0.8307191;0.5318952714331068;0.5541445051650924;0.9998981869165328;-0.0999325430337813;-0.1691790735666182;-0.468002915483426;-0.44575368175144037
Stippling of the epiphysis of the proximal phalanx of the 4th toe;Increased heart rate variability;0.9981184881180525;0.8912981;0.5005989041863586;0.5346693954764079;0.9999201345566091;-0.0018016464385566255;-0.10862201930316062;-0.49932123037025056;-0.4652507390802012
Stippling of the epiphysis of the proximal phalanx of the 4th toe;Aplastic zygomatic arch;0.8310859799385071;0.73602223;0.5540260216611784;0.5850345574615438;0.8072246192530101;0.023861360685496935;-0.07120238528999745;-0.2531985975918317;-0.2221900617914664
Stippling of the epiphysis of the proximal phalanx of the 4th toe;Testicular torsion;0.8659391105175018;0.802017;0.5428017733040258;0.5634391021020313;0.9999201345566091;-0.13398102403910728;-0.1979031610611257;-0.4571183612525833;-0.4364810324545778
Stippling of the epiphysis of the proximal phalanx of the 4th toe;Abolished vibration sense;0.8864201977849007;0.81633353;0.5362317610835912;0.5587966263751656;0.9999134918687169;-0.11349329408381625;-0.1835799595353429;-0.46368173078512576;-0.44111686549355134
Stippling of the epiphysis of the proximal phalanx of the 4th toe;Fractured metatarsal bone of digit 5;0.2286287546157837;0.40256834;0.7804288093170104;0.7038120801507421;1.0;-0.7713712453842163;-0.5974316596984863;-0.21957119068298958;-0.29618791984925785
Stippling of the epiphysis of the proximal phalanx of the 4th toe;Prolonged G2 phase of cell cycle;0.9497623592615128;0.9054003;0.5159978718167951;0.5301571313164055;0.9999056439461368;-0.050143284684624034;-0.09450536776205476;-0.48390777212934166;-0.4697485126297313
Stippling of the epiphysis of the proximal phalanx of the 4th toe;Single naris;0.9570926204323769;0.92429376;0.5136620373622691;0.52412113424245;0.9999056439461368;-0.04281302351375993;-0.07561188746115144;-0.48624360658386767;-0.4757845097036868
Stippling of the epiphysis of the proximal phalanx of the 4th toe;Perifoveal ring of hyperautofluorescence surrounded by normal autofluorescence;0.9397374242544174;0.88310045;0.5191938029015082;0.5372955550483764;1.0;-0.06026257574558258;-0.11689954996109009;-0.4808061970984918;-0.46270444495162355
Stippling of the epiphysis of the proximal phalanx of the 4th toe;Asymmetry of the thorax;0.9429761096835136;0.8357505;0.5181611196113078;0.5525202063445688;0.789736248610815;0.1532398610726986;0.04601427161852456;-0.2715751289995072;-0.23721604226624626
Stippling of the epiphysis of the proximal phalanx of the 4th toe;Type 2 muscle fiber predominance;0.960582610219717;0.9638515;0.512550196223821;0.511508923927553;0.8527273749847077;0.10785523523500928;0.11112413649371633;-0.3401771787608867;-0.34121845105715476
Stippling of the epiphysis of the proximal phalanx of the 4th toe;Dependency on parenteral nutrition;0.8835336416959763;0.7678962;0.5371567198785419;0.5745609231133125;0.9999134918687169;-0.11637985017274066;-0.23201731648419543;-0.46275677199017506;-0.4253525687554044
Stippling of the epiphysis of the proximal phalanx of the 4th toe;Limited shoulder flexion;0.7968825399875641;0.7745539;0.5651073283263544;0.5723839464859439;1.0;-0.2031174600124359;-0.22544610500335693;-0.43489267167364565;-0.42761605351405607
Stippling of the epiphysis of the proximal phalanx of the 4th toe;Paroxysmal vertigo;1.0626023188233376;0.87098825;0.4800600242344103;0.5411804938044833;0.9999134918687169;0.06268882695462064;-0.12892524208996936;-0.5198534676343066;-0.4587329980642336
Stippling of the epiphysis of the proximal phalanx of the 4th toe;Long hallux;0.4576873183250427;0.6194311;0.6824511795016885;0.6242718189830885;0.1431341874814257;0.314553130843617;0.4762968909525648;0.5393169920202628;0.4811376315016628
Stippling of the epiphysis of the proximal phalanx of the 4th toe;Broad medial eyebrow;0.8606295436620712;0.83712226;0.5445078828709233;0.5520776069126562;0.9999201345566091;-0.13929059089453788;-0.16279787303240867;-0.4554122516856858;-0.44784252764395294
Stippling of the epiphysis of the proximal phalanx of the 4th toe;Myxoid subcutaneous tumors;0.8907711654901505;0.86235046;0.5348381287689578;0.543954774981337;0.9999201345566091;-0.10914896906645866;-0.1375696706894216;-0.46508200578765135;-0.45596535957527207
Stippling of the epiphysis of the proximal phalanx of the 4th toe;Bulbous tips of toes;0.4372115135192871;0.5339549;0.6902714465044479;0.6543215495824615;0.36317310279071235;0.07403841072857476;0.17078181559383965;0.3270983437137356;0.2911484467917491
Stippling of the epiphysis of the proximal phalanx of the 4th toe;Absent internal genitalia;0.8520487546920776;0.83553195;0.5472678713435417;0.5525907530308876;1.0;-0.14795124530792236;-0.16446805000305176;-0.4527321286564583;-0.44740924696911244
Stippling of the epiphysis of the proximal phalanx of the 4th toe;Hyperphalangy of the 2nd finger;0.4064522981643677;0.4978894;0.702273167553676;0.6674429706615582;0.6245600766986774;-0.21810777853430974;-0.126670677170174;0.07771309085499856;0.04288289396288081
Stippling of the epiphysis of the proximal phalanx of the 4th toe;Renal interstitial hemosiderin;0.9527614414691925;0.86416644;0.5150420980909233;0.5433712462198557;1.0;-0.047238558530807495;-0.13583356142044067;-0.4849579019090767;-0.45662875378014434
Stippling of the epiphysis of the proximal phalanx of the 4th toe;Abnormality of depressor anguli oris muscle;0.9277746751904488;0.9256394;0.5230100698961375;0.5236915945924344;1.0;-0.07222532480955124;-0.07436060905456543;-0.4769899301038625;-0.4763084054075656
Stippling of the epiphysis of the proximal phalanx of the 4th toe;Paroxysmal dyspnea;0.9128781110048294;0.7715453;0.5277669606472462;0.5733672739710413;1.0;-0.0871218889951706;-0.22845470905303955;-0.47223303935275385;-0.42663272602895874
Stippling of the epiphysis of the proximal phalanx of the 4th toe;Phenylpyruvic acidemia;0.8607689738273621;0.7214232;0.5444630638912418;0.5898626751133506;0.9999201345566091;-0.13915116072924705;-0.2784969258430776;-0.45545707066536734;-0.41005745944325855
Stippling of the epiphysis of the proximal phalanx of the 4th toe;Lateral ventricle dilatation;0.9995267270132899;0.7993154;0.5001506474761575;0.5643166483679364;0.9998579617208769;-0.0003312347075870026;-0.2005425687498381;-0.4997073142447195;-0.43554131335294055
Stippling of the epiphysis of the proximal phalanx of the 4th toe;Neonatal unconjugated hyperbilirubinemia;0.9862975403666496;0.9006526;0.5043617648658634;0.5316755205557909;0.9999201345566091;-0.01362259418995948;-0.09926754714282127;-0.49555836969074574;-0.4682446140008182
Stippling of the epiphysis of the proximal phalanx of the 4th toe;High maternal circulating alpha-fetoprotein concentration;0.9138144478201866;0.76892626;0.5274677900382267;0.5742238534443853;1.0;-0.08618555217981339;-0.23107373714447021;-0.47253220996177325;-0.4257761465556147
Stippling of the epiphysis of the proximal phalanx of the 4th toe;Prominent nasolabial fold;0.8890495151281357;0.88195014;0.5353894985838037;0.5376642654960878;0.9998944404568447;-0.11084492532870904;-0.11794430045745508;-0.46450494187304103;-0.4622301749607569
Stippling of the epiphysis of the proximal phalanx of the 4th toe;Abnormality of inferior alveolar nerve;0.9286695122718811;0.8564835;0.5227244978035275;0.5458410025024452;1.0;-0.0713304877281189;-0.14351648092269897;-0.4772755021964725;-0.45415899749755484
Stippling of the epiphysis of the proximal phalanx of the 4th toe;Unilateral conductive hearing impairment;1.0309149026870728;0.8688267;0.4901579126878931;0.5418744378786027;0.9999201345566091;0.030994768130463646;-0.1310934472206411;-0.509762221868716;-0.45804569667800643
Stippling of the epiphysis of the proximal phalanx of the 4th toe;Macular hypopigmented whorls, streaks, and patches;0.9510362483561039;0.88355964;0.51559188057312;0.537148388704992;0.9999201345566091;-0.04888388620050521;-0.11636049033434959;-0.4843282539834891;-0.46277174585161707
Stippling of the epiphysis of the proximal phalanx of the 4th toe;Delayed ossification of pubic rami;0.6613641381263733;0.64279795;0.6099654732506989;0.6162692321976538;0.0;0.6613641381263733;0.6427979469299316;0.6099654732506989;0.6162692321976538
Stippling of the epiphysis of the proximal phalanx of the 4th toe;Hyperphenylalaninemia;0.9179804474115372;0.7410619;0.5261369953291675;0.5833725488179482;0.9999028053808913;-0.0819223579693541;-0.25884087949282975;-0.4737658100517238;-0.41653025656294307
Stippling of the epiphysis of the proximal phalanx of the 4th toe;Ureteropelvic junction obstruction;0.8527943044900894;0.72935975;0.5470279281724839;0.5872353846575604;0.9998847295244674;-0.14709042503437797;-0.2705249835451583;-0.4528568013519835;-0.41264934486690696
Stippling of the epiphysis of the proximal phalanx of the 4th toe;Cone-shaped epiphysis of the proximal phalanx of the 2nd toe;0.1269310712814331;0.31006724;0.8378736185850991;0.7423599264350165;1.0;-0.8730689287185669;-0.6899327635765076;-0.16212638141490088;-0.25764007356498353
Stippling of the epiphysis of the proximal phalanx of the 4th toe;Difficulty walking;0.8844980746507645;0.8231299;0.5368476453984541;0.556597241599087;0.7552776988623575;0.12922037578840695;0.06785219348688565;-0.21843005346390343;-0.19868045726327055
Stippling of the epiphysis of the proximal phalanx of the 4th toe;Bilobate gallbladder;1.0592808350920677;1.0005112;0.4811192545907611;0.49983729741636607;0.9999134918687169;0.0593673432233508;0.0005976775648768307;-0.5187942372779558;-0.5000761944523509
Stippling of the epiphysis of the proximal phalanx of the 4th toe;Histidinuria;0.8685139715671539;0.7995347;0.5419748480776332;0.5642453900566877;0.9999090677057578;-0.1313950961386039;-0.20037438924659035;-0.45793421962812464;-0.4356636776490701
Stippling of the epiphysis of the proximal phalanx of the 4th toe;Widened interpedicular distance;0.7264364361763;0.6970777;0.5882023901368887;0.5979622699215763;1.0;-0.27356356382369995;-0.3029223084449768;-0.4117976098631113;-0.4020377300784237
Ankle joint effusion;Reduced C-peptide level;1.0505648888647556;0.91638124;0.4838978293101096;0.5266477985092471;0.9999056439461368;0.05065924491861884;-0.08352440405508454;-0.5160078146360272;-0.47325784543688965
Ankle joint effusion;Loss of voice;1.0336722359061241;0.9282586;0.4892797679687003;0.5228556247564996;0.9999056439461368;0.033766591959987324;-0.07164704609533723;-0.5106258759774365;-0.4770500191896372
Ankle joint effusion;Elevated circulating growth hormone concentration;0.9346085786819458;0.7837963;0.5208295985942386;0.5693675164106595;0.9998962300503706;-0.06528765136842485;-0.21609991962556596;-0.47906663145613204;-0.4305287136397111
Ankle joint effusion;Visual acuity no light perception;1.0160151366144419;0.89497656;0.49490200574502996;0.53349176967177;1.0;0.01601513661444187;-0.10502344369888306;-0.50509799425497;-0.46650823032822997
Ankle joint effusion;Spinal hypomyelination;1.0321415401995182;0.88888526;0.48976726761185063;0.5354421080299849;1.0;0.032141540199518204;-0.1111147403717041;-0.5102327323881494;-0.46455789197001507
Ankle joint effusion;Bladder polyp;0.9661076255142689;0.84321934;0.5107903443367112;0.5501115692471346;0.9999201345566091;-0.03381250904234023;-0.1567007947090444;-0.4891297902198979;-0.44980856530947455
Ankle joint effusion;Aberrant melanosome maturation;1.0853851586580276;0.9924127;0.47278792579978;0.5024151466396629;0.9999201345566091;0.08546502410141854;-0.007507448208647682;-0.5271322087568291;-0.4975049879169462
Ankle joint effusion;Vertebral artery tortuosity;0.8509942293167114;0.7101854;0.5476072995590464;0.5935936555126113;0.9999201345566091;-0.14892590523989768;-0.289734725964385;-0.4523128349975627;-0.40632647904399777
Ankle joint effusion;Warm reactive autoantibody positivity;0.7455833554267883;0.69396263;0.5818834520051642;0.5990032513036341;1.0;-0.25441664457321167;-0.30603736639022827;-0.4181165479948358;-0.4009967486963659
Ankle joint effusion;Right aortic arch with retroesophageal left subclavian artery;0.9374134168028831;0.7555479;0.5199349571188562;0.578608090097628;1.0;-0.06258658319711685;-0.2444521188735962;-0.4800650428811438;-0.42139190990237196
Ankle joint effusion;Elevated urine suberic acid level;0.8859999477863312;0.78898185;0.5363664053508923;0.5676779204785738;0.9999201345566091;-0.11392018677027793;-0.2109382796409902;-0.4635537292057168;-0.4322422140780353
Ankle joint effusion;Burkitt lymphoma;0.9355796277523041;0.84496063;0.5205198509255324;0.5495504421872315;0.9999090677057578;-0.06432943995345375;-0.15494843776572487;-0.4793892167802254;-0.45035862551852635
Ankle joint effusion;Snail-like ilia;0.9493179619312286;0.87667733;0.5161395083136189;0.5393550166882659;0.822027235707794;0.12729072622343462;0.054650098600830255;-0.30588772739417514;-0.2826722190195281
Ankle joint effusion;Indurated nodule;0.6939247250556946;0.6063504;0.5990159261960633;0.6287876571534093;1.0;-0.3060752749443054;-0.3936495780944824;-0.40098407380393675;-0.37121234284659066
Ankle joint effusion;Absent leukocyte alkaline phosphatase;0.7487179040908813;0.6872387;0.580852183250029;0.6012539828177298;0.9999201345566091;-0.25120223046572776;-0.3126814413193044;-0.41906795130658014;-0.3986661517388793
Ankle joint effusion;Hippocampal sclerosis;1.0521479025483131;0.9088115;0.48339327453578307;0.5290665787756778;1.0;0.05214790254831314;-0.09118849039077759;-0.5166067254642169;-0.47093342122432225
Ankle joint effusion;Decreased sensitivity to hypoxemia;0.9501910395920277;0.8856759;0.5158612475819517;0.536470224707478;0.9999201345566091;-0.049729094964581444;-0.11424422742159934;-0.4840588869746574;-0.46344990984913115
Ankle joint effusion;Decreased level of tissue plasminogen activator;0.8970159441232681;0.82707226;0.5328390654562677;0.555322719189736;1.0;-0.10298405587673187;-0.17292773723602295;-0.4671609345437323;-0.44467728081026403
Ankle joint effusion;Submandibular lymph node enlargement;0.9685187004506588;0.7871511;0.5100224648393241;0.5682742090191674;0.9999201345566091;-0.03140143410595031;-0.21276903630526633;-0.489897669717285;-0.43164592553744174
Ankle joint effusion;Hepatic hemangioma;0.9553944990038872;0.7949558;0.5142030844659442;0.5657338218965133;0.9999134918687169;-0.04451899286482974;-0.20495770182583972;-0.4857104074027727;-0.4341796699722036
Ankle joint effusion;Triangular epiphysis of the distal phalanx of the 2nd finger;0.848529726266861;0.7898303;0.5484007815973626;0.5674016524589982;1.0;-0.15147027373313904;-0.21016967296600342;-0.4515992184026374;-0.4325983475410018
Ankle joint effusion;Acne inversa;0.8561708331108093;0.730847;0.5459415817658835;0.5867437211390549;0.9998962300503706;-0.14372539693956132;-0.269049228974626;-0.45395464828448717;-0.4131525089113157
Ankle joint effusion;Dentin dysplasia;1.0354542583227158;0.937121;0.4887121934219748;0.520028228244902;1.0;0.03545425832271576;-0.06287902593612671;-0.5112878065780252;-0.479971771755098
Ankle joint effusion;Aplasia of the inner ear;1.0298908837139606;0.8076175;0.490484018815616;0.5616214272677255;0.9999201345566091;0.02997074915735154;-0.19230264903338523;-0.5094361157409931;-0.43829870728888365
Ankle joint effusion;Polycystic liver disease;0.9625897333025932;0.7882359;0.5119108370954654;0.5679208397920562;0.9999056439461368;-0.03731591064354356;-0.2116697411598819;-0.4879948068506714;-0.4319848041540806
Ankle joint effusion;Subungual hyperkeratosis;0.9441531375050545;0.8652928;0.5177858619321181;0.543009397072046;0.9999003561294039;-0.05574721862434939;-0.13460756857752398;-0.4821144941972858;-0.4568909590573579
Ankle joint effusion;Broad humeral epiphyses;0.7856423109769821;0.7856034;0.5687658170548107;0.5687784962960366;1.0;-0.21435768902301788;-0.21439659595489502;-0.43123418294518934;-0.4312215037039634
Ankle joint effusion;Autoimmune thrombocytopenia;0.8391561359167099;0.67151725;0.5514215582867731;0.6065372893004939;0.9998726169824932;-0.1607164810657833;-0.3283553640604351;-0.4484510586957201;-0.3933353276819993
Ankle joint effusion;Adenomyosis;0.9985043681226671;0.7699508;0.5004760745901364;0.5738887108635014;0.9999201345566091;-0.001415766433942034;-0.22996932746203513;-0.4994440599664727;-0.42603142369310776
Ankle joint effusion;Elevated leukocyte alkaline phosphatase;0.7318428158760071;0.63581526;0.586414655281684;0.6186523360396736;0.9999201345566091;-0.26807731868060203;-0.3641048717621145;-0.4135054792749251;-0.3812677985169355
Ankle joint effusion;Clasp-knife sign;0.961921464651823;0.92912775;0.5121237053019165;0.5225782604620265;1.0;-0.038078535348176956;-0.0708722472190857;-0.48787629469808347;-0.4774217395379735
Ankle joint effusion;Keratosis pilaris;1.0013957880437374;0.90523255;0.49955570672239724;0.5302107591846459;0.9998710980331391;0.0015246900105982952;-0.09463854931945503;-0.5003153913107419;-0.46966033884849323
Ankle joint effusion;Lamina lucida cleavage;1.027133196592331;0.8954552;0.4913621751837106;0.5333385751686892;0.9998962300503706;0.027236966541960284;-0.10444104845170732;-0.50853405486666;-0.46655765488168144
Ankle joint effusion;Abnormal central response of multifocal electroretinogram;1.0492658652365208;0.8571041;0.48431183748435824;0.5456414105171896;1.0;0.04926586523652077;-0.1428958773612976;-0.5156881625156418;-0.4543585894828104
Ankle joint effusion;Atypical or prolonged hepatitis;0.9751584753394127;0.81956685;0.507908116381145;0.5577499538020634;0.9999201345566091;-0.02476165921719642;-0.18035328866274924;-0.49201201817546414;-0.4421701807545457
Ankle joint effusion;Cubitus varus;0.7807328104972839;0.8167286;0.5703666398084527;0.5586687035787029;1.0;-0.21926718950271606;-0.1832714080810547;-0.4296333601915473;-0.4413312964212971
Ankle joint effusion;Nasal regurgitation;0.8631411790847778;0.7724062;0.5437006681135514;0.5730858362159408;0.9999134918687169;-0.1367723127839391;-0.22750727143262073;-0.4562128237551655;-0.42682765565277614
Ankle joint effusion;Moon facies;1.0060440115630627;0.9738388;0.49807611965389764;0.5083283102907787;0.9999134918687169;0.0061305196943457485;-0.02607468571637317;-0.5018373722148193;-0.4915851815779382
Ankle joint effusion;Intestinal pseudo-obstruction;0.9079080671072006;0.79573536;0.5293553662591877;0.5654803067502059;0.9998912449978579;-0.09198317789065724;-0.20415588580596333;-0.4705358787386702;-0.434410938247652
Ankle joint effusion;Bilateral renal atrophy;0.7860763967037201;0.63047296;0.5686243619174527;0.6204802871986141;0.9999201345566091;-0.21384373785288902;-0.36944717646868797;-0.4312957726391564;-0.37943984735799496
Ankle joint effusion;Fractured left clavicle;0.8459499627351761;0.81062603;0.5492316983099608;0.5606458544849926;1.0;-0.1540500372648239;-0.18937397003173828;-0.45076830169003923;-0.4393541455150074
Ankle joint effusion;Positive urine norcotinine test;1.0205809902399778;0.90761214;0.4934484047659595;0.529449964498587;1.0;0.020580990239977837;-0.092387855052948;-0.5065515952340405;-0.47055003550141306
Ankle joint effusion;Long fibula;0.7348102927207947;0.7307553;0.5854345863137033;0.5867740295580428;0.6164553286055281;0.11835496411526658;0.11430000052655198;-0.031020742291824832;-0.029681299047485288
Ankle joint effusion;Fragmentation of the epiphysis of the distal phalanx of the hallux;0.6434949636459351;0.6812477;0.6160317378181042;0.6032637976440258;1.0;-0.35650503635406494;-0.3187522888183594;-0.38396826218189584;-0.3967362023559742
Ankle joint effusion;Type II cryptotia;0.9848693758249283;0.9215839;0.5048164110457884;0.5249862793969787;1.0;-0.015130624175071716;-0.07841610908508301;-0.49518358895421155;-0.47501372060302127
Ankle joint effusion;Increased variability in muscle fiber diameter;0.8871834427118301;0.81454384;0.5359872410014279;0.5593762693547998;0.7712186293488323;0.1159648133629978;0.043325213920515804;-0.23523138834740442;-0.21184235999403256
Ankle joint effusion;Widened proximal tibial metaphyses;0.615215539932251;0.6900581;0.6257242218569801;0.6003096023291121;0.7527521012230838;-0.1375365612908328;-0.06269398907861357;-0.1270278793661037;-0.15244249889397166
Ankle joint effusion;Wide anterior fontanel;0.9587123207747936;0.80797786;0.5131460132215989;0.5615045435177104;0.6617971500655027;0.29691517070929097;0.14618070514003323;-0.14865113684390374;-0.10029260654779226
Ankle joint effusion;Increased circulating oleate level;0.8010918498039246;0.6366066;0.5637395438596949;0.6183819053087025;1.0;-0.19890815019607544;-0.3633934259414673;-0.43626045614030506;-0.3816180946912975
Ankle joint effusion;Lozenge-shaped umbilicus;1.0228718128055334;0.89788115;0.4927190409726092;0.532562211614735;0.9999134918687169;0.02295832093681649;-0.10203234162305042;-0.5071944508961077;-0.46735128025398187
Ankle joint effusion;Anti-myelin-associated glycoprotein antibody positivity;0.913349486887455;0.795071;0.5276163474598191;0.565696337353138;1.0;-0.08665051311254501;-0.20492899417877197;-0.4723836525401809;-0.43430366264686204
Ankle joint effusion;Fractured radius;0.841180682182312;0.7844465;0.5507687325394641;0.5691555638797655;0.7527521012230838;0.08842858095922823;0.03169437666693087;-0.20198336868361966;-0.18359653734331827
Ankle joint effusion;Abnormal manual kinetic perimetry test;1.0443642288446426;0.8803503;0.48587379094748673;0.5381771410948756;1.0;0.04436422884464264;-0.11964970827102661;-0.5141262090525133;-0.4618228589051244
Ankle joint effusion;Small radial epiphyses;0.9090869203209877;0.90798485;0.5289785447802837;0.5293308108698866;1.0;-0.0909130796790123;-0.09201514720916748;-0.4710214552197163;-0.47066918913011335
Ankle joint effusion;Generalized keratosis follicularis;0.9397074058651924;0.8117351;0.5192033754577934;0.5602863522707929;0.9999201345566091;-0.060212728691416695;-0.1881850409630117;-0.4807167590988157;-0.4396337822858162
Ankle joint effusion;Hypoplasia of the calcaneus;0.6452087461948395;0.71466196;0.6154480630799574;0.592105867583262;0.6483560786248226;-0.0031473324299831074;0.06630587720861247;-0.03290801554486522;-0.05625021104156058
Ankle joint effusion;2-hydroxyadipic aciduria;0.9151353389024734;0.7717474;0.5270457911192674;0.5733012059813092;1.0;-0.08486466109752655;-0.2282525897026062;-0.4729542088807326;-0.4266987940186908
Ankle joint effusion;Potter facies;1.032518733292818;1.0222584;0.48964714052344127;0.4929143475525941;0.9998981869165328;0.03262054637628531;0.022360214000520462;-0.5102510463930915;-0.5069838393639386
Ankle joint effusion;Increased heart rate variability;0.9507303982973099;0.7695795;0.5156893533158613;0.5740101595602545;0.9999201345566091;-0.04918973625929923;-0.23034060479434104;-0.4842307812407478;-0.42590997499635463
Ankle joint effusion;Aplastic zygomatic arch;0.9967402219772339;0.846634;0.5010376214090706;0.549011353283783;0.8072246192530101;0.18951560272422374;0.03940935148444713;-0.30618699784393955;-0.2582132659692271
Ankle joint effusion;Testicular torsion;0.9253998547792435;0.8145623;0.5237680441764235;0.5593702791555368;0.9999201345566091;-0.07452027977736564;-0.1853578138473806;-0.4761520903801856;-0.4405498554010723
Ankle joint effusion;Abolished vibration sense;0.8856653422117233;0.83507407;0.536473614598045;0.5527385195493446;0.9999134918687169;-0.11424814965699359;-0.16483942475293323;-0.46343987727067193;-0.4471749723193723
Ankle joint effusion;Fractured metatarsal bone of digit 5;0.7776400744915009;0.89374554;0.5713760038341853;0.533885804427396;1.0;-0.22235992550849915;-0.1062544584274292;-0.4286239961658147;-0.46611419557260403
Ankle joint effusion;Prolonged G2 phase of cell cycle;0.9914556294679642;0.87669516;0.5027197907058771;0.5393493025968148;0.9999056439461368;-0.008450014478172618;-0.12321048784872468;-0.49718585324025966;-0.460556341349322
Ankle joint effusion;Single naris;1.0414895825088024;0.98449826;0.486789663850264;0.5049345527889761;0.9999056439461368;0.04158393856266562;-0.015407381540741283;-0.5131159800958728;-0.49497109115716065
Ankle joint effusion;Perifoveal ring of hyperautofluorescence surrounded by normal autofluorescence;0.9575159624218941;0.7823554;0.5135271604295117;0.5698373511437729;1.0;-0.042484037578105927;-0.2176445722579956;-0.48647283957048826;-0.4301626488562271
Ankle joint effusion;Asymmetry of the thorax;0.8604153394699097;0.75400996;0.5445767392380845;0.5791130523998754;0.789736248610815;0.07067909085909463;-0.03572628652890586;-0.24515950937273057;-0.2106231962109396
Ankle joint effusion;Type 2 muscle fiber predominance;0.8395868837833405;0.82143426;0.5512826431596818;0.5571457188350801;0.8527273749847077;-0.013140491201367288;-0.03129311557003489;-0.30144473182502596;-0.2955816561496276
Ankle joint effusion;Dependency on parenteral nutrition;0.938239861279726;0.8690138;0.519671381741792;0.5418143640963995;0.9999134918687169;-0.06167363058899089;-0.13089970555279895;-0.48024211012692497;-0.4580991277723174
Ankle joint effusion;Limited shoulder flexion;0.7200232744216919;0.6956818;0.5903267534638923;0.5984285971111252;1.0;-0.2799767255783081;-0.3043181896209717;-0.4096732465361077;-0.40157140288887483
Ankle joint effusion;Paroxysmal vertigo;0.9809518344700336;0.7876883;0.5060635861173522;0.5680992125967548;0.9999134918687169;-0.018961657398683274;-0.21222517695401355;-0.49384990575136467;-0.43181427927196214
Ankle joint effusion;Long hallux;0.5885413289070129;0.63698924;0.6349805512646203;0.6182511929426149;0.5268546983069159;0.06168663060009705;0.11013453757107483;0.10812585295770438;0.09139649463569899
Ankle joint effusion;Broad medial eyebrow;1.0211303941905499;0.93830085;0.49327348600932086;0.5196519414754661;0.9999201345566091;0.021210259633940742;-0.06161928654940696;-0.5066466485472882;-0.480268193081143
Ankle joint effusion;Myxoid subcutaneous tumors;0.98522446770221;0.9562253;0.5047033691516696;0.5139383837252656;0.9999201345566091;-0.014695666854399159;-0.04369485856326194;-0.49521676540493953;-0.48598175083134354
Ankle joint effusion;Bulbous tips of toes;0.7126825153827667;0.7251621;0.5927634761219851;0.5886241942248377;0.6483560786248226;0.06432643675794414;0.07680601024617961;-0.055592602502837485;-0.05973188439998489
Ankle joint effusion;Absent internal genitalia;0.9565721489489079;0.85183626;0.5138278631583226;0.5473362629498032;1.0;-0.04342785105109215;-0.14816373586654663;-0.48617213684167737;-0.4526637370501968
Ankle joint effusion;Hyperphalangy of the 2nd finger;0.7957448065280914;0.7541535;0.5654772348028789;0.5790659185701744;0.7527521012230838;0.04299270530500765;0.0014013888434445398;-0.18727486642020486;-0.17368618265290936
Ankle joint effusion;Renal interstitial hemosiderin;0.8082320690155029;0.6803567;0.561422092432603;0.6035630871464093;1.0;-0.19176793098449707;-0.3196433186531067;-0.438577907567397;-0.39643691285359073
Ankle joint effusion;Abnormality of depressor anguli oris muscle;0.8806046172976494;0.7846477;0.5380956094057234;0.5690899811082005;1.0;-0.11939538270235062;-0.21535229682922363;-0.46190439059427657;-0.4309100188917995
Ankle joint effusion;Paroxysmal dyspnea;0.8358050882816315;0.7077279;0.5525026025369273;0.5944112881145397;1.0;-0.16419491171836853;-0.29227209091186523;-0.4474973974630727;-0.4055887118854603
Ankle joint effusion;Phenylpyruvic acidemia;0.9546065852046013;0.8011344;0.5144541395402056;0.5637257211745257;0.9999201345566091;-0.04531354935200782;-0.19878572703631492;-0.48546599501640353;-0.4361944133820834
Ankle joint effusion;Lateral ventricle dilatation;1.0140751143917441;0.7545553;0.4955196039972892;0.5789339806600733;0.9998579617208769;0.014217152670867206;-0.2453026767439177;-0.5043383577235877;-0.42092398106080364
Ankle joint effusion;Neonatal unconjugated hyperbilirubinemia;0.9452738873660564;0.80709505;0.5174285696856467;0.561790892960957;0.9999201345566091;-0.054646247190552666;-0.19282508374484153;-0.48249156487096245;-0.43812924159565214
Ankle joint effusion;High maternal circulating alpha-fetoprotein concentration;0.9696954041719437;0.8012291;0.5096477295284932;0.5636949593613185;1.0;-0.030304595828056335;-0.19877088069915771;-0.49035227047150676;-0.4363050406386815
Ankle joint effusion;Prominent nasolabial fold;0.91059610247612;0.796901;0.5284961927209014;0.5651013409481355;0.9998944404568447;-0.08929833798072473;-0.20299345283172265;-0.4713982477359433;-0.43479309950870926
Ankle joint effusion;Abnormality of inferior alveolar nerve;0.9953362131491303;0.7821118;0.5014845348433823;0.5699168043090708;1.0;-0.004663786850869656;-0.21788817644119263;-0.4985154651566177;-0.43008319569092923
Ankle joint effusion;Unilateral conductive hearing impairment;1.015507847070694;0.81548446;0.49506350108465136;0.5590716022170189;0.9999201345566091;0.015587712514084862;-0.18443567038806052;-0.5048566334719577;-0.4408485323395902
Ankle joint effusion;Macular hypopigmented whorls, streaks, and patches;1.0674854069948196;0.93946147;0.47850238898442166;0.5192818050245714;0.9999201345566091;0.06756527243821053;-0.06045866490634055;-0.5214177455721875;-0.48063832953203767
Ankle joint effusion;Delayed ossification of pubic rami;0.8357761353254318;0.7678772;0.5525119453734078;0.5745671258516261;0.8072246192530101;0.02855151607242168;-0.039347398145527235;-0.2547126738796024;-0.23265749340138409
Ankle joint effusion;Hyperphenylalaninemia;0.9806206375360489;0.7494664;0.5061690288410705;0.5806060499130146;0.9999028053808913;-0.01928216784484238;-0.25043638616092057;-0.49373377653982076;-0.4192967554678767
Ankle joint effusion;Ureteropelvic junction obstruction;0.8594120144844055;0.7074927;0.5448992880736538;0.594489565887294;0.9998847295244674;-0.14047271504006187;-0.2923920203646163;-0.45498544145081354;-0.40539516363717343
Ankle joint effusion;Cone-shaped epiphysis of the proximal phalanx of the 2nd toe;0.6756495833396912;0.71834797;0.6051456935095799;0.590882377723053;1.0;-0.32435041666030884;-0.28165203332901;-0.3948543064904201;-0.40911762227694703
Ankle joint effusion;Difficulty walking;0.8394113183021545;0.76875347;0.5513392614043384;0.5742803914749419;0.7552776988623575;0.08413361943979702;0.013475770127968412;-0.2039384374580191;-0.1809973073874156
Ankle joint effusion;Bilobate gallbladder;0.9909967100247741;0.85587484;0.5028658749257857;0.5460367876370107;0.9999134918687169;-0.008916781843942845;-0.14403865542386218;-0.4970476169429312;-0.45387670423170623
Ankle joint effusion;Histidinuria;0.927544042468071;0.8534098;0.5230836754195944;0.5468298573492313;0.9999090677057578;-0.07236502523768684;-0.14649924095023414;-0.4768253922861634;-0.45307921035652654
Ankle joint effusion;Widened interpedicular distance;0.6501762866973877;0.64227784;0.6137585167497058;0.6164465009601603;1.0;-0.3498237133026123;-0.3577221632003784;-0.38624148325029417;-0.3835534990398397
Reduced C-peptide level;Loss of voice;0.8999210149049759;0.743098;0.5319095489261182;0.5827017535952111;0.9999528219730685;-0.10003180706809256;-0.2568548014194796;-0.46804327304695026;-0.4172510683778573
Reduced C-peptide level;Elevated circulating growth hormone concentration;0.7607372105121613;0.79172146;0.5769057427654227;0.5667860557064041;0.9999505803237132;-0.23921336981155195;-0.20822911712028302;-0.4230448375582905;-0.43316452461730914
Reduced C-peptide level;Visual acuity no light perception;0.9900647029280663;0.8549589;0.5031625553109977;0.5463314522339939;0.9999056439461368;-0.009840941018070537;-0.14494675207754548;-0.49674308863513905;-0.45357419171214286
Reduced C-peptide level;Spinal hypomyelination;0.6926435828208923;0.60568696;0.5994443773364944;0.6290174269520654;0.9999056439461368;-0.30726206112524446;-0.3942186813416141;-0.40046126660964243;-0.3708882169940714
Reduced C-peptide level;Bladder polyp;0.8531250208616257;0.759817;0.5469215010716382;0.5772074509456813;0.9999567459343585;-0.1468317250727328;-0.24013974173056207;-0.4530352448627203;-0.4227492949886772
Reduced C-peptide level;Aberrant melanosome maturation;0.8573117554187775;0.80543697;0.5455746298867342;0.5623288693722799;0.9999567459343585;-0.142644990515581;-0.1945197771309527;-0.45438211604762424;-0.4376278765620786
Reduced C-peptide level;Vertebral artery tortuosity;0.8680268228054047;0.81431156;0.5421312755038561;0.5594515130902701;0.9999567459343585;-0.1319299231289538;-0.1856451819657;-0.45782547043050237;-0.4405052328440884
Reduced C-peptide level;Warm reactive autoantibody positivity;0.9579252153635025;0.94257736;0.5133967745836892;0.5182882603695209;0.9999056439461368;-0.04198042858263429;-0.057328281885589916;-0.48650886936244764;-0.4816173835766159
Reduced C-peptide level;Right aortic arch with retroesophageal left subclavian artery;0.9892725124955177;0.8935245;0.5034147308226867;0.5339565734387062;0.9999056439461368;-0.01063313145061906;-0.10638111639639314;-0.49649091312345006;-0.4659490705074306
Reduced C-peptide level;Elevated urine suberic acid level;0.8935213461518288;0.82457864;0.5339575823582897;0.5561287841671007;0.851762385589393;0.041758960562435776;-0.02718374274423918;-0.31780480323110327;-0.29563360142229234
Reduced C-peptide level;Burkitt lymphoma;0.9588623978197575;0.90496814;0.5130982015936079;0.5302952871805618;0.9999536937290383;-0.041091295909280845;-0.09498555121957786;-0.48685549213543045;-0.46965840654847646
Reduced C-peptide level;Snail-like ilia;0.8997340202331543;0.92249405;0.5319693720842014;0.5246956858236563;0.9999567459343585;-0.10022272570120416;-0.07746269209372125;-0.4679873738501571;-0.4752610601107021
Reduced C-peptide level;Indurated nodule;0.9680384248495102;0.86446834;0.5101754182867781;0.5432742570740761;0.9999056439461368;-0.0318672190966266;-0.1354373078407901;-0.48973022565935864;-0.45663138687206073
Reduced C-peptide level;Absent leukocyte alkaline phosphatase;0.8722770661115646;0.7593302;0.5407668284114686;0.5773670838297611;0.851762385589393;0.020514680522171647;-0.09243217251947722;-0.3109955571779244;-0.2743953017596319
Reduced C-peptide level;Hippocampal sclerosis;0.802869588136673;0.7362899;0.5631622403952676;0.5849462206712469;0.9999056439461368;-0.19703605580946382;-0.2636157255234378;-0.43674340355086916;-0.4149594232748899
Reduced C-peptide level;Decreased sensitivity to hypoxemia;0.7720596343278885;0.5771496;0.573199126271132;0.6389704140586088;0.9999567459343585;-0.22789711160646997;-0.42280711634146295;-0.42675761966322645;-0.3609863318757497
Reduced C-peptide level;Decreased level of tissue plasminogen activator;0.5974910855293274;0.44751406;0.6318617600969116;0.6863207042019687;0.9999056439461368;-0.4024145584168094;-0.552391586786713;-0.36804388384922515;-0.3135849397441681
Reduced C-peptide level;Submandibular lymph node enlargement;1.0017123278230429;0.93632704;0.4994549488591833;0.5202814574487313;0.9999567459343585;0.00175558188868441;-0.06362970573889337;-0.5005017970751752;-0.4796752884856271
Reduced C-peptide level;Hepatic hemangioma;0.9077746123075485;0.8519695;0.529398027794497;0.5472933908434219;0.9999548690865008;-0.09218025677895225;-0.1479853885719744;-0.4705568412920038;-0.4526614782430789
Reduced C-peptide level;Triangular epiphysis of the distal phalanx of the 2nd finger;0.8703826069831848;0.77396846;0.5413749082744916;0.572575253842362;0.9999056439461368;-0.12952303696295198;-0.2259371857704776;-0.45853073567164515;-0.4273303901037748
Reduced C-peptide level;Acne inversa;1.0347740054130554;0.89356977;0.48892885826774224;0.5339420884442272;0.9999505803237132;0.03482342508934222;-0.10638081284858503;-0.511021722055971;-0.466008491879486
Reduced C-peptide level;Dentin dysplasia;0.9230629950761795;0.7973591;0.5245140342965775;0.564952414848445;0.9999056439461368;-0.07684264886995729;-0.20254653502127107;-0.4753916096495593;-0.43495322909769174
Reduced C-peptide level;Aplasia of the inner ear;0.8878081664443016;0.7638627;0.5357871147059673;0.5758814928944074;0.9999567459343585;-0.11214857949005685;-0.23609401686178766;-0.46416963122839117;-0.4240752530399511
Reduced C-peptide level;Polycystic liver disease;0.8777878135442734;0.74322885;0.5389988411049271;0.582658662931256;0.9999528219730685;-0.12216500842879507;-0.2567239692241976;-0.4609539808681413;-0.41729415904181244
Reduced C-peptide level;Subungual hyperkeratosis;1.0385961383581161;0.9294129;0.4877114153306572;0.5224872693229634;0.9999515360511232;0.03864460230699296;-0.07053863464960342;-0.512240120720466;-0.4774642667281598
Reduced C-peptide level;Broad humeral epiphyses;0.9887789823114872;0.8908192;0.5035718358216826;0.5348227590416443;0.9999056439461368;-0.011126661634649593;-0.10908645201345857;-0.49633380812445416;-0.46508288490449246
Reduced C-peptide level;Autoimmune thrombocytopenia;0.832913726568222;0.75277984;0.5534358435295573;0.5795170804921896;0.9999457950338347;-0.1670320684656127;-0.24716595361080007;-0.4465099515042774;-0.4204287145416451
Reduced C-peptide level;Adenomyosis;0.9029257223010063;0.85653025;0.5309484393629831;0.5458259723257224;0.9999567459343585;-0.09703102363335214;-0.14342649681555353;-0.4690083065713754;-0.4541307736086361
Reduced C-peptide level;Elevated leukocyte alkaline phosphatase;0.8811309412121773;0.84798086;0.5379268736293706;0.5485775390476246;0.851762385589393;0.029368555622784287;-0.0037815286939462123;-0.31383551196002235;-0.30318484654176836
Reduced C-peptide level;Clasp-knife sign;0.787916362285614;0.717859;0.5680249263832696;0.5910445897109051;0.9999056439461368;-0.21198928166052278;-0.28204661417623933;-0.43188071756286717;-0.40886105423523167
Reduced C-peptide level;Keratosis pilaris;0.934412457048893;0.78097904;0.5208921603528893;0.5702863205131175;0.9999455218634979;-0.06553306481460497;-0.21896648457864687;-0.4790533615106086;-0.4296592013503805
Reduced C-peptide level;Lamina lucida cleavage;0.8539025336503983;0.76228696;0.5466713121977267;0.5763977800058497;0.9999505803237132;-0.14604804667331495;-0.2376636192450694;-0.4532792681259865;-0.42355280031786346
Reduced C-peptide level;Abnormal central response of multifocal electroretinogram;0.8379379212856293;0.70993066;0.5518144830873384;0.5936783846424354;0.9999056439461368;-0.16196772266050752;-0.2899749856056827;-0.4480911608587984;-0.4062272593037014
Reduced C-peptide level;Atypical or prolonged hepatitis;0.9441968910396099;0.89255476;0.5177719129971189;0.5342670411216066;0.9999567459343585;-0.05575985489474855;-0.10740198595511041;-0.48218483293723957;-0.46568970481275185
Reduced C-peptide level;Cubitus varus;0.9737665224820375;0.8528353;0.5083513333212413;0.5470147455793346;0.9999056439461368;-0.026139121464099246;-0.1470703463616031;-0.4915543106248955;-0.4528908983668022
Reduced C-peptide level;Nasal regurgitation;1.0039197374135256;0.8244616;0.49875230563501605;0.5561666339584078;0.9999548690865008;0.003964868327024806;-0.17549328976368583;-0.5012025634514847;-0.44378823512809296
Reduced C-peptide level;Moon facies;1.0243483483791351;1.0011451;0.49224891400834925;0.499635494305833;0.9999548690865008;0.024393479292634357;0.0011902553489240297;-0.5077059550781515;-0.5003193747806678
Reduced C-peptide level;Intestinal pseudo-obstruction;0.8506108224391937;0.7704738;0.54773072318826;0.5737176669711952;0.9999494774285466;-0.14933865498935284;-0.2294756991807133;-0.45221875424028657;-0.42623181045735137
Reduced C-peptide level;Bilateral renal atrophy;0.8324026465415955;0.7707131;0.5536008521533498;0.5736394041740032;0.9999567459343585;-0.167554099392763;-0.22924365503775201;-0.4463558937810087;-0.4263173417603553
Reduced C-peptide level;Fractured left clavicle;0.8834966793656349;0.72478414;0.5371685659965117;0.5887493259310925;0.9999056439461368;-0.11640896458050187;-0.27512150812765535;-0.46273707794962504;-0.41115631801504426
Reduced C-peptide level;Positive urine norcotinine test;0.7830926477909088;0.7450857;0.5695969531385632;0.5820472562318264;0.6766288643064248;0.10646378348448404;0.06845685194113382;-0.1070319111678616;-0.09458160807459837
Reduced C-peptide level;Long fibula;0.9671227112412453;0.91482794;0.5104670522882401;0.5271440010178291;0.9999528219730685;-0.03283011073182318;-0.08512487912486288;-0.4894857696848284;-0.47280882095523935
Reduced C-peptide level;Fragmentation of the epiphysis of the distal phalanx of the hallux;0.9340647682547569;0.788405;0.5210030732184662;0.5678657757950734;0.9999056439461368;-0.06584087569137986;-0.21150064278265412;-0.4789025707276706;-0.43203986815106343
Reduced C-peptide level;Type II cryptotia;0.8969442844390869;0.81934583;0.5328619974565596;0.5578214656777462;0.9999056439461368;-0.10296135950704988;-0.18055981207510408;-0.4670436464895772;-0.44208417826839064
Reduced C-peptide level;Increased variability in muscle fiber diameter;0.8959274813532829;0.8642346;0.5331874057376815;0.5433493336629038;0.9999413779434757;-0.10401389659019278;-0.13570675165029333;-0.4667539722057942;-0.4565920442805719
Reduced C-peptide level;Widened proximal tibial metaphyses;0.9540951885282993;0.88322955;0.5146170920319504;0.5372541838543412;0.9999567459343585;-0.04586155740605913;-0.11672719223486505;-0.4853396539024081;-0.46270256208001725
Reduced C-peptide level;Wide anterior fontanel;0.9900562511757016;0.9880162;0.5031652457202327;0.5038146579857685;0.9999418169014338;-0.009885565725732182;-0.011925628756749962;-0.4967765711812011;-0.4961271589156653
Reduced C-peptide level;Increased circulating oleate level;0.973465945571661;0.9025414;0.5084470432415195;0.531071356093932;0.4583148495442064;0.5151510960274546;0.44422654945786877;0.05013219369731303;0.07275650654972554
Reduced C-peptide level;Lozenge-shaped umbilicus;0.8923943713307381;0.88565004;0.5343183825885012;0.5364785180104845;0.9999548690865008;-0.10756049775576271;-0.11430483036732353;-0.4656364864979996;-0.46347635107601626
Reduced C-peptide level;Anti-myelin-associated glycoprotein antibody positivity;0.7887018173933029;0.774241;0.567769110611362;0.5724861941586233;0.9999056439461368;-0.21120382655283387;-0.22566467333456453;-0.43213653333477475;-0.42741944978751345
Reduced C-peptide level;Fractured radius;0.877797394990921;0.7341063;0.5389957682030623;0.5856670277220773;0.9999567459343585;-0.12215935094343744;-0.2658504436730059;-0.4609609777312962;-0.4142897182122811
Reduced C-peptide level;Abnormal manual kinetic perimetry test;0.8731202185153961;0.76188284;0.540496243199168;0.5765302229520124;0.9999056439461368;-0.12678542543074067;-0.23802280235907014;-0.4594094007469688;-0.4233754209941244
Reduced C-peptide level;Small radial epiphyses;0.8841557800769806;0.74942666;0.5369573374714025;0.5806191216892418;0.9999056439461368;-0.1157498638691562;-0.2504789810242313;-0.4629483064747343;-0.419286522256895
Reduced C-peptide level;Generalized keratosis follicularis;1.009485175833106;0.89537656;0.4969807294857397;0.5333637406007088;0.9999567459343585;0.009528429898747581;-0.10458018286215387;-0.5029760164486188;-0.46659300533364967
Reduced C-peptide level;Hypoplasia of the calcaneus;0.8957167789340019;0.69057655;0.5332548413394822;0.6001360452978377;0.9999548690865008;-0.10423809015249885;-0.3093783157417742;-0.4667000277470186;-0.39981882378866307
Reduced C-peptide level;2-hydroxyadipic aciduria;0.8854797706007957;0.8845444;0.5365330744319737;0.5368328138359262;0.6766288643064248;0.20885090629437097;0.20791550825216898;-0.14009578987445104;-0.1397960504704986
Reduced C-peptide level;Potter facies;0.9998109228909016;0.9547815;0.5000601851134356;0.5143984198403977;0.9999510285821799;-0.00014010569127831385;-0.045169555899227;-0.49989084346874424;-0.4855526087417822
Reduced C-peptide level;Increased heart rate variability;0.9269451573491096;0.9080374;0.5232748130267424;0.5293140151796938;0.9999567459343585;-0.07301158858524881;-0.09191932184683405;-0.47668193290761607;-0.4706427307546647
Reduced C-peptide level;Aplastic zygomatic arch;0.9860367104411125;0.9330791;0.5044447975544768;0.521317512974437;0.9999548690865008;-0.013918158645388257;-0.0668757455894915;-0.495510071532024;-0.4786373561120638
Reduced C-peptide level;Testicular torsion;0.9142025858163834;0.8748931;0.5273437825363911;0.5399273749663684;0.9999567459343585;-0.0857541601179751;-0.12506361706244074;-0.4726129633979673;-0.46002937096799
Reduced C-peptide level;Abolished vibration sense;0.900066003203392;0.71191275;0.5318631651856328;0.5930193067451107;0.9999548690865008;-0.09988886588310875;-0.28804211788868583;-0.46809170390086796;-0.40693556234139006
Reduced C-peptide level;Fractured metatarsal bone of digit 5;0.917503833770752;0.80160004;0.5262892220485849;0.5635744926871664;0.9999056439461368;-0.08240181017538484;-0.19830560494085725;-0.47361642189755193;-0.4363311512589704
Reduced C-peptide level;Prolonged G2 phase of cell cycle;0.828693762421608;0.8956636;0.5547987508336125;0.5332718459349954;0.8383144321532123;-0.009620669731604359;0.05734918688823054;-0.2835156813195998;-0.3050425862182169
Reduced C-peptide level;Single naris;0.9947660826146603;0.91241556;0.501666015253722;0.5279147660287272;0.9999528219730685;-0.005186739358408188;-0.08753725791285727;-0.49828680671934644;-0.47203805594434123
Reduced C-peptide level;Perifoveal ring of hyperautofluorescence surrounded by normal autofluorescence;0.9404270350933075;0.8333814;0.5189738978496492;0.5532848669412478;0.9999056439461368;-0.059478608852829296;-0.16652422953268464;-0.4809317460964876;-0.446620777004889
Reduced C-peptide level;Asymmetry of the thorax;0.9160467684268951;0.81128556;0.526754635001843;0.5604320564578762;0.9999528219730685;-0.08390605354617331;-0.18866726661036703;-0.4731981869712254;-0.43952076551519226
Reduced C-peptide level;Type 2 muscle fiber predominance;0.9510377161204815;0.9022883;0.5155914128081671;0.5311522935659693;0.9999515360511232;-0.0489138199306417;-0.0976632183707643;-0.4843601232429561;-0.4687992424851539
Reduced C-peptide level;Dependency on parenteral nutrition;0.6861866414546967;0.6824451;0.6016066232998387;0.6028617740983442;0.9999548690865008;-0.3137682276318041;-0.3175097601959673;-0.39834824578666206;-0.3970930949881566
Reduced C-peptide level;Limited shoulder flexion;0.9003803431987762;0.73965263;0.5317626058500349;0.5838370812549765;0.9999056439461368;-0.09952530074736055;-0.2602530102791446;-0.4681430380961019;-0.4160685626911603
Reduced C-peptide level;Paroxysmal vertigo;0.9063236266374588;0.7168932;0.5298618991603428;0.5913651005889854;0.9999548690865008;-0.09363124244904197;-0.28306167298054374;-0.470092969926158;-0.4085897684975154
Reduced C-peptide level;Long hallux;1.0517027154564857;0.99207973;0.4835351734151705;0.5025211301125203;0.9999478876548411;0.05175482780164464;-0.007868152852595012;-0.5164127142396706;-0.4974267575423208
Reduced C-peptide level;Broad medial eyebrow;0.9754640087485313;0.97089565;0.507810832422587;0.5092655184827242;0.9999567459343585;-0.024492737185827118;-0.029061097931733948;-0.4921459135117715;-0.4906912274516343
Reduced C-peptide level;Myxoid subcutaneous tumors;0.9028036966919899;0.82695055;0.530987465869785;0.5553620497518512;0.9999567459343585;-0.09715304924236856;-0.17300619585501276;-0.4689692800645735;-0.44459469618250724
Reduced C-peptide level;Bulbous tips of toes;0.9936184138059616;0.9315697;0.5020313357628259;0.5217990710555016;0.9999548690865008;-0.006336455280539166;-0.06838517361378349;-0.4979235333236749;-0.47815579803099917
Reduced C-peptide level;Absent internal genitalia;1.0195958837866783;0.9038543;0.49376203719051903;0.530651464273705;0.9999056439461368;0.019690239840541524;-0.09605133343359407;-0.5061436067556178;-0.46925417967243177
Reduced C-peptide level;Hyperphalangy of the 2nd finger;0.8917536735534668;0.7934973;0.5345235212574984;0.5662082135089317;0.9999567459343585;-0.10820307238089166;-0.2064594219444903;-0.4654332246768601;-0.43374853242542677
Reduced C-peptide level;Renal interstitial hemosiderin;0.8948718756437302;0.8370892;0.5335252688895717;0.5520882841408867;0.9999056439461368;-0.10503376830240663;-0.1628164629997867;-0.46638037505656504;-0.44781735980525006
Reduced C-peptide level;Abnormality of depressor anguli oris muscle;0.9611095413565636;0.80768687;0.5123823401181185;0.5615989275919764;0.9999056439461368;-0.03879610258957322;-0.19221877861639436;-0.48752330382801834;-0.4383067163541604
Reduced C-peptide level;Paroxysmal dyspnea;0.8564407080411911;0.697422;0.5458547770596314;0.5978472772319026;0.9999056439461368;-0.1434649359049457;-0.30248361635824617;-0.4540508668865054;-0.4020583667142342
Reduced C-peptide level;Phenylpyruvic acidemia;0.7991909980773926;0.695808;0.5643570624523386;0.5983864427788385;0.851762385589393;-0.05257138751200041;-0.15595439217737517;-0.28740532313705436;-0.25337594281055453
Reduced C-peptide level;Lateral ventricle dilatation;0.75031378865242;0.74933904;0.5803274698517105;0.5806479310419754;0.9999433058680118;-0.2496295172155918;-0.25060426177392614;-0.41961583601630137;-0.4192953748260364
Reduced C-peptide level;Neonatal unconjugated hyperbilirubinemia;0.8922801837325096;0.86636543;0.5343549421331344;0.5426648385740116;0.7516843477913018;0.14059583594120784;0.11468108494795604;-0.21732940565816738;-0.20901950921729018
Reduced C-peptide level;High maternal circulating alpha-fetoprotein concentration;0.8262656033039093;0.83026654;0.5555834235136888;0.5542906805505741;0.9999056439461368;-0.1736400406422275;-0.16963910866400178;-0.44432222043244796;-0.4456149633955627
Reduced C-peptide level;Prominent nasolabial fold;0.973446685820818;0.85652995;0.508453175971459;0.5458260825594246;0.9999501780647019;-0.02650349224388393;-0.14342022696912082;-0.4914970020932429;-0.4541240955052773
Reduced C-peptide level;Abnormality of inferior alveolar nerve;0.9646431058645248;0.82345617;0.5112567951512967;0.5564917435813829;0.9999056439461368;-0.03526253808161195;-0.17644947577139314;-0.48864884879484005;-0.4434139003647539
Reduced C-peptide level;Unilateral conductive hearing impairment;0.9986685086041689;0.83532107;0.5004238269998934;0.5526587921076742;0.9999567459343585;-0.0012882373301895678;-0.16463567717062555;-0.49953291893446505;-0.44729795382668425
Reduced C-peptide level;Macular hypopigmented whorls, streaks, and patches;1.0049615716561675;0.8973848;0.49842067621103414;0.5327210153291486;0.9999567459343585;0.0050048257218090475;-0.10257192356573663;-0.5015360697233243;-0.46723573060520984
Reduced C-peptide level;Delayed ossification of pubic rami;0.9326394498348236;0.7885616;0.5214577772097764;0.5678147902945598;0.9999548690865008;-0.06731541925167717;-0.21139328652119316;-0.4784970918767244;-0.43214007879194094
Reduced C-peptide level;Hyperphenylalaninemia;0.8579645305871964;0.8425007;0.5453647069610976;0.5503431965871497;0.7251438428351311;0.13282068775206524;0.1173568438103767;-0.1797791358740335;-0.17480064624798142
Reduced C-peptide level;Ureteropelvic junction obstruction;0.8490671515464783;0.7141819;0.5482277241660849;0.592265314177185;0.9999481150251853;-0.15088096347870705;-0.28576621500077126;-0.45172039085910043;-0.40768280084800035
Reduced C-peptide level;Cone-shaped epiphysis of the proximal phalanx of the 2nd toe;0.8832660391926765;0.76974845;0.5372424854132114;0.5739549001893307;0.9999056439461368;-0.11663960475346025;-0.23015719462057527;-0.4626631585329254;-0.4259507437568061
Reduced C-peptide level;Difficulty walking;0.9732844457030296;0.8830607;0.5085048369321585;0.5373082996527765;0.9999398952172014;-0.02665544951417176;-0.11687920147635666;-0.49143505828504286;-0.4626315955644249
Reduced C-peptide level;Bilobate gallbladder;0.929816797375679;0.8742265;0.5223583879721838;0.5401412555842113;0.9999548690865008;-0.07013807171082176;-0.12572835856175102;-0.47759648111431696;-0.45981361350228944
Reduced C-peptide level;Histidinuria;0.879366859793663;0.85018057;0.5384924683121823;0.5478692368079827;0.8413020594063172;0.03806480038734583;0.008878506904565375;-0.30280959109413486;-0.2934328225983345
Reduced C-peptide level;Widened interpedicular distance;0.9660196080803871;0.90001047;0.5108183773032087;0.5318809415666308;0.9999056439461368;-0.033886035865749675;-0.09989517737051423;-0.4890872666429281;-0.468024702379506
Loss of voice;Elevated circulating growth hormone concentration;1.1263290345668793;1.0839761;0.4596804870897795;0.4732380560246914;0.9999505803237132;0.12637845424316607;0.0840255692353078;-0.5402700932339337;-0.5267125242990218
Loss of voice;Visual acuity no light perception;0.8471383452415466;0.7286109;0.54884889021687;0.5874830360556715;0.9999056439461368;-0.15276729870459016;-0.2712947707237857;-0.4510567537292668;-0.41242260789046525
Loss of voice;Spinal hypomyelination;0.8687950074672699;0.7388429;0.5418846098063586;0.5841040620399829;0.9999056439461368;-0.1311106364788669;-0.2610627393784183;-0.45802103413977824;-0.4158015819061539
Loss of voice;Bladder polyp;0.8790161162614822;0.84869945;0.5386049371877633;0.5483461267914059;0.9999567459343585;-0.12094062967287622;-0.15125729544149957;-0.4613518087465952;-0.45161061914295253
Loss of voice;Aberrant melanosome maturation;0.9256518930196762;0.89240795;0.5236875944995039;0.5343140339269987;0.9999567459343585;-0.07430485291468225;-0.1075487921951922;-0.4762691514348546;-0.46564271200735974
Loss of voice;Vertebral artery tortuosity;0.9749968126416206;0.8419894;0.5079595912047384;0.5505080085455846;0.9999567459343585;-0.024959933292737824;-0.15796734793173395;-0.49199715472962;-0.4494487373887739
Loss of voice;Warm reactive autoantibody positivity;1.1346180737018585;1.0743954;0.45701924706356967;0.4762973088162332;0.9999056439461368;0.13471242975572173;0.07448977422097747;-0.5428863968825671;-0.5236083351299036
Loss of voice;Right aortic arch with retroesophageal left subclavian artery;0.994305957108736;1.0178404;0.5018124799388088;0.49432091461381356;0.9999056439461368;-0.0055996868374007525;0.017934741490874928;-0.49809316400732795;-0.5055847293323232
Loss of voice;Elevated urine suberic acid level;1.0016118325293064;0.9854588;0.4994869375488925;0.5046287742262193;0.9999567459343585;0.001655086594947952;-0.014497954678407532;-0.500469808385466;-0.49532797170813914
Loss of voice;Burkitt lymphoma;1.035476677119732;0.9791837;0.48870505280510335;0.5066265115418827;0.9999536937290383;0.0355229833906936;-0.02077001987039573;-0.511248640923935;-0.49332718218715566
Loss of voice;Snail-like ilia;1.0585289224982262;1.0316912;0.48135901212360366;0.4899107023257723;0.9999567459343585;0.058572176563867706;0.03173444764626898;-0.5185977338107548;-0.5100460436085862
Loss of voice;Indurated nodule;0.9873546715825796;0.913616;0.5040252403297265;0.5275311962744575;0.9999056439461368;-0.012550972363557178;-0.08628964234014924;-0.4958804036164103;-0.47237444767167924
Loss of voice;Absent leukocyte alkaline phosphatase;1.0478037148714066;0.92102695;0.48477780358699496;0.5251641051170559;0.9999567459343585;0.047846968937048096;-0.07892980082022272;-0.5151789423473635;-0.47479264081730255
Loss of voice;Hippocampal sclerosis;1.0356300547719002;0.9500962;0.48865620029647994;0.5158914791201548;0.9999056439461368;0.035724410825763386;-0.049809453970398265;-0.5112494436496569;-0.48401416482598203
Loss of voice;Decreased sensitivity to hypoxemia;0.7335567474365234;0.6454151;0.585848493058646;0.6153778018879683;0.9999567459343585;-0.266399998497835;-0.3545416186569842;-0.4141082528757125;-0.38457894404639015
Loss of voice;Decreased level of tissue plasminogen activator;1.0288387723267078;0.8663419;0.4908190607703853;0.5426724006480412;0.9999056439461368;0.02893312838057105;-0.13356375504156526;-0.5090865831757515;-0.45723324329809556
Loss of voice;Submandibular lymph node enlargement;0.8946703672409058;0.9381668;0.5335897691097816;0.5196946833079816;0.9999567459343585;-0.1052863786934527;-0.061789948773256165;-0.46636697682457684;-0.48026206262637683
Loss of voice;Hepatic hemangioma;1.0342193059623241;0.9650287;0.4891055297415655;0.5111339761879965;0.9999548690865008;0.03426443687582337;-0.03492616587376274;-0.5108493393449353;-0.4888208928985043
Loss of voice;Triangular epiphysis of the distal phalanx of the 2nd finger;1.0933465510606766;0.9928882;0.4702435485901386;0.502263770261021;0.9999056439461368;0.09344090711453978;-0.0070174317421572985;-0.5296620953559982;-0.4976418736851158
Loss of voice;Acne inversa;0.8663059175014496;0.84694564;0.5426839543952795;0.5489109690982632;0.9999505803237132;-0.13364466282226362;-0.1530049368987254;-0.4572666259284337;-0.45103961122545
Loss of voice;Dentin dysplasia;0.9659914374351501;0.8975427;0.5108273494838225;0.5326704926004977;0.9999056439461368;-0.033914206510986644;-0.10236292887350495;-0.4890782944623143;-0.4672351513456391
Loss of voice;Aplasia of the inner ear;0.6360850036144257;0.7344979;0.6185601387549716;0.5855377194699936;0.9999567459343585;-0.3638717423199328;-0.2654588411568316;-0.38139660717938684;-0.4144190264643649
Loss of voice;Polycystic liver disease;1.0334087386727333;0.94671935;0.4893636889606571;0.5169677903356309;0.9999528219730685;0.033455916699664856;-0.053233473542434906;-0.5105891330124114;-0.48298503163743756
Loss of voice;Subungual hyperkeratosis;0.9264186397194862;0.9403002;0.5234428610789656;0.5190143343405642;0.9999515360511232;-0.07353289633163695;-0.05965130983957534;-0.47650867497215754;-0.480937201710559
Loss of voice;Broad humeral epiphyses;1.1147963777184486;1.0929438;0.463378441272819;0.4703722976928689;0.9999056439461368;0.11489073377231185;0.09303814362863128;-0.5365272026733178;-0.5295333462532679
Loss of voice;Autoimmune thrombocytopenia;1.0494803041219711;0.9175755;0.48424349611825424;0.526266338873689;0.9999457950338347;0.04953450908813639;-0.08237031648006277;-0.5157022989155805;-0.47367945616014573
Loss of voice;Adenomyosis;0.9427913390100002;0.92884976;0.5182200301128954;0.5226669828222046;0.9999567459343585;-0.05716540692435823;-0.07110698921667657;-0.48173671582146305;-0.4772897631121539
Loss of voice;Elevated leukocyte alkaline phosphatase;1.1067354828119278;1.0470022;0.4659601978916843;0.4850332398110657;0.9999567459343585;0.10677873687756934;0.047045450377592224;-0.5339965480426742;-0.5149235061232927
Loss of voice;Clasp-knife sign;0.939417626708746;0.9225433;0.5192957839525922;0.524679962322907;0.9999056439461368;-0.060488017237390834;-0.07736235666891511;-0.48060985999354455;-0.47522568162322976
Loss of voice;Keratosis pilaris;0.8948947191238403;0.8774984;0.5335179570757872;0.5390916750503068;0.9999455218634979;-0.10505080273965761;-0.12244713357309267;-0.46642756478771075;-0.4608538468131912
Loss of voice;Lamina lucida cleavage;0.9457976594567299;0.89697987;0.5172616000198267;0.532850602963411;0.9999505803237132;-0.05415292086698331;-0.10297071191169538;-0.4826889803038865;-0.4670999773603022
Loss of voice;Abnormal central response of multifocal electroretinogram;0.9230519905686378;0.8506346;0.5245175475550656;0.5477230671634133;0.9999056439461368;-0.07685365337749894;-0.14927106905600007;-0.47538809639107116;-0.45218257678272344
Loss of voice;Atypical or prolonged hepatitis;0.9829550310969353;0.93383014;0.505425844862495;0.5210779110167201;0.9999567459343585;-0.017001714837423187;-0.06612660391317926;-0.4945309010718635;-0.4788788349176384
Loss of voice;Cubitus varus;0.9876207858324051;0.9244613;0.5039405269014058;0.5240676368018237;0.9999056439461368;-0.0122848581137317;-0.07544433880468782;-0.495965117044731;-0.4758380071443131
Loss of voice;Nasal regurgitation;0.5519732534885406;0.62104577;0.6478730687085461;0.6237162244514526;0.9999548690865008;-0.4479816155979601;-0.37890910082554496;-0.35208180037795467;-0.3762386446350482
Loss of voice;Moon facies;0.9490819238126278;0.99389845;0.5162147387146793;0.501942196796606;0.9999548690865008;-0.05087294527387298;-0.006056417758223187;-0.4837401303718215;-0.49801267228989476
Loss of voice;Intestinal pseudo-obstruction;1.003238445147872;0.94200623;0.49896916909175193;0.518470363087759;0.9999494774285466;0.0032889677193254085;-0.05794324707423748;-0.5009803083367946;-0.4814791143407876
Loss of voice;Bilateral renal atrophy;0.9774309620261192;0.8658235;0.5071845579196268;0.542838906435827;0.9999567459343585;-0.022525783908239227;-0.1341332386253985;-0.49277218801473166;-0.45711783949853146
Loss of voice;Fractured left clavicle;1.0125769153237343;0.83837557;0.49599653796622556;0.5516733049753482;0.9999056439461368;0.012671271377597493;-0.1615300755562442;-0.5039091059799112;-0.4482323389707886
Loss of voice;Positive urine norcotinine test;0.9101054221391678;0.89126045;0.5286530125755007;0.5346814482111645;0.9999056439461368;-0.089800221806969;-0.10864519882818635;-0.4712526313706361;-0.4652241957349723
Loss of voice;Long fibula;1.1011543720960617;1.0230805;0.4677463987687108;0.49265262000715837;0.9999528219730685;0.10120155012299326;0.02312764620472696;-0.5322064232043576;-0.5073002019659101
Loss of voice;Fragmentation of the epiphysis of the distal phalanx of the hallux;1.0506032556295395;0.8904109;0.48388560113514556;0.5349534878345485;0.9999056439461368;0.0506976116834027;-0.10949474383017;-0.5160200428109912;-0.46495215611158824
Loss of voice;Type II cryptotia;1.0140641452744603;0.9218994;0.49552309592140154;0.5248855429522872;0.9999056439461368;0.014158501328323525;-0.07800626564642366;-0.5043825480247353;-0.4750201009938496
Loss of voice;Increased variability in muscle fiber diameter;1.0074618393555284;0.97487664;0.4976248007222004;0.5079978522831833;0.9999413779434757;0.007520461412052648;-0.025064735716302855;-0.5023165772212753;-0.4919435256602924
Loss of voice;Widened proximal tibial metaphyses;1.1729617416858673;1.1505893;0.4446663008934929;0.451882870363844;0.9999567459343585;0.17300499575150885;0.1506326009513227;-0.5552904450408656;-0.5480738755705145
Loss of voice;Wide anterior fontanel;0.8079017400741577;0.97850406;0.5615292313258502;0.5068428872434758;0.9999418169014338;-0.19204007682727608;-0.021437755202520226;-0.4384125855755836;-0.493098929657958
Loss of voice;Increased circulating oleate level;1.1215151846408844;1.074559;0.4612246874609428;0.47624510022692323;0.9999056439461368;0.12160954069474761;0.07465332936624114;-0.538680956485194;-0.5236605437192136
Loss of voice;Lozenge-shaped umbilicus;0.9029867053031921;0.88287;0.5309289358159592;0.5373694086809716;0.9999548690865008;-0.09696816378330864;-0.11708485060429252;-0.46902593327054154;-0.46258546040552917
Loss of voice;Anti-myelin-associated glycoprotein antibody positivity;1.065284825861454;1.0234907;0.47920440445176316;0.49252199516554895;0.9999056439461368;0.06537918191531722;0.023585023397002858;-0.5207012394943736;-0.5073836487805878
Loss of voice;Fractured radius;1.0049428972415626;0.8311467;0.4984266205347133;0.5540063970570146;0.9999567459343585;0.004986151307204145;-0.16881002886282526;-0.5015301253996451;-0.44595034887734386
Loss of voice;Abnormal manual kinetic perimetry test;0.9588343054056168;0.89398646;0.5131071512679164;0.5338086976705687;0.9999056439461368;-0.04107133854052003;-0.10591918039938386;-0.4867984926782204;-0.4660969462755681
Loss of voice;Small radial epiphyses;1.1447252184152603;1.0286503;0.45377018042215256;0.49087909993752055;0.9999056439461368;0.14481957446912352;0.028744639867339772;-0.5461354635239842;-0.5090265440086162
Loss of voice;Generalized keratosis follicularis;0.98737758025527;0.94877213;0.5040179476907001;0.5163134736846284;0.9999567459343585;-0.012579165679088455;-0.05118461353766046;-0.4959387982436584;-0.48364327224973
Loss of voice;Hypoplasia of the calcaneus;1.000384595245123;0.84970635;0.49987757952828016;0.5480219078777147;0.9999548690865008;0.0004297261586221346;-0.15024851732945121;-0.5000772895582206;-0.4519329612087861
Loss of voice;2-hydroxyadipic aciduria;1.028017733246088;0.959447;0.4910805113030656;0.512911947219624;0.9999056439461368;0.028112089299951237;-0.04045861769339021;-0.5088251326430712;-0.4869936967265128
Loss of voice;Potter facies;0.9993894267827272;1.093894;0.5001943515033727;0.4700685080029118;0.9999510285821799;-0.0005616017994526379;0.09394297623959746;-0.4997566770788072;-0.5298825205792681
Loss of voice;Increased heart rate variability;0.9340437352657318;1.0082567;0.5210097828322295;0.4973718052445737;0.9999567459343585;-0.06591301066862665;0.008299927878507751;-0.4789469631021289;-0.5025849406897848
Loss of voice;Aplastic zygomatic arch;0.8441801965236664;0.9044772;0.5498019180589788;0.5304522870484999;0.9999548690865008;-0.1557746725628344;-0.09547769003605522;-0.45015295102752195;-0.4695025820380009
Loss of voice;Testicular torsion;1.0281389467418194;0.95891607;0.49104191263054653;0.5130811033651769;0.9999567459343585;0.028182200807460922;-0.04104067785727106;-0.5089148333038119;-0.4868756425691816
Loss of voice;Abolished vibration sense;0.6065072417259216;0.53963137;0.6287333575592717;0.6522827520416787;0.9999548690865008;-0.39344762736057914;-0.46032350235676445;-0.37122151152722904;-0.34767211704482204
Loss of voice;Fractured metatarsal bone of digit 5;1.052085041999817;0.91288257;0.483413310898976;0.5277655346408788;0.9999056439461368;0.052179398053680104;-0.08702307749411042;-0.5164923330471608;-0.47214010930525796
Loss of voice;Prolonged G2 phase of cell cycle;1.0939171016216278;1.059916;0.4700611353421592;0.48091671146775583;0.9999528219730685;0.09396427964855936;0.059963197466628815;-0.5298916866309092;-0.5190361105053126
Loss of voice;Single naris;0.8023764193058014;0.8749846;0.5633223710563263;0.5398980309058841;0.9999528219730685;-0.19757640266726706;-0.1249681999714205;-0.43663045091674213;-0.4600547910671844
Loss of voice;Perifoveal ring of hyperautofluorescence surrounded by normal autofluorescence;1.0087791522964835;0.97458273;0.4972054731335974;0.5080914320434415;0.9999056439461368;0.008873508350346726;-0.02532291222235139;-0.5027001708125394;-0.49181421190269525
Loss of voice;Asymmetry of the thorax;0.9101820513606071;0.9131544;0.5286285216647344;0.5276786707177776;0.9999528219730685;-0.0897707706124613;-0.08679839873622153;-0.47132430030833405;-0.4722741512552908
Loss of voice;Type 2 muscle fiber predominance;1.0276269186288118;1.0172093;0.49120495963612487;0.4945218342615274;0.9999515360511232;0.027675382577688645;0.017257755407006692;-0.5087465764149983;-0.5054297017895958
Loss of voice;Dependency on parenteral nutrition;1.0169877745211124;0.9304416;0.49459236331105905;0.5221590212703129;0.9999548690865008;0.017032905434611667;-0.06951325112080253;-0.5053625057754417;-0.4777958478161879
Loss of voice;Limited shoulder flexion;0.9489376246929169;0.8332293;0.5162607303792405;0.5533339724500395;0.9999056439461368;-0.05096801925321992;-0.16667634058615144;-0.4836449135668963;-0.44657167149609733
Loss of voice;Paroxysmal vertigo;0.4852679967880249;0.5811501;0.672108574396171;0.6375666512598529;0.9999548690865008;-0.5146868722984759;-0.4188047545502154;-0.3278462946903298;-0.3623882178266479
Loss of voice;Long hallux;0.9959887936711311;0.9376738;0.5012768100539489;0.5198519101656606;0.9999478876548411;-0.0039590939837099715;-0.062274080510676066;-0.49867107760089224;-0.48009597748918054
Loss of voice;Broad medial eyebrow;0.9782253764569759;1.0221419;0.5069316257687853;0.4929514169866692;0.9999567459343585;-0.021731369477382523;0.02218518750680365;-0.4930251201655732;-0.5070053289476892
Loss of voice;Myxoid subcutaneous tumors;0.9610678292810917;0.918426;0.5123956275471102;0.5259946972020302;0.9999567459343585;-0.03888891665326677;-0.08153076870428644;-0.48756111838724825;-0.4739620487323283
Loss of voice;Bulbous tips of toes;0.9830241166055202;0.9421646;0.5054038510798847;0.5184198629915291;0.9999548690865008;-0.016930752480980527;-0.05779026919102348;-0.49455101800661605;-0.4815350060949717
Loss of voice;Absent internal genitalia;0.8691772222518921;0.8194792;0.541761889275451;0.5577782997170809;0.9999056439461368;-0.1307284216942447;-0.18042641688009675;-0.4581437546706858;-0.44212734422905586
Loss of voice;Hyperphalangy of the 2nd finger;0.9738231636583805;0.9379572;0.5083332976811508;0.5197615281317167;0.9999567459343585;-0.02613358227597795;-0.06199951870428644;-0.4916234482532077;-0.48019521780264174
Loss of voice;Renal interstitial hemosiderin;1.0897453725337982;0.9928498;0.4713946737023249;0.5022759993971947;0.9999056439461368;0.08983972858766143;-0.00705581713339265;-0.5285109702438119;-0.4976296445489421
Loss of voice;Abnormality of depressor anguli oris muscle;0.8181445151567459;0.80121434;0.5582103068778719;0.5636997604101335;0.9999056439461368;-0.18176112878939088;-0.1986913065971988;-0.4416953370682649;-0.4362058835360033
Loss of voice;Paroxysmal dyspnea;0.608261227607727;0.6436867;0.6281263013422802;0.6159664125787557;0.9999056439461368;-0.39164441633840974;-0.3562189321579593;-0.3717793426038566;-0.38393923136738106
Loss of voice;Phenylpyruvic acidemia;0.9859113823622465;0.92021894;0.5044846946456405;0.5254221090376758;0.9999567459343585;-0.014045363572111946;-0.07973780138479791;-0.49547205128871796;-0.4745346368966826
Loss of voice;Lateral ventricle dilatation;0.9019732475280762;0.86033124;0.5312530744456934;0.5446037746179404;0.9999433058680118;-0.09797005833993566;-0.13961206855188024;-0.46869023142231847;-0.4553395312500714
Loss of voice;Neonatal unconjugated hyperbilirubinemia;0.966732531785965;0.9026325;0.5105913182455737;0.5310422176678655;0.9999567459343585;-0.033224214148393494;-0.09732427103506647;-0.48936542768878477;-0.46891452826649294
Loss of voice;High maternal circulating alpha-fetoprotein concentration;1.0780459716916084;1.0821645;0.47513190594639765;0.4738166971626898;0.9999056439461368;0.07814032774547164;0.08225888203958098;-0.5247737379997391;-0.526088946783447
Loss of voice;Prominent nasolabial fold;0.6679919958114624;0.7518375;0.6077261031643744;0.5798266921999465;0.9999501780647019;-0.3319581822532395;-0.24811268607556614;-0.3922240749003275;-0.42012348586475534
Loss of voice;Abnormality of inferior alveolar nerve;0.7911937385797501;0.83381546;0.5669578071740637;0.5531447539451606;0.9999056439461368;-0.20871190536638673;-0.16609018850943025;-0.43294783677207305;-0.4467608900009762
Loss of voice;Unilateral conductive hearing impairment;0.5459771156311035;0.6620909;0.650011569436203;0.6097196466087627;0.9999567459343585;-0.45397963030325494;-0.33786584837423883;-0.3499451764981555;-0.3902370993255958
Loss of voice;Macular hypopigmented whorls, streaks, and patches;0.9209292680025101;0.89462996;0.5251952966184819;0.533602714155414;0.9999567459343585;-0.07902747793184839;-0.10532679064261041;-0.4747614493158766;-0.4663540317789444
Loss of voice;Delayed ossification of pubic rami;1.0570061318576336;0.93826437;0.48184454229180607;0.5196635690341116;0.9999548690865008;0.057051262771132816;-0.061690499121901166;-0.5181103267946947;-0.4802913000523892
Loss of voice;Hyperphenylalaninemia;1.009152416139841;0.9872808;0.49708665478569236;0.5040487666502436;0.9999521228478421;0.009200293291999007;-0.012671336810397005;-0.5028654680621497;-0.4959033561975985
Loss of voice;Ureteropelvic junction obstruction;0.9296818524599075;0.78565395;0.522401448660054;0.5687620244729775;0.9999481150251853;-0.07026626256527779;-0.2142941662413108;-0.4775466663651313;-0.4311860905522078
Loss of voice;Cone-shaped epiphysis of the proximal phalanx of the 2nd toe;1.0684888064861298;0.93622637;0.4781822562697656;0.5203135724331527;0.9999056439461368;0.06858316253999297;-0.06367927599569734;-0.5217233876763712;-0.4795920715129841
Loss of voice;Difficulty walking;0.8537069112062454;0.8036628;0.5467342570509465;0.5629047182912676;0.9999398952172014;-0.14623298401095597;-0.1962771182701799;-0.4532056381662549;-0.43703517692593374
Loss of voice;Bilobate gallbladder;0.9851072207093239;0.8789687;0.5047406941355999;0.5386201321813219;0.9999548690865008;-0.014847648377176892;-0.12098615341877617;-0.4952141749509009;-0.4613347369051789
Loss of voice;Histidinuria;1.0514781437814236;0.9817138;0.483606752119071;0.5058210057223878;0.9999536937290383;0.05152445005238526;-0.018239921908969947;-0.5163469416099673;-0.49413268800665056
Loss of voice;Widened interpedicular distance;1.0840333700180054;1.0641081;0.47321976567905377;0.4795797555664605;0.9999056439461368;0.08412772607186858;0.06420248936990325;-0.526685878267083;-0.5203258883796763
Elevated circulating growth hormone concentration;Visual acuity no light perception;0.9707978405058384;0.9103875;0.5092966576967499;0.5285628554299542;0.9998962300503706;-0.029098389544532255;-0.08950871402864213;-0.4905995723536207;-0.47133337462041647
Elevated circulating growth hormone concentration;Spinal hypomyelination;0.973030798137188;0.9116243;0.508585604562507;0.5281676073489805;0.6800123916089407;0.2930184065282473;0.2316119207918772;-0.17142678704643366;-0.15184478425996017
Elevated circulating growth hormone concentration;Bladder polyp;0.9420083463191986;0.87758285;0.5184696789173869;0.5390645843980446;0.9999548690865008;-0.05794652276730217;-0.12237202101444877;-0.48148519016911384;-0.46089028468845616
Elevated circulating growth hormone concentration;Aberrant melanosome maturation;0.8476651608943939;0.80869555;0.5486792123691502;0.5612717870089793;0.9999548690865008;-0.15228970819210685;-0.1912593143532244;-0.4512756567173506;-0.4386830820775215
Elevated circulating growth hormone concentration;Vertebral artery tortuosity;0.9034615308046341;0.7814401;0.5307770813886178;0.5701359127217552;0.9999548690865008;-0.09649333828186668;-0.21851478987431205;-0.469177787697883;-0.42981895636474554
Elevated circulating growth hormone concentration;Warm reactive autoantibody positivity;0.8224816918373108;0.73338103;0.5568068973323338;0.585906514065911;0.9998962300503706;-0.17741453821305986;-0.26651519710664506;-0.44308933271803685;-0.41398971598445966
Elevated circulating growth hormone concentration;Right aortic arch with retroesophageal left subclavian artery;0.9644044451415539;0.8162433;0.511332811069496;0.5588258581202503;0.9998962300503706;-0.03549178490881677;-0.18365293914918657;-0.48856341898087463;-0.44107037193012033
Elevated circulating growth hormone concentration;Elevated urine suberic acid level;0.775319516658783;0.6777122;0.5721338341767239;0.6044518764843079;0.9999548690865008;-0.22463535242771782;-0.3222426670143572;-0.42782103490977685;-0.3955029926021929
Elevated circulating growth hormone concentration;Burkitt lymphoma;0.9446426816284657;0.9025055;0.5176297937599956;0.5310828251911259;0.9999515360511232;-0.05530885442265754;-0.09744601904520278;-0.48232174229112756;-0.46886871085999726
Elevated circulating growth hormone concentration;Snail-like ilia;0.949745699763298;0.96445185;0.5160031814064593;0.511317712250374;0.9999548690865008;-0.05020916932320274;-0.03550301962589897;-0.4839516876800415;-0.48863715683612674
Elevated circulating growth hormone concentration;Indurated nodule;0.8641642928123474;0.75850594;0.543371930840981;0.5776374221714868;0.9998962300503706;-0.13573193723802324;-0.24139028961305375;-0.45652429920938964;-0.4222588078788838
Elevated circulating growth hormone concentration;Absent leukocyte alkaline phosphatase;0.8737987577915192;0.79146296;0.5402785071507537;0.5668701830365901;0.9999548690865008;-0.1261561112949816;-0.20849191122746147;-0.4596763619357471;-0.4330846860499107
Elevated circulating growth hormone concentration;Hippocampal sclerosis;0.9089678525924683;0.8151781;0.5290166030279544;0.5591708239287461;0.6486170521183526;0.26035080047411563;0.16656104417605044;-0.11960044909039824;-0.08944622818960657
Elevated circulating growth hormone concentration;Decreased sensitivity to hypoxemia;0.9785100854933262;0.93692935;0.5068409788556996;0.5200893564477278;0.9999548690865008;-0.021444783593174588;-0.06302552395558036;-0.4931138902308012;-0.479865512638773
Elevated circulating growth hormone concentration;Decreased level of tissue plasminogen activator;0.9257494360208511;0.8810985;0.5236564595403792;0.5379372804674248;0.9998962300503706;-0.07414679402951951;-0.11879772121553178;-0.47623977050999144;-0.4619589495829458
Elevated circulating growth hormone concentration;Submandibular lymph node enlargement;0.8571972548961639;0.7789152;0.5456114536313146;0.5709597545542073;0.9999548690865008;-0.14275761419033683;-0.2210396426269976;-0.4543434154551862;-0.42899511453229344
Elevated circulating growth hormone concentration;Hepatic hemangioma;0.8140896409749985;0.675886;0.559523405180083;0.605066150480192;0.9999528219730685;-0.18586318099806998;-0.3240668466121981;-0.4404294167929854;-0.3948866714928765
Elevated circulating growth hormone concentration;Triangular epiphysis of the distal phalanx of the 2nd finger;0.9069096595048904;0.84748113;0.5296745403869121;0.5487384881227266;0.9998962300503706;-0.09298657054548021;-0.15241509849672075;-0.47022168966345856;-0.451157741927644
Elevated circulating growth hormone concentration;Acne inversa;0.9839270655065775;0.95897037;0.5051163942595874;0.5130638093531525;0.9999481150251853;-0.016021049518607833;-0.04097774711670754;-0.4948317207655979;-0.4868843056720328
Elevated circulating growth hormone concentration;Dentin dysplasia;0.9897611094638705;0.96128273;0.5032591970291498;0.5123271649436865;0.9998962300503706;-0.010135120586500124;-0.03861349994783159;-0.49663703302122086;-0.4875690651066842
Elevated circulating growth hormone concentration;Aplasia of the inner ear;0.9258401021361351;0.7408195;0.523627519832506;0.5834524481174734;0.9999548690865008;-0.07411476695036567;-0.25913535528874077;-0.4763273492539948;-0.41650242096902734
Elevated circulating growth hormone concentration;Polycystic liver disease;0.817035585641861;0.7462932;0.5585693133340364;0.5816498500873708;0.9999505803237132;-0.18291499468185224;-0.25365739318229474;-0.44138126698967683;-0.4183007302363424
Elevated circulating growth hormone concentration;Subungual hyperkeratosis;0.8698936104774475;0.75271237;0.5415318900051096;0.5795392654418908;0.9999491674684583;-0.1300555569910108;-0.24723679850330937;-0.4584172774633487;-0.4204099020265675
Elevated circulating growth hormone concentration;Broad humeral epiphyses;0.7966574430465698;0.59986264;0.5651805060523525;0.631037589438689;0.9998962300503706;-0.20323878700380082;-0.40003359491472;-0.43471572399801817;-0.3688586406116816
Elevated circulating growth hormone concentration;Autoimmune thrombocytopenia;0.9056181088089943;0.75750005;0.5300874718768946;0.5779674146434836;0.9999428147971705;-0.09432470598817622;-0.2424427623450831;-0.46985534292027586;-0.42197540015368695
Elevated circulating growth hormone concentration;Adenomyosis;0.8374332189559937;0.76651376;0.5519772938496863;0.5750133745979643;0.9999548690865008;-0.16252165013050712;-0.23344110422825493;-0.4479775752368145;-0.42494149448853646
Elevated circulating growth hormone concentration;Elevated leukocyte alkaline phosphatase;0.8006922751665115;0.6750062;0.5638693310740175;0.6053622150539507;0.9999548690865008;-0.19926259391998924;-0.3249486582825152;-0.4360855380124833;-0.39459265403255006
Elevated circulating growth hormone concentration;Clasp-knife sign;0.9702573586255312;0.93006027;0.5094687731925824;0.5222807076414074;0.8372878781858968;0.1329694804396344;0.09277238926252851;-0.32781910499331435;-0.31500717054448935
Elevated circulating growth hormone concentration;Keratosis pilaris;1.0500761717557907;0.95803106;0.4840535901293297;0.5133630586885909;0.9999425106785123;0.05013366107727846;-0.04191145236704985;-0.5158889205491826;-0.48657945198992136
Elevated circulating growth hormone concentration;Lamina lucida cleavage;1.076291799545288;1.0115716;0.4756919463766406;0.49631655033409827;0.9999481150251853;0.07634368452010276;0.011623530711509011;-0.5242561686485447;-0.503631564691087
Elevated circulating growth hormone concentration;Abnormal central response of multifocal electroretinogram;0.848722904920578;0.7256979;0.5483385740804753;0.5884468316360298;0.9998962300503706;-0.15117332512979265;-0.27419835502748247;-0.4515576559698954;-0.4114493984143408
Elevated circulating growth hormone concentration;Atypical or prolonged hepatitis;0.8389179110527039;0.7162789;0.5514983894606293;0.591568983937397;0.9999548690865008;-0.16103695803379692;-0.2836759584495989;-0.44845647962587143;-0.4083858851491038
Elevated circulating growth hormone concentration;Cubitus varus;0.9840292111039162;0.9342462;0.5050838761321399;0.5209452040786309;0.9998962300503706;-0.01586701894645448;-0.06565004760865922;-0.49481235391823075;-0.4789510259717398
Elevated circulating growth hormone concentration;Nasal regurgitation;1.0450172759592533;0.90612656;0.4856657116926453;0.5299248983031499;0.9999528219730685;0.04506445398618486;-0.09382626319239828;-0.5142871102804232;-0.4700279236699185
Elevated circulating growth hormone concentration;Moon facies;0.8476603925228119;0.86062443;0.5486807481132896;0.5445095258192922;0.9999528219730685;-0.15229242945025656;-0.1393283894092867;-0.45127207385977886;-0.4554432961537762
Elevated circulating growth hormone concentration;Intestinal pseudo-obstruction;0.8952857702970505;0.88319534;0.5333927909219001;0.5372651420847916;0.9999468979947994;-0.10466112769774893;-0.11675155736140708;-0.46655410707289935;-0.4626817559100078
Elevated circulating growth hormone concentration;Bilateral renal atrophy;0.8504576236009598;0.7903204;0.5477800418950647;0.5672420936813818;0.9999548690865008;-0.149497245485541;-0.20963447266316093;-0.4521748271914361;-0.432712775405119
Elevated circulating growth hormone concentration;Fractured left clavicle;0.9402418322861195;0.87325317;0.519032954948976;0.5404535800488378;0.9998962300503706;-0.05965439776425119;-0.12664306337480302;-0.4808632751013946;-0.45944265000153284
Elevated circulating growth hormone concentration;Positive urine norcotinine test;0.7908411175012589;0.7464999;0.567072584301973;0.5815818092527563;0.9998962300503706;-0.2090551125491118;-0.25339633400087114;-0.4328236457483976;-0.4183144207976144
Elevated circulating growth hormone concentration;Long fibula;0.8521296977996826;0.7448013;0.5472418198037052;0.5821409008592225;0.9999505803237132;-0.14782088252403058;-0.25514929744102277;-0.45270876052000797;-0.41780967946449066
Elevated circulating growth hormone concentration;Fragmentation of the epiphysis of the distal phalanx of the hallux;0.9525673426687717;0.89353096;0.5151039509926065;0.5339545126678549;0.9998962300503706;-0.047328887381598905;-0.10636526519899125;-0.4847922790577641;-0.4659417173825158
Elevated circulating growth hormone concentration;Type II cryptotia;0.9818830471485853;0.9517663;0.5057671207140277;0.5153592238858355;0.9998962300503706;-0.01801318290178533;-0.04812991792802568;-0.4941291093363429;-0.4845370061645351
Elevated circulating growth hormone concentration;Increased variability in muscle fiber diameter;0.7312145531177521;0.6436179;0.5866222591530694;0.6159898454149388;0.999937876518323;-0.2687233234005709;-0.3563199484902163;-0.4133156173652536;-0.38394803110338416
Elevated circulating growth hormone concentration;Widened proximal tibial metaphyses;0.8094906210899353;0.59868014;0.561013958080467;0.6314484186209324;0.9999548690865008;-0.19046424799656547;-0.4012747304985491;-0.43894091100603383;-0.3685064504655684
Elevated circulating growth hormone concentration;Wide anterior fontanel;0.8155796229839325;0.68181396;0.5590407833278221;0.6030736765151227;0.9999383692587659;-0.1843587462748334;-0.31812441395175906;-0.44089758593094375;-0.3968646927436432
Elevated circulating growth hormone concentration;Increased circulating oleate level;0.7338948249816895;0.63429374;0.5857368489826711;0.6191725217552484;0.9998962300503706;-0.2660014050686812;-0.3656024950230574;-0.41415938106769956;-0.38072370829512225
Elevated circulating growth hormone concentration;Lozenge-shaped umbilicus;0.9330436289310455;0.9487909;0.52132883188976;0.5163074953513607;0.9999528219730685;-0.06690919304202292;-0.051161914113266205;-0.47862399008330847;-0.4836453266217078
Elevated circulating growth hormone concentration;Anti-myelin-associated glycoprotein antibody positivity;0.8960017040371895;0.7365601;0.5331636510208732;0.5848570645478638;0.9998962300503706;-0.10389452601318117;-0.26333612377290483;-0.4667325790294975;-0.41503916550250686
Elevated circulating growth hormone concentration;Fractured radius;0.848548024892807;0.7773576;0.5483948889819846;0.571468237240337;0.9999548690865008;-0.15140684419369377;-0.22259729080891288;-0.45155998010451615;-0.42848663184616376
Elevated circulating growth hormone concentration;Abnormal manual kinetic perimetry test;0.8715571910142899;0.7551403;0.5409978747978006;0.5787418968826139;0.9998962300503706;-0.1283390390360808;-0.24475592548494096;-0.45889835525257006;-0.42115433316775674
Elevated circulating growth hormone concentration;Small radial epiphyses;0.8589603006839752;0.8363426;0.5450445201222736;0.5523291600725637;0.9998962300503706;-0.14093592936639543;-0.1635536568844771;-0.4548517099280971;-0.44756706997780693
Elevated circulating growth hormone concentration;Generalized keratosis follicularis;0.840069979429245;0.7205015;0.5511268577217455;0.5901682053079834;0.9999548690865008;-0.15988488965725578;-0.2794533865997759;-0.44882801136475525;-0.40978666377851736
Elevated circulating growth hormone concentration;Hypoplasia of the calcaneus;0.9127813205122948;0.85688;0.5277978877442113;0.545713484110977;0.9999528219730685;-0.08717150146077368;-0.14307281279872153;-0.4721549342288571;-0.4542393378620915
Elevated circulating growth hormone concentration;2-hydroxyadipic aciduria;0.7681844532489777;0.7835413;0.5744665787265959;0.569450650435464;0.9998962300503706;-0.231711776801393;-0.21635490829591508;-0.42542965132377475;-0.4304455796149067
Elevated circulating growth hormone concentration;Potter facies;0.8834932744503021;0.86202294;0.5371696572460212;0.5440600250164774;0.9999486088983908;-0.11645533444808864;-0.13792567255424404;-0.4627789516523696;-0.45588858388191333
Elevated circulating growth hormone concentration;Increased heart rate variability;0.7030147016048431;0.5252312;0.5959812378320282;0.657468326792995;0.9999548690865008;-0.29694016748165764;-0.47472368651127494;-0.4039736312544726;-0.3424865422935057
Elevated circulating growth hormone concentration;Aplastic zygomatic arch;0.9073191285133362;0.7835473;0.5295436364267954;0.5694487070886998;0.9999528219730685;-0.09263369345973227;-0.21640553975413535;-0.4704091855462731;-0.4305041148843687
Elevated circulating growth hormone concentration;Testicular torsion;0.81550033390522;0.7594045;0.5590664624792333;0.5773427281244395;0.9999548690865008;-0.18445453518128074;-0.24055038862919487;-0.44088840660726747;-0.42261214096206123
Elevated circulating growth hormone concentration;Abolished vibration sense;0.9173960462212563;0.8738604;0.5263236493945261;0.5402587265110731;0.9260244715116542;-0.008628425290397979;-0.05216405271511493;-0.3997008221171281;-0.38576574500058114
Elevated circulating growth hormone concentration;Fractured metatarsal bone of digit 5;0.9479846656322479;0.88949364;0.5165644703544181;0.5352472460282998;0.9998962300503706;-0.051911564418122724;-0.11040258581285234;-0.48333175969595255;-0.4646489840220709
Elevated circulating growth hormone concentration;Prolonged G2 phase of cell cycle;0.6794158518314362;0.61880887;0.6038791964484521;0.6244860313619115;0.9999505803237132;-0.32053472849227704;-0.381141714776533;-0.3960713838752611;-0.3754645489618017
Elevated circulating growth hormone concentration;Single naris;0.9989224728196859;0.9663837;0.5003429876204974;0.5107024160214335;0.9999505803237132;-0.0010281075040272647;-0.03356688472129621;-0.49960759270321575;-0.4892481643022797
Elevated circulating growth hormone concentration;Perifoveal ring of hyperautofluorescence surrounded by normal autofluorescence;0.8436357527971268;0.7268953;0.5499773704871443;0.5880505559479487;0.9998962300503706;-0.15626047725324388;-0.27300095731858964;-0.4499188595632263;-0.4118456741024219
Elevated circulating growth hormone concentration;Asymmetry of the thorax;0.8267235904932022;0.71872175;0.5554353965245771;0.5907583769649998;0.9999505803237132;-0.173226989830511;-0.28122883292533674;-0.4445151837991361;-0.4091922033587134
Elevated circulating growth hormone concentration;Type 2 muscle fiber predominance;0.8772029429674149;0.8130068;0.53918642408018;0.5598742303941899;0.9999491674684583;-0.12274622450104344;-0.18694234917393315;-0.4607627433882783;-0.44007493707426837
Elevated circulating growth hormone concentration;Dependency on parenteral nutrition;0.7773818969726562;0.7500608;0.571460297084815;0.5804106365482168;0.9999528219730685;-0.2225709250004122;-0.24989202523539755;-0.4284925248882534;-0.41954218542485167
Elevated circulating growth hormone concentration;Limited shoulder flexion;0.9049060046672821;0.82984936;0.5303151657812912;0.5544254308833743;0.9998962300503706;-0.09499022538308854;-0.1700468676770186;-0.4695810642690794;-0.4454707991669964
Elevated circulating growth hormone concentration;Paroxysmal vertigo;1.0075242258608341;0.8971527;0.49760494192329463;0.532795288175095;0.9999528219730685;0.007571403887765671;-0.102800100091202;-0.5023478800497738;-0.4671575337979734
Elevated circulating growth hormone concentration;Long hallux;0.9170895516872406;0.7769662;0.5264215454441097;0.5715960352098716;0.9999451389191131;-0.08285558723187247;-0.2229789247391204;-0.4735235934750034;-0.4283491037092415
Elevated circulating growth hormone concentration;Broad medial eyebrow;0.7726375609636307;0.6806723;0.5730102059686252;0.6034570702226942;0.9999548690865008;-0.2273173081228701;-0.31928258114552177;-0.4269446631178756;-0.39649779886380654
Elevated circulating growth hormone concentration;Myxoid subcutaneous tumors;0.8871583789587021;0.87372446;0.5359952703137264;0.5403023474043676;0.9999548690865008;-0.11279649012779869;-0.12623040848469413;-0.4639595987727744;-0.4596525216821332
Elevated circulating growth hormone concentration;Bulbous tips of toes;0.7986828833818436;0.71384263;0.5645221722071382;0.5923780240672697;0.9999528219730685;-0.20126993859122488;-0.2861101915867159;-0.43543064976593027;-0.40757479790579876
Elevated circulating growth hormone concentration;Absent internal genitalia;0.9345056712627411;0.8955494;0.5208624254134302;0.5333084165112987;0.9998962300503706;-0.06539055878762956;-0.10434681350831743;-0.47903380463694045;-0.46658781353907197
Elevated circulating growth hormone concentration;Hyperphalangy of the 2nd finger;0.8605887591838837;0.7465384;0.5445209929615558;0.5815691586674927;0.9999548690865008;-0.1393661099026171;-0.25341646843647636;-0.455433876124945;-0.41838571041900807
Elevated circulating growth hormone concentration;Renal interstitial hemosiderin;0.9143655896186829;0.81999785;0.5272917051499294;0.5576104733719425;0.9998962300503706;-0.08553064043168779;-0.17989838297013994;-0.47260452490044125;-0.4422857566784282
Elevated circulating growth hormone concentration;Abnormality of depressor anguli oris muscle;0.9418496415019035;0.85080665;0.5185202816241041;0.547667681736701;0.9998962300503706;-0.058046588548467115;-0.14908957655076738;-0.4813759484262665;-0.45222854831366965
Elevated circulating growth hormone concentration;Paroxysmal dyspnea;1.0287614408880472;0.9240058;0.49084368634674314;0.5242130540158683;0.9998962300503706;0.02886521083767657;-0.07589042360429521;-0.5090525437036275;-0.4756831760345024
Elevated circulating growth hormone concentration;Phenylpyruvic acidemia;0.9160773903131485;0.8340179;0.5267448532327121;0.5530794102387846;0.9999548690865008;-0.08387747877335228;-0.165936996276137;-0.47321001585378863;-0.4468754588477162
Elevated circulating growth hormone concentration;Lateral ventricle dilatation;0.7977197766304016;0.75145257;0.5648351780836511;0.5799531910147306;0.796956230946341;0.0007635456840605626;-0.04550366575316478;-0.23212105286268991;-0.2170030399316104
Elevated circulating growth hormone concentration;Neonatal unconjugated hyperbilirubinemia;0.832543283700943;0.7456973;0.553555444226796;0.5818459424095037;0.9999548690865008;-0.16741158538555778;-0.2542575495789019;-0.44639942485970474;-0.41810892667699706
Elevated circulating growth hormone concentration;High maternal circulating alpha-fetoprotein concentration;0.6005431115627289;0.5704974;0.6308012796868663;0.6413111024368443;0.9998962300503706;-0.39935311848764177;-0.4293988364422774;-0.36909495036350437;-0.35858512761352634
Elevated circulating growth hormone concentration;Prominent nasolabial fold;0.949797511100769;0.79333013;0.5159866685022355;0.5662626005388683;0.9999476714516888;-0.05015016035091979;-0.20661753849041564;-0.4839610029494533;-0.4336850709128205
Elevated circulating growth hormone concentration;Abnormality of inferior alveolar nerve;0.9275170862674713;0.8362559;0.5230922784652983;0.5523571332915982;0.705060803258061;0.22245628300941034;0.13119510475432916;-0.1819685247927627;-0.15270366996646279
Elevated circulating growth hormone concentration;Unilateral conductive hearing impairment;1.0328857190907001;0.880647;0.48953026280191203;0.5380820178502769;0.9999548690865008;0.032930850004199375;-0.11930786543583549;-0.5104246062845887;-0.4618728512362239
Elevated circulating growth hormone concentration;Macular hypopigmented whorls, streaks, and patches;0.9782276377081871;0.93395656;0.5069309058194907;0.5210375911079925;0.9999548690865008;-0.02172723137831367;-0.06599830561375297;-0.49302396326701003;-0.47891727797850825
Elevated circulating growth hormone concentration;Delayed ossification of pubic rami;0.7425467669963837;0.71444786;0.582883330549554;0.5921769761610027;0.9999528219730685;-0.2574060549766848;-0.2855049660236666;-0.41706949142351446;-0.4077758458120657
Elevated circulating growth hormone concentration;Hyperphenylalaninemia;0.7419930994510651;0.61852705;0.5830657304283191;0.6245830666841232;0.9999498126421364;-0.2579567131910714;-0.3814227578554543;-0.41688408221381734;-0.3753667459580132
Elevated circulating growth hormone concentration;Ureteropelvic junction obstruction;0.9346274733543396;0.8485951;0.5208235713367544;0.5483797352481826;0.9999453908499725;-0.06531791749563287;-0.1513503080901153;-0.4791218195132181;-0.45156565560178985
Elevated circulating growth hormone concentration;Cone-shaped epiphysis of the proximal phalanx of the 2nd toe;0.9159338101744652;0.8496921;0.5267907182870628;0.5480264992642871;0.9998962300503706;-0.08396241987590547;-0.1502041238034224;-0.47310551176330784;-0.4518697307860835
Elevated circulating growth hormone concentration;Difficulty walking;0.9530181065201759;0.8506548;0.5149603082560252;0.5477165720363245;0.8999749757540185;0.05304313076615741;-0.04932019488930295;-0.3850146674979933;-0.352258403717694
Elevated circulating growth hormone concentration;Bilobate gallbladder;0.926680713891983;0.88258064;0.5233592143385664;0.5374621757384814;0.9999528219730685;-0.07327210808108542;-0.11737218404124472;-0.4765936076345021;-0.462490646234587
Elevated circulating growth hormone concentration;Histidinuria;0.8049488365650177;0.7298348;0.5624872912917176;0.5870783208039361;0.9999515360511232;-0.1950026994861055;-0.27011674105295425;-0.4374642447594056;-0.4128732152471871
Elevated circulating growth hormone concentration;Widened interpedicular distance;0.8460987955331802;0.67485565;0.5491837515772096;0.6054128924923421;0.9998962300503706;-0.1537974345171904;-0.3250405805790877;-0.4507124784731611;-0.39448333755802856
Visual acuity no light perception;Spinal hypomyelination;0.8212713301181793;0.7147124;0.5571984287754803;0.5920891304362295;1.0;-0.17872866988182068;-0.28528761863708496;-0.4428015712245197;-0.40791086956377054
Visual acuity no light perception;Bladder polyp;0.9913540631532669;0.8928465;0.5027521214622287;0.5341736206961206;0.9999201345566091;-0.008566071403342201;-0.10707360984118552;-0.4971680130943804;-0.4657465138604885
Visual acuity no light perception;Aberrant melanosome maturation;0.7719791829586029;0.7956183;0.5732254273586841;0.5655183722764896;0.9999201345566091;-0.2279409515980062;-0.20430183888705344;-0.426694707197925;-0.4344017622801195
Visual acuity no light perception;Vertebral artery tortuosity;0.9066205844283104;0.79522604;0.5297669584017168;0.565645934577784;0.9999201345566091;-0.09329955012829871;-0.2046940970543203;-0.47015317615489227;-0.4342741999788251
Visual acuity no light perception;Warm reactive autoantibody positivity;0.9759985022246838;0.91401386;0.5076406477386118;0.5274040873433664;1.0;-0.02400149777531624;-0.08598613739013672;-0.49235935226138816;-0.4725959126566336
Visual acuity no light perception;Right aortic arch with retroesophageal left subclavian artery;0.950792983174324;0.89139616;0.5156694077379662;0.5346379946626625;1.0;-0.049207016825675964;-0.108603835105896;-0.4843305922620338;-0.4653620053373375
Visual acuity no light perception;Elevated urine suberic acid level;0.9688613340258598;0.8951376;0.5099133476867574;0.5334402182817104;0.9999201345566091;-0.031058800530749275;-0.10478252650530906;-0.49000678686985166;-0.4664799162748987
Visual acuity no light perception;Burkitt lymphoma;0.9449389241635799;0.92883545;0.5175353527915127;0.5226715502311775;0.9999090677057578;-0.054970143542177885;-0.07107361610282203;-0.4823737149142451;-0.4772375174745803
Visual acuity no light perception;Snail-like ilia;0.9850602149963379;0.952178;0.5047556581835608;0.5152280253414341;0.9999201345566091;-0.014859919560271218;-0.047742133152800514;-0.4951644763730483;-0.484692109215175
Visual acuity no light perception;Indurated nodule;0.9257817715406418;0.84621227;0.5236461383467302;0.5491472018299528;1.0;-0.07421822845935822;-0.1537877321243286;-0.47635386165326976;-0.4508527981700472
Visual acuity no light perception;Absent leukocyte alkaline phosphatase;0.9792786482721567;0.7615557;0.506596283213381;0.5766374481004246;0.9999201345566091;-0.020641486284452393;-0.23836446286471458;-0.4933238513432281;-0.4232826864561845
Visual acuity no light perception;Hippocampal sclerosis;0.9539414867758751;0.85989547;0.5146660686226439;0.5447438713620446;1.0;-0.04605851322412491;-0.1401045322418213;-0.48533393137735614;-0.4552561286379554
Visual acuity no light perception;Decreased sensitivity to hypoxemia;0.8748307079076767;0.79881513;0.5399474015990406;0.5644792019829057;0.9999201345566091;-0.1250894266489324;-0.20110500336917014;-0.45997273295756846;-0.4354409325737034
Visual acuity no light perception;Decreased level of tissue plasminogen activator;0.9911863096058369;0.92201513;0.5028055211097036;0.5248485922919846;1.0;-0.008813690394163132;-0.07798486948013306;-0.49719447889029644;-0.47515140770801545
Visual acuity no light perception;Submandibular lymph node enlargement;0.9483260624110699;0.9230941;0.5164556540438264;0.5245041082276607;0.9999201345566091;-0.05159407214553924;-0.07682604075701804;-0.4834644805127827;-0.4754160263289484
Visual acuity no light perception;Hepatic hemangioma;0.9908447861671448;0.9426343;0.5029142357849647;0.5182700972257036;0.9999134918687169;-0.009068705701572144;-0.057279207372409546;-0.49699925608375217;-0.4816433946430133
Visual acuity no light perception;Triangular epiphysis of the distal phalanx of the 2nd finger;0.9467093572020531;0.89101213;0.5169709775420861;0.5347609612492003;1.0;-0.05329064279794693;-0.10898786783218384;-0.4830290224579139;-0.46523903875079975
Visual acuity no light perception;Acne inversa;0.9067299365997314;0.8446065;0.5297319979473545;0.5496645517202766;0.9998962300503706;-0.0931662934506392;-0.15528971130494829;-0.47016423210301617;-0.45023167833009403
Visual acuity no light perception;Dentin dysplasia;0.9215992540121078;0.85292995;0.5249813693114892;0.5469842662387857;1.0;-0.07840074598789215;-0.147070050239563;-0.4750186306885108;-0.4530157337612143
Visual acuity no light perception;Aplasia of the inner ear;0.8161184191703796;0.7479179;0.5588662950690084;0.581115295587509;0.9999201345566091;-0.18380171538622947;-0.25200224400790305;-0.4410538394876007;-0.41880483896910015
Visual acuity no light perception;Polycystic liver disease;1.0160295329988003;0.952808;0.49489742264524994;0.5150272448369555;0.9999056439461368;0.016123889052663487;-0.04709762144705232;-0.5050082213008869;-0.4848783991091813
Visual acuity no light perception;Subungual hyperkeratosis;0.9171391576528549;0.8836942;0.5264057008546349;0.5371052671119873;0.9999003561294039;-0.08276119847654895;-0.11620618422388629;-0.47349465527476897;-0.4627950890174166
Visual acuity no light perception;Broad humeral epiphyses;0.9832511469721794;0.9039848;0.5053315747933271;0.5306097470420039;1.0;-0.016748853027820587;-0.09601521492004395;-0.49466842520667287;-0.4693902529579961
Visual acuity no light perception;Autoimmune thrombocytopenia;0.9630515947937965;0.87751937;0.511763720300296;0.539084941191323;0.9998726169824932;-0.03682102218869665;-0.12235324785712698;-0.48810889668219715;-0.4607876757911702
Visual acuity no light perception;Adenomyosis;0.9736584015190601;0.85677683;0.5083857611901583;0.5457466725920993;0.9999201345566091;-0.026261733037548973;-0.14314330102236839;-0.4915343733664508;-0.4541734619645098
Visual acuity no light perception;Elevated leukocyte alkaline phosphatase;1.063371442258358;0.97627795;0.4798147175432237;0.5075516787576291;0.9999201345566091;0.0634513077017489;-0.023642187130766823;-0.5201054170133854;-0.49236845579898003
Visual acuity no light perception;Clasp-knife sign;1.0506323389708996;1.0147561;0.4838763317376047;0.49530283857808577;1.0;0.05063233897089958;0.014756083488464355;-0.5161236682623953;-0.5046971614219142
Visual acuity no light perception;Keratosis pilaris;0.8287204802036285;0.8605966;0.554790118718111;0.5445184782323971;0.9998710980331391;-0.17115061782951058;-0.13927450083846749;-0.4450809793150281;-0.45535261980074204
Visual acuity no light perception;Lamina lucida cleavage;0.9922230350784957;0.98355144;0.5024755097730738;0.5052359763267706;0.9998962300503706;-0.007673194971874908;-0.01634478742723222;-0.4974207202772969;-0.4946602537236
Visual acuity no light perception;Abnormal central response of multifocal electroretinogram;0.38208162784576416;0.5415617;0.7120237878867146;0.651590979417353;1.0;-0.6179183721542358;-0.45843827724456787;-0.2879762121132854;-0.348409020582647
Visual acuity no light perception;Atypical or prolonged hepatitis;1.0004682913422585;0.92787683;0.4998509382306967;0.5229774584424064;0.9999201345566091;0.0005481567856493452;-0.07204330445559592;-0.5000691963259124;-0.4769426761142027
Visual acuity no light perception;Cubitus varus;0.9277016520500183;0.87957764;0.523033374809786;0.5384248904019124;1.0;-0.07229834794998169;-0.12042236328125;-0.47696662519021404;-0.46157510959808756
Visual acuity no light perception;Nasal regurgitation;0.9789872113615274;0.84844345;0.5066890706671964;0.5484285606095329;0.9999134918687169;-0.020926280507189476;-0.15147004332516834;-0.49322442120152055;-0.451484931259184
Visual acuity no light perception;Moon facies;0.844469353556633;0.9007017;0.5497087405231864;0.531659802173589;0.9999134918687169;-0.15544413831208392;-0.09921179022763416;-0.4502047513455305;-0.46825368969512793
Visual acuity no light perception;Intestinal pseudo-obstruction;0.9294759929180145;0.81841564;0.5224671388730553;0.5581225385344118;0.9998912449978579;-0.07041525207984334;-0.1814756032131899;-0.47742410612480257;-0.441768706463446
Visual acuity no light perception;Bilateral renal atrophy;0.8693050146102905;0.81162405;0.5417208594302978;0.5603223376193449;0.9999201345566091;-0.13061511994631858;-0.18829608441622825;-0.4581992751263113;-0.4395977969372642
Visual acuity no light perception;Fractured left clavicle;1.0057563013397157;0.89121854;0.49816770225675466;0.5346948775739928;1.0;0.005756301339715719;-0.10878145694732666;-0.5018322977432453;-0.4653051224260072
Visual acuity no light perception;Positive urine norcotinine test;0.9242027848958969;0.82898885;0.5241501653270171;0.5547034146719605;1.0;-0.07579721510410309;-0.17101114988327026;-0.4758498346729829;-0.4452965853280395
Visual acuity no light perception;Long fibula;1.0155641483142972;0.9171822;0.4950455776790138;0.5263919481468236;0.9999056439461368;0.01565850436816041;-0.08272343683859285;-0.504860066267123;-0.47351369579931324
Visual acuity no light perception;Fragmentation of the epiphysis of the distal phalanx of the hallux;0.9177282974123955;0.82968813;0.5262175293447569;0.5544775123395561;1.0;-0.08227170258760452;-0.17031186819076538;-0.47378247065524315;-0.4455224876604439
Visual acuity no light perception;Type II cryptotia;0.9233984872698784;0.89680773;0.5244069277303767;0.5329056898523614;1.0;-0.07660151273012161;-0.1031922698020935;-0.47559307226962333;-0.4670943101476386
Visual acuity no light perception;Increased variability in muscle fiber diameter;0.9601619392633438;0.91440177;0.5126842052113492;0.5272801462498977;0.9998452077479463;-0.03968326848460246;-0.08544343810988475;-0.4871610025365971;-0.47256506149804856
Visual acuity no light perception;Widened proximal tibial metaphyses;0.9947434598580003;0.934614;0.5016732163998809;0.5208278612412551;0.9999201345566091;-0.00517667469860883;-0.06530613185198875;-0.49824691815672817;-0.479092273315354
Visual acuity no light perception;Wide anterior fontanel;0.8926703929901123;0.83653843;0.5342300103650368;0.5522659646002358;0.999848231156753;-0.10717783816664073;-0.16330979712812754;-0.4656182207917162;-0.4475822665565172
Visual acuity no light perception;Increased circulating oleate level;1.0199197307229042;0.98666835;0.4936589333823269;0.504243725210618;1.0;0.019919730722904205;-0.01333165168762207;-0.5063410666176731;-0.495756274789382
Visual acuity no light perception;Lozenge-shaped umbilicus;1.009753355756402;0.944378;0.49689536121495637;0.517714166313343;0.9999134918687169;0.009839863887685096;-0.055535473489505494;-0.5030181306537606;-0.4821993255553739
Visual acuity no light perception;Anti-myelin-associated glycoprotein antibody positivity;0.9011092260479927;0.8146464;0.531529443876244;0.5593430459795141;1.0;-0.0988907739520073;-0.1853535771369934;-0.468470556123756;-0.4406569540204859
Visual acuity no light perception;Fractured radius;0.9261922389268875;0.81095695;0.52351512318049;0.5605385752536622;0.9999201345566091;-0.0737278956297216;-0.18896317960055442;-0.4764050113761191;-0.43938155930294687
Visual acuity no light perception;Abnormal manual kinetic perimetry test;0.40552961826324463;0.6092003;0.7026382556553621;0.6278014905493109;1.0;-0.5944703817367554;-0.39079970121383667;-0.2973617443446379;-0.3721985094506891
Visual acuity no light perception;Small radial epiphyses;0.9427884295582771;0.869633;0.5182209577394461;0.5416155514080817;1.0;-0.05721157044172287;-0.1303669810295105;-0.4817790422605539;-0.4583844485919183
Visual acuity no light perception;Generalized keratosis follicularis;0.8313920646905899;0.7971283;0.5539271740879512;0.5650274307219505;0.9999201345566091;-0.1685280698660192;-0.2027918148163137;-0.4459929604686579;-0.4348927038346586
Visual acuity no light perception;Hypoplasia of the calcaneus;0.9536216855049133;0.8652133;0.5147679734289872;0.5430349300912598;0.9999134918687169;-0.04629180636380359;-0.1347002169129674;-0.48514551843972975;-0.4568785617774571
Visual acuity no light perception;2-hydroxyadipic aciduria;0.9303699731826782;0.8513568;0.5221818748093411;0.547490588597352;1.0;-0.06963002681732178;-0.14864319562911987;-0.4778181251906589;-0.452509411402648
Visual acuity no light perception;Potter facies;0.9891159292310476;0.996599;0.5034645757339815;0.5010825603899349;0.9998981869165328;-0.01078225768548513;-0.0032991683427717744;-0.49643361118255125;-0.49881562652659783
Visual acuity no light perception;Increased heart rate variability;1.0104412250220776;1.010854;0.4966763944602792;0.496544982055799;0.9999201345566091;0.010521090465468452;0.010933871256989525;-0.5032437400963299;-0.5033751525008101
Visual acuity no light perception;Aplastic zygomatic arch;0.9739212468266487;0.8967758;0.5083020661769151;0.5329159138435652;0.9999134918687169;-0.025992245042068207;-0.10313770976041003;-0.49161142569180183;-0.46699757802515174
Visual acuity no light perception;Testicular torsion;0.9652813971042633;0.89773536;0.5110534959081049;0.5326088584216813;0.9999201345566091;-0.0346387374523458;-0.10218477727206321;-0.4888666386485042;-0.46731127613492784
Visual acuity no light perception;Abolished vibration sense;0.7082509398460388;0.6262586;0.594237215302986;0.6219252460859723;0.9999134918687169;-0.2916625520226781;-0.37365488018963977;-0.4056762765657309;-0.3779882457827446
Visual acuity no light perception;Fractured metatarsal bone of digit 5;0.9358287155628204;0.861778;0.520440399418213;0.5441387382389491;1.0;-0.06417128443717957;-0.13822197914123535;-0.47955960058178704;-0.4558612617610509
Visual acuity no light perception;Prolonged G2 phase of cell cycle;0.9994577616453171;0.9755728;0.5001725998374216;0.5077761831363221;0.9999056439461368;-0.00044788230081971303;-0.024332819467987377;-0.4997330441087152;-0.4921294608098147
Visual acuity no light perception;Single naris;0.7312189638614655;0.7349789;0.586620801530225;0.5853789206622164;0.9999056439461368;-0.26868668008467134;-0.26492672968527253;-0.4132848424159118;-0.4145267232839204
Visual acuity no light perception;Perifoveal ring of hyperautofluorescence surrounded by normal autofluorescence;0.4767190217971802;0.6455024;0.675292174890034;0.6153480961091525;1.0;-0.5232809782028198;-0.35449761152267456;-0.324707825109966;-0.38465190389084747
Visual acuity no light perception;Asymmetry of the thorax;0.9860632224008441;0.94402343;0.5044363577143409;0.5178272089379585;0.9999056439461368;-0.013842421545292694;-0.055882213598694164;-0.49546928623179587;-0.48207843500817826
Visual acuity no light perception;Type 2 muscle fiber predominance;0.9873030409216881;0.92502576;0.5040416761990276;0.5238874491616494;0.9999003561294039;-0.012597315207715787;-0.07487459500193194;-0.49585867993037624;-0.47601290696775445
Visual acuity no light perception;Dependency on parenteral nutrition;0.9910540990531445;0.92369974;0.5028476066949872;0.524310762764894;0.9999134918687169;-0.008859392815572464;-0.07621375527356311;-0.49706588517372974;-0.47560272910382295
Visual acuity no light perception;Limited shoulder flexion;0.8655798137187958;0.7654162;0.5429171856507136;0.5753727233102021;1.0;-0.13442018628120422;-0.2345837950706482;-0.45708281434928644;-0.42462727668979794
Visual acuity no light perception;Paroxysmal vertigo;0.8008158951997757;0.76503164;0.5638291764763885;0.5754986602248755;0.9999134918687169;-0.19909759666894122;-0.23488185610745593;-0.4360843153923284;-0.4244148316438414
Visual acuity no light perception;Long hallux;0.9396082907915115;0.89925104;0.5192349823612433;0.5321238906956107;0.9998836012415208;-0.06027531045000922;-0.10063255744498145;-0.48064861888027743;-0.46775971054591003
Visual acuity no light perception;Broad medial eyebrow;0.8502945601940155;0.8884709;0.5478325375339401;0.5355748243700132;0.9999201345566091;-0.1496255743625936;-0.11144924641879173;-0.452087597022669;-0.46434531018659586
Visual acuity no light perception;Myxoid subcutaneous tumors;0.9560809768736362;0.9184556;0.5139843574046629;0.5259852314681457;0.9999201345566091;-0.04383915768297286;-0.08146453381808372;-0.48593577715194625;-0.4739349030884634
Visual acuity no light perception;Bulbous tips of toes;0.9525889903306961;0.9109787;0.5150970525667428;0.5283739190996617;0.9999134918687169;-0.04732450153802081;-0.08893481698010608;-0.48481643930197416;-0.4715395727690552
Visual acuity no light perception;Absent internal genitalia;0.824769988656044;0.66488636;0.5560669090011547;0.6087747153325591;1.0;-0.175230011343956;-0.33511364459991455;-0.44393309099884526;-0.3912252846674409
Visual acuity no light perception;Hyperphalangy of the 2nd finger;0.9608934596180916;0.9396956;0.5124511734354595;0.5192071484135212;0.9999201345566091;-0.039026674938517525;-0.06022453786166282;-0.48746896112114957;-0.4807129861430879
Visual acuity no light perception;Renal interstitial hemosiderin;0.9386640004813671;0.8933327;0.5195361175952298;0.5340179678926678;1.0;-0.06133599951863289;-0.10666728019714355;-0.4804638824047702;-0.46598203210733224
Visual acuity no light perception;Abnormality of depressor anguli oris muscle;0.906705230474472;0.8245519;0.5297398965918185;0.5561374274932683;1.0;-0.09329476952552795;-0.17544811964035034;-0.4702601034081815;-0.44386257250673167
Visual acuity no light perception;Paroxysmal dyspnea;0.9440016783773899;0.8452016;0.517834148433041;0.5494727883825954;1.0;-0.05599832162261009;-0.15479838848114014;-0.482165851566959;-0.4505272116174046
Visual acuity no light perception;Phenylpyruvic acidemia;0.9759174138307571;0.9047668;0.5076664664389989;0.5303596715014354;0.9999201345566091;-0.024002720725851967;-0.09515333653719993;-0.4922536681176102;-0.46956046305517374
Visual acuity no light perception;Lateral ventricle dilatation;0.9546406641602516;0.9263028;0.5144432806866768;0.5234798468907595;0.9998579617208769;-0.045217297560625314;-0.07355517107909226;-0.48541468103420016;-0.4763781148301174
Visual acuity no light perception;Neonatal unconjugated hyperbilirubinemia;0.938363716006279;0.8105391;0.519631882305525;0.5606740171024394;0.9999201345566091;-0.061556418550330116;-0.1893810081604299;-0.48028825225108407;-0.43924611745416975
Visual acuity no light perception;High maternal circulating alpha-fetoprotein concentration;0.9586770460009575;0.9093663;0.5131572511215915;0.5288892461053823;1.0;-0.04132295399904251;-0.09063369035720825;-0.4868427488784085;-0.47111075389461765
Visual acuity no light perception;Prominent nasolabial fold;0.9130434989929199;0.82316124;0.5277141154621138;0.5565871213817557;0.9998944404568447;-0.0868509414639248;-0.1767331960644497;-0.47218032499473095;-0.443307319075089
Visual acuity no light perception;Abnormality of inferior alveolar nerve;0.9093760177493095;0.8104667;0.5288861407682353;0.560697494368822;1.0;-0.09062398225069046;-0.1895332932472229;-0.47111385923176474;-0.439302505631178
Visual acuity no light perception;Unilateral conductive hearing impairment;0.7041656672954559;0.6169236;0.5955976352712563;0.6251354136042011;0.9999201345566091;-0.2957544672611532;-0.38299656392367454;-0.4043224992853528;-0.374784720952408
Visual acuity no light perception;Macular hypopigmented whorls, streaks, and patches;0.5177304744720459;0.68803084;0.6601874083583217;0.6009885734313077;0.9999201345566091;-0.4821896600845632;-0.3118892955902395;-0.3397327261982874;-0.39893156112530137
Visual acuity no light perception;Delayed ossification of pubic rami;1.0321858376264572;0.90947336;0.4897531600038535;0.5288550232513114;0.9999134918687169;0.032272345757740295;-0.09044013228390857;-0.5101603318648634;-0.4710584686174055
Visual acuity no light perception;Hyperphenylalaninemia;1.006436413154006;0.9305249;0.49795121191535163;0.5221324425557516;0.9999028053808913;0.006533607773114736;-0.0693779197264418;-0.5019515934655396;-0.4777703628251396
Visual acuity no light perception;Ureteropelvic junction obstruction;0.9214855656027794;0.81619084;0.5250176693527545;0.5588428386264834;0.9998847295244674;-0.078399163921688;-0.18369389071068565;-0.4748670601717129;-0.44104189089798396
Visual acuity no light perception;Cone-shaped epiphysis of the proximal phalanx of the 2nd toe;0.9193632900714874;0.85229796;0.5256953598332393;0.5471876650821177;1.0;-0.08063670992851257;-0.14770203828811646;-0.47430464016676066;-0.4528123349178823
Visual acuity no light perception;Difficulty walking;0.7688430398702621;0.7494915;0.5742510910508825;0.5805977992831926;0.9998344221996177;-0.23099138232935557;-0.25034290942419657;-0.42558333114873526;-0.41923662291642516
Visual acuity no light perception;Bilobate gallbladder;1.0125582814216614;0.92899543;0.49600246978994167;0.5226204839640574;0.9999134918687169;0.012644789552944458;-0.07091806139920398;-0.5039110220787753;-0.47729300790465956
Visual acuity no light perception;Histidinuria;0.9637077450752258;0.87900233;0.511554720988999;0.5386093666626037;0.9999090677057578;-0.036201322630531996;-0.1209067350183799;-0.4883543467167588;-0.4612997010431541
Visual acuity no light perception;Widened interpedicular distance;0.9911054000258446;0.94129753;0.5028312764384849;0.5186963162327127;1.0;-0.008894599974155426;-0.05870246887207031;-0.4971687235615151;-0.48130368376728727
Spinal hypomyelination;Bladder polyp;0.9116227328777313;0.81164485;0.5281681073400009;0.5603156050978171;0.9999201345566091;-0.08829740167887778;-0.18827528239520164;-0.47175202721660825;-0.439604529458792
Spinal hypomyelination;Aberrant melanosome maturation;0.6806931495666504;0.56260574;0.6034500629133905;0.6440985804557855;0.9999201345566091;-0.3192269849899587;-0.43731439591677757;-0.39647007164321857;-0.3558215541008236
Spinal hypomyelination;Vertebral artery tortuosity;0.7125757038593292;0.6967659;0.592798972546966;0.598066404790413;0.9999201345566091;-0.2873444306972799;-0.303154234898406;-0.4071211620096431;-0.40185372976619615
Spinal hypomyelination;Warm reactive autoantibody positivity;0.9535900354385376;0.8978777;0.5147780588178374;0.5325633082810701;1.0;-0.0464099645614624;-0.10212230682373047;-0.48522194118216255;-0.4674366917189299
Spinal hypomyelination;Right aortic arch with retroesophageal left subclavian artery;0.9497693665325642;0.8374214;0.5159956385135291;0.5519810914889716;1.0;-0.05023063346743584;-0.16257858276367188;-0.48400436148647086;-0.44801890851102844
Spinal hypomyelination;Elevated urine suberic acid level;0.9438045136630535;0.8664298;0.5178970068923239;0.5426441530750075;0.9999201345566091;-0.056115620893555596;-0.13349032880099387;-0.48202312766428523;-0.45727598148160165
Spinal hypomyelination;Burkitt lymphoma;0.8805475980043411;0.8333131;0.5381138900384292;0.5533069132705639;0.9999090677057578;-0.1193614697014167;-0.16659596021521828;-0.4617951776673286;-0.4466021544351939
Spinal hypomyelination;Snail-like ilia;0.9318155199289322;0.8646456;0.5217206466413136;0.543217307338032;0.9999201345566091;-0.06810461462767692;-0.13527453423770042;-0.47819948791529554;-0.45670282721857713
Spinal hypomyelination;Indurated nodule;0.8938497602939606;0.8151012;0.5338524490528167;0.5591957376526755;1.0;-0.10615023970603943;-0.18489879369735718;-0.4661475509471833;-0.4408042623473245
Spinal hypomyelination;Absent leukocyte alkaline phosphatase;0.926176056265831;0.8062073;0.5235202883727084;0.5620789078932139;0.9999201345566091;-0.07374407829077811;-0.1937128353241262;-0.47639984618390074;-0.4378412266633952
Spinal hypomyelination;Hippocampal sclerosis;0.6916675567626953;0.6434287;0.5997709137831353;0.6160543195691845;1.0;-0.3083324432373047;-0.3565713167190552;-0.4002290862168647;-0.38394568043081545
Spinal hypomyelination;Decreased sensitivity to hypoxemia;0.6189329624176025;0.4515735;0.6244432949483747;0.6847729540942504;0.9999201345566091;-0.38098717213900657;-0.5483466434601125;-0.3754768396082344;-0.3151471804623587
Spinal hypomyelination;Decreased level of tissue plasminogen activator;0.8980186432600021;0.7341008;0.5325182070058988;0.5856688383962547;1.0;-0.10198135673999786;-0.2658991813659668;-0.4674817929941012;-0.4143311616037453
Spinal hypomyelination;Submandibular lymph node enlargement;0.9486802332103252;0.8617631;0.5163427681946147;0.5441435178223684;0.9999201345566091;-0.05123990134628387;-0.1381570148590383;-0.48357736636199444;-0.45577661673424075
Spinal hypomyelination;Hepatic hemangioma;0.9253210797905922;0.85381293;0.5237931891740701;0.5467001329256062;0.9999134918687169;-0.07459241207812473;-0.14610055890057727;-0.4761203026946468;-0.45321335894311077
Spinal hypomyelination;Triangular epiphysis of the distal phalanx of the 2nd finger;0.8643907755613327;0.7159452;0.5432991658406601;0.5916797703882998;1.0;-0.1356092244386673;-0.28405481576919556;-0.45670083415933993;-0.4083202296117002
Spinal hypomyelination;Acne inversa;0.9656773656606674;0.7989924;0.5109273800343082;0.5644215954727181;0.9998962300503706;-0.03421886438970323;-0.20090383464936967;-0.4889688500160625;-0.43547463457765256
Spinal hypomyelination;Dentin dysplasia;0.8159496188163757;0.63470364;0.5589209588587135;0.6190323476359313;1.0;-0.18405038118362427;-0.3652963638305664;-0.4410790411412865;-0.3809676523640687
Spinal hypomyelination;Aplasia of the inner ear;0.7728397846221924;0.642339;0.5729441066103715;0.6164256761175387;0.9999201345566091;-0.22708034993441673;-0.357581143391448;-0.42697602794623757;-0.3834944584390704
Spinal hypomyelination;Polycystic liver disease;0.8551428318023682;0.7156549;0.5462722678076485;0.5917761415309989;0.9999056439461368;-0.14476281214376863;-0.2842507343353885;-0.4536333761384883;-0.4081295024151379
Spinal hypomyelination;Subungual hyperkeratosis;0.9464656971395016;0.84162784;0.5170486478206591;0.55062457446315;0.9999003561294039;-0.053434658989902295;-0.15827251990198687;-0.4828517083087448;-0.4492757816662538
Spinal hypomyelination;Broad humeral epiphyses;1.0201913453638554;0.9540875;0.49357245836367436;0.5146195361644093;1.0;0.020191345363855362;-0.04591250419616699;-0.5064275416363256;-0.48538046383559075
Spinal hypomyelination;Autoimmune thrombocytopenia;0.8561977446079254;0.7403709;0.5459329255848591;0.5836002981174966;0.9998726169824932;-0.14367487237456777;-0.25950168774131277;-0.4539396913976341;-0.4162723188649966
Spinal hypomyelination;Adenomyosis;0.8775819092988968;0.75533926;0.5390648783146825;0.5786765742306295;0.9999201345566091;-0.12233822525771232;-0.24458086968691917;-0.4608552562419266;-0.42124356032597965
Spinal hypomyelination;Elevated leukocyte alkaline phosphatase;1.0334389805793762;0.9723208;0.48935405728125536;0.5088116887947729;0.9999201345566091;0.03351884602276711;-0.027599339497405007;-0.5105660772753537;-0.4911084457618362
Spinal hypomyelination;Clasp-knife sign;0.9945096271112561;0.94245774;0.5017476487496415;0.5183263898626802;1.0;-0.005490372888743877;-0.057542264461517334;-0.4982523512503585;-0.4816736101373198
Spinal hypomyelination;Keratosis pilaris;0.9017120152711868;0.80261004;0.5313366307572284;0.5632465130850224;0.9998710980331391;-0.09815908276195229;-0.19726105832214058;-0.46853446727591075;-0.43662458494811673
Spinal hypomyelination;Lamina lucida cleavage;0.8982580006122589;0.7995435;0.5324416188262411;0.5642425287536357;0.9998962300503706;-0.10163822943811174;-0.2003527301037764;-0.46745461122412957;-0.435653701296735
Spinal hypomyelination;Abnormal central response of multifocal electroretinogram;0.7877629697322845;0.7109854;0.5680748901818493;0.5933276079844108;1.0;-0.21223703026771545;-0.2890145778656006;-0.4319251098181507;-0.40667239201558925
Spinal hypomyelination;Atypical or prolonged hepatitis;0.9289288222789764;0.85882807;0.5226417468425065;0.5450870461427978;0.9999201345566091;-0.07099131227763267;-0.1410920667770681;-0.4772783877141026;-0.4548330884138113
Spinal hypomyelination;Cubitus varus;0.9696121215820312;0.922382;0.5096742514149543;0.5247314576075501;1.0;-0.03038787841796875;-0.07761800289154053;-0.49032574858504574;-0.47526854239244987
Spinal hypomyelination;Nasal regurgitation;0.9959587180055678;0.8642936;0.5012863835132279;0.5433303847580395;0.9999134918687169;-0.00395477386314913;-0.13561991658185168;-0.49862710835548907;-0.4565831071106774
Spinal hypomyelination;Moon facies;1.0656350180506706;1.032583;0.4790926952212473;0.48962667468457677;0.9999134918687169;0.0657215261819537;0.03266950640703992;-0.5208207966474696;-0.5102868171841402
Spinal hypomyelination;Intestinal pseudo-obstruction;0.8316821157932281;0.722409;0.5538335092962898;0.5895360095698299;0.9998912449978579;-0.16820912920462971;-0.2774822350643862;-0.44605773570156804;-0.410355235428028
Spinal hypomyelination;Bilateral renal atrophy;0.8024027198553085;0.7030615;0.5633138309254231;0.5959656306901175;0.9999201345566091;-0.19751741470130058;-0.2968586135032949;-0.436606303631186;-0.40395450386649157
Spinal hypomyelination;Fractured left clavicle;0.9887883961200714;0.79902196;0.5035688391248371;0.5644119937887218;1.0;-0.011211603879928589;-0.20097804069519043;-0.4964311608751629;-0.43558800621127824
Spinal hypomyelination;Positive urine norcotinine test;0.9555018469691277;0.9039502;0.5141688805854214;0.5306208047136234;1.0;-0.044498153030872345;-0.09604978561401367;-0.48583111941457857;-0.4693791952863766
Spinal hypomyelination;Long fibula;1.0473983585834503;0.9635542;0.4849069789313025;0.5116036200225322;0.9999056439461368;0.04749271463731353;-0.03635144043585237;-0.5149986650148343;-0.48830202392360456
Spinal hypomyelination;Fragmentation of the epiphysis of the distal phalanx of the hallux;0.9530836828052998;0.768206;0.514939411633101;0.5744595182818792;1.0;-0.04691631719470024;-0.23179399967193604;-0.485060588366899;-0.42554048171812076
Spinal hypomyelination;Type II cryptotia;0.8515352159738541;0.75865537;0.5474331612232473;0.5775884223514459;1.0;-0.14846478402614594;-0.2413446307182312;-0.45256683877675274;-0.4224115776485541
Spinal hypomyelination;Increased variability in muscle fiber diameter;0.8448602259159088;0.7723053;0.5495827932148332;0.5731188085578387;0.9998452077479463;-0.15498498183203746;-0.22753989797545482;-0.4502624145331131;-0.4267263991901076
Spinal hypomyelination;Widened proximal tibial metaphyses;1.0418223440647125;0.9536675;0.48668365053867757;0.5147533724332782;0.9999201345566091;0.041902209508103416;-0.0462526130798635;-0.5132364840179315;-0.4851667621233309
Spinal hypomyelination;Wide anterior fontanel;1.0372402593493462;1.0464636;0.48814331565949853;0.48520485201715924;0.999848231156753;0.03739202819259313;0.04661537758500722;-0.5117049154972545;-0.5146433791395938
Spinal hypomyelination;Increased circulating oleate level;1.0491381958127022;0.98370945;0.4843525252032179;0.5051856645307274;1.0;0.04913819581270218;-0.01629054546356201;-0.5156474747967821;-0.49481433546927256
Spinal hypomyelination;Lozenge-shaped umbilicus;0.9411551170051098;0.89005;0.5187417348702029;0.5350690710272206;0.9999134918687169;-0.05875837486360713;-0.10986349787686511;-0.481171756998514;-0.46484442084149635
Spinal hypomyelination;Anti-myelin-associated glycoprotein antibody positivity;0.4840230345726013;0.56411874;0.672570994981559;0.6435632488572989;1.0;-0.5159769654273987;-0.43588125705718994;-0.32742900501844097;-0.3564367511427011
Spinal hypomyelination;Fractured radius;0.915614016354084;0.7489159;0.5268928748179347;0.580787058365575;0.9999201345566091;-0.0843061182025251;-0.2510042238357839;-0.47302725973867443;-0.4191330761910341
Spinal hypomyelination;Abnormal manual kinetic perimetry test;0.7419946789741516;0.66517925;0.5830652100315812;0.6086757669829588;1.0;-0.2580053210258484;-0.3348207473754883;-0.4169347899684188;-0.3913242330170412
Spinal hypomyelination;Small radial epiphyses;0.8850247636437416;0.7229091;0.5366788706792528;0.5893703189432019;1.0;-0.11497523635625839;-0.2770909070968628;-0.4633211293207472;-0.4106296810567981
Spinal hypomyelination;Generalized keratosis follicularis;0.9076228439807892;0.7592766;0.5294465442640592;0.5773846471993596;0.9999201345566091;-0.09229729057581992;-0.2406435060623464;-0.47047359029254987;-0.42253548735724955
Spinal hypomyelination;Hypoplasia of the calcaneus;0.8353314399719238;0.6334758;0.552655449966156;0.6194523004666699;0.9999134918687169;-0.1645820518967931;-0.3664377113816564;-0.4472580419025609;-0.38046119140204704
Spinal hypomyelination;2-hydroxyadipic aciduria;0.7474605441093445;0.64385676;0.5812657507566212;0.6159084932474211;1.0;-0.2525394558906555;-0.3561432361602783;-0.41873424924337876;-0.38409150675257886
Spinal hypomyelination;Potter facies;0.9967279164120555;0.9815594;0.501041538413012;0.5058701498683249;0.9998981869165328;-0.0031702705044772683;-0.018338791126432663;-0.49885664850352074;-0.49402803704820786
Spinal hypomyelination;Increased heart rate variability;1.118564486503601;1.0462636;0.46217076522666767;0.4852685836071663;0.9999201345566091;0.11864435194699197;0.046343440997284935;-0.5377493693299414;-0.5146515509494428
Spinal hypomyelination;Aplastic zygomatic arch;1.0073630292899907;0.8620789;0.49765625380702216;0.5440420376348345;0.9999134918687169;0.007449537421273744;-0.1378345867631261;-0.5022572380616948;-0.4558714542338824
Spinal hypomyelination;Testicular torsion;0.9821289740502834;0.87708884;0.5056888270736146;0.5392230174954249;0.9999201345566091;-0.017791160506325676;-0.12283128978045554;-0.4942313074829945;-0.4606971170611842
Spinal hypomyelination;Abolished vibration sense;0.8663524240255356;0.752004;0.542669016856224;0.5797719815605602;0.8643545492165687;0.0019978748089668485;-0.11235052184993055;-0.3216855323603447;-0.28458256765600853
Spinal hypomyelination;Fractured metatarsal bone of digit 5;0.9369554370641708;0.77300644;0.5200810250606551;0.5728896455998844;1.0;-0.06304456293582916;-0.22699356079101562;-0.4799189749393449;-0.4271103544001156
Spinal hypomyelination;Prolonged G2 phase of cell cycle;0.9269035756587982;0.87365323;0.5232880843720984;0.5403252076765024;0.9999056439461368;-0.07300206828733857;-0.12625241089483674;-0.4766175595740384;-0.4595804362696344
Spinal hypomyelination;Single naris;0.9949935534968972;0.93795544;0.5015936080738018;0.519762092472403;0.9999056439461368;-0.00491209044923957;-0.06195020485540803;-0.49831203587233497;-0.4801435514737338
Spinal hypomyelination;Perifoveal ring of hyperautofluorescence surrounded by normal autofluorescence;0.8451161086559296;0.73740816;0.549500346645175;0.5845772789389286;1.0;-0.15488389134407043;-0.2625918388366699;-0.450499653354825;-0.41542272106107136
Spinal hypomyelination;Asymmetry of the thorax;0.88570137321949;0.83078873;0.5364620698891593;0.5541220206299495;0.9999056439461368;-0.11420427072664674;-0.16911691237112458;-0.46344357405697745;-0.44578362331618726
Spinal hypomyelination;Type 2 muscle fiber predominance;0.818302109837532;0.7198067;0.5581592930339758;0.5903985750750864;0.9999003561294039;-0.18159824629187182;-0.28009368498682574;-0.44174106309542804;-0.40950178105431745
Spinal hypomyelination;Dependency on parenteral nutrition;0.7405696511268616;0.73727715;0.5835347986452527;0.5846204788501895;0.9999134918687169;-0.25934384074185535;-0.26263634171460315;-0.4163786932234642;-0.4152930130185274
Spinal hypomyelination;Limited shoulder flexion;0.8265480995178223;0.6606736;0.5554921158935602;0.6101991152266911;1.0;-0.17345190048217773;-0.3393263816833496;-0.4445078841064398;-0.3898008847733089
Spinal hypomyelination;Paroxysmal vertigo;0.771090030670166;0.68167293;0.5735161421485763;0.6031210180933249;0.9999134918687169;-0.2288234611985509;-0.31824056115124866;-0.42639734972014065;-0.39679247377539206
Spinal hypomyelination;Long hallux;1.0850395038723946;1.0082834;0.47289835277919934;0.49736330368063375;0.9998836012415208;0.0851559026308738;0.008399775452204827;-0.5269852484623214;-0.502520297560887
Spinal hypomyelination;Broad medial eyebrow;1.051230426877737;1.0264444;0.48368570703985736;0.49158150178750937;0.9999201345566091;0.05131029232112794;0.026524300563019798;-0.5162344275167517;-0.5083386327690997
Spinal hypomyelination;Myxoid subcutaneous tumors;0.7697646021842957;0.65233815;0.5739496166213754;0.6130242884877637;0.9999201345566091;-0.23015553237231345;-0.347581987393218;-0.42597051793523366;-0.3868958460688454
Spinal hypomyelination;Bulbous tips of toes;1.013026038184762;0.92963266;0.49585356600280117;0.5224171352913483;0.9999134918687169;0.013112546316045082;-0.07028082814191028;-0.5040599258659157;-0.47749635657736866
Spinal hypomyelination;Absent internal genitalia;0.9376369118690491;0.80632746;0.5198636771870973;0.5620399395262274;1.0;-0.06236308813095093;-0.1936725378036499;-0.48013632281290275;-0.43796006047377256
Spinal hypomyelination;Hyperphalangy of the 2nd finger;0.8381774127483368;0.71231866;0.5517372308749499;0.5928844104990499;0.9999201345566091;-0.16174272180827232;-0.28760147572787376;-0.44818290368165925;-0.40703572405755917
Spinal hypomyelination;Renal interstitial hemosiderin;0.8568835109472275;0.7531356;0.5457123578680516;0.5794002244011655;1.0;-0.14311648905277252;-0.24686437845230103;-0.4542876421319484;-0.42059977559883455
Spinal hypomyelination;Abnormality of depressor anguli oris muscle;0.9409243389964104;0.76422715;0.5188153218090457;0.5757621229824361;1.0;-0.05907566100358963;-0.23577284812927246;-0.48118467819095434;-0.4242378770175639
Spinal hypomyelination;Paroxysmal dyspnea;0.7589828372001648;0.6283891;0.5774810105544657;0.621194427388327;1.0;-0.2410171627998352;-0.3716108798980713;-0.42251898944553434;-0.378805572611673
Spinal hypomyelination;Phenylpyruvic acidemia;0.7487280666828156;0.6834219;0.5808488411665134;0.6025339331851711;0.9999201345566091;-0.25119206787379356;-0.31649822474749656;-0.41907129339009574;-0.397386201371438
Spinal hypomyelination;Lateral ventricle dilatation;0.7140170335769653;0.71484804;0.5923200787072358;0.5920440770403432;0.5620072150087421;0.15200981856822326;0.15284082652568176;0.03031286369849373;0.030036862031601164
Spinal hypomyelination;Neonatal unconjugated hyperbilirubinemia;0.7692567408084869;0.73883253;0.5741157470052654;0.5841074819876748;0.9999201345566091;-0.23066339374812217;-0.2610876011970815;-0.42580438755134375;-0.4158126525689343
Spinal hypomyelination;High maternal circulating alpha-fetoprotein concentration;0.920602485537529;0.90172577;0.5252996427688781;0.5313322314975302;1.0;-0.07939751446247101;-0.09827423095703125;-0.4747003572311219;-0.46866776850246983
Spinal hypomyelination;Prominent nasolabial fold;1.0308129005134106;0.9545716;0.49019039646358675;0.5144652856699377;0.9998944404568447;0.030918460056565844;-0.045322835728145994;-0.509704043993258;-0.48542915478690707
Spinal hypomyelination;Abnormality of inferior alveolar nerve;0.8389750123023987;0.66807353;0.5514799731558362;0.607698598147476;1.0;-0.16102498769760132;-0.33192646503448486;-0.4485200268441638;-0.39230140185252405
Spinal hypomyelination;Unilateral conductive hearing impairment;0.7938987910747528;0.7060212;0.5660776131402321;0.5949795236756472;0.9999201345566091;-0.2060213434818563;-0.2938989448669729;-0.433842521416377;-0.4049406108809619
Spinal hypomyelination;Macular hypopigmented whorls, streaks, and patches;0.780196338891983;0.64833087;0.570541674069799;0.6143857819901685;0.9999201345566091;-0.21972379566462608;-0.3515892672661123;-0.42937846048681005;-0.38553435256644064
Spinal hypomyelination;Delayed ossification of pubic rami;0.9674641042947769;0.7669966;0.5103583253343738;0.5748553119482963;0.9999134918687169;-0.03244938757394;-0.23291686978314563;-0.48955516653434317;-0.4250581799204206
Spinal hypomyelination;Hyperphenylalaninemia;0.8735952973365784;0.8482081;0.5403437934565859;0.5485043465632302;0.9999028053808913;-0.1263075080443129;-0.15169467597491593;-0.45955901192430537;-0.45139845881766105
Spinal hypomyelination;Ureteropelvic junction obstruction;0.9419670142233372;0.76635504;0.5184828575266451;0.575065336229289;0.9998847295244674;-0.05791771530113021;-0.2335296918352584;-0.48140187199782225;-0.42481939329517837
Spinal hypomyelination;Cone-shaped epiphysis of the proximal phalanx of the 2nd toe;0.8873676806688309;0.7168354;0.535928220055731;0.5913842695793684;1.0;-0.11263231933116913;-0.2831646203994751;-0.46407177994426896;-0.4086157304206316
Spinal hypomyelination;Difficulty walking;0.7861744463443756;0.72220755;0.568592412473405;0.589602743098175;0.7403726674076037;0.04580177893677195;-0.018165121173472798;-0.17178025493419868;-0.1507699243094287
Spinal hypomyelination;Bilobate gallbladder;0.9369116127490997;0.8640929;0.5200950025980844;0.5433948681591736;0.9999134918687169;-0.06300187911961719;-0.13582060542081043;-0.47981848927063253;-0.4565186237095433
Spinal hypomyelination;Histidinuria;0.8043711930513382;0.7628156;0.5626747726543208;0.5762245516435689;0.9999090677057578;-0.19553787465441963;-0.2370934730326011;-0.43723429505143707;-0.42368451606218893
Spinal hypomyelination;Widened interpedicular distance;0.9640952870249748;0.91692907;0.5114312821014482;0.5264728064011054;1.0;-0.03590471297502518;-0.08307093381881714;-0.48856871789855183;-0.4735271935988946
Bladder polyp;Aberrant melanosome maturation;0.9533695578575134;0.84807736;0.5148483150746901;0.5485464659978196;0.9999600672783046;-0.046590509420791126;-0.15188271046296642;-0.48511175220361447;-0.4514136012804849
Bladder polyp;Vertebral artery tortuosity;0.981898583471775;0.8707218;0.5057621745376641;0.5412660277583754;0.9999600672783046;-0.0180614838065295;-0.129238250261703;-0.4941978927406404;-0.45869403951992915
Bladder polyp;Warm reactive autoantibody positivity;0.9660680890083313;0.8642243;0.51080293644017;0.5433526418377358;0.9999201345566091;-0.03385204554827781;-0.13569581986697288;-0.48911719811643906;-0.4565674927188733
Bladder polyp;Right aortic arch with retroesophageal left subclavian artery;0.9771431870758533;0.8961301;0.5072761831683364;0.5331225588029118;0.9999201345566091;-0.02277694748075576;-0.10379004956515403;-0.49264395138827266;-0.4667975757536973
Bladder polyp;Elevated urine suberic acid level;0.7300965189933777;0.7414675;0.5869917971755039;0.5832389173444763;0.8144325676816837;-0.08433604868830602;-0.07296509179057042;-0.22744077050617983;-0.2311936503372074
Bladder polyp;Burkitt lymphoma;0.8632989823818207;0.7082919;0.5436499611929819;0.5942235981824188;0.9999574798349273;-0.13665849745310665;-0.2916655915979278;-0.4563075186419454;-0.40573388165250857
Bladder polyp;Snail-like ilia;0.7897103875875473;0.813921;0.5674406933693061;0.5595780564227191;0.9999600672783046;-0.21024967969075725;-0.18603909254685924;-0.4325193739089984;-0.4403820108555855
Bladder polyp;Indurated nodule;0.7866779714822769;0.6641419;0.5684283500183023;0.6090262633666459;0.9999201345566091;-0.2132421630743322;-0.3357782411697683;-0.43149178453830683;-0.3908938711899632
Bladder polyp;Absent leukocyte alkaline phosphatase;0.9276312217116356;0.79858035;0.5230558523628045;0.5645554926257851;0.9999600672783046;-0.07232884556666896;-0.20137971878663585;-0.47690421491550006;-0.43540457465251947
Bladder polyp;Hippocampal sclerosis;0.9030701667070389;0.7910367;0.5309022434288402;0.567008903827043;0.9999201345566091;-0.09684996784957023;-0.20888340951235862;-0.4690178911277689;-0.43291123072956605
Bladder polyp;Decreased sensitivity to hypoxemia;0.9601312354207039;0.89928424;0.5126939863187321;0.5321132688477553;0.9999600672783046;-0.039828831857600666;-0.10067582369462535;-0.48726608095957247;-0.4678467984305492
Bladder polyp;Decreased level of tissue plasminogen activator;0.9184555336833;0.83293927;0.525985262401879;0.5534275929981789;0.9999201345566091;-0.08146460087330909;-0.1669808673981008;-0.47393487215473007;-0.4464925415584302
Bladder polyp;Submandibular lymph node enlargement;0.8798416331410408;0.78469926;0.5383402359183567;0.569073170599196;0.9999600672783046;-0.12011843413726375;-0.21526080608979747;-0.4616198313599479;-0.4308868966791085
Bladder polyp;Hepatic hemangioma;1.006954301148653;0.8448708;0.49778635934984605;0.5495793794800785;0.9999584729108851;0.006995828237767898;-0.1550876671705287;-0.5021721135610391;-0.4503790934308066
Bladder polyp;Triangular epiphysis of the distal phalanx of the 2nd finger;1.0141784669831395;0.96164393;0.4954867025624995;0.5122121069971194;0.9999201345566091;0.014258332426530407;-0.03827620030673118;-0.5044334319941096;-0.4877080275594897
Bladder polyp;Acne inversa;0.8222863376140594;0.79728866;0.55687008520821;0.5649753110855187;0.9999548690865008;-0.17766853147244133;-0.20266621285175956;-0.44308478387829076;-0.4349795580009821
Bladder polyp;Dentin dysplasia;0.9784997217357159;0.8550632;0.5068442785045766;0.5462978857512304;0.9999201345566091;-0.021420412820893242;-0.14485693455966087;-0.4930758560520325;-0.4536222488053787
Bladder polyp;Aplasia of the inner ear;0.923668697476387;0.7395414;0.5243206645851803;0.5838737396288284;0.9999600672783046;-0.07629136980191753;-0.26041865587846325;-0.4756394026931242;-0.4160863276494762
Bladder polyp;Polycystic liver disease;0.8938252851366997;0.68206054;0.5338602840143034;0.6029908769621175;0.9999567459343585;-0.10613146079765878;-0.31789620621191583;-0.46609646192005505;-0.39696586897224095
Bladder polyp;Subungual hyperkeratosis;0.9228367060422897;0.86904114;0.5245862791013747;0.5418055799384452;0.9999556674707869;-0.07711896142849717;-0.13091452262291703;-0.4753693883694122;-0.45815008753234165
Bladder polyp;Broad humeral epiphyses;0.9471711963415146;0.87397975;0.5168237622005913;0.5402204327460578;0.9999201345566091;-0.05274893821509452;-0.12594038726122947;-0.48309637235601777;-0.4596997018105513
Bladder polyp;Autoimmune thrombocytopenia;0.9991680239327252;0.8563034;0.5002648262378333;0.5458989434551403;0.9999509115718902;-0.0007828876391650086;-0.1436475177311004;-0.4996860853340569;-0.45405196811674986
Bladder polyp;Adenomyosis;0.607213020324707;0.7033986;0.6284890274635149;0.5958532782099604;0.8586132879499475;-0.2514002676252405;-0.15521470263042847;-0.23012426048643264;-0.26276000973998714
Bladder polyp;Elevated leukocyte alkaline phosphatase;0.9347084015607834;0.81396663;0.520797755935992;0.5595632650268816;0.9999600672783046;-0.06525166571752117;-0.1859934353889613;-0.4791623113423126;-0.44039680225142297
Bladder polyp;Clasp-knife sign;0.9123509079217911;0.90824735;0.5279354190281715;0.5292469046860933;0.9999201345566091;-0.08756922663481803;-0.09167278291018577;-0.47198471552843757;-0.47067322987051585
Bladder polyp;Keratosis pilaris;0.9056640490889549;0.7730959;0.5300727830938328;0.5728603947679144;0.9999506876445663;-0.09428663855561137;-0.22685478186377406;-0.4698779045507335;-0.4270902928766519
Bladder polyp;Lamina lucida cleavage;1.0263086911290884;0.92359823;0.4916247171767173;0.5243431584307979;0.9999548690865008;0.026353822042587627;-0.07635663920139946;-0.5083301519097835;-0.47561171065570285
Bladder polyp;Abnormal central response of multifocal electroretinogram;0.9352261051535606;0.8129864;0.5206326161830976;0.5598808645646809;0.9999201345566091;-0.06469402940304847;-0.18693376065524192;-0.47928751837351147;-0.4400392699919282
Bladder polyp;Atypical or prolonged hepatitis;1.009941477328539;0.86570346;0.49683547735506484;0.5428774665448508;0.9999600672783046;0.00998141005023434;-0.13425660372392223;-0.5031245899232397;-0.45708260073345375
Bladder polyp;Cubitus varus;0.9811298716813326;0.8903576;0.5060069049248905;0.5349705618446661;0.9999201345566091;-0.01879026287527652;-0.10956252099307151;-0.4939132296317186;-0.46494957271194304
Bladder polyp;Nasal regurgitation;0.6889079809188843;0.67219716;0.60069473861602;0.6063081709633344;0.9999584729108851;-0.31105049199200085;-0.32776130980587415;-0.39926373429486517;-0.3936503019475507
Bladder polyp;Moon facies;1.0585310496389866;1.0425069;0.4813583338709083;0.48646553557940575;0.9999584729108851;0.058572576728101455;0.04254846030139514;-0.5186001390399768;-0.5134929373314794
Bladder polyp;Intestinal pseudo-obstruction;0.6574941873550415;0.6082313;0.6112756413974203;0.6281366530744039;0.9999539510871024;-0.3424597637320609;-0.3917226450110526;-0.3886783096896821;-0.37181729801269847
Bladder polyp;Bilateral renal atrophy;0.7571933269500732;0.7029374;0.5780680660510482;0.5960069985811697;0.8144325676816837;-0.05723924073161046;-0.11149514349879186;-0.2363645016306355;-0.21842556910051403
Bladder polyp;Fractured left clavicle;1.01582813821733;0.9404601;0.4949615367296051;0.5189633587535225;0.9999201345566091;0.01590800366072087;-0.05946004868777366;-0.504958597827004;-0.4809567758030866
Bladder polyp;Positive urine norcotinine test;0.608673632144928;0.5647717;0.6279836393740195;0.6433323394279788;0.9999201345566091;-0.39124650241168113;-0.43514842273028465;-0.37193649518258964;-0.35658779512863026
Bladder polyp;Long fibula;0.9588824696838856;0.8628508;0.5130918071104731;0.5437939928334528;0.9999567459343585;-0.041074276250472885;-0.13710596067892633;-0.4868649388238854;-0.4561627531009057
Bladder polyp;Fragmentation of the epiphysis of the distal phalanx of the hallux;0.9831916149705648;0.8965789;0.5053505270859201;0.5329789204187754;0.9999201345566091;-0.016728519586044266;-0.10334122658999534;-0.494569607470689;-0.46694121413783374
Bladder polyp;Type II cryptotia;1.030358636751771;0.96952915;0.49033506079289413;0.5097006790539635;0.9999201345566091;0.030438502195161865;-0.030390982640105202;-0.509585073763715;-0.49021945550264556
Bladder polyp;Increased variability in muscle fiber diameter;0.8821244984865189;0.8355552;0.5376083752416856;0.5525832515213116;0.9999473166570552;-0.1178228181705363;-0.16439212084864452;-0.4623389414153696;-0.44736406513574356
Bladder polyp;Widened proximal tibial metaphyses;0.9712136164307594;0.85913193;0.5091642564440189;0.5449893275755601;0.9999600672783046;-0.028746450847545124;-0.1408281350196986;-0.4907958108342857;-0.4549707397027445
Bladder polyp;Wide anterior fontanel;1.0047530718147755;0.9202036;0.49848704455487514;0.5254270006292057;0.9999476714516888;0.0048054003630866315;-0.07974404529583556;-0.5014606268968137;-0.47452067082248317
Bladder polyp;Increased circulating oleate level;1.103260412812233;0.96381354;0.4670724959050412;0.5115210198532685;0.9999201345566091;0.10334027825562386;-0.03610659123690696;-0.5328476386515679;-0.48839911470334063
Bladder polyp;Lozenge-shaped umbilicus;0.7963501811027527;0.82259554;0.5652804007908121;0.5567700749303743;0.9999584729108851;-0.20360829180813245;-0.17736293620205335;-0.43467807212007303;-0.4431883979805108
Bladder polyp;Anti-myelin-associated glycoprotein antibody positivity;0.883394367992878;0.76188153;0.5372013562061716;0.5765306527140166;0.9999201345566091;-0.11652576656373115;-0.23803860427172752;-0.4627187783504375;-0.4233894818425925
Bladder polyp;Fractured radius;0.9285567253828049;0.8155545;0.5227604908142667;0.5590489295754332;0.9999600672783046;-0.07140334189549968;-0.18440556765214489;-0.4771995764640379;-0.4409111377028714
Bladder polyp;Abnormal manual kinetic perimetry test;0.9236720651388168;0.82066596;0.5243195894884907;0.5573942995903225;0.9999201345566091;-0.07624806941779227;-0.17925417901309104;-0.47560054506811844;-0.4425258349662866
Bladder polyp;Small radial epiphyses;0.9633626565337181;0.8965825;0.5116646391863275;0.532977783070057;0.9999201345566091;-0.036557478022891;-0.10333765031130882;-0.48825549537028157;-0.46694235148655205
Bladder polyp;Generalized keratosis follicularis;0.9725723918527365;0.940025;0.5087315738166206;0.5191021006400135;0.9999600672783046;-0.02738767542556808;-0.059935095316329456;-0.49122849346168396;-0.48085796663829106
Bladder polyp;Hypoplasia of the calcaneus;0.9647835493087769;0.85138917;0.5112120627565764;0.5474801610941282;0.9999584729108851;-0.03517492360210828;-0.14856930321789197;-0.48874641015430875;-0.4524783118167569
Bladder polyp;2-hydroxyadipic aciduria;0.8475671708583832;0.7680093;0.5487107721406821;0.5745238925853573;0.6288651353633673;0.21870203549501588;0.13914416963693788;-0.08015436322268521;-0.05434124277801
Bladder polyp;Potter facies;0.9046517238020897;0.8406544;0.5303964753537365;0.5509384324686952;0.9999552432134126;-0.09530351941132287;-0.15930087004446725;-0.4695587678596761;-0.44901681074471733
Bladder polyp;Increased heart rate variability;0.9639899358153343;0.89187807;0.5114648381328937;0.5344836961375328;0.9999600672783046;-0.035970131462970234;-0.10808199883119152;-0.4884952291454109;-0.4654763711407718
Bladder polyp;Aplastic zygomatic arch;1.0281059108674526;0.8990629;0.4910524324366844;0.5321840993260886;0.9999584729108851;0.02814743795656749;-0.10089560097790173;-0.5089060404742007;-0.46777437358479657
Bladder polyp;Testicular torsion;0.8442846983671188;0.7809526;0.5497682430430118;0.5702949443374974;0.8586132879499475;-0.014328589582828677;-0.07766071512737671;-0.30884504490693576;-0.2883183436124501
Bladder polyp;Abolished vibration sense;0.9737480580806732;0.9109275;0.5083572127476078;0.5283902959777464;0.9999584729108851;-0.026210414830211914;-0.08903099841213635;-0.4916012601632773;-0.4715681769331387
Bladder polyp;Fractured metatarsal bone of digit 5;1.0075387209653854;0.9710847;0.49760032785735075;0.5092053032833801;0.9999201345566091;0.007618586408776329;-0.028835420620757057;-0.5023198066992584;-0.490714831273229
Bladder polyp;Prolonged G2 phase of cell cycle;0.92168128490448;0.9191842;0.5249551775316457;0.5257525429669341;0.9999567459343585;-0.07827546102987848;-0.0807725380180987;-0.4750015684027128;-0.4742042029674244
Bladder polyp;Single naris;0.8169562965631485;0.76659226;0.5585949853770815;0.5749876823434354;0.9999567459343585;-0.18300044937120996;-0.23336448175894342;-0.44136176055727694;-0.424969063590923
Bladder polyp;Perifoveal ring of hyperautofluorescence surrounded by normal autofluorescence;1.0688166171312332;0.9520086;0.47807766412746877;0.5152819960007501;0.9999201345566091;0.06889648257462411;-0.047911529553252175;-0.5218424704291403;-0.484638138555859
Bladder polyp;Asymmetry of the thorax;0.9285718202590942;0.81689423;0.5227556736590688;0.5586150852009855;0.9999567459343585;-0.07138492567526422;-0.18306251270758234;-0.47720107227528963;-0.441341660733373
Bladder polyp;Type 2 muscle fiber predominance;0.9028147906064987;0.88086706;0.530983917769605;0.5380114647047949;0.9999556674707869;-0.09714087686428818;-0.11908860347161088;-0.46897174970118194;-0.461944202765992
Bladder polyp;Dependency on parenteral nutrition;0.8305808752775192;0.778569;0.5541891525989702;0.5710727682536328;0.9999584729108851;-0.1693775976333659;-0.2213894898328822;-0.44576932031191496;-0.4288857046572523
Bladder polyp;Limited shoulder flexion;0.9149829745292664;0.84781384;0.5270944661172441;0.5486313361181785;0.9999201345566091;-0.08493716002734275;-0.15210628987582298;-0.472825668439365;-0.4512887984384306
Bladder polyp;Paroxysmal vertigo;0.9149032011628151;0.7490012;0.5271199511237017;0.5807590199576464;0.9999584729108851;-0.08505527174807004;-0.25095726794338635;-0.47283852178718344;-0.4191994529532387
Bladder polyp;Long hallux;1.0535290390253067;0.98147345;0.4829530301160275;0.505897521547144;0.9999526340597648;0.053576404965541946;-0.01847918816743077;-0.5169996039437372;-0.4940551125126208
Bladder polyp;Broad medial eyebrow;1.0191550068557262;0.9850825;0.4939023990263126;0.5047485675147333;0.9999600672783046;0.019194939577421688;-0.014877560144820667;-0.5060576682519919;-0.49521149976357126
Bladder polyp;Myxoid subcutaneous tumors;0.8989707678556442;0.80590665;0.5322135628348454;0.5621764731540482;0.9999600672783046;-0.10098929942266033;-0.19405341387406871;-0.4677465044434591;-0.4377835941242564
Bladder polyp;Bulbous tips of toes;1.029782474040985;0.93812203;0.49051854205648815;0.5197089556140031;0.9999584729108851;0.029824001130099975;-0.061836438838009156;-0.509439930854397;-0.48024951729688203
Bladder polyp;Absent internal genitalia;0.7892605066299438;0.799113;0.5675871775312176;0.5643824143903545;0.717226575899895;0.07203393073004882;0.08188639969748657;-0.14963939836867746;-0.1528441615095405
Bladder polyp;Hyperphalangy of the 2nd finger;0.989790128543973;0.9284644;0.5032499594862153;0.5227899597441367;0.9999600672783046;-0.010169938734331585;-0.07149565458909557;-0.49671010779208924;-0.4771701075341679
Bladder polyp;Renal interstitial hemosiderin;0.7983254641294479;0.7985871;0.5646383246487945;0.5645533135327478;0.6288651353633673;0.16946032876608064;0.16972194845316102;-0.06422681071457281;-0.06431182183061945
Bladder polyp;Abnormality of depressor anguli oris muscle;0.8661191016435623;0.7946396;0.5427439591701164;0.5658366607787085;0.9999201345566091;-0.1338010329130468;-0.20528054715426536;-0.4571761753864927;-0.4340834737779006
Bladder polyp;Paroxysmal dyspnea;0.7062563598155975;0.5835993;0.594901199030327;0.6367086356790319;0.9999201345566091;-0.2936637747410116;-0.41632080556185813;-0.4050189355262821;-0.3632114988775772
Bladder polyp;Phenylpyruvic acidemia;0.7442094683647156;0.5954696;0.5823357383526542;0.6325650184115105;0.9999600672783046;-0.255750598913589;-0.40449047327653453;-0.4176243289256504;-0.3673950488667941
Bladder polyp;Lateral ventricle dilatation;1.0246884021908045;0.904964;0.4921406389680355;0.5302966165463752;0.9999488789551968;0.024739523235607686;-0.09498484916622585;-0.5078082399871613;-0.46965226240882163
Bladder polyp;Neonatal unconjugated hyperbilirubinemia;0.8785908222198486;0.74727094;0.5387413178123526;0.5813281166136068;0.9999600672783046;-0.12136924505845592;-0.2526891255439906;-0.461218749465952;-0.4186319506646977
Bladder polyp;High maternal circulating alpha-fetoprotein concentration;1.0343756675720215;0.92752457;0.4890557289959627;0.5230898815951456;0.9999201345566091;0.034455533015412376;-0.07239556790621848;-0.5108644055606464;-0.47683025296146353
Bladder polyp;Prominent nasolabial fold;0.9331592544913292;0.8253515;0.5212919444950057;0.5558789166270193;0.9999545338528789;-0.06679527936154972;-0.1746030571835674;-0.4786625893578732;-0.44407561722585964
Bladder polyp;Abnormality of inferior alveolar nerve;0.9792469795793295;0.8573233;0.5066063658395443;0.5455709207096606;0.9999201345566091;-0.020673154977279617;-0.1425968456390676;-0.4933137687170648;-0.4543492138469485
Bladder polyp;Unilateral conductive hearing impairment;0.9491331540048122;0.75835985;0.5161984104789112;0.5776853533876429;0.9999600672783046;-0.050826913273492313;-0.24160021782533214;-0.4837616567993933;-0.4222747138906616
Bladder polyp;Macular hypopigmented whorls, streaks, and patches;1.0124468058347702;0.90545964;0.49603795634495973;0.5301381398575771;0.9999600672783046;0.012486738556465649;-0.09450042486802623;-0.5039221109333448;-0.4698219274207275
Bladder polyp;Delayed ossification of pubic rami;0.9349812790751457;0.8439379;0.5207107113681005;0.5498799974724915;0.9999584729108851;-0.06497719383573941;-0.1560205990705531;-0.4792477615427846;-0.45007847543839363
Bladder polyp;Hyperphenylalaninemia;0.936073049902916;0.77911353;0.5203624653637271;0.570895017503203;0.9999561589935034;-0.06388310909058748;-0.22084262788083253;-0.47959369362977633;-0.4290611414903004
Bladder polyp;Ureteropelvic junction obstruction;0.36332976818084717;0.46363205;0.7196887378189751;0.6802040569134518;0.7807636207142028;-0.41743385253335563;-0.3171315735378417;-0.06107488289522767;-0.10055956380075104
Bladder polyp;Cone-shaped epiphysis of the proximal phalanx of the 2nd toe;1.0104356808587909;0.9544851;0.4966781593184173;0.5144928471930584;0.9999201345566091;0.010515546302181766;-0.04543501616747947;-0.5032419752381918;-0.4854272873635507
Bladder polyp;Difficulty walking;0.9646355658769608;0.88934946;0.5112591967057735;0.5352934266840448;0.9999461221900431;-0.03531055631308233;-0.11059666158823644;-0.4886869254842696;-0.4646526955059983
Bladder polyp;Bilobate gallbladder;0.6127794086933136;0.54784125;0.6265648147182779;0.6493459535123569;0.9999584729108851;-0.38717906421757153;-0.4521172220144313;-0.3733936581926073;-0.3506125193985282
Bladder polyp;Histidinuria;0.8492036312818527;0.7841315;0.548183778332091;0.5692582524222799;0.8024087134738423;0.04679491780801037;-0.018277186526820866;-0.2542249351417514;-0.23315046105156245
Bladder polyp;Widened interpedicular distance;1.0207348298281431;0.9200066;0.4933994256520965;0.5254899399613533;0.9999201345566091;0.02081469527153401;-0.07991356135638328;-0.5065207089045126;-0.4744301945952558
Aberrant melanosome maturation;Vertebral artery tortuosity;0.9372413903474808;0.82901627;0.5199898226983838;0.554694561557865;0.9999600672783046;-0.06271867693082378;-0.17094379902497814;-0.47997024457992077;-0.44526550572043955
Aberrant melanosome maturation;Warm reactive autoantibody positivity;0.8256292194128036;0.77841425;0.5557891306412743;0.5711232664735251;0.9999201345566091;-0.17429091514380546;-0.2215058851364431;-0.4441310039153348;-0.42879686808308404
Aberrant melanosome maturation;Right aortic arch with retroesophageal left subclavian artery;0.9804539475589991;0.9324354;0.506222097960918;0.5215228882336607;0.9999201345566091;-0.019466186997610047;-0.06748474122317405;-0.4936980365956911;-0.47839724632294844
Aberrant melanosome maturation;Elevated urine suberic acid level;0.86676225066185;0.8274011;0.5425373877651289;0.5552164389567551;0.9999600672783046;-0.13319781661645458;-0.17255896568910167;-0.4574226795131756;-0.44474362832154946
Aberrant melanosome maturation;Burkitt lymphoma;0.792241781949997;0.7329134;0.5666167242195228;0.5860609852748169;0.9999574798349273;-0.20771569788493038;-0.26704410493410946;-0.4333407556154045;-0.41389649456011046
Aberrant melanosome maturation;Snail-like ilia;0.979457775130868;0.9605977;0.5065392532240065;0.5125453959468527;0.9999600672783046;-0.020502292147436596;-0.039362373358169056;-0.49342081405429805;-0.4874146713314519
Aberrant melanosome maturation;Indurated nodule;0.890276625752449;0.855719;0.5349964975452262;0.5460869301998452;0.656988850480855;0.23328777527159406;0.1987301198179121;-0.12199235293562882;-0.11090192028100976
Aberrant melanosome maturation;Absent leukocyte alkaline phosphatase;0.8470415771007538;0.7937056;0.5488800590143155;0.5661404639451852;0.9999600672783046;-0.15291849017755077;-0.20625448465959118;-0.4510800082639891;-0.4338196033331193
Aberrant melanosome maturation;Hippocampal sclerosis;0.8546595126390457;0.76803106;0.5464277586103564;0.5745167781994391;0.9999201345566091;-0.1452606219175634;-0.23188907386096091;-0.4534923759462527;-0.42540335635716997
Aberrant melanosome maturation;Decreased sensitivity to hypoxemia;0.8246620297431946;0.7413082;0.5561018137893756;0.5832913880274615;0.9999600672783046;-0.17529803753510997;-0.2586518549980311;-0.44385825348892893;-0.41666867925084305
Aberrant melanosome maturation;Decreased level of tissue plasminogen activator;0.8719174712896347;0.7683329;0.5408822388979948;0.5744179999159955;0.9999201345566091;-0.1280026632669744;-0.23158723593981834;-0.4590378956586143;-0.4255021346406136
Aberrant melanosome maturation;Submandibular lymph node enlargement;0.906162828207016;0.8328087;0.5299133093455535;0.553469764899783;0.9999600672783046;-0.09379723907128856;-0.16715139389649913;-0.4700467579327511;-0.4464903023785216
Aberrant melanosome maturation;Hepatic hemangioma;0.8537055850028992;0.77057207;0.54673468378574;0.573685518248402;0.9999584729108851;-0.14625288790798596;-0.22938640660381726;-0.45322378912514516;-0.42627295466248316
Aberrant melanosome maturation;Triangular epiphysis of the distal phalanx of the 2nd finger;0.8591731488704681;0.81197935;0.5449760853997742;0.5602071833847917;0.9999201345566091;-0.14074698568614097;-0.18794078112872215;-0.45494404915683495;-0.4397129511718174
Aberrant melanosome maturation;Acne inversa;0.7987624406814575;0.8539374;0.5644963192327739;0.5466600879925811;0.8230814931248395;-0.02431905244338195;0.030855894341591195;-0.2585851738920656;-0.2764214051322583
Aberrant melanosome maturation;Dentin dysplasia;0.791651576757431;0.6861449;0.5668087953701368;0.6016206208992636;0.9999201345566091;-0.20826855779917808;-0.3137752461555776;-0.43311133918647227;-0.3982995136573455
Aberrant melanosome maturation;Aplasia of the inner ear;0.8206323087215424;0.6730674;0.5574051765887016;0.6060150150696413;0.9999600672783046;-0.1793277585567622;-0.32689267635957286;-0.44255489068960296;-0.39394505220866327
Aberrant melanosome maturation;Polycystic liver disease;0.8385589718818665;0.68925107;0.5516141585683783;0.600579826480568;0.9999567459343585;-0.161397774052492;-0.31070568068014703;-0.4483425873659802;-0.3993769194537905
Aberrant melanosome maturation;Subungual hyperkeratosis;0.6798257231712341;0.72394514;0.6037414707393753;0.5890271485566918;0.8095978540801885;-0.12977213090895434;-0.08565271324156543;-0.20585638334081313;-0.22057070552349667
Aberrant melanosome maturation;Broad humeral epiphyses;0.9720558375120163;0.86713195;0.5088960612244188;0.5424186488385307;0.9999201345566091;-0.027864297044592812;-0.13278818608553977;-0.49102407333219034;-0.45750148571807836
Aberrant melanosome maturation;Autoimmune thrombocytopenia;0.7961999177932739;0.7038485;0.5653292556642305;0.5957033351461731;0.9999509115718902;-0.20375099377861627;-0.2961024303936065;-0.43462165590765967;-0.40424757642571707
Aberrant melanosome maturation;Adenomyosis;0.8067115247249603;0.70357364;0.561915324426838;0.5957949313044655;0.9999600672783046;-0.19324854255334423;-0.2963864231170802;-0.43804474285146655;-0.4041651359738391
Aberrant melanosome maturation;Elevated leukocyte alkaline phosphatase;0.85677570104599;0.80208707;0.5457470320368736;0.5634163300631856;0.9999600672783046;-0.14318436623231456;-0.1978729987205653;-0.454213035241431;-0.43654373721511897
Aberrant melanosome maturation;Clasp-knife sign;0.9916522186249495;1.0033909;0.5026572122014952;0.4989206395009945;0.9999201345566091;-0.008267915931659653;0.0034707736846628645;-0.49726292235511393;-0.5009994950556146
Aberrant melanosome maturation;Keratosis pilaris;0.6043006181716919;0.6670278;0.6294977769632739;0.6080515405140144;0.7882101819680228;-0.18390956379633094;-0.12118241049509193;-0.15871240500474892;-0.1801586414540084
Aberrant melanosome maturation;Lamina lucida cleavage;0.819402888417244;0.8069999;0.5578030099399754;0.5618217630605247;0.8061689028324591;0.013233985584784835;0.0008310189662469325;-0.24836589289248368;-0.24434713977193445
Aberrant melanosome maturation;Abnormal central response of multifocal electroretinogram;0.6597255170345306;0.63681704;0.6105199885135324;0.6183100098998806;0.9999201345566091;-0.34019461752207847;-0.3631030964973745;-0.3894001460430767;-0.3816101246567285
Aberrant melanosome maturation;Atypical or prolonged hepatitis;0.8728214800357819;0.76043475;0.5405921112394987;0.5770049135894135;0.9999600672783046;-0.1271385872425227;-0.23952532053605602;-0.45936795603880587;-0.42295515368889103
Aberrant melanosome maturation;Cubitus varus;0.9549310766160488;0.9609255;0.5143507448959386;0.5124409547293893;0.9999201345566091;-0.044989057940560295;-0.03899461509020896;-0.48556938966067054;-0.4874791798272198
Aberrant melanosome maturation;Nasal regurgitation;0.9591875523328781;0.86981857;0.5129946147018105;0.541555991158428;0.9999584729108851;-0.04077092057800702;-0.13013990468120984;-0.4869638582090746;-0.4584024817524571
Aberrant melanosome maturation;Moon facies;0.6925778388977051;0.7618619;0.5994663690303392;0.5765370747427323;0.9999584729108851;-0.30738063401318005;-0.23809655255413464;-0.4004921038805459;-0.42342139816815283
Aberrant melanosome maturation;Intestinal pseudo-obstruction;0.9307738542556763;0.7691784;0.5220530045007387;0.5741413785972224;0.9999539510871024;-0.06918009683142612;-0.2307755605841727;-0.47790094658636373;-0.42581257248988
Aberrant melanosome maturation;Bilateral renal atrophy;0.8194779753684998;0.79390943;0.5577787096222779;0.5660741522047142;0.9999600672783046;-0.1804820919098048;-0.20605063677445934;-0.4421813576560266;-0.4338859150735903
Aberrant melanosome maturation;Fractured left clavicle;1.010548071935773;0.9635682;0.4966423821582566;0.5115991572772625;0.9999201345566091;0.010627937379163788;-0.03635192395480247;-0.5032777523983525;-0.48832097727934665
Aberrant melanosome maturation;Positive urine norcotinine test;0.8652870655059814;0.8751757;0.5430112256367174;0.5398367049276442;0.9999201345566091;-0.13463306905062766;-0.12474442006381126;-0.45690890891989167;-0.46008342962896487
Aberrant melanosome maturation;Long fibula;1.0151377581059933;0.9278188;0.49518131789337083;0.5229959956999017;0.9999567459343585;0.015181012171634811;-0.0721379707573565;-0.5047754280409876;-0.4769607502344567
Aberrant melanosome maturation;Fragmentation of the epiphysis of the distal phalanx of the hallux;0.9130110964179039;0.8255658;0.5277244687538587;0.5558096366539733;0.9999201345566091;-0.08690903813870521;-0.17435431958468528;-0.4721956658027504;-0.4441104979026358
Aberrant melanosome maturation;Type II cryptotia;0.8001762926578522;0.75368965;0.564036945058122;0.5792182486569191;0.9999201345566091;-0.19974384189875694;-0.24623048783572288;-0.43588318949848714;-0.42070188589969004
Aberrant melanosome maturation;Increased variability in muscle fiber diameter;0.7997489869594574;0.6905323;0.5641757665092086;0.6001508596957974;0.9999473166570552;-0.20019832969759777;-0.30941498995875194;-0.4357715501478465;-0.39979645696125776
Aberrant melanosome maturation;Widened proximal tibial metaphyses;0.9126071408390999;0.7216084;0.5278535433738558;0.589801288911735;0.9999600672783046;-0.08735292643920467;-0.2783516669334559;-0.47210652390444874;-0.41015877836656955
Aberrant melanosome maturation;Wide anterior fontanel;0.9095161706209183;0.88135475;0.5288413446813467;0.5378551303729479;0.9999476714516888;-0.09043150083077056;-0.11859292224896056;-0.47110632677034214;-0.462092541078741
Aberrant melanosome maturation;Increased circulating oleate level;0.8053715527057648;0.7732947;0.5623501074462055;0.5727954227573293;0.9999201345566091;-0.19454858185084434;-0.22662544728549094;-0.4375700271104036;-0.4271247117992798
Aberrant melanosome maturation;Lozenge-shaped umbilicus;0.9381250590085983;0.95010036;0.5197079944627059;0.5158901422474704;0.9999584729108851;-0.061833413902286805;-0.04985811061001233;-0.48025047844817925;-0.4840683306634147
Aberrant melanosome maturation;Anti-myelin-associated glycoprotein antibody positivity;0.7785207182168961;0.66056;0.5710885177439801;0.6102375489053062;0.9999201345566091;-0.22139941633971305;-0.3393601226929006;-0.42883161681262905;-0.38968258565130287
Aberrant melanosome maturation;Fractured radius;0.9572269581258297;0.90201366;0.5136192370529326;0.5312401463121588;0.9999600672783046;-0.04273310915247486;-0.09794640780107067;-0.486340830225372;-0.4687199209661458
Aberrant melanosome maturation;Abnormal manual kinetic perimetry test;0.6619381308555603;0.59115195;0.6097713143387704;0.6340693969496163;0.9999201345566091;-0.3379820037010488;-0.40876818181307883;-0.3901488202178387;-0.3658507376069928
Aberrant melanosome maturation;Small radial epiphyses;0.8276681452989578;0.74726224;0.5551301432119745;0.5813309991875281;0.9999201345566091;-0.17225198925765128;-0.25265789510043235;-0.4447899913446346;-0.41858913536908104
Aberrant melanosome maturation;Generalized keratosis follicularis;0.6237753331661224;0.7361319;0.6227779164674645;0.5849983741688973;0.8284944252404275;-0.20471909207430505;-0.09236251873102808;-0.205716508772963;-0.24349605107153016
Aberrant melanosome maturation;Hypoplasia of the calcaneus;0.9422152042388916;0.8778788;0.5184037233936423;0.5389696701899566;0.9999584729108851;-0.05774326867199353;-0.12207968777752332;-0.48155474951724286;-0.46098880272092857
Aberrant melanosome maturation;2-hydroxyadipic aciduria;0.7652910053730011;0.8044216;0.5754137201664561;0.5626584103836795;0.9999201345566091;-0.234629129183608;-0.19549853087695213;-0.424506414390153;-0.43726172417292963
Aberrant melanosome maturation;Potter facies;0.7642709016799927;0.7889106;0.57574780283728;0.5677011056851053;0.9999552432134126;-0.23568434153341988;-0.21104461584830025;-0.42420744037613256;-0.4322541375283072
Aberrant melanosome maturation;Increased heart rate variability;0.8951886296272278;0.8609935;0.5334238828489528;0.5443908917270435;0.9999600672783046;-0.10477143765107677;-0.1389665627540736;-0.46653618442935174;-0.4555691755512611
Aberrant melanosome maturation;Aplastic zygomatic arch;0.8313588201999664;0.70356524;0.5539379098705945;0.5957977422896683;0.9999584729108851;-0.1685996527109187;-0.2963932330045741;-0.4460205630402906;-0.4041607306212168
Aberrant melanosome maturation;Testicular torsion;0.7901808768510818;0.75737023;0.567287514518648;0.5780100093710556;0.9999600672783046;-0.2097791904272227;-0.24258983374253795;-0.43267255275965655;-0.42195005790724893
Aberrant melanosome maturation;Abolished vibration sense;0.8814640641212463;0.8663682;0.5378200822843722;0.5426639675012173;0.9999584729108851;-0.1184944087896388;-0.13359029835796765;-0.46213839062651296;-0.4572945054096679
Aberrant melanosome maturation;Fractured metatarsal bone of digit 5;0.8638339638710022;0.7784358;0.5434780639216549;0.5711162184042564;0.9999201345566091;-0.1360861706856069;-0.2214843082550344;-0.45644207063495423;-0.4288039161523527
Aberrant melanosome maturation;Prolonged G2 phase of cell cycle;0.7485883831977844;0.80476755;0.5808947784614639;0.5625461280381387;0.9999567459343585;-0.25136836273657404;-0.1951891968964251;-0.4190619674728946;-0.4374106178962197
Aberrant melanosome maturation;Single naris;0.7706110179424286;0.8476138;0.5736727847003431;0.5486957504739302;0.9999567459343585;-0.22934572799192987;-0.15234293444143854;-0.42628396123401535;-0.4512609954604283
Aberrant melanosome maturation;Perifoveal ring of hyperautofluorescence surrounded by normal autofluorescence;0.6518349051475525;0.7418626;0.6131951395526424;0.5831087277664859;0.9999201345566091;-0.3480852294090566;-0.25805753947527976;-0.38672499500396673;-0.4168114067901232
Aberrant melanosome maturation;Asymmetry of the thorax;0.9042467027902603;0.81139743;0.5305259901344233;0.5603958030859388;0.9999567459343585;-0.09571004314409814;-0.18855931265341364;-0.4694307557999352;-0.4395609428484196
Aberrant melanosome maturation;Type 2 muscle fiber predominance;0.8873992636799812;0.8126831;0.5359181025085187;0.5599791344887275;0.9999556674707869;-0.11255640379080567;-0.1872725620020369;-0.4640375649622682;-0.4399765329820594
Aberrant melanosome maturation;Dependency on parenteral nutrition;0.8299288153648376;0.7826373;0.5543997661451416;0.5697454380620708;0.9999584729108851;-0.17002965754604749;-0.21732117480373792;-0.4455587067657435;-0.43021303484881435
Aberrant melanosome maturation;Limited shoulder flexion;1.0018600523471832;0.93484926;0.4994079266076631;0.5207528229200677;0.9999201345566091;0.0019399177905741194;-0.06507087231906028;-0.500512207948946;-0.47916731163654136
Aberrant melanosome maturation;Paroxysmal vertigo;0.9073525741696358;0.78857225;0.5295329443402048;0.5678113107659919;0.9999584729108851;-0.09260589874124936;-0.21138622111416272;-0.4704255285706803;-0.43214716214489324
Aberrant melanosome maturation;Long hallux;0.990229956805706;0.94751996;0.5031099508145993;0.5167125877592614;0.9999526340597648;-0.009722677254058731;-0.052432676040508164;-0.49684268324516545;-0.4832400463005033
Aberrant melanosome maturation;Broad medial eyebrow;0.6819588840007782;0.72711045;0.6030250065128002;0.5879793599370505;0.8733283781844945;-0.1913694941837163;-0.14621793268507433;-0.27030337167169427;-0.28534901824744396
Aberrant melanosome maturation;Myxoid subcutaneous tumors;0.7551500499248505;0.66040856;0.5787387023388597;0.6102888031391812;0.8434590184411804;-0.08830896851632997;-0.1830504619798462;-0.2647203161023207;-0.23317021530199922
Aberrant melanosome maturation;Bulbous tips of toes;0.801009401679039;0.7899784;0.5637663232389409;0.5673534288708344;0.9999584729108851;-0.19894907123184613;-0.20998008793926648;-0.4361921496719442;-0.43260504404005073
Aberrant melanosome maturation;Absent internal genitalia;0.7956413328647614;0.81477344;0.5655108812004203;0.5593018929567257;0.9999201345566091;-0.20427880169184776;-0.18514669419558616;-0.43440925335618885;-0.4406182415998834
Aberrant melanosome maturation;Hyperphalangy of the 2nd finger;0.8480457663536072;0.827072;0.5485566348719694;0.5553227769785976;0.9999600672783046;-0.15191430092469738;-0.1728880429329066;-0.4514034324063352;-0.444637290299707
Aberrant melanosome maturation;Renal interstitial hemosiderin;0.811305820941925;0.7495357;0.5604254877092054;0.5805832677265095;0.9999201345566091;-0.18861431361468406;-0.2503844547394094;-0.4394946468474037;-0.41933686683009963
Aberrant melanosome maturation;Abnormality of depressor anguli oris muscle;0.939458828419447;0.82913774;0.5192826449234188;0.5546553079712053;0.9999201345566091;-0.06046130613716216;-0.17078239203723045;-0.4806374896331903;-0.4452648265854038
Aberrant melanosome maturation;Paroxysmal dyspnea;0.8907489404082298;0.7544279;0.5348452458249212;0.5789757957073911;0.9999201345566091;-0.10917119414837928;-0.2454922247055349;-0.4650748887316879;-0.420944338849218
Aberrant melanosome maturation;Phenylpyruvic acidemia;0.7253580093383789;0.7031664;0.5885593349243643;0.5959306620189195;0.9999600672783046;-0.27460205793992565;-0.29679364205018566;-0.41140073235394026;-0.404029405259385
Aberrant melanosome maturation;Lateral ventricle dilatation;0.8840232640504837;0.7940435;0.5369998048773108;0.5660305518820241;0.9999488789551968;-0.11592561490471309;-0.20590539760525173;-0.462949074077886;-0.4339183270731727
Aberrant melanosome maturation;Neonatal unconjugated hyperbilirubinemia;0.8070902228355408;0.79982483;0.5617924688396607;0.5641511247507058;0.9999600672783046;-0.19286984444276378;-0.20013523340837047;-0.43816759843864383;-0.4358089425275987
Aberrant melanosome maturation;High maternal circulating alpha-fetoprotein concentration;0.7397838830947876;0.76736635;0.5837938118866687;0.574734303447969;0.9999201345566091;-0.2601362514618215;-0.23255378485949607;-0.41612632266994043;-0.42518583110864006
Aberrant melanosome maturation;Prominent nasolabial fold;0.9273779094219208;0.90091664;0.5231366968917652;0.531591052142816;0.9999545338528789;-0.07257662443095814;-0.09903789786273609;-0.4768178369611137;-0.4683634817100629
Aberrant melanosome maturation;Abnormality of inferior alveolar nerve;0.9077374562621117;0.7988914;0.5294099055727546;0.5644544053064374;0.9999201345566091;-0.09218267829449744;-0.20102870942385764;-0.47051022898385453;-0.4354657292501717
Aberrant melanosome maturation;Unilateral conductive hearing impairment;0.8994647338986397;0.8249038;0.5320555239042235;0.5560236463167261;0.9999600672783046;-0.10049533337966488;-0.175056281095901;-0.46790454337408105;-0.4439364209615785
Aberrant melanosome maturation;Macular hypopigmented whorls, streaks, and patches;0.5302444696426392;0.5585228;0.6556579369624469;0.645545372983484;0.6434261658134761;-0.11318169617083695;-0.08490334534075883;0.012231771148970783;0.0021192071700079085
Aberrant melanosome maturation;Delayed ossification of pubic rami;0.8477658182382584;0.7398019;0.548646794036652;0.5837878678761397;0.9999584729108851;-0.15219265467262677;-0.26015658921337537;-0.4513116788742332;-0.41617060503474546
Aberrant melanosome maturation;Hyperphenylalaninemia;0.6958555579185486;0.6930249;0.5983705494749693;0.5993168431592688;0.9999561589935034;-0.30410060107495485;-0.3069312852599829;-0.40158560951853417;-0.4006393158342346
Aberrant melanosome maturation;Ureteropelvic junction obstruction;0.9238155484199524;0.83433115;0.5242737839676757;0.5529782942802987;0.9999528219730685;-0.07613727355311606;-0.16562166714976523;-0.4756790380053928;-0.4469745276927698
Aberrant melanosome maturation;Cone-shaped epiphysis of the proximal phalanx of the 2nd toe;0.8323273360729218;0.7849176;0.55362516831495;0.5690020013170909;0.9999201345566091;-0.16759279848368736;-0.21500254155428977;-0.4462949662416591;-0.4309181332395182
Aberrant melanosome maturation;Difficulty walking;0.8761772662401199;0.84307504;0.539515417948921;0.5501580779544726;0.9999461221900431;-0.12376885594992315;-0.1568710851874796;-0.4604307042411221;-0.4497880442355705
Aberrant melanosome maturation;Bilobate gallbladder;0.960958406329155;0.8605968;0.5124304844554277;0.544518411172991;0.9999584729108851;-0.039000066581730164;-0.13936169690227918;-0.4875279884554574;-0.4554400617378941
Aberrant melanosome maturation;Histidinuria;0.7105382084846497;0.7187848;0.5934763167466772;0.5907374792445204;0.9999574798349273;-0.2894192713502777;-0.2811726707223785;-0.4064811630882501;-0.409220000590407
Aberrant melanosome maturation;Widened interpedicular distance;0.9353083446621895;0.8446882;0.5206063835149641;0.5496382299994726;0.9999201345566091;-0.06461178989441962;-0.15523195744784446;-0.479313751041645;-0.45028190455713646
Vertebral artery tortuosity;Warm reactive autoantibody positivity;0.8894053250551224;0.79070306;0.5352755394362128;0.5671175245967468;0.9999201345566091;-0.11051480950148673;-0.20921707631381126;-0.46464459512039635;-0.4328026099598623
Vertebral artery tortuosity;Right aortic arch with retroesophageal left subclavian artery;0.7163160145282745;0.6985793;0.5915566673418295;0.5974608498297764;0.26000653562401765;0.4563094789042569;0.43857277574683196;0.3315501317178119;0.3374543142057588
Vertebral artery tortuosity;Elevated urine suberic acid level;0.9845932405441999;0.90791106;0.5049043178834354;0.5293544040466494;0.9999600672783046;-0.01536682673410461;-0.09204900503770397;-0.4950557493948692;-0.4706056632316552
Vertebral artery tortuosity;Burkitt lymphoma;0.9525971598923206;0.81329757;0.5150944491874274;0.5597800222183947;0.9999574798349273;-0.0473603199426067;-0.18665991008318783;-0.4848630306474999;-0.4401774576165326
Vertebral artery tortuosity;Snail-like ilia;0.9944275468587875;0.9489035;0.5017737761051764;0.5162716005382835;0.9999600672783046;-0.0055325204195170175;-0.051056566244521595;-0.4981862911731282;-0.4836884667400211
Vertebral artery tortuosity;Indurated nodule;0.922155037522316;0.80441463;0.5248039155784366;0.562660678746389;0.9999201345566091;-0.07776509703429313;-0.19550550462039085;-0.47511621897817247;-0.4372594558102201
Vertebral artery tortuosity;Absent leukocyte alkaline phosphatase;0.9797433223575354;0.8668847;0.5064483418006769;0.5424980531320409;0.9999600672783046;-0.020216744920769192;-0.13307535887376354;-0.49351172547762767;-0.45746201414626364
Vertebral artery tortuosity;Hippocampal sclerosis;0.8548344224691391;0.79417145;0.5463714862883318;0.5659889206847477;0.9999201345566091;-0.14508571208747;-0.20574868203433128;-0.45354864826827734;-0.4339312138718614
Vertebral artery tortuosity;Decreased sensitivity to hypoxemia;0.7329472899436951;0.69817764;0.5860497828792778;0.5975949526491335;0.9999600672783046;-0.2670127773346095;-0.3017824316085963;-0.4139102843990268;-0.402365114629171
Vertebral artery tortuosity;Decreased level of tissue plasminogen activator;0.8174854218959808;0.81135523;0.558423673632543;0.5604094620037154;0.9999201345566091;-0.18243471266062827;-0.18856490136416526;-0.44149646092406614;-0.43951067255289367
Vertebral artery tortuosity;Submandibular lymph node enlargement;1.039301786571741;0.9035638;0.48748662995654846;0.5307443691536553;0.8116988959058551;0.22760289066588602;0.09186490156805238;-0.32421226594930663;-0.2809545267521998
Vertebral artery tortuosity;Hepatic hemangioma;0.7631905674934387;0.64275813;0.57610170368476;0.6162828114445931;0.8041807220209305;-0.04099015452749177;-0.16142259099370881;-0.2280790183361705;-0.18789791057633742
Vertebral artery tortuosity;Triangular epiphysis of the distal phalanx of the 2nd finger;0.8956727087497711;0.81428033;0.5332689462524548;0.5594616308003239;0.9999201345566091;-0.10424742580683799;-0.18563980342181297;-0.4666511883041543;-0.44045850375628526
Vertebral artery tortuosity;Acne inversa;0.9987256582826376;0.8459082;0.5004056356768014;0.5492451445271427;0.9999548690865008;-0.0012292108038631788;-0.15404664450382866;-0.49954923340969937;-0.4507097245593581
Vertebral artery tortuosity;Dentin dysplasia;0.9177669733762741;0.7939006;0.52620517654605;0.5660770266225907;0.9999201345566091;-0.082153161180335;-0.20601952554019065;-0.4737149580105591;-0.43384310793401837
Vertebral artery tortuosity;Aplasia of the inner ear;1.0353444516658783;0.80616355;0.4887471678868036;0.562093122395609;0.9999600672783046;0.03538438438757374;-0.19379651785508678;-0.5112128993915009;-0.4378669448826955
Vertebral artery tortuosity;Polycystic liver disease;0.9311133250594139;0.75726634;0.5219446890118766;0.5780441028035057;0.9999567459343585;-0.06884342087494455;-0.24269040329443536;-0.47801205692248183;-0.42191264313085275
Vertebral artery tortuosity;Subungual hyperkeratosis;1.0396665632724762;0.9175667;0.4873704273105094;0.5262691373911013;0.9999556674707869;0.039710895801689294;-0.08238895079979691;-0.5125852401602775;-0.47368653007968564
Vertebral artery tortuosity;Broad humeral epiphyses;0.8579875528812408;0.7544986;0.5453573036919939;0.5789525981169851;0.9999201345566091;-0.14193258167536826;-0.24542153359683128;-0.45456283086461524;-0.42096753643962403
Vertebral artery tortuosity;Autoimmune thrombocytopenia;0.7392628788948059;0.6183245;0.5839655821598108;0.6246528029673126;0.9999509115718902;-0.2606880326770843;-0.38162639336815485;-0.41598532941207944;-0.3752981086045776
Vertebral artery tortuosity;Adenomyosis;1.0080049121752381;0.9074913;0.4974519301032946;0.5294885781350736;0.9999600672783046;0.008044844896933578;-0.09246874094621227;-0.50250813717501;-0.470471489143231
Vertebral artery tortuosity;Elevated leukocyte alkaline phosphatase;1.0145507548004389;0.88395965;0.4953681874411052;0.5370201864108037;0.9999600672783046;0.014590687522134327;-0.11600041628495739;-0.5045918798371993;-0.4629398808675008
Vertebral artery tortuosity;Clasp-knife sign;0.9546618424355984;0.94095564;0.5144365324898271;0.5188053377597086;0.9999201345566091;-0.045258292121010735;-0.05896449567111106;-0.485483602066782;-0.4811147967969005
Vertebral artery tortuosity;Keratosis pilaris;0.9952880796045065;0.8350888;0.5014998563948485;0.5527337537945015;0.9999506876445663;-0.004662608040059801;-0.16486189818152308;-0.4984508312497178;-0.4472169338500648
Vertebral artery tortuosity;Lamina lucida cleavage;0.884729266166687;0.7659712;0.5367735600139776;0.575191009658585;0.9999548690865008;-0.11522560291981376;-0.2339836853096453;-0.4631813090725232;-0.4247638594279157
Vertebral artery tortuosity;Abnormal central response of multifocal electroretinogram;0.966584101319313;0.78650635;0.5106385914139009;0.568484265413939;0.9999201345566091;-0.03333603323729606;-0.21341377974780174;-0.4892815431427082;-0.43143586914267007
Vertebral artery tortuosity;Atypical or prolonged hepatitis;0.9498357139527798;0.7802354;0.5159744928156382;0.5705289257177613;0.9999600672783046;-0.050124353325524784;-0.21972465754167125;-0.4839855744626663;-0.4294311415605433
Vertebral artery tortuosity;Cubitus varus;0.6378904581069946;0.59317315;0.6179433714320726;0.6333647768351035;0.9999201345566091;-0.3620296764496145;-0.40674698830874534;-0.38197676312453654;-0.3665553577215056
Vertebral artery tortuosity;Nasal regurgitation;0.9671589955687523;0.802892;0.5104554963878067;0.5631549541971346;0.9999584729108851;-0.03279947734213284;-0.19706644362545422;-0.4895029765230784;-0.43680351871375056
Vertebral artery tortuosity;Moon facies;0.9918204983696342;0.8930015;0.5026036452660398;0.5341240015404434;0.9999584729108851;-0.00813797454125098;-0.10695697611904553;-0.4973548276448453;-0.46583447137044176
Vertebral artery tortuosity;Intestinal pseudo-obstruction;0.8757584095001221;0.7637101;0.5396497817216059;0.5759315118081914;0.9999539510871024;-0.12419554158698032;-0.23624386950980136;-0.46030416936549645;-0.42402243927891103
Vertebral artery tortuosity;Bilateral renal atrophy;0.8993614092469215;0.72314143;0.5320885808179858;0.5892933520106023;0.9999600672783046;-0.10059865803138301;-0.2768186354698329;-0.46787148646031873;-0.41066671526770226
Vertebral artery tortuosity;Fractured left clavicle;0.768753781914711;0.715253;0.574280293968308;0.5919095912651169;0.9999201345566091;-0.2311663526418981;-0.2846671390655813;-0.42563984058830107;-0.4080105432914922
Vertebral artery tortuosity;Positive urine norcotinine test;0.9526939988136292;0.8786304;0.5150635897817759;0.5387286164948423;0.9999201345566091;-0.04722613574297996;-0.12128973485262962;-0.4848565447748332;-0.46119151806176684
Vertebral artery tortuosity;Long fibula;0.8825490698218346;0.7743587;0.5374722846416344;0.5724477353657873;0.9999567459343585;-0.1174076761125239;-0.2255980561493548;-0.462484461292724;-0.42750901056857116
Vertebral artery tortuosity;Fragmentation of the epiphysis of the distal phalanx of the hallux;0.8656456470489502;0.81327516;0.5428960384220083;0.5597872836686171;0.9999201345566091;-0.1342744875076589;-0.18664497615130515;-0.4570240961346008;-0.44013285088799203
Vertebral artery tortuosity;Type II cryptotia;0.8833472356200218;0.79002035;0.5372164619954429;0.5673397674233371;0.9999201345566091;-0.11657289893658729;-0.20989978791506858;-0.4627036725611662;-0.43258036713327197
Vertebral artery tortuosity;Increased variability in muscle fiber diameter;0.7558573782444;0.65038896;0.5785065056186901;0.613686249182096;0.9999473166570552;-0.24408993841265514;-0.3495583605871089;-0.42144081103836506;-0.38626106747495914
Vertebral artery tortuosity;Widened proximal tibial metaphyses;0.8407290577888489;0.71352017;0.5509143424732834;0.5924851416829577;0.9999600672783046;-0.15923100948945568;-0.2864398980201869;-0.44904572480502114;-0.4074749255953468
Vertebral artery tortuosity;Wide anterior fontanel;0.8809758797287941;0.7707988;0.5379765841446951;0.5736113749149455;0.9999476714516888;-0.11897179172289474;-0.22914886907589538;-0.46197108730699377;-0.4263362965367433
Vertebral artery tortuosity;Increased circulating oleate level;0.9472554177045822;0.7723115;0.5167969162797938;0.5731167870365763;0.9999201345566091;-0.052664716852026894;-0.227608625901061;-0.48312321827681526;-0.4268033475200328
Vertebral artery tortuosity;Lozenge-shaped umbilicus;0.89194405823946;0.78024435;0.5344625623731323;0.5705260133529437;0.9999584729108851;-0.10801441467142514;-0.21971412247753552;-0.46549591053775285;-0.4294324595579414
Vertebral artery tortuosity;Anti-myelin-associated glycoprotein antibody positivity;0.9300552159547806;0.8749018;0.5222823100195599;0.5399245925725873;0.9999201345566091;-0.06986491860182853;-0.12501836301119895;-0.47763782453704917;-0.4599955419840218
Vertebral artery tortuosity;Fractured radius;0.7413030862808228;0.67697805;0.583293087004622;0.6046987684252902;0.9999600672783046;-0.2586569809974818;-0.3229820156158595;-0.41666698027368254;-0.3952612988530143
Vertebral artery tortuosity;Abnormal manual kinetic perimetry test;0.9376478493213654;0.79526114;0.5198601888992334;0.5656345032028642;0.9999201345566091;-0.06227228523524375;-0.20465898991854758;-0.48005994565737575;-0.43428563135374487
Vertebral artery tortuosity;Small radial epiphyses;0.8873802125453949;0.84816146;0.5359242054926499;0.5485193668398753;0.9999201345566091;-0.11253992201121421;-0.1517586755874929;-0.46399592906395926;-0.45140076771673376
Vertebral artery tortuosity;Generalized keratosis follicularis;1.0064638573676348;0.8537383;0.4979424759691067;0.5467241448995281;0.9999600672783046;0.006503790089330219;-0.1462217593254237;-0.5020175913091979;-0.4532359223787764
Vertebral artery tortuosity;Hypoplasia of the calcaneus;0.7864683866500854;0.76733536;0.568496636323641;0.5747444525025862;0.9999584729108851;-0.21349008626079968;-0.2326231176290553;-0.43146183658724413;-0.4252140204082989
Vertebral artery tortuosity;2-hydroxyadipic aciduria;0.8802020400762558;0.79564285;0.5382246801133848;0.5655103869651303;0.9999201345566091;-0.11971809448035331;-0.20427728177340598;-0.46169545444322435;-0.43440974759147877
Vertebral artery tortuosity;Potter facies;1.0313006229698658;0.9594719;0.4900350746586839;0.5129040278875157;0.9999552432134126;0.03134537975645324;-0.04048336182379464;-0.5099201685547287;-0.4870512153258969
Vertebral artery tortuosity;Increased heart rate variability;0.863462507724762;0.66926813;0.5435974167838744;0.6072955719728272;0.8658135241678199;-0.0023510164430579072;-0.19654539291171635;-0.32221610738394546;-0.25851795219499263
Vertebral artery tortuosity;Aplastic zygomatic arch;0.9270288869738579;0.79456115;0.5232480897346964;0.5658621680324651;0.9999584729108851;-0.07292958593702725;-0.2053973252210658;-0.47671038317618875;-0.43409630487842
Vertebral artery tortuosity;Testicular torsion;0.7930979430675507;0.61268026;0.5663381464547232;0.6265990471696953;0.9999600672783046;-0.2068621242107539;-0.3872798109115748;-0.4336219208235813;-0.3733610201086093
Vertebral artery tortuosity;Abolished vibration sense;0.8409799635410309;0.7356466;0.5508334456733142;0.5851585274621844;0.9999584729108851;-0.15897850936985425;-0.26431186741924695;-0.449125027237571;-0.4147999454487007
Vertebral artery tortuosity;Fractured metatarsal bone of digit 5;0.8169510662555695;0.8058008;0.5585966788480865;0.562210812659422;0.9999201345566091;-0.18296906830103965;-0.19411933900149436;-0.4413234557085226;-0.43770932189718714
Vertebral artery tortuosity;Prolonged G2 phase of cell cycle;0.9695864580571651;0.8954623;0.5096824241461387;0.5333363073569375;0.9999567459343585;-0.030370287877193314;-0.10449447138296686;-0.4902743217882197;-0.46662043857742097
Vertebral artery tortuosity;Single naris;1.1044450551271439;1.0654682;0.4666933624275673;0.4791459049001858;0.9999567459343585;0.1044883091927854;0.06551144616616644;-0.5332633835067911;-0.5208108410341726
Vertebral artery tortuosity;Perifoveal ring of hyperautofluorescence surrounded by normal autofluorescence;0.8915814757347107;0.7818854;0.5345786580206962;0.5699906629346897;0.9999201345566091;-0.10833865882189841;-0.21803474904330344;-0.46534147653591296;-0.4299294716219194
Vertebral artery tortuosity;Asymmetry of the thorax;0.6515601873397827;0.57662356;0.6132884263613505;0.6391552256412936;0.9999567459343585;-0.34839655859457574;-0.42333318693625055;-0.38666831957300796;-0.3608015202930649
Vertebral artery tortuosity;Type 2 muscle fiber predominance;0.9415872097015381;0.86192495;0.5186039584961086;0.5440915224313496;0.9999556674707869;-0.058368457769248816;-0.13803072116265092;-0.48135170897467827;-0.4558641450394373
Vertebral artery tortuosity;Dependency on parenteral nutrition;0.9112053215503693;0.8647821;0.5283014979135381;0.5431734374583113;0.9999584729108851;-0.08875315136051587;-0.1351763779554408;-0.47165697499734704;-0.4567850354525739
Vertebral artery tortuosity;Limited shoulder flexion;0.8352413922548294;0.7554005;0.5526845099624638;0.5786564933193885;0.9999201345566091;-0.1646787423017797;-0.24451965571673484;-0.44723562459414534;-0.4212636412372206
Vertebral artery tortuosity;Paroxysmal vertigo;0.7983246147632599;0.546938;0.5646386006822448;0.649668382956915;0.9999584729108851;-0.20163385814762524;-0.45302047080135754;-0.4353198722286403;-0.35029008995397015
Vertebral artery tortuosity;Long hallux;0.8981644883751869;0.83067155;0.5324715401058407;0.5541598575621985;0.9999526340597648;-0.10178814568457784;-0.16928108521638097;-0.467481093953924;-0.4457927764975662
Vertebral artery tortuosity;Broad medial eyebrow;1.0567928478121758;0.94807494;0.4819125428791279;0.5165356960576859;0.9999600672783046;0.0568327805338712;-0.0518851304115443;-0.5180475243991767;-0.48342437122061865
Vertebral artery tortuosity;Myxoid subcutaneous tumors;1.009462358430028;0.92089355;0.49698799281667405;0.5252066922469156;0.9999600672783046;0.009502291151723408;-0.07906651735917614;-0.5029720744616305;-0.4747533750313889
Vertebral artery tortuosity;Bulbous tips of toes;0.882726639509201;0.79141223;0.5374153691218808;0.5668867015898001;0.9999584729108851;-0.11723183340168408;-0.20854623860454968;-0.4625431037890043;-0.433071771321085
Vertebral artery tortuosity;Absent internal genitalia;0.9043187201023102;0.81346947;0.53050296057316;0.5597243263966726;0.9999201345566091;-0.09560141445429893;-0.18645066500933738;-0.46941717398344907;-0.44019580815993653
Vertebral artery tortuosity;Hyperphalangy of the 2nd finger;0.8589434921741486;0.79303145;0.5450499244657303;0.5663597787947973;0.9999600672783046;-0.141016575104156;-0.20692861319200084;-0.45491014281257425;-0.4336002884835073
Vertebral artery tortuosity;Renal interstitial hemosiderin;0.9448019824922085;0.8385732;0.5175790090714031;0.5516095590084911;0.9999201345566091;-0.05511815206440063;-0.16134691716464133;-0.482341125485206;-0.44831057554811804
Vertebral artery tortuosity;Abnormality of depressor anguli oris muscle;0.8402106761932373;0.73510206;0.5510814890989213;0.5853382700953922;0.9999201345566091;-0.1597094583633718;-0.2648180770996389;-0.4488386454576878;-0.4145818644612169
Vertebral artery tortuosity;Paroxysmal dyspnea;0.8022594004869461;0.723662;0.563360369150669;0.5891209165708604;0.9999201345566091;-0.197660734069663;-0.27625811578066917;-0.4365597654059401;-0.4107992179857487
Vertebral artery tortuosity;Phenylpyruvic acidemia;0.904670961201191;0.7910282;0.5303903238788081;0.567011683030791;0.9999600672783046;-0.0952891060771136;-0.20893186569825695;-0.4695697433994964;-0.4329483842475136
Vertebral artery tortuosity;Lateral ventricle dilatation;0.6957651972770691;0.5561178;0.5984007429856086;0.6463991345450408;0.9999488789551968;-0.3041836816781277;-0.4438311058991665;-0.40154813596958816;-0.35354974441015596
Vertebral artery tortuosity;Neonatal unconjugated hyperbilirubinemia;0.7750063240528107;0.7213174;0.5722361460348506;0.58989774037347;0.9999600672783046;-0.22495374322549389;-0.2786426568092494;-0.42772392124345393;-0.4100623269048346
Vertebral artery tortuosity;High maternal circulating alpha-fetoprotein concentration;0.8815785944461823;0.79232377;0.5377833675530268;0.5665900404601868;0.9999201345566091;-0.11834154011042686;-0.2075963664177236;-0.4621367670035823;-0.4333300940964223
Vertebral artery tortuosity;Prominent nasolabial fold;0.9806337654590607;0.8011029;0.506164849309017;0.5637359623399403;0.9999545338528789;-0.019320768393818244;-0.1988516571896709;-0.49378968454386196;-0.43621857151293864
Vertebral artery tortuosity;Abnormality of inferior alveolar nerve;0.9212925136089325;0.7505792;0.5250793104674789;0.5802402287280778;0.9999201345566091;-0.07862762094767661;-0.24934095622332664;-0.4748408240891302;-0.4196799058285313
Vertebral artery tortuosity;Unilateral conductive hearing impairment;1.0194492358714342;0.80621105;0.49380872556979827;0.5620776991828087;0.9999600672783046;0.019489168593129658;-0.1937490129532008;-0.5061513417085063;-0.43788236809549586
Vertebral artery tortuosity;Macular hypopigmented whorls, streaks, and patches;0.9304833710193634;0.8268472;0.5221456914788397;0.5553954527461851;0.9999600672783046;-0.06947669625894115;-0.17311287165299938;-0.47781437579946484;-0.4445646145321195
Vertebral artery tortuosity;Delayed ossification of pubic rami;0.7831408977508545;0.64269924;0.5695812202173046;0.6163028912606799;0.9999584729108851;-0.21681757516003064;-0.35725923127270154;-0.4303772526935805;-0.3836555816502052
Vertebral artery tortuosity;Hyperphenylalaninemia;0.9499587565660477;0.7798542;0.5159352778840929;0.5706533267407141;0.9999561589935034;-0.04999740242745576;-0.22010198056485353;-0.48402088110941055;-0.4293028322527893
Vertebral artery tortuosity;Ureteropelvic junction obstruction;0.8357042670249939;0.64611024;0.5525351367700939;0.6151411993373093;0.9999528219730685;-0.16424855494807455;-0.3538425853283236;-0.44741768520297454;-0.3848116226357592
Vertebral artery tortuosity;Cone-shaped epiphysis of the proximal phalanx of the 2nd toe;0.8895554840564728;0.81371737;0.535227447729105;0.5596440061986705;0.9999201345566091;-0.11036465050013633;-0.18620276929171653;-0.4646926868275041;-0.4402761283579386
Vertebral artery tortuosity;Difficulty walking;0.9482337906956673;0.8570359;0.5164850644052639;0.545663364462112;0.9999461221900431;-0.05171233149437582;-0.14291024686960851;-0.4834610577847792;-0.45428275772793103
Vertebral artery tortuosity;Bilobate gallbladder;0.9077759832143784;0.7736784;0.529397589553614;0.5726700117871094;0.9999584729108851;-0.09218248969650678;-0.226280050936703;-0.4705608833572711;-0.4272884611237757
Vertebral artery tortuosity;Histidinuria;0.9923906065523624;0.88614565;0.502422168537713;0.5363197153605591;0.9999574798349273;-0.00756687328256489;-0.11381182849444271;-0.4975353112972143;-0.4636377644743682
Vertebral artery tortuosity;Widened interpedicular distance;0.8012384474277496;0.7186338;0.563691929674766;0.5907875692033349;0.9999201345566091;-0.19868168712885947;-0.2812863636139211;-0.4362282048818431;-0.40913256535327425
Warm reactive autoantibody positivity;Right aortic arch with retroesophageal left subclavian artery;0.8556136935949326;0.7714671;0.5461207954155773;0.5733928426252437;1.0;-0.14438630640506744;-0.22853291034698486;-0.45387920458442266;-0.4266071573747563
Warm reactive autoantibody positivity;Elevated urine suberic acid level;0.8940125033259392;0.8103125;0.5338003524486754;0.5607474740414387;0.9999201345566091;-0.10590763123066993;-0.18960762501986594;-0.4661197821079337;-0.43917266051517045
Warm reactive autoantibody positivity;Burkitt lymphoma;0.6917963624000549;0.68095565;0.5997278147317064;0.6033618953816633;0.9999090677057578;-0.3081127053057029;-0.3189534192835166;-0.4001812529740514;-0.39654717232409453
Warm reactive autoantibody positivity;Snail-like ilia;1.0268174968659878;0.9827753;0.49146270210992626;0.5054830815945708;0.9999201345566091;0.02689736230937867;-0.017144863617735817;-0.5084574324466828;-0.4944370529620383
Warm reactive autoantibody positivity;Indurated nodule;0.7064407169818878;0.7093185;0.5948398098287451;0.59388198851195;1.0;-0.2935592830181122;-0.29068148136138916;-0.40516019017125493;-0.40611801148805005
Warm reactive autoantibody positivity;Absent leukocyte alkaline phosphatase;0.7640624940395355;0.7403645;0.5758160665278831;0.5836024199366214;0.9999201345566091;-0.23585764051707359;-0.25955564261706443;-0.424104068028726;-0.4163177146199877
Warm reactive autoantibody positivity;Hippocampal sclerosis;0.9131850302219391;0.89041543;0.5276688936566403;0.5349520467125477;1.0;-0.08681496977806091;-0.10958456993103027;-0.47233110634335973;-0.4650479532874523
Warm reactive autoantibody positivity;Decreased sensitivity to hypoxemia;0.9563029333949089;0.9163369;0.513913638557049;0.5266619686294427;0.9999201345566091;-0.0436172011617002;-0.08358324052126975;-0.48600649599956014;-0.4732581659271664
Warm reactive autoantibody positivity;Decreased level of tissue plasminogen activator;0.8276605606079102;0.81202173;0.5551325941645705;0.5601934536920491;1.0;-0.17233943939208984;-0.18797826766967773;-0.4448674058354295;-0.4398065463079509
Warm reactive autoantibody positivity;Submandibular lymph node enlargement;0.8570302873849869;0.77328426;0.5456651520337257;0.5727988414909044;0.6369582787135069;0.22007200867148002;0.13632597774477562;-0.09129312667978118;-0.06415943722260242
Warm reactive autoantibody positivity;Hepatic hemangioma;0.8797735646367073;0.7633835;0.5383620610147201;0.5760384924124777;0.9999134918687169;-0.12013992723200961;-0.23652998414014026;-0.46155143085399686;-0.4238749994562392
Warm reactive autoantibody positivity;Triangular epiphysis of the distal phalanx of the 2nd finger;1.0120550729334354;1.0106306;0.49616265815931493;0.4966161111373919;1.0;0.01205507293343544;0.010630607604980469;-0.5038373418406851;-0.5033838888626081
Warm reactive autoantibody positivity;Acne inversa;0.8440341949462891;0.8405598;0.549848967026163;0.5509689225417906;0.45807765254028776;0.3859565424060013;0.382482128057399;0.09177131448587528;0.09289127000150288
Warm reactive autoantibody positivity;Dentin dysplasia;0.9654529392719269;0.9385431;0.5109988595640236;0.5195746884374686;1.0;-0.03454706072807312;-0.061456918716430664;-0.4890011404359764;-0.48042531156253143
Warm reactive autoantibody positivity;Aplasia of the inner ear;1.028946690261364;0.8929617;0.4907846950778092;0.5341367580826016;0.9999201345566091;0.029026555704754875;-0.10695845366747947;-0.5091354394787999;-0.46578337647400747
Warm reactive autoantibody positivity;Polycystic liver disease;0.9545792303979397;0.8473605;0.5144628558358841;0.5487773487164533;0.9999056439461368;-0.04532641354819711;-0.15254515219351228;-0.48544278811025265;-0.45112829522968345
Warm reactive autoantibody positivity;Subungual hyperkeratosis;0.8997601792216301;0.78677404;0.5319610032572998;0.5683970602774804;0.9999003561294039;-0.10014017690777377;-0.21312631686091021;-0.4679393528721041;-0.4315032958519235
Warm reactive autoantibody positivity;Broad humeral epiphyses;0.9264908879995346;0.8286495;0.5234198012885316;0.5548130350762236;1.0;-0.0735091120004654;-0.17135047912597656;-0.4765801987114684;-0.4451869649237764
Warm reactive autoantibody positivity;Autoimmune thrombocytopenia;0.6380952894687653;0.59089017;0.6178734276717706;0.6341607112583719;0.0;0.6380952894687653;0.5908901691436768;0.6178734276717706;0.6341607112583719
Warm reactive autoantibody positivity;Adenomyosis;0.9543416872620583;0.8337833;0.5145385466910766;0.5531551196800533;0.9999201345566091;-0.04557844729455085;-0.1661368060234365;-0.48538158786553254;-0.44676501487655584
Warm reactive autoantibody positivity;Elevated leukocyte alkaline phosphatase;0.7525623589754105;0.6778574;0.5795885368267112;0.6044030550504176;0.9999201345566091;-0.24735777558119865;-0.3220627355697927;-0.4203315977298979;-0.3955170795061915
Warm reactive autoantibody positivity;Clasp-knife sign;0.9868965307250619;0.9203769;0.5041710831824533;0.5253716826943524;1.0;-0.013103469274938107;-0.07962310314178467;-0.4958289168175467;-0.4746283173056476
Warm reactive autoantibody positivity;Keratosis pilaris;0.8985380828380585;0.83260244;0.5323520021298935;0.553536344166903;0.9998710980331391;-0.10133301519508064;-0.16726865672225655;-0.4675190959032456;-0.4463347538662361
Warm reactive autoantibody positivity;Lamina lucida cleavage;0.9641346037387848;0.91704726;0.5114187591370086;0.5264350483797466;0.9998962300503706;-0.03576162631158586;-0.08284896785859819;-0.488477470913362;-0.473461181670624
Warm reactive autoantibody positivity;Abnormal central response of multifocal electroretinogram;0.932009145617485;0.8171431;0.5216588703085929;0.558534499166174;1.0;-0.06799085438251495;-0.18285691738128662;-0.4783411296914071;-0.44146550083382596
Warm reactive autoantibody positivity;Atypical or prolonged hepatitis;0.834089607000351;0.73389757;0.553056250681764;0.5857359534330493;0.5829152011936182;0.2511744058067328;0.15098236560173095;-0.029858950511854165;0.0028207522394311235
Warm reactive autoantibody positivity;Cubitus varus;0.980206111446023;0.9667442;0.5063010019117853;0.5105876141386163;1.0;-0.019793888553977013;-0.033255815505981445;-0.4936989980882147;-0.4894123858613837
Warm reactive autoantibody positivity;Nasal regurgitation;1.0015342012047768;0.9138601;0.49951164839754614;0.5274532098054998;0.9999134918687169;0.0016207093360598446;-0.08605340924237415;-0.5004018434711708;-0.4724602820632171
Warm reactive autoantibody positivity;Moon facies;0.929558739066124;0.9253223;0.5224407342880315;0.5237928015218853;0.9999134918687169;-0.07035475280259296;-0.07459119763348743;-0.4774727575806854;-0.4761206903468316
Warm reactive autoantibody positivity;Intestinal pseudo-obstruction;0.9456189461052418;0.84454757;0.5173185702708631;0.5496835321885373;0.9998912449978579;-0.05427229889261609;-0.15534367524611836;-0.4825726747269947;-0.4502077128093206
Warm reactive autoantibody positivity;Bilateral renal atrophy;0.8720195591449738;0.820826;0.5408494736699421;0.5573425094216551;0.9999201345566091;-0.12790057541163535;-0.17909414054186912;-0.45907066088666704;-0.442577625134954
Warm reactive autoantibody positivity;Fractured left clavicle;1.0458699725568295;0.986962;0.48539400923294107;0.5041502442856665;1.0;0.04586997255682945;-0.01303797960281372;-0.5146059907670589;-0.49584975571433354
Warm reactive autoantibody positivity;Positive urine norcotinine test;0.7562159597873688;0.6992301;0.5783888093099135;0.5972436248333574;1.0;-0.24378404021263123;-0.3007699251174927;-0.42161119069008646;-0.40275637516664264
Warm reactive autoantibody positivity;Long fibula;0.9360094368457794;0.8536582;0.5203827555720428;0.5467499264244681;0.9999056439461368;-0.06389620710035737;-0.14624744463583406;-0.47952288837409396;-0.4531557175216687
Warm reactive autoantibody positivity;Fragmentation of the epiphysis of the distal phalanx of the hallux;0.9838065356016159;1.0312093;0.505154765113851;0.4900641266425959;1.0;-0.016193464398384094;0.031209349632263184;-0.49484523488614895;-0.5099358733574041
Warm reactive autoantibody positivity;Type II cryptotia;0.8689166903495789;0.85758185;0.541845539503808;0.5454877581857405;1.0;-0.13108330965042114;-0.14241814613342285;-0.458154460496192;-0.45451224181425953
Warm reactive autoantibody positivity;Increased variability in muscle fiber diameter;0.8795299530029297;0.81728244;0.5384401727429597;0.558489400047059;0.9998452077479463;-0.12031525474501659;-0.18256276946974803;-0.46140503500498653;-0.4413558077008872
Warm reactive autoantibody positivity;Widened proximal tibial metaphyses;0.8955550193786621;0.77036726;0.5333066137260742;0.5737524919632683;0.9999201345566091;-0.104365115177947;-0.22955286980898948;-0.46661352083053487;-0.42616764259334083
Warm reactive autoantibody positivity;Wide anterior fontanel;0.9205760806798935;0.7468864;0.5253080743231029;0.5814546523444746;0.999848231156753;-0.07927215047685954;-0.2529618585905299;-0.47454015683365014;-0.41839357881227845
Warm reactive autoantibody positivity;Increased circulating oleate level;0.8882535770535469;0.78861386;0.5356444389141812;0.5677977566975894;1.0;-0.1117464229464531;-0.21138614416122437;-0.46435556108581877;-0.43220224330241064
Warm reactive autoantibody positivity;Lozenge-shaped umbilicus;0.9946180693805218;0.92538863;0.5017131299931887;0.523771628155938;0.9999134918687169;-0.005295422488195145;-0.07452485766385242;-0.4982003618755282;-0.4761418637127789
Warm reactive autoantibody positivity;Anti-myelin-associated glycoprotein antibody positivity;0.5645194053649902;0.48736513;0.6434215488992365;0.6713305403385024;1.0;-0.43548059463500977;-0.5126348733901978;-0.35657845110076347;-0.32866945966149763
Warm reactive autoantibody positivity;Fractured radius;1.0059178238734603;0.9418454;0.4981162871614694;0.5185216226580267;0.9999201345566091;0.005997689316851185;-0.05807471753390403;-0.5018038473951397;-0.4813985118985824
Warm reactive autoantibody positivity;Abnormal manual kinetic perimetry test;0.9795862138271332;0.8972465;0.5064983613423104;0.5327652970078729;1.0;-0.02041378617286682;-0.10275352001190186;-0.4935016386576896;-0.4672347029921271
Warm reactive autoantibody positivity;Small radial epiphyses;1.0269048642367125;1.0406594;0.49143488217391273;0.4870541430426025;1.0;0.026904864236712456;0.040659427642822266;-0.5085651178260873;-0.5129458569573975
Warm reactive autoantibody positivity;Generalized keratosis follicularis;0.7720574587583542;0.70525366;0.5731998374996269;0.5952351521945185;0.9999201345566091;-0.22786267579825492;-0.2946664738777456;-0.4267202970569822;-0.4046849823620906
Warm reactive autoantibody positivity;Hypoplasia of the calcaneus;1.000700954347849;0.98299015;0.49977687928304493;0.5054146635498844;0.9999134918687169;0.0007874624791319729;-0.016923346185428345;-0.500136612585672;-0.4944988283188325
Warm reactive autoantibody positivity;2-hydroxyadipic aciduria;0.8008924722671509;0.81283647;0.5638043030201915;0.5599294242110449;1.0;-0.19910752773284912;-0.18716353178024292;-0.43619569697980853;-0.44007057578895514
Warm reactive autoantibody positivity;Potter facies;0.9276031404733658;0.8816393;0.5230648144066892;0.537763911720736;0.9998981869165328;-0.07229504644316698;-0.11825888513964677;-0.4768333725098436;-0.46213427519579675
Warm reactive autoantibody positivity;Increased heart rate variability;0.9197483584284782;0.75988173;0.5255723902373339;0.5771862156169931;0.9999201345566091;-0.08017177612813087;-0.24003839970858665;-0.4743477443192752;-0.422733918939616
Warm reactive autoantibody positivity;Aplastic zygomatic arch;0.9889065930619836;0.8492625;0.5035312135297099;0.5481648405012358;0.9999134918687169;-0.011006898806733334;-0.1506510159013097;-0.49638227833900705;-0.4517486513674811
Warm reactive autoantibody positivity;Testicular torsion;0.8979801684617996;0.8275001;0.5325305181251754;0.555184435715622;0.9999201345566091;-0.10193996609480949;-0.1724200296524343;-0.46738961643143373;-0.44473569884098707
Warm reactive autoantibody positivity;Abolished vibration sense;0.9684641286730766;0.89470094;0.5100398442048181;0.5335799888165962;0.9999134918687169;-0.03144936319564029;-0.10521254744504138;-0.48987364766389885;-0.46633350305212073
Warm reactive autoantibody positivity;Fractured metatarsal bone of digit 5;1.0093641486018896;1.0594168;0.4970192553610109;0.48107591083785717;1.0;0.00936414860188961;0.059416770935058594;-0.5029807446389891;-0.5189240891621428
Warm reactive autoantibody positivity;Prolonged G2 phase of cell cycle;0.9063820689916611;0.84687656;0.5298432142695275;0.5489332064073433;0.9999056439461368;-0.09352357495447572;-0.15302908230444368;-0.4700624296766093;-0.45097243753879346
Warm reactive autoantibody positivity;Single naris;0.9669127613306046;0.9445889;0.5105339177995651;0.5176469370487515;0.9999056439461368;-0.03299288261553224;-0.05531674433371003;-0.48937172614657165;-0.48225870689738526
Warm reactive autoantibody positivity;Perifoveal ring of hyperautofluorescence surrounded by normal autofluorescence;0.7465065121650696;0.6260932;0.5815796419725956;0.6219820109338208;1.0;-0.2534934878349304;-0.37390679121017456;-0.4184203580274044;-0.3780179890661792
Warm reactive autoantibody positivity;Asymmetry of the thorax;0.9668064601719379;0.88923925;0.5105677731057993;0.5353287218739854;0.9999056439461368;-0.03309918377419885;-0.11066639233251985;-0.48933787084033753;-0.4645769220721514
Warm reactive autoantibody positivity;Type 2 muscle fiber predominance;0.8181493133306503;0.7587166;0.5582087536730982;0.5775683293018192;0.9999003561294039;-0.18175104279875354;-0.24118377287745074;-0.4416916024563057;-0.42233202682758464
Warm reactive autoantibody positivity;Dependency on parenteral nutrition;0.9455651231110096;0.8968484;0.5173357280763523;0.5328926834015952;0.9999134918687169;-0.05434836875770732;-0.10306511130307361;-0.4825777637923646;-0.4670208084671217
Warm reactive autoantibody positivity;Limited shoulder flexion;0.9150678813457489;0.84828335;0.5270673413310522;0.5484801223974956;1.0;-0.0849321186542511;-0.15171664953231812;-0.47293265866894785;-0.45151987760250445
Warm reactive autoantibody positivity;Paroxysmal vertigo;0.9732153546065092;0.80494916;0.5085268371839777;0.5624871848981141;0.9999134918687169;-0.02669813726220771;-0.19496432747815295;-0.4913866546847392;-0.4374263069706028
Warm reactive autoantibody positivity;Long hallux;0.9077269062399864;0.87625957;0.5294132781356865;0.5394890183007153;0.9998836012415208;-0.09215669500153434;-0.1236240358881272;-0.47047032310583425;-0.4603945829408055
Warm reactive autoantibody positivity;Broad medial eyebrow;0.8998202905058861;0.82781464;0.531941772439707;0.5550828101383116;0.9999201345566091;-0.10009984405072303;-0.17210549594195457;-0.46797836211690214;-0.4448373244182975
Warm reactive autoantibody positivity;Myxoid subcutaneous tumors;0.8092900812625885;0.8149896;0.5610789840826889;0.5592318685132445;0.9999201345566091;-0.1906300532940206;-0.18493050814898582;-0.43884115047392025;-0.44068826604336464
Warm reactive autoantibody positivity;Bulbous tips of toes;0.917169414460659;0.8830447;0.5263960365915727;0.5373134194807909;0.9999134918687169;-0.08274407740805789;-0.116868772172672;-0.4735174552771442;-0.462600072387926
Warm reactive autoantibody positivity;Absent internal genitalia;0.9321603998541832;0.89737856;0.5216106131685468;0.5327230156561709;1.0;-0.0678396001458168;-0.10262143611907959;-0.47838938683145316;-0.46727698434382914
Warm reactive autoantibody positivity;Hyperphalangy of the 2nd finger;0.9188536927103996;0.85261726;0.5258581030368047;0.5470848986256882;0.9999201345566091;-0.08106644184620948;-0.1473028707626638;-0.4740620315198044;-0.4528352359309209
Warm reactive autoantibody positivity;Renal interstitial hemosiderin;0.803841158747673;0.7290355;0.5628468212375779;0.5873425927532772;1.0;-0.19615884125232697;-0.27096450328826904;-0.4371531787624221;-0.41265740724672284
Warm reactive autoantibody positivity;Abnormality of depressor anguli oris muscle;0.9507866725325584;0.9125496;0.5156714189142781;0.5278719152993164;1.0;-0.04921332746744156;-0.08745038509368896;-0.48432858108572185;-0.47212808470068357
Warm reactive autoantibody positivity;Paroxysmal dyspnea;0.9049866124987602;0.8290695;0.5302893908063269;0.554677370559496;1.0;-0.09501338750123978;-0.17093050479888916;-0.46971060919367313;-0.44532262944050405
Warm reactive autoantibody positivity;Phenylpyruvic acidemia;0.8487017303705215;0.74381727;0.5483453926321513;0.5824648820602841;0.9999201345566091;-0.15121840418608756;-0.2561028647545156;-0.4515747419244578;-0.417455252496325
Warm reactive autoantibody positivity;Lateral ventricle dilatation;1.0288253724575043;0.91784966;0.4908233278551841;0.526178767246988;0.9998579617208769;0.02896741073662734;-0.08200830180113816;-0.5090346338656928;-0.47367919447388895
Warm reactive autoantibody positivity;Neonatal unconjugated hyperbilirubinemia;0.8275558799505234;0.7787247;0.5551664214999052;0.5710219508450656;0.9999201345566091;-0.17236425460608573;-0.22119546414645286;-0.44475371305670386;-0.42889818371154353
Warm reactive autoantibody positivity;High maternal circulating alpha-fetoprotein concentration;0.7958642840385437;0.68217444;0.5654383853781034;0.6029526365134933;1.0;-0.2041357159614563;-0.3178255558013916;-0.4345616146218966;-0.3970473634865067
Warm reactive autoantibody positivity;Prominent nasolabial fold;0.9941302724182606;0.8954316;0.5018684030474783;0.5333461250147944;0.9998944404568447;-0.00576416803858415;-0.10446286229751245;-0.49802603740936646;-0.46654831544205033
Warm reactive autoantibody positivity;Abnormality of inferior alveolar nerve;0.9975975342094898;0.89397514;0.5007647293479884;0.5338123086140507;1.0;-0.0024024657905101776;-0.1060248613357544;-0.49923527065201156;-0.4661876913859493
Warm reactive autoantibody positivity;Unilateral conductive hearing impairment;1.0279999859631062;0.8756483;0.49108616265585914;0.5396851030430101;0.9999201345566091;0.028079851406497047;-0.12427181483538718;-0.50883397190075;-0.460235031513599
Warm reactive autoantibody positivity;Macular hypopigmented whorls, streaks, and patches;0.8337745070457458;0.81408083;0.5531579624507008;0.5595262629698056;0.9999201345566091;-0.16614562751086326;-0.1858393001678762;-0.4467621721059083;-0.44039387158680354
Warm reactive autoantibody positivity;Delayed ossification of pubic rami;1.0015018614940345;0.97977;0.4995219424590531;0.5064398378955209;0.9999134918687169;0.0015883696253176094;-0.020143487119418824;-0.5003915494096638;-0.493473653973196
Warm reactive autoantibody positivity;Hyperphenylalaninemia;0.7610242515802383;0.6381011;0.576811644998239;0.6178714534982952;0.9999028053808913;-0.23887855380065293;-0.3618017044592604;-0.42309116038265226;-0.38203135188259607
Warm reactive autoantibody positivity;Ureteropelvic junction obstruction;0.9727376513183117;0.86948067;0.5086789504166864;0.5416644636678684;0.9998847295244674;-0.027147078206155695;-0.13040406002602378;-0.49120577910778096;-0.45822026585659903
Warm reactive autoantibody positivity;Cone-shaped epiphysis of the proximal phalanx of the 2nd toe;0.9566560015082359;0.93168193;0.5138011469033378;0.5217632639455128;1.0;-0.04334399849176407;-0.06831806898117065;-0.4861988530966622;-0.47823673605448724
Warm reactive autoantibody positivity;Difficulty walking;1.02418327704072;0.99220264;0.492301473323873;0.5024820094702546;0.9998344221996177;0.024348854841102274;-0.0076317826198447625;-0.5075329488757447;-0.49735241272936315
Warm reactive autoantibody positivity;Bilobate gallbladder;1.0019087325781584;0.91671;0.4993924311813688;0.526542773720708;0.9999134918687169;0.0019952407094414593;-0.08320347275708362;-0.5005210606873481;-0.4733707181480089
Warm reactive autoantibody positivity;Histidinuria;0.693254292011261;0.7342295;0.5992401152805508;0.5856263375053483;0.9999090677057578;-0.30665477569449684;-0.26567956264365455;-0.40066895242520706;-0.4142827302004095
Warm reactive autoantibody positivity;Widened interpedicular distance;0.9022390618920326;0.78419304;0.5311680547441777;0.5692381901780692;1.0;-0.09776093810796738;-0.2158069610595703;-0.4688319452558223;-0.4307618098219308
Right aortic arch with retroesophageal left subclavian artery;Elevated urine suberic acid level;0.8909278064966202;0.7205875;0.5347879686932346;0.5901396916085195;0.9999201345566091;-0.10899232805998893;-0.27933264256747337;-0.46513216586337447;-0.4097804429480896
Right aortic arch with retroesophageal left subclavian artery;Burkitt lymphoma;1.0165956672281027;0.97439057;0.49471719253945257;0.5081526200999136;0.9999090677057578;0.016686599522344858;-0.025518501356728285;-0.5051918751663053;-0.49175644760584425
Right aortic arch with retroesophageal left subclavian artery;Snail-like ilia;1.0551378540694714;0.96378905;0.48244017075495715;0.5115288168336294;0.9999201345566091;0.05521771951286225;-0.036131088745909645;-0.517479963801652;-0.4883913177229797
Right aortic arch with retroesophageal left subclavian artery;Indurated nodule;0.9467138983309269;0.85190785;0.5169695299991518;0.5473132320944871;1.0;-0.053286101669073105;-0.1480921506881714;-0.4830304700008482;-0.4526867679055129
Right aortic arch with retroesophageal left subclavian artery;Absent leukocyte alkaline phosphatase;0.9839730020612478;0.814301;0.5051017703164018;0.5594549403612006;0.9999201345566091;-0.015947132495361283;-0.1856191206100759;-0.4948183642402073;-0.4404651941954085
Right aortic arch with retroesophageal left subclavian artery;Hippocampal sclerosis;0.9971623085439205;0.9149531;0.5009032664566699;0.5271039964943391;1.0;-0.002837691456079483;-0.08504688739776611;-0.49909673354333006;-0.47289600350566086
Right aortic arch with retroesophageal left subclavian artery;Decreased sensitivity to hypoxemia;0.7479473054409027;0.8062926;0.5811056299152839;0.5620512383217677;0.9999201345566091;-0.2519728291157064;-0.19362754107745261;-0.4188145046413252;-0.4378688962348414
Right aortic arch with retroesophageal left subclavian artery;Decreased level of tissue plasminogen activator;0.727160781621933;0.70446223;0.5879627054558135;0.5954988177563953;1.0;-0.272839218378067;-0.2955377697944641;-0.41203729454418647;-0.40450118224360465
Right aortic arch with retroesophageal left subclavian artery;Submandibular lymph node enlargement;0.8962448164820671;0.77013755;0.5330858450093726;0.5738276275338238;0.6233977918117102;0.27284702467035693;0.1467397566349451;-0.09031194680233756;-0.04957016427788641
Right aortic arch with retroesophageal left subclavian artery;Hepatic hemangioma;0.8305819779634476;0.745945;0.5541887964547845;0.5817644238617615;0.5920744707068977;0.2385075072565499;0.15387050609974295;-0.0378856742521132;-0.010310046845136145
Right aortic arch with retroesophageal left subclavian artery;Triangular epiphysis of the distal phalanx of the 2nd finger;0.9249160140752792;0.7998449;0.5239224886122779;0.5641445988650136;1.0;-0.07508398592472076;-0.2001550793647766;-0.47607751138772214;-0.43585540113498644
Right aortic arch with retroesophageal left subclavian artery;Acne inversa;0.8220455646514893;0.70571095;0.5569479670205362;0.5950828375108878;0.9998962300503706;-0.1778506653988814;-0.2941852825367903;-0.4429482630298345;-0.4048133925394829
Right aortic arch with retroesophageal left subclavian artery;Dentin dysplasia;0.9470875933766365;0.9528127;0.5168504111227769;0.5150257704348562;1.0;-0.052912406623363495;-0.04718732833862305;-0.48314958887722315;-0.4849742295651438
Right aortic arch with retroesophageal left subclavian artery;Aplasia of the inner ear;0.9731503091752529;0.77522206;0.508547549236786;0.5721656786472966;0.9999201345566091;-0.026769825381356194;-0.2246980714920339;-0.4913725853198231;-0.4277544559093125
Right aortic arch with retroesophageal left subclavian artery;Polycystic liver disease;0.8368100523948669;0.7875272;0.552178338651184;0.5681516787459143;0.9999056439461368;-0.16309559155126985;-0.2123784403862613;-0.44772730529495275;-0.43175396520022247
Right aortic arch with retroesophageal left subclavian artery;Subungual hyperkeratosis;1.0389093980193138;0.9511025;0.48761162672487346;0.5155707611377874;0.9999003561294039;0.039009041889909946;-0.04879786093592242;-0.5122887294045304;-0.48432959499161643
Right aortic arch with retroesophageal left subclavian artery;Broad humeral epiphyses;0.9381224401295185;0.7657926;0.5197088296782235;0.5752494720445452;1.0;-0.06187755987048149;-0.2342073917388916;-0.4802911703217765;-0.42475052795545476
Right aortic arch with retroesophageal left subclavian artery;Autoimmune thrombocytopenia;0.7677170038223267;0.72971;0.5746195479448145;0.5871195849080737;0.9998726169824932;-0.23215561316016653;-0.2701626341104839;-0.4252530690376787;-0.4127530320744195
Right aortic arch with retroesophageal left subclavian artery;Adenomyosis;0.8905910030007362;0.6947036;0.5348958220420361;0.5987555455015035;0.9999201345566091;-0.10932913155587287;-0.3052165556076345;-0.465024312514573;-0.40116458905510566
Right aortic arch with retroesophageal left subclavian artery;Elevated leukocyte alkaline phosphatase;1.050830826163292;0.87115574;0.483813069841068;0.541126731682383;0.9999201345566091;0.05091069160668282;-0.1287643957260427;-0.5161070647155411;-0.4587934028742261
Right aortic arch with retroesophageal left subclavian artery;Clasp-knife sign;0.9672911241650581;0.9606735;0.5104134159419135;0.5125212415186029;1.0;-0.032708875834941864;-0.039326488971710205;-0.4895865840580865;-0.4874787584813971
Right aortic arch with retroesophageal left subclavian artery;Keratosis pilaris;0.9532766900956631;0.913816;0.5148779080565539;0.5274673068067309;0.9998710980331391;-0.046594407937476046;-0.08605512284393013;-0.48499318997658525;-0.4724037912264082
Right aortic arch with retroesophageal left subclavian artery;Lamina lucida cleavage;1.0111645758152008;0.92183095;0.4964461313100743;0.5249073904588295;0.9998962300503706;0.011268345764830157;-0.07806527788285966;-0.5034500987402963;-0.47498883959154115
Right aortic arch with retroesophageal left subclavian artery;Abnormal central response of multifocal electroretinogram;1.0026310491375625;0.8497721;0.4991625100822339;0.5480007454099658;1.0;0.0026310491375625134;-0.15022790431976318;-0.5008374899177661;-0.4519992545900342
Right aortic arch with retroesophageal left subclavian artery;Atypical or prolonged hepatitis;0.9306498467922211;0.8153564;0.5220925723963324;0.5591130874692385;0.9999201345566091;-0.06927028776438804;-0.18456376076968284;-0.47782756216027666;-0.4408070470873706
Right aortic arch with retroesophageal left subclavian artery;Cubitus varus;0.8669836819171906;0.8476729;0.5424662709956722;0.5486767263857448;1.0;-0.13301631808280945;-0.15232712030410767;-0.45753372900432776;-0.45132327361425517
Right aortic arch with retroesophageal left subclavian artery;Nasal regurgitation;0.7550035715103149;0.7358843;0.5787867925754459;0.5850800758525234;0.9999134918687169;-0.24490992035840198;-0.2640291830537145;-0.42112669929327107;-0.4148334160161935
Right aortic arch with retroesophageal left subclavian artery;Moon facies;0.9183253645896912;0.89991164;0.5260268351823859;0.531912542679065;0.9999134918687169;-0.08158812727902576;-0.10000184979413196;-0.473886656686331;-0.46800094918965196
Right aortic arch with retroesophageal left subclavian artery;Intestinal pseudo-obstruction;0.8299032896757126;0.77200174;0.5544080113606211;0.5732180567673633;0.9998912449978579;-0.16998795532214528;-0.22788950168120747;-0.44548323363723674;-0.4266731882304946
Right aortic arch with retroesophageal left subclavian artery;Bilateral renal atrophy;0.826217919588089;0.6215998;0.5555988361638404;0.6235256726516927;0.9999201345566091;-0.17370221496852012;-0.37832034112246604;-0.4443212983927687;-0.37639446190491643
Right aortic arch with retroesophageal left subclavian artery;Fractured left clavicle;0.7429790794849396;0.6911494;0.5827409291640724;0.5999443063658662;1.0;-0.2570209205150604;-0.30885058641433716;-0.4172590708359276;-0.40005569363413385
Right aortic arch with retroesophageal left subclavian artery;Positive urine norcotinine test;0.9455988556146622;0.8973354;0.5173249747531335;0.5327368296305127;1.0;-0.05440114438533783;-0.10266458988189697;-0.48267502524686645;-0.4672631703694873
Right aortic arch with retroesophageal left subclavian artery;Long fibula;1.021402919664979;0.8502537;0.4931867188329596;0.5478456916314189;0.9999056439461368;0.02149727571884219;-0.14965194273611482;-0.5067189251131772;-0.45205995231471785
Right aortic arch with retroesophageal left subclavian artery;Fragmentation of the epiphysis of the distal phalanx of the hallux;0.9978273157030344;0.9316036;0.5006915874353941;0.5217882502095115;1.0;-0.002172684296965599;-0.06839638948440552;-0.4993084125646059;-0.4782117497904885
Right aortic arch with retroesophageal left subclavian artery;Type II cryptotia;0.9611514396965504;0.9236541;0.5123689933760862;0.5243253217550246;1.0;-0.03884856030344963;-0.07634592056274414;-0.4876310066239138;-0.47567467824497545
Right aortic arch with retroesophageal left subclavian artery;Increased variability in muscle fiber diameter;0.9619232639670372;0.85662;0.5121231321464339;0.5457971056645027;0.9998452077479463;-0.03792194378090907;-0.1432251940341096;-0.4877220756015124;-0.4540481020834436
Right aortic arch with retroesophageal left subclavian artery;Widened proximal tibial metaphyses;0.9925485970452428;0.82442856;0.5023718771759002;0.5561773010379025;0.9999201345566091;-0.007371537511366322;-0.17549157620699973;-0.49754825738070896;-0.4437428335187066
Right aortic arch with retroesophageal left subclavian artery;Wide anterior fontanel;0.7185550630092621;0.65551627;0.5908136777929442;0.6119460127508298;0.999848231156753;-0.28129316814749095;-0.3443319643339381;-0.4090345533638088;-0.3879022184059232
Right aortic arch with retroesophageal left subclavian artery;Increased circulating oleate level;0.967087097465992;0.83655715;0.5104783946433584;0.5522599451765031;1.0;-0.032912902534008026;-0.16344285011291504;-0.4895216053566416;-0.4477400548234969
Right aortic arch with retroesophageal left subclavian artery;Lozenge-shaped umbilicus;0.9055347293615341;0.8791068;0.5301141314914879;0.538575851923045;0.9999134918687169;-0.0943787625071828;-0.12080667223904773;-0.469799360377229;-0.4613376399456719
Right aortic arch with retroesophageal left subclavian artery;Anti-myelin-associated glycoprotein antibody positivity;0.9198068380355835;0.73437274;0.5255537154110833;0.5855790461555996;1.0;-0.0801931619644165;-0.26562726497650146;-0.4744462845889167;-0.41442095384440036
Right aortic arch with retroesophageal left subclavian artery;Fractured radius;0.9338033199310303;0.7969548;0.5210864770206498;0.5650838391423442;0.9999201345566091;-0.06611681462557883;-0.20296532393725486;-0.4788336575359593;-0.43483629541426494
Right aortic arch with retroesophageal left subclavian artery;Abnormal manual kinetic perimetry test;1.0335824564099312;0.94239193;0.48930836184145066;0.5183473777060894;1.0;0.03358245640993118;-0.057608067989349365;-0.5106916381585493;-0.4816526222939106
Right aortic arch with retroesophageal left subclavian artery;Small radial epiphyses;0.931882917881012;0.7908376;0.5216991432120859;0.5670737338641019;1.0;-0.06811708211898804;-0.2091624140739441;-0.4783008567879141;-0.43292626613589813
Right aortic arch with retroesophageal left subclavian artery;Generalized keratosis follicularis;0.9964816998690367;0.8935467;0.5011199120247153;0.5339494752340099;0.9999201345566091;-0.0034384346875724336;-0.10637343407900901;-0.4988002225318938;-0.4659706593225992
Right aortic arch with retroesophageal left subclavian artery;Hypoplasia of the calcaneus;0.8870648592710495;0.7778608;0.5360252300673276;0.5713039406933967;0.9999134918687169;-0.11284863259766742;-0.2220526715752904;-0.4638882618013893;-0.4286095511753202
Right aortic arch with retroesophageal left subclavian artery;2-hydroxyadipic aciduria;0.8489504754543304;0.7621488;0.5482652940543966;0.5764430623426906;1.0;-0.15104952454566956;-0.23785120248794556;-0.4517347059456034;-0.4235569376573094
Right aortic arch with retroesophageal left subclavian artery;Potter facies;1.0234365686774254;1.0127586;0.4925392253853933;0.4959387026118136;0.9998981869165328;0.023538381760892624;0.012860425716218704;-0.5073589615311395;-0.5039594843047192
Right aortic arch with retroesophageal left subclavian artery;Increased heart rate variability;0.8008252829313278;0.74581176;0.5638261271697964;0.5818082770394553;0.7316270483356397;0.06919823459568808;0.014184712089927887;-0.16780092116584333;-0.14981877129618448
Right aortic arch with retroesophageal left subclavian artery;Aplastic zygomatic arch;0.7020193338394165;0.56423295;0.5963130974930129;0.643522848873822;0.9999134918687169;-0.2978941580293004;-0.4356805464265172;-0.40360039437570405;-0.35639064299489487
Right aortic arch with retroesophageal left subclavian artery;Testicular torsion;0.9423759281635284;0.835063;0.5183524779897704;0.5527420878619927;0.9999201345566091;-0.057544206393080666;-0.16485715390475364;-0.48156765656683875;-0.44717804669461636
Right aortic arch with retroesophageal left subclavian artery;Abolished vibration sense;0.9436693713068962;0.91352034;0.5179400922885097;0.5275617500157371;0.9999134918687169;-0.05624412056182071;-0.08639315571759387;-0.48197339958020724;-0.4723517418529798
Right aortic arch with retroesophageal left subclavian artery;Fractured metatarsal bone of digit 5;0.9511239342391491;0.8532124;0.5155639358315458;0.5468933726689187;1.0;-0.048876065760850906;-0.1467875838279724;-0.4844360641684542;-0.4531066273310813
Right aortic arch with retroesophageal left subclavian artery;Prolonged G2 phase of cell cycle;0.9176330268383026;0.8908579;0.5262479581857386;0.5348103645444535;0.9999056439461368;-0.08227261710783418;-0.10904776859899934;-0.47365768576039824;-0.46509527940168327
Right aortic arch with retroesophageal left subclavian artery;Single naris;0.91329225897789;0.8625963;0.5276346324889009;0.5438757807718163;0.9999056439461368;-0.08661338496824678;-0.13730937052389558;-0.47227101145723593;-0.4560298631743205
Right aortic arch with retroesophageal left subclavian artery;Perifoveal ring of hyperautofluorescence surrounded by normal autofluorescence;0.9603787213563919;0.7758521;0.512615146803818;0.5719598756619546;1.0;-0.03962127864360809;-0.22414791584014893;-0.48738485319618197;-0.4280401243380454
Right aortic arch with retroesophageal left subclavian artery;Asymmetry of the thorax;0.732119083404541;0.69927907;0.5863233770551786;0.5972272622329524;0.9999056439461368;-0.2677865605415958;-0.3006265740456241;-0.41358226689095823;-0.4026783817131844
Right aortic arch with retroesophageal left subclavian artery;Type 2 muscle fiber predominance;0.9509224891662598;0.8533257;0.5156281348340102;0.5468569252139244;0.9999003561294039;-0.0489778669631441;-0.14657463152765826;-0.4842722212953937;-0.4530434309154795
Right aortic arch with retroesophageal left subclavian artery;Dependency on parenteral nutrition;0.905710831284523;0.87607026;0.5300578251856505;0.5395497527181873;0.9999134918687169;-0.09420266058419391;-0.12384323086713;-0.46985566668306644;-0.46036373915052964
Right aortic arch with retroesophageal left subclavian artery;Limited shoulder flexion;0.9098769724369049;0.7521106;0.5287260267410894;0.5797369697773043;1.0;-0.09012302756309509;-0.24788939952850342;-0.47127397325891063;-0.42026303022269573
Right aortic arch with retroesophageal left subclavian artery;Paroxysmal vertigo;0.9991652313619852;0.9048141;0.5002657151410164;0.5303445455411591;0.9999134918687169;-0.0007482605067317127;-0.09509936776135608;-0.49964777672770055;-0.46956894632755786
Right aortic arch with retroesophageal left subclavian artery;Long hallux;1.0318143591284752;0.9280446;0.4898714658714399;0.5229239157861121;0.9998836012415208;0.03193075788695443;-0.07183898406546485;-0.5100121353700808;-0.4769596854554087
Right aortic arch with retroesophageal left subclavian artery;Broad medial eyebrow;0.926535502076149;0.85287595;0.5234055616856927;0.5470016541794396;0.9999201345566091;-0.07338463248046012;-0.1470441866043386;-0.47651457287091636;-0.45291848037716953
Right aortic arch with retroesophageal left subclavian artery;Myxoid subcutaneous tumors;0.951777957379818;0.85600626;0.5153555080181322;0.5459945261295212;0.9999201345566091;-0.048142177176791145;-0.14391386987002464;-0.4845646265384769;-0.45392560842708796
Right aortic arch with retroesophageal left subclavian artery;Bulbous tips of toes;0.987024113535881;0.93554515;0.5041304688593965;0.5205308518945725;0.9999134918687169;-0.012889378332835877;-0.0643683454034154;-0.4957830230093204;-0.47938263997414443
Right aortic arch with retroesophageal left subclavian artery;Absent internal genitalia;0.8671884089708328;0.7591622;0.5424005209887581;0.5774221986267533;1.0;-0.13281159102916718;-0.24083781242370605;-0.45759947901124187;-0.42257780137324674
Right aortic arch with retroesophageal left subclavian artery;Hyperphalangy of the 2nd finger;0.8882102072238922;0.8119911;0.5356583310031684;0.5602033827163264;0.9999201345566091;-0.1117099273327169;-0.1879290390137014;-0.4642618035534407;-0.4397167518402827
Right aortic arch with retroesophageal left subclavian artery;Renal interstitial hemosiderin;0.9031825959682465;0.7348465;0.5308662869691212;0.5854226422739282;1.0;-0.09681740403175354;-0.26515352725982666;-0.4691337130308788;-0.41457735772607185
Right aortic arch with retroesophageal left subclavian artery;Abnormality of depressor anguli oris muscle;0.8324613869190216;0.7464003;0.5535818863438686;0.5816145935144426;1.0;-0.1675386130809784;-0.25359970331192017;-0.4464181136561314;-0.41838540648555744
Right aortic arch with retroesophageal left subclavian artery;Paroxysmal dyspnea;0.8098439276218414;0.81957954;0.5608994030100208;0.5577458451777508;1.0;-0.19015607237815857;-0.18042045831680298;-0.43910059698997916;-0.44225415482224917
Right aortic arch with retroesophageal left subclavian artery;Phenylpyruvic acidemia;0.9189031645655632;0.8065499;0.5258423035846068;0.5619677586737946;0.9999201345566091;-0.0810169699910459;-0.19337022782595725;-0.4740778309720023;-0.43795237588281455
Right aortic arch with retroesophageal left subclavian artery;Lateral ventricle dilatation;0.8834557682275772;0.8166142;0.5371816777346506;0.558705754460904;0.9998579617208769;-0.11640219349329972;-0.1832437511152556;-0.4626762839862263;-0.44115220725997295
Right aortic arch with retroesophageal left subclavian artery;Neonatal unconjugated hyperbilirubinemia;0.8472289443016052;0.8535238;0.5488197088941614;0.5467931808168804;0.9999201345566091;-0.15269119025500388;-0.14639634372027488;-0.4511004256624477;-0.45312695373972867
Right aortic arch with retroesophageal left subclavian artery;High maternal circulating alpha-fetoprotein concentration;0.8398493528366089;0.75131863;0.551198002368132;0.5799971997998232;1.0;-0.1601506471633911;-0.24868136644363403;-0.448801997631868;-0.4200028002001768
Right aortic arch with retroesophageal left subclavian artery;Prominent nasolabial fold;0.8855984508991241;0.76125777;0.5364950473967129;0.5767351085994099;0.9998944404568447;-0.11429598955772058;-0.2386366727795376;-0.4633993930601318;-0.4231593318574348
Right aortic arch with retroesophageal left subclavian artery;Abnormality of inferior alveolar nerve;0.8283974826335907;0.71944153;0.5548944771287716;0.5905196587606745;1.0;-0.1716025173664093;-0.2805584669113159;-0.4451055228712284;-0.40948034123932553
Right aortic arch with retroesophageal left subclavian artery;Unilateral conductive hearing impairment;1.023657601326704;0.87557745;0.4924688489944795;0.5397078429870104;0.9999201345566091;0.023737466770094917;-0.12434268475802512;-0.5074512855621296;-0.46021229156959875
Right aortic arch with retroesophageal left subclavian artery;Macular hypopigmented whorls, streaks, and patches;0.9996283277869225;0.93699086;0.5001183069425662;0.520069718539705;0.9999201345566091;-0.0002918067696866533;-0.0629292774322805;-0.4998018276140429;-0.47985041601690415
Right aortic arch with retroesophageal left subclavian artery;Delayed ossification of pubic rami;0.8922589868307114;0.7361148;0.5343617288140423;0.5850040096009397;0.9999134918687169;-0.10765450503800555;-0.26379869189236804;-0.4655517630546746;-0.41490948226777724
Right aortic arch with retroesophageal left subclavian artery;Hyperphenylalaninemia;0.9461162611842155;0.76272047;0.517160037517058;0.5762557219669141;0.9999028053808913;-0.05378654419667572;-0.23718233972079605;-0.4827427678638333;-0.42364708341397717
Right aortic arch with retroesophageal left subclavian artery;Ureteropelvic junction obstruction;0.8779277727007866;0.7132448;0.5389539546392406;0.5925766343438411;0.9998847295244674;-0.1219569568236808;-0.286639933725212;-0.4609307748852268;-0.4073080951806263
Right aortic arch with retroesophageal left subclavian artery;Cone-shaped epiphysis of the proximal phalanx of the 2nd toe;0.9341543465852737;0.81447;0.5209744974512232;0.5594001917487055;1.0;-0.06584565341472626;-0.18553000688552856;-0.47902550254877685;-0.4405998082512945
Right aortic arch with retroesophageal left subclavian artery;Difficulty walking;1.0038140248507261;0.96188027;0.4987859552404429;0.5121368285559139;0.9998344221996177;0.003979602651108416;-0.03795415553320536;-0.5010484669591748;-0.4876975936437038
Right aortic arch with retroesophageal left subclavian artery;Bilobate gallbladder;0.992885475512594;0.89928114;0.50226464258481;0.5321142700078257;0.9999134918687169;-0.007028016356122935;-0.10063234772656604;-0.49764884928390696;-0.4677992218608912
Right aortic arch with retroesophageal left subclavian artery;Histidinuria;0.9917862229049206;0.8960879;0.5026145558518318;0.5331360765148186;0.9999090677057578;-0.008122844800837248;-0.10382118280280372;-0.49729451185392604;-0.4667729911909392
Right aortic arch with retroesophageal left subclavian artery;Widened interpedicular distance;0.9679608568549156;0.81335664;0.5102001215979344;0.5597608741568565;1.0;-0.03203914314508438;-0.18664336204528809;-0.4897998784020656;-0.4402391258431435
Elevated urine suberic acid level;Burkitt lymphoma;1.0051110489293933;0.9735919;0.4983730955137301;0.508406928503538;0.9999574798349273;0.0051535690944659596;-0.02636555612124325;-0.5015843843211972;-0.49155055133138936
Elevated urine suberic acid level;Snail-like ilia;0.8070666790008545;0.8413409;0.561800106555725;0.5507170884612129;0.9999600672783046;-0.19289338827745006;-0.1586191678108363;-0.43815996072257957;-0.44924297881709163
Elevated urine suberic acid level;Indurated nodule;0.9385914504528046;0.82800305;0.5195592546010923;0.5550219338135831;0.9999201345566091;-0.06132868410380454;-0.17191708565981956;-0.4803608799555168;-0.444898200743026
Elevated urine suberic acid level;Absent leukocyte alkaline phosphatase;0.749096155166626;0.73353463;0.5807277972342958;0.5858557959660293;0.8631450867506595;-0.11404893158403351;-0.12961045263734772;-0.2824172895163637;-0.27728929078463016
Elevated urine suberic acid level;Hippocampal sclerosis;0.9096487984061241;0.82325983;0.5287989543129319;0.5565552286178189;0.9999201345566091;-0.090271336150485;-0.1766603040817556;-0.4711211802436772;-0.4433649059387902
Elevated urine suberic acid level;Decreased sensitivity to hypoxemia;0.9139853045344353;0.8745346;0.5274132019434159;0.5400423928237104;0.9999600672783046;-0.08597476274386928;-0.1254254603447108;-0.47254686533488865;-0.4599176744545942
Elevated urine suberic acid level;Decreased level of tissue plasminogen activator;0.9846330378204584;0.8781979;0.5048916485170984;0.5388673165227092;0.9999201345566091;-0.015287096736150696;-0.12172222615511985;-0.49502848603951066;-0.46105281803389986
Elevated urine suberic acid level;Submandibular lymph node enlargement;0.9253714233636856;0.6817783;0.5237771194748005;0.6030856442748768;0.9999600672783046;-0.07458864391461895;-0.3181817555488734;-0.476182947803504;-0.3968744230034278
Elevated urine suberic acid level;Hepatic hemangioma;0.9652167595922947;0.876181;0.5110740831017625;0.5395142133962876;0.9999584729108851;-0.03474171331859044;-0.12377746647930554;-0.48888438980912263;-0.46044425951459755
Elevated urine suberic acid level;Triangular epiphysis of the distal phalanx of the 2nd finger;0.9636406227946281;0.87978154;0.5115761007851714;0.5383594953142654;0.9999201345566091;-0.036279511761980965;-0.1201385903480825;-0.48834403377143776;-0.4615606392423437
Elevated urine suberic acid level;Acne inversa;0.9679490737617016;0.8589032;0.510203874200233;0.545062870029555;0.9999548690865008;-0.03200579532479919;-0.141051639849898;-0.4897509948862677;-0.4548919990569458
Elevated urine suberic acid level;Dentin dysplasia;0.9591634981334209;0.90093386;0.5130022777797525;0.5315855347583873;0.9999201345566091;-0.040756636423188164;-0.0989862728241262;-0.4869178567768566;-0.4683345997982218
Elevated urine suberic acid level;Aplasia of the inner ear;0.9710061270743608;0.7729583;0.5092303299370872;0.5729053670850963;0.9999600672783046;-0.028953940203943707;-0.2270017886222987;-0.4907297373412174;-0.42705470019320824
Elevated urine suberic acid level;Polycystic liver disease;0.9474781900644302;0.87676436;0.5167259072103692;0.5393270963866653;0.9999567459343585;-0.05247855586992822;-0.12319238884436212;-0.4832308387239893;-0.46062964954769314
Elevated urine suberic acid level;Subungual hyperkeratosis;0.8173283636569977;0.6370826;0.5584745216508578;0.6182192969244336;0.9999556674707869;-0.18262730381378922;-0.3628730907190779;-0.44148114581992914;-0.38173637054635334
Elevated urine suberic acid level;Broad humeral epiphyses;0.8206456303596497;0.7237392;0.5574008662807064;0.5890953516619648;0.9999201345566091;-0.17927450419695945;-0.27618092776568504;-0.4425192682759027;-0.4108247828946443
Elevated urine suberic acid level;Autoimmune thrombocytopenia;1.0153447818011045;0.90782344;0.4951154125491961;0.5293824154975048;0.9999509115718902;0.015393870229214346;-0.09212746815910944;-0.5048354990226941;-0.47056849607438545
Elevated urine suberic acid level;Adenomyosis;0.9513171352446079;0.84879327;0.515502364745528;0.5483159257089334;0.8586132879499475;0.09270384729466041;-0.00982001974621216;-0.3431109232044195;-0.3102973622410141
Elevated urine suberic acid level;Elevated leukocyte alkaline phosphatase;0.7080686688423157;0.6843354;0.5942978746429466;0.6022274394629974;0.8631450867506595;-0.1550764179083438;-0.1788096761557193;-0.2688472121077129;-0.2609176472876621
Elevated urine suberic acid level;Clasp-knife sign;0.9564307257533073;0.9517914;0.5138729222085161;0.5153512223075031;0.9999201345566091;-0.043489408803301766;-0.0481287288788137;-0.486047212348093;-0.48456891224910603
Elevated urine suberic acid level;Keratosis pilaris;0.9014369994401932;0.85487103;0.5314245981478262;0.546359717129741;0.9999506876445663;-0.09851368820437312;-0.1450796530223739;-0.46852608949674013;-0.45359097051482533
Elevated urine suberic acid level;Lamina lucida cleavage;1.0382480174303055;0.96032554;0.4878223075470147;0.5126320826253583;0.9999548690865008;0.038293148343804706;-0.03962932997440971;-0.512132561539486;-0.48732278646114247
Elevated urine suberic acid level;Abnormal central response of multifocal electroretinogram;0.9586711786687374;0.8316851;0.5131591203482846;0.5538325421169941;0.9999201345566091;-0.0412489558878717;-0.1682350087288198;-0.4867610142083245;-0.44608759243961504
Elevated urine suberic acid level;Atypical or prolonged hepatitis;0.9057456254959106;0.8350697;0.5300467002994994;0.5527399093630443;0.9999600672783046;-0.09421444178239391;-0.16489035130158947;-0.46991336697880515;-0.44722015791526026
Elevated urine suberic acid level;Cubitus varus;0.9834630228579044;0.972389;0.5052641232618977;0.5087899863489133;0.9999201345566091;-0.016457111698704674;-0.02753115178378196;-0.4946560112947114;-0.49113014820769585
Elevated urine suberic acid level;Nasal regurgitation;0.8934396654367447;0.80366737;0.5339837309066006;0.5629032332289602;0.9999584729108851;-0.10651880747414044;-0.19629110640621594;-0.46597474200428457;-0.43705523968192495
Elevated urine suberic acid level;Moon facies;0.8897005617618561;0.8684541;0.5351809841851559;0.5419940636214857;0.9999584729108851;-0.11025791114902905;-0.13150437420940808;-0.4647774887257292;-0.4579644092893994
Elevated urine suberic acid level;Intestinal pseudo-obstruction;0.7718378305435181;0.74045753;0.5732716393928461;0.583571761984335;0.9999539510871024;-0.22811612054358432;-0.2594964162970633;-0.4266823116942563;-0.41638218910276736
Elevated urine suberic acid level;Bilateral renal atrophy;0.6928650438785553;0.72275376;0.5993703010384714;0.589421778023296;0.8144325676816837;-0.12156752380312841;-0.09167880448283117;-0.21506226664321226;-0.22501078965838772
Elevated urine suberic acid level;Fractured left clavicle;0.9276813119649887;0.85918105;0.5230398662525022;0.5449735366252951;0.9999201345566091;-0.0722388225916204;-0.14073908807070823;-0.4768802683041069;-0.454946597931314
Elevated urine suberic acid level;Positive urine norcotinine test;0.6692101657390594;0.6435606;0.6073151234315031;0.616009380049889;0.726290173501319;-0.05708000776225952;-0.0827295851414862;-0.1189750500698159;-0.11028079345142994
Elevated urine suberic acid level;Long fibula;0.8965624570846558;0.8616079;0.5329841899015793;0.5441934071184165;0.9999567459343585;-0.1033942888497027;-0.13834883673178278;-0.4669725560327792;-0.455763338815942
Elevated urine suberic acid level;Fragmentation of the epiphysis of the distal phalanx of the hallux;1.0033381218090653;0.94691557;0.498937440853523;0.5169052530341303;0.9999201345566091;0.003417987252456234;-0.05300456763537498;-0.5009826937030861;-0.48301488152247884
Elevated urine suberic acid level;Type II cryptotia;0.9011391624808311;0.8815758;0.5315198678892852;0.5377842512610274;0.9999201345566091;-0.09878097207577796;-0.11834431172640891;-0.46840026666732393;-0.46213588329558175
Elevated urine suberic acid level;Increased variability in muscle fiber diameter;0.8491303622722626;0.77458984;0.5482073704940555;0.572372213393338;0.9999473166570552;-0.1508169543847926;-0.22535748005961254;-0.4517399461629996;-0.42757510326371717
Elevated urine suberic acid level;Widened proximal tibial metaphyses;0.8829021900892258;0.75773174;0.5373591019577817;0.5778914106484319;0.9999600672783046;-0.11705787718907879;-0.2422283315719752;-0.46260096532052286;-0.4220686566298727
Elevated urine suberic acid level;Wide anterior fontanel;0.929964691400528;0.79106176;0.5223111957168209;0.5670007699568622;0.9999476714516888;-0.06998298005116088;-0.20888591245663268;-0.4776364757348679;-0.4329469014948266
Elevated urine suberic acid level;Increased circulating oleate level;0.8620679676532745;0.75826925;0.5440455527297026;0.5777150681247449;0.726290173501319;0.13577779415195557;0.03197907689159485;-0.1822446207716164;-0.14857510537657403
Elevated urine suberic acid level;Lozenge-shaped umbilicus;0.892061784863472;0.8765028;0.5344248683605067;0.539410994428352;0.9999584729108851;-0.10789668804741315;-0.12345566100216321;-0.4655336045503784;-0.4605474784825331
Elevated urine suberic acid level;Anti-myelin-associated glycoprotein antibody positivity;0.9365603476762772;0.7995591;0.5202070381708161;0.5642374549161553;0.9999201345566091;-0.06335978688033195;-0.20036101819308372;-0.47971309638579296;-0.4356826796404538
Elevated urine suberic acid level;Fractured radius;0.812799870967865;0.7466551;0.5599412879087959;0.5815307369998;0.9999600672783046;-0.18716019631043956;-0.2533049607338099;-0.4400187793695086;-0.4184293302785046
Elevated urine suberic acid level;Abnormal manual kinetic perimetry test;0.954005416482687;0.84697443;0.5146456975760494;0.5489016864248459;0.9999201345566091;-0.04591471807392211;-0.1529457020881948;-0.4852744369805597;-0.45101844813176317
Elevated urine suberic acid level;Small radial epiphyses;0.834905669093132;0.77500635;0.5527928576928378;0.5722361314308465;0.9999201345566091;-0.1650144654634771;-0.22491378070147605;-0.4471272768637713;-0.4276840031257626
Elevated urine suberic acid level;Generalized keratosis follicularis;0.8974146470427513;0.78725207;0.5327114786269651;0.56824131580237;0.9999600672783046;-0.10254542023555324;-0.21270799875871227;-0.46724858865133945;-0.4317187514759345
Elevated urine suberic acid level;Hypoplasia of the calcaneus;0.9135099649429321;0.86042005;0.527565073211669;0.5445752255729501;0.9999584729108851;-0.086448507967953;-0.1395384246740382;-0.4723933996992161;-0.455383247337935
Elevated urine suberic acid level;2-hydroxyadipic aciduria;0.6481088995933533;0.7230769;0.6144612609147746;0.5893147355637991;0.0;0.6481088995933533;0.7230768799781799;0.6144612609147746;0.5893147355637991
Elevated urine suberic acid level;Potter facies;0.8972824215888977;0.921519;0.5327537908151518;0.5250069998330628;0.9999552432134126;-0.10267282162451485;-0.07843626175665597;-0.4672014523982607;-0.4749482433803498
Elevated urine suberic acid level;Increased heart rate variability;0.9316674917936325;0.8385843;0.5217678756138484;0.5516059927950366;0.9999600672783046;-0.06829257548467205;-0.16137576342240856;-0.47819219166445615;-0.4483540744832679
Elevated urine suberic acid level;Aplastic zygomatic arch;1.0183902345597744;0.8925539;0.4941458765206236;0.5342673035158995;0.9999584729108851;0.018431761648889267;-0.10740454739666394;-0.5058125963902615;-0.46569116939498567
Elevated urine suberic acid level;Testicular torsion;0.9215072914958;0.8695345;0.5250107323775518;0.5416471930876103;0.8586132879499475;0.0628940035458525;0.010921204542728269;-0.3336025555723957;-0.3169660948623372
Elevated urine suberic acid level;Abolished vibration sense;0.9166332483291626;0.86958194;0.5265672959043697;0.5416319510657506;0.9999584729108851;-0.08332522458172253;-0.13037653512096814;-0.47339117700651545;-0.45832652184513456
Elevated urine suberic acid level;Fractured metatarsal bone of digit 5;0.9670796543359756;0.910518;0.5104807651498017;0.5285211589443152;0.9999201345566091;-0.03284048022063346;-0.08940214396746726;-0.48943936940680743;-0.47139897561229394
Elevated urine suberic acid level;Prolonged G2 phase of cell cycle;0.8573840856552124;0.8499051;0.5455513685613913;0.5479579317670704;0.851762385589393;0.005621700065819413;-0.0018573119466622767;-0.3062110170280017;-0.3038044538223226
Elevated urine suberic acid level;Single naris;0.7506379187107086;0.7008915;0.5802209259127402;0.5966892542204569;0.9999567459343585;-0.24931882722364984;-0.2990652511833819;-0.41973582002161824;-0.4032674917139015
Elevated urine suberic acid level;Perifoveal ring of hyperautofluorescence surrounded by normal autofluorescence;0.9761703163385391;0.85669327;0.507585941960646;0.5457735496380669;0.9999201345566091;-0.023749818218069985;-0.14322686673434348;-0.4923341925959631;-0.4541465849185422
Elevated urine suberic acid level;Asymmetry of the thorax;0.9779362380504608;0.87412256;0.5070236834996474;0.5401746091371037;0.9999567459343585;-0.022020507883897644;-0.12583418591009699;-0.492933062434711;-0.45978213679725477
Elevated urine suberic acid level;Type 2 muscle fiber predominance;0.8509329110383987;0.8198721;0.5476270382204158;0.5576511710856574;0.9999556674707869;-0.14902275643238816;-0.18008358619103226;-0.4523286292503711;-0.4423044963851295
Elevated urine suberic acid level;Dependency on parenteral nutrition;0.7467588186264038;0.7664314;0.581496621381317;0.5750403502938158;0.9999584729108851;-0.2531996542844813;-0.23352708167171887;-0.41846185152956816;-0.4249181226170693
Elevated urine suberic acid level;Limited shoulder flexion;0.7947583794593811;0.70747507;0.5657980202629149;0.5944954486139259;0.9999201345566091;-0.205161755097228;-0.29244506837161155;-0.4341221142936942;-0.4054246859426832
Elevated urine suberic acid level;Paroxysmal vertigo;1.0074341110885143;0.86500937;0.49763362714853265;0.5431004345220025;0.9999584729108851;0.007475638177629196;-0.13494910544491223;-0.5023248457623525;-0.4568580383888826
Elevated urine suberic acid level;Long hallux;1.0372401997447014;0.98409814;0.4881433346454159;0.5050619301766864;0.9999526340597648;0.03728756568493663;-0.015854497634746445;-0.5118092994143488;-0.4948907038830783
Elevated urine suberic acid level;Broad medial eyebrow;0.9219633638858795;0.8414406;0.524865113356245;0.5506849256901674;0.9999600672783046;-0.07799670339242504;-0.15851944924012706;-0.4750949539220596;-0.4492751415881372
Elevated urine suberic acid level;Myxoid subcutaneous tumors;0.8951093852519989;0.7915044;0.5334492469252463;0.5668567103178996;0.9999600672783046;-0.10485068202630565;-0.20845568419114635;-0.46651082035305824;-0.4331033569604049
Elevated urine suberic acid level;Bulbous tips of toes;0.8861550837755203;0.87205034;0.5363167004349518;0.5408395977961987;0.9999584729108851;-0.11380338913536481;-0.1279081279668849;-0.4636417724759333;-0.4591188751146864
Elevated urine suberic acid level;Absent internal genitalia;0.8874156773090363;0.8415326;0.5359128444534343;0.5506552758727506;0.717226575899895;0.17018910140914123;0.1243060121051709;-0.18131373144646068;-0.16657130002714438
Elevated urine suberic acid level;Hyperphalangy of the 2nd finger;0.9340835884213448;0.8531395;0.5209970695124794;0.5469168353564002;0.9999600672783046;-0.0658764788569598;-0.14682054758683727;-0.4789629977658252;-0.4530432319219043
Elevated urine suberic acid level;Renal interstitial hemosiderin;0.683796763420105;0.67363673;0.6024081520701351;0.605823269378404;0.6288651353633673;0.05493162805673768;0.04477159912225892;-0.026456983293232206;-0.023041865984963272
Elevated urine suberic acid level;Abnormality of depressor anguli oris muscle;0.9425108879804611;0.82236564;0.5183094476119585;0.5568444338387002;0.9999201345566091;-0.05740924657614799;-0.177554492962676;-0.4816106869446506;-0.4430757007179089
Elevated urine suberic acid level;Paroxysmal dyspnea;0.8979938328266144;0.8335644;0.5325261458127;0.553225786167238;0.9999201345566091;-0.10192630172999473;-0.1663557338836965;-0.46739398874390914;-0.44669434838937105
Elevated urine suberic acid level;Phenylpyruvic acidemia;0.7089260220527649;0.743553;0.5940125803007383;0.5825519146934368;0.8631450867506595;-0.1542190646978946;-0.11959210394350006;-0.26913250644992115;-0.2805931720572227
Elevated urine suberic acid level;Lateral ventricle dilatation;0.9374260455369949;0.83549356;0.5199309293732914;0.5526031402035358;0.9999488789551968;-0.06252283341820186;-0.1644553143494839;-0.48001794958190536;-0.44734573875166095
Elevated urine suberic acid level;Neonatal unconjugated hyperbilirubinemia;0.7985813021659851;0.75139475;0.5645551827101438;0.5799721762532342;0.8631450867506595;-0.06456378458467438;-0.11175033806291534;-0.29858990404051566;-0.2831729104974253
Elevated urine suberic acid level;High maternal circulating alpha-fetoprotein concentration;0.7949351370334625;0.70559776;0.5657405338354307;0.595120536877202;0.9999201345566091;-0.20498499752314658;-0.29432237626345725;-0.43417960072117845;-0.4047995976794071
Elevated urine suberic acid level;Prominent nasolabial fold;1.0026100277900696;0.8171258;0.4991692014079373;0.5585400956309625;0.9999545338528789;0.002655493937190667;-0.1828287365811504;-0.5007853324449416;-0.4414144382219164
Elevated urine suberic acid level;Abnormality of inferior alveolar nerve;1.0289707817137241;0.8012793;0.4907770233128723;0.5636786494563837;0.9999201345566091;0.029050647157115028;-0.19864082814486594;-0.5091431112437368;-0.4362414851002254
Elevated urine suberic acid level;Unilateral conductive hearing impairment;1.0275693535804749;0.8370235;0.49122329014222166;0.5521094849359512;0.9999600672783046;0.0276092863021703;-0.16293657065049694;-0.5087367771360829;-0.4478505823423533
Elevated urine suberic acid level;Macular hypopigmented whorls, streaks, and patches;1.0196423269808292;0.9847707;0.4937472510167318;0.5048478145616124;0.9999600672783046;0.019682259702524685;-0.015189352041640736;-0.5062128162615728;-0.4951122527166921
Elevated urine suberic acid level;Delayed ossification of pubic rami;1.0006739925593138;0.90531415;0.4997854614889131;0.5301846610231726;0.9999584729108851;0.0007155196484286419;-0.09464432543850354;-0.500173011421972;-0.4697738118877125
Elevated urine suberic acid level;Hyperphenylalaninemia;0.7685665190219879;0.71694404;0.5743415636614542;0.591348216729549;0.8497508587917271;-0.08118433976973916;-0.13280681992377663;-0.2754092951302729;-0.2584026420621781
Elevated urine suberic acid level;Ureteropelvic junction obstruction;0.6881310343742371;0.67119026;0.6009549955089;0.6066474853593486;0.7807636207142028;-0.09263258633996574;-0.10957335887338249;-0.17980862520530283;-0.17411613535485415
Elevated urine suberic acid level;Cone-shaped epiphysis of the proximal phalanx of the 2nd toe;0.9270156994462013;0.88225865;0.523252298677967;0.5375653728759827;0.9999201345566091;-0.07290443511040778;-0.11766148091586204;-0.47666783587864214;-0.4623547616806264
Elevated urine suberic acid level;Difficulty walking;0.9605571515858173;0.9452495;0.5125583062656126;0.5174363376282638;0.9999461221900431;-0.03938897060422575;-0.05469662429957067;-0.4873878159244305;-0.4825097845617793
Elevated urine suberic acid level;Bilobate gallbladder;0.9015967696905136;0.9314501;0.5313734932625189;0.5218372223459231;0.9999584729108851;-0.09836170322037152;-0.06850834435558728;-0.4685849796483662;-0.478121250564962
Elevated urine suberic acid level;Histidinuria;0.693280041217804;0.71714693;0.5992315039499977;0.591280881739361;0.6496512029409973;0.043628838276806636;0.06749573013776855;-0.05041969899099963;-0.05837032120163632
Elevated urine suberic acid level;Widened interpedicular distance;0.9218162596225739;0.81705564;0.5249120815981687;0.55856281457126;0.9999201345566091;-0.07810387493403526;-0.18286449195178123;-0.4750080529584404;-0.4413573199853491
Burkitt lymphoma;Snail-like ilia;0.8660428076982498;0.8471165;0.5427684650292091;0.5488559360324534;0.9999574798349273;-0.13391467213667752;-0.15284100949801327;-0.4571890148057183;-0.4511015438024739
Burkitt lymphoma;Indurated nodule;0.7873272895812988;0.6997824;0.5682168114194446;0.5970593047727004;0.9999090677057578;-0.212581778124459;-0.30012669618476173;-0.43169225628631325;-0.4028497629330574
Burkitt lymphoma;Absent leukocyte alkaline phosphatase;0.7638688832521439;0.7333323;0.5758794867106243;0.5859226266101143;0.9999574798349273;-0.23608859658278347;-0.266625203490628;-0.42407799312430305;-0.41403485322481304
Burkitt lymphoma;Hippocampal sclerosis;0.864401787519455;0.8114075;0.543295627946548;0.5603925284399196;0.9999090677057578;-0.13550728018630287;-0.18850156123984596;-0.45661343975920987;-0.4395165392658382
Burkitt lymphoma;Decreased sensitivity to hypoxemia;0.9498200863599777;0.87995154;0.5159794735056694;0.5383049950767587;0.9999574798349273;-0.05013739347494961;-0.1200059431795013;-0.4839780063292579;-0.46165248475816867
Burkitt lymphoma;Decreased level of tissue plasminogen activator;0.9554963000118732;0.91592246;0.514170647987643;0.5267943478167402;0.5147561151225537;0.44074018488931954;0.40116634781766236;-0.0005854671349106999;0.012038232694186468
Burkitt lymphoma;Submandibular lymph node enlargement;0.7735021859407425;0.6866216;0.5727276147701409;0.6014608145756817;0.9999574798349273;-0.22645529389418484;-0.31333587348498226;-0.42722986506478644;-0.39849666525924565
Burkitt lymphoma;Hepatic hemangioma;0.7966427505016327;0.6794121;0.5651852826359689;0.6038804383047095;0.6730162381792475;0.1236265123223852;0.006395888361890201;-0.1078309555432786;-0.069135799874538
Burkitt lymphoma;Triangular epiphysis of the distal phalanx of the 2nd finger;0.9915489628911018;0.93751985;0.502690080681856;0.5199010124722812;0.9999090677057578;-0.008360104814655989;-0.06238921935904762;-0.49721898702390177;-0.48000805523347667
Burkitt lymphoma;Acne inversa;0.993907418102026;0.89375615;0.5019393410485482;0.5338824104383615;0.9999515360511232;-0.006044117949097205;-0.10619538485178237;-0.498012195002575;-0.4660691256127617
Burkitt lymphoma;Dentin dysplasia;0.8601780831813812;0.73855317;0.5446530081988274;0.5841995982857162;0.9999090677057578;-0.1397309845243766;-0.2613559013162925;-0.4552560595069304;-0.4157094694200416
Burkitt lymphoma;Aplasia of the inner ear;0.9196213781833649;0.7872399;0.5256129403008268;0.5682452672211116;0.9999574798349273;-0.08033610165156246;-0.21271757066286923;-0.4743445395341005;-0.43171221261381576
Burkitt lymphoma;Polycystic liver disease;0.8279335647821426;0.7501736;0.5550443763950232;0.5803735444298996;0.9999536937290383;-0.17202012894689567;-0.2497800653988076;-0.44490931733401506;-0.41958014929913867
Burkitt lymphoma;Subungual hyperkeratosis;0.8917036652565002;0.76942325;0.5345395335228327;0.5740612875903888;0.9999524555142131;-0.10824879025771283;-0.2305292091305461;-0.4654129219913804;-0.4258911679238243
Burkitt lymphoma;Broad humeral epiphyses;1.0717185288667679;0.9587519;0.4771516677053794;0.5131334033892408;0.9999090677057578;0.07180946116101006;-0.04115715082038185;-0.5227574000003784;-0.486775664316517
Burkitt lymphoma;Autoimmune thrombocytopenia;0.6875858902931213;0.6187428;0.6011376462976915;0.6245087703555114;0.71686901029889;-0.029283120005768715;-0.09812618669812101;-0.11573136400119854;-0.09236023994337861
Burkitt lymphoma;Adenomyosis;1.0388060733675957;0.9810992;0.4876445408413046;0.506016671702839;0.9999574798349273;0.03884859353266834;-0.018858291507138025;-0.5123129389936227;-0.4939408081320883
Burkitt lymphoma;Elevated leukocyte alkaline phosphatase;0.7976714968681335;0.7337893;0.5648508704858424;0.5857716972284854;0.9999574798349273;-0.2022859829667938;-0.2661681550744903;-0.43510660934908496;-0.4141857826064419
Burkitt lymphoma;Clasp-knife sign;0.9764905907213688;0.9664739;0.507483966888225;0.5106736940644049;0.9999090677057578;-0.023418476984389036;-0.03343519027579567;-0.4924251008175329;-0.48923537364135294
Burkitt lymphoma;Keratosis pilaris;0.868175819516182;0.77629983;0.5420834303645117;0.5718136389319822;0.9999466809608285;-0.13177086144464656;-0.2236468467094247;-0.45786325059631683;-0.4281330420288463
Burkitt lymphoma;Lamina lucida cleavage;0.8271831721067429;0.6684666;0.5552868663718824;0.6075659522338461;0.9999515360511232;-0.17276836394438033;-0.33148490845331435;-0.4446646696792408;-0.39238558381727706
Burkitt lymphoma;Abnormal central response of multifocal electroretinogram;0.8873855322599411;0.8445356;0.535922501333838;0.5496874070492541;0.9999090677057578;-0.11252353544581672;-0.15537347848761818;-0.4639865663719198;-0.4502216606565037
Burkitt lymphoma;Atypical or prolonged hepatitis;0.7715252935886383;0.7255955;0.5733738219951043;0.5884807274336628;0.9999574798349273;-0.22843218624628903;-0.27436200559176327;-0.426583657839823;-0.4114767524012646
Burkitt lymphoma;Cubitus varus;0.9882800551131368;0.9427668;0.5037306597317804;0.5182278585256912;0.9999090677057578;-0.011629012592621057;-0.05714228208411476;-0.4961784079739774;-0.4816812091800666
Burkitt lymphoma;Nasal regurgitation;1.0287987384945154;0.9668546;0.49083180922998393;0.5105524596009949;0.9999556674707869;0.028843071023728517;-0.033101095174644324;-0.509123858240803;-0.48940320786979197
Burkitt lymphoma;Moon facies;0.9863700959831476;1.0389961;0.5043386675388474;0.48758399210317116;0.9999556674707869;-0.01358557148763928;0.03904043295493331;-0.49561699993193953;-0.5123716753676157
Burkitt lymphoma;Intestinal pseudo-obstruction;0.8848337382078171;0.74740666;0.5367400825764721;0.5812834768067934;0.9999504758588345;-0.11511673765101738;-0.2525438143483669;-0.46321039328236235;-0.4186669990520411
Burkitt lymphoma;Bilateral renal atrophy;0.8943247646093369;0.86395174;0.5337003952441878;0.5434402168286324;0.9999574798349273;-0.10563271522559048;-0.13600573718584896;-0.46625708459073956;-0.4565172630062949
Burkitt lymphoma;Fractured left clavicle;1.0757495686411858;0.9711865;0.47586504474114655;0.5091728920334021;0.9999090677057578;0.07584050093542793;-0.028722549036629408;-0.5240440229646113;-0.4907361756723557
Burkitt lymphoma;Positive urine norcotinine test;0.9066630303859711;0.8657163;0.5297533881669412;0.5428733453311974;0.9999090677057578;-0.09324603731978676;-0.1341927891527488;-0.47015567953881665;-0.45703572237456047
Burkitt lymphoma;Long fibula;1.016692379489541;0.8599852;0.4946864038056126;0.5447150187487848;0.9999536937290383;0.016738685760502747;-0.13996852098047263;-0.5052672899234257;-0.4552386749802535
Burkitt lymphoma;Fragmentation of the epiphysis of the distal phalanx of the hallux;0.9441545344889164;0.8273264;0.5177854165632949;0.5552405838154468;0.9999090677057578;-0.05575453321684143;-0.1725826507364585;-0.4821236511424629;-0.444668483890311
Burkitt lymphoma;Type II cryptotia;0.7664436846971512;0.7678419;0.5750363209777816;0.5745786829174062;0.9999090677057578;-0.23346538300860664;-0.23206719215262672;-0.42487274672797626;-0.4253303847883516
Burkitt lymphoma;Increased variability in muscle fiber diameter;0.9352005869150162;0.8261063;0.520640755991319;0.5556349119130453;0.9999427179139311;-0.0647421309989149;-0.173836408023184;-0.4793019619226121;-0.4443078060008858
Burkitt lymphoma;Widened proximal tibial metaphyses;0.9801840987056494;0.85829926;0.5063080101592391;0.5452570720872153;0.9999574798349273;-0.019773381129277956;-0.14165822446383358;-0.49364946967568823;-0.45470040774771203
Burkitt lymphoma;Wide anterior fontanel;0.9306676015257835;0.84740704;0.5220869072530956;0.5487623505618063;0.9999431371057684;-0.06927553557998489;-0.15253609412557434;-0.47785622985267284;-0.4511807865439621
Burkitt lymphoma;Increased circulating oleate level;0.8729862570762634;0.81111234;0.5405392322511974;0.5604882010022842;0.9999090677057578;-0.1269228106294944;-0.1887967234407737;-0.45936983545456045;-0.4394208667034736
Burkitt lymphoma;Lozenge-shaped umbilicus;0.7662012875080109;0.64226544;0.5751156753936172;0.61645073710178;0.9999556674707869;-0.23375437996277604;-0.3576902284372786;-0.4248399920771697;-0.3835049303690069
Burkitt lymphoma;Anti-myelin-associated glycoprotein antibody positivity;0.7326838970184326;0.7042208;0.5861367864292966;0.59557927322389;0.9999090677057578;-0.2672251706873252;-0.29568829591620704;-0.41377228127646126;-0.4043297944818678
Burkitt lymphoma;Fractured radius;1.0746860951185226;0.9512547;0.47620452058561424;0.5155222492625656;0.9999574798349273;0.07472861528359531;-0.04870275437868954;-0.5237529592493131;-0.4844352305723617
Burkitt lymphoma;Abnormal manual kinetic perimetry test;0.9421738460659981;0.8793866;0.5184169101589947;0.5384861349741418;0.9999090677057578;-0.05773522163975975;-0.12052246387351295;-0.4814921575467631;-0.46142293273161605
Burkitt lymphoma;Small radial epiphyses;1.0694167017936707;0.9957297;0.4778861933577335;0.5013592841096578;0.9999090677057578;0.06950763408791283;-0.004179382876045912;-0.5220228743480243;-0.4985497835961
Burkitt lymphoma;Generalized keratosis follicularis;0.8686236143112183;0.7916423;0.5419396423085212;0.5668118118326511;0.9999574798349273;-0.13133386552370907;-0.20831517159975887;-0.4580178375264061;-0.4331456680022763
Burkitt lymphoma;Hypoplasia of the calcaneus;0.953289270401001;0.87344956;0.5148738992440276;0.5403905478005587;0.9999556674707869;-0.046666397069785925;-0.12650610349068436;-0.4850817682267593;-0.4595651196702282
Burkitt lymphoma;2-hydroxyadipic aciduria;0.9151997938752174;0.92950946;0.5270252002388773;0.522456459096093;0.9999090677057578;-0.08470927383054039;-0.07039960677970192;-0.4728838674668805;-0.4774526086096649
Burkitt lymphoma;Potter facies;0.9355173781514168;0.95441806;0.5205397068725839;0.5145142125228099;0.999951967215123;-0.06443458906370625;-0.0455339040513657;-0.47941226034253914;-0.4854377546923131
Burkitt lymphoma;Increased heart rate variability;0.9737215787172318;0.8581488;0.5083656442995673;0.5453054527498675;0.9999574798349273;-0.02623590111769558;-0.14180866658724667;-0.49159183553536;-0.4546520270850598
Burkitt lymphoma;Aplastic zygomatic arch;0.9219070672988892;0.8393555;0.5248830879697843;0.5513572582952416;0.9999556674707869;-0.07804860017189774;-0.16060013911614213;-0.47507257950100257;-0.4485984091755453
Burkitt lymphoma;Testicular torsion;0.9935773089528084;0.9368726;0.5020444201121049;0.520107449815554;0.9999574798349273;-0.006380170882118952;-0.0630848783258331;-0.4979130597228224;-0.4798500300193733
Burkitt lymphoma;Abolished vibration sense;1.1166632696986198;0.9980161;0.4627801710688225;0.500631494091694;0.9999556674707869;0.11670760222783294;-0.0019395484674910035;-0.5371754964019644;-0.49932417337909285
Burkitt lymphoma;Fractured metatarsal bone of digit 5;0.9994020480662584;0.92667186;0.5001903340233149;0.5233620417741018;0.9999090677057578;-0.0005070196394993953;-0.07323720510352394;-0.4997187336824429;-0.476547025931656
Burkitt lymphoma;Prolonged G2 phase of cell cycle;0.7615935653448105;0.81893235;0.5766250328743414;0.5579552913333229;0.9999536937290383;-0.23836012838422782;-0.18102133927881248;-0.4233286608546969;-0.4419984023957154
Burkitt lymphoma;Single naris;0.9431028068065643;0.9146586;0.5181207250811293;0.5271980995660936;0.9999536937290383;-0.056850886922473975;-0.08529508767663962;-0.48183296864790903;-0.47275559416294466
Burkitt lymphoma;Perifoveal ring of hyperautofluorescence surrounded by normal autofluorescence;0.9340944439172745;0.84239125;0.5209936065706624;0.5503784759208821;0.9999090677057578;-0.06581462378848335;-0.15751781518805763;-0.4789154611350954;-0.44953059178487575
Burkitt lymphoma;Asymmetry of the thorax;0.9501368552446365;0.8138265;0.5158785164534989;0.5596086582257543;0.9999536937290383;-0.04981683848440177;-0.186127192359562;-0.4840751772755394;-0.44034503550328397
Burkitt lymphoma;Type 2 muscle fiber predominance;0.902314156293869;0.86306596;0.531144036493066;0.5437248392838734;0.9999524555142131;-0.09763829922034406;-0.1368864974911418;-0.4688084190211471;-0.4562276162303397
Burkitt lymphoma;Dependency on parenteral nutrition;0.8424010425806046;0.86041343;0.550375325011516;0.5445773619487192;0.9999556674707869;-0.15755462489018235;-0.13954223534951005;-0.4495803424592709;-0.4553783055220677
Burkitt lymphoma;Limited shoulder flexion;1.091431125998497;0.98116577;0.4708558662999448;0.5059954818935946;0.9999090677057578;0.09152205829273918;-0.018743300989754408;-0.529053201405813;-0.49391358581216327
Burkitt lymphoma;Paroxysmal vertigo;0.9192654564976692;0.8052225;0.5257266030925306;0.5623984792730348;0.9999556674707869;-0.08069021097311768;-0.194733156179283;-0.4742290643782563;-0.43755718819775213
Burkitt lymphoma;Long hallux;0.9220039695501328;0.800151;0.5248521486565221;0.5640451551056395;0.9999489492479948;-0.07794497969786207;-0.1997979587618498;-0.47509680059147275;-0.43590379414235536
Burkitt lymphoma;Broad medial eyebrow;0.9213902428746223;0.9170406;0.5250481055911698;0.5264371830568754;0.9999574798349273;-0.07856723696030499;-0.08291689336336971;-0.47490937424375756;-0.47352029677805196
Burkitt lymphoma;Myxoid subcutaneous tumors;0.8410762846469879;0.7549091;0.5508023907915648;0.5788178149320656;0.6863837057007169;0.15469257894627098;0.06852539244762901;-0.13558131490915215;-0.1075658907686513
Burkitt lymphoma;Bulbous tips of toes;0.9827987533062696;0.8690029;0.5054755969225126;0.5418178662859516;0.9999556674707869;-0.017156914164517256;-0.13095278880486283;-0.49448007054827425;-0.45813780118483527
Burkitt lymphoma;Absent internal genitalia;0.9798544496297836;0.91138715;0.5064129616714906;0.5282433853551748;0.9999090677057578;-0.020054618075974195;-0.08852192218650123;-0.4934961060342672;-0.47166568235058304
Burkitt lymphoma;Hyperphalangy of the 2nd finger;0.9873947203159332;0.9060089;0.5040124914058512;0.5299625287446934;0.9999574798349273;-0.012562759518994104;-0.09394858062304379;-0.4959449884290761;-0.4699949510902339
Burkitt lymphoma;Renal interstitial hemosiderin;0.8245763182640076;0.8119308;0.5561295261232244;0.5602229415222074;0.9999090677057578;-0.17533274944175026;-0.1879782920633628;-0.4437795415825334;-0.4396861261835504
Burkitt lymphoma;Abnormality of depressor anguli oris muscle;1.019783342257142;0.87704325;0.4937023557362338;0.539237649749983;0.9999090677057578;0.01987427455138424;-0.12286582048285744;-0.506206711969524;-0.4606714179557748
Burkitt lymphoma;Paroxysmal dyspnea;0.9079042300581932;0.79646486;0.5293565928423924;0.5652431211725821;0.9999090677057578;-0.09200483764756462;-0.2034442072664573;-0.4705524748633654;-0.4346659465331757
Burkitt lymphoma;Phenylpyruvic acidemia;0.8822322934865952;0.82330006;0.5375738223589516;0.5565422172289016;0.9999574798349273;-0.11772518634833218;-0.17665741622485043;-0.46238365747597576;-0.4434152626060257
Burkitt lymphoma;Lateral ventricle dilatation;0.9384857788681984;0.82581925;0.5195929546223482;0.5557276958922932;0.9999445600944175;-0.06145878122621906;-0.17412530617290867;-0.48035160547206923;-0.44421686420212425
Burkitt lymphoma;Neonatal unconjugated hyperbilirubinemia;0.6464274525642395;0.6065067;0.6150332469421464;0.6287335432979888;0.9999574798349273;-0.35353002727068783;-0.3934507745508087;-0.3849242328927809;-0.3712239365369385
Burkitt lymphoma;High maternal circulating alpha-fetoprotein concentration;0.9135260879993439;0.89413244;0.5275599217831562;0.5337619537572547;0.9999090677057578;-0.08638297970641395;-0.10577663238394996;-0.4723491459226016;-0.46614711394850317
Burkitt lymphoma;Prominent nasolabial fold;0.9472058787941933;0.8738517;0.5168127070055124;0.5402615140561021;0.9999511492611326;-0.05274527046693933;-0.1260994327427305;-0.4831384422556202;-0.4596896352050305
Burkitt lymphoma;Abnormality of inferior alveolar nerve;0.9086532443761826;0.7654001;0.5291171649187463;0.5753779930084888;0.9999090677057578;-0.09125582332957527;-0.23450895603049537;-0.47079190278701155;-0.42453107469726903
Burkitt lymphoma;Unilateral conductive hearing impairment;0.9027350544929504;0.7329536;0.5310094193787582;0.5860476959775944;0.9999574798349273;-0.09722242534197689;-0.26700387179888607;-0.4689480604561691;-0.4139097838573329
Burkitt lymphoma;Macular hypopigmented whorls, streaks, and patches;0.8563793152570724;0.81630456;0.5458745236181232;0.5588060260298215;0.9999574798349273;-0.14357816457785488;-0.18365291535891415;-0.45408295621680417;-0.4411514538051058
Burkitt lymphoma;Delayed ossification of pubic rami;0.9537980109453201;0.83537257;0.5147117870683117;0.5526421872522398;0.9999556674707869;-0.04615765652546677;-0.16458310029396805;-0.48524388040247524;-0.4473134802185471
Burkitt lymphoma;Hyperphenylalaninemia;0.8625021725893021;0.79129016;0.5439060114423683;0.5669264225234731;0.9999530203863651;-0.13745084779706307;-0.20866285639252968;-0.45604700894399686;-0.433026597862892
Burkitt lymphoma;Ureteropelvic junction obstruction;0.9244861006736755;0.8111267;0.5240597239096572;0.5604835495882118;0.9999491674684583;-0.07546306679478276;-0.1888224584840833;-0.47588944355880114;-0.4394656178802465
Burkitt lymphoma;Cone-shaped epiphysis of the proximal phalanx of the 2nd toe;0.9755841623991728;0.94434863;0.5077725748665023;0.5177235415141689;0.9999090677057578;-0.024324905306585043;-0.05556043441642067;-0.49213649283925553;-0.48218552619158894
Burkitt lymphoma;Difficulty walking;0.9485121704638004;0.8915338;0.5163963350464067;0.5345939214883252;0.9999413030146577;-0.05142913255085724;-0.10840751099576729;-0.48354496796825097;-0.4653473815263325
Burkitt lymphoma;Bilobate gallbladder;0.7697323858737946;0.63893485;0.573960154533024;0.6175868050096118;0.9999556674707869;-0.23022328159699235;-0.3610208167780379;-0.42599551293776294;-0.3823688624611751
Burkitt lymphoma;Histidinuria;0.8019337058067322;0.7979591;0.5634661328328031;0.5647573868115138;0.9999545338528789;-0.19802082804614674;-0.2019954445737041;-0.4364884010200758;-0.43519714704136514
Burkitt lymphoma;Widened interpedicular distance;0.9883639700710773;0.8902867;0.5037039469495163;0.5349932812193707;0.9999090677057578;-0.011545097634680479;-0.10962238366950294;-0.49620512075624157;-0.4649157864863871
Snail-like ilia;Indurated nodule;0.8535652160644531;0.7677924;0.5467798510255579;0.574594872730718;0.9999201345566091;-0.14635491849215598;-0.23212773085864158;-0.4531402835310512;-0.42532526182589114
Snail-like ilia;Absent leukocyte alkaline phosphatase;0.9810162950307131;0.9614551;0.5060430639728168;0.5122722630758907;0.9999600672783046;-0.018943772247591473;-0.03850496054307506;-0.4939170033054877;-0.48768780420241387
Snail-like ilia;Hippocampal sclerosis;0.9483156129717827;0.9173107;0.5164589846542205;0.5263509140154122;0.9999201345566091;-0.051604521584826424;-0.08260941983492942;-0.48346114990238864;-0.4735692205411969
Snail-like ilia;Decreased sensitivity to hypoxemia;0.9912481093779206;0.95976275;0.502785848872535;0.5128113795335091;0.9999600672783046;-0.008711957900383926;-0.04019731522218273;-0.4971742184057696;-0.48714868774479547
Snail-like ilia;Decreased level of tissue plasminogen activator;0.9463358893990517;0.95383334;0.517090026388253;0.5147005337072283;0.9999201345566091;-0.05358424515755744;-0.046086792958098366;-0.48283010816835614;-0.48521960084938076
Snail-like ilia;Submandibular lymph node enlargement;1.0018751546740532;0.92687464;0.49940311937933235;0.523297313224408;0.9999600672783046;0.001915087395748638;-0.07308542967454479;-0.5005569478989722;-0.4766627540538966
Snail-like ilia;Hepatic hemangioma;0.9895903095602989;0.93123287;0.5033135672248452;0.5219065510983265;0.9999584729108851;-0.010368163350586213;-0.06872560328579358;-0.4966449056860399;-0.4780519218125586
Snail-like ilia;Triangular epiphysis of the distal phalanx of the 2nd finger;0.9717246908694506;0.8918866;0.5090015101438539;0.5344809574945979;0.683723727808895;0.28800096306055556;0.2081628641024209;-0.17472221766504115;-0.1492427703142971
Snail-like ilia;Acne inversa;0.9089482873678207;0.81052595;0.5290228568039415;0.5606782874280865;0.9999548690865008;-0.09100658171868004;-0.18942891531681694;-0.4709320122825593;-0.4392765816584143
Snail-like ilia;Dentin dysplasia;0.9681228920817375;0.91062635;0.5101485178245092;0.5284865182077697;0.9999201345566091;-0.03179724247487159;-0.0892937827232656;-0.4897716167320999;-0.4714336163488394
Snail-like ilia;Aplasia of the inner ear;0.9299145042896271;0.74010205;0.5223272101217622;0.5836889167738907;0.9999600672783046;-0.07004556298867748;-0.2598580145897059;-0.47763285715654236;-0.4162711505044139
Snail-like ilia;Polycystic liver disease;1.084778070449829;1.0013013;0.47298187123024427;0.49958577647970237;0.9999567459343585;0.08482132451547064;0.0013445426703778685;-0.5269748747041142;-0.5003709694546561
Snail-like ilia;Subungual hyperkeratosis;0.9191062301397324;0.8694942;0.5257774527361367;0.5416601244827786;0.9999556674707869;-0.08084943733105454;-0.13046146771797928;-0.47417821473465016;-0.45829554298800834
Snail-like ilia;Broad humeral epiphyses;0.9909339658915997;0.9338389;0.5028858478188399;0.5210751301585761;0.683723727808895;0.30721023808270465;0.25011517609506617;-0.18083787999005507;-0.16264859765031892
Snail-like ilia;Autoimmune thrombocytopenia;1.055422317236662;0.9850874;0.4823494846469669;0.5047470106868999;0.9999509115718902;0.05547140566477171;-0.014863516857534731;-0.5176014269249233;-0.49520390088499033
Snail-like ilia;Adenomyosis;0.910745844244957;0.9650272;0.5284483371169474;0.511134448423966;0.9999600672783046;-0.08921422303334758;-0.0349328541816859;-0.47151173016135717;-0.4888256188543385
Snail-like ilia;Elevated leukocyte alkaline phosphatase;0.9307572543621063;0.9335485;0.522058301120652;0.5211677692551203;0.9999600672783046;-0.06920281291619823;-0.06641155720368908;-0.47790176615765256;-0.47879229802318424
Snail-like ilia;Clasp-knife sign;0.8872708678245544;0.90647393;0.5359592340617454;0.5298138365129337;0.8819596887815145;0.005311179043039904;0.024514245868906603;-0.34600045471976915;-0.35214585226858086
Snail-like ilia;Keratosis pilaris;0.9472520351409912;0.9324362;0.5167979944841438;0.5215226101217201;0.9999506876445663;-0.05269865250357508;-0.06751445984610438;-0.48315269316042253;-0.4784280775228462
Snail-like ilia;Lamina lucida cleavage;0.9333246871829033;0.8573053;0.5212391678994;0.5455767001278103;0.9999548690865008;-0.06663018190359749;-0.14264958077168144;-0.47871570118710083;-0.45437816895869043
Snail-like ilia;Abnormal central response of multifocal electroretinogram;0.9662421829998493;0.9070002;0.5107474888354575;0.5296456023617949;0.9999201345566091;-0.03367795155675979;-0.09291995049746604;-0.4891726457211516;-0.4702745321948142
Snail-like ilia;Atypical or prolonged hepatitis;0.9980172887444496;0.9144176;0.500631117007592;0.5272750856719844;0.9999600672783046;-0.0019427785338549386;-0.08554244280473278;-0.49932895027071256;-0.4726849816063201
Snail-like ilia;Cubitus varus;1.06503214687109;1.0497738;0.4792850059566569;0.48414994005736045;0.822027235707794;0.24300491116329592;0.22774657658621233;-0.3427422297511371;-0.33787729565043356
Snail-like ilia;Nasal regurgitation;1.0267139114439487;0.9882651;0.49149568619090345;0.5037354296307014;0.9999584729108851;0.026755438533063614;-0.011693375769619263;-0.5084627867199817;-0.49622304328018374
Snail-like ilia;Moon facies;0.8893246054649353;0.90657216;0.535301391985964;0.5297824414460552;0.9999584729108851;-0.11063386744594983;-0.09338630980587415;-0.4646570809249211;-0.4701760314648299
Snail-like ilia;Intestinal pseudo-obstruction;0.8191002905368805;0.7911829;0.5579009428545282;0.5669613428993306;0.9999539510871024;-0.1808536605502219;-0.20877107545386264;-0.4420530082325742;-0.43299260818777174
Snail-like ilia;Bilateral renal atrophy;0.8876748010516167;0.93136644;0.5358298362704608;0.5218639324773704;0.9999600672783046;-0.11228526622668789;-0.06859362364427135;-0.4641302310078438;-0.47809613480093416
Snail-like ilia;Fractured left clavicle;1.0642393678426743;0.98952264;0.4795378841534276;0.5033351072113543;0.683723727808895;0.38051564003377925;0.30579890812784205;-0.20418584365546744;-0.18038862059754068
Snail-like ilia;Positive urine norcotinine test;0.8579581677913666;0.9039389;0.5453667530469486;0.5306244167514271;0.9999201345566091;-0.14196196676524253;-0.0959812450531301;-0.4545533815096605;-0.469295717805182
Snail-like ilia;Long fibula;0.9602485820651054;0.932001;0.5126566040874503;0.521661473227456;0.8287089627579918;0.13153961930711366;0.10329203192432024;-0.3160523586705415;-0.30704748953053573
Snail-like ilia;Fragmentation of the epiphysis of the distal phalanx of the hallux;0.9850635267794132;0.91103894;0.5047546038926292;0.5283546660066383;0.683723727808895;0.3013397989705182;0.22731520737558375;-0.17896912391626585;-0.15536906180225674
Snail-like ilia;Type II cryptotia;0.7343470454216003;0.72779524;0.5855875281486553;0.5877528150798075;0.9999201345566091;-0.26557308913500877;-0.2721248912933645;-0.4143326064079538;-0.41216731947680163
Snail-like ilia;Increased variability in muscle fiber diameter;0.9808645136654377;0.9208266;0.5060913862597409;0.525228077575228;0.922134556158444;0.058729957506993724;-0.00130794225539832;-0.41604316989870305;-0.3969064785832159
Snail-like ilia;Widened proximal tibial metaphyses;1.0296264439821243;0.9686236;0.49056822989280613;0.5099890669766999;0.8418618639044475;0.18776458007767682;0.1267617146439839;-0.3512936340116414;-0.3318727969277476
Snail-like ilia;Wide anterior fontanel;1.014010296203196;0.9860386;0.4955402383021299;0.5044441879955385;0.8833906631088758;0.13061963309432023;0.10264796213145011;-0.3878504248067459;-0.37894647511333734
Snail-like ilia;Increased circulating oleate level;1.055085700005293;0.95465845;0.4824567971781776;0.5144376103016586;0.9999201345566091;0.055165565448683784;-0.045261685860472634;-0.5174633373784315;-0.48548252425495053
Snail-like ilia;Lozenge-shaped umbilicus;0.7843032777309418;0.7380582;0.5692022537137893;0.5843628465397321;0.9999584729108851;-0.21565519517994336;-0.26190026349163464;-0.43075621919709584;-0.415595626371153
Snail-like ilia;Anti-myelin-associated glycoprotein antibody positivity;0.9528186060488224;0.917671;0.5150238817286124;0.5262358218396571;0.9999201345566091;-0.047101528507786705;-0.08224910975726218;-0.48489625282799675;-0.473684312716952
Snail-like ilia;Fractured radius;0.9226728081703186;0.86250055;0.5246386057600525;0.5439065334073898;0.8418618639044475;0.0808109442658711;0.02063868445828443;-0.317223258144395;-0.2979553304970577
Snail-like ilia;Abnormal manual kinetic perimetry test;1.0045047514140606;0.940629;0.49856608824039894;0.5189094899472404;0.9999201345566091;0.0045846168574514845;-0.0592911291244802;-0.5013540463162102;-0.4810106446093687
Snail-like ilia;Small radial epiphyses;0.9164878278970718;0.8519834;0.5266137466463978;0.5472889065640811;0.683723727808895;0.23276410008817683;0.1682597001925088;-0.1571099811624972;-0.13643482124481388
Snail-like ilia;Generalized keratosis follicularis;0.9406681805849075;0.90541744;0.5188970028391291;0.5301516330254831;0.9999600672783046;-0.05929188669339702;-0.09454262495652721;-0.48106306443917546;-0.4698084342528215
Snail-like ilia;Hypoplasia of the calcaneus;1.0474830009043217;1.0150925;0.4848800060738736;0.49519572934160994;0.8355479869321181;0.2119350139722036;0.1795445051714586;-0.35066798085824447;-0.34035225759050813
Snail-like ilia;2-hydroxyadipic aciduria;0.8611477911472321;0.81606245;0.5443412998421038;0.5588844196266278;0.9999201345566091;-0.13877234340937705;-0.18385768414767356;-0.45557883471450533;-0.4410357149299813
Snail-like ilia;Potter facies;0.9065372347831726;0.9672256;0.5297936059558771;0.5104342746176361;0.9999552432134126;-0.09341800843023995;-0.032729632003543174;-0.47016163725753546;-0.48952096859577643
Snail-like ilia;Increased heart rate variability;1.013645158149302;0.9722222;0.4956564764684034;0.5088430883147494;0.9999600672783046;0.013685090870997452;-0.02773785830155895;-0.5043035908099012;-0.4911169789635551
Snail-like ilia;Aplastic zygomatic arch;1.0072055980563164;0.94690776;0.4977063670546994;0.5169077372240484;0.9074607173141833;0.09974488074213306;0.039447041398585236;-0.4097543502594839;-0.39055298009013495
Snail-like ilia;Testicular torsion;0.9541261605918407;0.93018436;0.5146072229211172;0.5222410976988328;0.9999600672783046;-0.04583390668646381;-0.0697757029594569;-0.4853528443571874;-0.4777189695794718
Snail-like ilia;Abolished vibration sense;0.9578891769051552;0.9400323;0.5134082561573239;0.5190997734755505;0.9999584729108851;-0.04206929600572995;-0.05992616957760266;-0.48655021675356125;-0.48085869943533466
Snail-like ilia;Fractured metatarsal bone of digit 5;1.0171849858015776;0.982934;0.494529579845409;0.5054325325430182;0.683723727808895;0.33346125799268256;0.29921027029901515;-0.189194147963486;-0.17829119526587678
Snail-like ilia;Prolonged G2 phase of cell cycle;0.9402979239821434;0.92275405;0.5190150684724084;0.5246126730813846;0.9999567459343585;-0.05965882195221506;-0.077202696633211;-0.48094167746195005;-0.47534407285297386
Snail-like ilia;Single naris;0.8873758018016815;0.8585719;0.5359256184654461;0.5451694078765768;0.9999567459343585;-0.11258094413267694;-0.14138485891806207;-0.4640311274689124;-0.4547873380577817
Snail-like ilia;Perifoveal ring of hyperautofluorescence surrounded by normal autofluorescence;0.9362768977880478;0.88027966;0.5202974459988052;0.5381997913560879;0.9999201345566091;-0.06364323676856132;-0.11964047433169456;-0.4796226885578039;-0.46172034320052124
Snail-like ilia;Asymmetry of the thorax;1.080948531627655;1.0078386;0.47420505869827323;0.497504882628542;0.9036123096265051;0.17733622200114996;0.10422629720790655;-0.42940725092823184;-0.4061074269979631
Snail-like ilia;Type 2 muscle fiber predominance;1.0015850747004151;0.9553785;0.4994954548412428;0.5142081920347743;0.9344769737294281;0.06710810097098707;0.02090149907559513;-0.43498151888818526;-0.42026878169465376
Snail-like ilia;Dependency on parenteral nutrition;0.8697696328163147;0.8863883;0.5415716919592366;0.5362419728606976;0.9999584729108851;-0.13018884009457043;-0.1135701710615199;-0.45838678095164853;-0.4637165000501875
Snail-like ilia;Limited shoulder flexion;0.9669378027319908;0.89577526;0.5105259425105144;0.5332361175562451;0.8332104407109631;0.13372736202102775;0.06256481783014411;-0.32268449820044864;-0.29997432315471795
Snail-like ilia;Paroxysmal vertigo;1.0106222927570343;0.9353062;0.49661875561341495;0.5206070703442232;0.9999584729108851;0.01066381984614917;-0.06465228146648816;-0.5033397172974702;-0.479351402566662
Snail-like ilia;Long hallux;0.9959484292194247;0.95978457;0.5012896585623863;0.5128044286959952;0.8124254700108346;0.18352295920859008;0.14735909734527497;-0.3111358114484484;-0.29962104131483946
Snail-like ilia;Broad medial eyebrow;1.0466056428849697;1.0241055;0.48515958736577547;0.49232621684979294;0.9999600672783046;0.04664557560666516;0.024145481580338024;-0.5148004799125291;-0.5076338504285116
Snail-like ilia;Myxoid subcutaneous tumors;0.9492931514978409;0.8884865;0.5161474158873256;0.5355698246939586;0.9999600672783046;-0.05066691578046367;-0.11147356272355602;-0.48381265139097895;-0.4643902425843459
Snail-like ilia;Bulbous tips of toes;0.8885849043726921;0.8554884;0.535538311425461;0.5461610844426544;0.8355479869321181;0.05303691744057404;0.01994043260065781;-0.300009675506657;-0.28938690248946364
Snail-like ilia;Absent internal genitalia;0.8370542079210281;0.8227178;0.5520995671653756;0.556730544719447;0.9999201345566091;-0.16286592663558097;-0.177202348721343;-0.44782056739123355;-0.44318958983716206
Snail-like ilia;Hyperphalangy of the 2nd finger;0.9728612434118986;0.9101859;0.508639595269877;0.5286272953377453;0.8418618639044475;0.1309993795074511;0.06832400960400586;-0.3332222686345705;-0.3132345685667022
Snail-like ilia;Renal interstitial hemosiderin;0.7868253290653229;0.76753396;0.5683803403250108;0.5746794530730616;0.9999201345566091;-0.21309480549128623;-0.23238617659838767;-0.4315397942315983;-0.42524068148354754
Snail-like ilia;Abnormality of depressor anguli oris muscle;0.9995976625941694;0.9699799;0.5001280679773126;0.5095571296029502;0.8819596887815145;0.11763797381265484;0.08802019345878087;-0.38183162080420197;-0.37240255917856435
Snail-like ilia;Paroxysmal dyspnea;1.0145609844475985;0.95636564;0.4953649308982766;0.5138936637318245;0.9999201345566091;0.01464084989098935;-0.043554489624815895;-0.5045552036583325;-0.48602647082478456
Snail-like ilia;Phenylpyruvic acidemia;0.9932411992922425;0.95675266;0.502151409464132;0.513770356092066;0.9999600672783046;-0.006718867986062027;-0.04320740938798473;-0.4978086578141726;-0.48618971118623855
Snail-like ilia;Lateral ventricle dilatation;1.03016796708107;0.940897;0.4903957806462039;0.5188240514825987;0.9999488789551968;0.03021908812587315;-0.059051891040157733;-0.5095530983089929;-0.4811248274725981
Snail-like ilia;Neonatal unconjugated hyperbilirubinemia;1.0360742509365082;0.8953782;0.48851471730599216;0.5333632207403356;0.9999600672783046;0.036114183658203625;-0.10458189488069103;-0.5114453499723124;-0.46659684653796896
Snail-like ilia;High maternal circulating alpha-fetoprotein concentration;1.0317493043839931;1.0070945;0.4898921839058852;0.49774171833761316;0.9999201345566091;0.03182916982738404;0.007174367892426536;-0.5100279506507239;-0.502178416218996
Snail-like ilia;Prominent nasolabial fold;1.0849601328372955;1.0152477;0.47292370912983117;0.4951463361132844;0.9999545338528789;0.08500559898441662;0.015293168745692864;-0.5270308247230477;-0.5048081977395945
Snail-like ilia;Abnormality of inferior alveolar nerve;1.0111745931208134;0.7612651;0.49644294250374155;0.5767326956931678;0.9999201345566091;0.011254458564204262;-0.2386550355079946;-0.5034771920528676;-0.42318743886344135
Snail-like ilia;Unilateral conductive hearing impairment;1.0095768813043833;0.82317954;0.49695153740166276;0.5565811890336161;0.9999600672783046;0.009616814026078724;-0.1767805242599635;-0.5030085298766418;-0.44337887824468847
Snail-like ilia;Macular hypopigmented whorls, streaks, and patches;0.9366042912006378;0.9115145;0.5201930222996511;0.5282026830785932;0.9999600672783046;-0.06335577607766674;-0.08844554663316295;-0.4797670449786534;-0.47175738419971136
Snail-like ilia;Delayed ossification of pubic rami;1.0373915992677212;0.98831624;0.48809510909226095;0.503719138038313;0.6462043805334825;0.3911872187342387;0.34211185739300065;-0.15810927144122155;-0.14248524249516947
Snail-like ilia;Hyperphenylalaninemia;1.0333828255534172;0.949771;0.48937194196620026;0.5159951137289313;0.9999561589935034;0.033426666559913776;-0.050185171959659436;-0.5105842170273032;-0.4839610452645722
Snail-like ilia;Ureteropelvic junction obstruction;0.7879660427570343;0.8079983;0.5680087445736985;0.5614979221450294;0.9999528219730685;-0.21198677921603415;-0.1919545223743746;-0.4319440773993699;-0.4384548998280391
Snail-like ilia;Cone-shaped epiphysis of the proximal phalanx of the 2nd toe;0.9038866758346558;0.8222824;0.5306411212864184;0.5568713624845796;0.683723727808895;0.22016294802576075;0.13855864609628687;-0.15308260652247663;-0.12685236532431543
Snail-like ilia;Difficulty walking;0.9681996777653694;0.95260125;0.5101240637845668;0.5150931516531074;0.9203691460904122;0.04783053167495721;0.03223210789594644;-0.41024508230584544;-0.4052759944373048
Snail-like ilia;Bilobate gallbladder;0.9439073875546455;0.905036;0.517864209383382;0.5302736147807392;0.9999584729108851;-0.056051085356239594;-0.09492250031567029;-0.4820942635275032;-0.46968485813014593
Snail-like ilia;Histidinuria;0.8222976177930832;0.79489374;0.5568664365408116;0.5657540062644163;0.9999574798349273;-0.17765986204184414;-0.20506373822726132;-0.44309104329411575;-0.43420347357051103
Snail-like ilia;Widened interpedicular distance;1.0211356598883867;0.94346744;0.49327180951123395;0.5180044709899423;0.822027235707794;0.1991084241805927;0.12144020251318377;-0.32875542619656006;-0.3040227647178517
Indurated nodule;Absent leukocyte alkaline phosphatase;0.8787326812744141;0.843757;0.538695826547749;0.5499382997013923;0.9999201345566091;-0.12118745328219505;-0.1561631608131704;-0.46122430800886016;-0.4499818348552168
Indurated nodule;Hippocampal sclerosis;0.9347452223300934;0.8531074;0.5207860104730992;0.5469271785846586;1.0;-0.06525477766990662;-0.14689260721206665;-0.47921398952690075;-0.45307282141534144
Indurated nodule;Decreased sensitivity to hypoxemia;0.91892309486866;0.87887883;0.5258359386124847;0.5386489575182865;0.9999201345566091;-0.08099703968794914;-0.12104130269320579;-0.47408419594412443;-0.46127117703832266
Indurated nodule;Decreased level of tissue plasminogen activator;0.9527561515569687;0.872203;0.5150437838043616;0.5407906111770755;1.0;-0.04724384844303131;-0.12779700756072998;-0.48495621619563845;-0.4592093888229245
Indurated nodule;Submandibular lymph node enlargement;0.5539780259132385;0.4910611;0.6471596829334256;0.6699620932906809;0.9999201345566091;-0.4459421086433706;-0.5088590431335744;-0.3527604516231835;-0.3299580412659282
Indurated nodule;Hepatic hemangioma;0.8172268122434616;0.69337577;0.5585073999916248;0.599199491189573;0.9999134918687169;-0.1826866796252553;-0.3065377255914037;-0.4414060918770921;-0.40071400067914387
Indurated nodule;Triangular epiphysis of the distal phalanx of the 2nd finger;0.8720644861459732;0.83063966;0.5408350544293026;0.5541701663591688;1.0;-0.1279355138540268;-0.16936033964157104;-0.4591649455706974;-0.4458298336408312
Indurated nodule;Acne inversa;0.5357207655906677;0.5554043;0.6536865850446802;0.6466526457180721;0.593209551425613;-0.05748878583494532;-0.0378052459675442;0.0604770336190672;0.05344309429245908
Indurated nodule;Dentin dysplasia;0.8340242803096771;0.78720134;0.5530773371703076;0.5682578399881697;1.0;-0.16597571969032288;-0.21279865503311157;-0.4469226628296924;-0.4317421600118303
Indurated nodule;Aplasia of the inner ear;0.9351010546088219;0.7441596;0.5206725049374876;0.5823521651332657;0.9999201345566091;-0.06481907994778724;-0.25576055527957053;-0.4792476296191215;-0.4175679694233434
Indurated nodule;Polycystic liver disease;0.9366272836923599;0.82204795;0.5201856888160528;0.5569471958011527;0.9999056439461368;-0.06327836025377687;-0.17785769510885652;-0.47971995513008403;-0.4429584481449841
Indurated nodule;Subungual hyperkeratosis;0.7371775507926941;0.7397901;0.5846533468524269;0.5837917683226498;0.5720432123760241;0.16513433841667002;0.16774686960182017;0.012610134476402801;0.011748555946625716
Indurated nodule;Broad humeral epiphyses;0.9057280793786049;0.85841775;0.530052310382025;0.5452189749129691;1.0;-0.09427192062139511;-0.14158225059509277;-0.46994768961797495;-0.4547810250870309
Indurated nodule;Autoimmune thrombocytopenia;0.9020219966769218;0.7671819;0.5312374820506964;0.5747946819526315;0.9998726169824932;-0.09785062030557135;-0.23269074366096;-0.46863513493179676;-0.4250779350298617
Indurated nodule;Adenomyosis;0.8663799464702606;0.7886234;0.5426601769024709;0.5677946557306356;0.9999201345566091;-0.1335401880863485;-0.2112967419746694;-0.4572599576541382;-0.4321254788259735
Indurated nodule;Elevated leukocyte alkaline phosphatase;0.8616611063480377;0.7905793;0.5441763142722305;0.5671578143738123;0.9999201345566091;-0.1382590282085714;-0.20934081555636497;-0.45574382028437865;-0.4327623201827968
Indurated nodule;Clasp-knife sign;0.9509624652564526;0.95218414;0.5156153947096052;0.5152260606002217;1.0;-0.04903753474354744;-0.04781585931777954;-0.48438460529039484;-0.4847739393997783
Indurated nodule;Keratosis pilaris;0.860068216919899;0.90533674;0.5446883269377979;0.5301774307606821;0.44638369298437486;0.41368452393552413;0.4589530446483766;0.09830463395342304;0.08379373777630728
Indurated nodule;Lamina lucida cleavage;0.9345122501254082;0.86954796;0.5208603267909913;0.5416428682857115;0.55432226759585;0.38018998252955816;0.315225695546545;-0.03346194080485876;-0.012679399310138506
Indurated nodule;Abnormal central response of multifocal electroretinogram;0.9315505921840668;0.7777233;0.5218051732440561;0.5713488185711082;1.0;-0.06844940781593323;-0.2222766876220703;-0.47819482675594394;-0.4286511814288918
Indurated nodule;Atypical or prolonged hepatitis;0.8504593819379807;0.73978835;0.547779475833905;0.5837923381622612;0.9999201345566091;-0.14946075261862846;-0.26013178111346336;-0.45214065872270415;-0.41612779639434794
Indurated nodule;Cubitus varus;0.913051038980484;0.8934762;0.5277117062846224;0.5339720316508011;1.0;-0.08694896101951599;-0.10652381181716919;-0.4722882937153776;-0.4660279683491989
Indurated nodule;Nasal regurgitation;0.8401223719120026;0.76098454;0.5511099632890712;0.576824672609531;0.9999134918687169;-0.15979111995671436;-0.23892895188306018;-0.44880352857964567;-0.42308881925918596
Indurated nodule;Moon facies;0.9697099830955267;0.9796857;0.5096430867816468;0.506466684514431;0.9999134918687169;-0.030203508773190224;-0.020227768087131226;-0.4902704050870701;-0.4934468073542859
Indurated nodule;Intestinal pseudo-obstruction;0.8243007361888885;0.6792141;0.556218630550551;0.6039469901782801;0.9998912449978579;-0.17559050880896931;-0.320677125086664;-0.4436726144473069;-0.39594425481957773
Indurated nodule;Bilateral renal atrophy;0.9082445204257965;0.7838758;0.5292478144725483;0.5693415987391927;0.9999201345566091;-0.0916756141308126;-0.21604431153567405;-0.4706723200840608;-0.43057853581741645
Indurated nodule;Fractured left clavicle;0.921375036239624;0.87230426;0.5250529610416983;0.5407581006290915;1.0;-0.07862496376037598;-0.1276957392692566;-0.4749470389583017;-0.45924189937090854
Indurated nodule;Positive urine norcotinine test;0.7785686552524567;0.68058807;0.5710728703961441;0.6034853602599819;1.0;-0.22143134474754333;-0.3194119334220886;-0.42892712960385593;-0.3965146397400181
Indurated nodule;Long fibula;0.9414362944662571;0.8516706;0.5186520786846096;0.5473895869088755;0.9999056439461368;-0.058469349479879695;-0.14823502112051423;-0.4812535652615272;-0.4525160570372613
Indurated nodule;Fragmentation of the epiphysis of the distal phalanx of the hallux;0.8808633983135223;0.8351713;0.5380126446756066;0.5527071408076393;1.0;-0.11913660168647766;-0.16482871770858765;-0.4619873553243934;-0.4472928591923607
Indurated nodule;Type II cryptotia;0.8295584619045258;0.8742337;0.5545193999914416;0.5401389510689727;1.0;-0.17044153809547424;-0.12576627731323242;-0.4454806000085584;-0.4598610489310273
Indurated nodule;Increased variability in muscle fiber diameter;0.9003639444708824;0.76756847;0.5317678518271942;0.5746681682312871;0.9998452077479463;-0.09948126327706386;-0.2322767387003999;-0.46807735592075206;-0.4251770395166592
Indurated nodule;Widened proximal tibial metaphyses;0.919587254524231;0.8253307;0.5256238374727225;0.5558856414837634;0.9999201345566091;-0.08033288003237815;-0.1745894599083242;-0.47429629708388665;-0.4440344930728457
Indurated nodule;Wide anterior fontanel;0.9843075964599848;0.86732554;0.5049952522138275;0.5423564749100157;0.999848231156753;-0.015540634696768252;-0.13252268679945323;-0.49485297894292557;-0.4574917562467373
Indurated nodule;Increased circulating oleate level;0.9243445470929146;0.7859441;0.5241049110768831;0.568667465646577;1.0;-0.07565545290708542;-0.2140558958053589;-0.47589508892311694;-0.431332534353423
Indurated nodule;Lozenge-shaped umbilicus;0.8384419083595276;0.7564018;0.5516519167040699;0.5783278329954876;0.9999134918687169;-0.16147158350918933;-0.24351171460126086;-0.44826157516464704;-0.4215856588732293
Indurated nodule;Anti-myelin-associated glycoprotein antibody positivity;0.7312259078025818;0.6644163;0.5866185067628997;0.6089335307759612;1.0;-0.2687740921974182;-0.3355836868286133;-0.4133814932371003;-0.39106646922403876
Indurated nodule;Fractured radius;0.8973379284143448;0.7929543;0.5327360285422889;0.5663848730867832;0.9999201345566091;-0.10258220614226432;-0.20696580888064475;-0.46718410601432026;-0.4335352614698259
Indurated nodule;Abnormal manual kinetic perimetry test;0.968036163598299;0.8551246;0.510176138433344;0.546278130570117;1.0;-0.031963836401700974;-0.1448754072189331;-0.489823861566656;-0.453721869429883
Indurated nodule;Small radial epiphyses;0.9186433628201485;0.8813019;0.525925275216229;0.5378720694126895;1.0;-0.08135663717985153;-0.1186981201171875;-0.474074724783771;-0.4621279305873105
Indurated nodule;Generalized keratosis follicularis;0.6599090099334717;0.7240377;0.6104578765092743;0.5889964930725176;0.656988850480855;0.0029201594526166996;0.06704885637110425;-0.04653097397158068;-0.06799235740833742
Indurated nodule;Hypoplasia of the calcaneus;0.948519516736269;0.9260582;0.5163939935499875;0.5235579145596826;0.9999134918687169;-0.05139397513244792;-0.07385531868909045;-0.4835194983187294;-0.47635557730903433
Indurated nodule;2-hydroxyadipic aciduria;0.9350162297487259;0.8324672;0.5206995626456608;0.5535800147916499;1.0;-0.06498377025127411;-0.1675328016281128;-0.47930043735433925;-0.44641998520835013
Indurated nodule;Potter facies;0.8108272552490234;0.8819064;0.5605806137387452;0.5376782800372581;0.9998981869165328;-0.18907093166750932;-0.11799179672640825;-0.4393175731777875;-0.4622199068792746
Indurated nodule;Increased heart rate variability;0.8738988041877747;0.7327433;0.5402464049298328;0.5861171564032837;0.9999201345566091;-0.12602133036883445;-0.2671768117073354;-0.45967372962677633;-0.41380297815332545
Indurated nodule;Aplastic zygomatic arch;0.9906975254416466;0.9294383;0.5029611123260964;0.5224791691062973;0.9999134918687169;-0.009215966427070343;-0.07047519888852283;-0.4969523795426205;-0.4774343227624196
Indurated nodule;Testicular torsion;0.8858935087919235;0.7936847;0.5364005084703929;0.5661472407036933;0.9999201345566091;-0.11402662576468559;-0.20623541356356712;-0.4635196260862162;-0.43377289385291584
Indurated nodule;Abolished vibration sense;0.85980623960495;0.8455407;0.5447725470969607;0.5493635480330996;0.9999134918687169;-0.14010725226376697;-0.15437278952572986;-0.45514094477175626;-0.4505499438356173
Indurated nodule;Fractured metatarsal bone of digit 5;0.9531748071312904;0.94841665;0.5149103739457408;0.5164267840797307;1.0;-0.046825192868709564;-0.05158334970474243;-0.4850896260542592;-0.48357321592026925
Indurated nodule;Prolonged G2 phase of cell cycle;0.8787904158234596;0.8343922;0.538677312499503;0.5529585748204662;0.9999056439461368;-0.12111522812267717;-0.16551345396658357;-0.4612283314466338;-0.4469470691256706
Indurated nodule;Single naris;0.9345879182219505;0.8753389;0.520836189133163;0.5397843629373232;0.9999056439461368;-0.06531772572418626;-0.12456673193594392;-0.4790694548129738;-0.46012128100881355
Indurated nodule;Perifoveal ring of hyperautofluorescence surrounded by normal autofluorescence;0.8272795379161835;0.73988235;0.5552557238746594;0.5837613510761417;1.0;-0.17272046208381653;-0.26011765003204346;-0.4447442761253406;-0.4162386489238583
Indurated nodule;Asymmetry of the thorax;0.78110471367836;0.7258398;0.5702453118831738;0.5883998566825954;0.9999056439461368;-0.2188009302677768;-0.2740658502640384;-0.42966033206296295;-0.41150578726354137
Indurated nodule;Type 2 muscle fiber predominance;0.941887304186821;0.8843654;0.5185082729116157;0.5368901636265437;0.9999003561294039;-0.05801305194258288;-0.11553497631907061;-0.48139208321778815;-0.46301019250286013
Indurated nodule;Dependency on parenteral nutrition;1.0096328854560852;0.9232003;0.4969337099041603;0.52447019374429;0.9999134918687169;0.009719393587368286;-0.07671318259213611;-0.5029797819645566;-0.47544329812442687
Indurated nodule;Limited shoulder flexion;0.8732659071683884;0.79521585;0.5404494916548523;0.5656492346218727;1.0;-0.12673409283161163;-0.20478415489196777;-0.45955050834514766;-0.43435076537812733
Indurated nodule;Paroxysmal vertigo;0.8757828325033188;0.74680376;0.5396419469463614;0.581481824188788;0.9999134918687169;-0.12413065936539813;-0.25310973134015247;-0.46027154492235556;-0.4184316676799289
Indurated nodule;Long hallux;0.8787385150790215;0.8292904;0.5386939557842867;0.5546059990689212;0.9998836012415208;-0.1211450861624993;-0.17059321122687232;-0.46118964545723407;-0.4452776021725996
Indurated nodule;Broad medial eyebrow;0.8664661794900894;0.8824682;0.5426324798713006;0.5374982006707661;0.746656756368989;0.11980942312110043;0.13581146720278836;-0.2040242764976884;-0.20915855569822284
Indurated nodule;Myxoid subcutaneous tumors;0.5685302019119263;0.6164887;0.6420048524313446;0.625285284983202;0.6869180368823609;-0.11838783497043459;-0.07042934173770754;-0.04491318445101622;-0.061632751899158844
Indurated nodule;Bulbous tips of toes;0.8679511547088623;0.82453775;0.542155574061969;0.5561420045223915;0.9999134918687169;-0.13196233715985461;-0.17537573780987903;-0.4577579178067479;-0.44377148734632543
Indurated nodule;Absent internal genitalia;0.8220868110656738;0.80926925;0.5569346249728396;0.561085739049386;1.0;-0.17791318893432617;-0.1907307505607605;-0.44306537502716037;-0.43891426095061403
Indurated nodule;Hyperphalangy of the 2nd finger;0.8376946300268173;0.81423205;0.5518929641442334;0.5594772708915798;0.9999201345566091;-0.1622255045297918;-0.18568808318408103;-0.4480271704123757;-0.44044286366502927
Indurated nodule;Renal interstitial hemosiderin;0.8124583959579468;0.6591828;0.5600519425584738;0.6107037374139248;1.0;-0.18754160404205322;-0.3408172130584717;-0.4399480574415262;-0.3892962625860752
Indurated nodule;Abnormality of depressor anguli oris muscle;0.8165572285652161;0.7233572;0.5587242005900768;0.5892218889273135;1.0;-0.18344277143478394;-0.2766427993774414;-0.44127579940992323;-0.41077811107268647
Indurated nodule;Paroxysmal dyspnea;0.7501509338617325;0.6788108;0.5803810048918207;0.6040825522451364;1.0;-0.24984906613826752;-0.3211892247200012;-0.41961899510817935;-0.3959174477548636
Indurated nodule;Phenylpyruvic acidemia;0.9415100812911987;0.8554876;0.5186285512789459;0.5461613576723876;0.9999201345566091;-0.05841005326541038;-0.14443254948886008;-0.4812915832776632;-0.4537587768842215
Indurated nodule;Lateral ventricle dilatation;0.9636981040239334;0.79354835;0.5115577918545037;0.5661916200137975;0.9998579617208769;-0.03615985769694352;-0.20630961615508103;-0.48830016986637326;-0.4336663417070794
Indurated nodule;Neonatal unconjugated hyperbilirubinemia;0.8899131789803505;0.7398281;0.5351128913502632;0.5837792319207517;0.9999201345566091;-0.11000695557625861;-0.26009202481539817;-0.4648072432063459;-0.41614090263585746
Indurated nodule;High maternal circulating alpha-fetoprotein concentration;0.9837479740381241;0.89158714;0.5051734082918571;0.5345768377656615;1.0;-0.016252025961875916;-0.10841286182403564;-0.4948265917081429;-0.46542316223433855
Indurated nodule;Prominent nasolabial fold;0.8089324831962585;0.7571807;0.5611949433794177;0.5780722025806084;0.9998944404568447;-0.19096195726058618;-0.24271374969146386;-0.43869949707742706;-0.4218222378762363
Indurated nodule;Abnormality of inferior alveolar nerve;0.8088202923536301;0.6684787;0.5612313255027288;0.6075618698917293;1.0;-0.19117970764636993;-0.33152127265930176;-0.4387686744972712;-0.39243813010827067
Indurated nodule;Unilateral conductive hearing impairment;0.8955300599336624;0.69459164;0.5333146022666369;0.5987929634232465;0.9999201345566091;-0.1043900746229467;-0.3053284931305227;-0.46660553228997226;-0.4011271711333626
Indurated nodule;Macular hypopigmented whorls, streaks, and patches;0.8030649721622467;0.7667377;0.5630988041826237;0.574940064941345;0.41730404449774616;0.38576092766450054;0.34943365501092083;0.14579475968487754;0.1576360204435988
Indurated nodule;Delayed ossification of pubic rami;0.8961670622229576;0.80892485;0.5331107293638717;0.5611974223056684;0.9999134918687169;-0.10374642964575931;-0.19098863806698962;-0.4668027625048452;-0.43871606956304854
Indurated nodule;Hyperphenylalaninemia;0.9453153237700462;0.8024948;0.5174153602880464;0.5632839287346869;0.9999028053808913;-0.054587481610845034;-0.19740798144824356;-0.4824874450928449;-0.43661887664620436
Indurated nodule;Ureteropelvic junction obstruction;0.9416929483413696;0.7989675;0.5185702433778825;0.5644297010252879;0.9998847295244674;-0.05819178118309776;-0.20091724886498252;-0.4813144861465849;-0.4354550284991795
Indurated nodule;Cone-shaped epiphysis of the proximal phalanx of the 2nd toe;0.916906550526619;0.8887112;0.5264799982208381;0.5354978589722323;1.0;-0.08309344947338104;-0.11128878593444824;-0.47352000177916187;-0.46450214102776766
Indurated nodule;Difficulty walking;0.9114251881837845;0.847129;0.5282312353378826;0.5488519139631094;0.9998344221996177;-0.08840923401583323;-0.15270543488730082;-0.4716031868617351;-0.4509825082365083
Indurated nodule;Bilobate gallbladder;0.8970609679818153;0.75164616;0.5328246573427147;0.5798895678545204;0.9999134918687169;-0.10285252388690158;-0.24826733078931018;-0.46708883452600225;-0.4200239240141965
Indurated nodule;Histidinuria;0.8189931511878967;0.72534;0.5579356188098332;0.5885652938507361;0.9999090677057578;-0.1809159165178611;-0.2745690589701011;-0.4419734488959246;-0.41134377385502174
Indurated nodule;Widened interpedicular distance;0.8789875954389572;0.77616197;0.5386140828431034;0.5718586646512609;1.0;-0.12101240456104279;-0.22383803129196167;-0.4613859171568966;-0.4281413353487391
Absent leukocyte alkaline phosphatase;Hippocampal sclerosis;0.8562930822372437;0.7847808;0.5459022601644837;0.5690466025255342;0.9999201345566091;-0.14362705231936546;-0.2151393342140493;-0.4540178743921254;-0.4308735320310749
Absent leukocyte alkaline phosphatase;Decreased sensitivity to hypoxemia;0.9582680761814117;0.83033776;0.513287542653404;0.5542676696266677;0.9999600672783046;-0.04169199109689281;-0.16962230444566295;-0.4866725246249005;-0.4456923976516368
Absent leukocyte alkaline phosphatase;Decreased level of tissue plasminogen activator;0.7460112571716309;0.64502084;0.5817426204681386;0.6155120490052572;0.9999201345566091;-0.25390887738497825;-0.35489929200442405;-0.4181775140884705;-0.38440808555135186
Absent leukocyte alkaline phosphatase;Submandibular lymph node enlargement;0.9221776723861694;0.8276689;0.5247966887539182;0.5551299024506009;0.9999600672783046;-0.07778239489213512;-0.17229116202012584;-0.4751633785243864;-0.44483016482770366
Absent leukocyte alkaline phosphatase;Hepatic hemangioma;0.8292101472616196;0.73812485;0.5546319218208577;0.584340867789346;0.9999584729108851;-0.17074832564926556;-0.26183362549877576;-0.4453265510900274;-0.4156176051215391
Absent leukocyte alkaline phosphatase;Triangular epiphysis of the distal phalanx of the 2nd finger;0.8375881612300873;0.8029424;0.5519273099207835;0.5631386111734737;0.9999201345566091;-0.16233197332652183;-0.196977739346343;-0.44799282463582557;-0.43678152338313536
Absent leukocyte alkaline phosphatase;Acne inversa;1.0210156384855509;0.9037834;0.49331002199794405;0.5306741493867003;0.9999548690865008;0.021060769399050105;-0.09617148810124077;-0.5066448470885567;-0.46928071969980045
Absent leukocyte alkaline phosphatase;Dentin dysplasia;0.9012001305818558;0.8250098;0.5315003656628692;0.5559893596959609;0.9999201345566091;-0.09872000397475333;-0.17491031171115012;-0.46841976889373993;-0.44393077486064825
Absent leukocyte alkaline phosphatase;Aplasia of the inner ear;0.9004189223051071;0.72737;0.5317502643713408;0.5878934771312829;0.9999600672783046;-0.09954114497319744;-0.27259004355088756;-0.4682098029069638;-0.4120665901470216
Absent leukocyte alkaline phosphatase;Polycystic liver disease;0.8155703544616699;0.71355546;0.5590437850803875;0.5924734185165698;0.9999567459343585;-0.18438639147268854;-0.28640129072653375;-0.4409129608539709;-0.4074833274177887
Absent leukocyte alkaline phosphatase;Subungual hyperkeratosis;0.8275678902864456;0.78;0.5551625403530361;0.5706057384687673;0.9999556674707869;-0.17238777718434128;-0.2199556960810164;-0.44479312711775076;-0.4293499290020196
Absent leukocyte alkaline phosphatase;Broad humeral epiphyses;0.8786714598536491;0.7562124;0.5387154588936132;0.5783899733072524;0.9999201345566091;-0.12124867470295997;-0.24370772124560447;-0.46120467566299594;-0.4215301612493567
Absent leukocyte alkaline phosphatase;Autoimmune thrombocytopenia;0.6527649760246277;0.584639;0.6128793877018117;0.6363447312261209;0.9999509115718902;-0.3471859355472625;-0.4153118987583221;-0.3870715238700785;-0.3636061803457693
Absent leukocyte alkaline phosphatase;Adenomyosis;0.9928572848439217;0.8058505;0.5022736161813564;0.5621946968864225;0.9999600672783046;-0.007102782434382893;-0.19410956144944713;-0.4976864510969482;-0.437765370391882
Absent leukocyte alkaline phosphatase;Elevated leukocyte alkaline phosphatase;0.19940054416656494;0.27579153;0.7954854686552778;0.7577946776993327;0.493452701440124;-0.29405215727355904;-0.2176611755993647;0.3020327672151538;0.26434197625920874
Absent leukocyte alkaline phosphatase;Clasp-knife sign;0.8686057180166245;0.86330235;0.541945388689239;0.5436488694981725;0.9999201345566091;-0.13131441653998466;-0.13661778451235862;-0.4579747458673701;-0.4562712650584366
Absent leukocyte alkaline phosphatase;Keratosis pilaris;0.7369528710842133;0.65482175;0.5847274728515792;0.6121815488423795;0.9999506876445663;-0.26299781656035304;-0.3451289341426742;-0.41522321479298707;-0.3877691388021868
Absent leukocyte alkaline phosphatase;Lamina lucida cleavage;0.8969504460692406;0.81658435;0.5328600256506835;0.5587154238168484;0.9999548690865008;-0.1030044230172602;-0.1833705204079119;-0.4670948434358173;-0.4412394452696524
Absent leukocyte alkaline phosphatase;Abnormal central response of multifocal electroretinogram;1.0173730049282312;0.87138486;0.49446972256224286;0.541053178974609;0.9999201345566091;0.01745287037162213;-0.1285352754715261;-0.5054504119943662;-0.4588669555820001
Absent leukocyte alkaline phosphatase;Atypical or prolonged hepatitis;0.8152202665805817;0.7237723;0.5591571702824936;0.589084405323528;0.9999600672783046;-0.1847398006977229;-0.27618777990953014;-0.440802896995811;-0.41087566195477654
Absent leukocyte alkaline phosphatase;Cubitus varus;0.9795493315905333;0.9393471;0.5065101037741926;0.5193182771916175;0.9999201345566091;-0.02037080296607585;-0.06057304621966453;-0.4934100307824165;-0.4806018573649916
Absent leukocyte alkaline phosphatase;Nasal regurgitation;1.0417062938213348;0.8910981;0.4867206227370652;0.5347334482703832;0.9999584729108851;0.04174782091044971;-0.10886039084530286;-0.51323785017382;-0.46522502464050197
Absent leukocyte alkaline phosphatase;Moon facies;1.0040629487484694;0.9880857;0.4987067196881386;0.503792538333059;0.9999584729108851;0.0041044758375842205;-0.011872785750393189;-0.5012517532227465;-0.4961659345778261
Absent leukocyte alkaline phosphatase;Intestinal pseudo-obstruction;0.9575623832643032;0.8044186;0.5135123708782294;0.562659372865544;0.9999539510871024;-0.04239156782279918;-0.19553532763968418;-0.48644158020887296;-0.43729457822155837
Absent leukocyte alkaline phosphatase;Bilateral renal atrophy;0.8350006639957428;0.7072913;0.5527621994203853;0.5945566190378467;0.9999600672783046;-0.16495940328256176;-0.2926687622131495;-0.44719786785791926;-0.4054034482404578
Absent leukocyte alkaline phosphatase;Fractured left clavicle;0.8735677897930145;0.780558;0.5403526201965583;0.5704236711203421;0.9999201345566091;-0.12635234476359458;-0.2193621444824514;-0.45956751436005083;-0.429496463436267
Absent leukocyte alkaline phosphatase;Positive urine norcotinine test;0.9387052245438099;0.83700144;0.519522970832201;0.5521165999942752;0.726290173501319;0.21241505104249092;0.11071126940792175;-0.20676720266911797;-0.17417357350704377
Absent leukocyte alkaline phosphatase;Long fibula;0.8703174442052841;0.795815;0.5413958267868431;0.5654544231225405;0.9999567459343585;-0.12963930172907434;-0.204141754937044;-0.4585609191475154;-0.434502322811818
Absent leukocyte alkaline phosphatase;Fragmentation of the epiphysis of the distal phalanx of the hallux;0.7563925087451935;0.68930244;0.5783308651137472;0.6005626302525975;0.9999201345566091;-0.24352762581141563;-0.3106176900986013;-0.4215892694428619;-0.3993575043040116
Absent leukocyte alkaline phosphatase;Type II cryptotia;0.8711870610713959;0.8431468;0.5411166777225696;0.5501349531370192;0.9999201345566091;-0.12873307348521323;-0.15677333356173606;-0.45880345683403956;-0.4497851814195899
Absent leukocyte alkaline phosphatase;Increased variability in muscle fiber diameter;1.0195504613220692;0.9341551;0.49377649838043225;0.520974245515577;0.9999473166570552;0.019603144665014005;-0.06579221011256053;-0.5061708182766229;-0.47897307114147814
Absent leukocyte alkaline phosphatase;Widened proximal tibial metaphyses;0.8165431320667267;0.7473283;0.5587287651090119;0.5813092623951852;0.9999600672783046;-0.18341693521157787;-0.25263178587571666;-0.4412313021692926;-0.41865080488311934
Absent leukocyte alkaline phosphatase;Wide anterior fontanel;0.9249641671776772;0.8186931;0.5239071176426278;0.5580327344773817;0.9999476714516888;-0.07498350427401168;-0.18125457004559142;-0.4760405538090611;-0.44191493697430717
Absent leukocyte alkaline phosphatase;Increased circulating oleate level;0.8325663805007935;0.78878844;0.5535479870014095;0.5677408921165485;0.726290173501319;0.10627620699947449;0.062498264342003784;-0.17274218649990947;-0.15854928138477042
Absent leukocyte alkaline phosphatase;Lozenge-shaped umbilicus;0.8813670426607132;0.83723557;0.5378511846335305;0.5520410471079561;0.9999584729108851;-0.11859143025017194;-0.16272290295696668;-0.4621072882773546;-0.44791742580292904
Absent leukocyte alkaline phosphatase;Anti-myelin-associated glycoprotein antibody positivity;0.7901031374931335;0.67476225;0.5673128233039868;0.6054443315531819;0.9999201345566091;-0.20981699706347556;-0.3251578855636892;-0.4326073112526223;-0.3944758030034272
Absent leukocyte alkaline phosphatase;Fractured radius;0.9357288852334023;0.8367935;0.5204722421323158;0.5521836895562228;0.9999600672783046;-0.0642311820449023;-0.16316658497468517;-0.47948782514598876;-0.4477763777220818
Absent leukocyte alkaline phosphatase;Abnormal manual kinetic perimetry test;0.9591865092515945;0.7622395;0.5129949470017663;0.576413332965424;0.9999201345566091;-0.040733625305014565;-0.23768061877520652;-0.4869251875548428;-0.42350680159118514
Absent leukocyte alkaline phosphatase;Small radial epiphyses;0.9136948883533478;0.8302703;0.5275059893317904;0.5542894628559353;0.9999201345566091;-0.08622524620326133;-0.16964984418185325;-0.4724141452248187;-0.44563067170067383
Absent leukocyte alkaline phosphatase;Generalized keratosis follicularis;0.8418616354465485;0.75112253;0.5505492040599027;0.5800616414304947;0.9999600672783046;-0.1580984318317561;-0.24883753300324962;-0.44941086321840185;-0.4198984258478099
Absent leukocyte alkaline phosphatase;Hypoplasia of the calcaneus;0.8058785200119019;0.7087265;0.5621855970823373;0.5940789681465378;0.9999584729108851;-0.19407995289898328;-0.29123194760418347;-0.43777287582854785;-0.4058795047643473
Absent leukocyte alkaline phosphatase;2-hydroxyadipic aciduria;0.7862102091312408;0.7582873;0.5685807593554635;0.577709158361337;0.726290173501319;0.059920035629921875;0.03199713709896179;-0.1577094141458555;-0.148581015139982
Absent leukocyte alkaline phosphatase;Potter facies;0.846268892288208;0.8402691;0.5491289560027903;0.5510626538841656;0.9999552432134126;-0.15368635092520455;-0.15968615446829537;-0.45082628721062223;-0.4488925893292469
Absent leukocyte alkaline phosphatase;Increased heart rate variability;1.0275536347180605;0.92464;0.4912282955130187;0.5240105915328144;0.9999600672783046;0.02759356743975594;-0.07532006741181896;-0.5087317717652858;-0.4759494757454902
Absent leukocyte alkaline phosphatase;Aplastic zygomatic arch;0.8415649980306625;0.6982994;0.5506448322480828;0.5975542861055774;0.9999584729108851;-0.1583934748802226;-0.30165906495190076;-0.4493136406628023;-0.40240418680530776
Absent leukocyte alkaline phosphatase;Testicular torsion;0.9857108574360609;0.9247772;0.5045485301383206;0.5239667919457744;0.9999600672783046;-0.014249209842243649;-0.07518285751954601;-0.495411537139984;-0.4759932753325301
Absent leukocyte alkaline phosphatase;Abolished vibration sense;0.931102842092514;0.7950845;0.5219480337906386;0.5656919759278408;0.9999584729108851;-0.0688556308183711;-0.20487399643993787;-0.47801043912024654;-0.4342664969830443
Absent leukocyte alkaline phosphatase;Fractured metatarsal bone of digit 5;0.8185064643621445;0.8070572;0.5580931451455957;0.5618031761542943;0.9999201345566091;-0.18141367019446464;-0.1928629326942739;-0.4418269894110134;-0.4381169584023148
Absent leukocyte alkaline phosphatase;Prolonged G2 phase of cell cycle;0.863831639289856;0.85313797;0.5434788108154807;0.5469173292599994;0.851762385589393;0.012069253700462967;0.0013755843813101354;-0.30828357477391233;-0.3048450563293936
Absent leukocyte alkaline phosphatase;Single naris;0.9378601387143135;0.85228527;0.519792483795378;0.5471917415054592;0.9999567459343585;-0.06209660722004495;-0.14767148001181207;-0.48016426213898045;-0.4527650044288992
Absent leukocyte alkaline phosphatase;Perifoveal ring of hyperautofluorescence surrounded by normal autofluorescence;0.8960312679409981;0.73575735;0.5331541892459322;0.5851219763791269;0.9999201345566091;-0.10388886661561103;-0.26416278363497825;-0.46676594531067694;-0.4147981581774822
Absent leukocyte alkaline phosphatase;Asymmetry of the thorax;0.8949283510446548;0.7588741;0.5335071920958866;0.5775166684933042;0.9999567459343585;-0.10502839488970361;-0.24108262760626398;-0.46644955383847186;-0.4224400774410543
Absent leukocyte alkaline phosphatase;Type 2 muscle fiber predominance;0.9387312307953835;0.8879729;0.5195146771973849;0.5357343437273927;0.9999556674707869;-0.06122443667540345;-0.11198277614006791;-0.48044099027340204;-0.4642213237433942
Absent leukocyte alkaline phosphatase;Dependency on parenteral nutrition;0.8403956741094589;0.8300937;0.5510218368627959;0.5543465076579592;0.9999584729108851;-0.1595627988014262;-0.16986479109859876;-0.4489366360480892;-0.4456119652529259
Absent leukocyte alkaline phosphatase;Limited shoulder flexion;0.9587925598025322;0.81239074;0.513120450590914;0.560073860930584;0.9999201345566091;-0.04112757475407691;-0.1875293898704824;-0.48679968396569506;-0.43984627362602513
Absent leukocyte alkaline phosphatase;Paroxysmal vertigo;0.9842358287423849;0.8144468;0.505018099413987;0.5594076929082206;0.9999584729108851;-0.01572264416850022;-0.18551166600323132;-0.4949403734968981;-0.44055078000266457
Absent leukocyte alkaline phosphatase;Long hallux;0.8130241334438324;0.7617079;0.5598686198571547;0.5765875681348808;0.9999526340597648;-0.18692850061593236;-0.23824473210511388;-0.44008401420261;-0.423365065924884
Absent leukocyte alkaline phosphatase;Broad medial eyebrow;0.9160485714673996;0.87337637;0.5267540590429591;0.5404140448429127;0.9999600672783046;-0.08391149581090496;-0.1265836978019862;-0.4732060082353454;-0.4595460224353919
Absent leukocyte alkaline phosphatase;Myxoid subcutaneous tumors;0.9726301729679108;0.95044935;0.5087131746090787;0.5157789227814182;0.9999600672783046;-0.027329894310393787;-0.04951071978227184;-0.49124689266922583;-0.4841811444968863
Absent leukocyte alkaline phosphatase;Bulbous tips of toes;0.851916640996933;0.8770689;0.5473103928226484;0.5392294219343332;0.9999584729108851;-0.14804183191395215;-0.12288959569073132;-0.45264808008823676;-0.4607290509765519
Absent leukocyte alkaline phosphatase;Absent internal genitalia;0.8535091876983643;0.6492909;0.5467978798277695;0.6140593886702467;0.9999201345566091;-0.14641094685824485;-0.35062921525271507;-0.4531222547288396;-0.38586074588636243
Absent leukocyte alkaline phosphatase;Hyperphalangy of the 2nd finger;0.8314314037561417;0.7930373;0.5539144702387013;0.5663578880130922;0.9999600672783046;-0.1685286635221629;-0.20692277193681285;-0.4460455970396032;-0.4336021792652124
Absent leukocyte alkaline phosphatase;Renal interstitial hemosiderin;0.8486379683017731;0.82235456;0.5483659251968973;0.5568480198025286;0.9999201345566091;-0.15128216625483604;-0.17756557942660423;-0.4515542093597118;-0.4430721147540805
Absent leukocyte alkaline phosphatase;Abnormality of depressor anguli oris muscle;0.9942642319947481;0.831693;0.5018257616719877;0.5538299966574646;0.9999201345566091;-0.005655902561860993;-0.16822714091570945;-0.49809437288462144;-0.44609013789914453
Absent leukocyte alkaline phosphatase;Paroxysmal dyspnea;0.9247662201523781;0.7562834;0.5239703047433976;0.5783666691104592;0.9999201345566091;-0.07515391440423103;-0.24363673211367698;-0.47594982981321154;-0.4215534654461499
Absent leukocyte alkaline phosphatase;Phenylpyruvic acidemia;0.6843872964382172;0.5881151;0.6022100339047286;0.6351294257628257;0.8631450867506595;-0.17875779031244232;-0.27502999065843536;-0.2609350528459309;-0.22801566098783377
Absent leukocyte alkaline phosphatase;Lateral ventricle dilatation;0.919615738093853;0.7762426;0.5256147414251978;0.5718323362051085;0.9999488789551968;-0.0803331408613438;-0.22370626516277736;-0.474334137529999;-0.42811654275008826
Absent leukocyte alkaline phosphatase;Neonatal unconjugated hyperbilirubinemia;0.7397840917110443;0.67608154;0.5837937431128221;0.6050003511191939;0.8631450867506595;-0.12336099503961517;-0.18706354855028107;-0.2793513436378374;-0.25814473563146556
Absent leukocyte alkaline phosphatase;High maternal circulating alpha-fetoprotein concentration;0.750985860824585;0.672943;0.5801065649939066;0.6060569145716719;0.9999201345566091;-0.24893427373202415;-0.32697713853152366;-0.41981356956270255;-0.39386321998493723
Absent leukocyte alkaline phosphatase;Prominent nasolabial fold;0.9559597596526146;0.8309971;0.5140229794140924;0.5540547178448278;0.9999545338528789;-0.04399477420026432;-0.16895742443973194;-0.48593155443878655;-0.44589981600805106
Absent leukocyte alkaline phosphatase;Abnormality of inferior alveolar nerve;0.9760659318417311;0.815359;0.5076191780573154;0.5591122284111409;0.9999201345566091;-0.023854202714878037;-0.18456113816531272;-0.49230095649929373;-0.44080790614546816
Absent leukocyte alkaline phosphatase;Unilateral conductive hearing impairment;0.912881463766098;0.7426145;0.5277658893569347;0.5828610160172247;0.9999600672783046;-0.08707860351220653;-0.25734555960313366;-0.47219417792136986;-0.4170990512610798
Absent leukocyte alkaline phosphatase;Macular hypopigmented whorls, streaks, and patches;0.9780625365674496;0.8871368;0.5069834717000773;0.5360021802189141;0.9999600672783046;-0.021897530710854984;-0.11282325029984996;-0.49297659557822726;-0.46395788705939045
Absent leukocyte alkaline phosphatase;Delayed ossification of pubic rami;0.9310903772711754;0.80382264;0.521952010918793;0.5628528241677804;0.9999584729108851;-0.06886809563970975;-0.19613583630657605;-0.4780064619920922;-0.43710564874310476
Absent leukocyte alkaline phosphatase;Hyperphenylalaninemia;0.7141323685646057;0.582051;0.5922817669998177;0.6372509342378214;0.8497508587917271;-0.13561849022712136;-0.2676998796543064;-0.25746909179190935;-0.21249992455390565
Absent leukocyte alkaline phosphatase;Ureteropelvic junction obstruction;0.9558533057570457;0.7962342;0.5140568977301023;0.5653181076625081;0.9999528219730685;-0.044099516216022705;-0.20371863150904868;-0.4858959242429661;-0.43463471431056033
Absent leukocyte alkaline phosphatase;Cone-shaped epiphysis of the proximal phalanx of the 2nd toe;0.7722254395484924;0.7653344;0.5731449229855518;0.575399506282251;0.9999201345566091;-0.22769469500811668;-0.23458570719988914;-0.42677521157105736;-0.4245206282743581
Absent leukocyte alkaline phosphatase;Difficulty walking;0.9219119399785995;0.85848504;0.5248815321967566;0.5451973320219848;0.9999461221900431;-0.07803418221144354;-0.14146107914118444;-0.4750645899932865;-0.45474879016805825
Absent leukocyte alkaline phosphatase;Bilobate gallbladder;0.8771988525986671;0.789409;0.5391877360142989;0.5675388314463505;0.9999584729108851;-0.12275962031221799;-0.2105494911108058;-0.4607707368965862;-0.4324196414645346
Absent leukocyte alkaline phosphatase;Histidinuria;0.7230304479598999;0.71848404;0.5893301169720874;0.5908372363664824;0.8542775634790427;-0.1312471155191428;-0.1357935194040305;-0.26494744650695534;-0.26344032711256027
Absent leukocyte alkaline phosphatase;Widened interpedicular distance;0.9039388447999954;0.8185584;0.530624438194935;0.5580763360566761;0.9999201345566091;-0.09598128975661369;-0.18136173964770408;-0.4692956963616741;-0.44184379849993305
Hippocampal sclerosis;Decreased sensitivity to hypoxemia;0.899459719657898;0.7851816;0.5320571281147699;0.5689159695072565;0.9999201345566091;-0.10046041489871116;-0.21473855258257957;-0.4678630064418392;-0.43100416504935257
Hippocampal sclerosis;Decreased level of tissue plasminogen activator;0.8712626993656158;0.80292344;0.5410923991580808;0.5631447458351677;1.0;-0.12873730063438416;-0.19707655906677246;-0.45890760084191917;-0.4368552541648323
Hippocampal sclerosis;Submandibular lymph node enlargement;0.9428435266017914;0.8576338;0.5182033910606467;0.5454710628019084;0.9999201345566091;-0.057076607954817726;-0.14228630543978782;-0.4817167434959624;-0.45444907175470073
Hippocampal sclerosis;Hepatic hemangioma;0.8068134486675262;0.7120272;0.561882257788541;0.5929812669977603;0.9999134918687169;-0.19310004320119067;-0.28788629975293323;-0.43803123408017597;-0.4069322248709566
Hippocampal sclerosis;Triangular epiphysis of the distal phalanx of the 2nd finger;0.9593499787151814;0.8466239;0.5129428698374409;0.5490145884683046;1.0;-0.04065002128481865;-0.15337610244750977;-0.48705713016255914;-0.45098541153169536
Hippocampal sclerosis;Acne inversa;0.9641800448298454;0.88779646;0.5114042854883665;0.5357908617669973;0.9998962300503706;-0.03571618522052522;-0.11209976846818681;-0.4884919445620042;-0.46410536828337334
Hippocampal sclerosis;Dentin dysplasia;0.9074808061122894;0.78233707;0.5294919507753498;0.569843348004883;1.0;-0.09251919388771057;-0.21766293048858643;-0.47050804922465017;-0.430156651995117
Hippocampal sclerosis;Aplasia of the inner ear;0.8409498333930969;0.70699894;0.550843160032614;0.5946539475491746;0.9999201345566091;-0.15897030116351218;-0.29292119027407737;-0.4490769745239951;-0.40526618700743455
Hippocampal sclerosis;Polycystic liver disease;0.8682059645652771;0.7556124;0.5420737504411735;0.5785869390349117;0.9999056439461368;-0.1316996793808597;-0.244293270594086;-0.45783189350496334;-0.42131870491122514
Hippocampal sclerosis;Subungual hyperkeratosis;0.8880617469549179;0.7811415;0.5357058858514402;0.5702332953541577;0.9999003561294039;-0.11183860917448596;-0.21875883658289508;-0.4641944702779637;-0.4296670607752462
Hippocampal sclerosis;Broad humeral epiphyses;1.003404158167541;0.8543384;0.49891642070832576;0.5465310641701261;1.0;0.003404158167541027;-0.1456615924835205;-0.5010835792916742;-0.4534689358298739
Hippocampal sclerosis;Autoimmune thrombocytopenia;0.8549671322107315;0.7407348;0.5463287916326691;0.5834803527545989;0.9998726169824932;-0.14490548477176168;-0.259137801384959;-0.45354382534982407;-0.4163922642278943
Hippocampal sclerosis;Adenomyosis;0.9597281143069267;0.886316;0.512822406894895;0.5362651464293562;0.9999201345566091;-0.04019202024968238;-0.11360413314135642;-0.4870977276617141;-0.4636549881272529
Hippocampal sclerosis;Elevated leukocyte alkaline phosphatase;0.8922098278999329;0.83912635;0.5343774682489648;0.5514311554101863;0.9999201345566091;-0.10771030665667625;-0.1607937860611257;-0.4655426663076443;-0.44848897914642283
Hippocampal sclerosis;Clasp-knife sign;1.0823686718940735;0.99097025;0.4737514992473084;0.5028743059868142;1.0;0.08236867189407349;-0.009029746055603027;-0.5262485007526916;-0.49712569401318585
Hippocampal sclerosis;Keratosis pilaris;0.9232671931385994;0.83596724;0.5244488433187856;0.5524502777259426;0.9998710980331391;-0.07660390489453972;-0.1639038553153962;-0.4754222547143535;-0.44742082030719654
Hippocampal sclerosis;Lamina lucida cleavage;0.95036181807518;0.90470964;0.5158068197761436;0.530377954254931;0.9998962300503706;-0.049534411975190595;-0.09518659288530107;-0.484089410274227;-0.4695182757954397
Hippocampal sclerosis;Abnormal central response of multifocal electroretinogram;0.8578493744134903;0.7545233;0.5454017380528507;0.5789444905598062;1.0;-0.1421506255865097;-0.24547672271728516;-0.45459826194714925;-0.42105550944019376
Hippocampal sclerosis;Atypical or prolonged hepatitis;0.9119710177183151;0.82644415;0.5280568110552086;0.5555257139408758;0.9999201345566091;-0.08794911683829398;-0.17347598553927512;-0.4718633235014005;-0.4443944206157333
Hippocampal sclerosis;Cubitus varus;1.013858962804079;0.9354984;0.4955884138966733;0.5205457480395557;1.0;0.013858962804079056;-0.06450158357620239;-0.5044115861033267;-0.47945425196044433
Hippocampal sclerosis;Nasal regurgitation;0.9855455318465829;0.8791555;0.5046011603435838;0.5385602462614145;0.9999134918687169;-0.01436796002213403;-0.12075797524426624;-0.4953123315251331;-0.4613532456073024
Hippocampal sclerosis;Moon facies;0.9801649115979671;0.9432054;0.5063141188059223;0.5180880189094899;0.9999134918687169;-0.01974858027074977;-0.05670807566617175;-0.49359937306279467;-0.48182547295922706
Hippocampal sclerosis;Intestinal pseudo-obstruction;0.9602351523935795;0.83489716;0.5126608822672813;0.5527955941179633;0.9998912449978579;-0.03965609260427838;-0.16499408446776753;-0.4872303627305765;-0.44709565087989456
Hippocampal sclerosis;Bilateral renal atrophy;0.9161633923649788;0.82555705;0.5267173811147723;0.5558124594403112;0.9999201345566091;-0.08375674219163032;-0.17436308146746726;-0.4732027534418368;-0.4441076751162979
Hippocampal sclerosis;Fractured left clavicle;1.0033512176014483;0.8738541;0.4989332723100236;0.5402607442534768;1.0;0.0033512176014482975;-0.12614589929580688;-0.5010667276899764;-0.4597392557465232
Hippocampal sclerosis;Positive urine norcotinine test;0.8109918534755707;0.8026446;0.5605272579399694;0.5632352784022973;1.0;-0.18900814652442932;-0.19735538959503174;-0.4394727420600306;-0.43676472159770274
Hippocampal sclerosis;Long fibula;0.9604524150490761;0.88577586;0.5125916709732121;0.536438204770002;0.9999056439461368;-0.03945322889706071;-0.1141297798218387;-0.48731397297292467;-0.46346743917613475
Hippocampal sclerosis;Fragmentation of the epiphysis of the distal phalanx of the hallux;0.8411459028720856;0.6815479;0.5507799454876128;0.6031630080789965;1.0;-0.15885409712791443;-0.3184521198272705;-0.4492200545123872;-0.3968369919210035
Hippocampal sclerosis;Type II cryptotia;0.8112948089838028;0.7567856;0.5604290570480825;0.578201864670618;1.0;-0.1887051910161972;-0.2432144284248352;-0.43957094295191745;-0.42179813532938204
Hippocampal sclerosis;Increased variability in muscle fiber diameter;0.9858203437179327;0.89099544;0.504513676041167;0.5347663078442733;0.9998452077479463;-0.014024864030013573;-0.10884976488066722;-0.49533153170677924;-0.465078899903673
Hippocampal sclerosis;Widened proximal tibial metaphyses;0.9476643577218056;0.80533683;0.5166665665914342;0.5623613842427204;0.9999201345566091;-0.052255776834803536;-0.194583301556426;-0.48325356796517493;-0.4375587503138887
Hippocampal sclerosis;Wide anterior fontanel;0.9937398713082075;0.94807035;0.5019926738667444;0.5165371553706782;0.999848231156753;-0.006108359848545519;-0.05177788384764048;-0.49785555729000863;-0.4833110757860748
Hippocampal sclerosis;Increased circulating oleate level;1.0016726069152355;0.9689787;0.4994675924349359;0.5098759746632282;1.0;0.0016726069152355194;-0.031021296977996826;-0.5005324075650641;-0.4901240253367718
Hippocampal sclerosis;Lozenge-shaped umbilicus;0.9406445063650608;0.89355975;0.5189045518816947;0.5339452845344221;0.9999134918687169;-0.05926898550365611;-0.10635373797391101;-0.4810089399870222;-0.4659682073342948
Hippocampal sclerosis;Anti-myelin-associated glycoprotein antibody positivity;0.7414494156837463;0.7646036;0.583244868422878;0.575638830380774;1.0;-0.25855058431625366;-0.2353963851928711;-0.41675513157712196;-0.424361169619226
Hippocampal sclerosis;Fractured radius;1.035538423806429;0.8924303;0.4886853858224456;0.534306868072043;0.9999201345566091;0.0356182892498198;-0.10748982907565208;-0.5112347487341635;-0.46561326648456614
Hippocampal sclerosis;Abnormal manual kinetic perimetry test;0.8622874170541763;0.7801176;0.5439750267845919;0.5705673753306535;1.0;-0.13771258294582367;-0.21988242864608765;-0.45602497321540814;-0.4294326246693465
Hippocampal sclerosis;Small radial epiphyses;0.9642404168844223;0.8079281;0.5113850561470918;0.5615206910804447;1.0;-0.0357595831155777;-0.19207191467285156;-0.48861494385290816;-0.43847930891955533
Hippocampal sclerosis;Generalized keratosis follicularis;0.931768499314785;0.90792334;0.5217356487056121;0.5293504932746952;0.9999201345566091;-0.0681516352418241;-0.09199679375918479;-0.47818448585099704;-0.4705696412819139
Hippocampal sclerosis;Hypoplasia of the calcaneus;0.9539624601602554;0.7711203;0.5146593854977703;0.573506250877287;0.9999134918687169;-0.04595103170846149;-0.228793182039005;-0.48525410637094657;-0.4264072409914299
Hippocampal sclerosis;2-hydroxyadipic aciduria;0.8536660671234131;0.79140484;0.5467473995624541;0.5668890974256753;1.0;-0.14633393287658691;-0.2085951566696167;-0.4532526004375459;-0.4331109025743247
Hippocampal sclerosis;Potter facies;0.9554790891706944;0.8993236;0.5141761318039004;0.5321006733278127;0.9998981869165328;-0.04441909774583841;-0.1005746042673018;-0.48572205511263233;-0.46779751358872
Hippocampal sclerosis;Increased heart rate variability;0.9698250591754913;0.90206635;0.5096064401763323;0.5312232909633473;0.9999201345566091;-0.030095075381117775;-0.09785378457339378;-0.49031369438027683;-0.4686968435932618
Hippocampal sclerosis;Aplastic zygomatic arch;0.9628011137247086;0.8938751;0.5118435057507158;0.5338443231342958;0.9999134918687169;-0.03711237814400836;-0.10603836979840442;-0.4880699861180011;-0.46606916873442117
Hippocampal sclerosis;Testicular torsion;0.9167444109916687;0.8527131;0.5265317882905824;0.5470540634191559;0.9999201345566091;-0.08317572356494041;-0.14720702649386497;-0.47338834626602666;-0.45286607113745325
Hippocampal sclerosis;Abolished vibration sense;1.0837292075157166;0.9367585;0.47331692602784026;0.5201438268544494;0.8643545492165687;0.21937465829914782;0.0724039690024254;-0.3910376231887285;-0.34421072236211936
Hippocampal sclerosis;Fractured metatarsal bone of digit 5;0.9297227039933205;0.8654363;0.522388412963505;0.5429632813344893;1.0;-0.07027729600667953;-0.13456368446350098;-0.477611587036495;-0.45703671866551066
Hippocampal sclerosis;Prolonged G2 phase of cell cycle;0.9819093141704798;0.96144915;0.5057587582907808;0.5122741688819235;0.9999056439461368;-0.017996329775657016;-0.03845649767538484;-0.494146885655356;-0.48763147506421334
Hippocampal sclerosis;Single naris;0.9785274360328913;0.917598;0.5068354547327425;0.5262591403157142;0.9999056439461368;-0.021378207913245517;-0.08230763483663972;-0.4930701892133943;-0.4736465036304226
Hippocampal sclerosis;Perifoveal ring of hyperautofluorescence surrounded by normal autofluorescence;0.8695598393678665;0.75527287;0.5416390458179035;0.5786983920994451;1.0;-0.13044016063213348;-0.24472713470458984;-0.45836095418209655;-0.42130160790055493
Hippocampal sclerosis;Asymmetry of the thorax;0.9556461274623871;0.80764127;0.5141229092894889;0.5616137178915183;0.9999056439461368;-0.044259516483749706;-0.19226437616964753;-0.4857827346566479;-0.43829192605461853
Hippocampal sclerosis;Type 2 muscle fiber predominance;1.0480855703353882;0.93930954;0.4846879829117524;0.5193302497071187;0.9999003561294039;0.04818521420598432;-0.06059081871866778;-0.5152123732176515;-0.48057010642228515
Hippocampal sclerosis;Dependency on parenteral nutrition;0.9649413377046585;0.91650826;0.5111618061159805;0.5266072257066642;0.9999134918687169;-0.03497215416405841;-0.08340523447964832;-0.4887516857527364;-0.47330626616205274
Hippocampal sclerosis;Limited shoulder flexion;1.0254015065729618;0.8898237;0.49191357956584647;0.5351415508948423;1.0;0.025401506572961807;-0.11017632484436035;-0.5080864204341535;-0.4648584491051577
Hippocampal sclerosis;Paroxysmal vertigo;0.8675990700721741;0.7777744;0.5422686388208511;0.5713321466968595;0.9999134918687169;-0.13231442179654285;-0.22213909831021472;-0.45764485304786584;-0.4285813451718574
Hippocampal sclerosis;Long hallux;0.8926189094781876;0.7742335;0.5342464933356534;0.5724886286038213;0.9998836012415208;-0.1072646917633332;-0.22565008121054542;-0.4656371079058673;-0.42739497263769943
Hippocampal sclerosis;Broad medial eyebrow;1.043718833476305;1.0121052;0.48607942620499833;0.49614669735649086;0.9999201345566091;0.0437986989196959;0.012185091960114525;-0.5138407083516108;-0.5037734372001182
Hippocampal sclerosis;Myxoid subcutaneous tumors;0.8771843910217285;0.7904171;0.5391923743878326;0.5672106302700447;0.9999201345566091;-0.12273574353488059;-0.20950305939944358;-0.4607277601687765;-0.4327095042865644
Hippocampal sclerosis;Bulbous tips of toes;0.9778024964034557;0.89331794;0.5070662652169078;0.5340226953659724;0.9999134918687169;-0.022110995465261185;-0.10659555401776477;-0.49284722665180913;-0.46589079650274456
Hippocampal sclerosis;Absent internal genitalia;0.9794627502560616;0.91397655;0.5065376692583147;0.5274160036936362;1.0;-0.020537249743938446;-0.08602344989776611;-0.49346233074168533;-0.47258399630636383
Hippocampal sclerosis;Hyperphalangy of the 2nd finger;1.0062349122017622;0.89482325;0.49801535294797816;0.5335408274200046;0.9999201345566091;0.006314777645153091;-0.10509688140185447;-0.501904781608631;-0.46637930713660447
Hippocampal sclerosis;Renal interstitial hemosiderin;0.8400958180427551;0.7342909;0.5511185258076148;0.5856060667354552;1.0;-0.15990418195724487;-0.2657091021537781;-0.4488814741923852;-0.41439393326454477
Hippocampal sclerosis;Abnormality of depressor anguli oris muscle;1.0498083606362343;0.96608526;0.484138943568582;0.5107974620231908;1.0;0.04980836063623428;-0.03391474485397339;-0.515861056431418;-0.48920253797680924
Hippocampal sclerosis;Paroxysmal dyspnea;0.9397655390202999;0.8027528;0.5191848374069341;0.5632001620662926;1.0;-0.06023446097970009;-0.1972472071647644;-0.4808151625930659;-0.43679983793370736
Hippocampal sclerosis;Phenylpyruvic acidemia;0.9078333079814911;0.8267516;0.5293792644658407;0.5554263472117932;0.9999201345566091;-0.09208682657511802;-0.17316854478152366;-0.4705408700907684;-0.4444937873448159
Hippocampal sclerosis;Lateral ventricle dilatation;0.5641500651836395;0.6483897;0.6435521604852079;0.614365778364895;0.5190338878590747;0.045116177324564855;0.12935580921581546;0.12451827262613324;0.09533189050582036
Hippocampal sclerosis;Neonatal unconjugated hyperbilirubinemia;0.9540439136326313;0.9096003;0.514633430581207;0.5288144496822581;0.9999201345566091;-0.045876220923977806;-0.09031981707842918;-0.4852867039754021;-0.471105684874351
Hippocampal sclerosis;High maternal circulating alpha-fetoprotein concentration;0.8963226154446602;0.8495656;0.5330609465511498;0.548067232068931;1.0;-0.10367738455533981;-0.15043437480926514;-0.4669390534488502;-0.45193276793106896
Hippocampal sclerosis;Prominent nasolabial fold;1.0179292671382427;0.9323211;0.4942926312095295;0.5215593519418076;0.9998944404568447;0.018034826681397997;-0.06757336883208886;-0.5056018092473152;-0.47833508851503714
Hippocampal sclerosis;Abnormality of inferior alveolar nerve;1.0361442863941193;0.9560412;0.488492409779542;0.5139970209001319;1.0;0.03614428639411926;-0.04395878314971924;-0.511507590220458;-0.4860029790998681
Hippocampal sclerosis;Unilateral conductive hearing impairment;0.9335616379976273;0.8189179;0.5211635764986542;0.5579599888505848;0.9999201345566091;-0.06635849655898185;-0.1810022640350637;-0.4787565580579549;-0.44196014570602427
Hippocampal sclerosis;Macular hypopigmented whorls, streaks, and patches;0.7877373099327087;0.69648916;0.568083248387861;0.5981588620662048;0.9999201345566091;-0.21218282462390037;-0.3034309792640981;-0.43183688616874816;-0.4017612724904043
Hippocampal sclerosis;Delayed ossification of pubic rami;0.9861260950565338;0.8715368;0.5044163427913395;0.5410044176813931;0.9999134918687169;-0.013787396812183106;-0.12837670054410144;-0.4954971490773774;-0.45890907418732385
Hippocampal sclerosis;Hyperphenylalaninemia;0.8783294707536697;0.81811106;0.5388251299046112;0.5582211407613364;0.9999028053808913;-0.12157333462722153;-0.18179174333102555;-0.4610776754762801;-0.4416816646195548
Hippocampal sclerosis;Ureteropelvic junction obstruction;1.0239062514156103;0.88472974;0.4923896788210751;0.5367734167634819;0.9998847295244674;0.024021521891142927;-0.11515498652062217;-0.5074950507033923;-0.4631113127609855
Hippocampal sclerosis;Cone-shaped epiphysis of the proximal phalanx of the 2nd toe;0.9344840496778488;0.8129999;0.5208693225911949;0.5598764659232274;1.0;-0.06551595032215118;-0.1870000958442688;-0.4791306774088051;-0.4401235340767726
Hippocampal sclerosis;Difficulty walking;0.9239988625049591;0.8102046;0.5242152636163706;0.5607824597481061;0.7403726674076037;0.18362619509735545;0.06983195772209605;-0.21615740379123305;-0.1795902076594975
Hippocampal sclerosis;Bilobate gallbladder;0.9765619840472937;0.94424295;0.5074612354232166;0.5177572313197207;0.9999134918687169;-0.023351507821423256;-0.05567053761456653;-0.4924522564455003;-0.4821562605489962
Hippocampal sclerosis;Histidinuria;0.7751613706350327;0.6643324;0.5721854954107288;0.6089618994006154;0.9999090677057578;-0.22474769707072517;-0.33557667787421486;-0.427723572295029;-0.3909471683051424
Hippocampal sclerosis;Widened interpedicular distance;1.0499738901853561;0.93547535;0.4840861881783075;0.5205531129498342;1.0;0.04997389018535614;-0.06452465057373047;-0.5159138118216925;-0.4794468870501658
Decreased sensitivity to hypoxemia;Decreased level of tissue plasminogen activator;0.7787686288356781;0.6270159;0.5710075979843403;0.6216654071776464;0.9999201345566091;-0.221151505720931;-0.3729042458656606;-0.4289125365722688;-0.3782547273789627
Decreased sensitivity to hypoxemia;Submandibular lymph node enlargement;1.063580460846424;0.954756;0.4797480504170888;0.5144065223814869;0.9999600672783046;0.06362039356811955;-0.045204045778670765;-0.5202120168612158;-0.4855535448968177
Decreased sensitivity to hypoxemia;Hepatic hemangioma;0.8961894065141678;0.846241;0.5331035783102024;0.5491379420883311;0.9999584729108851;-0.10376906639671735;-0.153717475596432;-0.46685489460068275;-0.450820530822554
Decreased sensitivity to hypoxemia;Triangular epiphysis of the distal phalanx of the 2nd finger;0.8241342306137085;0.71323323;0.5562724692421825;0.5925804764156126;0.9999201345566091;-0.1757859039429006;-0.28668690205844016;-0.44364766531442656;-0.4073396581409965
Decreased sensitivity to hypoxemia;Acne inversa;0.8741478770971298;0.7899872;0.5401664858614109;0.5673505568515305;0.9999548690865008;-0.12580699198937095;-0.20996766262745536;-0.45978838322508986;-0.4326043122349703
Decreased sensitivity to hypoxemia;Dentin dysplasia;0.8852019906044006;0.7385744;0.5366220815626408;0.5841926104419914;0.9999201345566091;-0.11471814395220847;-0.26134574891360374;-0.4632980529939683;-0.41572752411461766
Decreased sensitivity to hypoxemia;Aplasia of the inner ear;0.8790558725595474;0.73754245;0.5385921887519354;0.5845329697180064;0.9999600672783046;-0.12090419471875713;-0.2624176168502955;-0.4613678785263692;-0.41542709756029816
Decreased sensitivity to hypoxemia;Polycystic liver disease;0.9281119927763939;0.83312637;0.522902418537811;0.5533671944387446;0.9999567459343585;-0.07184475315796457;-0.1668303797959002;-0.4770543273965474;-0.44658955149561386
Decreased sensitivity to hypoxemia;Subungual hyperkeratosis;0.9275028854608536;0.8395466;0.5230968106459775;0.5512956274401285;0.9999556674707869;-0.07245278200993333;-0.16040904662499222;-0.47685885682480944;-0.4486600400306584
Decreased sensitivity to hypoxemia;Broad humeral epiphyses;0.8940045088529587;0.8113711;0.5338029115839757;0.56040433265152;0.9999201345566091;-0.10591562570365043;-0.188549046528655;-0.46611722297263336;-0.4395158019050891
Decreased sensitivity to hypoxemia;Autoimmune thrombocytopenia;0.8108126074075699;0.76139444;0.5605853620342524;0.5766903044967909;0.9999509115718902;-0.18913830416432031;-0.2385564704441131;-0.43936554953763785;-0.42326060707509927
Decreased sensitivity to hypoxemia;Adenomyosis;0.8999109789729118;0.857337;0.53191275958325;0.5455665166690036;0.9999600672783046;-0.10004908830539272;-0.1426230692924647;-0.46804730769505454;-0.454393550609301
Decreased sensitivity to hypoxemia;Elevated leukocyte alkaline phosphatase;1.0271934755146503;0.96701145;0.4913429807242127;0.5105024841413272;0.9999600672783046;0.02723340823634579;-0.03294861555711315;-0.5086170865540919;-0.4894575831369774
Decreased sensitivity to hypoxemia;Clasp-knife sign;1.040490061044693;1.0228759;0.4871080890430429;0.4927177392201053;0.9999201345566091;0.040569926488083885;0.02295577048031716;-0.5128120455135662;-0.5072023953365038
Decreased sensitivity to hypoxemia;Keratosis pilaris;0.8579283505678177;0.78635395;0.545376341404151;0.568533934184372;0.9999506876445663;-0.1420223370767486;-0.2135967419124496;-0.45457434624041526;-0.43141675346019426
Decreased sensitivity to hypoxemia;Lamina lucida cleavage;0.8918829411268234;0.8109407;0.5344821311983992;0.5605438451005125;0.9999548690865008;-0.10807192795967735;-0.18901418619846977;-0.4654727378881016;-0.4394110239859883
Decreased sensitivity to hypoxemia;Abnormal central response of multifocal electroretinogram;0.9289860725402832;0.8439116;0.5226234773565723;0.5498884730643645;0.9999201345566091;-0.0709340620163259;-0.15600854636462302;-0.4772966572000368;-0.4500316614922446
Decreased sensitivity to hypoxemia;Atypical or prolonged hepatitis;0.9824730753898621;0.89714295;0.5055792790553302;0.53279843060065;0.9999600672783046;-0.017486991888442494;-0.10281712055818126;-0.4943807882229744;-0.46716163667765453
Decreased sensitivity to hypoxemia;Cubitus varus;0.8995278403162956;0.8561107;0.5320353342811421;0.5459609216959456;0.9999201345566091;-0.10039229424031348;-0.14380944253237815;-0.46788480027546697;-0.45395921286066354
Decreased sensitivity to hypoxemia;Nasal regurgitation;0.8215338885784149;0.76848376;0.557113488166793;0.5743686378904889;0.9999584729108851;-0.17842458433247022;-0.23147471493816785;-0.4428449847440922;-0.42558983502039627
Decreased sensitivity to hypoxemia;Moon facies;0.9680055230855942;0.9838921;0.5101858966024084;0.5051275344833861;0.9999584729108851;-0.031952949825290955;-0.016066389742855347;-0.4897725763084767;-0.49483093842749903
Decreased sensitivity to hypoxemia;Intestinal pseudo-obstruction;0.899100087583065;0.7747818;0.532172187660855;0.5723094892955878;0.9999539510871024;-0.10085386350403736;-0.22517212792883823;-0.46778176342624744;-0.4276444617915146
Decreased sensitivity to hypoxemia;Bilateral renal atrophy;0.7771658301353455;0.68801004;0.5715308453946015;0.600995532783438;0.9999600672783046;-0.2227942371429591;-0.31195003033296154;-0.428429221883703;-0.3989645344948666
Decreased sensitivity to hypoxemia;Fractured left clavicle;0.8943049609661102;0.81775963;0.5337067344413711;0.5583348910104571;0.9999201345566091;-0.10561517359049888;-0.1821605014923391;-0.46621340011523804;-0.44158524354615203
Decreased sensitivity to hypoxemia;Positive urine norcotinine test;0.920847162604332;0.93155104;0.525221513749455;0.5218050306139241;0.9999201345566091;-0.07907297195227714;-0.06836909533770652;-0.4746986208071541;-0.47811510394268497
Decreased sensitivity to hypoxemia;Long fibula;1.023972112685442;0.985797;0.49236870851802894;0.5045211138108134;0.9999567459343585;0.02401536675108351;-0.014159757923951966;-0.5075880374163295;-0.495435632123545
Decreased sensitivity to hypoxemia;Fragmentation of the epiphysis of the distal phalanx of the hallux;0.8642635941505432;0.73561805;0.5433400267534817;0.585167950667414;0.9999201345566091;-0.1356565404060659;-0.26430207968981834;-0.4565801078031274;-0.4147521838891951
Decreased sensitivity to hypoxemia;Type II cryptotia;0.7984784096479416;0.68829256;0.5645886200602361;0.6009008818866304;0.9999201345566091;-0.20144172490866752;-0.31162757159503074;-0.435331514496373;-0.39901925266997873
Decreased sensitivity to hypoxemia;Increased variability in muscle fiber diameter;0.803503543138504;0.763394;0.5629564206089974;0.5760350507372842;0.9999473166570552;-0.19644377351855113;-0.23655331851099803;-0.43699089604805774;-0.42391226591977094
Decreased sensitivity to hypoxemia;Widened proximal tibial metaphyses;0.9766732007265091;0.9284306;0.5074258243731066;0.5228007330478653;0.9999600672783046;-0.02328686655179546;-0.07152945042268322;-0.492534242905198;-0.4771593342304392
Decreased sensitivity to hypoxemia;Wide anterior fontanel;0.9591538608074188;1.0143132;0.5130053479975464;0.49544382365530437;0.9999476714516888;-0.04079381064427001;0.014365549526094368;-0.48694232345414246;-0.5045038477963845
Decreased sensitivity to hypoxemia;Increased circulating oleate level;0.8875908404588699;0.85318196;0.535856732095077;0.5469031787271904;0.9999201345566091;-0.11232929409773917;-0.14673817635806174;-0.4640634024615321;-0.4530169558294187
Decreased sensitivity to hypoxemia;Lozenge-shaped umbilicus;0.8553782850503922;0.8577537;0.5461965231043477;0.5454325019302728;0.9999584729108851;-0.14458018786049298;-0.14220477885342053;-0.4537619498065374;-0.4545259709806123
Decreased sensitivity to hypoxemia;Anti-myelin-associated glycoprotein antibody positivity;0.9368682131171227;0.8627149;0.5201088447232863;0.5438376542053676;0.9999201345566091;-0.06305192143948646;-0.13720524789126487;-0.4798112898333228;-0.45608248035124155
Decreased sensitivity to hypoxemia;Fractured radius;0.8489914983510971;0.7551482;0.5482520845388069;0.5787393089591031;0.9999600672783046;-0.15096856892720745;-0.24481189489976452;-0.45170798273949764;-0.42122075831920147
Decreased sensitivity to hypoxemia;Abnormal manual kinetic perimetry test;0.8797368332743645;0.7830324;0.5383738384241775;0.5696166025268601;0.9999201345566091;-0.12018330128224464;-0.21688771725924583;-0.4615462961324316;-0.430303532029749
Decreased sensitivity to hypoxemia;Small radial epiphyses;0.7771411836147308;0.61606145;0.5715388929943523;0.625432565855172;0.9999201345566091;-0.22277895094187827;-0.3838586855057058;-0.42838124156225676;-0.37448756870143707
Decreased sensitivity to hypoxemia;Generalized keratosis follicularis;0.9368495866656303;0.84587157;0.5201147855612298;0.5492569490443064;0.9999600672783046;-0.06311048061267421;-0.1540884995521693;-0.47984528171707475;-0.4507031182339981
Decreased sensitivity to hypoxemia;Hypoplasia of the calcaneus;0.7944722920656204;0.59318405;0.5658910683712288;0.6333609657022982;0.9999584729108851;-0.2054861808452647;-0.40677441901302747;-0.4340674045396563;-0.36659750720858697
Decreased sensitivity to hypoxemia;2-hydroxyadipic aciduria;0.773091584444046;0.693729;0.5728618071313573;0.5990813758648336;0.9999201345566091;-0.2268285501125631;-0.3061911511543569;-0.42705832742525185;-0.40083875869177554
Decreased sensitivity to hypoxemia;Potter facies;0.9866273738443851;1.0032268;0.5042567659868753;0.49897288747327895;0.9999552432134126;-0.013327869369027412;0.003271513836147988;-0.49569847722653726;-0.5009823557401336
Decreased sensitivity to hypoxemia;Increased heart rate variability;0.8111694902181625;0.8625041;0.5604696775358129;0.5439053793380975;0.9999600672783046;-0.18879057706014202;-0.1374559426368861;-0.43949038974249166;-0.4560546879402071
Decreased sensitivity to hypoxemia;Aplastic zygomatic arch;0.8989627063274384;0.8032159;0.5322161420969307;0.5630497918681944;0.9999584729108851;-0.10099576658344678;-0.19674255198574475;-0.46774233081395444;-0.43690868104269076
Decreased sensitivity to hypoxemia;Testicular torsion;0.9182872399687767;0.89106125;0.5260390113250866;0.5347452459908285;0.9999600672783046;-0.08167282730952785;-0.10889882088319347;-0.473921055953218;-0.46521482128747604
Decreased sensitivity to hypoxemia;Abolished vibration sense;0.7364658713340759;0.65430796;0.5848881592574882;0.6123558014932269;0.9999584729108851;-0.2634926015768092;-0.3456505114469569;-0.41507031365339697;-0.38760267141765825
Decreased sensitivity to hypoxemia;Fractured metatarsal bone of digit 5;0.8809070438146591;0.780584;0.5379986522619917;0.570415202085361;0.9999201345566091;-0.11901309074194999;-0.21933615685732932;-0.4619214822946174;-0.4295049324712481
Decreased sensitivity to hypoxemia;Prolonged G2 phase of cell cycle;0.9117868840694427;0.8794873;0.5281156515188448;0.5384538497611666;0.9999567459343585;-0.08816986186491571;-0.12046946985708795;-0.4718410944155137;-0.46150289617319185
Decreased sensitivity to hypoxemia;Single naris;1.01985496096313;0.99116427;0.4936795543154524;0.5028125436713929;0.9999567459343585;0.019898215028771538;-0.00879247887121759;-0.506277191618906;-0.4971442022629655
Decreased sensitivity to hypoxemia;Perifoveal ring of hyperautofluorescence surrounded by normal autofluorescence;0.8467904776334763;0.7815188;0.5489609397841358;0.5701102387281486;0.9999201345566091;-0.15312965692313285;-0.2184013176086721;-0.45095919477247326;-0.4298098958284605
Decreased sensitivity to hypoxemia;Asymmetry of the thorax;0.7471573352813721;0.7665418;0.5813655023618747;0.5750042088400107;0.9999567459343585;-0.2527994106529864;-0.23341496689306818;-0.4185912435724838;-0.42495253709434777
Decreased sensitivity to hypoxemia;Type 2 muscle fiber predominance;0.8744820952415466;0.79291487;0.5400592505666943;0.5663977209833223;0.9999556674707869;-0.12547357222924027;-0.20704080006966386;-0.45989641690409255;-0.4335579464874646
Decreased sensitivity to hypoxemia;Dependency on parenteral nutrition;0.8072270750999451;0.80834115;0.56174807411977;0.5613867064416563;0.9999584729108851;-0.19273139781094006;-0.19161732739544324;-0.4382103987911151;-0.4385717664692288
Decreased sensitivity to hypoxemia;Limited shoulder flexion;0.9142564609646797;0.7460973;0.5273265701149645;0.581714295277495;0.9999201345566091;-0.08566367359192939;-0.2538228082779226;-0.4725935644416446;-0.41820583927911414
Decreased sensitivity to hypoxemia;Paroxysmal vertigo;0.7919803112745285;0.6890678;0.5667018118790574;0.6006412183946102;0.9999584729108851;-0.20797816163635663;-0.31089069193935803;-0.4332566610318277;-0.399317254516275
Decreased sensitivity to hypoxemia;Long hallux;1.01493252068758;0.9918924;0.49524665437803184;0.5025807586302242;0.9999526340597648;0.014979886627815353;-0.008060236656047715;-0.5047059796817329;-0.49737187542954053
Decreased sensitivity to hypoxemia;Broad medial eyebrow;1.0757371634244919;1.0590183;0.47586900482020067;0.48120296900273773;0.9999600672783046;0.07577709614618733;0.05905818700178578;-0.5240910624581039;-0.5187570982755668
Decreased sensitivity to hypoxemia;Myxoid subcutaneous tumors;0.8566538691520691;0.75937676;0.5457862166622034;0.5773518125921225;0.9999600672783046;-0.14330619812623546;-0.2405833029808192;-0.45417385061610116;-0.422608254686182
Decreased sensitivity to hypoxemia;Bulbous tips of toes;0.8487017452716827;0.82769114;0.5483453878337257;0.555122718145872;0.9999584729108851;-0.1512567276392024;-0.1722673351202052;-0.45161308507715947;-0.44483575476501314
Decreased sensitivity to hypoxemia;Absent internal genitalia;0.9331861287355423;0.8186805;0.5212833709918094;0.5580368148439514;0.9999201345566091;-0.06673400582106681;-0.1812396097305593;-0.47863676356479967;-0.4418833197126577
Decreased sensitivity to hypoxemia;Hyperphalangy of the 2nd finger;0.8243372738361359;0.7343033;0.5562068165142604;0.5856019732639401;0.9999600672783046;-0.1756227934421687;-0.26565677166596935;-0.44375325076404415;-0.4143580940143644
Decreased sensitivity to hypoxemia;Renal interstitial hemosiderin;0.8711674809455872;0.79983747;0.5411229626383802;0.5641470194425711;0.9999201345566091;-0.12875265361102195;-0.20008266450198264;-0.4587971719182289;-0.43577311511403805
Decreased sensitivity to hypoxemia;Abnormality of depressor anguli oris muscle;0.8738200664520264;0.6984563;0.5402716697352619;0.5975019205264411;0.9999201345566091;-0.12610006810458274;-0.3014638471725759;-0.45964846482134725;-0.402418214030168
Decreased sensitivity to hypoxemia;Paroxysmal dyspnea;0.4896377921104431;0.57011926;0.6704886624387294;0.6414444090183142;0.5071389135049151;-0.01750112139447202;0.06298034823672305;0.16334974893381426;0.1343054955133991
Decreased sensitivity to hypoxemia;Phenylpyruvic acidemia;0.7644769847393036;0.74868596;0.5756803040523377;0.5808626799997234;0.9999600672783046;-0.23548308253900097;-0.2512741112770228;-0.42427976322596683;-0.41909738727858115
Decreased sensitivity to hypoxemia;Lateral ventricle dilatation;0.8395684957504272;0.7742784;0.5512885730535431;0.5724739587023943;0.9999488789551968;-0.16038038320476955;-0.22567047662670559;-0.44866030590165373;-0.42747492025280254
Decreased sensitivity to hypoxemia;Neonatal unconjugated hyperbilirubinemia;0.7656596750020981;0.7930392;0.5752930021737401;0.5663572480567456;0.9999600672783046;-0.23430039227620647;-0.20692086458818004;-0.4246670651045644;-0.43360281922155897
Decreased sensitivity to hypoxemia;High maternal circulating alpha-fetoprotein concentration;0.912466511130333;0.92994034;0.5278984794064374;0.5223189651686833;0.9999201345566091;-0.08745362342627616;-0.0699797916534719;-0.4720216551501717;-0.47760116938792585
Decreased sensitivity to hypoxemia;Prominent nasolabial fold;0.9895533360540867;0.91806245;0.5033253368973751;0.5261108006595485;0.9999545338528789;-0.010401197798792228;-0.081892085351292;-0.4966291969555038;-0.4738437331933304
Decreased sensitivity to hypoxemia;Abnormality of inferior alveolar nerve;0.9613453708589077;0.8016941;0.5123072167678078;0.5635439467640107;0.9999201345566091;-0.03857476369770141;-0.198226039421874;-0.48761291778880134;-0.43637618779259846
Decreased sensitivity to hypoxemia;Unilateral conductive hearing impairment;0.8984083458781242;0.8324884;0.5323935131825384;0.5535731684867398;0.9999600672783046;-0.10155172140018032;-0.1674716496528773;-0.4675665540957662;-0.4463868987915648
Decreased sensitivity to hypoxemia;Macular hypopigmented whorls, streaks, and patches;0.8222990036010742;0.7116544;0.5568659882902518;0.5931051884860121;0.9999600672783046;-0.17766106367723034;-0.28830564261094616;-0.44309407898805275;-0.40685487879229243
Decreased sensitivity to hypoxemia;Delayed ossification of pubic rami;0.9844899196177721;0.81349576;0.5049372098859981;0.5597158196215053;0.9999584729108851;-0.01546855329311303;-0.18646271771526746;-0.495021263024887;-0.44024265328937984
Decreased sensitivity to hypoxemia;Hyperphenylalaninemia;1.032215490937233;0.9523788;0.48974371616452816;0.5151640261237085;0.9999561589935034;0.03225933194372954;-0.047577349541446545;-0.5102124428289753;-0.48479213286979495
Decreased sensitivity to hypoxemia;Ureteropelvic junction obstruction;0.9138210266828537;0.77448577;0.5274656881007045;0.5724062152946179;0.9999528219730685;-0.08613179529021475;-0.22546705508540366;-0.47248713387236396;-0.42754660667845057
Decreased sensitivity to hypoxemia;Cone-shaped epiphysis of the proximal phalanx of the 2nd toe;0.8125932514667511;0.69727904;0.5600082418833499;0.5978950225295805;0.9999201345566091;-0.187326883089858;-0.30264109851153465;-0.43991189267325925;-0.4020251120270286
Decreased sensitivity to hypoxemia;Difficulty walking;0.822300598025322;0.77357835;0.5568654725612541;0.5727027257378476;0.9999461221900431;-0.17764552416472112;-0.22636777641443884;-0.443080649628789;-0.42724339645219545
Decreased sensitivity to hypoxemia;Bilobate gallbladder;1.016733618453145;0.9185026;0.49467327520210325;0.5259702167389078;0.9999584729108851;0.016775145542259895;-0.08145584410763196;-0.5052851977087819;-0.4739882561719774
Decreased sensitivity to hypoxemia;Histidinuria;0.9481436610221863;0.8859173;0.5165137921557963;0.5363928766494811;0.9999574798349273;-0.05181381881274105;-0.11404017388857723;-0.48344368767913104;-0.46356460318544623
Decreased sensitivity to hypoxemia;Widened interpedicular distance;0.9871930610388517;0.94829273;0.5040766867297188;0.5164662799440383;0.9999201345566091;-0.01272707351775737;-0.05162740231783958;-0.49584344782689027;-0.48345385461257084
Decreased level of tissue plasminogen activator;Submandibular lymph node enlargement;1.1093436256051064;0.95496184;0.465125111914077;0.514340946194062;0.9999201345566091;0.10942349104849725;-0.044958298218565895;-0.5347950226425321;-0.4855791883625471
Decreased level of tissue plasminogen activator;Hepatic hemangioma;0.7139565646648407;0.69758606;0.5923401656794314;0.597792477947563;0.9999134918687169;-0.2859569272038762;-0.3023274322984044;-0.40757332618928555;-0.40212101392115396
Decreased level of tissue plasminogen activator;Triangular epiphysis of the distal phalanx of the 2nd finger;0.8453303724527359;0.7899013;0.5494313124617395;0.5673785301683957;1.0;-0.1546696275472641;-0.21009868383407593;-0.4505686875382605;-0.4326214698316043
Decreased level of tissue plasminogen activator;Acne inversa;0.9543668664991856;0.81201106;0.5145305235283556;0.5601969114583676;0.9998962300503706;-0.04552936355118509;-0.18788516695146318;-0.48536570652201505;-0.43969931859200306
Decreased level of tissue plasminogen activator;Dentin dysplasia;0.9272437244653702;0.79685116;0.5231795225793043;0.5651175301750986;1.0;-0.07275627553462982;-0.20314884185791016;-0.47682047742069567;-0.4348824698249014
Decreased level of tissue plasminogen activator;Aplasia of the inner ear;0.9743969701230526;0.81587785;0.5081505881638559;0.5589442040483293;0.9999201345566091;-0.02552316443355651;-0.18404227973254295;-0.49176954639275317;-0.44097593050827977
Decreased level of tissue plasminogen activator;Polycystic liver disease;0.8330408185720444;0.7552959;0.5533948125276508;0.5786908389649281;0.9999056439461368;-0.16686482537409242;-0.24460977125784333;-0.446510831418486;-0.42121480498120867
Decreased level of tissue plasminogen activator;Subungual hyperkeratosis;0.9302764683961868;0.8341961;0.5222117108201465;0.5530218798243461;0.9999003561294039;-0.06962388773321704;-0.16570426543116168;-0.47768864530925736;-0.4468784763050577
Decreased level of tissue plasminogen activator;Broad humeral epiphyses;0.9740496538579464;0.9364001;0.5082611791117282;0.5202581496185275;1.0;-0.025950346142053604;-0.06359988451004028;-0.4917388208882718;-0.47974185038147255
Decreased level of tissue plasminogen activator;Autoimmune thrombocytopenia;0.5088308453559875;0.5819408;0.6634303095558604;0.637289529455245;0.32024336570956036;0.1885874796464272;0.2616974640443154;0.3431869438463;0.3170461637456846
Decreased level of tissue plasminogen activator;Adenomyosis;0.9621573127806187;0.8252106;0.5120485783619326;0.5559244736890047;0.9999201345566091;-0.03776282177599044;-0.1747095632675466;-0.4878715561946765;-0.44399566086760445
Decreased level of tissue plasminogen activator;Elevated leukocyte alkaline phosphatase;0.753041684627533;0.685732;0.5794310759312422;0.6017590492345262;0.9999201345566091;-0.24687844992907615;-0.31418812752993674;-0.4204890586253669;-0.39816108532208294
Decreased level of tissue plasminogen activator;Clasp-knife sign;0.9081082716584206;0.88568014;0.5292913678024604;0.5364688783013913;1.0;-0.09189172834157944;-0.11431986093521118;-0.47070863219753956;-0.46353112169860866
Decreased level of tissue plasminogen activator;Keratosis pilaris;0.8466188013553619;0.7504144;0.5490162396623719;0.5802944114463182;0.9998710980331391;-0.15325229667777718;-0.2494567265426606;-0.4508548583707672;-0.4195766865868209
Decreased level of tissue plasminogen activator;Lamina lucida cleavage;0.8410713970661163;0.7676605;0.5508039665844597;0.5746380302719762;0.9998962300503706;-0.15882483298425432;-0.23223573143129106;-0.4490922634659109;-0.4252581997783944
Decreased level of tissue plasminogen activator;Abnormal central response of multifocal electroretinogram;0.9710675664246082;0.85574424;0.5092107649766051;0.5460788102955701;1.0;-0.02893243357539177;-0.14425575733184814;-0.4907892350233949;-0.45392118970442985
Decreased level of tissue plasminogen activator;Atypical or prolonged hepatitis;0.8793024271726608;0.82482123;0.538513128813739;0.556050340907421;0.9999201345566091;-0.12061770738394828;-0.17509890080721946;-0.4614070057428701;-0.4438697936491881
Decreased level of tissue plasminogen activator;Cubitus varus;0.974533325061202;0.9425351;0.5081071708820144;0.5183017188556919;1.0;-0.02546667493879795;-0.05746489763259888;-0.4918928291179856;-0.4816982811443081
Decreased level of tissue plasminogen activator;Nasal regurgitation;0.9907159693539143;0.84521294;0.5029552411929474;0.549469139581434;0.9999134918687169;-0.009197522514802658;-0.15470055546734973;-0.4969582506757695;-0.45044435228728297
Decreased level of tissue plasminogen activator;Moon facies;0.9615744799375534;0.93439144;0.5122342348613824;0.5208988698125514;0.9999134918687169;-0.038339011931163514;-0.06552205290768787;-0.4876792570073345;-0.4790146220561655
Decreased level of tissue plasminogen activator;Intestinal pseudo-obstruction;0.8294218629598618;0.7600176;0.5545635269828221;0.577141689016381;0.9998912449978579;-0.1704693820379961;-0.2398736711643923;-0.4453277180150358;-0.4227495559814769
Decreased level of tissue plasminogen activator;Bilateral renal atrophy;0.7989460080862045;0.70644605;0.5644366687354572;0.5948380235824673;0.9999201345566091;-0.20097412647040458;-0.2934740829590139;-0.43548346582115194;-0.4050821109741418
Decreased level of tissue plasminogen activator;Fractured left clavicle;0.8491037786006927;0.804739;0.5482159303356908;0.5625554039942846;1.0;-0.15089622139930725;-0.19526100158691406;-0.4517840696643092;-0.4374445960057154
Decreased level of tissue plasminogen activator;Positive urine norcotinine test;0.9414957240223885;0.8771879;0.5186331291788405;0.5391912464569714;1.0;-0.05850427597761154;-0.12281209230422974;-0.4813668708211595;-0.46080875354302864
Decreased level of tissue plasminogen activator;Long fibula;0.8756009042263031;0.85477686;0.5397003091927997;0.5463900054643049;0.9999056439461368;-0.12430473971983369;-0.14512878466268953;-0.46020533475333714;-0.45351563848183185
Decreased level of tissue plasminogen activator;Fragmentation of the epiphysis of the distal phalanx of the hallux;0.8562398850917816;0.8000092;0.5459193710135214;0.5640912309261903;1.0;-0.14376011490821838;-0.19999080896377563;-0.4540806289864786;-0.4359087690738097
Decreased level of tissue plasminogen activator;Type II cryptotia;0.9648869335651398;0.91879946;0.5111791341602914;0.5258754254011442;1.0;-0.03511306643486023;-0.08120054006576538;-0.48882086583970863;-0.4741245745988558
Decreased level of tissue plasminogen activator;Increased variability in muscle fiber diameter;0.9587028697133064;0.8781799;0.5131490241559162;0.5388731036168195;0.9998452077479463;-0.04114233803463985;-0.12166529994917918;-0.48669618359203004;-0.46097210413112677
Decreased level of tissue plasminogen activator;Widened proximal tibial metaphyses;0.8714651763439178;0.84535515;0.5410274087855318;0.5494233188782299;0.9999201345566091;-0.12845495821269126;-0.15456498147280784;-0.4588927257710773;-0.4504968156783792
Decreased level of tissue plasminogen activator;Wide anterior fontanel;0.9969318173825741;0.9510045;0.5009766343920458;0.5156019945144442;0.999848231156753;-0.0029164137741789498;-0.04884372599928233;-0.49887159676470727;-0.4842462366423088
Decreased level of tissue plasminogen activator;Increased circulating oleate level;0.9686249941587448;0.89463204;0.5099886137792219;0.5336020440070623;1.0;-0.03137500584125519;-0.10536795854568481;-0.4900113862207781;-0.46639795599293765
Decreased level of tissue plasminogen activator;Lozenge-shaped umbilicus;0.9591128677129745;0.9652822;0.5130184074144792;0.5110532396215064;0.9999134918687169;-0.04080062415574237;-0.034631290101749146;-0.4868950844542377;-0.4888602522472105
Decreased level of tissue plasminogen activator;Anti-myelin-associated glycoprotein antibody positivity;0.8762511014938354;0.7473084;0.5394917332981075;0.5813158216299754;1.0;-0.12374889850616455;-0.2526916265487671;-0.4605082667018925;-0.4186841783700246
Decreased level of tissue plasminogen activator;Fractured radius;0.9400978349149227;0.8970443;0.5190788729947723;0.532829995704236;0.9999201345566091;-0.059822299641686394;-0.10287583352358909;-0.4808412615618368;-0.46709013885237316
Decreased level of tissue plasminogen activator;Abnormal manual kinetic perimetry test;0.9543140679597855;0.82564056;0.5145473473716895;0.5557854649211122;1.0;-0.04568593204021454;-0.17435944080352783;-0.4854526526283105;-0.44421453507888775
Decreased level of tissue plasminogen activator;Small radial epiphyses;0.8919862359762192;0.8052192;0.5344490577413807;0.5623995673295087;1.0;-0.10801376402378082;-0.19478082656860352;-0.46555094225861926;-0.4376004326704913
Decreased level of tissue plasminogen activator;Generalized keratosis follicularis;0.9408844150602818;0.8686801;0.5188280522412507;0.5419214893859666;0.9999201345566091;-0.059035719496327355;-0.13124001504214378;-0.4810920823153584;-0.4579986451706425
Decreased level of tissue plasminogen activator;Hypoplasia of the calcaneus;0.8862026631832123;0.7331481;0.536301456371882;0.5859834665412171;0.9999134918687169;-0.11371082868550464;-0.26676539387677356;-0.46361203549683494;-0.4139300253274998
Decreased level of tissue plasminogen activator;2-hydroxyadipic aciduria;0.9159740209579468;0.8355788;0.5267778733500745;0.552575634634052;1.0;-0.08402597904205322;-0.1644212007522583;-0.47322212664992547;-0.447424365365948
Decreased level of tissue plasminogen activator;Potter facies;0.9947740249335766;0.9442758;0.501663487100516;0.5177467503686586;0.9998981869165328;-0.005124161982956177;-0.05562239050311113;-0.49823469981601676;-0.4821514365478742
Decreased level of tissue plasminogen activator;Increased heart rate variability;0.8960956260561943;0.85596;0.5331335918647381;0.5460094040809622;0.9999201345566091;-0.1038245085004148;-0.14396012307437034;-0.46678654269187103;-0.4539107304756469
Decreased level of tissue plasminogen activator;Aplastic zygomatic arch;0.9573511593043804;0.8575598;0.5135796664806194;0.5454948647837337;0.9999134918687169;-0.0425623325643365;-0.14235369172070667;-0.48633382538809755;-0.45441862708498326
Decreased level of tissue plasminogen activator;Testicular torsion;0.9230747893452644;0.83644265;0.5245102689050543;0.5522968793500124;0.9999201345566091;-0.07684534521134467;-0.16347748519213767;-0.47540986565155485;-0.44762325520659674
Decreased level of tissue plasminogen activator;Abolished vibration sense;0.9786232151091099;0.8265887;0.5068049603063525;0.5554789918259877;0.9999134918687169;-0.02129027675960704;-0.1733248015878026;-0.49310853156236445;-0.4444345000427292
Decreased level of tissue plasminogen activator;Fractured metatarsal bone of digit 5;0.8135465234518051;0.7807233;0.5596993614031898;0.5703697511667898;1.0;-0.18645347654819489;-0.21927672624588013;-0.44030063859681023;-0.4296302488332102
Decreased level of tissue plasminogen activator;Prolonged G2 phase of cell cycle;0.9231877624988556;0.93183;0.5244742017185915;0.5217160326426646;0.9999056439461368;-0.0767178814472812;-0.06807565498968537;-0.4754314422275453;-0.47818961130347215
Decreased level of tissue plasminogen activator;Single naris;1.047207459807396;0.96737665;0.48496781199616334;0.5103861719520122;0.9999056439461368;0.047301815861259144;-0.032528994566406566;-0.5149378319499734;-0.4895194719941246
Decreased level of tissue plasminogen activator;Perifoveal ring of hyperautofluorescence surrounded by normal autofluorescence;0.8835476487874985;0.7987329;0.5371522307362785;0.5645059214390415;1.0;-0.11645235121250153;-0.20126712322235107;-0.4628477692637215;-0.43549407856095845
Decreased level of tissue plasminogen activator;Asymmetry of the thorax;0.8650161921977997;0.7562147;0.5430982420756749;0.5783892348046149;0.9999056439461368;-0.1348894517483371;-0.2436909656586307;-0.45680740187046187;-0.4215164091415219
Decreased level of tissue plasminogen activator;Type 2 muscle fiber predominance;0.9776619989424944;0.8644187;0.5071109980395752;0.5432901942495623;0.9999003561294039;-0.022238357186909474;-0.1354816706931551;-0.4927893580898287;-0.4566101618798416
Decreased level of tissue plasminogen activator;Dependency on parenteral nutrition;0.8171833902597427;0.7719384;0.5585214585093122;0.5732387607771213;0.9999134918687169;-0.18273010160897418;-0.22797510828946277;-0.4413920333594047;-0.4266747310915956
Decreased level of tissue plasminogen activator;Limited shoulder flexion;0.9184912741184235;0.7754607;0.5259738478709692;0.5720877189220249;1.0;-0.08150872588157654;-0.22453927993774414;-0.47402615212903076;-0.4279122810779751
Decreased level of tissue plasminogen activator;Paroxysmal vertigo;1.007138168439269;0.83904827;0.49772783112045016;0.5514563378711499;0.9999134918687169;0.0072246765705521465;-0.16086522545788928;-0.5021856607482668;-0.448457153997567
Decreased level of tissue plasminogen activator;Long hallux;0.9662902541458607;0.9283441;0.510732178600682;0.5228283500119758;0.9998836012415208;-0.03359334709566009;-0.07153953033011329;-0.4891514226408388;-0.47705525122954495
Decreased level of tissue plasminogen activator;Broad medial eyebrow;1.0220448654145002;1.0120406;0.49298233291761895;0.4961672451539859;0.9999201345566091;0.02212473085789113;0.012120480525178001;-0.5069378016389902;-0.5037528894026232
Decreased level of tissue plasminogen activator;Myxoid subcutaneous tumors;0.8974731490015984;0.79674923;0.5326927581662646;0.5651506551641168;0.9999201345566091;-0.10244698555501075;-0.20317090035708518;-0.4672273763903445;-0.43476947939249233
Decreased level of tissue plasminogen activator;Bulbous tips of toes;0.9294809103012085;0.951814;0.5224655697145677;0.5153440208953043;0.9999134918687169;-0.07043258156750842;-0.048099496030551636;-0.4774479221541492;-0.48456947097341263
Decreased level of tissue plasminogen activator;Absent internal genitalia;1.0106093185022473;0.876277;0.4966228856797057;0.5394834090678893;1.0;0.010609318502247334;-0.12372297048568726;-0.5033771143202943;-0.4605165909321107
Decreased level of tissue plasminogen activator;Hyperphalangy of the 2nd finger;0.8608226031064987;0.79427886;0.5444458253215454;0.5659539938225558;0.9999201345566091;-0.1390975314501104;-0.20564127446444602;-0.4554743092350637;-0.43396614073405326
Decreased level of tissue plasminogen activator;Renal interstitial hemosiderin;0.7437471747398376;0.71202767;0.5824879645254474;0.592981118407678;1.0;-0.25625282526016235;-0.2879723310470581;-0.4175120354745526;-0.407018881592322
Decreased level of tissue plasminogen activator;Abnormality of depressor anguli oris muscle;0.917656421661377;0.7455225;0.52624048599951;0.5819034726392277;1.0;-0.08234357833862305;-0.25447750091552734;-0.47375951400049;-0.4180965273607723
Decreased level of tissue plasminogen activator;Paroxysmal dyspnea;0.9067479893565178;0.7696205;0.529726226422313;0.5739967600387648;1.0;-0.09325201064348221;-0.23037952184677124;-0.47027377357768696;-0.42600323996123524
Decreased level of tissue plasminogen activator;Phenylpyruvic acidemia;0.8688481450080872;0.75803137;0.541867548168337;0.5777931196496692;0.9999201345566091;-0.13107198954852195;-0.24188876630099387;-0.45805258638827206;-0.42212701490693993
Decreased level of tissue plasminogen activator;Lateral ventricle dilatation;0.8824477866292;0.8162398;0.5375047489734466;0.5588269969042308;0.9998579617208769;-0.11741017509167695;-0.1836181874937346;-0.46235321274743035;-0.44103096481664616
Decreased level of tissue plasminogen activator;Neonatal unconjugated hyperbilirubinemia;0.8432235419750214;0.91242445;0.5501102197230996;0.5279119258041305;0.9999201345566091;-0.15669659258158775;-0.0874956894043264;-0.4498099148335095;-0.4720082087524786
Decreased level of tissue plasminogen activator;High maternal circulating alpha-fetoprotein concentration;0.7500443756580353;0.7064167;0.5804160348866385;0.594847788433035;1.0;-0.24995562434196472;-0.2935832738876343;-0.4195839651133615;-0.405152211566965
Decreased level of tissue plasminogen activator;Prominent nasolabial fold;1.0297735538333654;0.88863754;0.4905213827064846;0.5355214416491152;0.9998944404568447;0.029879113376520716;-0.11125689773223535;-0.5093730577503601;-0.46437299880772953
Decreased level of tissue plasminogen activator;Abnormality of inferior alveolar nerve;1.0534799993038177;0.85601866;0.4829686623356715;0.5459905382422088;1.0;0.05347999930381775;-0.14398133754730225;-0.5170313376643285;-0.4540094617577912
Decreased level of tissue plasminogen activator;Unilateral conductive hearing impairment;1.0693858116865158;0.9257966;0.4778960497497037;0.5236414058261742;0.9999201345566091;0.0694656771299067;-0.07412350655825706;-0.5220240848069054;-0.47627872873043486
Decreased level of tissue plasminogen activator;Macular hypopigmented whorls, streaks, and patches;0.9450332820415497;0.8682836;0.5175052721917087;0.5420488019709169;0.9999201345566091;-0.054886852515059426;-0.13163650513918967;-0.4824148623649004;-0.45787133258569224
Decreased level of tissue plasminogen activator;Delayed ossification of pubic rami;0.9199464023113251;0.7664371;0.5255091474342124;0.5750384722212585;0.9999134918687169;-0.07996708955739185;-0.23347637858365222;-0.4744043444345045;-0.42487501964745844
Decreased level of tissue plasminogen activator;Hyperphenylalaninemia;0.8890435248613358;0.78112346;0.5353914171911944;0.5702391966627307;0.9999028053808913;-0.11085928051955551;-0.21877934604174942;-0.46451138818969684;-0.42966360871816056
Decreased level of tissue plasminogen activator;Ureteropelvic junction obstruction;0.8547161519527435;0.7725086;0.5464095363431056;0.5730523532275582;0.9998847295244674;-0.14516857757172386;-0.22737610830864707;-0.45347519318136176;-0.4268323762969092
Decreased level of tissue plasminogen activator;Cone-shaped epiphysis of the proximal phalanx of the 2nd toe;0.854670912027359;0.8022883;0.5464240911330459;0.56335099171854;1.0;-0.145329087972641;-0.19771170616149902;-0.4535759088669541;-0.43664900828146
Decreased level of tissue plasminogen activator;Difficulty walking;0.9979026075452566;0.9108221;0.5006676212430365;0.5284239738190769;0.9998344221996177;-0.001931814654361097;-0.08901232871283182;-0.49916680095658117;-0.4714104483805408
Decreased level of tissue plasminogen activator;Bilobate gallbladder;0.9478192254900932;0.90243727;0.5166172031998605;0.5311046601955336;0.9999134918687169;-0.05209426637862369;-0.09747622218106433;-0.48329628866885643;-0.4688088316731833
Decreased level of tissue plasminogen activator;Histidinuria;0.7865935266017914;0.7458458;0.5684558632126262;0.5817970757413443;0.9999090677057578;-0.21331554110396644;-0.25406327302802345;-0.4314532044931316;-0.4181119919644135
Decreased level of tissue plasminogen activator;Widened interpedicular distance;1.0132543742656708;0.96476454;0.49578087809511695;0.5112181235677804;1.0;0.013254374265670776;-0.035235464572906494;-0.504219121904883;-0.4887818764322196
Submandibular lymph node enlargement;Hepatic hemangioma;0.9835761412978172;0.8602515;0.5052281116533608;0.5446294115849115;0.8041807220209305;0.17939541927688674;0.056070764280491625;-0.2989526103675697;-0.259551310436019
Submandibular lymph node enlargement;Triangular epiphysis of the distal phalanx of the 2nd finger;0.970359206199646;0.8752112;0.5094363398030843;0.5398253415229495;0.9999201345566091;-0.029560928356963112;-0.1247089553001699;-0.49048379475352477;-0.46009479303365963
Submandibular lymph node enlargement;Acne inversa;0.7408095896244049;0.74710757;0.5834557188487872;0.5813818767592891;0.7948498897099963;-0.05404030008559135;-0.04774232430701164;-0.21139417086120904;-0.21346801295070716
Submandibular lymph node enlargement;Dentin dysplasia;0.6829925775527954;0.7574427;0.6026780148458624;0.5779862330061434;0.9999201345566091;-0.3169275570038137;-0.24247742177279563;-0.39724211971074674;-0.42193390155046573
Submandibular lymph node enlargement;Aplasia of the inner ear;0.8257387578487396;0.75600237;0.5557537213495091;0.5784589151594323;0.9999600672783046;-0.17422130942956493;-0.2439577007354884;-0.4442063459287955;-0.4215011521188723
Submandibular lymph node enlargement;Polycystic liver disease;0.9925761567428708;0.8448193;0.5023631044090343;0.5495959872816969;0.9999567459343585;-0.007380589191487652;-0.15513743860708795;-0.49759364152532415;-0.45036075865266156
Submandibular lymph node enlargement;Subungual hyperkeratosis;0.7283247709274292;0.6694804;0.5875776504834851;0.6072239840530829;0.9999556674707869;-0.2716308965433577;-0.3304752840746382;-0.4123780169873018;-0.39273168341770404
Submandibular lymph node enlargement;Broad humeral epiphyses;1.0765807926654816;0.87125385;0.47559968710155753;0.5410952498202546;0.9999201345566091;0.07666065810887246;-0.1286662864807424;-0.5243204474550516;-0.4588248847363545
Submandibular lymph node enlargement;Autoimmune thrombocytopenia;1.0490971766412258;0.8644517;0.4843655977896606;0.5432795949864188;0.7768603456063276;0.27223683103489826;0.0875913608031268;-0.29249474781666696;-0.2335807506199088
Submandibular lymph node enlargement;Adenomyosis;0.8265403360128403;0.7572358;0.5554946251298083;0.5780541261432878;0.9999600672783046;-0.17341973126546428;-0.24272424221650646;-0.44446544214849626;-0.4219059411350168
Submandibular lymph node enlargement;Elevated leukocyte alkaline phosphatase;0.9156414419412613;0.7840285;0.5268841137430618;0.5692918439486263;0.9999600672783046;-0.08431862533704326;-0.21593159676209972;-0.4730759535352428;-0.43066822332967825
Submandibular lymph node enlargement;Clasp-knife sign;0.9842643458396196;0.9479707;0.505009021013949;0.5165689254963614;0.9999201345566091;-0.01565578871698947;-0.05194944621356101;-0.49491111354266015;-0.48335120906024776
Submandibular lymph node enlargement;Keratosis pilaris;0.9166290387511253;0.9024984;0.5265686405356633;0.5310851056709169;0.9999506876445663;-0.08332164889344096;-0.09745226359137416;-0.47338204710890297;-0.46886558197364936
Submandibular lymph node enlargement;Lamina lucida cleavage;0.9176380038261414;0.8350533;0.5262463685601932;0.5527452137478415;0.9999548690865008;-0.08231686526035942;-0.16490154438709892;-0.47370850052630753;-0.4472096553386593
Submandibular lymph node enlargement;Abnormal central response of multifocal electroretinogram;0.8788700923323631;0.7598624;0.5386517624209562;0.5771925578390636;0.9999201345566091;-0.12105004222424598;-0.24005771161349387;-0.46126837213565286;-0.42272757671754546
Submandibular lymph node enlargement;Atypical or prolonged hepatitis;0.9835759159177542;0.8554268;0.5052281834037409;0.5461809296386996;0.8184791393567534;0.16509677656100075;0.0369476489733247;-0.31325095595301256;-0.27229820971805385
Submandibular lymph node enlargement;Cubitus varus;1.1072921752929688;1.0420686;0.4657819737224618;0.4866052003306707;0.9999201345566091;0.10737204073635964;0.04214846609799294;-0.5341381608341473;-0.5133149342259384
Submandibular lymph node enlargement;Nasal regurgitation;0.8228389471769333;0.8126675;0.5566913479328435;0.5599841900996382;0.9999584729108851;-0.17711952573395184;-0.18729098385906628;-0.44326712497804166;-0.43997428281124695
Submandibular lymph node enlargement;Moon facies;0.9434053376317024;0.9233856;0.5180242711072858;0.5244110355439445;0.9999584729108851;-0.05655313527918271;-0.07657285279369763;-0.48193420180359936;-0.4755474373669406
Submandibular lymph node enlargement;Intestinal pseudo-obstruction;0.8921690285205841;0.75449896;0.5343905312329613;0.5789524660079095;0.9999539510871024;-0.10778492256651828;-0.2454549924994559;-0.46556341985414107;-0.4210014850791929
Submandibular lymph node enlargement;Bilateral renal atrophy;1.0135067626833916;0.8464301;0.49570053317360097;0.5490770179694882;0.9999600672783046;0.013546695405087017;-0.15352994442597911;-0.5042595341047036;-0.4508830493088164
Submandibular lymph node enlargement;Fractured left clavicle;1.0832150876522064;0.9425335;0.4734811485834842;0.5183022379066042;0.9999201345566091;0.08329495309559731;-0.05738664151461692;-0.5264389859731249;-0.4816178966500049
Submandibular lymph node enlargement;Positive urine norcotinine test;0.8346570730209351;0.7830347;0.55287309092853;0.5696158445335887;0.9999201345566091;-0.16526306153567405;-0.21688545228274436;-0.4470470436280791;-0.4303042900230204
Submandibular lymph node enlargement;Long fibula;0.9644763059914112;0.8255948;0.5113099225748737;0.5558002675399776;0.9999567459343585;-0.03548043994294725;-0.1743619631050738;-0.4886468233594847;-0.4441564783943809
Submandibular lymph node enlargement;Fragmentation of the epiphysis of the distal phalanx of the hallux;0.9623953178524971;0.9073669;0.5119727650311263;0.5295283783601913;0.9999201345566091;-0.03752481670411201;-0.09255326272280784;-0.4879473695254828;-0.4703917561964178
Submandibular lymph node enlargement;Type II cryptotia;1.0130111761391163;0.9869505;0.49585829713980245;0.5041538932926402;0.9999201345566091;0.013091041582507179;-0.01296961785586448;-0.5040618374168067;-0.49576624126396895
Submandibular lymph node enlargement;Increased variability in muscle fiber diameter;0.893701083958149;0.7074218;0.5339000434818679;0.5945131961981589;0.9999473166570552;-0.1062462326989062;-0.2925255370244868;-0.46604727317518724;-0.40543412045889626
Submandibular lymph node enlargement;Widened proximal tibial metaphyses;0.9843103475868702;0.7769794;0.5049943763951181;0.5715917290262247;0.9999600672783046;-0.01564971969143436;-0.22298068047181652;-0.4949656908831864;-0.42836833825207987
Submandibular lymph node enlargement;Wide anterior fontanel;0.82654869556427;0.7390714;0.5554919232460076;0.584028707783459;0.9999476714516888;-0.17339897588741882;-0.2608762426759015;-0.44445574820568123;-0.4159189636682299
Submandibular lymph node enlargement;Increased circulating oleate level;0.9771629348397255;0.8196957;0.5072698956186557;0.5577082411080355;0.9999201345566091;-0.022757199716883614;-0.18022442342074485;-0.49265023893795346;-0.4422118934485736
Submandibular lymph node enlargement;Lozenge-shaped umbilicus;0.9472060427069664;0.8342574;0.5168126547575925;0.5530020781457408;0.9999584729108851;-0.05275243020391873;-0.16570104903316907;-0.4831458181532926;-0.44695639476514437
Submandibular lymph node enlargement;Anti-myelin-associated glycoprotein antibody positivity;0.7817173302173615;0.64547324;0.570045477385239;0.6153580182093444;0.6369582787135069;0.1447590515038546;0.00851496309252342;-0.06691280132826782;-0.021600260504162416
Submandibular lymph node enlargement;Fractured radius;1.1285173296928406;1.0190948;0.4589782062865968;0.4939215661929146;0.9999600672783046;0.12855726241453602;0.019134757512650036;-0.5409818609917078;-0.50603850108539
Submandibular lymph node enlargement;Abnormal manual kinetic perimetry test;0.9768896922469139;0.9138667;0.5073568943991303;0.5274510888327834;0.9999201345566091;-0.023030442309695198;-0.08605343581469627;-0.49256324015747877;-0.47246904572382575
Submandibular lymph node enlargement;Small radial epiphyses;1.1484531164169312;0.9744249;0.45257059430877533;0.508141688216665;0.9999201345566091;0.14853298186032204;-0.025495235932188942;-0.5473495402478338;-0.49177844633994405
Submandibular lymph node enlargement;Generalized keratosis follicularis;0.7670868486166;0.77143097;0.5748257891698718;0.5734046721885925;0.9999600672783046;-0.23287321866170452;-0.2285290980400233;-0.42513427810843274;-0.4265553950897121
Submandibular lymph node enlargement;Hypoplasia of the calcaneus;0.9960892582312226;0.93066525;0.501244830940381;0.5220876584844436;0.9999584729108851;-0.0038692146796625027;-0.06929321831798962;-0.49871364197050416;-0.4778708144264415
Submandibular lymph node enlargement;2-hydroxyadipic aciduria;0.958720289170742;0.84693253;0.5131434746381599;0.5489151736735447;0.9999201345566091;-0.04119984538586707;-0.1529876041534719;-0.4867766599184492;-0.4510049608830644
Submandibular lymph node enlargement;Potter facies;0.9132868349552155;0.90957224;0.527636365536368;0.5288234130714591;0.9999552432134126;-0.0866684082581971;-0.09038299952292184;-0.4723188776770446;-0.4711318301419535
Submandibular lymph node enlargement;Increased heart rate variability;0.9478856474161148;0.7901509;0.5165960316379095;0.5672972702595789;0.8658135241678199;0.08207212324829494;-0.07566264335422124;-0.3492174925299104;-0.298516253908241
Submandibular lymph node enlargement;Aplastic zygomatic arch;0.7344346046447754;0.81391656;0.5855586187805648;0.5595794805359108;0.9999584729108851;-0.26552386826610974;-0.1860419089231532;-0.4143998541303203;-0.44037899237497435
Submandibular lymph node enlargement;Testicular torsion;0.9996087197214365;0.9048387;0.5001245483841135;0.5303366907421545;0.9999600672783046;-0.0003513475568680535;-0.09512138605729625;-0.4998355188941911;-0.46962337653615005
Submandibular lymph node enlargement;Abolished vibration sense;0.9435610361397266;0.9133347;0.5179746313911051;0.5276210680880516;0.9999584729108851;-0.05639743677115849;-0.08662374562359265;-0.48198384151978;-0.4723374048228335
Submandibular lymph node enlargement;Fractured metatarsal bone of digit 5;1.0006743241101503;0.9389328;0.4997853559529801;0.5194503993038482;0.9999201345566091;0.0007541895535412291;-0.06098735810549827;-0.500134778603629;-0.48046973525276093
Submandibular lymph node enlargement;Prolonged G2 phase of cell cycle;0.8250331580638885;0.73473746;0.5559818251099445;0.585458632184477;0.9999567459343585;-0.1749235878704699;-0.2652192900894793;-0.4439749208244139;-0.41449811374988144
Submandibular lymph node enlargement;Single naris;0.8395221680402756;0.8187226;0.5513035131979962;0.5580231943671681;0.9999567459343585;-0.16043457789408289;-0.18123414022909723;-0.44865323273636226;-0.4419335515671904
Submandibular lymph node enlargement;Perifoveal ring of hyperautofluorescence surrounded by normal autofluorescence;0.9839279614388943;0.899915;0.5051161090386315;0.531911474843294;0.9999201345566091;-0.015992173117714836;-0.10000515462191673;-0.49480402551797764;-0.46800865971331507
Submandibular lymph node enlargement;Asymmetry of the thorax;0.8970410004258156;0.7827576;0.5328310471646541;0.5697062089057747;0.9999567459343585;-0.10291574550854288;-0.2171991656540545;-0.46712569876970433;-0.43025053702858373
Submandibular lymph node enlargement;Type 2 muscle fiber predominance;0.8481111228466034;0.7170321;0.548535586941403;0.5913190093647822;0.9999556674707869;-0.1518445446241835;-0.2829235925425032;-0.45142008052938387;-0.4086366581060047
Submandibular lymph node enlargement;Dependency on parenteral nutrition;1.0267477296292782;0.9152291;0.49148491768024394;0.5270158533352103;0.9999584729108851;0.02678925671839305;-0.08472939080334119;-0.5084735552306412;-0.47294261957567485
Submandibular lymph node enlargement;Limited shoulder flexion;0.9783335570245981;0.80916214;0.50689718269884;0.561120480698713;0.9999201345566091;-0.021586577532010987;-0.19075799466403098;-0.4930229518577691;-0.4387996538578961
Submandibular lymph node enlargement;Paroxysmal vertigo;0.8212545365095139;0.8020319;0.5572038618364015;0.563434263137222;0.9999584729108851;-0.17870393640137128;-0.19792659825420789;-0.44275461107448366;-0.43652420977366313
Submandibular lymph node enlargement;Long hallux;0.8869449645280838;0.8185452;0.5360636397423157;0.5580806094565811;0.9999526340597648;-0.11300766953168095;-0.1814074117773551;-0.463888994317449;-0.44187202460318364
Submandibular lymph node enlargement;Broad medial eyebrow;0.7489543557167053;0.776128;0.5807744258123949;0.5718697607081249;0.9999600672783046;-0.25100571156159923;-0.2238320732177882;-0.41918564146590964;-0.42809030657017966
Submandibular lymph node enlargement;Myxoid subcutaneous tumors;0.6297456622123718;0.59074664;0.6207294655815199;0.6342107707039739;0.9999600672783046;-0.37021440506593273;-0.40921342611924694;-0.3792306016967847;-0.36574929657433064
Submandibular lymph node enlargement;Bulbous tips of toes;1.0370090082287788;0.94349074;0.48821697595575897;0.517997047893926;0.9999584729108851;0.03705053531789371;-0.05646772927380017;-0.5117414969551262;-0.48196142501695916
Submandibular lymph node enlargement;Absent internal genitalia;0.8212499916553497;0.8400701;0.5572053321885269;0.5511268192814608;0.9999201345566091;-0.17867014290125938;-0.15985000611575217;-0.44271480236808225;-0.4487933152751483
Submandibular lymph node enlargement;Hyperphalangy of the 2nd finger;0.9271745830774307;0.82664275;0.5232015895051629;0.5554615140872292;0.9999600672783046;-0.07278548420087383;-0.17331731558457897;-0.4767584777731416;-0.44449855319107534
Submandibular lymph node enlargement;Renal interstitial hemosiderin;1.071794554591179;0.8816294;0.4771274054218111;0.5377670715522567;0.9999201345566091;0.07187442003456979;-0.11829072715075584;-0.522792729134798;-0.46215306300435244
Submandibular lymph node enlargement;Abnormality of depressor anguli oris muscle;0.7764778584241867;0.71905744;0.5717554999066137;0.5906470424189716;0.9999201345566091;-0.2234422761324224;-0.28086269379885764;-0.42816463464999543;-0.4092730921376375
Submandibular lymph node enlargement;Paroxysmal dyspnea;0.8875495120882988;0.7818313;0.5358699712647489;0.5700082958687074;0.9999201345566091;-0.11237062246831031;-0.21808881045611472;-0.4640501632918602;-0.4299118386879017
Submandibular lymph node enlargement;Phenylpyruvic acidemia;1.0568174086511135;0.91331977;0.48190471227709064;0.5276258506167629;0.9999600672783046;0.056857341372808956;-0.0866403007568507;-0.5180553550012139;-0.47233421666154163
Submandibular lymph node enlargement;Lateral ventricle dilatation;0.9500170014798641;0.7715877;0.5159167147224643;0.5733533985006949;0.9999488789551968;-0.049931877475332676;-0.22836114950115627;-0.48403216423273254;-0.4265954804545019
Submandibular lymph node enlargement;Neonatal unconjugated hyperbilirubinemia;1.0346306264400482;0.888964;0.48897452471757163;0.5354168818153342;0.9999600672783046;0.034670559161743664;-0.11099606991426036;-0.5109855425607329;-0.46454318546297035
Submandibular lymph node enlargement;High maternal circulating alpha-fetoprotein concentration;0.9973592907190323;0.8907345;0.500840564847596;0.5348498672682127;0.9999201345566091;-0.0025608438375768205;-0.10918564082415672;-0.4990795697090131;-0.4650702672883964
Submandibular lymph node enlargement;Prominent nasolabial fold;0.563873291015625;0.6105713;0.6436500545094656;0.6273275254218487;0.9999545338528789;-0.4360812428372539;-0.38938320902759205;-0.35630447934341336;-0.37262700843103025
Submandibular lymph node enlargement;Abnormality of inferior alveolar nerve;0.44220268726348877;0.577465;0.6883533539081663;0.638859647435101;0.9999201345566091;-0.5577174472931203;-0.422455136788207;-0.3115667806484428;-0.36106048712150807
Submandibular lymph node enlargement;Unilateral conductive hearing impairment;0.7733900845050812;0.70700574;0.572764250340116;0.5946516754545164;0.9999600672783046;-0.22656998277322338;-0.2929543280662684;-0.42719581693818853;-0.4053083918237882
Submandibular lymph node enlargement;Macular hypopigmented whorls, streaks, and patches;0.8583106249570847;0.82372457;0.5452534161484668;0.5564049336139494;0.9999600672783046;-0.1416494423212199;-0.17623549938813732;-0.45470665112983777;-0.4435551336643552
Submandibular lymph node enlargement;Delayed ossification of pubic rami;0.9004857242107391;0.8157115;0.5317288945158722;0.5589980644279496;0.9999584729108851;-0.099472748700146;-0.18424697465038709;-0.4682295783950129;-0.4409604084829355
Submandibular lymph node enlargement;Hyperphenylalaninemia;0.9814922455698252;0.8095288;0.5058915375837446;0.5610015793699867;0.9999561589935034;-0.018463913423678258;-0.1904273313262671;-0.4940646214097588;-0.4389545796235167
Submandibular lymph node enlargement;Ureteropelvic junction obstruction;1.0282982923090458;0.8553383;0.4909911711546243;0.5462093891158006;0.9999528219730685;0.02834547033597734;-0.14461454654048178;-0.5089616508184441;-0.4537434328572678
Submandibular lymph node enlargement;Cone-shaped epiphysis of the proximal phalanx of the 2nd toe;0.9930302435532212;0.8835671;0.5022185603435712;0.5371459889305952;0.9999201345566091;-0.006889891003387882;-0.11635303975375266;-0.49770157421303796;-0.46277414562601393
Submandibular lymph node enlargement;Difficulty walking;0.9389709234237671;0.8651522;0.5194382376190134;0.5430545563358931;0.9999461221900431;-0.060975198766275995;-0.13479394199518835;-0.48050788457102966;-0.45689156585415003
Submandibular lymph node enlargement;Bilobate gallbladder;0.9514990225434303;0.8529495;0.515444399746871;0.5469779843644549;0.9999584729108851;-0.048459450367454804;-0.1470089728269618;-0.4845140731640142;-0.45298048854643025
Submandibular lymph node enlargement;Histidinuria;1.0137280970811844;0.9004576;0.4956300737133804;0.5317378871890663;0.9999574798349273;0.013770617246257055;-0.09949985921419979;-0.5043274061215469;-0.468219592645861
Submandibular lymph node enlargement;Widened interpedicular distance;0.9938334813341498;0.78095406;0.5019628762948511;0.5702944582129694;0.9999201345566091;-0.006086653222459271;-0.21896607161791892;-0.49795725826175796;-0.4296256763436397
Hepatic hemangioma;Triangular epiphysis of the distal phalanx of the 2nd finger;0.9814169332385063;0.86196107;0.5059155143669097;0.5440799137851475;0.9999134918687169;-0.018496558630210602;-0.13795242514584705;-0.4939979775018072;-0.4558335780835694
Hepatic hemangioma;Acne inversa;1.0104914177209139;0.90530944;0.49666041675286965;0.5301861666349874;0.9999528219730685;0.010538595747845436;-0.09464338326762411;-0.5032924052201988;-0.46976665533808104
Hepatic hemangioma;Dentin dysplasia;0.9440570846199989;0.82677686;0.517816484388391;0.5554181696386347;0.9999134918687169;-0.05585640724871799;-0.1731366297242467;-0.4820970074803259;-0.44449532223008226
Hepatic hemangioma;Aplasia of the inner ear;0.9925664588809013;0.75053155;0.5023661914195543;0.5802558827931124;0.9999584729108851;-0.0073920140299837955;-0.2494269186887782;-0.49759228149133083;-0.4197025901177728
Hepatic hemangioma;Polycystic liver disease;0.4489338994026184;0.5921413;0.685778792810416;0.633724402512219;0.6905613626982415;-0.24162746329562312;-0.09842009206072933;-0.00478256988782555;-0.05683696018602258
Hepatic hemangioma;Subungual hyperkeratosis;0.858784481883049;0.7020013;0.5451010507768308;0.5963191198361129;0.9999536937290383;-0.1411692118459893;-0.29795242009698875;-0.4548526429522075;-0.40363457389292545
Hepatic hemangioma;Broad humeral epiphyses;0.9835999868810177;0.7836807;0.5052205203460517;0.5694052351090155;0.9999134918687169;-0.016313504987699234;-0.2162328144547765;-0.4946929715226652;-0.4305082567597014
Hepatic hemangioma;Autoimmune thrombocytopenia;0.6853692829608917;0.59179795;0.6018806775805361;0.6338441136871383;0.9999484800242363;-0.3145791970633446;-0.40815053214063035;-0.3980678024437002;-0.366104366337098
Hepatic hemangioma;Adenomyosis;1.0453490689396858;0.8656342;0.4855599907355094;0.5428997240955111;0.9999584729108851;0.04539059602880069;-0.1343242699537318;-0.5143984821753758;-0.457058748815374
Hepatic hemangioma;Elevated leukocyte alkaline phosphatase;0.7967680990695953;0.6695758;0.5651445319768266;0.6071917904255644;0.9999584729108851;-0.2031903738412898;-0.33038266247845105;-0.43481394093405856;-0.39276668248532076
Hepatic hemangioma;Clasp-knife sign;0.9014317244291306;0.89670783;0.5314262854522387;0.5329376709345566;0.9999134918687169;-0.09848176743958637;-0.10320565905545398;-0.46848720641647823;-0.46697582093416035
Hepatic hemangioma;Keratosis pilaris;0.8709810078144073;0.7733681;0.5411828184210933;0.572771438292691;0.9999482333076865;-0.1289672254932791;-0.226580113114205;-0.45876541488659317;-0.4271767950149955
Hepatic hemangioma;Lamina lucida cleavage;0.9417213723063469;0.8467547;0.5185611803373662;0.5489724498694731;0.9999528219730685;-0.05823144966672156;-0.15319809222529623;-0.48139164163570225;-0.4509803721035953
Hepatic hemangioma;Abnormal central response of multifocal electroretinogram;0.9465855807065964;0.83173347;0.5170104330191718;0.5538169277744178;0.9999134918687169;-0.053327911162120545;-0.16818002667401477;-0.4829030588495451;-0.4460965640942991
Hepatic hemangioma;Atypical or prolonged hepatitis;0.4512660503387451;0.48953664;0.6848899995162228;0.6705261035915938;0.7152708671182011;-0.264004816779456;-0.22573422408994182;-0.030380867601978334;-0.04474476352660728
Hepatic hemangioma;Cubitus varus;1.0657183304429054;0.9892893;0.4790661186832479;0.5034093938378827;0.9999134918687169;0.0658048385741885;-0.010624208116275513;-0.520847373185469;-0.4965040980308342
Hepatic hemangioma;Nasal regurgitation;1.0756391286849976;0.9135893;0.47590030001605665;0.527539720826003;0.8526023716255289;0.22303675705946868;0.0609869270995993;-0.3767020716094722;-0.3250626507995259
Hepatic hemangioma;Moon facies;0.9420844987034798;0.9555165;0.5184453980512467;0.5141642110372626;0.9999567459343585;-0.05787224723087869;-0.04444022877203546;-0.4815113478831118;-0.48579253489709584
Hepatic hemangioma;Intestinal pseudo-obstruction;0.7909757047891617;0.7116201;0.5670287754903713;0.5931166016037486;0.7306935736890814;0.060282131100080294;-0.019073481297113615;-0.16366479819871005;-0.13757697208533282
Hepatic hemangioma;Bilateral renal atrophy;0.7708259671926498;0.76501304;0.5736024916323357;0.5755047453580191;0.9999584729108851;-0.2291325057182353;-0.23494543379879407;-0.42635598127854946;-0.42445372755286603
Hepatic hemangioma;Fractured left clavicle;0.9738592021167278;0.886299;0.5083218223567147;0.5362705961130589;0.9999134918687169;-0.02605428975198909;-0.11361447777722522;-0.49159166951200217;-0.463642895755658
Hepatic hemangioma;Positive urine norcotinine test;1.0192800052464008;0.97780555;0.4938626034535972;0.5070652985544241;0.9999134918687169;0.019366513377683914;-0.022107937001926148;-0.5060508884151197;-0.49284819331429286
Hepatic hemangioma;Long fibula;0.9696386344730854;0.80552995;0.5096658082037935;0.5622987052139286;0.9999548690865008;-0.03031623461341537;-0.1944249170372454;-0.4902890608827073;-0.4376561638725722
Hepatic hemangioma;Fragmentation of the epiphysis of the distal phalanx of the hallux;1.0558119714260101;0.88648045;0.48222526158917767;0.5362124523815887;0.9999134918687169;0.05589847955729321;-0.11343304123852893;-0.5176882302795393;-0.46370103948712826
Hepatic hemangioma;Type II cryptotia;0.853400707244873;0.81019115;0.5468327870874742;0.5607868366369538;0.9999134918687169;-0.14651278462384387;-0.18972233738873645;-0.45308070478124274;-0.4391266552317631
Hepatic hemangioma;Increased variability in muscle fiber diameter;0.9518095031380653;0.8172908;0.5153454550037997;0.5584866887343607;0.9999445057306702;-0.048135002592604836;-0.18265372280220338;-0.4845990507268705;-0.4414578169963095
Hepatic hemangioma;Widened proximal tibial metaphyses;1.053822759538889;0.839301;0.48285940099762237;0.5513748324550705;0.9999584729108851;0.0538642866280038;-0.16065748280620984;-0.5170990719132628;-0.44858364045581467
Hepatic hemangioma;Wide anterior fontanel;0.9454563967883587;0.8009269;0.5173703882323484;0.5637931030756584;0.9999448992541466;-0.05448850246578796;-0.1990179755023156;-0.48257451102179827;-0.4361517961784882
Hepatic hemangioma;Increased circulating oleate level;0.7986237406730652;0.7183572;0.5645413915269173;0.5908793227625158;0.9999134918687169;-0.20128975119565173;-0.28155628647778674;-0.43537210034179963;-0.40903416910620116
Hepatic hemangioma;Lozenge-shaped umbilicus;0.8200856447219849;0.7575022;0.5575820626888203;0.5779667106103712;0.8526023716255289;-0.03251672690354401;-0.09510017340622956;-0.2950203089367086;-0.2746356610151577
Hepatic hemangioma;Anti-myelin-associated glycoprotein antibody positivity;0.9445855617523193;0.804796;0.5176480035328344;0.5625369053342544;0.9999134918687169;-0.05532793011639758;-0.1951175114152257;-0.48226548833588256;-0.43737658653446254
Hepatic hemangioma;Fractured radius;1.0240827724337578;0.87285376;0.4923334742539637;0.5405817581928616;0.9999584729108851;0.02412429952287265;-0.1271047169599574;-0.5076249986569215;-0.45937671471802355
Hepatic hemangioma;Abnormal manual kinetic perimetry test;1.0095226503908634;0.8920147;0.49696880042476976;0.5344399425676107;0.9999134918687169;0.0096091585221465;-0.10789880957577869;-0.5029446914439472;-0.4654735493011062
Hepatic hemangioma;Small radial epiphyses;1.0255752820521593;0.8862731;0.49185824713626713;0.5362788959803703;0.9999134918687169;0.02566179018344239;-0.11364040579770252;-0.5080552447324498;-0.46363459588834666
Hepatic hemangioma;Generalized keratosis follicularis;0.8602302521467209;0.78532726;0.544636237620191;0.5688684973301898;0.9999584729108851;-0.13972822076416425;-0.21463121718502454;-0.45532223529069416;-0.4310899755806953
Hepatic hemangioma;Hypoplasia of the calcaneus;1.0816200152039528;0.9371465;0.4739906092111672;0.5200200918147017;0.9999567459343585;0.08166326926959433;-0.0628102610825213;-0.5259661367231913;-0.4799366541196568
Hepatic hemangioma;2-hydroxyadipic aciduria;0.8232891857624054;0.755371;0.5565457351135235;0.5786661644028825;0.9999134918687169;-0.17662430610631152;-0.24454251732800647;-0.44336775675519347;-0.4212473274658344
Hepatic hemangioma;Potter facies;0.9483139291405678;0.93611383;0.516459521351679;0.5203494637992168;0.9999532306564473;-0.05163930151587948;-0.06383939627534374;-0.4834937093047682;-0.4796037668572305
Hepatic hemangioma;Increased heart rate variability;0.88176279515028;0.7002238;0.5377243198023959;0.59691200814434;0.8604559493242481;0.021306845826031928;-0.16023214580404543;-0.3227316295218522;-0.2635439411799081
Hepatic hemangioma;Aplastic zygomatic arch;1.0044578351080418;0.8242494;0.49858102231438306;0.5562352435692202;0.9999567459343585;0.004501089173683304;-0.1757073591469439;-0.5013757236199754;-0.4437215023651383
Hepatic hemangioma;Testicular torsion;0.9326853454113007;0.8245772;0.5214431349597708;0.5561292418672704;0.9999584729108851;-0.06727312749958447;-0.17538126057720593;-0.47851533795111434;-0.4438292310436147
Hepatic hemangioma;Abolished vibration sense;1.0924958437681198;0.97650427;0.4705155138067928;0.507479620928545;0.9999567459343585;0.09253909783376135;-0.023452479672304016;-0.5294412321275657;-0.4924771250058134
Hepatic hemangioma;Fractured metatarsal bone of digit 5;1.0026121297851205;0.8785558;0.49916853231985103;0.5387525593424102;0.9999134918687169;0.002698637916403568;-0.12135771717999622;-0.5007449595488659;-0.46116093252630674
Hepatic hemangioma;Prolonged G2 phase of cell cycle;0.875877782702446;0.8242099;0.539611487634587;0.5562480021642826;0.9999548690865008;-0.12407708638405479;-0.17574494057392753;-0.4603433814519138;-0.44370686692221817
Hepatic hemangioma;Single naris;1.0961534976959229;1.047875;0.46934603157959476;0.48475508142163715;0.9999548690865008;0.09619862860942208;0.04792017764354073;-0.530608837506906;-0.5151997876648636
Hepatic hemangioma;Perifoveal ring of hyperautofluorescence surrounded by normal autofluorescence;0.7855534255504608;0.68903;0.5687947837720269;0.6006538745332417;0.9999134918687169;-0.2143600663182561;-0.3108835002419774;-0.43111870809669006;-0.3992596173354752
Hepatic hemangioma;Asymmetry of the thorax;0.8438939899206161;0.6924358;0.5498941490897382;0.5995138831328938;0.9999548690865008;-0.15606087916588463;-0.30751906805729545;-0.45006071999676256;-0.400440985953607
Hepatic hemangioma;Type 2 muscle fiber predominance;0.9814725387841463;0.8643973;0.5058978115242162;0.5432970641681367;0.9999536937290383;-0.018481154944891998;-0.1355564063602639;-0.4940558822048221;-0.4566566295609016
Hepatic hemangioma;Dependency on parenteral nutrition;0.8273290395736694;0.8428607;0.5552397266530209;0.5502271706405211;0.8526023716255289;-0.025273332051859443;-0.009741672925577705;-0.297362644972508;-0.3023752009850078
Hepatic hemangioma;Limited shoulder flexion;1.0004587098956108;0.8737579;0.4998539881002162;0.540291613046249;0.9999134918687169;0.00054521802689389;-0.12615559306119128;-0.5000595037685007;-0.45962187882246797
Hepatic hemangioma;Paroxysmal vertigo;1.0166354663670063;0.81739986;0.4947045223309795;0.5584513648710114;0.9999567459343585;0.016678720432647842;-0.1825568865059527;-0.505252223603379;-0.441505381063347
Hepatic hemangioma;Long hallux;1.0015174206346273;0.823094;0.49951698982513826;0.5566088510053213;0.9999503740898522;0.0015670465447751303;-0.17685636373676383;-0.500433384264714;-0.4433415230845309
Hepatic hemangioma;Broad medial eyebrow;0.8645986318588257;0.78410363;0.5432323872015024;0.5692673363875064;0.9999584729108851;-0.13535984105205945;-0.21585484093761853;-0.4567260857093828;-0.43069113652337876
Hepatic hemangioma;Myxoid subcutaneous tumors;0.8676705807447433;0.7979398;0.5422456742015562;0.5647636828088887;0.693708343348085;0.1739622373966584;0.10423143402618262;-0.15146266914652873;-0.1289446605391963
Hepatic hemangioma;Bulbous tips of toes;0.989170229062438;0.9182963;0.5034472905420733;0.5260361177923094;0.9999567459343585;-0.010786516871920449;-0.08166046841131769;-0.4965094553922852;-0.47392062814204905
Hepatic hemangioma;Absent internal genitalia;1.0495587028563023;0.9011091;0.484218510372454;0.531529491541756;0.9999134918687169;0.04964521098758534;-0.09880439248059436;-0.5156949814962629;-0.4683840003269609
Hepatic hemangioma;Hyperphalangy of the 2nd finger;0.853899285197258;0.7566545;0.5466723574278358;0.5782448927018267;0.9999584729108851;-0.14605918771362714;-0.24330397194958142;-0.4532861154830493;-0.42171358020905847
Hepatic hemangioma;Renal interstitial hemosiderin;0.5909044742584229;0.53552383;0.6341557211021467;0.6537573656697502;0.9999134918687169;-0.40900901761029407;-0.4643896600243871;-0.36575777076657023;-0.34615612619896674
Hepatic hemangioma;Abnormality of depressor anguli oris muscle;1.0517290197312832;0.86551404;0.48352678928513904;0.5429383234966592;0.9999134918687169;0.05181552786256627;-0.1343994518754308;-0.5163867025835779;-0.45697516837205776
Hepatic hemangioma;Paroxysmal dyspnea;0.9750562272965908;0.8501314;0.5079406730323615;0.5478850776600259;0.9999134918687169;-0.024857264572126114;-0.14978209938977405;-0.49197281883635546;-0.452028414208691
Hepatic hemangioma;Phenylpyruvic acidemia;0.9036576375365257;0.81011033;0.5307143663471153;0.5608130209170226;0.9999584729108851;-0.0963008353743594;-0.1898481423292201;-0.4692441065637698;-0.43914545199386257
Hepatic hemangioma;Lateral ventricle dilatation;0.7514345049858093;0.6793548;0.5799591211160549;0.6038997073167671;0.9999462364511621;-0.24851173146535277;-0.3205914495782983;-0.41998711533510724;-0.396046529134395
Hepatic hemangioma;Neonatal unconjugated hyperbilirubinemia;0.6953809559345245;0.7084595;0.598529145333015;0.5941678224062366;0.9999584729108851;-0.3045775169763606;-0.2914989764127772;-0.4014293275778701;-0.4057906505046486
Hepatic hemangioma;High maternal circulating alpha-fetoprotein concentration;0.7504087388515472;0.6846532;0.5802962580697175;0.6021208316369692;0.9999134918687169;-0.24950475301716968;-0.31526026930783435;-0.4196172337989994;-0.39779266023174775
Hepatic hemangioma;Prominent nasolabial fold;1.0520550273358822;0.8852532;0.4834228778414107;0.5366056755584252;0.9999524555142131;0.05210257182166911;-0.11469926451995038;-0.5165295776728024;-0.4633467799557879
Hepatic hemangioma;Abnormality of inferior alveolar nerve;0.9988605454564095;0.82255036;0.5003626997245676;0.5567846881267646;0.9999134918687169;-0.001052946412307465;-0.17736313548062488;-0.4995507921441493;-0.4431288037419523
Hepatic hemangioma;Unilateral conductive hearing impairment;1.059560153633356;0.8779503;0.4810301873592667;0.5389467313004452;0.9999584729108851;0.05960168072247096;-0.12200816220379285;-0.5189282855516184;-0.4610117416104399
Hepatic hemangioma;Macular hypopigmented whorls, streaks, and patches;0.7914028763771057;0.7197508;0.5668897376091919;0.5904170945128024;0.9999584729108851;-0.20855559653377942;-0.28020765132046155;-0.4330687353016932;-0.4095413783980827
Hepatic hemangioma;Delayed ossification of pubic rami;0.9987699929624796;0.8163711;0.5003915234988421;0.5587844860355313;0.9999567459343585;-0.0011867529718788683;-0.18358566267477594;-0.4995652224355164;-0.44117225989882713
Hepatic hemangioma;Hyperphenylalaninemia;0.708605170249939;0.6179934;0.5941193383808567;0.6247668371801971;0.9999542297279059;-0.29134905947796697;-0.3819608153258979;-0.4058348913470492;-0.37518739254770883
Hepatic hemangioma;Ureteropelvic junction obstruction;0.949615053832531;0.832078;0.5160448200471158;0.5537056823728239;0.9999505803237132;-0.050335526491182225;-0.1678726002822093;-0.4839057602765974;-0.4462448979508893
Hepatic hemangioma;Cone-shaped epiphysis of the proximal phalanx of the 2nd toe;1.0559531971812248;0.94884336;0.48218023767834195;0.5162907702970507;0.9999134918687169;0.056039705312507904;-0.05107013192151233;-0.517733254190375;-0.4836227215716662
Hepatic hemangioma;Difficulty walking;1.04978172108531;0.97434247;0.4841474337334154;0.508167940884769;0.9999431787962207;0.04983854228908924;-0.025600713395524943;-0.5157957450628053;-0.4917752379114517
Hepatic hemangioma;Bilobate gallbladder;0.6644707918167114;0.64214504;0.6089151223668634;0.6164917891757686;0.7034299088560918;-0.038959117039380375;-0.06128487120502979;-0.0945147864892284;-0.08693811968032317
Hepatic hemangioma;Histidinuria;0.7748299986124039;0.6353986;0.5722937502992023;0.6187947367913158;0.9999556674707869;-0.22512566885838303;-0.36455704114327225;-0.42766191717158464;-0.3811609306794711
Hepatic hemangioma;Widened interpedicular distance;1.026872392743826;0.85781705;0.49144522190959994;0.545412131595439;0.9999134918687169;0.026958900875108993;-0.14209643807385608;-0.508468269959117;-0.4545013602732779
Triangular epiphysis of the distal phalanx of the 2nd finger;Acne inversa;0.92618827521801;0.9013434;0.5235163883190785;0.5314545288671245;0.9998962300503706;-0.0737079548323607;-0.09855282480363603;-0.4763798417312921;-0.46844170118324613
Triangular epiphysis of the distal phalanx of the 2nd finger;Dentin dysplasia;0.713634192943573;0.67436564;0.5924472596866552;0.60557783406661;1.0;-0.286365807056427;-0.3256343603134155;-0.40755274031334476;-0.39442216593338997
Triangular epiphysis of the distal phalanx of the 2nd finger;Aplasia of the inner ear;1.0062714577652514;0.8289312;0.49800371990638104;0.5547220453453123;0.9999201345566091;0.00635132320864229;-0.17098892213137717;-0.5019164146502281;-0.4451980892112968
Triangular epiphysis of the distal phalanx of the 2nd finger;Polycystic liver disease;1.0411365404725075;0.90963936;0.486902136644775;0.5288019762260584;0.9999056439461368;0.041230896526370686;-0.09026628542562898;-0.5130035073013618;-0.4711036677200784
Triangular epiphysis of the distal phalanx of the 2nd finger;Subungual hyperkeratosis;0.7096926271915436;0.7734047;0.5937575493162184;0.5727594583927134;0.9999003561294039;-0.2902077289378603;-0.22649563868403033;-0.4061428068131855;-0.4271408977366905
Triangular epiphysis of the distal phalanx of the 2nd finger;Broad humeral epiphyses;0.5860984921455383;0.6071567;0.6358342124013868;0.6285085238818117;1.0;-0.41390150785446167;-0.3928433060646057;-0.3641657875986132;-0.37149147611818834
Triangular epiphysis of the distal phalanx of the 2nd finger;Autoimmune thrombocytopenia;0.8811245039105415;0.769936;0.5379289373185994;0.573893550664887;0.9998726169824932;-0.11874811307195166;-0.2299365918398235;-0.4619436796638938;-0.4259790663176062
Triangular epiphysis of the distal phalanx of the 2nd finger;Adenomyosis;1.0498276464641094;0.9821213;0.48413279706687085;0.5056912767281394;0.9999201345566091;0.04990751190750031;-0.017798845780211403;-0.5157873374897383;-0.4942288578284697
Triangular epiphysis of the distal phalanx of the 2nd finger;Elevated leukocyte alkaline phosphatase;0.8445282876491547;0.82207704;0.5496897502152225;0.556937777311691;0.9999201345566091;-0.15539184690745445;-0.17784309865267844;-0.4502303843413866;-0.4429823572449181
Triangular epiphysis of the distal phalanx of the 2nd finger;Clasp-knife sign;0.8342480212450027;0.8890646;0.5530051178847477;0.5353846591171652;1.0;-0.16575197875499725;-0.11093538999557495;-0.4469948821152523;-0.46461534088283485
Triangular epiphysis of the distal phalanx of the 2nd finger;Keratosis pilaris;0.789290651679039;0.7729092;0.5675773616535145;0.5729214150703638;0.9998710980331391;-0.21058044635410011;-0.2269618739997834;-0.43229373637962465;-0.42694968296277536
Triangular epiphysis of the distal phalanx of the 2nd finger;Lamina lucida cleavage;0.9868817599490285;0.9123881;0.5041757852706403;0.5279235295521943;0.9998962300503706;-0.013014470101342157;-0.08750814373140092;-0.4957204447797303;-0.4719727004981763
Triangular epiphysis of the distal phalanx of the 2nd finger;Abnormal central response of multifocal electroretinogram;0.9783844016492367;0.89724594;0.5068809945609867;0.5327654686712475;1.0;-0.02161559835076332;-0.10275405645370483;-0.4931190054390133;-0.4672345313287525
Triangular epiphysis of the distal phalanx of the 2nd finger;Atypical or prolonged hepatitis;1.0488189086318016;0.92568994;0.48445427959237986;0.5236754515530739;0.9999201345566091;0.0488987740751925;-0.074230198872405;-0.5154658549642293;-0.4762446830035352
Triangular epiphysis of the distal phalanx of the 2nd finger;Cubitus varus;0.904533714056015;0.9262329;0.5304342111612451;0.5235021531533381;1.0;-0.09546628594398499;-0.07376712560653687;-0.4695657888387549;-0.47649784684666185
Triangular epiphysis of the distal phalanx of the 2nd finger;Nasal regurgitation;1.1099539026618004;1.0333159;0.4649296762910827;0.4893932436096521;0.9999134918687169;0.11004041079308347;0.03340240511919812;-0.5349838155776342;-0.5105202482590648
Triangular epiphysis of the distal phalanx of the 2nd finger;Moon facies;0.9831553418189287;0.9149258;0.5053620748235712;0.5271127342815538;0.9999134918687169;-0.0167581500497882;-0.08498767819379016;-0.4945514170451457;-0.4728007575871631
Triangular epiphysis of the distal phalanx of the 2nd finger;Intestinal pseudo-obstruction;0.9600092433393002;0.82088923;0.5127328485973941;0.557322043519517;0.9998912449978579;-0.03988200165855771;-0.17900201045501118;-0.48715839640046377;-0.4425692014783409
Triangular epiphysis of the distal phalanx of the 2nd finger;Bilateral renal atrophy;0.8792843744158745;0.763862;0.5385189175103299;0.5758817467183652;0.9999201345566091;-0.12063576014073463;-0.2360581207397756;-0.46140121704627923;-0.4240383878382439
Triangular epiphysis of the distal phalanx of the 2nd finger;Fractured left clavicle;0.6174298524856567;0.611029;0.6249609702660637;0.6271693631228665;1.0;-0.38257014751434326;-0.3889709711074829;-0.3750390297339363;-0.37283063687713347
Triangular epiphysis of the distal phalanx of the 2nd finger;Positive urine norcotinine test;0.9763768687844276;0.9671345;0.5075201757610897;0.5104633138224324;1.0;-0.023623131215572357;-0.03286552429199219;-0.49247982423891035;-0.4895366861775676
Triangular epiphysis of the distal phalanx of the 2nd finger;Long fibula;0.7484297156333923;0.81212723;0.5809469610836442;0.5601592724167527;0.6109530888848884;0.13747662674850392;0.2011741436666863;-0.03000612780124423;-0.050793816468135744
Triangular epiphysis of the distal phalanx of the 2nd finger;Fragmentation of the epiphysis of the distal phalanx of the hallux;0.3441349267959595;0.38922274;0.7276959832014684;0.7091429171326366;1.0;-0.6558650732040405;-0.6107772588729858;-0.27230401679853156;-0.29085708286736345
Triangular epiphysis of the distal phalanx of the 2nd finger;Type II cryptotia;0.9052650928497314;0.7152281;0.5302003461010084;0.5919178643892391;1.0;-0.09473490715026855;-0.2847719192504883;-0.4697996538989916;-0.4080821356107609
Triangular epiphysis of the distal phalanx of the 2nd finger;Increased variability in muscle fiber diameter;0.9443977698683739;0.82774115;0.5177078718496693;0.5551065487487672;0.7712186293488323;0.17317914051954153;0.056522516738814144;-0.2535107574991631;-0.21611208060006515
Triangular epiphysis of the distal phalanx of the 2nd finger;Widened proximal tibial metaphyses;0.6565746665000916;0.69256234;0.6115872326322325;0.5994715530006474;0.4693866352828394;0.18718803121725214;0.22317570640722406;0.14220059734939305;0.13008491771780795
Triangular epiphysis of the distal phalanx of the 2nd finger;Wide anterior fontanel;1.07623752951622;1.0023065;0.47570927152100506;0.49926584531967666;0.6617971500655027;0.41444037945071743;0.34050931126872586;-0.1860878785444976;-0.162531304745826
Triangular epiphysis of the distal phalanx of the 2nd finger;Increased circulating oleate level;0.9807727448642254;0.89260864;0.5061206025516165;0.5342497899408376;1.0;-0.019227255135774612;-0.107391357421875;-0.4938793974483835;-0.4657502100591624
Triangular epiphysis of the distal phalanx of the 2nd finger;Lozenge-shaped umbilicus;0.8480512350797653;0.7979648;0.5485548736712191;0.5647555319187251;0.9999134918687169;-0.1518622567889516;-0.20194868054364368;-0.4513586181974978;-0.43515795994999185
Triangular epiphysis of the distal phalanx of the 2nd finger;Anti-myelin-associated glycoprotein antibody positivity;0.9960142755880952;0.9052764;0.5012686988430199;0.5301967178481852;1.0;-0.003985724411904812;-0.09472358226776123;-0.49873130115698006;-0.46980328215181477
Triangular epiphysis of the distal phalanx of the 2nd finger;Fractured radius;0.5288196504116058;0.56101024;0.6561719049540433;0.6446635639396835;0.4693866352828394;0.05943301512876642;0.09162360622564447;0.1867852696712039;0.17527692865684408
Triangular epiphysis of the distal phalanx of the 2nd finger;Abnormal manual kinetic perimetry test;0.8401794880628586;0.71721494;0.5510915458321022;0.5912583124021894;1.0;-0.15982051193714142;-0.2827850580215454;-0.4489084541678978;-0.4087416875978106
Triangular epiphysis of the distal phalanx of the 2nd finger;Small radial epiphyses;0.4581564664840698;0.45746714;0.6822734697470736;0.6825346039242648;1.0;-0.5418435335159302;-0.5425328612327576;-0.3177265302529264;-0.3174653960757352
Triangular epiphysis of the distal phalanx of the 2nd finger;Generalized keratosis follicularis;0.8741283863782883;0.8736893;0.540172739681686;0.5403136268975814;0.9999201345566091;-0.12579174817832084;-0.12623084069521995;-0.4597473948749231;-0.45960650765902766
Triangular epiphysis of the distal phalanx of the 2nd finger;Hypoplasia of the calcaneus;0.6347269415855408;0.66224635;0.6190243785979721;0.6096670748106265;0.6433114794007544;-0.008584537815213622;0.018934867072939454;-0.02428710080278229;-0.03364440459012785
Triangular epiphysis of the distal phalanx of the 2nd finger;2-hydroxyadipic aciduria;0.8686793297529221;0.68474704;0.5419217525401636;0.602089363403353;1.0;-0.13132067024707794;-0.31525295972824097;-0.4580782474598364;-0.39791063659664705
Triangular epiphysis of the distal phalanx of the 2nd finger;Potter facies;0.9284459799528122;0.8839396;0.5227958326299269;0.5370266046197354;0.9998981869165328;-0.07145220696372057;-0.11595856308383012;-0.47710235428660586;-0.46287158229679737
Triangular epiphysis of the distal phalanx of the 2nd finger;Increased heart rate variability;1.0379344448447227;0.9565865;0.4879221932919634;0.513823301839601;0.9999201345566091;0.03801431028811364;-0.04333365441592307;-0.5119979412646457;-0.4860968327170081
Triangular epiphysis of the distal phalanx of the 2nd finger;Aplastic zygomatic arch;0.8386178910732269;0.7449597;0.5515951548144702;0.5820887454483183;0.8072246192530101;0.031393271820216784;-0.06226490722450673;-0.25562946443853996;-0.2251358738046918
Triangular epiphysis of the distal phalanx of the 2nd finger;Testicular torsion;0.8660465776920319;0.79449767;0.5427672540891677;0.5658828145372412;0.9999201345566091;-0.13387355686457725;-0.20542246581347556;-0.4571528804674414;-0.4340373200193679
Triangular epiphysis of the distal phalanx of the 2nd finger;Abolished vibration sense;0.9291892871260643;0.9060813;0.5225586288921934;0.5299393601393347;0.9999134918687169;-0.07072420474265262;-0.09383217301343127;-0.4773548629765235;-0.4699741317293822
Triangular epiphysis of the distal phalanx of the 2nd finger;Fractured metatarsal bone of digit 5;0.3288254737854004;0.42921174;0.7342098896736358;0.6933622895991924;1.0;-0.6711745262145996;-0.5707882642745972;-0.26579011032636424;-0.30663771040080756
Triangular epiphysis of the distal phalanx of the 2nd finger;Prolonged G2 phase of cell cycle;0.8825738430023193;0.75680983;0.537464344146354;0.5781938988500883;0.9999056439461368;-0.11733180094381745;-0.2430958132805484;-0.46244129979978277;-0.4217117450960485
Triangular epiphysis of the distal phalanx of the 2nd finger;Single naris;1.0410061366856098;1.0066298;0.4869436805133971;0.4978896548556958;0.9999056439461368;0.04110049273947303;0.0067241806922299086;-0.5129619634327397;-0.502015989090441
Triangular epiphysis of the distal phalanx of the 2nd finger;Perifoveal ring of hyperautofluorescence surrounded by normal autofluorescence;0.8960742875933647;0.7965058;0.5331404210805775;0.565229813125878;1.0;-0.10392571240663528;-0.20349419116973877;-0.46685957891942254;-0.43477018687412206
Triangular epiphysis of the distal phalanx of the 2nd finger;Asymmetry of the thorax;0.8837840706110001;0.7587452;0.5370764608649958;0.5775589647092236;0.789736248610815;0.09404782200018502;-0.030991055129369727;-0.2526597877458192;-0.2121772839015914
Triangular epiphysis of the distal phalanx of the 2nd finger;Type 2 muscle fiber predominance;0.8856171891093254;0.72997624;0.5364890434271149;0.5870315605746224;0.8527273749847077;0.03288981412461767;-0.1227511381644868;-0.31623833155759284;-0.2656958144100854
Triangular epiphysis of the distal phalanx of the 2nd finger;Dependency on parenteral nutrition;0.9497571364045143;0.88279414;0.5159995364059197;0.5373937380530149;0.9999134918687169;-0.05015635546420261;-0.11711935009930774;-0.48391395546279725;-0.462519753815702
Triangular epiphysis of the distal phalanx of the 2nd finger;Limited shoulder flexion;0.7137676179409027;0.6868262;0.5924029337190522;0.6013922286615048;1.0;-0.2862323820590973;-0.313173770904541;-0.40759706628094783;-0.39860777133849523
Triangular epiphysis of the distal phalanx of the 2nd finger;Paroxysmal vertigo;1.0779274553060532;0.89996105;0.4751697461297397;0.5318967420834186;0.9999134918687169;0.07801396343733624;-0.09995243754361316;-0.5247437457389772;-0.4680167497852983
Triangular epiphysis of the distal phalanx of the 2nd finger;Long hallux;0.7107720375061035;0.817706;0.5933985606330385;0.5583522573867892;0.4528204051665701;0.25795163233953344;0.3648855837174021;0.14057815546646846;0.1055318522202191
Triangular epiphysis of the distal phalanx of the 2nd finger;Broad medial eyebrow;0.8707310408353806;0.85995924;0.5412630573141954;0.5447233635974122;0.9999201345566091;-0.12918909372122855;-0.13996088982852073;-0.45865707724241367;-0.45519677095919686
Triangular epiphysis of the distal phalanx of the 2nd finger;Myxoid subcutaneous tumors;0.876251183450222;0.83250517;0.5394917070085063;0.553567751119139;0.9999201345566091;-0.12366895110638709;-0.16741496802599998;-0.46042842754810276;-0.4463523834374701
Triangular epiphysis of the distal phalanx of the 2nd finger;Bulbous tips of toes;0.589790940284729;0.6747112;0.634544268228136;0.605461496085901;0.593333426887708;-0.003542486602978956;0.08137780052928423;0.04121084134042807;0.012128069198193092
Triangular epiphysis of the distal phalanx of the 2nd finger;Absent internal genitalia;0.9026166424155235;0.8475696;0.5310472908997588;0.5487099946587617;1.0;-0.09738335758447647;-0.15243041515350342;-0.4689527091002412;-0.4512900053412383
Triangular epiphysis of the distal phalanx of the 2nd finger;Hyperphalangy of the 2nd finger;0.25995397567749023;0.280998;0.7651963126874455;0.7554008097805415;0.40280785677892184;-0.1428538811014316;-0.12180986521703219;0.36238845590852364;0.35259295300161964
Triangular epiphysis of the distal phalanx of the 2nd finger;Renal interstitial hemosiderin;0.9589129760861397;0.8414085;0.5130820884081991;0.5506952974662509;1.0;-0.04108702391386032;-0.15859150886535645;-0.48691791159180087;-0.4493047025337491
Triangular epiphysis of the distal phalanx of the 2nd finger;Abnormality of depressor anguli oris muscle;0.8251714110374451;0.7837347;0.5559371289014561;0.569387609607426;1.0;-0.17482858896255493;-0.21626532077789307;-0.4440628710985439;-0.43061239039257404
Triangular epiphysis of the distal phalanx of the 2nd finger;Paroxysmal dyspnea;0.9156723767518997;0.7733574;0.5268742316749584;0.572774925145078;1.0;-0.08432762324810028;-0.22664260864257812;-0.4731257683250416;-0.427225074854922
Triangular epiphysis of the distal phalanx of the 2nd finger;Phenylpyruvic acidemia;0.8866524621844292;0.7729182;0.5361573484831172;0.5729184733314777;0.9999201345566091;-0.11326767237217994;-0.2270019102218923;-0.46376278607349186;-0.4270016612251314
Triangular epiphysis of the distal phalanx of the 2nd finger;Lateral ventricle dilatation;1.0509267896413803;0.85337126;0.4837824841036831;0.5468422524229567;0.9998579617208769;0.05106882792050338;-0.14648669917052293;-0.5160754776171939;-0.45301570929792023
Triangular epiphysis of the distal phalanx of the 2nd finger;Neonatal unconjugated hyperbilirubinemia;0.9502973668277264;0.8991591;0.5158273605996764;0.532153325034293;0.9999201345566091;-0.049622767728882744;-0.10076106072695823;-0.48409277395693273;-0.4677668095223161
Triangular epiphysis of the distal phalanx of the 2nd finger;High maternal circulating alpha-fetoprotein concentration;0.9745042901486158;0.88512915;0.5081164159836042;0.5366454158819127;1.0;-0.025495709851384163;-0.11487084627151489;-0.49188358401639576;-0.4633545841180873
Triangular epiphysis of the distal phalanx of the 2nd finger;Prominent nasolabial fold;0.908188208937645;0.88672733;0.5292658149564526;0.5361333642456272;0.9998944404568447;-0.09170623151919977;-0.11316710738799707;-0.4706286255003921;-0.46376107621121754
Triangular epiphysis of the distal phalanx of the 2nd finger;Abnormality of inferior alveolar nerve;0.858134999871254;0.80408406;0.5453098898129634;0.5627679629277759;1.0;-0.14186500012874603;-0.19591593742370605;-0.45469011018703664;-0.43723203707222413
Triangular epiphysis of the distal phalanx of the 2nd finger;Unilateral conductive hearing impairment;1.0596638172864914;0.9529103;0.48099713140771927;0.514994656114697;0.9999201345566091;0.059743682729882286;-0.047009830487090065;-0.5189230031488898;-0.48492547844191214
Triangular epiphysis of the distal phalanx of the 2nd finger;Macular hypopigmented whorls, streaks, and patches;0.9261470586061478;0.85529673;0.5235295438799947;0.5462227537417359;0.9999201345566091;-0.07377307595046134;-0.14462340356143089;-0.4763905906766144;-0.4536973808148732
Triangular epiphysis of the distal phalanx of the 2nd finger;Delayed ossification of pubic rami;0.7511140704154968;0.7189358;0.5800644279859013;0.5906873915954268;0.6574179255159834;0.09369614489951339;0.061517862161781456;-0.07735349753008214;-0.06673053392055661
Triangular epiphysis of the distal phalanx of the 2nd finger;Hyperphenylalaninemia;0.9975106474012136;0.8578072;0.500792386360779;0.5454152894403017;0.9999028053808913;-0.0023921579796776227;-0.14209558635241837;-0.4991104190201122;-0.45448751594058956
Triangular epiphysis of the distal phalanx of the 2nd finger;Ureteropelvic junction obstruction;0.9209824949502945;0.8262844;0.5251783007768177;0.5555773451859869;0.9998847295244674;-0.07890223457417289;-0.17360032095513145;-0.4747064287476497;-0.4443073843384805
Triangular epiphysis of the distal phalanx of the 2nd finger;Cone-shaped epiphysis of the proximal phalanx of the 2nd toe;0.179995596408844;0.20218551;0.8060290809517636;0.7940105848100782;1.0;-0.820004403591156;-0.7978144884109497;-0.19397091904823638;-0.20598941518992175
Triangular epiphysis of the distal phalanx of the 2nd finger;Difficulty walking;1.0382008403539658;0.98235035;0.48783733545952324;0.5056183440566723;0.7552776988623575;0.28292314149160824;0.22707265056391202;-0.2674403634028343;-0.24965935480568524
Triangular epiphysis of the distal phalanx of the 2nd finger;Bilobate gallbladder;1.0144665576517582;0.91167307;0.49539499104716955;0.5281520267113379;0.9999134918687169;0.014553065783041275;-0.08824042286847278;-0.5045185008215474;-0.47176146515737905
Triangular epiphysis of the distal phalanx of the 2nd finger;Histidinuria;0.9031853377819061;0.8287492;0.53086541010347;0.5547808559690506;0.9999090677057578;-0.0967237299238517;-0.17115988786566994;-0.46904365760228783;-0.44512821173670725
Triangular epiphysis of the distal phalanx of the 2nd finger;Widened interpedicular distance;0.8020653426647186;0.74364805;0.5634233851985684;0.5825205967437376;1.0;-0.19793465733528137;-0.25635194778442383;-0.4365766148014316;-0.4174794032562624
Acne inversa;Dentin dysplasia;0.8554726243019104;0.8693605;0.5461661751496232;0.5417030478337543;0.9998962300503706;-0.14442360574846025;-0.13053572351579423;-0.45373005490074747;-0.4581931822166163
Acne inversa;Aplasia of the inner ear;0.9844117574393749;0.7914312;0.5049620926883331;0.5668805131732315;0.9999548690865008;-0.015543111647125851;-0.20852368050312675;-0.49499277639816763;-0.43307435591326926
Acne inversa;Polycystic liver disease;1.0800339430570602;0.95938575;0.47449712896812024;0.5129314637256008;0.9999505803237132;0.08008336273334704;-0.04056482764579572;-0.525453451355593;-0.48701911659811237
Acne inversa;Subungual hyperkeratosis;0.651587724685669;0.8460622;0.6132790749581541;0.5491955557394891;0.8007304775429361;-0.1491427528572672;0.04533170583719082;-0.187451402584782;-0.25153492180344705
Acne inversa;Broad humeral epiphyses;0.9977505276910961;0.94882905;0.5007160298784885;0.5162953249786835;0.9998962300503706;-0.0021457023592745816;-0.05106717521791215;-0.49918020017188214;-0.4836009050716872
Acne inversa;Autoimmune thrombocytopenia;1.012194124981761;0.85707;0.4961183932638831;0.5456523706889478;0.7013592136452191;0.31083491133654184;0.15571081513667173;-0.20524082038133606;-0.15570684295627135
Acne inversa;Adenomyosis;0.7357981204986572;0.659936;0.5851085208340703;0.6104487371235692;0.9999548690865008;-0.26415674858784355;-0.34001885824894584;-0.4148463482524305;-0.3895061319629316
Acne inversa;Elevated leukocyte alkaline phosphatase;0.9862625747919083;0.8881323;0.5043728958016555;0.5356832872945078;0.9999548690865008;-0.01369229429459251;-0.11182259493565239;-0.4955819732848453;-0.464271581791993
Acne inversa;Clasp-knife sign;1.0000635292381048;0.9809842;0.4999797780154359;0.5060532802700168;0.9998962300503706;0.00016729918773417118;-0.01891201908235307;-0.49991645203493473;-0.4938429497803538
Acne inversa;Keratosis pilaris;0.6345437169075012;0.82188505;0.6190870324305864;0.5569998901429813;0.7746350753780699;-0.14009135847056864;0.04724997396503927;-0.15554804294748348;-0.2176351852350885
Acne inversa;Lamina lucida cleavage;0.8303526192903519;0.7901976;0.554262875920777;0.5672820666614045;0.7966047757128065;0.033747843577545344;-0.006407164857703984;-0.24234189979202947;-0.22932270905140206
Acne inversa;Abnormal central response of multifocal electroretinogram;0.9655798375606537;0.884306;0.5109584425466758;0.5369091953319507;0.9998962300503706;-0.03431639248971696;-0.11559021646623369;-0.4889377875036949;-0.46298703471841995
Acne inversa;Atypical or prolonged hepatitis;0.9906327649950981;0.90963256;0.502981727114671;0.5288041480044756;0.7102929024706535;0.28033986252444465;0.19933966112034995;-0.20731117535598242;-0.18148875446617785
Acne inversa;Cubitus varus;0.8599885851144791;0.7940245;0.5447139265435618;0.566036717409975;0.9998962300503706;-0.13990764493589158;-0.20587170297746415;-0.4551823035068089;-0.4338595126403957
Acne inversa;Nasal regurgitation;0.7197325527667999;0.723897;0.590423152433436;0.589043088559157;0.9999528219730685;-0.2802202692062685;-0.2760558416874239;-0.40952966953963243;-0.41090973341391146
Acne inversa;Moon facies;0.8471990525722504;0.881526;0.5488293367651058;0.5378002249306886;0.9999528219730685;-0.15275376940081808;-0.11842682862590048;-0.45112348520796264;-0.4621525970423799
Acne inversa;Intestinal pseudo-obstruction;0.8975076526403427;0.7079587;0.5326817171530528;0.5943344842022207;0.9999468979947994;-0.1024392453544567;-0.29198819972209433;-0.4672651808417466;-0.40561241379257873
Acne inversa;Bilateral renal atrophy;0.899219386279583;0.772928;0.5321340191472496;0.5729152734670728;0.9999548690865008;-0.1007354828069178;-0.22702686959004081;-0.4678208499392512;-0.42703959561942795
Acne inversa;Fractured left clavicle;0.9333183169364929;0.86861527;0.5212412001345237;0.5419423169336395;0.9998962300503706;-0.06657791311387773;-0.13128096038942094;-0.47865502991584696;-0.45795391311673117
Acne inversa;Positive urine norcotinine test;0.8139704316854477;0.82804596;0.5595620243706796;0.5550080475745873;0.9998962300503706;-0.18592579836492296;-0.17185026580934282;-0.44033420567969106;-0.4448881824757833
Acne inversa;Long fibula;1.0821372866630554;1.0267817;0.4738254018743593;0.49147412069050334;0.9999505803237132;0.08218670633934222;0.026831097876054866;-0.5261251784493539;-0.5084764596332099
Acne inversa;Fragmentation of the epiphysis of the distal phalanx of the hallux;0.9069610387086868;0.8781304;0.5296581145915606;0.5388889787670503;0.9998962300503706;-0.09293519134168382;-0.12176585371141191;-0.47023811545881;-0.4610072512833203
Acne inversa;Type II cryptotia;0.9559312164783478;0.87274367;0.5140320738181409;0.5406170878433807;0.9998962300503706;-0.04396501357202287;-0.12715256387834306;-0.4858641562322298;-0.45927914220698995
Acne inversa;Increased variability in muscle fiber diameter;0.8795857354998589;0.81357086;0.5384222864164563;0.5596914775441488;0.999937876518323;-0.12035214101846414;-0.18636701947028833;-0.4615155901018667;-0.44024639897417417
Acne inversa;Widened proximal tibial metaphyses;1.0199706628918648;0.9584413;0.49364271794376047;0.5132323457333465;0.9999548690865008;0.020015793805364;-0.04151355200504936;-0.5063121511427403;-0.48672252335315425
Acne inversa;Wide anterior fontanel;0.9877375345677137;0.8841752;0.503903361803741;0.5369511295398592;0.9999383692587659;-0.012200834691052154;-0.11576318786991091;-0.49603500745502493;-0.46298723971890665
Acne inversa;Increased circulating oleate level;1.0425866916775703;0.97034955;0.48644013415610865;0.5094394147397316;0.9998962300503706;0.042690461627199694;-0.029546679803178266;-0.513456095894262;-0.490456815310639
Acne inversa;Lozenge-shaped umbilicus;0.8551502525806427;0.8415094;0.5462698805221458;0.5506627555402215;0.9999528219730685;-0.14480256939242575;-0.15844342017482016;-0.4536829414509227;-0.44929006643284697
Acne inversa;Anti-myelin-associated glycoprotein antibody positivity;0.8701340556144714;0.74313956;0.5414546990376813;0.5826880704236899;0.45807765254028776;0.4120564030741837;0.28506191245070955;0.08337704649739353;0.1246104178834021
Acne inversa;Fractured radius;0.950644988566637;0.8719239;0.5157165731929994;0.5408801680423443;0.9999548690865008;-0.049309880519863736;-0.12803094559406913;-0.4842382958935014;-0.4590747010441565
Acne inversa;Abnormal manual kinetic perimetry test;0.9797824770212173;0.9134644;0.5064358759312371;0.5275796205611223;0.9998962300503706;-0.020113753029153303;-0.08643180305604692;-0.4934603541191336;-0.47231660948924836
Acne inversa;Small radial epiphyses;0.9471850097179413;0.8609818;0.5168193591193877;0.5443946564247433;0.9998962300503706;-0.052711220332429365;-0.13891440803651567;-0.48307687093098295;-0.4555015736256274
Acne inversa;Generalized keratosis follicularis;0.4200623631477356;0.67752767;0.6969230914855264;0.6045139391014096;0.8230814931248395;-0.4030191299771039;-0.14555382703292052;-0.12615840163931302;-0.21856755402342987
Acne inversa;Hypoplasia of the calcaneus;0.9179897829890251;0.7985544;0.5261340136776879;0.5645639281659769;0.9999528219730685;-0.08196303898404333;-0.20139840150187704;-0.4738188082953806;-0.43538889380709156
Acne inversa;2-hydroxyadipic aciduria;0.8662609755992889;0.7441058;0.5426983894796135;0.5823698776540582;0.9998962300503706;-0.1336352544510817;-0.2557904141629195;-0.4571978405707572;-0.4175263523963124
Acne inversa;Potter facies;0.8945331051945686;0.99543345;0.5336337056989656;0.5014535816616539;0.9999486088983908;-0.10541550370382213;-0.004515159153212545;-0.46631490319942515;-0.4984950272367369
Acne inversa;Increased heart rate variability;0.8789642080664635;0.8437326;0.5386215823999523;0.5499461704635905;0.9999548690865008;-0.1209906610200373;-0.1562222736427752;-0.4613332866865485;-0.45000869862291026
Acne inversa;Aplastic zygomatic arch;0.8415646106004715;0.7902571;0.550644957148513;0.5672626912742342;0.9999528219730685;-0.15838821137259695;-0.20969572568248007;-0.4493078648245554;-0.4326901306988342
Acne inversa;Testicular torsion;0.8894355967640877;0.8450558;0.5352658441937466;0.549519772084275;0.9999548690865008;-0.1105192723224131;-0.15489905052876152;-0.4646890248927542;-0.4504350970022257
Acne inversa;Abolished vibration sense;0.8485929071903229;0.854891;0.5483804358300195;0.5463532788756973;0.9999528219730685;-0.15135991478274557;-0.1450618197948763;-0.45157238614304895;-0.45359954309737116
Acne inversa;Fractured metatarsal bone of digit 5;1.002923995256424;1.061956;0.4990692620764601;0.4802661434950234;0.9998962300503706;0.003027765206053301;0.062059817961409136;-0.5008269679739106;-0.5196300865553473
Acne inversa;Prolonged G2 phase of cell cycle;0.8887563720345497;0.89081144;0.5354833901589535;0.5348252331757264;0.9999505803237132;-0.11119420828916349;-0.10913913699485578;-0.4644671901647597;-0.4651253471479868
Acne inversa;Single naris;0.8155300617218018;0.8331885;0.559056834561644;0.5533471389861588;0.9999505803237132;-0.18442051860191144;-0.166762106145399;-0.4408937457620692;-0.44660344133755436
Acne inversa;Perifoveal ring of hyperautofluorescence surrounded by normal autofluorescence;0.8250408619642258;0.7999236;0.5559793344641204;0.5641190377954988;0.9998962300503706;-0.17485536808614488;-0.19997263128404374;-0.44391689558625025;-0.4357771922548719
Acne inversa;Asymmetry of the thorax;0.8893771842122078;0.76712346;0.5352845522470766;0.5748138153900153;0.9999505803237132;-0.1105733961115054;-0.23282711955405988;-0.4646660280766366;-0.4251367649336979
Acne inversa;Type 2 muscle fiber predominance;0.9004185870289803;0.812153;0.5317503716261638;0.5601509179592203;0.9999491674684583;-0.09953058043947804;-0.18779618571034062;-0.4681987958422945;-0.43979824950923796
Acne inversa;Dependency on parenteral nutrition;1.0719802305102348;0.9935541;0.4770681496317851;0.5020517938452644;0.9999528219730685;0.07202740853716638;-0.006398706677658295;-0.5228846723412833;-0.497901028127804
Acne inversa;Limited shoulder flexion;0.903194859623909;0.7907553;0.5308623649033861;0.5671005378303201;0.9998962300503706;-0.09670137042646165;-0.20914095813874956;-0.46903386514698453;-0.43279569222005054
Acne inversa;Paroxysmal vertigo;0.9620409421622753;0.85991096;0.5120856469138468;0.5447388797328856;0.9999528219730685;-0.037911879810793137;-0.14004185700724814;-0.4878671750592216;-0.45521394224018286
Acne inversa;Long hallux;0.9567799121141434;0.9602521;0.513761667936444;0.5126554897436201;0.9999451389191131;-0.0431652268049697;-0.03969303272938529;-0.4861834709826691;-0.487289649175493
Acne inversa;Broad medial eyebrow;0.7765236049890518;0.92477673;0.5717405604148242;0.5239669441590163;0.8568390591914515;-0.08031545420239972;0.0679376737301488;-0.2850984987766273;-0.3328721150324352
Acne inversa;Myxoid subcutaneous tumors;0.6800965666770935;0.6540317;0.6036504724663253;0.6124495331797787;0.8230814931248395;-0.14298492644774596;-0.16904979918944518;-0.21943102065851416;-0.2106319599450608
Acne inversa;Bulbous tips of toes;0.991532763466239;1.0303241;0.5026952373034399;0.49034607539381503;0.9999528219730685;-0.008420058506829475;0.03037127947499063;-0.49725758466962855;-0.5096067465792534
Acne inversa;Absent internal genitalia;0.6295718848705292;0.7073915;0.6207890148302351;0.5945232655323232;0.9998962300503706;-0.3703243451798415;-0.2925047295773482;-0.3791072152201356;-0.4053729645180475
Acne inversa;Hyperphalangy of the 2nd finger;0.8319126665592194;0.88360333;0.5537590620162928;0.5371343793056997;0.9999548690865008;-0.16804220252728141;-0.11635153465962089;-0.446195807070208;-0.46282048978080104
Acne inversa;Renal interstitial hemosiderin;0.8716290146112442;0.7299959;0.5409748217941037;0.5870250580404612;0.9998962300503706;-0.12826721543912645;-0.2699003236973738;-0.4589214082562669;-0.4128711720099094
Acne inversa;Abnormality of depressor anguli oris muscle;0.7238879203796387;0.65287715;0.5890460989259207;0.6128413126827461;0.9998962300503706;-0.276008309670732;-0.3470190780842757;-0.4108501311244499;-0.38705491736762454
Acne inversa;Paroxysmal dyspnea;0.8282246589660645;0.7771413;0.5549503177767009;0.5715388638010406;0.9998962300503706;-0.1716715710843062;-0.22275495702867265;-0.44494591227366975;-0.4283573662493301
Acne inversa;Phenylpyruvic acidemia;0.9837103057652712;0.90326756;0.5051854000629636;0.530839116156997;0.9999548690865008;-0.016244563321229588;-0.096687306697127;-0.49476946902353713;-0.4691157529295038
Acne inversa;Lateral ventricle dilatation;1.0528467074036598;0.9329115;0.4831705308883938;0.5213709702480392;0.9999400373813975;0.05290667002226235;-0.0670285221454966;-0.5167695064930037;-0.47856906713335823
Acne inversa;Neonatal unconjugated hyperbilirubinemia;0.9980861656367779;0.88258725;0.5006091927702203;0.5374600455421399;0.9999548690865008;-0.0018687034497228971;-0.11736761503910698;-0.49934567631628046;-0.4624948235443609
Acne inversa;High maternal circulating alpha-fetoprotein concentration;0.9913982963189483;0.9160374;0.5027380410847034;0.5267576337974513;0.9998962300503706;-0.00849793373142238;-0.08385884935502763;-0.4971581889656672;-0.4731385962529193
Acne inversa;Prominent nasolabial fold;0.7133539021015167;0.7152355;0.5925403829014888;0.5919154200504639;0.9999476714516888;-0.2865937693501721;-0.28471219972622497;-0.40740728855020003;-0.4080322514012249
Acne inversa;Abnormality of inferior alveolar nerve;0.7601633667945862;0.64139795;0.5770938807023376;0.6167464772769544;0.9998962300503706;-0.23973286325578447;-0.3584982770169234;-0.42280234934803307;-0.38314975277341623
Acne inversa;Unilateral conductive hearing impairment;0.9814714677631855;0.8174299;0.5058981524993074;0.5584416535895893;0.9999548690865008;-0.018483401323315274;-0.18252496891712822;-0.4940567165871934;-0.44151321549691147
Acne inversa;Macular hypopigmented whorls, streaks, and patches;0.6852636337280273;0.7763041;0.6019161066937035;0.5718122373766364;0.8230814931248395;-0.13781785939681213;-0.04677736733901183;-0.22116538643113592;-0.251269255748203
Acne inversa;Delayed ossification of pubic rami;0.9079627692699432;0.8627745;0.5293378797554726;0.5438184906013019;0.9999528219730685;-0.09199005270312521;-0.13717833066294882;-0.4706149422175958;-0.4561343313717665
Acne inversa;Hyperphenylalaninemia;1.0290471315383911;0.9078409;0.4907527101767236;0.5293768398644547;0.9999498126421364;0.029097318896254665;-0.0921089050684365;-0.5091971024654128;-0.47057297277768173
Acne inversa;Ureteropelvic junction obstruction;0.8905773311853409;0.7926782;0.5349002002022316;0.566474723394984;0.9999453908499725;-0.10936805966463159;-0.2072672134932525;-0.46504519064774086;-0.4334706674549885
Acne inversa;Cone-shaped epiphysis of the proximal phalanx of the 2nd toe;0.9402138255536556;0.89829785;0.5190418857366423;0.5324288646434507;0.9998962300503706;-0.059682404496715025;-0.10159838373307939;-0.4808543443137283;-0.4674673654069199
Acne inversa;Difficulty walking;0.9474555924534798;0.9098146;0.5167331101993493;0.5287459605239593;0.99993620886009;-0.05248061640661028;-0.09012161268394259;-0.48320309866074074;-0.47119024833613077
Acne inversa;Bilobate gallbladder;1.0599868223071098;0.9465109;0.4808941312283258;0.5170342256556228;0.9999528219730685;0.06003400033404138;-0.05344191098521445;-0.5190586907447426;-0.4829185963174456
Acne inversa;Histidinuria;0.838506430387497;0.80146605;0.5516311054210041;0.563618009070217;0.9999515360511232;-0.16144510566362624;-0.19848548828729873;-0.44832043063011906;-0.4363335269809062
Acne inversa;Widened interpedicular distance;0.9841707032173872;0.87499595;0.5050388320993858;0.5398943928015796;0.9998962300503706;-0.01572552683298345;-0.12490028316621538;-0.4948573979509848;-0.46000183724879107
Dentin dysplasia;Aplasia of the inner ear;0.8766582012176514;0.7550941;0.5393611490147276;0.5787570674068978;0.9999201345566091;-0.12326193333895774;-0.24482602359088035;-0.46055898554188146;-0.4211630671497113
Dentin dysplasia;Polycystic liver disease;1.0161701459437609;0.82815963;0.49485265835277015;0.5549713294783771;0.9999056439461368;0.01626450199762408;-0.1717460136475223;-0.5050529855933666;-0.44493431446775966
Dentin dysplasia;Subungual hyperkeratosis;0.5934346914291382;0.67323756;0.6332736371356005;0.6059576999620884;0.9999003561294039;-0.4064656647002657;-0.32666279394983844;-0.3666267189938034;-0.3939426561673155
Dentin dysplasia;Broad humeral epiphyses;0.9530382454395294;0.85621375;0.5149538907553549;0.5459277826983786;1.0;-0.04696175456047058;-0.1437862515449524;-0.4850461092446451;-0.4540722173016214
Dentin dysplasia;Autoimmune thrombocytopenia;0.9776154346764088;0.8597239;0.5071258236128713;0.5447990195417927;0.9998726169824932;-0.022257182306084422;-0.14014869139197805;-0.4927467933696219;-0.45507359744070053
Dentin dysplasia;Adenomyosis;0.9343456327915192;0.8698667;0.5209134771203376;0.5415405248687497;0.9999201345566091;-0.06557450176508994;-0.1300534057739553;-0.47900665743627147;-0.4583796096878594
Dentin dysplasia;Elevated leukocyte alkaline phosphatase;0.8881986290216446;0.8310833;0.5356620397084463;0.5540268782572546;0.9999201345566091;-0.11172150553496452;-0.16883683682711692;-0.46425809484816283;-0.4458932562993545
Dentin dysplasia;Clasp-knife sign;0.8546661138534546;0.8873661;0.5464256348286214;0.5359287212798243;1.0;-0.1453338861465454;-0.11263388395309448;-0.4535743651713786;-0.46407127872017573
Dentin dysplasia;Keratosis pilaris;0.7291103303432465;0.69859314;0.5873178568282582;0.5974562235118166;0.9998710980331391;-0.27076076768989266;-0.3012779583847016;-0.4125532412048809;-0.4024148745213225
Dentin dysplasia;Lamina lucida cleavage;0.7625424861907959;0.71010524;0.5763140511446782;0.593620308569913;0.9998962300503706;-0.23735374385957475;-0.28979098970536943;-0.4235821789056925;-0.40627592148045766
Dentin dysplasia;Abnormal central response of multifocal electroretinogram;0.8931452110409737;0.8128244;0.5340779968685099;0.5599333256538361;1.0;-0.10685478895902634;-0.18717557191848755;-0.4659220031314901;-0.44006667434616387
Dentin dysplasia;Atypical or prolonged hepatitis;0.9232475087046623;0.7823164;0.5244551276014736;0.5698500884290908;0.9999201345566091;-0.07667262585194679;-0.2176037478569326;-0.4754650069551355;-0.4300700461275183
Dentin dysplasia;Cubitus varus;0.9935525096952915;0.94333977;0.5020523141243916;0.5180451758597607;1.0;-0.006447490304708481;-0.056660234928131104;-0.49794768587560845;-0.48195482414023927
Dentin dysplasia;Nasal regurgitation;0.9087604284286499;0.8551695;0.5290829041040779;0.5462636918082775;0.9999134918687169;-0.09115306344006702;-0.14474401679013416;-0.47083058776463904;-0.4536498000604394
Dentin dysplasia;Moon facies;0.9372314214706421;0.9609015;0.51999300215899;0.5124486054073174;0.7692950606685226;0.1679363608021195;0.19160643812603306;-0.24930205850953258;-0.2568464552612052
Dentin dysplasia;Intestinal pseudo-obstruction;0.9282728284597397;0.74566287;0.5228510904463801;0.5818572814847609;0.9998912449978579;-0.07161841653811818;-0.25422837697493916;-0.47704015455147775;-0.41803396351309696
Dentin dysplasia;Bilateral renal atrophy;0.9523940645158291;0.7975287;0.5151591695210767;0.5648972947783171;0.9999201345566091;-0.04752607004078002;-0.2023914504173574;-0.48476096503553245;-0.43502283977829204
Dentin dysplasia;Fractured left clavicle;1.0027320720255375;0.8915544;0.499130353382631;0.5345873275078314;1.0;0.002732072025537491;-0.10844558477401733;-0.500869646617369;-0.46541267249216856
Dentin dysplasia;Positive urine norcotinine test;0.9915499147027731;0.9257849;0.5026897776999728;0.5236451395228605;1.0;-0.008450085297226906;-0.0742151141166687;-0.4973102223000272;-0.4763548604771395
Dentin dysplasia;Long fibula;0.9773100428283215;0.8976099;0.5072230575547202;0.5326490044193595;0.9999056439461368;-0.022595601117815334;-0.10229575443884309;-0.4926825863914166;-0.4672566395267773
Dentin dysplasia;Fragmentation of the epiphysis of the distal phalanx of the hallux;0.7183757722377777;0.62156546;0.5908731535480566;0.6235374891755803;1.0;-0.2816242277622223;-0.37843453884124756;-0.4091268464519434;-0.3764625108244197
Dentin dysplasia;Type II cryptotia;0.9057913720607758;0.8370137;0.530032073631537;0.552112633826766;1.0;-0.09420862793922424;-0.16298627853393555;-0.46996792636846296;-0.447887366173234
Dentin dysplasia;Increased variability in muscle fiber diameter;0.9535985961556435;0.8402724;0.5147753309181177;0.5510615679818751;0.9998452077479463;-0.04624661159230281;-0.15957278114272166;-0.4850698768298286;-0.44878363976607116
Dentin dysplasia;Widened proximal tibial metaphyses;0.9129059240221977;0.8334258;0.5277580737084916;0.5532705222938635;0.9999201345566091;-0.08701421053441138;-0.1664943146827993;-0.4721620608481175;-0.4466496122627456
Dentin dysplasia;Wide anterior fontanel;0.967168141156435;0.9876612;0.510452583686126;0.5039276677324271;0.6559975620430308;0.3111705791134042;0.3316636208373708;-0.14554497835690483;-0.1520698943106037
Dentin dysplasia;Increased circulating oleate level;1.043547123670578;0.9419227;0.48613413523712934;0.5184969792820355;1.0;0.043547123670578;-0.05807727575302124;-0.5138658647628707;-0.48150302071796447
Dentin dysplasia;Lozenge-shaped umbilicus;0.9425538964569569;0.90921646;0.5182957349267239;0.5289371315154723;0.9999134918687169;-0.057359595411760056;-0.0906970283028905;-0.48161775694199305;-0.47097636035324464
Dentin dysplasia;Anti-myelin-associated glycoprotein antibody positivity;0.9129308462142944;0.8286034;0.5277501104774858;0.554827940491725;1.0;-0.08706915378570557;-0.17139661312103271;-0.47224988952251423;-0.445172059508275
Dentin dysplasia;Fractured radius;0.9060955718159676;0.80780256;0.529934812670083;0.5615614111028313;0.9999201345566091;-0.09382456274064155;-0.19211757661135764;-0.4699853218865261;-0.4383587234537778
Dentin dysplasia;Abnormal manual kinetic perimetry test;0.9077828228473663;0.8000666;0.5293954031135224;0.5640725884020141;1.0;-0.09221717715263367;-0.19993340969085693;-0.4706045968864776;-0.43592741159798587
Dentin dysplasia;Small radial epiphyses;0.8516895174980164;0.7529385;0.547383495689113;0.5794649630767582;1.0;-0.14831048250198364;-0.24706149101257324;-0.45261650431088696;-0.4205350369232418
Dentin dysplasia;Generalized keratosis follicularis;0.7498118579387665;0.72488785;0.5804924763286345;0.5887149976728607;0.9999201345566091;-0.25010827661784263;-0.2750322866562185;-0.41942765822797456;-0.4112051368837484
Dentin dysplasia;Hypoplasia of the calcaneus;0.8486266732215881;0.7772002;0.5483695624426435;0.5715196060797948;0.9999134918687169;-0.15128681864712878;-0.22271326985333606;-0.45154392942607346;-0.4283938857889221
Dentin dysplasia;2-hydroxyadipic aciduria;0.888437032699585;0.74897563;0.5355856757258841;0.5807674284727213;1.0;-0.11156296730041504;-0.25102436542510986;-0.4644143242741159;-0.41923257152727866
Dentin dysplasia;Potter facies;0.8147859424352646;0.8239889;0.5592978481793967;0.5563194529485577;0.7284789198879239;0.08630702254734068;0.09550999460182219;-0.16918107170852725;-0.17215946693936623
Dentin dysplasia;Increased heart rate variability;1.0272691771388054;0.96129227;0.4913188752095171;0.5123241294001772;0.9999201345566091;0.02734904258219628;-0.03862786771090598;-0.508601259347092;-0.48759600515643187
Dentin dysplasia;Aplastic zygomatic arch;0.7270159721374512;0.81840426;0.5880106185709648;0.5581262284192472;0.7692950606685226;-0.04227908853107143;0.04910919662899327;-0.18128444209755779;-0.2111688322492754
Dentin dysplasia;Testicular torsion;0.9599414095282555;0.86657214;0.5127544580859338;0.5425984369460382;0.9999201345566091;-0.039978725028353645;-0.13334799290927024;-0.4871656764706753;-0.45732169761057095
Dentin dysplasia;Abolished vibration sense;0.9172791764140129;0.8974594;0.5263609779625689;0.5326971569398111;0.9999134918687169;-0.08263431545470401;-0.10245410408948108;-0.47355251390614805;-0.4672163349289058
Dentin dysplasia;Fractured metatarsal bone of digit 5;0.8159754127264023;0.74841654;0.5589126057241427;0.5809513032014195;1.0;-0.18402458727359772;-0.251583456993103;-0.4410873942758573;-0.4190486967985805
Dentin dysplasia;Prolonged G2 phase of cell cycle;0.9484861269593239;0.889658;0.5164046359670842;0.5351946282393594;0.9999056439461368;-0.05141951698681291;-0.11024766970297273;-0.4835010079790526;-0.4647110157067774
Dentin dysplasia;Single naris;0.9832088276743889;1.0223924;0.5053450473387888;0.49287169863670255;0.7483657621638067;0.2348430655105822;0.2740266299947016;-0.24302071482501786;-0.25549406352710413
Dentin dysplasia;Perifoveal ring of hyperautofluorescence surrounded by normal autofluorescence;0.8559631854295731;0.78983295;0.5460083735494912;0.5674007985870421;1.0;-0.14403681457042694;-0.2101670503616333;-0.45399162645050883;-0.43259920141295793
Dentin dysplasia;Asymmetry of the thorax;0.9943642914295197;0.89533776;0.5017939112498524;0.533376143351053;0.9999056439461368;-0.005541352516617137;-0.10456788349768098;-0.4981117326962844;-0.4665295005950838
Dentin dysplasia;Type 2 muscle fiber predominance;0.9216720908880234;0.85176694;0.5249581130959995;0.5473585842210682;0.9999003561294039;-0.07822826524138049;-0.14813341219782428;-0.4749422430334044;-0.45254177190833567
Dentin dysplasia;Dependency on parenteral nutrition;0.9721940755844116;0.86842525;0.5088520415739383;0.5420033269466142;0.9999134918687169;-0.027719416284305298;-0.13148824181531116;-0.49106145029477866;-0.4579101649221027
Dentin dysplasia;Limited shoulder flexion;1.032573726028204;0.9034167;0.48962962651372044;0.5307914254097419;1.0;0.032573726028203964;-0.0965833067893982;-0.5103703734862796;-0.4692085745902581
Dentin dysplasia;Paroxysmal vertigo;0.9340142980217934;0.8125063;0.5210191734550765;0.5600364081652077;0.9999134918687169;-0.06589919384692355;-0.18740717377637073;-0.4788943184136404;-0.4398770837035092
Dentin dysplasia;Long hallux;0.8417631238698959;0.849321;0.5505809611194985;0.5481459844076084;0.9998836012415208;-0.15812047737162482;-0.1505625935129441;-0.44930264012202226;-0.45173761683391234
Dentin dysplasia;Broad medial eyebrow;0.9541107378900051;1.0348455;0.5146121372949735;0.4889060854697823;0.7870101688836642;0.16710056900634096;0.24783530249847696;-0.2723980315886907;-0.29810408341388184
Dentin dysplasia;Myxoid subcutaneous tumors;0.8119304031133652;0.76270217;0.5602230525975647;0.5762617276129842;0.9999201345566091;-0.18798973144324393;-0.23721796752245994;-0.43969708195904444;-0.4236584069436249
Dentin dysplasia;Bulbous tips of toes;0.8721006512641907;0.8461174;0.540823447360488;0.5491777655152776;0.9999134918687169;-0.12781284060452625;-0.15379611458752795;-0.4590900445082289;-0.4507357263534393
Dentin dysplasia;Absent internal genitalia;0.8770738840103149;0.8739407;0.5392278184333923;0.5402329693593177;1.0;-0.12292611598968506;-0.12605929374694824;-0.4607721815666077;-0.45976703064068225
Dentin dysplasia;Hyperphalangy of the 2nd finger;0.8042973279953003;0.75599384;0.5626987480610002;0.5784617030403525;0.9999201345566091;-0.19562280656130882;-0.24392629147799583;-0.43722138649560893;-0.4214584315162566
Dentin dysplasia;Renal interstitial hemosiderin;0.9793337993323803;0.8623903;0.5065787243256314;0.5439419794202356;1.0;-0.020666200667619705;-0.13760972023010254;-0.49342127567436855;-0.4560580205797644
Dentin dysplasia;Abnormality of depressor anguli oris muscle;0.8916004970669746;0.7772025;0.5345725674470339;0.571518881122776;1.0;-0.10839950293302536;-0.22279751300811768;-0.46542743255296615;-0.42848111887722395
Dentin dysplasia;Paroxysmal dyspnea;0.9115345180034637;0.71913564;0.5281962974226572;0.5906210959811277;1.0;-0.08846548199653625;-0.2808643579483032;-0.47180370257734283;-0.40937890401887234
Dentin dysplasia;Phenylpyruvic acidemia;0.9714865665882826;0.8434722;0.5090773380307834;0.5500300855566309;0.9999201345566091;-0.028433567968326523;-0.1564479518059072;-0.49084279652582574;-0.4498900489999782
Dentin dysplasia;Lateral ventricle dilatation;0.9375178292393684;0.76406074;0.5199016564323148;0.5758166522463088;0.9998579617208769;-0.06234013248150849;-0.23579722601836228;-0.47995630528856215;-0.4240413094745681
Dentin dysplasia;Neonatal unconjugated hyperbilirubinemia;0.9623272605240345;0.8474704;0.5119944437128465;0.5487419436478935;0.9999201345566091;-0.03759287403257461;-0.15244973183901878;-0.4879256908437626;-0.4511781909087156
Dentin dysplasia;High maternal circulating alpha-fetoprotein concentration;0.9806502498686314;0.9248275;0.506159601175069;0.5239507382362346;1.0;-0.019349750131368637;-0.07517248392105103;-0.493840398824931;-0.4760492617637654
Dentin dysplasia;Prominent nasolabial fold;0.711452066898346;0.85837543;0.5931724602895414;0.5452325826829805;0.7184876422794455;-0.007035575381099557;0.1398877878276712;-0.1253151819899041;-0.17325505959646503
Dentin dysplasia;Abnormality of inferior alveolar nerve;0.5068703591823578;0.6718097;0.6641471788045189;0.6064387357856033;1.0;-0.4931296408176422;-0.32819032669067383;-0.3358528211954811;-0.39356126421439674
Dentin dysplasia;Unilateral conductive hearing impairment;0.9113562852144241;0.82750916;0.528253254447206;0.5551815224181678;0.9999201345566091;-0.08856384934218497;-0.17241096974642844;-0.47166688010940305;-0.44473861213844135
Dentin dysplasia;Macular hypopigmented whorls, streaks, and patches;0.7581473886966705;0.68594176;0.5777550489543992;0.6016887234729349;0.9999201345566091;-0.24177274585993858;-0.31397837878497215;-0.4221650856022099;-0.3982314110836742
Dentin dysplasia;Delayed ossification of pubic rami;0.8143379092216492;0.70609033;0.5594429787332409;0.5949564881515675;0.9999134918687169;-0.18557558264706775;-0.29382316079114124;-0.440470513135476;-0.4049570037171494
Dentin dysplasia;Hyperphenylalaninemia;1.0456919893622398;0.9122536;0.4854507225072281;0.5279664975506645;0.9999028053808913;0.04578918398134857;-0.08764918714053482;-0.5144520828736632;-0.4719363078302268
Dentin dysplasia;Ureteropelvic junction obstruction;0.97667639516294;0.82749104;0.5074248072756886;0.5551873634638836;0.9998847295244674;-0.02320833436152736;-0.17239368452629844;-0.49245992224877877;-0.44469736606058374
Dentin dysplasia;Cone-shaped epiphysis of the proximal phalanx of the 2nd toe;0.7867777049541473;0.73916507;0.5683958562791451;0.5839978324060805;1.0;-0.21322229504585266;-0.2608349323272705;-0.43160414372085487;-0.4160021675939195
Dentin dysplasia;Difficulty walking;0.9461947530508041;0.88005334;0.5171350164827444;0.5382723513748299;0.9998344221996177;-0.053639669148813574;-0.11978108081091532;-0.4826994057168733;-0.46156207082478784
Dentin dysplasia;Bilobate gallbladder;0.9617038480937481;0.80910915;0.5121930253661231;0.561137648854017;0.9999134918687169;-0.03820964377496883;-0.19080434050534412;-0.4877204665025938;-0.43877584301469996
Dentin dysplasia;Histidinuria;0.9149366617202759;0.76702464;0.5271092615382831;0.5748461570367127;0.9999090677057578;-0.08497240598548195;-0.2328844314371421;-0.47279980616747475;-0.4250629106690451
Dentin dysplasia;Widened interpedicular distance;1.015849482268095;0.91569686;0.49495474185487376;0.5268664131495894;1.0;0.015849482268095016;-0.08430314064025879;-0.5050452581451262;-0.4731335868504106
Aplasia of the inner ear;Polycystic liver disease;0.9853265807032585;0.75575805;0.5046708620497873;0.5785391156551309;0.9999567459343585;-0.014630165231099945;-0.24419869883047662;-0.4952858838845712;-0.4214176302792275
Aplasia of the inner ear;Subungual hyperkeratosis;0.9222242534160614;0.80987936;0.5247818164746316;0.5608879141232592;0.9999556674707869;-0.0777314140547255;-0.1900763048876265;-0.4751738509961553;-0.4390677533475277
Aplasia of the inner ear;Broad humeral epiphyses;1.0328802801668644;0.81024224;0.48953199500189915;0.5607702615265611;0.9999201345566091;0.03296014561025529;-0.18967789889605613;-0.51038813955471;-0.43914987303004804
Aplasia of the inner ear;Autoimmune thrombocytopenia;0.9525663964450359;0.7465926;0.5151042525243756;0.5815513205854417;0.9999509115718902;-0.047384515126854265;-0.25335833029976496;-0.48484665904751456;-0.4183995909864485
Aplasia of the inner ear;Adenomyosis;0.9357733279466629;0.7192325;0.5204580662886821;0.5905889825614173;0.9999600672783046;-0.06418673933164165;-0.28072756767884777;-0.4795020009896225;-0.4093710847168872
Aplasia of the inner ear;Elevated leukocyte alkaline phosphatase;0.9644109010696411;0.7871452;0.5113307547808812;0.5682761313729171;0.9999600672783046;-0.03554916620866344;-0.21281486988679454;-0.48862931249742336;-0.43168393590538745
Aplasia of the inner ear;Clasp-knife sign;1.055204652249813;1.0099859;0.4824188757995632;0.4968213146816839;0.9999201345566091;0.05528451769320397;0.010065789210480736;-0.5175012587570459;-0.5030988198749252
Aplasia of the inner ear;Keratosis pilaris;0.9157728776335716;0.77854574;0.5268421270331366;0.5710803414114306;0.9999506876445663;-0.08417781001099467;-0.22140495037802577;-0.4731085606114297;-0.4288703462331357
Aplasia of the inner ear;Lamina lucida cleavage;0.9636356681585312;0.8600291;0.5115776789384736;0.5447009111387676;0.9999548690865008;-0.036319200927969586;-0.13992576771473564;-0.48837719014802716;-0.45525395794773316
Aplasia of the inner ear;Abnormal central response of multifocal electroretinogram;0.6906910538673401;0.62425464;0.6000977184485843;0.6226132660096483;0.9999201345566091;-0.309229080689269;-0.37566549063952537;-0.3998224161080248;-0.3773068685469608
Aplasia of the inner ear;Atypical or prolonged hepatitis;0.989509760402143;0.7908598;0.5033392082182762;0.5670664969730115;0.9999600672783046;-0.010450306876161553;-0.20910024881974743;-0.4966208590600284;-0.4328935703052931
Aplasia of the inner ear;Cubitus varus;1.0866867154836655;0.99738306;0.4723720854428326;0.5008330012170126;0.9999201345566091;0.08676658092705636;-0.0025370764854726335;-0.5275480491137765;-0.49908713333959653
Aplasia of the inner ear;Nasal regurgitation;0.7105582356452942;0.70752263;0.5934696568088091;0.5944796159211446;0.9999584729108851;-0.28940023726559094;-0.2924358422193568;-0.406488816102076;-0.4054788569897405
Aplasia of the inner ear;Moon facies;1.066278487443924;0.990734;0.4788874255700839;0.5029494981323485;0.9999584729108851;0.06632001453303882;-0.009224491778377808;-0.5210710473408012;-0.49700897477853667
Aplasia of the inner ear;Intestinal pseudo-obstruction;0.9094081968069077;0.68564767;0.5288758555493172;0.6017873288748854;0.9999539510871024;-0.09054575428019473;-0.3143062846327872;-0.47107809553778524;-0.398166622212217
Aplasia of the inner ear;Bilateral renal atrophy;1.0232011433690786;0.79487485;0.4926141839715221;0.5657601367437821;0.9999600672783046;0.023241076090774082;-0.20508522034303234;-0.5073458833067824;-0.43419993053452244
Aplasia of the inner ear;Fractured left clavicle;1.074660874903202;0.8739465;0.47621257090567204;0.5402311046417032;0.9999201345566091;0.07474074034659295;-0.12597364665301414;-0.5237075636509371;-0.4596890299149059
Aplasia of the inner ear;Positive urine norcotinine test;0.9744154438376427;0.83956873;0.5081447058709765;0.5512884865557727;0.9999201345566091;-0.02550469071896644;-0.16035140038760276;-0.4917754286856326;-0.44863164800083644
Aplasia of the inner ear;Long fibula;0.9688977748155594;0.78043735;0.5099017426021152;0.5704630416166983;0.9999567459343585;-0.031058971118799072;-0.21951939566122614;-0.4900550033322433;-0.4294937043176602
Aplasia of the inner ear;Fragmentation of the epiphysis of the distal phalanx of the hallux;0.9714908562600613;0.75249386;0.5090759720305285;0.5796110314646088;0.9999201345566091;-0.028429278296547844;-0.24742627621920676;-0.49084416252608065;-0.4203091030920003
Aplasia of the inner ear;Type II cryptotia;0.9477080702781677;0.80679524;0.5166526333737875;0.5618881749267505;0.5881001503332186;0.3596079199449491;0.21869508911532876;-0.07144751695943108;-0.026211975406468135
Aplasia of the inner ear;Increased variability in muscle fiber diameter;1.009797053411603;0.8000767;0.4968814511547006;0.5640692917336991;0.9999473166570552;0.009849736754547811;-0.19987059355830028;-0.5030658655023545;-0.43587802492335603
Aplasia of the inner ear;Widened proximal tibial metaphyses;1.0325369983911514;0.76433855;0.4896413234838607;0.5757256396214491;0.9999600672783046;0.032576931112846874;-0.2356215143264918;-0.5103187437944439;-0.4242344276568555
Aplasia of the inner ear;Wide anterior fontanel;0.7211237549781799;0.6876977;0.5899619275199048;0.6011001787096066;0.9999476714516888;-0.2788239164735089;-0.31224996284496886;-0.409985743931784;-0.3988474927420822
Aplasia of the inner ear;Increased circulating oleate level;0.9107628613710403;0.7148687;0.5284428986962555;0.5920371984484856;0.9999201345566091;-0.08915727318556876;-0.2850514102104482;-0.4714772358603536;-0.40788293610812354
Aplasia of the inner ear;Lozenge-shaped umbilicus;0.925706572830677;0.80322754;0.5236701411057613;0.5630460184036901;0.9999584729108851;-0.0742519000802081;-0.19673092908001355;-0.47628833180512387;-0.43691245450719507
Aplasia of the inner ear;Anti-myelin-associated glycoprotein antibody positivity;0.7866028547286987;0.6766982;0.5684528239671245;0.6047928960139358;0.9999201345566091;-0.21331727982791038;-0.3232219267013845;-0.4314673105894846;-0.3951272385426733
Aplasia of the inner ear;Fractured radius;1.0240774117410183;0.7922665;0.4923351811103923;0.5666086943121242;0.9999600672783046;0.02411734446271374;-0.2076935792030482;-0.5076248861679122;-0.4333513729661803
Aplasia of the inner ear;Abnormal manual kinetic perimetry test;0.7550050467252731;0.6865469;0.5787863082393961;0.6014858487500079;0.9999201345566091;-0.24491508783133598;-0.3133732128265676;-0.42113382631721297;-0.39843428580660123
Aplasia of the inner ear;Small radial epiphyses;1.0688742399215698;0.83426;0.47805927860100594;0.5530012604952583;0.9999201345566091;0.06895410536496072;-0.1656601476791677;-0.5218608559556032;-0.4469188740613508
Aplasia of the inner ear;Generalized keratosis follicularis;1.0028735678642988;0.8856101;0.49908531368135;0.5364913232629416;0.9999600672783046;0.0029135005859942664;-0.11434996367112682;-0.5008747535969545;-0.463468744015363
Aplasia of the inner ear;Hypoplasia of the calcaneus;0.9543528109788895;0.75817716;0.5145350022064507;0.5777452919327448;0.9999584729108851;-0.04560566193199567;-0.2417813116941493;-0.4854234707044345;-0.4222131809781403
Aplasia of the inner ear;2-hydroxyadipic aciduria;0.9740518108010292;0.79253364;0.5082604923041462;0.5665217500429336;0.9999201345566091;-0.025868323755579903;-0.20738649846346946;-0.49165964225246295;-0.4333983845136755
Aplasia of the inner ear;Potter facies;1.0080112107098103;0.9423243;0.4974499251531831;0.5183689523896451;0.9999552432134126;0.008055967496397698;-0.05763096247458199;-0.5025053180602295;-0.48158629082376747
Aplasia of the inner ear;Increased heart rate variability;0.9705006517469883;0.80429006;0.5093912965900169;0.5627010987052998;0.9999600672783046;-0.029459415531316258;-0.19567001104966686;-0.49056877068828764;-0.4372589685730047
Aplasia of the inner ear;Aplastic zygomatic arch;0.6246773600578308;0.56096286;0.622468085304997;0.6446803515434221;0.9999584729108851;-0.3752811128530543;-0.4389956170949977;-0.37749038760588816;-0.35527812136746306
Aplasia of the inner ear;Testicular torsion;0.9997269287705421;0.8423983;0.500086921273049;0.550376213605879;0.9999600672783046;-0.0002331385077624093;-0.15756178141252086;-0.49987314600525556;-0.4495838536724256
Aplasia of the inner ear;Abolished vibration sense;0.8015996515750885;0.7791796;0.5635746185112707;0.5708734829181046;0.9999584729108851;-0.19835882133579663;-0.2207788998518031;-0.43638385439961447;-0.42908498999278055
Aplasia of the inner ear;Fractured metatarsal bone of digit 5;1.029154483228922;0.8361472;0.4907185245940969;0.5523922037648912;0.9999201345566091;0.029234348672312782;-0.16377294541628928;-0.5092016099625122;-0.44752793079171793
Aplasia of the inner ear;Prolonged G2 phase of cell cycle;1.0469788238406181;0.91530275;0.4850406699205705;0.5269923159977428;0.9999567459343585;0.047022077906259674;-0.08465399248587213;-0.514916076013788;-0.4729644299366157
Aplasia of the inner ear;Single naris;0.8604718148708344;0.7946261;0.5445585849035146;0.5658410371590423;0.9999567459343585;-0.1394849310635241;-0.20533062918173395;-0.45539816103084385;-0.43411570877531613
Aplasia of the inner ear;Perifoveal ring of hyperautofluorescence surrounded by normal autofluorescence;0.9398209452629089;0.78376794;0.5191671690003867;0.5693767759582169;0.9999201345566091;-0.06009918929370017;-0.2161521959427175;-0.4807529655562224;-0.4305433585983922
Aplasia of the inner ear;Asymmetry of the thorax;0.9528356418013573;0.7371325;0.5150184530366173;0.5846682129709878;0.9999567459343585;-0.04712110413300119;-0.26282425625311456;-0.48493829289774115;-0.41528853296337065
Aplasia of the inner ear;Type 2 muscle fiber predominance;1.0676359310746193;0.94300157;0.4784543659571061;0.5181529955482185;0.9999556674707869;0.06768026360383239;-0.05695409915337357;-0.5215013015136808;-0.4818026719225684
Aplasia of the inner ear;Dependency on parenteral nutrition;0.9930157642811537;0.8480462;0.502223169351196;0.5485564909045494;0.9999584729108851;-0.006942708629731453;-0.15191228932476453;-0.4977353035596891;-0.45140198200633574
Aplasia of the inner ear;Limited shoulder flexion;1.026433838531375;0.83337563;0.4915848676623582;0.553286723768109;0.9999201345566091;0.026513703974765823;-0.16654450179370017;-0.5083352668942509;-0.44663341078850016
Aplasia of the inner ear;Paroxysmal vertigo;0.4476020932197571;0.64014506;0.6862870857008032;0.6171738293545004;0.8384531378237817;-0.39085104460402464;-0.19830807442351317;-0.1521660521229785;-0.22127930846928134
Aplasia of the inner ear;Long hallux;0.95337825268507;0.80721486;0.5148455444117811;0.5617520282168467;0.9999526340597648;-0.04657438137469472;-0.19273777791199864;-0.48510708964798366;-0.4382006058429181
Aplasia of the inner ear;Broad medial eyebrow;0.8315985947847366;0.78298056;0.5538604798464478;0.5696334971348667;0.9999600672783046;-0.16836147249356792;-0.21697950602189586;-0.44609958743185674;-0.4303265701434379
Aplasia of the inner ear;Myxoid subcutaneous tumors;0.949653297662735;0.80712426;0.5160326311882206;0.5617814377209426;0.9999600672783046;-0.05030676961556957;-0.19283581019059703;-0.48392743609008393;-0.438178629557362
Aplasia of the inner ear;Bulbous tips of toes;0.9564277157187462;0.8202417;0.5138738812430288;0.5575315688106478;0.9999584729108851;-0.04353075719213895;-0.1797167832288783;-0.48608459166785634;-0.44242690410023733
Aplasia of the inner ear;Absent internal genitalia;0.8492391258478165;0.72312325;0.5481723494001827;0.5892993741143675;0.9999201345566091;-0.15068100870879264;-0.2767968821647939;-0.45174778515642644;-0.4106207604422416
Aplasia of the inner ear;Hyperphalangy of the 2nd finger;1.0195725075900555;0.8663715;0.4937694794923555;0.5426628906259545;0.9999600672783046;0.01961244031175091;-0.13358855486527965;-0.506190587785949;-0.45729717665235003
Aplasia of the inner ear;Renal interstitial hemosiderin;1.0541213303804398;0.84575975;0.48276422422147314;0.5492929726860696;0.9999201345566091;0.05420119582383065;-0.1541603851440725;-0.517155910335136;-0.4506271618705395
Aplasia of the inner ear;Abnormality of depressor anguli oris muscle;0.8732736855745316;0.7466827;0.5404469955860334;0.5815216662115953;0.9999201345566091;-0.12664644898207755;-0.2532374310615835;-0.45947313897057573;-0.4183984683450138
Aplasia of the inner ear;Paroxysmal dyspnea;0.8793960064649582;0.7291787;0.5384831224034049;0.5872952401909479;0.9999201345566091;-0.12052412809165092;-0.2707414078834829;-0.4614370121532042;-0.4126248943656612
Aplasia of the inner ear;Phenylpyruvic acidemia;0.9771144259721041;0.769163;0.5072853405073741;0.5741463996777176;0.9999600672783046;-0.02284564130620048;-0.23079705477372692;-0.4926747267709305;-0.4258136676005869
Aplasia of the inner ear;Lateral ventricle dilatation;0.7611240446567535;0.6688045;0.5767789324484621;0.6074519652732109;0.9999488789551968;-0.23882483429844326;-0.33114435262615627;-0.4231699465067347;-0.3924969136819859
Aplasia of the inner ear;Neonatal unconjugated hyperbilirubinemia;0.9930635578930378;0.75306696;0.5022079558035109;0.5794227694868537;0.9999600672783046;-0.006896509385266758;-0.24689311028138683;-0.4977521114747937;-0.4205372977914509
Aplasia of the inner ear;High maternal circulating alpha-fetoprotein concentration;0.9032852053642273;0.7339462;0.5308334713853243;0.5857198730230422;0.9999201345566091;-0.09663492919238181;-0.26597393037112327;-0.4690866631712848;-0.4142002615335669
Aplasia of the inner ear;Prominent nasolabial fold;0.7157300114631653;0.7558905;0.5917512068946076;0.5784956472061635;0.9999545338528789;-0.28422452238971363;-0.24406404522830616;-0.40820332695827133;-0.4214588866467154
Aplasia of the inner ear;Abnormality of inferior alveolar nerve;0.6343590617179871;0.50498;0.6191501803268857;0.6648392630197122;0.9999201345566091;-0.36556107283862205;-0.49494010688098045;-0.3807699542297234;-0.3350808715368969
Aplasia of the inner ear;Unilateral conductive hearing impairment;0.24432528018951416;0.4065565;0.7726908903809925;0.7022319612552276;0.7940500751666093;-0.5497247949770951;-0.38749358808317425;-0.021359184785616825;-0.09181811391138173
Aplasia of the inner ear;Macular hypopigmented whorls, streaks, and patches;0.8796141669154167;0.74230576;0.5384131700987388;0.5829627355749332;0.9999600672783046;-0.12034590036288784;-0.2576543116630702;-0.46154689717956576;-0.4169973317033714
Aplasia of the inner ear;Delayed ossification of pubic rami;0.9362552762031555;0.7086487;0.5203043423838827;0.5941048600531305;0.9999584729108851;-0.06370319670772961;-0.29130979127026013;-0.47965413052700245;-0.4058536128577547
Aplasia of the inner ear;Hyperphenylalaninemia;0.9015428274869919;0.6979611;0.5313907473859474;0.5976672549999182;0.9999561589935034;-0.09841333150651155;-0.30199506699826417;-0.46856541160755605;-0.4022889039935852
Aplasia of the inner ear;Ureteropelvic junction obstruction;1.0023008678108454;0.7542503;0.499267610382794;0.5790341316380492;0.9999528219730685;0.002348045837776924;-0.2457025339634249;-0.5006852115902745;-0.4209186903350193
Aplasia of the inner ear;Cone-shaped epiphysis of the proximal phalanx of the 2nd toe;0.9783568400889635;0.80758584;0.5068897697309849;0.5616317032706064;0.9999201345566091;-0.0215632944676456;-0.19233429909976096;-0.49303036482562423;-0.4382884312860027
Aplasia of the inner ear;Difficulty walking;0.9426443018019199;0.8552151;0.5182669104861712;0.5462490278385161;0.9999461221900431;-0.05730182038812315;-0.14473104955820715;-0.48167921170387185;-0.45369709435152694
Aplasia of the inner ear;Bilobate gallbladder;1.0207050517201424;0.8290725;0.4934089063535919;0.5546764077528135;0.9999584729108851;0.020746578809257232;-0.17088599747753552;-0.5065495665572932;-0.44528206515807167
Aplasia of the inner ear;Histidinuria;0.9150769263505936;0.72582376;0.5270644517769927;0.5884051735720282;0.9999574798349273;-0.08488055348433377;-0.2741337198022735;-0.47289302805793465;-0.4115523062628992
Aplasia of the inner ear;Widened interpedicular distance;0.9660809822380543;0.7680729;0.5107988300338964;0.5745030859170813;0.9999201345566091;-0.03383915231855483;-0.2318472314003286;-0.48912130452271274;-0.4254170486395278
Polycystic liver disease;Subungual hyperkeratosis;1.0403815656900406;0.9212891;0.48714265245515054;0.5250804119324171;0.9999515360511232;0.0404300296389174;-0.07866244970926528;-0.5128088835959727;-0.47487112411870613
Polycystic liver disease;Broad humeral epiphyses;0.9608766883611679;0.7826803;0.5124565159808936;0.5697314139888646;0.9999056439461368;-0.03902895558496888;-0.21722537089010652;-0.4874491279652432;-0.43017422995727217
Polycystic liver disease;Autoimmune thrombocytopenia;0.7618593573570251;0.63199025;0.5765379196203577;0.6199606968057746;0.9999457950338347;-0.2380864376768096;-0.36795554110851125;-0.423407875413477;-0.37998509822806015
Polycystic liver disease;Adenomyosis;0.9120781868696213;0.6764933;0.5280225652718726;0.6048618186758281;0.9999567459343585;-0.08787855906473718;-0.32346345884787164;-0.4719341806624858;-0.39509492725853035
Polycystic liver disease;Elevated leukocyte alkaline phosphatase;0.8214764595031738;0.6803979;0.5571320667656985;0.6035492311893542;0.9999567459343585;-0.17848028643118463;-0.3195588181732806;-0.44282467916866;-0.39640751474500424
Polycystic liver disease;Clasp-knife sign;0.9524335414171219;0.8477856;0.5151465893815216;0.5486404208106825;0.9999056439461368;-0.0474721025290149;-0.1521200518669742;-0.4847590545646152;-0.45126522313545425
Polycystic liver disease;Keratosis pilaris;0.9603018686175346;0.72727215;0.5126396290519282;0.587925847571298;0.9999455218634979;-0.039643653245963306;-0.27267336896280214;-0.4873058928115698;-0.4120196742922
Polycystic liver disease;Lamina lucida cleavage;1.0103787072002888;0.86386;0.496696295579366;0.5434697044725763;0.9999505803237132;0.010428126876575572;-0.13609056922294416;-0.5032542847443472;-0.45648087585113695
Polycystic liver disease;Abnormal central response of multifocal electroretinogram;0.8820917755365372;0.7044266;0.5376188644271445;0.5955106940253911;0.9999056439461368;-0.11781386840959962;-0.2954790573181766;-0.46228677951899233;-0.40439494992074565
Polycystic liver disease;Atypical or prolonged hepatitis;0.4623223543167114;0.51311344;0.6806982534831312;0.6618674936301616;0.6815865513953562;-0.21926419707864475;-0.1684731123122568;-0.0008882979122250001;-0.01971905776519456
Polycystic liver disease;Cubitus varus;0.948346022516489;0.7766769;0.516449292048663;0.5716905021232312;0.9999056439461368;-0.05155962142964776;-0.22322875071188386;-0.4834563518974738;-0.42821514182290554
Polycystic liver disease;Nasal regurgitation;0.9518168643116951;0.781684;0.5153431091443699;0.5700563501246679;0.8462066046856518;0.10561025962604331;-0.06452262326704217;-0.3308634955412819;-0.27615025456098385
Polycystic liver disease;Moon facies;0.924266591668129;0.86300516;0.5241297964539046;0.5437443755974312;0.9999548690865008;-0.07568827741837181;-0.13694970780110038;-0.4758250726325962;-0.4562104934890696
Polycystic liver disease;Intestinal pseudo-obstruction;0.7499407529830933;0.65533054;0.5804501008087879;0.6120089986907935;0.8278333585256364;-0.07789260554254318;-0.17250281977594162;-0.24738325771684855;-0.21582435983484294
Polycystic liver disease;Bilateral renal atrophy;0.6640328168869019;0.6231221;0.6090631254337742;0.6230023689538752;0.9999567459343585;-0.3359239290474566;-0.3768346498726519;-0.3908936205005843;-0.3769543769804833
Polycystic liver disease;Fractured left clavicle;0.9331449270248413;0.80573;0.5212965152933002;0.5622338043883653;0.9999056439461368;-0.06676071692129548;-0.1941756587090152;-0.47860912865283656;-0.43767183955777145
Polycystic liver disease;Positive urine norcotinine test;0.9740846082568169;0.8599734;0.5082500490378086;0.5447188127289406;0.9999056439461368;-0.025821035689319927;-0.13993227291723664;-0.4916555949083282;-0.45518683121719616
Polycystic liver disease;Long fibula;0.9916100380942225;0.8222858;0.5026706391516378;0.5568702587249457;0.9999528219730685;-0.008342783878845905;-0.17766705060313437;-0.49728218282143066;-0.4430825632481228
Polycystic liver disease;Fragmentation of the epiphysis of the distal phalanx of the hallux;1.065883383154869;0.8689077;0.4790134666644663;0.5418484197567206;0.9999056439461368;0.06597773920873229;-0.13099795389791902;-0.5208921772816705;-0.4580572241894162
Polycystic liver disease;Type II cryptotia;0.9493231922388077;0.84243786;0.5161378413128668;0.5503634563107087;0.9999056439461368;-0.05058245170732911;-0.15746778059622224;-0.48376780263327;-0.4495421876354281
Polycystic liver disease;Increased variability in muscle fiber diameter;0.9365577697753906;0.7782097;0.5202078603984537;0.5711900522168771;0.9999413779434757;-0.06338360816808508;-0.22173169166417883;-0.479733517545022;-0.4287513257265986
Polycystic liver disease;Widened proximal tibial metaphyses;0.9890262819826603;0.75754833;0.5034931130437315;0.5779515886597691;0.9999567459343585;-0.010930463951698166;-0.242408413720003;-0.496463632890627;-0.4220051572745893
Polycystic liver disease;Wide anterior fontanel;0.9911923855543137;0.87331015;0.5028035870001639;0.5404352994807766;0.9999418169014338;-0.00874943134712014;-0.1266316681854609;-0.4971382299012699;-0.4595065174206572
Polycystic liver disease;Increased circulating oleate level;0.7418621182441711;0.6741718;0.5831088848731013;0.6056431125471845;0.9999056439461368;-0.25804352570196565;-0.3257338385643619;-0.4167967590730355;-0.3942625313989523
Polycystic liver disease;Lozenge-shaped umbilicus;0.9365001022815704;0.9171581;0.5202262536184821;0.5263996443264203;0.8462066046856518;0.09029349759591865;0.0709515221454029;-0.3259803510671697;-0.3198069603592315
Polycystic liver disease;Anti-myelin-associated glycoprotein antibody positivity;0.9496982470154762;0.80633444;0.5160183052128984;0.5620376720410691;0.9999056439461368;-0.050207396930660564;-0.19357120800634797;-0.4838873387332384;-0.43786797190506765
Polycystic liver disease;Fractured radius;1.0639152228832245;0.89973813;0.47964127517394495;0.5319680611015931;0.9999567459343585;0.06395847694886603;-0.10021861298071466;-0.5203154707604135;-0.46798868483276534
Polycystic liver disease;Abnormal manual kinetic perimetry test;0.9348058328032494;0.74059457;0.5207666763906171;0.5835265869093065;0.9999056439461368;-0.06509981114288743;-0.2593110780777591;-0.47913896755551966;-0.4163790570368303
Polycystic liver disease;Small radial epiphyses;1.0193373020738363;0.8634385;0.4938443619062137;0.5436051446727992;0.9999056439461368;0.019431658127699536;-0.1364671568932193;-0.5060612820399231;-0.4563004992733376
Polycystic liver disease;Generalized keratosis follicularis;0.9901050012558699;0.8633945;0.5031497273242842;0.5436192598675396;0.9999567459343585;-0.009851744678488594;-0.13656224710928522;-0.49680701861007426;-0.4563374860668189
Polycystic liver disease;Hypoplasia of the calcaneus;0.9686464257538319;0.7574903;0.5099817885327416;0.5779706316886309;0.9999548690865008;-0.03130844333266891;-0.24246459179615654;-0.4899730805537592;-0.42198423739786983
Polycystic liver disease;2-hydroxyadipic aciduria;0.7418985068798065;0.6927578;0.5830968957340461;0.5994061771563262;0.9999056439461368;-0.25800713706633027;-0.3071478586258548;-0.4168087482120907;-0.40049946678981063
Polycystic liver disease;Potter facies;0.9293608143925667;0.80790055;0.5225038930008611;0.5615296276484576;0.9999510285821799;-0.0705902141896132;-0.19205048060091767;-0.4774471355813188;-0.4384214009337223
Polycystic liver disease;Increased heart rate variability;0.8817723765969276;0.76340556;0.537721248390164;0.5760312673459322;0.9999567459343585;-0.11818436933743082;-0.2365511844872149;-0.46223549754419446;-0.4239254785884262
Polycystic liver disease;Aplastic zygomatic arch;1.0502389706671238;0.8295555;0.4840017043185406;0.5545203530886134;0.9999548690865008;0.05028410158062302;-0.1703993576118914;-0.5159531647679602;-0.4454345159978874
Polycystic liver disease;Testicular torsion;0.9208116456866264;0.7963868;0.5252328547339087;0.5652685022201197;0.9999567459343585;-0.07914510024773203;-0.20356996757971368;-0.4747238912004498;-0.43468824371423875
Polycystic liver disease;Abolished vibration sense;1.080801472067833;0.94142824;0.4742520230534689;0.5186546515367927;0.9999548690865008;0.08084660298133217;-0.058526624972578656;-0.5257028460330319;-0.4813002175497081
Polycystic liver disease;Fractured metatarsal bone of digit 5;1.0598413348197937;0.9163072;0.48094052467796733;0.5266714455516086;0.9999056439461368;0.05993569087365691;-0.08359843302389558;-0.5189651192681695;-0.4732341983945282
Polycystic liver disease;Prolonged G2 phase of cell cycle;0.828247606754303;0.76589257;0.5549429030726161;0.5752167546467182;0.9999528219730685;-0.17170521521876547;-0.23406025672267172;-0.4450099189004524;-0.4247360673263503
Polycystic liver disease;Single naris;1.090125560760498;1.020629;0.4712731636223383;0.4934330887281799;0.9999528219730685;0.0901727387874296;0.020676226374404694;-0.5286796583507302;-0.5065197332448885
Polycystic liver disease;Perifoveal ring of hyperautofluorescence surrounded by normal autofluorescence;0.9294679462909698;0.81463933;0.5224697065881234;0.5593453483774213;0.9999056439461368;-0.07043769765516694;-0.18526631403585847;-0.4774359373580134;-0.44056029556871545
Polycystic liver disease;Asymmetry of the thorax;0.8104561418294907;0.684865;0.5607009193724495;0.6020497996637146;0.9999528219730685;-0.1894966801435778;-0.3150878241092989;-0.43925190260061897;-0.3979030223093538
Polycystic liver disease;Type 2 muscle fiber predominance;0.9843343142420053;0.87482345;0.5049867466341351;0.5399497202812682;0.9999515360511232;-0.015617221809117843;-0.1251280850089479;-0.49496478941698807;-0.460001815769855
Polycystic liver disease;Dependency on parenteral nutrition;0.7503563910722733;0.6915062;0.5803134655977034;0.5998249049445188;0.8462066046856518;-0.09585021361337853;-0.15470039769636346;-0.2658931390879484;-0.246381699741133
Polycystic liver disease;Limited shoulder flexion;0.9915148802101612;0.85839343;0.5027009299251453;0.5452267993705578;0.9999056439461368;-0.008390763735975582;-0.14151221323629792;-0.49720471402099153;-0.45467884457557894
Polycystic liver disease;Paroxysmal vertigo;0.9879323225468397;0.7429961;0.5038413542757927;0.5827353241619473;0.9999548690865008;-0.012022546539661061;-0.2569587724754778;-0.4961135148107081;-0.4172195449245535
Polycystic liver disease;Long hallux;1.0480602830648422;0.89655757;0.4846960414169762;0.5329857635950355;0.9999478876548411;0.04811239541000112;-0.10339031815105693;-0.5152518462378649;-0.46696212405980564
Polycystic liver disease;Broad medial eyebrow;0.9625843167304993;0.9005576;0.5119125624518521;0.5317059088533573;0.9999567459343585;-0.03737242920385919;-0.09939916832434259;-0.48804418348250633;-0.4682508370810011
Polycystic liver disease;Myxoid subcutaneous tumors;0.9946899563074112;0.8669354;0.5016902473466769;0.5424817863296023;0.9999567459343585;-0.005266789626947266;-0.13302137358175836;-0.49826649858768157;-0.45747495960475615
Polycystic liver disease;Bulbous tips of toes;0.9756668843328953;0.8636019;0.507746235831815;0.543552630011022;0.9999548690865008;-0.024287984753605496;-0.13635294609760917;-0.4922086332546858;-0.4564022390754787
Polycystic liver disease;Absent internal genitalia;1.144862562417984;1.0311918;0.453725996854658;0.490069734634033;0.9999056439461368;0.14495691847184722;0.03128618192056243;-0.5461796470914788;-0.5098359093121038
Polycystic liver disease;Hyperphalangy of the 2nd finger;0.9220931231975555;0.7911947;0.5248236835542825;0.5669574919177598;0.9999567459343585;-0.07786362273680292;-0.2087620685814532;-0.4751330623800759;-0.43299925401659867
Polycystic liver disease;Renal interstitial hemosiderin;0.7600879371166229;0.74149907;0.5771186127940948;0.5832284981188465;0.9999056439461368;-0.23981770682951387;-0.25840657759329255;-0.42278703115204197;-0.4166771458272903
Polycystic liver disease;Abnormality of depressor anguli oris muscle;1.1010550409555435;0.9020811;0.46777817970493585;0.531218591594325;0.9999056439461368;0.10114939700940673;-0.09782457161566194;-0.5321274642412009;-0.46868705235181174
Polycystic liver disease;Paroxysmal dyspnea;0.8232247680425644;0.57666105;0.5565665678801905;0.6391420530687293;0.9999056439461368;-0.1766808759035724;-0.42324459362646516;-0.44333907606594625;-0.3607635908774075
Polycystic liver disease;Phenylpyruvic acidemia;0.7367416024208069;0.527335;0.5847971785920972;0.656707931928848;0.9999567459343585;-0.2632151435135516;-0.47262175781714044;-0.4151595673422612;-0.34324881400551044
Polycystic liver disease;Lateral ventricle dilatation;0.7328184247016907;0.6367545;0.5860923486259945;0.6183313609840325;0.9999433058680118;-0.26712488116632116;-0.3631887930811466;-0.41385095724201737;-0.3816119448839793
Polycystic liver disease;Neonatal unconjugated hyperbilirubinemia;0.5529798269271851;0.6273236;0.6475147859516097;0.6215598393982729;0.9999567459343585;-0.4469769190071734;-0.37263311846243463;-0.35244195998274874;-0.3783969065360856
Polycystic liver disease;High maternal circulating alpha-fetoprotein concentration;0.7874936759471893;0.7575995;0.5681626100370454;0.5779347997403134;0.9999056439461368;-0.21241196799894746;-0.24230617094656404;-0.4317430339090914;-0.4219708442058234
Polycystic liver disease;Prominent nasolabial fold;1.101995050907135;0.9365363;0.4674774111567013;0.5202147043794052;0.9999501780647019;0.10204487284243313;-0.0634138659614304;-0.5324727669080006;-0.4797354736852967
Polycystic liver disease;Abnormality of inferior alveolar nerve;1.0840226113796234;0.94115794;0.4732232024143894;0.5187408261611131;0.9999056439461368;0.08411696743348662;-0.05874770689627107;-0.5266824415317474;-0.48116481778502374
Polycystic liver disease;Unilateral conductive hearing impairment;0.9927004650235176;0.8111139;0.5023235347821025;0.5604877034983894;0.9999567459343585;-0.007256280910840851;-0.18884285194861017;-0.497633211152256;-0.43946904243596907
Polycystic liver disease;Macular hypopigmented whorls, streaks, and patches;0.9211854785680771;0.7423572;0.5251134869474787;0.5829457800772652;0.9999567459343585;-0.07877126736628137;-0.2575995515106829;-0.47484325898687973;-0.4170109658570933
Polycystic liver disease;Delayed ossification of pubic rami;0.9503602869808674;0.74985254;0.5158073077401485;0.5804790923653675;0.9999548690865008;-0.04959458210563339;-0.2501023309776751;-0.4841475613463523;-0.41947577672113323
Polycystic liver disease;Hyperphenylalaninemia;0.60296630859375;0.55629134;0.6299603927194981;0.646337492517016;0.9999521228478421;-0.3969858142540921;-0.44366078106622586;-0.36999173012834397;-0.3536146303308261
Polycystic liver disease;Ureteropelvic junction obstruction;0.8991134762763977;0.7011237;0.5321679040492491;0.5966117929684838;0.9999481150251853;-0.10083463874878762;-0.29882440057816384;-0.46778021097593625;-0.40333632205670156
Polycystic liver disease;Cone-shaped epiphysis of the proximal phalanx of the 2nd toe;1.0300562735646963;0.86298424;0.4904313499264048;0.543751093637685;0.9999056439461368;0.03015062961855952;-0.13692140389105256;-0.509474294019732;-0.45615455030845176
Polycystic liver disease;Difficulty walking;0.9861332075670362;0.8383502;0.5044140785911198;0.5516815046761394;0.9999398952172014;-0.01380668765016524;-0.16158971840598313;-0.49552581662608164;-0.448258390541062
Polycystic liver disease;Bilobate gallbladder;0.4790220260620117;0.49904954;0.6744326385749675;0.6670161199334225;0.6905613626982415;-0.2115393366362298;-0.1915118183638299;-0.01612872412327404;-0.023545242764819063
Polycystic liver disease;Histidinuria;0.7824715375900269;0.7286776;0.5697994947170417;0.5874609680535;0.9999536937290383;-0.21748215613901145;-0.27127612290918357;-0.4301541990119966;-0.4124927256755383
Polycystic liver disease;Widened interpedicular distance;0.9517602398991585;0.76213545;0.5153611542383829;0.5764474378143463;0.9999056439461368;-0.04814540404697831;-0.23777019787451203;-0.4845444897077539;-0.4234582061317905
Subungual hyperkeratosis;Broad humeral epiphyses;0.9625847414135933;0.81805694;0.5119124271763043;0.5582386555230889;0.9999003561294039;-0.037315614715810574;-0.1818434150969942;-0.4879879289530996;-0.44166170060631493
Subungual hyperkeratosis;Autoimmune thrombocytopenia;0.9596919901669025;0.822659;0.5128339149099536;0.5567495530401326;0.9999440906008153;-0.04025210043391281;-0.17728507494529777;-0.4871101756908618;-0.4431945375606827
Subungual hyperkeratosis;Adenomyosis;0.9635589271783829;0.9278857;0.5116021225523151;0.522974633633728;0.9999556674707869;-0.03639674029240403;-0.07206995627770219;-0.4883535449184718;-0.4769810338370589
Subungual hyperkeratosis;Elevated leukocyte alkaline phosphatase;0.7889182418584824;0.72163147;0.5676986308968273;0.5897936541502864;0.9999556674707869;-0.21103742561230454;-0.2783242001284102;-0.43225703657395964;-0.4101620133205005
Subungual hyperkeratosis;Clasp-knife sign;0.8241881430149078;0.7920544;0.5562550367761434;0.5666776966716145;0.9999003561294039;-0.17571221311449603;-0.20784594138025836;-0.44364531935326046;-0.43322265945778937
Subungual hyperkeratosis;Keratosis pilaris;0.42294764518737793;0.566201;0.6957971495477968;0.6428272154639534;0.7586284122695459;-0.335680767082168;-0.19242744066615236;-0.0628312627217491;-0.11580119680559253
Subungual hyperkeratosis;Lamina lucida cleavage;0.8597190231084824;0.87205184;0.5448005860534587;0.540839105199173;0.7816812336249286;0.07803778948355378;0.09037060143519104;-0.23688064757146987;-0.24084212842575559
Subungual hyperkeratosis;Abnormal central response of multifocal electroretinogram;0.9643439389765263;0.8827454;0.5113520830138438;0.5374093559634401;0.9999003561294039;-0.035556417152877606;-0.11715497095942096;-0.48854827311556004;-0.4624910001659638
Subungual hyperkeratosis;Atypical or prolonged hepatitis;0.9090971350669861;0.7813868;0.528975279806362;0.5701532946967313;0.9999556674707869;-0.09085853240380082;-0.21856887481102738;-0.47098038766442485;-0.42980237277405564
Subungual hyperkeratosis;Cubitus varus;1.014201184734702;1.0215864;0.4954794705494613;0.49312831018543024;0.9999003561294039;0.014300828605298244;0.021686062022451602;-0.5044208855799426;-0.5067720459439736
Subungual hyperkeratosis;Nasal regurgitation;0.9688794314861298;0.9637151;0.5099075842930445;0.5115523881761237;0.9999536937290383;-0.031074262242908546;-0.0362386172825051;-0.4900461094359938;-0.4884013055529146
Subungual hyperkeratosis;Moon facies;0.872454971075058;0.90559435;0.5407097325348393;0.5300950688092063;0.9999536937290383;-0.12749872265398032;-0.0943593448215676;-0.45924396119419897;-0.469858624919832
Subungual hyperkeratosis;Intestinal pseudo-obstruction;1.0031516291201115;0.90477055;0.4989968036327267;0.5303584802908552;0.999947999865749;0.003203629254362461;-0.09517744675371898;-0.5009511962330223;-0.4695895195748938
Subungual hyperkeratosis;Bilateral renal atrophy;0.9590799175202847;0.9153781;0.5130289045716643;0.5269682480390396;0.9999556674707869;-0.04087574995050225;-0.08457757375130448;-0.4869267628991226;-0.47298741943174727
Subungual hyperkeratosis;Fractured left clavicle;1.0465342551469803;0.9778967;0.48518233546951417;0.5070362749884427;0.9999003561294039;0.04663389901757642;-0.022003665760751523;-0.5147180206598897;-0.49286408114096114
Subungual hyperkeratosis;Positive urine norcotinine test;0.9313509836792946;0.8634279;0.521868860413623;0.5436085441860313;0.9999003561294039;-0.06854937245010928;-0.1364724787032564;-0.47803149571578085;-0.45629181194337254
Subungual hyperkeratosis;Long fibula;0.9559214934706688;0.89109457;0.5140351717579237;0.5347345624312159;0.9999515360511232;-0.0440300425804544;-0.10885697065958266;-0.4859163642931995;-0.4652169736199073
Subungual hyperkeratosis;Fragmentation of the epiphysis of the distal phalanx of the hallux;0.7134506404399872;0.7732839;0.5925082418472714;0.5727989535008386;0.9999003561294039;-0.2864497156894167;-0.22661645729899005;-0.4073921142821325;-0.4271014026285652
Subungual hyperkeratosis;Type II cryptotia;0.9254992380738258;0.9165906;0.5237363212139293;0.5265809302497235;0.9999003561294039;-0.07440111805557803;-0.08330978472590045;-0.47616403491547454;-0.47331942587968034
Subungual hyperkeratosis;Increased variability in muscle fiber diameter;0.9351424872875214;0.8117848;0.5206592886620427;0.5602702458079281;0.9999393792871378;-0.06479689199961647;-0.18815457541979774;-0.47928009062509513;-0.4396691334792098
Subungual hyperkeratosis;Widened proximal tibial metaphyses;0.8482398241758347;0.7073701;0.5484941395555639;0.5945303885290473;0.9999556674707869;-0.15171584329495225;-0.2925855650652388;-0.451461527915223;-0.40542527894173963
Subungual hyperkeratosis;Wide anterior fontanel;0.888546422123909;0.83853865;0.5355506374748042;0.5516207142817222;0.9999398485671395;-0.11139342644323047;-0.16140120186914142;-0.4643892110923352;-0.44831913428541725
Subungual hyperkeratosis;Increased circulating oleate level;0.9920387677848339;0.9057712;0.5025341656905244;0.530038529368023;0.9999003561294039;-0.007861588344569959;-0.09412916024088458;-0.4973661904388794;-0.4698618267613809
Subungual hyperkeratosis;Lozenge-shaped umbilicus;0.8154871463775635;0.79851365;0.5590707335278483;0.5645771626623848;0.9999536937290383;-0.18446654735147483;-0.20144004283487327;-0.44088296020119;-0.4353765310666535
Subungual hyperkeratosis;Anti-myelin-associated glycoprotein antibody positivity;0.9688001088798046;0.90346515;0.5099328457297421;0.5307759305338262;0.9999003561294039;-0.031100247249599255;-0.09643520434259967;-0.4899675103996618;-0.46912442559557765
Subungual hyperkeratosis;Fractured radius;0.9733826965093613;0.903048;0.508473551603713;0.5309093323070271;0.9999556674707869;-0.026572970961425635;-0.09690768859276566;-0.4914821158670739;-0.4690463351637598
Subungual hyperkeratosis;Abnormal manual kinetic perimetry test;0.9270044490695;0.8671839;0.5232558893616035;0.542401971020225;0.9999003561294039;-0.0728959070599039;-0.1327164324080904;-0.47664446676780037;-0.45749838510917884
Subungual hyperkeratosis;Small radial epiphyses;0.8752161040902138;0.81702864;0.5398237567694706;0.5585715664372146;0.9999003561294039;-0.12468425203919009;-0.18287171442865924;-0.4600765993599333;-0.44132878969218925
Subungual hyperkeratosis;Generalized keratosis follicularis;0.35079073905944824;0.4915253;0.7249000557578849;0.6697904671696611;0.5961274693045353;-0.24533673024508706;-0.1046021769079899;0.12877258645334955;0.07366299786512576
Subungual hyperkeratosis;Hypoplasia of the calcaneus;0.8686884939670563;0.84821814;0.5419188099994194;0.5485011169780303;0.9999536937290383;-0.13126519976198203;-0.1517355507427407;-0.45803488372961887;-0.45145257675100803
Subungual hyperkeratosis;2-hydroxyadipic aciduria;0.8982851058244705;0.84362185;0.5324329459762585;0.5499818558004508;0.9999003561294039;-0.10161525030493335;-0.15627850611567096;-0.4674674101531454;-0.4499185003289531
Subungual hyperkeratosis;Potter facies;0.7618815898895264;0.79258233;0.5765306331793771;0.5665059094764315;0.9999496416008017;-0.23806805171127532;-0.20736730851288054;-0.42341900842142455;-0.43344373212437015
Subungual hyperkeratosis;Increased heart rate variability;0.9421888962388039;0.8532436;0.5184121115125644;0.5468833508757329;0.9999556674707869;-0.05776677123198304;-0.14671207806954178;-0.4815435559582225;-0.453072316595054
Subungual hyperkeratosis;Aplastic zygomatic arch;0.8966908007860184;0.96678203;0.5329431167883975;0.5105755597838126;0.9999536937290383;-0.10326289294301993;-0.03317166028558738;-0.46701057694064085;-0.48937813394522567
Subungual hyperkeratosis;Testicular torsion;0.9256188496947289;0.9107865;0.5236981417205216;0.5284353363527723;0.9999556674707869;-0.07433681777605805;-0.08916915795693192;-0.47625752575026525;-0.4715203311180146
Subungual hyperkeratosis;Abolished vibration sense;0.8705941140651703;0.8662605;0.5413070116470969;0.5426985426374805;0.9999536937290383;-0.12935957966386802;-0.13369316516458518;-0.45864668208194137;-0.4572551510915578
Subungual hyperkeratosis;Fractured metatarsal bone of digit 5;0.7855297774076462;0.8518648;0.5688024905216638;0.5473270640068103;0.9999003561294039;-0.2143705787217577;-0.14803554137110309;-0.4310978656077401;-0.45257329212259356
Subungual hyperkeratosis;Prolonged G2 phase of cell cycle;0.9638007692992687;0.9107537;0.5115250909891607;0.5284458202986309;0.9999515360511232;-0.03615076675185447;-0.08919780909189468;-0.48842644506196253;-0.47150571575249234
Subungual hyperkeratosis;Single naris;0.7779356092214584;0.783553;0.5712795199499352;0.5694468463366381;0.9999515360511232;-0.22201592682966476;-0.21639853178629165;-0.428672016101188;-0.4305046897144851
Subungual hyperkeratosis;Perifoveal ring of hyperautofluorescence surrounded by normal autofluorescence;0.800281211733818;0.7931698;0.5640028612364925;0.5663147691386696;0.9999003561294039;-0.1996191443955858;-0.20673055966257647;-0.4358974948929114;-0.43358558699073424
Subungual hyperkeratosis;Asymmetry of the thorax;1.0276222322136164;0.8933835;0.49120645193792156;0.5340017104032073;0.9999515360511232;0.02767069616249318;-0.10656803309091811;-0.5087450841132016;-0.46594982564791587
Subungual hyperkeratosis;Type 2 muscle fiber predominance;0.93337182700634;0.84166765;0.5212241293864269;0.5506117435187707;0.9999501780647019;-0.06657835105836185;-0.15828252593457492;-0.47872604867827495;-0.44933843454593114
Subungual hyperkeratosis;Dependency on parenteral nutrition;0.9651658460497856;0.84573567;0.5110902992127513;0.5493007257252291;0.9999536937290383;-0.03478784767925269;-0.15421802459299094;-0.488863394516287;-0.45065296800380916
Subungual hyperkeratosis;Limited shoulder flexion;0.9937687236815691;0.8308289;0.5019834896919296;0.5541090507577773;0.9999003561294039;-0.006131632447834767;-0.16907145102381305;-0.49791686643747424;-0.4457913053716266
Subungual hyperkeratosis;Paroxysmal vertigo;0.9607611373066902;0.86510384;0.5124933252888098;0.5430700755464131;0.9999536937290383;-0.03919255642234809;-0.1348498529010964;-0.48746036844022855;-0.45688361818262524
Subungual hyperkeratosis;Long hallux;0.7394006848335266;0.75510085;0.5839201463815324;0.5787548463641985;0.9999463141932816;-0.260545629359755;-0.24484546790269324;-0.41602616781174917;-0.4211914678290831
Subungual hyperkeratosis;Broad medial eyebrow;0.696501225233078;0.78863037;0.5981548298865027;0.5677923797512228;0.7760104688418579;-0.07950924360877987;0.012619897483520548;-0.17785563895535517;-0.2082180890906351
Subungual hyperkeratosis;Myxoid subcutaneous tumors;0.6723932027816772;0.6877811;0.6062421224052821;0.6010722487243327;0.8262112537450956;-0.15381805096341838;-0.1384301582403349;-0.21996913133981355;-0.2251390050207629
Subungual hyperkeratosis;Bulbous tips of toes;0.6290549635887146;0.6619046;0.6209661773997159;0.6097826643060784;0.9999536937290383;-0.3708987301403237;-0.33804912028848655;-0.37898751632932237;-0.3901710294229599
Subungual hyperkeratosis;Absent internal genitalia;0.735824704170227;0.8096691;0.5850997472731163;0.5609560949336903;0.9999003561294039;-0.2640756519591768;-0.19023127873301104;-0.41480060885628756;-0.4389442611957136
Subungual hyperkeratosis;Hyperphalangy of the 2nd finger;0.6616110801696777;0.6926559;0.6098819373592128;0.5994402502102041;0.9999556674707869;-0.33834458730110917;-0.30729974648842606;-0.3900737301115741;-0.4005154172605828
Subungual hyperkeratosis;Renal interstitial hemosiderin;0.8333685845136642;0.68051994;0.5532889991050747;0.6035082551887389;0.9999003561294039;-0.16653177161573962;-0.31938041766047076;-0.4466113570243292;-0.396392100940665
Subungual hyperkeratosis;Abnormality of depressor anguli oris muscle;0.9794447273015976;0.9894665;0.506543407354192;0.5033529787472042;0.9999003561294039;-0.02045562882780627;-0.010433867768045224;-0.49335694877521186;-0.4965473773821997
Subungual hyperkeratosis;Paroxysmal dyspnea;0.9778038673102856;0.8826796;0.5070658287361709;0.5374304426741242;0.9999003561294039;-0.0220964888191183;-0.11722077448725299;-0.49283452739323297;-0.46246991345527966
Subungual hyperkeratosis;Phenylpyruvic acidemia;0.9701692443341017;0.8862791;0.509496833293556;0.5362769719939677;0.9999556674707869;-0.029786423136685225;-0.11367656133065018;-0.4904588341772309;-0.46367869547681917
Subungual hyperkeratosis;Lateral ventricle dilatation;1.0177532937377691;0.8843755;0.4943486541997626;0.536886928416933;0.9999414386047084;0.017811855133060717;-0.11556592600476334;-0.5055927844049458;-0.46305451018777544
Subungual hyperkeratosis;Neonatal unconjugated hyperbilirubinemia;0.9443275220692158;0.7975631;0.5177302671079255;0.5648861111666533;0.9999556674707869;-0.05562814540157113;-0.2023925914514998;-0.48222540036286143;-0.4350695563041336
Subungual hyperkeratosis;High maternal circulating alpha-fetoprotein concentration;0.9132975488901138;0.8221799;0.5276329422922995;0.5569045141550941;0.9999003561294039;-0.08660280723929004;-0.17772044260859088;-0.47226741383710436;-0.44299584197430975
Subungual hyperkeratosis;Prominent nasolabial fold;0.7127452194690704;0.76231754;0.5927426383720775;0.5763877744482193;0.9999487417813083;-0.2872035223122379;-0.23763120351989475;-0.4072061034092308;-0.423560967333089
Subungual hyperkeratosis;Abnormality of inferior alveolar nerve;0.8336120247840881;0.8970909;0.5532104125778136;0.5328150678661905;0.9999003561294039;-0.16628833134531573;-0.10280944426416949;-0.4466899435515903;-0.4670852882632134
Subungual hyperkeratosis;Unilateral conductive hearing impairment;0.9151447489857674;0.80325377;0.527042784953148;0.5630375184658929;0.9999556674707869;-0.08481091848501954;-0.19670189759621415;-0.47291288251763886;-0.436918149004894
Subungual hyperkeratosis;Macular hypopigmented whorls, streaks, and patches;0.6545291244983673;0.743842;0.6122807911168271;0.5824567463821724;0.8095978540801885;-0.15506872958182116;-0.06575584835051318;-0.19731706296336138;-0.2271411076980161
Subungual hyperkeratosis;Delayed ossification of pubic rami;0.9004955962300301;0.86438084;0.531725736480029;0.5433023590460564;0.9999536937290383;-0.09945809749900825;-0.1355728572422219;-0.46822795724900934;-0.4566513346829819
Subungual hyperkeratosis;Hyperphenylalaninemia;0.8995736390352249;0.7771522;0.5320206819875006;0.5715353119526859;0.9999507979965523;-0.10037715896132737;-0.2227986173248604;-0.46793011600905166;-0.42841548604386637
Subungual hyperkeratosis;Ureteropelvic junction obstruction;0.9317351281642914;0.83693177;0.5217462958979955;0.5521390750977302;0.9999465554694025;-0.0682114273051111;-0.16301479038990419;-0.478200259571407;-0.4478074803716723
Subungual hyperkeratosis;Cone-shaped epiphysis of the proximal phalanx of the 2nd toe;0.7027673125267029;0.7573922;0.5960637082930842;0.5780028074764363;0.9999003561294039;-0.297133043602701;-0.24250812847971515;-0.4038366478363197;-0.4218975486529676
Subungual hyperkeratosis;Difficulty walking;0.9067423045635223;0.86216104;0.52972804386806;0.5440156410732984;0.9999377923649526;-0.09319548780143028;-0.1377767520588613;-0.47020974849689257;-0.45592215129165425
Subungual hyperkeratosis;Bilobate gallbladder;1.0548993460834026;0.99025357;0.4825162053724148;0.5031024360629175;0.9999536937290383;0.05494565235436433;-0.00970012603342063;-0.5174374883566235;-0.4968512576661208
Subungual hyperkeratosis;Histidinuria;0.7793532013893127;0.6941123;0.5708168078784661;0.598953210977927;0.9999524555142131;-0.22059925412490033;-0.30584015464141034;-0.42913564763574696;-0.4009992445362861
Subungual hyperkeratosis;Widened interpedicular distance;0.9969714758917689;0.86917084;0.5009640106378439;0.5417639369585756;0.9999003561294039;-0.0029288802376349343;-0.13072951157450274;-0.49893634549155996;-0.45813641917082826
Broad humeral epiphyses;Autoimmune thrombocytopenia;1.0159495882689953;0.85194474;0.494922873096718;0.5473013474650127;0.9998726169824932;0.016076971286502095;-0.1479278723955486;-0.5049497438857752;-0.4525712695174805
Broad humeral epiphyses;Adenomyosis;0.9674153327941895;0.88210905;0.5103738580210189;0.537613326074791;0.9999201345566091;-0.032504801762419655;-0.11781108857424827;-0.48954627653559024;-0.46230680848181815
Broad humeral epiphyses;Elevated leukocyte alkaline phosphatase;0.8552611917257309;0.70992506;0.5462341913956676;0.5936802482050157;0.9999201345566091;-0.1446589428308782;-0.2899950790527639;-0.45368594316094146;-0.40623988635159336
Broad humeral epiphyses;Clasp-knife sign;0.9581381306052208;0.96937406;0.5133289417925538;0.5097500697876425;1.0;-0.041861869394779205;-0.03062593936920166;-0.48667105820744616;-0.4902499302123575
Broad humeral epiphyses;Keratosis pilaris;1.0068255588412285;0.8329923;0.49782734027181474;0.5534104810786343;0.9998710980331391;0.006954460808089369;-0.16687878274078072;-0.5020437577613244;-0.4464606169545048
Broad humeral epiphyses;Lamina lucida cleavage;1.1596753895282745;1.005266;0.4489552490124826;0.49832380454105074;0.9998962300503706;0.1597791594779039;0.005369721106245562;-0.550940981037888;-0.5015724255093199
Broad humeral epiphyses;Abnormal central response of multifocal electroretinogram;1.0503368638455868;0.87227106;0.48397050447681667;0.5407687461365478;1.0;0.05033686384558678;-0.12772893905639648;-0.5160294955231833;-0.4592312538634522
Broad humeral epiphyses;Atypical or prolonged hepatitis;0.9869317933917046;0.7958489;0.5041598577658906;0.5654433904929457;0.9999201345566091;-0.012988341164904549;-0.20407122851641746;-0.49576027679071855;-0.43447674406366343
Broad humeral epiphyses;Cubitus varus;0.7736624479293823;0.8177665;0.5726752416815117;0.5583326768100985;1.0;-0.22633755207061768;-0.1822335124015808;-0.42732475831848826;-0.44166732318990154
Broad humeral epiphyses;Nasal regurgitation;0.9687434546649456;0.8946327;0.509950888126061;0.5336018174444861;0.9999134918687169;-0.031170037203771317;-0.1052807947633092;-0.4899626037426559;-0.4663116744242308
Broad humeral epiphyses;Moon facies;0.9001915007829666;0.7854199;0.531823017340916;0.5688383053495758;0.9999134918687169;-0.0997219910857503;-0.21449361052487537;-0.46809047452780095;-0.4310751865191411
Broad humeral epiphyses;Intestinal pseudo-obstruction;0.9489872753620148;0.8387715;0.5162449054563412;0.551545603662895;0.9998912449978579;-0.050903969635843094;-0.16111972295272237;-0.4836463395415167;-0.4483456413349629
Broad humeral epiphyses;Bilateral renal atrophy;0.8744165599346161;0.7237831;0.5400802774844107;0.5890808223706083;0.9999201345566091;-0.12550357462199302;-0.27613705874713035;-0.45983985707219843;-0.4108393121860008
Broad humeral epiphyses;Fractured left clavicle;0.5230099558830261;0.6667593;0.6582722270837731;0.6081421696716041;1.0;-0.4769900441169739;-0.33324068784713745;-0.3417277729162269;-0.39185783032839594
Broad humeral epiphyses;Positive urine norcotinine test;0.9284959062933922;0.8578988;0.5227798997703794;0.545385853133789;1.0;-0.07150409370660782;-0.1421012282371521;-0.4772201002296206;-0.45461414686621104
Broad humeral epiphyses;Long fibula;0.5851931571960449;0.64983594;0.6361508502516982;0.6138741555793392;0.6109530888848884;-0.025759931688843496;0.0388828552908318;0.025197761366809734;0.0029210666944508024
Broad humeral epiphyses;Fragmentation of the epiphysis of the distal phalanx of the hallux;0.5346970856189728;0.6023326;0.6540545994863625;0.6301802194860382;1.0;-0.4653029143810272;-0.39766740798950195;-0.34594540051363754;-0.3698197805139618
Broad humeral epiphyses;Type II cryptotia;0.944161631166935;0.7923081;0.5177831540902109;0.5665951463653942;1.0;-0.05583836883306503;-0.20769190788269043;-0.4822168459097891;-0.4334048536346058
Broad humeral epiphyses;Increased variability in muscle fiber diameter;0.8342810273170471;0.6891666;0.5529944643904958;0.6006081215735918;0.7712186293488323;0.06306239796821478;-0.08205202387626764;-0.21822416495833652;-0.17061050777524056
Broad humeral epiphyses;Widened proximal tibial metaphyses;0.4065682291984558;0.3743279;0.7022273175425775;0.7151751942806639;0.4693866352828394;-0.0628184060843836;-0.09505873725732672;0.23284068225973809;0.24578855899782448
Broad humeral epiphyses;Wide anterior fontanel;0.9406005591154099;0.6946513;0.5189185654512495;0.598773018977385;0.6617971500655027;0.2788034090499072;0.03285415561000393;-0.14287858461425318;-0.06302413108811766
Broad humeral epiphyses;Increased circulating oleate level;0.8685723841190338;0.71446395;0.5419560920178754;0.5921716408738429;1.0;-0.1314276158809662;-0.2855360507965088;-0.4580439079821246;-0.4078283591261571
Broad humeral epiphyses;Lozenge-shaped umbilicus;0.9649915285408497;0.9088426;0.5111458200633641;0.5290566335803794;0.9999134918687169;-0.034921963327867234;-0.09107086863492175;-0.48876767180535285;-0.47085685828833757
Broad humeral epiphyses;Anti-myelin-associated glycoprotein antibody positivity;1.0326175466179848;0.866242;0.4896156705708796;0.5427044918710746;1.0;0.03261754661798477;-0.13375800848007202;-0.5103843294291204;-0.4572955081289254
Broad humeral epiphyses;Fractured radius;0.4613981246948242;0.5854665;0.6810472948267705;0.6360552329778095;0.35601339282121613;0.10538473187360808;0.22945311127576873;0.3250339020055544;0.2800418401565934
Broad humeral epiphyses;Abnormal manual kinetic perimetry test;0.9497044607996941;0.85455936;0.5160163247971845;0.546459979942612;1.0;-0.05029553920030594;-0.14544063806533813;-0.4839836752028155;-0.453540020057388
Broad humeral epiphyses;Small radial epiphyses;0.28045332431793213;0.3953048;0.7556503656488864;0.7067050664076628;1.0;-0.7195466756820679;-0.604695200920105;-0.24434963435111356;-0.29329493359233716
Broad humeral epiphyses;Generalized keratosis follicularis;0.9448921494185925;0.75272024;0.5175502642954286;0.5795366660816137;0.9999201345566091;-0.055027985138016655;-0.24719989777834983;-0.4823698702611805;-0.4203834684749954
Broad humeral epiphyses;Hypoplasia of the calcaneus;0.6439780592918396;0.7543062;0.6158671653617936;0.5790157674179799;0.6433114794007544;0.0006665798910852061;0.11099471776568848;-0.02744431403896075;-0.0642957119827745
Broad humeral epiphyses;2-hydroxyadipic aciduria;0.846513569355011;0.7510551;0.5490501374344454;0.5800837920256183;1.0;-0.153486430644989;-0.24894487857818604;-0.4509498625655546;-0.41991620797438167
Broad humeral epiphyses;Potter facies;0.8191468417644501;0.7185224;0.5578858766337556;0.5908244931215709;0.9998981869165328;-0.1807513451520827;-0.2813757574502852;-0.4420123102827772;-0.40907369379496183
Broad humeral epiphyses;Increased heart rate variability;0.9970474587753415;0.72575396;0.5009398244266638;0.5884282663299754;0.9999201345566091;-0.0028726757812675974;-0.2741661715629873;-0.49898031012994526;-0.41149186822663375
Broad humeral epiphyses;Aplastic zygomatic arch;0.9821765273809433;0.73659515;0.5056736879670645;0.5848454902900193;0.8072246192530101;0.17495190812793315;-0.0706294654444164;-0.3015509312859457;-0.22237912896299084
Broad humeral epiphyses;Testicular torsion;0.8912090435624123;0.824329;0.5346979122511747;0.5562094857472651;0.9999201345566091;-0.10871109099419685;-0.17559111596377464;-0.4652222223054344;-0.44371064880934397
Broad humeral epiphyses;Abolished vibration sense;0.9311697855591774;0.91992384;0.5219266743176704;0.5255163541267835;0.9999134918687169;-0.06874370630953952;-0.07998964991543933;-0.47798681755104655;-0.4743971377419334
Broad humeral epiphyses;Fractured metatarsal bone of digit 5;0.6077196300029755;0.742991;0.628313696079496;0.5827370027149967;1.0;-0.39228036999702454;-0.25700902938842773;-0.37168630392050395;-0.41726299728500327
Broad humeral epiphyses;Prolonged G2 phase of cell cycle;0.9661104530096054;0.7962049;0.5107894437996667;0.5653276277892899;0.9999056439461368;-0.03379519093653138;-0.20370071936270173;-0.48911620014647006;-0.4345780161568469
Broad humeral epiphyses;Single naris;1.0421345084905624;0.9718011;0.4865841978495893;0.5089771702610884;0.9999056439461368;0.04222886454442565;-0.02810454178472932;-0.5133214460965475;-0.49092847368504844
Broad humeral epiphyses;Perifoveal ring of hyperautofluorescence surrounded by normal autofluorescence;0.9255935698747635;0.7557009;0.5237062108972896;0.5785578740218977;1.0;-0.07440643012523651;-0.24429911375045776;-0.47629378910271036;-0.42144212597810227
Broad humeral epiphyses;Asymmetry of the thorax;0.7122465670108795;0.6497857;0.5929083613022896;0.613891240955099;0.789736248610815;-0.07748968159993552;-0.13995055115064048;-0.1968278873085254;-0.1758450076557161
Broad humeral epiphyses;Type 2 muscle fiber predominance;0.8455700874328613;0.8033762;0.549354080876326;0.5629977720645889;0.8527273749847077;-0.007157287551846414;-0.049351177169766336;-0.30337329410838176;-0.28972960292011884
Broad humeral epiphyses;Dependency on parenteral nutrition;0.9467887580394745;0.87522507;0.5169456675597925;0.5398208908301786;0.9999134918687169;-0.05312473382924243;-0.12468842473004504;-0.4829678243089244;-0.46009260103853833
Broad humeral epiphyses;Limited shoulder flexion;0.5196467936038971;0.70568043;0.6594915167744083;0.5950930017122762;1.0;-0.4803532063961029;-0.2943195700645447;-0.3405084832255917;-0.4049069982877238
Broad humeral epiphyses;Paroxysmal vertigo;1.0945164561271667;0.9073532;0.4698695024351772;0.5295327418839979;0.9999134918687169;0.09460296425844983;-0.09256026949856921;-0.5300439894335397;-0.470380749984719
Broad humeral epiphyses;Long hallux;0.6815111041069031;0.7139778;0.6031753572515373;0.592333106981225;0.5200670694678955;0.16144403463900758;0.19391074425280763;0.08310828778364177;0.0722660375133295
Broad humeral epiphyses;Broad medial eyebrow;0.8696334660053253;0.6730547;0.5416154078876474;0.6060192912610383;0.9999201345566091;-0.1302866685512838;-0.3268654394272146;-0.4583047266689617;-0.39390084329557085
Broad humeral epiphyses;Myxoid subcutaneous tumors;1.0024416111409664;0.91588205;0.4992228102634144;0.5268072475504794;0.9999201345566091;0.0025214765843573073;-0.08403808356555076;-0.5006973242931947;-0.47311288700612975
Broad humeral epiphyses;Bulbous tips of toes;0.7523094117641449;0.70563924;0.579671639278587;0.5951067294983984;0.6433114794007544;0.1089979323633905;0.062327763725161134;-0.06363984012216739;-0.048204749902356014
Broad humeral epiphyses;Absent internal genitalia;0.9690496064722538;0.8578808;0.5098533898061324;0.5453916416521996;1.0;-0.0309503935277462;-0.14211922883987427;-0.4901466101938676;-0.45460835834780045
Broad humeral epiphyses;Hyperphalangy of the 2nd finger;0.7351608872413635;0.6996014;0.5853188504103176;0.5971196934397398;0.660589513309896;0.07457137393146751;0.03901189850956199;-0.0752706628995784;-0.06346981987015621
Broad humeral epiphyses;Renal interstitial hemosiderin;0.9398874156177044;0.82790226;0.5191459724551177;0.5550544927401848;1.0;-0.06011258438229561;-0.17209774255752563;-0.48085402754488227;-0.4449455072598152
Broad humeral epiphyses;Abnormality of depressor anguli oris muscle;0.7787255644798279;0.8080854;0.5710216541561839;0.5614696680356281;1.0;-0.22127443552017212;-0.1919146180152893;-0.4289783458438161;-0.43853033196437186
Broad humeral epiphyses;Paroxysmal dyspnea;0.9702302925288677;0.8341242;0.509477392415435;0.5530450726294143;1.0;-0.02976970747113228;-0.16587579250335693;-0.490522607584565;-0.44695492737058573
Broad humeral epiphyses;Phenylpyruvic acidemia;0.9131338819861412;0.77044445;0.5276852363849214;0.5737272625167347;0.9999201345566091;-0.0867862525704679;-0.22947568179400535;-0.47223489817168773;-0.42619287203987444
Broad humeral epiphyses;Lateral ventricle dilatation;0.9977194247767329;0.794471;0.5007259302690159;0.5658914754904514;0.9998579617208769;-0.0021385369441440094;-0.20538693625395799;-0.499132031451861;-0.43396648623042555
Broad humeral epiphyses;Neonatal unconjugated hyperbilirubinemia;0.9530796147882938;0.824504;0.5149407079507298;0.5561528978988861;0.9999201345566091;-0.04684051976831527;-0.1754161167267141;-0.48497942660587934;-0.443767236657723
Broad humeral epiphyses;High maternal circulating alpha-fetoprotein concentration;0.9344758242368698;0.734581;0.5208719464684274;0.5855102970777633;1.0;-0.06552417576313019;-0.26541900634765625;-0.4791280535315726;-0.41448970292223675
Broad humeral epiphyses;Prominent nasolabial fold;0.9555693864822388;0.7532782;0.5141473608069843;0.5793533832200629;0.9998944404568447;-0.044325053974605955;-0.24661624459884302;-0.4857470796498604;-0.4205410572367818
Broad humeral epiphyses;Abnormality of inferior alveolar nerve;1.0499367490410805;0.91430587;0.4840980253509748;0.5273107812224218;1.0;0.049936749041080475;-0.08569413423538208;-0.5159019746490252;-0.4726892187775782
Broad humeral epiphyses;Unilateral conductive hearing impairment;1.047025166451931;0.90121984;0.4850259022879826;0.5314940643456127;0.9999201345566091;0.04710503189532189;-0.09870028973849387;-0.5148942322686265;-0.46842607021099636
Broad humeral epiphyses;Macular hypopigmented whorls, streaks, and patches;1.061640102416277;0.91744643;0.48036689993733217;0.5263075600987981;0.9999201345566091;0.061719967859667824;-0.08247370005877586;-0.5195532346192769;-0.473612574457811
Broad humeral epiphyses;Delayed ossification of pubic rami;0.6384468078613281;0.6517926;0.6177534085964858;0.6132095093907496;0.6574179255159834;-0.018971117654655312;-0.005625339666221474;-0.03966451691949768;-0.04420841612523385
Broad humeral epiphyses;Hyperphenylalaninemia;0.893825352191925;0.6945304;0.5338602625486273;0.5988134263232314;0.9999028053808913;-0.10607745318896622;-0.30537237792498917;-0.466042542832264;-0.40108937905765984
Broad humeral epiphyses;Ureteropelvic junction obstruction;0.9217940792441368;0.8197985;0.5249191635160531;0.5576749681168025;0.9998847295244674;-0.07809065028033058;-0.18008620037636558;-0.47496556600841433;-0.4422097614076649
Broad humeral epiphyses;Cone-shaped epiphysis of the proximal phalanx of the 2nd toe;0.555653989315033;0.61790025;0.6465639128303192;0.6247989258178324;1.0;-0.44434601068496704;-0.3820997476577759;-0.3534360871696808;-0.37520107418216764
Broad humeral epiphyses;Difficulty walking;1.0286240205168724;0.95228034;0.4908874466265186;0.5151954071509801;0.7552776988623575;0.2733463216545149;0.19700264371653042;-0.2643902522358389;-0.2400822917113774
Broad humeral epiphyses;Bilobate gallbladder;0.9482763335108757;0.8310403;0.5164715044407637;0.5540407667184315;0.9999134918687169;-0.05163715835784122;-0.1688731690881078;-0.4834419874279532;-0.4458727251502854
Broad humeral epiphyses;Histidinuria;0.8820943981409073;0.7811085;0.5376180237623164;0.570244067448261;0.9999090677057578;-0.11781466956485054;-0.2188005691324546;-0.46229104394344145;-0.4296650002574969
Broad humeral epiphyses;Widened interpedicular distance;0.5463722944259644;0.53756213;0.649870406116084;0.6530251716642874;1.0;-0.45362770557403564;-0.46243786811828613;-0.35012959388391596;-0.3469748283357126
Autoimmune thrombocytopenia;Adenomyosis;1.0053154360502958;0.8112351;0.4983080361883311;0.5604484156532705;0.9999509115718902;0.00536452447840563;-0.18871584134331354;-0.5016428753835591;-0.4395024959186197
Autoimmune thrombocytopenia;Elevated leukocyte alkaline phosphatase;0.7176089882850647;0.5784105;0.591127554033887;0.6385276645060791;0.9999509115718902;-0.2823419232868255;-0.4215404053234161;-0.40882335753800325;-0.3614232470658111
Autoimmune thrombocytopenia;Clasp-knife sign;1.02124734967947;0.979191;0.4932362495610022;0.5066241916209665;0.9998726169824932;0.021374732696976873;-0.02068161175254324;-0.506636367421491;-0.4932484253615267
Autoimmune thrombocytopenia;Keratosis pilaris;0.866925448179245;0.7298045;0.5424849736377918;0.5870883213981204;0.9999359310045346;-0.1330104828252896;-0.27013141516591155;-0.4574509573667428;-0.4128476096064142
Autoimmune thrombocytopenia;Lamina lucida cleavage;0.8855332881212234;0.8544563;0.536515926511422;0.5464931462187961;0.9999428147971705;-0.11440952667594706;-0.1454865092933253;-0.4634268882857485;-0.45344966857837443
Autoimmune thrombocytopenia;Abnormal central response of multifocal electroretinogram;0.9293278008699417;0.79709977;0.5225144278605971;0.5650367116902042;0.9998726169824932;-0.07054481611255148;-0.2027728478670452;-0.4773581891218961;-0.434835905292289
Autoimmune thrombocytopenia;Atypical or prolonged hepatitis;0.7785695195198059;0.6291514;0.5710725882882741;0.6209331217708736;0.7436433544643041;0.034926165055501834;-0.11449195056034289;-0.17257076617602995;-0.12271023269343051
Autoimmune thrombocytopenia;Cubitus varus;1.0006923519540578;0.9411846;0.499779617510698;0.5187323425079413;0.9998726169824932;0.0008197349715646229;-0.05868803665641287;-0.5000929994717952;-0.4811402744745519
Autoimmune thrombocytopenia;Nasal regurgitation;1.0170445311814547;0.87903416;0.4945742944888647;0.5385991506898768;0.9999484800242363;0.01709605115721835;-0.12091431845654832;-0.5053741855353716;-0.46134932933435946
Autoimmune thrombocytopenia;Moon facies;0.9655999913811684;0.9285113;0.5109520235850373;0.5227749851093797;0.9999484800242363;-0.03434848864306794;-0.07143715847958909;-0.488996456439199;-0.4771734949148566
Autoimmune thrombocytopenia;Intestinal pseudo-obstruction;0.9099423289299011;0.7129357;0.5287051381819319;0.5926793353212312;0.9999413328681149;-0.0899990039382138;-0.28700564675666473;-0.47123619468618305;-0.40726199754688375
Autoimmune thrombocytopenia;Bilateral renal atrophy;0.8269016742706299;0.6698318;0.5553778409695389;0.6071054672756715;0.9999509115718902;-0.17304923730126032;-0.3301190991901458;-0.4445730706023513;-0.3928454442962187
Autoimmune thrombocytopenia;Fractured left clavicle;0.8601454496383667;0.7867983;0.5446634988555796;0.5683891469195258;0.9998726169824932;-0.1397271673441265;-0.21307431862357595;-0.45520911812691356;-0.4314834700629674
Autoimmune thrombocytopenia;Positive urine norcotinine test;0.9727403651922941;0.8693727;0.5086780862425977;0.5416991152346524;0.9998726169824932;-0.02713225179019907;-0.13049989149573782;-0.4911945307398955;-0.4581735017478408
Autoimmune thrombocytopenia;Long fibula;0.998462634626776;0.8557607;0.5004893587897399;0.5460735184733811;0.9999457950338347;-0.001483160407058759;-0.14418510148372488;-0.49945643624409486;-0.4538722765604536
Autoimmune thrombocytopenia;Fragmentation of the epiphysis of the distal phalanx of the hallux;0.9324977695941925;0.8085031;0.5215029783127041;0.561334194312228;0.9998726169824932;-0.06737484738830068;-0.19136952564719656;-0.4783696386697891;-0.4385384226702652
Autoimmune thrombocytopenia;Type II cryptotia;0.8967668861150742;0.7965357;0.5329187678882387;0.5652200998266088;0.9998726169824932;-0.10310573086741903;-0.2033369462251995;-0.4669538490942545;-0.4346525171558844
Autoimmune thrombocytopenia;Increased variability in muscle fiber diameter;1.0257228035479784;0.88834286;0.49181127413199366;0.53561584113835;0.9999301217850027;0.025792681762975667;-0.11158726442416289;-0.5081188476530091;-0.4643142806466527
Autoimmune thrombocytopenia;Widened proximal tibial metaphyses;0.9478202685713768;0.7376638;0.516616870723838;0.5844929385118642;0.9999509115718902;-0.0521306430005134;-0.26228710608711847;-0.4833340408480522;-0.41545797306002596
Autoimmune thrombocytopenia;Wide anterior fontanel;0.9501443691551685;0.8323342;0.5158761217230401;0.5536229454948159;0.9999307446020095;-0.04978637544684095;-0.16759652419261617;-0.4840546228789694;-0.44630779910719354
Autoimmune thrombocytopenia;Increased circulating oleate level;0.9191456735134125;0.7987028;0.5257648562584343;0.5645157125548267;0.9998726169824932;-0.08072694346908071;-0.20116984055045584;-0.4741077607240589;-0.4353569044276665
Autoimmune thrombocytopenia;Lozenge-shaped umbilicus;0.9132698476314545;0.87241;0.5276417932178153;0.5407241653910096;0.9999484800242363;-0.08667863239278184;-0.12753848065366136;-0.47230668680642096;-0.45922431463322666
Autoimmune thrombocytopenia;Anti-myelin-associated glycoprotein antibody positivity;0.8447594344615936;0.6955831;0.5496152695950718;0.598461580908148;0.0;0.8447594344615936;0.6955831050872803;0.5496152695950718;0.598461580908148
Autoimmune thrombocytopenia;Fractured radius;0.9653347693383694;0.83854735;0.5110364967657783;0.5516178978215236;0.9999509115718902;-0.03461614223352083;-0.16140356259575495;-0.48891441480611186;-0.4483330137503666
Autoimmune thrombocytopenia;Abnormal manual kinetic perimetry test;0.9555118903517723;0.7372414;0.5141656805083675;0.5846322868415313;0.9998726169824932;-0.04436072663072088;-0.26263122961524465;-0.48570693647412566;-0.41524033014096184
Autoimmune thrombocytopenia;Small radial epiphyses;1.0235617756843567;0.9181144;0.49249935974859804;0.5260942030204878;0.9998726169824932;0.0236891587018635;-0.08175819323066214;-0.5073732572338951;-0.4737784139620054
Autoimmune thrombocytopenia;Generalized keratosis follicularis;0.9500073492527008;0.84573853;0.515919790967632;0.5492998232027457;0.9999509115718902;-0.049943562319189394;-0.15421238141289362;-0.48403112060425824;-0.45065108836914447
Autoimmune thrombocytopenia;Hypoplasia of the calcaneus;0.9845569115132093;0.8261462;0.5049158831490895;0.5556220276340436;0.9999484800242363;-0.015391568511026965;-0.1738022946261345;-0.4950325968751468;-0.44432645239019275
Autoimmune thrombocytopenia;2-hydroxyadipic aciduria;0.9013459384441376;0.7870564;0.5314537257221176;0.5683050640732583;0.9998726169824932;-0.09852667853835562;-0.2128162305116985;-0.4684188912603756;-0.4315675529092349
Autoimmune thrombocytopenia;Potter facies;0.9809745475649834;0.9028562;0.506056355004287;0.5309706785527848;0.9999434141430041;-0.01896886657802077;-0.0970872430118701;-0.4938870591387171;-0.46897273559021935
Autoimmune thrombocytopenia;Increased heart rate variability;0.8560135662555695;0.740266;0.5459921679068186;0.5836348763846595;0.9999509115718902;-0.14393734531632074;-0.25968488650551447;-0.4539587436650716;-0.4163160351872307
Autoimmune thrombocytopenia;Aplastic zygomatic arch;0.9034507721662521;0.7194266;0.5307805220417887;0.5905246201976994;0.9999484800242363;-0.09649770785798417;-0.28052190770139085;-0.4691679579824476;-0.40942385982653695
Autoimmune thrombocytopenia;Testicular torsion;0.8196089714765549;0.6900467;0.5577363162930778;0.600313413826255;0.9999509115718902;-0.18034194009533533;-0.3099041839145721;-0.44221459527881235;-0.3996374977456352
Autoimmune thrombocytopenia;Abolished vibration sense;0.9832705818116665;0.82586557;0.5053253876249029;0.5557127349170017;0.9999484800242363;-0.01667789821256982;-0.17408291329373704;-0.49462309239933344;-0.4442357451072346
Autoimmune thrombocytopenia;Fractured metatarsal bone of digit 5;0.8760378360748291;0.81747997;0.5395601445382091;0.5584254344732409;0.9998726169824932;-0.12383478090766409;-0.1823926489115093;-0.4603124724442841;-0.4414471825092523
Autoimmune thrombocytopenia;Prolonged G2 phase of cell cycle;0.8278725892305374;0.8116478;0.5550640794856025;0.5603146584900935;0.9999457950338347;-0.17207320580329732;-0.18829802224483327;-0.4448817155482322;-0.4396311365437412
Autoimmune thrombocytopenia;Single naris;1.1037314683198929;1.0406172;0.46692174472604464;0.4870675631180703;0.9999457950338347;0.10378567328605814;0.04067143252048655;-0.5330240503077901;-0.5128782319157644
Autoimmune thrombocytopenia;Perifoveal ring of hyperautofluorescence surrounded by normal autofluorescence;0.8391594886779785;0.6990487;0.5514204769913975;0.5973041637880312;0.9998726169824932;-0.16071312830451467;-0.3008239190340374;-0.4484521399910957;-0.402568453194462
Autoimmune thrombocytopenia;Asymmetry of the thorax;0.7803480625152588;0.56977427;0.5704921690994129;0.6415660249494036;0.9999457950338347;-0.21959773251857595;-0.4301715249761565;-0.4294536259344218;-0.3583797700844311
Autoimmune thrombocytopenia;Type 2 muscle fiber predominance;1.070795625448227;0.94424725;0.4774461856676371;0.5177558643413283;0.9999440906008153;0.07085153484741158;-0.05569684481224113;-0.5224979049331783;-0.4821882262594871
Autoimmune thrombocytopenia;Dependency on parenteral nutrition;0.8501946032047272;0.8014556;0.547864717725516;0.5636213870604865;0.9999484800242363;-0.14975387681950914;-0.19849286307324754;-0.45208376229872027;-0.43632709296374983
Autoimmune thrombocytopenia;Limited shoulder flexion;0.9970256527885795;0.7965269;0.5009467655183067;0.5652229387196752;0.9998726169824932;-0.002846964193913726;-0.20334570810798147;-0.49892585146418644;-0.434649678262818
Autoimmune thrombocytopenia;Paroxysmal vertigo;0.9185165464878082;0.670717;0.5259657765780936;0.6068070023940246;0.9999484800242363;-0.08143193353642808;-0.3292314790629326;-0.4739827034461427;-0.3931414776302117
Autoimmune thrombocytopenia;Long hallux;0.9913383927196264;0.87296814;0.50275710970296;0.5405450470676898;0.9999391782875108;-0.00860078556788435;-0.12697104102325907;-0.49718206858455083;-0.459394131219821
Autoimmune thrombocytopenia;Broad medial eyebrow;0.9912313111126423;0.918933;0.5027911961316294;0.5258327834936933;0.9999509115718902;-0.008719600459247911;-0.0810179372333587;-0.49715971544026083;-0.47411812807819687
Autoimmune thrombocytopenia;Myxoid subcutaneous tumors;0.959252193570137;0.8507216;0.512974021626472;0.5476950624673571;0.9999509115718902;-0.040698718001753176;-0.1492293139003814;-0.4869768899454182;-0.4522558491045331
Autoimmune thrombocytopenia;Bulbous tips of toes;0.8651489317417145;0.79919225;0.5430555998822912;0.5643566605819406;0.9999484800242363;-0.13479954828252183;-0.20075623024930345;-0.45689288014194507;-0.43559181944229575
Autoimmune thrombocytopenia;Absent internal genitalia;0.9899408593773842;0.83623683;0.503201977907628;0.5523632972630569;0.9998726169824932;-0.009931757605109004;-0.16363578245643118;-0.4966706390748652;-0.4475093197194363
Autoimmune thrombocytopenia;Hyperphalangy of the 2nd finger;0.8252547085285187;0.72836894;0.5559101999497877;0.5875630423415468;0.9999509115718902;-0.17469620304337152;-0.27158197360268244;-0.44404071162210246;-0.41238786923034343
Autoimmune thrombocytopenia;Renal interstitial hemosiderin;0.8010864406824112;0.71202284;0.5637413007433215;0.5929827231816711;0.9998726169824932;-0.198786176300082;-0.2878497760057781;-0.4361313162391717;-0.4068898938008221
Autoimmune thrombocytopenia;Abnormality of depressor anguli oris muscle;1.003241565078497;0.8079072;0.4989681759817771;0.5615274430421151;0.9998726169824932;0.0033689480960037432;-0.19196539328101614;-0.5009044410007161;-0.4383451739403781
Autoimmune thrombocytopenia;Paroxysmal dyspnea;0.8284169733524323;0.6552298;0.5548881796356412;0.6120431563041571;0.9998726169824932;-0.17145564363006094;-0.3446428100824688;-0.444984437346852;-0.3878294606783361
Autoimmune thrombocytopenia;Phenylpyruvic acidemia;0.7996740341186523;0.6480402;0.5642001181781562;0.6144846214242297;0.9999509115718902;-0.20027687745323786;-0.35191073613396295;-0.435750793393734;-0.38546629014766054
Autoimmune thrombocytopenia;Lateral ventricle dilatation;0.912288598716259;0.8326888;0.5279553293454824;0.5535084690131005;0.9999328439703079;-0.0876442452540489;-0.1672440355291458;-0.4719775146248255;-0.44642437495720744
Autoimmune thrombocytopenia;Neonatal unconjugated hyperbilirubinemia;0.6232390403747559;0.6992018;0.622962182120146;0.5972530545861698;0.9999509115718902;-0.37671187119713434;-0.3007490892910064;-0.3769887294517442;-0.40269785698572036
Autoimmune thrombocytopenia;High maternal circulating alpha-fetoprotein concentration;0.7607908248901367;0.7022751;0.5768881663863741;0.5962278145965246;0.9998726169824932;-0.23908179209235647;-0.2975975196123455;-0.4229844505961191;-0.40364480238596856
Autoimmune thrombocytopenia;Prominent nasolabial fold;1.038852408528328;0.8984143;0.4876297807704141;0.5323916012732981;0.9999422754987515;0.038910133029576466;-0.1015279617055691;-0.5123124947283374;-0.4675506742254534
Autoimmune thrombocytopenia;Abnormality of inferior alveolar nerve;1.0526290945708752;0.8301966;0.48323989573347637;0.5543132585834973;0.9998726169824932;0.05275647758838198;-0.1696759979486797;-0.5166327212490168;-0.44555935839899585
Autoimmune thrombocytopenia;Unilateral conductive hearing impairment;1.0445358641445637;0.8702731;0.48581910368219294;0.5414100579836446;0.9999509115718902;0.044584952572673475;-0.12967779832115778;-0.5141318078896973;-0.4585408535882456
Autoimmune thrombocytopenia;Macular hypopigmented whorls, streaks, and patches;0.8522731959819794;0.732373;0.5471956356959804;0.5862394803709805;0.9999509115718902;-0.14767771558991083;-0.267577912380606;-0.4527552758759098;-0.4137114312009097
Autoimmune thrombocytopenia;Delayed ossification of pubic rami;0.9225115031003952;0.7301657;0.5246901052822897;0.5869689308959707;0.9999484800242363;-0.0774369769238411;-0.2697827600382744;-0.47525837474194665;-0.4129795491282656
Autoimmune thrombocytopenia;Hyperphenylalaninemia;0.8065526485443115;0.5961429;0.5619668691241523;0.6323306990867481;0.9999448700945737;-0.19339222155026214;-0.40380198202542084;-0.4379780009704214;-0.36761417100782556
Autoimmune thrombocytopenia;Ureteropelvic junction obstruction;0.8824070021510124;0.7163664;0.5375178217450209;0.5915399486545493;0.9999394877822739;-0.11753248563126151;-0.2835730775268418;-0.462421666037253;-0.40839953912772464
Autoimmune thrombocytopenia;Cone-shaped epiphysis of the proximal phalanx of the 2nd toe;0.9174566194415092;0.814765;0.5263043022685374;0.5593046297029671;0.9998726169824932;-0.08241599754098394;-0.18510764048102835;-0.4735683147139558;-0.44056798727952606
Autoimmune thrombocytopenia;Difficulty walking;0.9617986343801022;0.8409474;0.512162831859947;0.5508439479451555;0.9999280047072615;-0.03812937032715935;-0.15898061510460038;-0.48776517284731447;-0.44908405676210605
Autoimmune thrombocytopenia;Bilobate gallbladder;0.9435319267213345;0.8185614;0.517983912007223;0.5580753762312908;0.9999484800242363;-0.05641655330290185;-0.1813871048830925;-0.48196456801701326;-0.44187310379294553
Autoimmune thrombocytopenia;Histidinuria;0.7349104583263397;0.65068614;0.5854015191379142;0.6135852954532404;0.9999469426585951;-0.26503648433225535;-0.3492607978297987;-0.4145454235206809;-0.3863616472053547
Autoimmune thrombocytopenia;Widened interpedicular distance;0.9790253825485706;0.7788813;0.5066769177225798;0.5709708288719524;0.9998726169824932;-0.020847234433922557;-0.2209913055658672;-0.49319569925991336;-0.4289017881105408
Adenomyosis;Elevated leukocyte alkaline phosphatase;0.9893433898687363;0.8022616;0.5033921685643853;0.5633596675348813;0.9999600672783046;-0.010616677409568287;-0.19769847632066295;-0.49656789871391926;-0.43660039974342324
Adenomyosis;Clasp-knife sign;0.9841724745929241;0.95592993;0.5050382681823944;0.514032482128902;0.9999201345566091;-0.01574765996368499;-0.043990199578124;-0.4948818663742147;-0.48588765242770715
Adenomyosis;Keratosis pilaris;0.9873776882886887;0.8965508;0.504017913299855;0.5329879310014385;0.9999506876445663;-0.012572999355877634;-0.10339991307028651;-0.4959327743447113;-0.4669627566431278
Adenomyosis;Lamina lucida cleavage;0.9233235344290733;0.950201;0.5244308563368494;0.5158580740089229;0.9999548690865008;-0.07663133465742744;-0.04975389414524711;-0.4755240127496514;-0.48409679507757786
Adenomyosis;Abnormal central response of multifocal electroretinogram;0.9195541441440582;0.8093778;0.5256344110892432;0.5610505342853587;0.9999201345566091;-0.08036599041255088;-0.19054234505923362;-0.47428572346736586;-0.43886960027125044
Adenomyosis;Atypical or prolonged hepatitis;0.9599184915423393;0.7293013;0.5127617589709599;0.5872547186144941;0.9999600672783046;-0.04004157573596523;-0.27065879345552013;-0.4871983083073447;-0.4127053486638105
Adenomyosis;Cubitus varus;0.9415681771934032;0.8830958;0.51861002709703;0.5372970475275176;0.9999201345566091;-0.058351957363205864;-0.11682433367999168;-0.48131010745957914;-0.4626230870290915
Adenomyosis;Nasal regurgitation;0.8764866888523102;0.8563509;0.5394161637618491;0.5458836732366804;0.9999584729108851;-0.12347178405857495;-0.14360757416820935;-0.46054230914903604;-0.4540747996742047
Adenomyosis;Moon facies;0.940506100654602;0.8700059;0.5189486857814893;0.5414958439671907;0.9999584729108851;-0.05945237225628308;-0.1299525672826808;-0.4810097871293958;-0.4584626289436944
Adenomyosis;Intestinal pseudo-obstruction;0.7652682512998581;0.6615915;0.575421171172128;0.609888570744229;0.9999539510871024;-0.2346856997872443;-0.33836248084555576;-0.4245327799149744;-0.3900653803428734
Adenomyosis;Bilateral renal atrophy;0.856876015663147;0.7029204;0.5457147685078673;0.5960126813327756;0.8586132879499475;-0.0017372722868005397;-0.15569291069546143;-0.31289851944208025;-0.2626006066171719
Adenomyosis;Fractured left clavicle;1.00378486700356;0.9711117;0.4987952365384477;0.5091967080025401;0.9999201345566091;0.003864732446950958;-0.028808419716673805;-0.5011248980181614;-0.490723426554069
Adenomyosis;Positive urine norcotinine test;0.7763704359531403;0.7859957;0.5717905815799383;0.5686506406187504;0.9999201345566091;-0.22354969860346885;-0.2139244127395925;-0.42812955297667077;-0.43126949393785874
Adenomyosis;Long fibula;0.8988641798496246;0.8132363;0.532247665523389;0.559799870578799;0.9999567459343585;-0.10109256608473383;-0.18672044975744806;-0.4677090804109695;-0.4401568753555595
Adenomyosis;Fragmentation of the epiphysis of the distal phalanx of the hallux;0.9993455344811082;0.92123264;0.5002083228597013;0.5250984327028256;0.9999201345566091;-0.0005746000755009195;-0.07868749381335349;-0.4997118116969078;-0.4748217018537835
Adenomyosis;Type II cryptotia;1.0183439552783966;0.952037;0.4941606101588202;0.5152729581225044;0.9999201345566091;0.0184238207217875;-0.04788315774233909;-0.5057595243977889;-0.4846471764341047
Adenomyosis;Increased variability in muscle fiber diameter;0.7007063627243042;0.6534327;0.596751012726822;0.6126527629932249;0.9999473166570552;-0.29924095393275096;-0.3465145897970088;-0.4031963039302332;-0.38729455366383025
Adenomyosis;Widened proximal tibial metaphyses;0.9306546002626419;0.81335986;0.5220910556682493;0.5597598457875808;0.9999600672783046;-0.06930546701566265;-0.18660021067277477;-0.47786901161005524;-0.4402002214907238
Adenomyosis;Wide anterior fontanel;0.9619954042136669;0.7864872;0.5121001525599245;0.5684904994071072;0.9999476714516888;-0.03795226723802192;-0.21346044973385436;-0.48784751889176436;-0.43145717204458167
Adenomyosis;Increased circulating oleate level;0.951829344034195;0.7946435;0.5153391321072622;0.565835371614816;0.9999201345566091;-0.04809079052241416;-0.20527661324771018;-0.4845810024493469;-0.4340847629417931
Adenomyosis;Lozenge-shaped umbilicus;0.9010308906435966;0.9942047;0.531554501733712;0.501844716354879;0.9999584729108851;-0.09892758226728848;-0.005753772917751587;-0.46840397117717314;-0.4981137565560061
Adenomyosis;Anti-myelin-associated glycoprotein antibody positivity;0.833490177989006;0.6747327;0.5532497463197912;0.6054542831312645;0.9999201345566091;-0.16642995656760307;-0.3251874494674978;-0.44667038823681793;-0.3944658514253446
Adenomyosis;Fractured radius;0.9921318739652634;0.93045175;0.502504528144524;0.5221557904505083;0.9999600672783046;-0.007828193313041187;-0.0695083165229945;-0.4974555391337806;-0.47780427682779625
Adenomyosis;Abnormal manual kinetic perimetry test;0.9281359240412712;0.8053583;0.5228947812262592;0.5623544208598668;0.9999201345566091;-0.0717842105153379;-0.19456184388430686;-0.4770253533303499;-0.43756571369674235
Adenomyosis;Small radial epiphyses;0.9570298679172993;0.86898464;0.5136820305477934;0.5418237224175616;0.9999201345566091;-0.04289026663930984;-0.1309354949119863;-0.48623810400881573;-0.4580964121390475
Adenomyosis;Generalized keratosis follicularis;0.8794068843126297;0.80616343;0.5384796344194085;0.5620931610746982;0.9999600672783046;-0.12055318296567485;-0.19379663706437633;-0.46148043285889606;-0.43786690620360635
Adenomyosis;Hypoplasia of the calcaneus;0.9974158508703113;0.84878737;0.5008225611308417;0.5483178114643581;0.9999584729108851;-0.002542622040573872;-0.15117110556698254;-0.49913591178004346;-0.45164066144652704
Adenomyosis;2-hydroxyadipic aciduria;0.8222317397594452;0.6630862;0.556887745443566;0.6093831038608677;0.717226575899895;0.10500516385955017;-0.05414039998131592;-0.16033883045632902;-0.10784347203902733
Adenomyosis;Potter facies;0.9156213477253914;0.8392036;0.5268905328171101;0.5514062520057427;0.9999552432134126;-0.08433389548802117;-0.16075164709830025;-0.4730647103963025;-0.4485489912076699
Adenomyosis;Increased heart rate variability;0.8407235741615295;0.7499293;0.5509161105363379;0.5804538631081346;0.9999600672783046;-0.159236493116775;-0.25003075838700817;-0.4490439567419666;-0.4195062041701699
Adenomyosis;Aplastic zygomatic arch;0.9613236002624035;0.77225745;0.5123141517498178;0.5731344596180337;0.9999584729108851;-0.038634872648481644;-0.22770102566814832;-0.4876443211610674;-0.42682401329285147
Adenomyosis;Testicular torsion;0.6809923052787781;0.70478046;0.6033495838125527;0.5953927913873223;0.764574615032594;-0.08358230975381598;-0.05979415562860235;-0.1612250312200414;-0.1691818236452718
Adenomyosis;Abolished vibration sense;0.902887187898159;0.84568006;0.5309607634725797;0.5493186562414385;0.9999584729108851;-0.0970712850127261;-0.1542784149084132;-0.46899770943830543;-0.45063981666944664
Adenomyosis;Fractured metatarsal bone of digit 5;0.9997212318703532;0.94236374;0.5000887346527687;0.5183563631880731;0.9999201345566091;-0.00019890268625588625;-0.05755639554293723;-0.4998313999038404;-0.481563771368536
Adenomyosis;Prolonged G2 phase of cell cycle;0.8339009881019592;0.82191443;0.5531171347102097;0.5569903749666776;0.9999567459343585;-0.16605575783239923;-0.17804231150137506;-0.4468396112241487;-0.4429663709676809
Adenomyosis;Single naris;0.9323708415031433;0.83805;0.5215434733170189;0.5517783368209668;0.9999567459343585;-0.06758590443121515;-0.16190673811422907;-0.47841327261733957;-0.4481784091133917
Adenomyosis;Perifoveal ring of hyperautofluorescence surrounded by normal autofluorescence;0.9850859828293324;0.81670475;0.5047474551136493;0.5586764427510945;0.9999201345566091;-0.014834151727276756;-0.18321538449557395;-0.49517267944295984;-0.4412436918055146
Adenomyosis;Asymmetry of the thorax;0.8493627905845642;0.72693944;0.5481325309527687;0.5880359416612981;0.9999567459343585;-0.15059395534979425;-0.2730173061607989;-0.45182421498158976;-0.4119208042730603
Adenomyosis;Type 2 muscle fiber predominance;0.7840939462184906;0.7000686;0.5692704939289508;0.5969637862538888;0.9999556674707869;-0.2158617212522963;-0.2998870744455794;-0.4306851735418361;-0.4029918812168981
Adenomyosis;Dependency on parenteral nutrition;0.9750917367637157;0.8935165;0.5079293665049674;0.5339591350933534;0.9999584729108851;-0.024866736147169388;-0.10644199198818616;-0.4920291064059177;-0.4659993378175318
Adenomyosis;Limited shoulder flexion;0.8944613933563232;0.8007225;0.5336566603959503;0.5638595101400796;0.9999201345566091;-0.10545874120028587;-0.19919765473635764;-0.46626347416065883;-0.4360606244165295
Adenomyosis;Paroxysmal vertigo;0.9793951828032732;0.86110616;0.5065591811985832;0.5443546723974183;0.9999584729108851;-0.02056329010761193;-0.1388523156080287;-0.4933992917123019;-0.45560380051346683
Adenomyosis;Long hallux;1.0134836733341217;0.9266266;0.49570788341108574;0.5233764786078854;0.9999526340597648;0.013531039274356949;-0.07332601138291539;-0.504244750648679;-0.47657615545187937
Adenomyosis;Broad medial eyebrow;1.015527117997408;0.91229784;0.4950573662195038;0.5279523724314481;0.9999600672783046;0.01556705071910336;-0.08766222239152477;-0.5049027010588008;-0.47200769484685645
Adenomyosis;Myxoid subcutaneous tumors;0.7959314435720444;0.6850734;0.5654165481522805;0.6019799023829411;0.9999600672783046;-0.20402862370626018;-0.31488669157640026;-0.43454351912602407;-0.3979801648953635
Adenomyosis;Bulbous tips of toes;1.0332326330244541;0.9643283;0.48941977627421474;0.5113570772093881;0.9999584729108851;0.033274160113568985;-0.03563018387890271;-0.5105386966366704;-0.4886013957014971
Adenomyosis;Absent internal genitalia;0.7414383888244629;0.7975538;0.5832485019342334;0.5648891334945803;0.20582233176176257;0.5356160570627003;0.5917314459329396;0.3774261701724708;0.3590668017328177
Adenomyosis;Hyperphalangy of the 2nd finger;1.0652172416448593;0.9460907;0.47922596312015875;0.5171681886733124;0.9999600672783046;0.06525717436655476;-0.053869369036117054;-0.5207341041581458;-0.4827918786049922
Adenomyosis;Renal interstitial hemosiderin;0.9394626915454865;0.8667655;0.5192814129926236;0.5425363444485054;0.717226575899895;0.22223611564559143;0.1495389232150952;-0.19794516290727138;-0.17469023145138962
Adenomyosis;Abnormality of depressor anguli oris muscle;0.8429092019796371;0.70161057;0.5502115326042554;0.5964494238318323;0.9999201345566091;-0.15701093257697196;-0.29830956937106223;-0.44970860195235374;-0.4034707107247768
Adenomyosis;Paroxysmal dyspnea;0.7764872014522552;0.6689244;0.5717524487334988;0.60741151978597;0.9999201345566091;-0.22343293310435386;-0.33099574328692527;-0.42816768582311027;-0.39250861477063914
Adenomyosis;Phenylpyruvic acidemia;0.7969180941581726;0.63599294;0.565095770188409;0.6185915999561373;0.9999600672783046;-0.20304197312013195;-0.3639671230377345;-0.4348642970898956;-0.3813684673221672
Adenomyosis;Lateral ventricle dilatation;0.9664901159703732;0.85089713;0.510668524643423;0.5476385553228941;0.9999488789551968;-0.03345876298482364;-0.14905174560482448;-0.48928035431177375;-0.4523103236323027
Adenomyosis;Neonatal unconjugated hyperbilirubinemia;0.9894601320847869;0.83137774;0.5033550062757178;0.5539318033151835;0.9999600672783046;-0.010499935193517662;-0.16858232260362194;-0.4966050610025867;-0.446028263963121
Adenomyosis;High maternal circulating alpha-fetoprotein concentration;0.7604598701000214;0.70455253;0.5769966669762279;0.5954687205681233;0.9999201345566091;-0.23946026445658775;-0.2953676033142385;-0.42292346758038124;-0.40445141398848583
Adenomyosis;Prominent nasolabial fold;0.9948542714118958;0.84971654;0.5016379435096537;0.5480186214682208;0.9999545338528789;-0.005100262440983161;-0.15023798970157276;-0.4983165903432252;-0.45193591238465813
Adenomyosis;Abnormality of inferior alveolar nerve;0.9326603710651398;0.78219664;0.5214511026200449;0.5698891368627272;0.9999201345566091;-0.06725976349146934;-0.21772349358828635;-0.4784690319365642;-0.43003099769388187
Adenomyosis;Unilateral conductive hearing impairment;0.9915692433714867;0.84727466;0.5026836249744683;0.5488049744031589;0.9999600672783046;-0.00839082390681789;-0.1526854062141566;-0.4972764423038363;-0.45115509287514566
Adenomyosis;Macular hypopigmented whorls, streaks, and patches;0.9313315153121948;0.81608635;0.521875072045525;0.5588766795097087;0.9999600672783046;-0.06862855196610973;-0.18387371540681408;-0.4780849952327796;-0.4410833877685959
Adenomyosis;Delayed ossification of pubic rami;0.8357967734336853;0.73540425;0.5525052856525616;0.5852385091013281;0.9999584729108851;-0.16416169947719983;-0.2645542199049037;-0.4474531872583235;-0.414719963809557
Adenomyosis;Hyperphenylalaninemia;0.9628932252526283;0.70528847;0.511814165484078;0.595223557064621;0.9999561589935034;-0.037062933740875104;-0.2946676892020911;-0.48814199350942544;-0.4047326019288824
Adenomyosis;Ureteropelvic junction obstruction;0.7197327017784119;0.79107237;0.5904231030212228;0.5669973068914445;0.832960393740828;-0.11322769196241611;-0.041888025119001804;-0.24253729071960517;-0.2659630868493835
Adenomyosis;Cone-shaped epiphysis of the proximal phalanx of the 2nd toe;1.0219899043440819;0.9284177;0.49299983181163254;0.5228048654763213;0.9999201345566091;0.02206976978747277;-0.07150245190890403;-0.5069203027449766;-0.4771152690802878
Adenomyosis;Difficulty walking;0.9493013247847557;0.86986506;0.5161448108987298;0.5415410558779881;0.9999461221900431;-0.05064479740528738;-0.130081062337443;-0.4838013112913133;-0.458405066312055
Adenomyosis;Bilobate gallbladder;0.9191547706723213;0.9143505;0.5257619510319722;0.5272965253361568;0.9999584729108851;-0.08080370223856381;-0.08560796326733044;-0.4741965218789129;-0.47266194757472835
Adenomyosis;Histidinuria;0.9231966286897659;0.80604017;0.5244713711606698;0.5621331460799257;0.8494521264714628;0.07374450221830309;-0.04341195866293013;-0.32498075531079307;-0.28731898039153714
Adenomyosis;Widened interpedicular distance;0.9217363148927689;0.7751251;0.5249376070102019;0.5721973486096588;0.9999201345566091;-0.07818381966384025;-0.22479504824908347;-0.47498252754640724;-0.42772278594695035
Elevated leukocyte alkaline phosphatase;Clasp-knife sign;0.8212620913982391;0.8350512;0.5572014176800248;0.5527458918252955;0.9999201345566091;-0.17865804315836997;-0.16486895562441917;-0.44271871687658426;-0.44717424273131356
Elevated leukocyte alkaline phosphatase;Keratosis pilaris;0.6643187999725342;0.560024;0.6089664815668456;0.6450130465677841;0.9999506876445663;-0.3356318876720321;-0.439926664588536;-0.39098420607772066;-0.35493764107678216
Elevated leukocyte alkaline phosphatase;Lamina lucida cleavage;0.8615047335624695;0.7670145;0.5442265730656861;0.5748494736729401;0.9999548690865008;-0.1384501355240313;-0.23294036560749687;-0.45572829602081466;-0.4251053954135606
Elevated leukocyte alkaline phosphatase;Abnormal central response of multifocal electroretinogram;1.032631367444992;0.88684505;0.4896112689219253;0.5360956434337902;0.9999201345566091;0.03271123288838296;-0.11307508231433006;-0.5103088656346838;-0.46382449112281887
Elevated leukocyte alkaline phosphatase;Atypical or prolonged hepatitis;0.7700397372245789;0.61201066;0.5738596236823932;0.6268302673494686;0.9999600672783046;-0.2299203300537257;-0.38794940949098156;-0.42610044359591137;-0.373129799928836
Elevated leukocyte alkaline phosphatase;Cubitus varus;0.9966603554785252;0.99325305;0.5010630438435926;0.5021476406197387;0.9999201345566091;-0.0032597790780839464;-0.00666708232195945;-0.49885709071301654;-0.4977724939368704
Elevated leukocyte alkaline phosphatase;Nasal regurgitation;1.0965437069535255;0.98367625;0.46922124355699957;0.5051962438371991;0.9999584729108851;0.09658523404264041;-0.016282218161587036;-0.5307372293538856;-0.49476222907368606
Elevated leukocyte alkaline phosphatase;Moon facies;0.9939574841409922;0.9644692;0.5019234042400209;0.5113121781984151;0.9999584729108851;-0.006000988769892968;-0.03548927849865369;-0.4980350686708642;-0.48864629471247
Elevated leukocyte alkaline phosphatase;Intestinal pseudo-obstruction;0.9507931135594845;0.80347395;0.5156693661847433;0.562966037580484;0.9999539510871024;-0.04916083752761791;-0.19648000165472934;-0.48428458490235904;-0.43698791350661836
Elevated leukocyte alkaline phosphatase;Bilateral renal atrophy;0.8521679043769836;0.74194014;0.5472295231272513;0.5830831687598237;0.9999600672783046;-0.1477921629013209;-0.2580199265541224;-0.4527305441510533;-0.41687689851848087
Elevated leukocyte alkaline phosphatase;Fractured left clavicle;0.9048118218779564;0.8440184;0.5303452817061648;0.5498540571006652;0.9999201345566091;-0.09510831267865272;-0.15590173484118552;-0.4695748528504443;-0.45006607745594396
Elevated leukocyte alkaline phosphatase;Positive urine norcotinine test;0.9074845984578133;0.8161397;0.5294907384346423;0.5588594043134129;0.726290173501319;0.1811944249564943;0.08984952452724548;-0.19679943506667663;-0.16743076918790611
Elevated leukocyte alkaline phosphatase;Long fibula;0.8640435189008713;0.79542243;0.543410734347453;0.5655820721380511;0.9999567459343585;-0.13591322703348718;-0.20453431112753473;-0.45654601158690544;-0.43437467379630734
Elevated leukocyte alkaline phosphatase;Fragmentation of the epiphysis of the distal phalanx of the hallux;0.7531951069831848;0.71609735;0.579380680108732;0.5916292433065583;0.9999201345566091;-0.2467250275734243;-0.2838227796676931;-0.4205394544478771;-0.4082908912500508
Elevated leukocyte alkaline phosphatase;Type II cryptotia;0.8981063738465309;0.91337985;0.5324901352617173;0.5276066491231902;0.9999201345566091;-0.1018137607100782;-0.08654028655322166;-0.4674299992948918;-0.4723134854334189
Elevated leukocyte alkaline phosphatase;Increased variability in muscle fiber diameter;0.9864408355206251;0.87405944;0.5043161483637237;0.540194867238238;0.9999473166570552;-0.013506481136430049;-0.12588787795161083;-0.4956311682933314;-0.4597524494188172
Elevated leukocyte alkaline phosphatase;Widened proximal tibial metaphyses;0.7575428932905197;0.6212464;0.5779533682786464;0.6236472182152665;0.9999600672783046;-0.24241717398778484;-0.3787136697830348;-0.42200669899965815;-0.3763128490630381
Elevated leukocyte alkaline phosphatase;Wide anterior fontanel;0.9566635340452194;0.798347;0.5137987469672975;0.5646313366604915;0.9999476714516888;-0.043284137406469414;-0.2016006751443158;-0.4861489244843913;-0.43531633479119736
Elevated leukocyte alkaline phosphatase;Increased circulating oleate level;0.7293171584606171;0.62064487;0.5872494662887369;0.62385413227524;0.726290173501319;0.0030269849592980957;-0.10564530608112244;-0.1390407072125821;-0.10243604122607897
Elevated leukocyte alkaline phosphatase;Lozenge-shaped umbilicus;0.8886832743883133;0.85222286;0.5355068032795883;0.5472118359885969;0.9999584729108851;-0.11127519852257184;-0.14773561305141858;-0.4644516696312968;-0.4527466369222882
Elevated leukocyte alkaline phosphatase;Anti-myelin-associated glycoprotein antibody positivity;0.8703300654888153;0.7327686;0.5413917750966203;0.5861088083294853;0.9999201345566091;-0.1295900690677938;-0.26715153933795066;-0.4585283594599888;-0.4138113262271238
Elevated leukocyte alkaline phosphatase;Fractured radius;0.927202120423317;0.8740164;0.5231928007678641;0.5402086755444697;0.9999600672783046;-0.0727579468549876;-0.12594366312638805;-0.47676726651044044;-0.45975139173383484
Elevated leukocyte alkaline phosphatase;Abnormal manual kinetic perimetry test;0.9907203130424023;0.79342985;0.5029538584943961;0.5662301639343137;0.9999201345566091;-0.00919982151420684;-0.2064902830246267;-0.496966276062213;-0.4336899706222954
Elevated leukocyte alkaline phosphatase;Small radial epiphyses;0.911822535097599;0.88109815;0.5281042590499894;0.53793738795162;0.9999201345566091;-0.08809759945901008;-0.1188219833496389;-0.47181587550661974;-0.46198274660498906
Elevated leukocyte alkaline phosphatase;Generalized keratosis follicularis;0.821439191699028;0.7583854;0.557144123195781;0.5776769655395051;0.9999600672783046;-0.17852087557927654;-0.2415746474327235;-0.44281594408252356;-0.42228310173879946
Elevated leukocyte alkaline phosphatase;Hypoplasia of the calcaneus;0.8191732615232468;0.7703289;0.5578773259848435;0.5737650459451666;0.9999584729108851;-0.18078521138763837;-0.22962959355450085;-0.4420811469260416;-0.4261934269657185
Elevated leukocyte alkaline phosphatase;2-hydroxyadipic aciduria;0.7866096794605255;0.7921836;0.568450600369798;0.5666356693466756;0.726290173501319;0.06031950595920654;0.06589340451305481;-0.15783957313152097;-0.15965450415464333
Elevated leukocyte alkaline phosphatase;Potter facies;0.8298254758119583;0.7950654;0.5544331467400551;0.5656981788475756;0.9999552432134126;-0.17012976740145425;-0.20488984022879342;-0.4455220964733575;-0.434257064365837
Elevated leukocyte alkaline phosphatase;Increased heart rate variability;0.9147679954767227;0.7441737;0.5271631453587144;0.5823475137998597;0.9999600672783046;-0.08519207180158184;-0.2557863617004542;-0.4727969219195901;-0.41761255347844484
Elevated leukocyte alkaline phosphatase;Aplastic zygomatic arch;0.8730488866567612;0.723042;0.5405191339400558;0.5893262962813532;0.9999584729108851;-0.12690958625412396;-0.2769164616498988;-0.45943933897082934;-0.4106321766295319
Elevated leukocyte alkaline phosphatase;Testicular torsion;0.9399338960647583;0.8652534;0.5191311504860474;0.5430220486626152;0.9999600672783046;-0.06002617121354625;-0.1347066783966212;-0.48082891679225714;-0.4569380186156894
Elevated leukocyte alkaline phosphatase;Abolished vibration sense;1.0277683548629284;0.94171387;0.4911599218055983;0.5185635809132103;0.9999584729108851;0.02780988195204326;-0.05824460333919934;-0.5087985511052868;-0.4813948919976748
Elevated leukocyte alkaline phosphatase;Fractured metatarsal bone of digit 5;0.8335461169481277;0.8606733;0.5532316883889605;0.5444938244548134;0.9999201345566091;-0.16637401760848136;-0.13924682618411155;-0.4466884461676486;-0.4554263101017957
Elevated leukocyte alkaline phosphatase;Prolonged G2 phase of cell cycle;0.8172838389873505;0.7912638;0.5584889369043725;0.5669349973400202;0.851762385589393;-0.034478546602042526;-0.06049856684854826;-0.2932734486850205;-0.2848273882493728
Elevated leukocyte alkaline phosphatase;Single naris;1.0201163366436958;0.9787469;0.49359633923128254;0.5067655935833217;0.9999567459343585;0.02015959070933737;-0.021209854912629944;-0.5063604067030759;-0.4931911523510367
Elevated leukocyte alkaline phosphatase;Perifoveal ring of hyperautofluorescence surrounded by normal autofluorescence;0.9211655780673027;0.79107934;0.5251198412449443;0.5669950418376053;0.9999201345566091;-0.0787545564893064;-0.20884079219134422;-0.47480029331166484;-0.4329250927190038
Elevated leukocyte alkaline phosphatase;Asymmetry of the thorax;0.8842743262648582;0.72245145;0.5369193475391322;0.5895219286997122;0.9999567459343585;-0.11568241966950021;-0.2775052974938067;-0.4630373983952263;-0.41043481723464625
Elevated leukocyte alkaline phosphatase;Type 2 muscle fiber predominance;0.941012367606163;0.925175;0.518787252482517;0.5238398099582742;0.9999556674707869;-0.05894329986462388;-0.0747806563127974;-0.4811684149882699;-0.47611585751251273
Elevated leukocyte alkaline phosphatase;Dependency on parenteral nutrition;0.8524104207754135;0.8054545;0.547151471580467;0.5623231923937554;0.9999584729108851;-0.14754805213547162;-0.1945039803419154;-0.4528070013304182;-0.43763528051712974
Elevated leukocyte alkaline phosphatase;Limited shoulder flexion;0.9986863322556019;0.9020817;0.5004181535504723;0.5312183675880613;0.9999201345566091;-0.0012338023010072252;-0.09783840657504173;-0.49950198100613685;-0.4687017669685478
Elevated leukocyte alkaline phosphatase;Paroxysmal vertigo;1.0521735399961472;0.85076094;0.4833851027584649;0.5476824033923058;0.9999584729108851;0.052215067085262024;-0.14919753617382459;-0.5165733701524202;-0.45227606951857935
Elevated leukocyte alkaline phosphatase;Long hallux;0.7835625112056732;0.70876074;0.5694437515663568;0.5940675842404364;0.9999526340597648;-0.21639012285409154;-0.291191895686962;-0.4305088824934079;-0.4058850498193284
Elevated leukocyte alkaline phosphatase;Broad medial eyebrow;0.9115013927221298;0.8570539;0.5282068830464193;0.5456575752320931;0.9999600672783046;-0.08845867455617473;-0.14290619135514782;-0.4717531842318853;-0.4543024920462114
Elevated leukocyte alkaline phosphatase;Myxoid subcutaneous tumors;0.9265801087021828;0.92646277;0.5233913245077896;0.5234287664600282;0.9999600672783046;-0.07337995857612178;-0.07349729776994274;-0.476568742770515;-0.4765313008182763
Elevated leukocyte alkaline phosphatase;Bulbous tips of toes;0.8253154754638672;0.8314866;0.5558905550769757;0.5538966561234042;0.9999584729108851;-0.17464299744701794;-0.16847189015484265;-0.4440679178339094;-0.4460618167874809
Elevated leukocyte alkaline phosphatase;Absent internal genitalia;1.0232461392879486;0.93467563;0.4925998574617735;0.5208082061420121;0.9999201345566091;0.0233260047313395;-0.06524450064929099;-0.5073202770948356;-0.47911192841459704
Elevated leukocyte alkaline phosphatase;Hyperphalangy of the 2nd finger;0.7891234755516052;0.7415265;0.5676317986264524;0.5832194832545735;0.9999600672783046;-0.21083659172669933;-0.25843358278886364;-0.43232826865185214;-0.41674058402373104
Elevated leukocyte alkaline phosphatase;Renal interstitial hemosiderin;0.8231450617313385;0.7946275;0.5565923453343398;0.565840596127894;0.9999201345566091;-0.1767750728252706;-0.20529264689715476;-0.44332778922226934;-0.43407953842871516
Elevated leukocyte alkaline phosphatase;Abnormality of depressor anguli oris muscle;1.000559888780117;0.8639953;0.49982178185681414;0.5434262319934065;0.9999201345566091;0.0006397542235079268;-0.13592482091219993;-0.500098352699795;-0.45649390256320266
Elevated leukocyte alkaline phosphatase;Paroxysmal dyspnea;0.9569842144846916;0.7361473;0.513696575935757;0.5849932895180342;0.9999201345566091;-0.04293592007191749;-0.26377285004885764;-0.4862235586208521;-0.4149268450385749
Elevated leukocyte alkaline phosphatase;Phenylpyruvic acidemia;0.6364262104034424;0.50301415;0.6184435422602403;0.6655599176301042;0.8631450867506595;-0.2267188763472171;-0.36013093946901276;-0.24470154449041914;-0.19758516912055524
Elevated leukocyte alkaline phosphatase;Lateral ventricle dilatation;0.9163289293646812;0.732038;0.5266645032635122;0.586350159124142;0.9999488789551968;-0.08361994959051555;-0.2679108578675503;-0.4732843756916846;-0.4135987198310548
Elevated leukocyte alkaline phosphatase;Neonatal unconjugated hyperbilirubinemia;0.8014766871929169;0.74110377;0.5636145536550191;0.5833587695562357;0.8631450867506595;-0.061668399557742615;-0.12204131840196564;-0.29953053309564037;-0.2797863171944238
Elevated leukocyte alkaline phosphatase;High maternal circulating alpha-fetoprotein concentration;0.6872699558734894;0.5427108;0.601243516052637;0.6511795649483846;0.9999201345566091;-0.31265017868311973;-0.457209353459197;-0.39867661850397207;-0.3487405696082245
Elevated leukocyte alkaline phosphatase;Prominent nasolabial fold;0.980208121240139;0.8429773;0.5063003620491009;0.5501895790439348;0.9999545338528789;-0.019746412612739905;-0.15697724846774708;-0.493654171803778;-0.4497649548089441
Elevated leukocyte alkaline phosphatase;Abnormality of inferior alveolar nerve;0.9898618375882506;0.83490497;0.5032271326070452;0.5527930789151094;0.9999201345566091;-0.010058296968358471;-0.1650151658180532;-0.4966930019495639;-0.4471270556414997
Elevated leukocyte alkaline phosphatase;Unilateral conductive hearing impairment;1.0019386354833841;0.84567976;0.49938291277339775;0.5493187522553368;0.9999600672783046;0.0019785682050795783;-0.1542803072990565;-0.5005771545049068;-0.4506413150229678
Elevated leukocyte alkaline phosphatase;Macular hypopigmented whorls, streaks, and patches;0.9797360692173243;0.89111567;0.5064506510209049;0.5347278035135006;0.9999600672783046;-0.020223998060980297;-0.10884440184251354;-0.49350941625739964;-0.465232263764804
Elevated leukocyte alkaline phosphatase;Delayed ossification of pubic rami;0.8917467296123505;0.8027171;0.5345257446478573;0.5632117642084506;0.9999584729108851;-0.10821174329853467;-0.19724138325787;-0.46543272826302784;-0.4367467087024345
Elevated leukocyte alkaline phosphatase;Hyperphenylalaninemia;0.6262771785259247;0.40962636;0.6219188743586195;0.7010195943242036;0.8497508587917271;-0.2234736802658024;-0.4401244940837803;-0.2278319844331076;-0.1487312644675235
Elevated leukocyte alkaline phosphatase;Ureteropelvic junction obstruction;0.9243941605091095;0.79590654;0.524089073274989;0.5654246541018068;0.9999528219730685;-0.07555866146395895;-0.204046278241379;-0.47586374869807946;-0.4345281678712617
Elevated leukocyte alkaline phosphatase;Cone-shaped epiphysis of the proximal phalanx of the 2nd toe;0.7638960182666779;0.7822566;0.5758705980354981;0.5698695906432568;0.9999201345566091;-0.23602411628993125;-0.2176635313156423;-0.424049536521111;-0.4300505439133523
Elevated leukocyte alkaline phosphatase;Difficulty walking;0.9718571566045284;0.89658475;0.5089593282042459;0.5329770653722365;0.9999461221900431;-0.028088965585514658;-0.10336137296824133;-0.49098679398579714;-0.46696905681780654
Elevated leukocyte alkaline phosphatase;Bilobate gallbladder;0.861809253692627;0.8010823;0.5441287001885424;0.5637426365569829;0.9999584729108851;-0.13814921921825818;-0.19887615985012463;-0.4558297727223427;-0.43621583635390226
Elevated leukocyte alkaline phosphatase;Histidinuria;0.737198144197464;0.72265995;0.5846465529418989;0.5894528501228165;0.8542775634790427;-0.11707941928157872;-0.13161761799106664;-0.2696310105371438;-0.26482471335622626
Elevated leukocyte alkaline phosphatase;Widened interpedicular distance;0.8807634711265564;0.72286797;0.5380446808449096;0.5893839437154894;0.9999201345566091;-0.11915666343005271;-0.2770521688583669;-0.46187545371169947;-0.4105361908411197
Clasp-knife sign;Keratosis pilaris;0.8110474050045013;0.80068725;0.5605092508672431;0.5638709574150085;0.9998710980331391;-0.18882369302863777;-0.1991838445579499;-0.439361847165896;-0.43600014061813064
Clasp-knife sign;Lamina lucida cleavage;0.7824244648218155;0.7768229;0.5698148461303447;0.571642810468073;0.9998962300503706;-0.21747176522855516;-0.223073305436418;-0.43008138392002593;-0.4282534195822977
Clasp-knife sign;Abnormal central response of multifocal electroretinogram;0.9960465412586927;0.8683502;0.5012584282801635;0.5420274375975203;1.0;-0.003953458741307259;-0.13164979219436646;-0.49874157171983646;-0.45797256240247974
Clasp-knife sign;Atypical or prolonged hepatitis;0.9260166883468628;0.85890627;0.5235711558597593;0.545061897432775;0.9999201345566091;-0.07390344620974632;-0.14101386548312278;-0.4763489786968498;-0.4548582371238341
Clasp-knife sign;Cubitus varus;0.7923306077718735;0.78931904;0.566587819663538;0.5675681135357983;1.0;-0.20766939222812653;-0.21068096160888672;-0.433412180336462;-0.4324318864642017
Clasp-knife sign;Nasal regurgitation;1.0988259017467499;1.0519588;0.46849130723700816;0.4834535496641956;0.9999134918687169;0.09891240987803296;0.0520453074934657;-0.5314221846317088;-0.5164599422045213
Clasp-knife sign;Moon facies;0.8932090997695923;0.95662045;0.5340575434213721;0.5138124748019531;0.9999134918687169;-0.10670439209912463;-0.04329303708050891;-0.4658559484473448;-0.4861010170667638
Clasp-knife sign;Intestinal pseudo-obstruction;0.9213579669594765;0.9386566;0.5250584112383487;0.5195384675262043;0.9998912449978579;-0.0785332780383814;-0.06123461686599141;-0.47483283375950913;-0.4803527774716536
Clasp-knife sign;Bilateral renal atrophy;0.9961888026446104;0.9905791;0.5012131447332968;0.5029987971153798;0.9999201345566091;-0.003731331911998703;-0.009341006291228249;-0.4987069898233123;-0.49692133744122935
Clasp-knife sign;Fractured left clavicle;0.7502946853637695;0.7130519;0.5803337495303158;0.5926407235012339;1.0;-0.24970531463623047;-0.2869480848312378;-0.4196662504696842;-0.40735927649876613
Clasp-knife sign;Positive urine norcotinine test;0.9126117378473282;0.852284;0.527852074480891;0.5471921539440199;1.0;-0.08738826215267181;-0.1477159857749939;-0.472147925519109;-0.4528078460559801
Clasp-knife sign;Long fibula;1.0369581803679466;1.024935;0.48823316604243483;0.49206212750478406;0.8605427142144324;0.17641546615351422;0.1643922928809045;-0.3723095481719976;-0.36848058670964834
Clasp-knife sign;Fragmentation of the epiphysis of the distal phalanx of the hallux;0.8816956952214241;0.91679657;0.5377458293403086;0.5265151340962171;1.0;-0.1183043047785759;-0.08320343494415283;-0.46225417065969143;-0.4734848659037829
Clasp-knife sign;Type II cryptotia;0.8356066197156906;0.83550394;0.5525666473231956;0.5525997741160575;1.0;-0.1643933802843094;-0.1644960641860962;-0.4474333526768044;-0.44740022588394246
Clasp-knife sign;Increased variability in muscle fiber diameter;1.0348387658596039;1.0254176;0.4889082318793073;0.49190845467637256;0.5611913088210261;0.4736474570385778;0.4642262574784124;-0.07228307694171876;-0.06928285414465352
Clasp-knife sign;Widened proximal tibial metaphyses;1.0107653057202697;1.0032245;0.49657323057019;0.4989736072556392;0.8819596887815145;0.12880561693875514;0.12126480329154454;-0.38538645821132456;-0.3829860815258753
Clasp-knife sign;Wide anterior fontanel;0.8319833874702454;0.8746104;0.5537362260816017;0.5400180865093178;0.7756871967460075;0.05629619072423786;0.09892322729574055;-0.22195097066440583;-0.23566911023668968
Clasp-knife sign;Increased circulating oleate level;1.057131316512823;0.9796235;0.4818046297310312;0.5064864937917382;1.0;0.057131316512823105;-0.020376503467559814;-0.5181953702689688;-0.49351350620826184
Clasp-knife sign;Lozenge-shaped umbilicus;0.7332550287246704;0.76700485;0.5859481394202333;0.5748526293624489;0.9999134918687169;-0.2666584631440465;-0.23290864434216663;-0.41396535244848365;-0.42506086250626807
Clasp-knife sign;Anti-myelin-associated glycoprotein antibody positivity;1.0090862922370434;0.9734989;0.4971077035529232;0.5084365535522976;1.0;0.00908629223704338;-0.026501119136810303;-0.5028922964470768;-0.49156344644770245
Clasp-knife sign;Fractured radius;0.8868453353643417;0.87076676;0.5360955575045339;0.5412515917205518;0.8819596887815145;0.004885646582827197;-0.011192929862752332;-0.3458641312769807;-0.3407080970609627
Clasp-knife sign;Abnormal manual kinetic perimetry test;0.993571687489748;0.92986983;0.5020462095163118;0.5223414652721172;1.0;-0.006428312510251999;-0.07013016939163208;-0.49795379048368815;-0.4776585347278828
Clasp-knife sign;Small radial epiphyses;0.9063467383384705;0.95325255;0.5298545099930756;0.5148855968634979;1.0;-0.09365326166152954;-0.046747446060180664;-0.4701454900069244;-0.4851144031365021
Clasp-knife sign;Generalized keratosis follicularis;0.8969161435961723;0.8437645;0.532871002927056;0.5499358842143474;0.9999201345566091;-0.10300399096043678;-0.1561556506279287;-0.4670491316295531;-0.44998425034226175
Clasp-knife sign;Hypoplasia of the calcaneus;0.8822979182004929;0.8224195;0.5375527870645629;0.556827010206947;0.872141863789474;0.010156054411018856;-0.049722339596663945;-0.3345890767249111;-0.315314853582527
Clasp-knife sign;2-hydroxyadipic aciduria;1.0026918910443783;1.0383232;0.499143143433206;0.4877983677319938;1.0;0.0026918910443782806;0.038323163986206055;-0.500856856566794;-0.5122016322680062
Clasp-knife sign;Potter facies;0.7461592555046082;0.88445044;0.5816939148882885;0.5368629044192347;0.9998981869165328;-0.2537389314119246;-0.11544775127810503;-0.4182042720282443;-0.4630352824972981
Clasp-knife sign;Increased heart rate variability;1.0517425835132599;1.0295949;0.4835224660095401;0.49057828808081927;0.9999201345566091;0.05182244895665078;0.029674763667267845;-0.516397668547069;-0.5093418464757898
Clasp-knife sign;Aplastic zygomatic arch;0.9524085558950901;0.9694684;0.5151545515374937;0.5097200159446686;0.872141863789474;0.0802666921056161;0.09732655099400378;-0.3569873122519803;-0.36242184784480536
Clasp-knife sign;Testicular torsion;0.8692622184753418;0.8800146;0.5417345997578517;0.5382847829279178;0.9999201345566091;-0.1306579160812673;-0.11990553618701072;-0.45818553479875745;-0.4616353516286913
Clasp-knife sign;Abolished vibration sense;0.848618358373642;0.8712971;0.5483722399970092;0.5410813600479072;0.8377124667083617;0.01090589166528022;0.033584654339611886;-0.2893402267113525;-0.29663110666045456
Clasp-knife sign;Fractured metatarsal bone of digit 5;0.9599513709545135;1.0093399;0.5127512847189505;0.49702697819994923;1.0;-0.04004862904548645;0.00933992862701416;-0.4872487152810495;-0.5029730218000508
Clasp-knife sign;Prolonged G2 phase of cell cycle;0.9090670049190521;0.93000054;0.5289849104165678;0.5222997555322546;0.9999056439461368;-0.09083863902708467;-0.06990510035177644;-0.470920733529569;-0.4776058884138822
Clasp-knife sign;Single naris;0.9458682015538216;1.0020008;0.517239112759077;0.4993631294952573;0.9999056439461368;-0.05403744239231523;0.002095164769683522;-0.4826665311870598;-0.5005425144508795
Clasp-knife sign;Perifoveal ring of hyperautofluorescence surrounded by normal autofluorescence;1.010786191560328;1.0032389;0.4965665820148025;0.49896901375156544;1.0;0.010786191560328007;0.0032389163970947266;-0.5034334179851975;-0.5010309862484346
Clasp-knife sign;Asymmetry of the thorax;0.9637662135064602;0.9722983;0.5115360976603759;0.5088188478232009;0.8605427142144324;0.10322349929202779;0.11175560989369138;-0.3490066165540565;-0.35172386639123154
Clasp-knife sign;Type 2 muscle fiber predominance;0.9458272717893124;0.9577886;0.517252160252482;0.5134403047232567;0.7175272285260154;0.228300043263297;0.24026135809050075;-0.20027506827353336;-0.2040869238027586
Clasp-knife sign;Dependency on parenteral nutrition;0.9458333849906921;0.91304374;0.5172502114987801;0.527714039282564;0.9999134918687169;-0.05408010687802478;-0.0868697544572179;-0.4826632803699368;-0.4721994525861529
Clasp-knife sign;Limited shoulder flexion;0.8658290207386017;0.86052585;0.5428371354430366;0.5445412210656629;1.0;-0.13417097926139832;-0.13947415351867676;-0.4571628645569634;-0.45545877893433706
Clasp-knife sign;Paroxysmal vertigo;1.0578964054584503;0.9244476;0.48156069055922557;0.5240720130395383;0.9999134918687169;0.0579829135897334;-0.07546589579556628;-0.5183528013094914;-0.4758414788291786
Clasp-knife sign;Long hallux;0.8119637072086334;0.85159093;0.5602122590051462;0.5474152277784308;0.8279638214854832;-0.016000114276849775;0.023627109930074663;-0.26775156248033705;-0.28054859370705243
Clasp-knife sign;Broad medial eyebrow;0.8755067586898804;0.91624516;0.5397305114290818;0.526691253871038;0.9999201345566091;-0.12441337586672874;-0.08367497206957908;-0.4601896231275273;-0.4732288806855711
Clasp-knife sign;Myxoid subcutaneous tumors;0.9906283188611269;0.9540746;0.5029831424251935;0.5146236481016824;0.9999201345566091;-0.009291815695482208;-0.045845513356047585;-0.4969369921314156;-0.48529648645492673
Clasp-knife sign;Bulbous tips of toes;0.7824194133281708;0.8648633;0.5698164935377787;0.5431473763447728;0.872141863789474;-0.08972245046130323;-0.007278587307845585;-0.30232537025169526;-0.32899448744470117
Clasp-knife sign;Absent internal genitalia;0.9165589511394501;0.9520017;0.5265910281215749;0.5152842183733302;1.0;-0.08344104886054993;-0.04799830913543701;-0.4734089718784251;-0.48471578162666984
Clasp-knife sign;Hyperphalangy of the 2nd finger;0.7328523099422455;0.7962774;0.58608115576865;0.56530406255568;0.8819596887815145;-0.14910737883926906;-0.0856822849500326;-0.2958785330128645;-0.31665562622583454
Clasp-knife sign;Renal interstitial hemosiderin;0.9392865300178528;0.9226437;0.5193375902816105;0.5246478970348152;1.0;-0.06071346998214722;-0.07735627889633179;-0.48066240971838947;-0.4753521029651848
Clasp-knife sign;Abnormality of depressor anguli oris muscle;0.9162263870239258;1.011947;0.526697258504008;0.4961970605999886;1.0;-0.08377361297607422;0.011947035789489746;-0.47330274149599205;-0.5038029394000114
Clasp-knife sign;Paroxysmal dyspnea;1.0127168782055378;0.9366749;0.49595198283390685;0.5201705109629795;1.0;0.012716878205537796;-0.06332510709762573;-0.5040480171660932;-0.4798294890370205
Clasp-knife sign;Phenylpyruvic acidemia;0.8820805996656418;0.8693414;0.5376224468086289;0.5417091763859936;0.9999201345566091;-0.11783953489096732;-0.1305787611130056;-0.4622976877479802;-0.4582109581706155
Clasp-knife sign;Lateral ventricle dilatation;1.0659946352243423;0.9602159;0.4789779767926814;0.5126670058240868;0.7772828274709305;0.2887118077534119;0.18293309869941865;-0.2983048506782491;-0.2646158216468437
Clasp-knife sign;Neonatal unconjugated hyperbilirubinemia;0.9899524319916964;0.9381018;0.5031982940439148;0.5197153985401394;0.9999201345566091;-0.00996770256491275;-0.06181830645831199;-0.4967218405126943;-0.48020473601646974
Clasp-knife sign;High maternal circulating alpha-fetoprotein concentration;1.0600011050701141;1.0523195;0.48088957667973276;0.4833385535788456;1.0;0.060001105070114136;0.05231952667236328;-0.5191104233202672;-0.5166614464211544
Clasp-knife sign;Prominent nasolabial fold;0.9119244143366814;0.92101854;0.5280717032156337;0.5251667957938113;0.9998944404568447;-0.08797002612016336;-0.07887589959762231;-0.47182273724121104;-0.4747276446630334
Clasp-knife sign;Abnormality of inferior alveolar nerve;0.9902458302676678;0.97353226;0.5031048978939547;0.5084259322026738;1.0;-0.00975416973233223;-0.026467740535736084;-0.49689510210604526;-0.49157406779732615
Clasp-knife sign;Unilateral conductive hearing impairment;0.9936410747468472;0.88140553;0.5020241224149508;0.5378388410990417;0.9999201345566091;-0.0062790598097619554;-0.1185146021965322;-0.49789601214165835;-0.46208129345756743
Clasp-knife sign;Macular hypopigmented whorls, streaks, and patches;1.0583674348890781;1.0604434;0.4814105032531222;0.48074853578571475;0.9999201345566091;0.05844730033246903;0.060523266780060814;-0.5185096313034869;-0.5191715987708944
Clasp-knife sign;Delayed ossification of pubic rami;0.9743540659546852;0.9640908;0.5081642494706464;0.5114327083488521;0.872141863789474;0.10221220216521121;0.09194896033772326;-0.3639776143188276;-0.3607091554406219
Clasp-knife sign;Hyperphenylalaninemia;1.0025178059004247;0.92754245;0.4991985566436302;0.5230841914116328;0.9999028053808913;0.0026150005195334503;-0.07236035733706803;-0.500704248737261;-0.4768186139692585
Clasp-knife sign;Ureteropelvic junction obstruction;0.8670024275779724;0.7970748;0.5424602505757266;0.565044839849377;0.9998847295244674;-0.13288230194649497;-0.20280993475518028;-0.45742447894874083;-0.43483988967509035
Clasp-knife sign;Cone-shaped epiphysis of the proximal phalanx of the 2nd toe;0.7904853820800781;0.7696469;0.5671883841098522;0.5739881179300486;1.0;-0.20951461791992188;-0.23035311698913574;-0.4328116158901478;-0.42601188206995144
Clasp-knife sign;Difficulty walking;0.9373181760311127;0.9742846;0.519965332839277;0.5081863695033365;0.4476650879283087;0.48965308810280395;0.5266195013623102;0.07230024491096831;0.060521281575027785
Clasp-knife sign;Bilobate gallbladder;0.8953107073903084;0.8598701;0.5333848093290812;0.5447520246995218;0.9999134918687169;-0.10460278447840854;-0.14004341568921252;-0.46652868253963575;-0.45516146716919514
Clasp-knife sign;Histidinuria;1.00589993968606;1.0056231;0.49812197997450813;0.4982100825768211;0.9999090677057578;0.005990871980302126;0.005714034482352526;-0.5017870877312497;-0.5016989851289367
Clasp-knife sign;Widened interpedicular distance;0.8796482384204865;0.91484374;0.5384022453708103;0.5271389430056259;1.0;-0.12035176157951355;-0.08515626192092896;-0.4615977546291897;-0.4728610569943741
Keratosis pilaris;Lamina lucida cleavage;0.6934642791748047;0.6603482;0.5991698912723185;0.6103092370823793;0.7530912318100624;-0.059626952635257746;-0.09274305485388568;-0.15392134053774398;-0.14278199472768316
Keratosis pilaris;Abnormal central response of multifocal electroretinogram;0.8119325488805771;0.7651858;0.5602223571693637;0.5754481844705475;0.9998710980331391;-0.18793854915256203;-0.23468532466048897;-0.43964874086377537;-0.42442291356259165
Keratosis pilaris;Atypical or prolonged hepatitis;0.905094712972641;0.7942992;0.5302548251598747;0.5659473730288965;0.9999506876445663;-0.0948559746719253;-0.2056515023685348;-0.46969586248469164;-0.43400331461566977
Keratosis pilaris;Cubitus varus;0.9203456491231918;0.91584784;0.5253816560917309;0.5268181885584982;0.9998710980331391;-0.07952544890994728;-0.08402326010818184;-0.4744894419414082;-0.47305290947464096
Keratosis pilaris;Nasal regurgitation;0.9014388769865036;0.87718695;0.5314239975820626;0.5391915499467943;0.9999482333076865;-0.09850935632118285;-0.1227612792862326;-0.46852423572562385;-0.46075668336089215
Keratosis pilaris;Moon facies;0.9083566889166832;0.98357964;0.5292119590646134;0.505226993296231;0.9999482333076865;-0.09159154439100325;-0.016368597687569264;-0.47073627424307307;-0.49472124001145545
Keratosis pilaris;Intestinal pseudo-obstruction;0.9637674912810326;0.7852868;0.5115356906648492;0.5688816825408856;0.9999410127389031;-0.03617352145787056;-0.21465422856684502;-0.48840532207405396;-0.43105933019801757
Keratosis pilaris;Bilateral renal atrophy;0.8905928060412407;0.77434105;0.534895244650287;0.5724534999776341;0.9999506876445663;-0.1093578816033256;-0.22560964083441615;-0.46505544299427926;-0.42749718766693223
Keratosis pilaris;Fractured left clavicle;0.9683930911123753;0.8430096;0.5100624674403808;0.5501791666759592;0.9998710980331391;-0.03147800692076386;-0.15686150693053902;-0.48980863059275837;-0.4496919313571799
Keratosis pilaris;Positive urine norcotinine test;0.9510235898196697;0.8972839;0.5155959147504325;0.5327533092058667;0.9998710980331391;-0.04884750821346939;-0.10258718632812203;-0.4842751832827066;-0.4671177888272724
Keratosis pilaris;Long fibula;0.9689493533223867;0.8464999;0.509885316719954;0.5490545246976892;0.9999455218634979;-0.030996168541111202;-0.15344560197214052;-0.490060205143544;-0.4508909971658087
Keratosis pilaris;Fragmentation of the epiphysis of the distal phalanx of the hallux;0.7585110366344452;0.6864654;0.5776357603014584;0.601513171306089;0.9998710980331391;-0.24136006139869393;-0.31340571545715035;-0.42223533773168076;-0.39835792672705017
Keratosis pilaris;Type II cryptotia;0.8461440801620483;0.8120152;0.5491691632821576;0.5601955737462436;0.9998710980331391;-0.15372701787109078;-0.18785592221374214;-0.4507019347509815;-0.4396755242868955
Keratosis pilaris;Increased variability in muscle fiber diameter;0.9727856498211622;0.90561795;0.5086636663478166;0.5300875171392188;0.9999296671401311;-0.02714401731896887;-0.09431171479332934;-0.49126600079231453;-0.46984215000091234
Keratosis pilaris;Widened proximal tibial metaphyses;0.8798589110374451;0.6893699;0.5383346960611862;0.6005400350902521;0.9999506876445663;-0.12009177660712123;-0.31058077072867274;-0.46161599158338007;-0.3994106525543142
Keratosis pilaris;Wide anterior fontanel;0.9763424545526505;0.96219134;0.5075311332135899;0.5120377407244665;0.9999302980513178;-0.023587843498667382;-0.03773895474382272;-0.49239916483772794;-0.48789255732685133
Keratosis pilaris;Increased circulating oleate level;1.0031372727826238;0.9563174;0.4990013734194705;0.5139090261467631;0.9998710980331391;0.0032661747494846516;-0.043553673258969194;-0.5008697246136686;-0.48596207188637597
Keratosis pilaris;Lozenge-shaped umbilicus;0.872229591012001;0.9059722;0.540782065041308;0.5299742679466455;0.9999482333076865;-0.12771864229568541;-0.09397605055698455;-0.45916616826637846;-0.46997396536104097
Keratosis pilaris;Anti-myelin-associated glycoprotein antibody positivity;0.8514965921640396;0.779836;0.5474455933767146;0.5706592541141507;0.9998710980331391;-0.1483745058690995;-0.2200350990211457;-0.4524255046564245;-0.42921184391898837
Keratosis pilaris;Fractured radius;0.9592598043382168;0.8348842;0.5129715970304107;0.5527997829239818;0.9999506876445663;-0.04069088330634951;-0.16506646132239222;-0.48697909061415556;-0.4471509047205845
Keratosis pilaris;Abnormal manual kinetic perimetry test;0.7825908958911896;0.7168157;0.5697605702205453;0.5913908076875733;0.9998710980331391;-0.21728020214194954;-0.2830553879653901;-0.43011052781259385;-0.40848029034556577
Keratosis pilaris;Small radial epiphyses;0.9018058627843857;0.7958801;0.5313066129592864;0.5654332591497104;0.9998710980331391;-0.09806523524875344;-0.20399101876372994;-0.46856448507385273;-0.4344378388834287
Keratosis pilaris;Generalized keratosis follicularis;0.382177472114563;0.53226745;0.711984987228439;0.6549289541682447;0.7882101819680228;-0.40603270985345985;-0.2559427306817069;-0.07622519473958389;-0.13328122779977813
Keratosis pilaris;Hypoplasia of the calcaneus;0.8653749078512192;0.76360273;0.5429830075005813;0.5759666731196074;0.9999482333076865;-0.13457332545646727;-0.2363454996956259;-0.4569652258071052;-0.4239815601880791
Keratosis pilaris;2-hydroxyadipic aciduria;0.8801104724407196;0.8599005;0.5382540385904424;0.5447422426142687;0.9998710980331391;-0.11976062559241951;-0.13997062348479927;-0.4616170594426967;-0.4551288554188704
Keratosis pilaris;Potter facies;0.7407922148704529;0.74810046;0.5834614451058078;0.581055253982627;0.9999431163823408;-0.2591509015118879;-0.2518426568066877;-0.416481671276533;-0.41888786239971376
Keratosis pilaris;Increased heart rate variability;0.9431094713509083;0.9160708;0.5181186002490437;0.5267469523839539;0.9999506876445663;-0.056841216293658015;-0.08387986874350428;-0.48183208739552263;-0.47320373526061243
Keratosis pilaris;Aplastic zygomatic arch;0.8175110220909119;0.7381278;0.558415385644994;0.5843398750200918;0.9999482333076865;-0.1824372112167746;-0.2618204056633383;-0.4415328476626924;-0.4156083582875947
Keratosis pilaris;Testicular torsion;0.9843069203197956;0.9189327;0.5049954674624395;0.5258328881883936;0.9999506876445663;-0.015643767324770685;-0.08101801132925868;-0.4949552201821268;-0.4741177994561727
Keratosis pilaris;Abolished vibration sense;0.9048784971237183;0.8934465;0.5303239615758307;0.5339815460879513;0.9999482333076865;-0.09506973618396819;-0.10650172823795379;-0.4696242717318557;-0.4659666872197351
Keratosis pilaris;Fractured metatarsal bone of digit 5;0.7999796569347382;0.7650274;0.5641008257891935;0.5755000363311129;0.9998710980331391;-0.19989144109840096;-0.23484369420165718;-0.4357702722439456;-0.4243710617020262
Keratosis pilaris;Prolonged G2 phase of cell cycle;0.9134250059723854;0.90394044;0.5275922183124608;0.5306239187855581;0.9999455218634979;-0.08652051589111254;-0.09600508263925478;-0.4723533035510371;-0.4693216030779398
Keratosis pilaris;Single naris;0.7802222520112991;0.8782936;0.57053321891424;0.5388366417943331;0.9999455218634979;-0.2197232698521988;-0.12165194800714418;-0.4294123029492579;-0.46110888006916484
Keratosis pilaris;Perifoveal ring of hyperautofluorescence surrounded by normal autofluorescence;0.7113942503929138;0.7969229;0.5931916815916867;0.5650942006910589;0.9998710980331391;-0.2884768476402253;-0.2029481758987397;-0.40667941644145245;-0.43477689734208025
Keratosis pilaris;Asymmetry of the thorax;0.9526195153594017;0.8199367;0.515087325216637;0.5576302675793637;0.9999455218634979;-0.04732600650409624;-0.18000882914880678;-0.4848581966468609;-0.4423152542841342
Keratosis pilaris;Type 2 muscle fiber predominance;0.937570258975029;0.9006709;0.519884934883996;0.5316696717355309;0.999943799935066;-0.062373540960037;-0.0992729138953321;-0.48005886505107;-0.46827412819953507
Keratosis pilaris;Dependency on parenteral nutrition;0.9136244878172874;0.7781356;0.5275284825146459;0.5712142281768029;0.9999482333076865;-0.086323745490399;-0.2218126356018454;-0.47241975079304055;-0.42873400513088356
Keratosis pilaris;Limited shoulder flexion;1.0233691819012165;0.8906367;0.4925606811388673;0.5348811987964284;0.9998710980331391;0.02349808386807739;-0.10923441552276314;-0.5073104168942718;-0.46498989923671075
Keratosis pilaris;Paroxysmal vertigo;0.9392311237752438;0.7426156;0.5193552592612746;0.5828606626007953;0.9999482333076865;-0.06071710953244269;-0.2573326527489096;-0.4805929740464119;-0.4170875707068912
Keratosis pilaris;Long hallux;0.8573619276285172;0.8744315;0.545558494532639;0.5400754964508441;0.9999388341437339;-0.1425769065152167;-0.12550734324560153;-0.4543803396110948;-0.4598633376928898
Keratosis pilaris;Broad medial eyebrow;0.684076577425003;0.80033064;0.6023142720362129;0.5639868143603299;0.8435749988201247;-0.1594984213951216;-0.04324435993462661;-0.24126072678391175;-0.2795881844597947
Keratosis pilaris;Myxoid subcutaneous tumors;0.7863145917654037;0.7944288;0.5685467473513441;0.5659051964415316;0.8066897472845033;-0.02037515551909952;-0.012260921906085298;-0.23814299993315913;-0.24078455084297168
Keratosis pilaris;Bulbous tips of toes;0.8353025615215302;0.89615977;0.5526647695063229;0.5331130566193666;0.9999482333076865;-0.1646456717861563;-0.10378846520313323;-0.4472834638013635;-0.46683517668831986
Keratosis pilaris;Absent internal genitalia;0.8624610304832458;0.90890855;0.5439192329966422;0.5290355525276759;0.9998710980331391;-0.13741006754989327;-0.09096255206222237;-0.4559518650364969;-0.47083554550546325
Keratosis pilaris;Hyperphalangy of the 2nd finger;0.6941365301609039;0.71745515;0.5989451103027164;0.5911786015155192;0.9999506876445663;-0.30581415748366236;-0.2824955389476669;-0.40100557734184994;-0.40877208612904714
Keratosis pilaris;Renal interstitial hemosiderin;0.8891614750027657;0.85010296;0.535353639476436;0.5478942214648714;0.9998710980331391;-0.11070962303037346;-0.1497681369697541;-0.4645174585567031;-0.4519768765682677
Keratosis pilaris;Abnormality of depressor anguli oris muscle;0.9490924924612045;0.9325931;0.5162113702407894;0.5214725549942414;0.9998710980331391;-0.05077860557193459;-0.06727799080962837;-0.48365972779234967;-0.47839854303889773
Keratosis pilaris;Paroxysmal dyspnea;0.8189115524291992;0.6202363;0.5579620289467593;0.6239947102861907;0.9998710980331391;-0.1809595456039399;-0.3796348204528779;-0.44190906908637984;-0.3758763877469484
Keratosis pilaris;Phenylpyruvic acidemia;0.675318717956543;0.49368626;0.6052570371201758;0.6689922240207455;0.9999506876445663;-0.3246319696880233;-0.5062644288516891;-0.39469365052439054;-0.33095846362382075
Keratosis pilaris;Lateral ventricle dilatation;0.9815763365477324;0.79509336;0.5058647660294264;0.5656890731639386;0.999932424164295;-0.0183560876165626;-0.20483906660127615;-0.4940676581348685;-0.4342433510003564
Keratosis pilaris;Neonatal unconjugated hyperbilirubinemia;0.8637553304433823;0.8178408;0.5435033291754179;0.5583086102282184;0.9999506876445663;-0.13619535720118403;-0.1821098730541122;-0.4564473584691484;-0.44164207741634787
Keratosis pilaris;High maternal circulating alpha-fetoprotein concentration;0.832083135843277;0.73347044;0.5537040175914527;0.5858769963126956;0.9998710980331391;-0.16778796218986214;-0.26640065812225044;-0.4461670804416864;-0.4139941017204435
Keratosis pilaris;Prominent nasolabial fold;0.7854315936565399;0.81881946;0.5688344882966225;0.557991834881765;0.9999419656013786;-0.21451037194483868;-0.18112250234835736;-0.43110747730475607;-0.44195013071961364
Keratosis pilaris;Abnormality of inferior alveolar nerve;0.908769391477108;0.9374297;0.5290800391284248;0.5199297531296143;0.9998710980331391;-0.09110170655603111;-0.0624413719093293;-0.4707910589047143;-0.4799413449035248
Keratosis pilaris;Unilateral conductive hearing impairment;0.9478143751621246;0.8442751;0.5166187492136036;0.5497713353781055;0.9999506876445663;-0.05213631248244166;-0.1556755707240951;-0.48333193843096267;-0.4501793522664608
Keratosis pilaris;Macular hypopigmented whorls, streaks, and patches;0.5154150724411011;0.5960836;0.6610293420722977;0.6323513453314706;0.7882101819680228;-0.27279510952692176;-0.19212660052042152;-0.12718083989572515;-0.1558588366365522
Keratosis pilaris;Delayed ossification of pubic rami;1.0351646579802036;0.9382919;0.48880443359287384;0.5196547928208184;0.9999482333076865;0.03521642467251718;-0.06165632599720061;-0.5111437997148126;-0.48029344048686806
Keratosis pilaris;Hyperphenylalaninemia;0.8017565160989761;0.70430845;0.5635236750901425;0.595550057489254;0.9999445874977825;-0.19818807139880634;-0.2956361372757671;-0.43642091240764;-0.40439453000852843
Keratosis pilaris;Ureteropelvic junction obstruction;0.9081915467977524;0.74360514;0.5292647479762248;0.5825347392829249;0.9999391471417843;-0.09174760034403195;-0.25633401027044644;-0.47067439916555953;-0.41740440785885946
Keratosis pilaris;Cone-shaped epiphysis of the proximal phalanx of the 2nd toe;0.7538469135761261;0.7197616;0.579166598814466;0.5904135170942393;0.9998710980331391;-0.24602418445701302;-0.2801094880020112;-0.42070449921867314;-0.40945758093889983
Keratosis pilaris;Difficulty walking;0.8329901993274689;0.79437256;0.5534111545839075;0.5659234976985861;0.9999275220014686;-0.16693732267399974;-0.20555496340771862;-0.44651636741756107;-0.43400402430288254
Keratosis pilaris;Bilobate gallbladder;0.9648172780871391;0.79786265;0.5112013198956507;0.5647887314467632;0.9999482333076865;-0.03513095522054732;-0.20208558434375823;-0.4887469134120358;-0.4351595018609232
Keratosis pilaris;Histidinuria;0.7788900434970856;0.77552867;0.5709679690924692;0.5720655136666846;0.9999466809608285;-0.22105663746374293;-0.2244180116035287;-0.42897871186835934;-0.42788116729414394
Keratosis pilaris;Widened interpedicular distance;0.9688056614249945;0.8572602;0.5099310774390019;0.5455911918697015;0.9998710980331391;-0.031065436608144648;-0.14261087082976998;-0.4899400205941372;-0.4542799061634376
Lamina lucida cleavage;Abnormal central response of multifocal electroretinogram;0.9334478825330734;0.8763535;0.5211998663063455;0.5394588906272948;0.9998962300503706;-0.06644834751729722;-0.12354272777681108;-0.47869636374402513;-0.46043733942307585
Lamina lucida cleavage;Atypical or prolonged hepatitis;0.9915708331391215;0.8640561;0.5026831189177319;0.5434066792190033;0.9999548690865008;-0.008384035947379243;-0.1358987587044207;-0.4972717501687689;-0.45654818986749746
Lamina lucida cleavage;Cubitus varus;0.9354377835988998;0.9071408;0.520565095508918;0.5296006511320113;0.9998962300503706;-0.06445844645147081;-0.09275543863420244;-0.4793311345414526;-0.4702955789183594
Lamina lucida cleavage;Nasal regurgitation;1.022557195276022;0.94088936;0.49281921268810025;0.5188264759324833;0.9999528219730685;0.022604373302953507;-0.05906346345256064;-0.5071336092849682;-0.48112634604058513
Lamina lucida cleavage;Moon facies;0.9648185819387436;0.9727031;0.5112009046096995;0.5086899610796558;0.9999528219730685;-0.03513424003432486;-0.027249722722274994;-0.488751917363369;-0.49126286089341265
Lamina lucida cleavage;Intestinal pseudo-obstruction;0.8875098004937172;0.77709246;0.5358826925735638;0.5715547937090835;0.9999468979947994;-0.11243709750108222;-0.22285444117717246;-0.4640642054212356;-0.42839210428571595
Lamina lucida cleavage;Bilateral renal atrophy;1.0373798534274101;0.9184288;0.48809885052495405;0.5259938167783493;0.9999548690865008;0.03742498434090935;-0.08152609043812431;-0.5118560185615467;-0.47396105230815144
Lamina lucida cleavage;Fractured left clavicle;0.8806873559951782;0.72980624;0.5380690832449877;0.5870877597860611;0.9998962300503706;-0.11920887405519243;-0.2700899856770491;-0.46182714680538295;-0.41280847026430956
Lamina lucida cleavage;Positive urine norcotinine test;1.0684160217642784;1.017376;0.4782054788375597;0.49446876725877476;0.9998962300503706;0.06851979171390776;0.017479715994551226;-0.5216907512128109;-0.5054274627915959
Lamina lucida cleavage;Long fibula;0.8977378681302071;0.7527838;0.5326080502143548;0.5795157979674435;0.9999505803237132;-0.10221271219350614;-0.24716680499412336;-0.46734253010935844;-0.42043478235626974
Lamina lucida cleavage;Fragmentation of the epiphysis of the distal phalanx of the hallux;0.9217855334281921;0.7898067;0.5249218920916771;0.5674093179224757;0.9998962300503706;-0.07811069662217851;-0.21008950645570512;-0.4749743379586936;-0.4324869121278949
Lamina lucida cleavage;Type II cryptotia;0.9035039246082306;0.8672545;0.5307635237252883;0.5423792874610198;0.9998962300503706;-0.09639230544214006;-0.1326417344296431;-0.4691327063250823;-0.45751694258935083
Lamina lucida cleavage;Increased variability in muscle fiber diameter;0.9415306113660336;0.8649353;0.5186220051501209;0.5431242260478759;0.999937876518323;-0.058407265152289445;-0.1350025976258059;-0.4813158713682021;-0.4568136504704471
Lamina lucida cleavage;Widened proximal tibial metaphyses;1.0074895732104778;0.89288783;0.4976159725152969;0.5341603940875109;0.9999548690865008;0.007534704123977054;-0.10706703835224785;-0.5023388965712039;-0.46579447499898985
Lamina lucida cleavage;Wide anterior fontanel;0.9841932095587254;0.93551606;0.5050316672120148;0.5205401346497024;0.9999383692587659;-0.015745159700040534;-0.06442230986011477;-0.49490670204675113;-0.4793982346090635
Lamina lucida cleavage;Increased circulating oleate level;0.8842329829931259;0.7916762;0.5369325965605152;0.5668007741312752;0.9998962300503706;-0.11566324705724473;-0.208220006772325;-0.4629636334898555;-0.4330954559190955
Lamina lucida cleavage;Lozenge-shaped umbilicus;0.6540250182151794;0.57535005;0.6124517979910085;0.6396028258097171;0.9999528219730685;-0.345927803757889;-0.42460277581523154;-0.38750102398206;-0.3603499961633514
Lamina lucida cleavage;Anti-myelin-associated glycoprotein antibody positivity;0.8836859464645386;0.81471837;0.5371079080182721;0.5593197373943216;0.9998962300503706;-0.11621028358583207;-0.18517786438112016;-0.4627883220320985;-0.44057649265604903
Lamina lucida cleavage;Fractured radius;0.9463423639535904;0.8326278;0.5170879624999203;0.5535281653594561;0.9999548690865008;-0.05361250513291038;-0.16732709580158867;-0.4828669065865805;-0.4464267037270446
Lamina lucida cleavage;Abnormal manual kinetic perimetry test;1.004837908782065;0.9300813;0.4984600397989526;0.5222739866935069;0.9998962300503706;0.004941678731694266;-0.06981492216233964;-0.5014361902514181;-0.47762224335686376
Lamina lucida cleavage;Small radial epiphyses;1.0122803188860416;0.90612155;0.49609095483748966;0.5299265062294943;0.9998962300503706;0.012384088835670992;-0.09377467805986162;-0.503805275212881;-0.4699697238208763
Lamina lucida cleavage;Generalized keratosis follicularis;0.7494686245918274;0.7397272;0.5806053247960614;0.5838124988716538;0.8061689028324591;-0.05670027824063173;-0.06644170375485292;-0.2255635780363977;-0.22235640396080536
Lamina lucida cleavage;Hypoplasia of the calcaneus;0.9224159941077232;0.80523556;0.5247205985378156;0.5623942334419475;0.9999528219730685;-0.07753682786534521;-0.19471725726435873;-0.47523222343525284;-0.43755858853112095
Lamina lucida cleavage;2-hydroxyadipic aciduria;1.0373411998152733;0.99442685;0.48811116294773016;0.5017739945916168;0.9998962300503706;0.037444969764902636;-0.005469383546159223;-0.5117850671026405;-0.4981222354587539
Lamina lucida cleavage;Potter facies;1.0191122684627771;1.0699009;0.4939160055701882;0.4777316929395361;0.9999486088983908;0.01916365956438637;0.06995226142479039;-0.5060326033282025;-0.5222169159588547
Lamina lucida cleavage;Increased heart rate variability;1.0017254538834095;0.96014655;0.4994507706982295;0.5126891135646354;0.9999548690865008;0.0017705847969087252;-0.03980832272267021;-0.5005040983882713;-0.48726575552186535
Lamina lucida cleavage;Aplastic zygomatic arch;0.9371549040079117;0.89716995;0.520017406605507;0.5327897734405811;0.9999528219730685;-0.06279791796515677;-0.10278287434886191;-0.47993541536756146;-0.46716304853248736
Lamina lucida cleavage;Testicular torsion;0.9347482547163963;0.8893402;0.5207850431729871;0.535296390403736;0.9999548690865008;-0.06520661437010444;-0.11061464720463432;-0.47916982591351365;-0.4646584786827648
Lamina lucida cleavage;Abolished vibration sense;0.8924917131662369;0.82693714;0.534287216925536;0.5553663840156435;0.9999528219730685;-0.10746110880683157;-0.1730156829387972;-0.4656656050475324;-0.4445864379574249
Lamina lucida cleavage;Fractured metatarsal bone of digit 5;0.9479142352938652;0.8457713;0.5165869194582688;0.5492892521978694;0.9998962300503706;-0.051981994756505445;-0.1541249173367476;-0.4833093105921018;-0.45060697785250126
Lamina lucida cleavage;Prolonged G2 phase of cell cycle;0.8909678012132645;0.86963564;0.5347751615983338;0.5416147142056682;0.9999505803237132;-0.10898277911044874;-0.13031493874885358;-0.4651754187253794;-0.458335866118045
Lamina lucida cleavage;Single naris;0.9336384609341621;0.94826144;0.5211390689123784;0.5164762539870954;0.9999505803237132;-0.06631211938955106;-0.05168914052345075;-0.4788115114113348;-0.4834743263366178
Lamina lucida cleavage;Perifoveal ring of hyperautofluorescence surrounded by normal autofluorescence;0.8812505900859833;0.8573232;0.5378885165304155;0.5455709398785182;0.9998962300503706;-0.11864563996438737;-0.14257300073747392;-0.4620077135199552;-0.4543252901718524
Lamina lucida cleavage;Asymmetry of the thorax;0.9873449467122555;0.8867805;0.5040283360998064;0.5361163333661009;0.9999505803237132;-0.012605633611457723;-0.1131700799117259;-0.49592224422390685;-0.46383424695761233
Lamina lucida cleavage;Type 2 muscle fiber predominance;0.9924260843545198;0.9137049;0.5024108752771076;0.5275028090177585;0.9999491674684583;-0.007523083113938456;-0.08624429533711064;-0.4975382921913507;-0.4724463584506998
Lamina lucida cleavage;Dependency on parenteral nutrition;0.9934823308140039;0.9257241;0.5020746532255036;0.5236645476636914;0.9999528219730685;-0.0064704911590645064;-0.07422873282740805;-0.49787816874756485;-0.47628827430937704
Lamina lucida cleavage;Limited shoulder flexion;1.1423370242118835;0.9830596;0.4545383199101848;0.5053925683802326;0.9998962300503706;0.1424407941615129;-0.016836644955918745;-0.5453579101401859;-0.49450366167013804
Lamina lucida cleavage;Paroxysmal vertigo;0.9867071770131588;0.86384344;0.5042313615912364;0.5434750093199252;0.9999528219730685;-0.013245644959909653;-0.13610938096354697;-0.49572146038183207;-0.45647781265314324
Lamina lucida cleavage;Long hallux;0.8957990035414696;0.8320116;0.5332285250616525;0.5537271225799256;0.9999451389191131;-0.1041461353776435;-0.16793355845188895;-0.46671661385746055;-0.44621801633918745
Lamina lucida cleavage;Broad medial eyebrow;1.0300525017082691;1.0451798;0.49043255108820183;0.48561392150112936;0.8568390591914515;0.17321344251681758;0.18834078471113636;-0.3664065081032497;-0.37122513769032217
Lamina lucida cleavage;Myxoid subcutaneous tumors;0.8567497432231903;0.79493463;0.5457553807573586;0.5657407082977762;0.8230814931248395;0.03366825009835084;-0.028146862730857536;-0.27732611236748084;-0.25734078482706324
Lamina lucida cleavage;Bulbous tips of toes;0.9854422155767679;0.97563016;0.5046340503943552;0.507757933034982;0.9999528219730685;-0.01451060639630053;-0.02432265782664511;-0.4953187715787133;-0.4921948889380865
Lamina lucida cleavage;Absent internal genitalia;0.8962038233876228;0.89655757;0.5330989643514965;0.5329857492887278;0.9998962300503706;-0.10369240666274782;-0.10333866054658647;-0.46679726569887414;-0.4669104807616429
Lamina lucida cleavage;Hyperphalangy of the 2nd finger;1.020070806145668;0.97976774;0.49361083496556246;0.5064405625656415;0.9999548690865008;0.020115937059167255;-0.020187129313704144;-0.5063440341209383;-0.49351430652085926
Lamina lucida cleavage;Renal interstitial hemosiderin;0.9912010692059994;0.93163705;0.5028008228008727;0.5217775839037977;0.9998962300503706;-0.008695160844371275;-0.06825918132905717;-0.49709540724949797;-0.47811864614657296
Lamina lucida cleavage;Abnormality of depressor anguli oris muscle;0.9752118568867445;0.88103646;0.5078911192728761;0.5379571579518612;0.9998962300503706;-0.02468437316362615;-0.11885976965074296;-0.49200511077749454;-0.4619390720985095
Lamina lucida cleavage;Paroxysmal dyspnea;0.9577341005206108;0.85314196;0.5134576624913948;0.5469160441518426;0.9998962300503706;-0.04216212952975984;-0.14675426656846757;-0.48643856755897585;-0.45298018589852806
Lamina lucida cleavage;Phenylpyruvic acidemia;0.9573418609797955;0.8868805;0.5135826289253043;0.5360842960209576;0.9999548690865008;-0.04261300810670532;-0.11307435208058036;-0.4863722401611965;-0.46387057306554313
Lamina lucida cleavage;Lateral ventricle dilatation;0.8487403988838196;0.6229036;0.5483329407548554;0.6230774636474317;0.9999400373813975;-0.1511996384975779;-0.3770364519474375;-0.4516070966265421;-0.3768625737339658
Lamina lucida cleavage;Neonatal unconjugated hyperbilirubinemia;0.8877456784248352;0.79473853;0.535807131706961;0.5658044853201852;0.9999548690865008;-0.11220919066166557;-0.20521633797382988;-0.46414773737953974;-0.43415038376631554
Lamina lucida cleavage;High maternal circulating alpha-fetoprotein concentration;0.9351926669478416;0.9277813;0.5206432823053488;0.5230079560293573;0.9998962300503706;-0.064703563102529;-0.07211494619493242;-0.4792529477450218;-0.4768882740210133
Lamina lucida cleavage;Prominent nasolabial fold;0.8730963319540024;0.8289864;0.5405039084896133;0.5547041993709214;0.9999476714516888;-0.12685133949768646;-0.1709612651253949;-0.45944376296207556;-0.4452434720807674
Lamina lucida cleavage;Abnormality of inferior alveolar nerve;0.859364241361618;0.7728685;0.5449146473282513;0.5729347065491;0.9998962300503706;-0.1405319886887526;-0.22702771598939653;-0.4549815827221193;-0.4269615235012707
Lamina lucida cleavage;Unilateral conductive hearing impairment;0.9904098622500896;0.86443174;0.5030526824497918;0.5432860148595478;0.9999548690865008;-0.00954500683641113;-0.13552313023304619;-0.49690218663670893;-0.456668854226953
Lamina lucida cleavage;Macular hypopigmented whorls, streaks, and patches;0.8591326177120209;0.8807324;0.5449891167733055;0.5380546414685412;0.8061689028324591;0.05296371487956175;0.0745635142741693;-0.2611797860591536;-0.2681142613639179
Lamina lucida cleavage;Delayed ossification of pubic rami;0.9882986657321453;0.8398263;0.503724735381518;0.5512054456521751;0.9999528219730685;-0.011654156240923141;-0.16012653613398764;-0.4962280865915505;-0.44874737632089334
Lamina lucida cleavage;Hyperphenylalaninemia;1.032121080905199;0.9191567;0.4897737833718696;0.5257613490483797;0.9999498126421364;0.0321712682630626;-0.08079314207176291;-0.5101760292702668;-0.47418846359375677
Lamina lucida cleavage;Ureteropelvic junction obstruction;0.9047221764922142;0.7390102;0.5303739470022109;0.584048902015228;0.9999453908499725;-0.09522321435775827;-0.26093517604436944;-0.4695714438477616;-0.4158964888347445
Lamina lucida cleavage;Cone-shaped epiphysis of the proximal phalanx of the 2nd toe;0.998408745508641;0.9118052;0.5005065122497898;0.5281097898093574;0.9998962300503706;-0.0014874845417296445;-0.08809101755265947;-0.49938971780058083;-0.47178644024101324
Lamina lucida cleavage;Difficulty walking;0.9520686343312263;0.9301409;0.515262875554628;0.5222549698169794;0.99993620886009;-0.0478675745288637;-0.06979529632728365;-0.48467333330546203;-0.47768123904311066
Lamina lucida cleavage;Bilobate gallbladder;0.9047151505947113;0.7611227;0.5303761936361673;0.5767793769467311;0.9999528219730685;-0.09523767137835715;-0.23883011842082236;-0.46957662833690117;-0.42317344502633736
Lamina lucida cleavage;Histidinuria;0.9484603479504585;0.94136626;0.5164128525953158;0.5186744183518226;0.9999515360511232;-0.051491188100664664;-0.05858528076776748;-0.4835386834558074;-0.4812771176993006
Lamina lucida cleavage;Widened interpedicular distance;0.993634570389986;0.9138292;0.5020261928579464;0.5274630672267218;0.9998962300503706;-0.006261659660384611;-0.08606702263002153;-0.4978700371924243;-0.4724331628236489
Abnormal central response of multifocal electroretinogram;Atypical or prolonged hepatitis;0.9184773489832878;0.80888;0.5259782951795313;0.561211981845062;0.9999201345566091;-0.0814427855733213;-0.19104016305239768;-0.4739418393770778;-0.43870815271154706
Abnormal central response of multifocal electroretinogram;Cubitus varus;0.9246959686279297;0.81226873;0.5239927301128178;0.5601134151710521;1.0;-0.07530403137207031;-0.18773126602172852;-0.4760072698871822;-0.43988658482894794
Abnormal central response of multifocal electroretinogram;Nasal regurgitation;0.9471222311258316;0.8094623;0.5168393701282075;0.561023128629579;0.9999134918687169;-0.052791260742885315;-0.19045118298504993;-0.48307412174050945;-0.4388903632391379
Abnormal central response of multifocal electroretinogram;Moon facies;0.918873742222786;0.9016559;0.5258516999679884;0.5313545805616446;0.9999134918687169;-0.08103974964593097;-0.09825757946942493;-0.4740617919007285;-0.4685589113070723
Abnormal central response of multifocal electroretinogram;Intestinal pseudo-obstruction;0.9252163991332054;0.7948374;0.5238266034983741;0.5657723202363117;0.9998912449978579;-0.07467484586465245;-0.2050538297795046;-0.4760646414994838;-0.4341189247615461
Abnormal central response of multifocal electroretinogram;Bilateral renal atrophy;0.8221527636051178;0.7472979;0.5569132914028949;0.5813192728409288;0.9999201345566091;-0.1777673709514913;-0.25262225152285667;-0.4430068431537142;-0.41860086171568034
Abnormal central response of multifocal electroretinogram;Fractured left clavicle;1.0638630017638206;0.8761452;0.47965793170174464;0.5395257116391702;1.0;0.06386300176382065;-0.12385481595993042;-0.5203420682982554;-0.4604742883608298
Abnormal central response of multifocal electroretinogram;Positive urine norcotinine test;0.8783804923295975;0.7494093;0.5388087677216049;0.5806248149125767;1.0;-0.12161950767040253;-0.2505906820297241;-0.4611912322783951;-0.41937518508742333
Abnormal central response of multifocal electroretinogram;Long fibula;1.001336857676506;0.84660065;0.4995744648583954;0.54902209565205;0.9999056439461368;0.0014312137303692518;-0.15330499220510896;-0.5003311790877414;-0.45088354829408683
Abnormal central response of multifocal electroretinogram;Fragmentation of the epiphysis of the distal phalanx of the hallux;0.9991506282240152;0.8713361;0.5002703634658496;0.5410688478409897;1.0;-0.0008493717759847641;-0.12866389751434326;-0.49972963653415037;-0.45893115215901026
Abnormal central response of multifocal electroretinogram;Type II cryptotia;0.9689706470817327;0.8653651;0.5098785354382327;0.5429861667660991;1.0;-0.03102935291826725;-0.13463491201400757;-0.4901214645617673;-0.4570138332339009
Abnormal central response of multifocal electroretinogram;Increased variability in muscle fiber diameter;0.8591331243515015;0.73312616;0.544988953880668;0.585990701401776;0.9998452077479463;-0.1407120833964448;-0.26671904426528026;-0.45485625386727824;-0.41385450634617027
Abnormal central response of multifocal electroretinogram;Widened proximal tibial metaphyses;1.008302003145218;0.79908514;0.497357359966596;0.5643914687542715;0.9999201345566091;0.008381868588608787;-0.20083499432833762;-0.5025627745900131;-0.4355286658023376
Abnormal central response of multifocal electroretinogram;Wide anterior fontanel;0.9717191010713577;0.8621249;0.5090032901436805;0.5440272446040879;0.999848231156753;-0.028129130085395304;-0.1377233112653956;-0.4908449410130725;-0.4558209865526651
Abnormal central response of multifocal electroretinogram;Increased circulating oleate level;0.8909215778112411;0.7788775;0.534789963245889;0.570972059357094;1.0;-0.10907842218875885;-0.22112250328063965;-0.465210036754111;-0.42902794064290595
Abnormal central response of multifocal electroretinogram;Lozenge-shaped umbilicus;1.0250292271375656;0.954743;0.49203211748131004;0.5144106662425453;0.9999134918687169;0.025115735268848693;-0.045170464181644165;-0.5078813743874069;-0.48550282562617164
Abnormal central response of multifocal electroretinogram;Anti-myelin-associated glycoprotein antibody positivity;0.7542116940021515;0.6609627;0.5790468052106224;0.6101012888462908;1.0;-0.2457883059978485;-0.33903729915618896;-0.42095319478937765;-0.3898987111537092
Abnormal central response of multifocal electroretinogram;Fractured radius;0.9724427219480276;0.81450737;0.5087728646367204;0.5593880808737006;0.9999201345566091;-0.027477412608581497;-0.1854127693298635;-0.49114726991988866;-0.4405320536829085
Abnormal central response of multifocal electroretinogram;Abnormal manual kinetic perimetry test;0.2699607014656067;0.41539025;0.7604982704984808;0.6987523622516107;1.0;-0.7300392985343933;-0.5846097469329834;-0.23950172950151916;-0.30124763774838925
Abnormal central response of multifocal electroretinogram;Small radial epiphyses;0.9786734562367201;0.8666765;0.5067889644121112;0.5425649257472052;1.0;-0.021326543763279915;-0.13332349061965942;-0.4932110355878888;-0.45743507425279484
Abnormal central response of multifocal electroretinogram;Generalized keratosis follicularis;0.8177196681499481;0.74234945;0.5583478385921516;0.5829483327135115;0.9999201345566091;-0.182200466406661;-0.25757068873675437;-0.44157229596445746;-0.41697180184309757
Abnormal central response of multifocal electroretinogram;Hypoplasia of the calcaneus;0.9938205210492015;0.8529016;0.5019670017602811;0.5469933965683893;0.9999134918687169;-0.006092970819515431;-0.147011913919193;-0.49794649010843584;-0.4529200953003276
Abnormal central response of multifocal electroretinogram;2-hydroxyadipic aciduria;0.9368524849414825;0.88722163;0.5201138611663849;0.5359750013567701;1.0;-0.06314751505851746;-0.11277836561203003;-0.4798861388336151;-0.4640249986432299
Abnormal central response of multifocal electroretinogram;Potter facies;1.039712656289339;0.9791507;0.48735574387784886;0.5066370158303359;0.9998981869165328;0.039814469372806305;-0.020747474426450974;-0.5125424430386839;-0.4932611710861968
Abnormal central response of multifocal electroretinogram;Increased heart rate variability;0.8225914686918259;0.7074146;0.5567713906914535;0.5945155771156655;0.9999201345566091;-0.17732866586478324;-0.2925055074814138;-0.44314874386515557;-0.4054045574409436
Abnormal central response of multifocal electroretinogram;Aplastic zygomatic arch;0.9509671181440353;0.83103085;0.5156139118657022;0.5540438177664384;0.9999134918687169;-0.04894637372468158;-0.16888264622662708;-0.48429958000301476;-0.4458696741022785
Abnormal central response of multifocal electroretinogram;Testicular torsion;0.9530336335301399;0.8562373;0.5149553603933361;0.5459202049910907;0.9999201345566091;-0.046886501026469185;-0.14368284226687522;-0.484964774163273;-0.4539999295655184
Abnormal central response of multifocal electroretinogram;Abolished vibration sense;0.8585887849330902;0.8012246;0.5451639744956897;0.5636964306489107;0.9999134918687169;-0.1413247069356267;-0.19868890252087756;-0.45474951737302727;-0.4362170612198062
Abnormal central response of multifocal electroretinogram;Fractured metatarsal bone of digit 5;0.9914546879008412;0.88261735;0.5027200904269431;0.5374503975887804;1.0;-0.008545312099158764;-0.11738264560699463;-0.4972799095730569;-0.46254960241121956
Abnormal central response of multifocal electroretinogram;Prolonged G2 phase of cell cycle;0.818567082285881;0.76731956;0.5580735241074337;0.5747496172842721;0.9999056439461368;-0.18133856166025575;-0.23258608389517244;-0.4418321198387031;-0.4251560266618647
Abnormal central response of multifocal electroretinogram;Single naris;0.8650437295436859;0.8745958;0.5430893957192484;0.5400227574724509;0.9999056439461368;-0.13486191440245088;-0.12530982304235871;-0.4568162482268884;-0.4598828864736859
Abnormal central response of multifocal electroretinogram;Perifoveal ring of hyperautofluorescence surrounded by normal autofluorescence;0.401469349861145;0.50050217;0.7042485307562706;0.6664821239730494;1.0;-0.598530650138855;-0.49949783086776733;-0.2957514692437294;-0.3335178760269506
Abnormal central response of multifocal electroretinogram;Asymmetry of the thorax;1.0382191464304924;0.86447406;0.48783150419599974;0.5432724091539121;0.9999056439461368;0.03831350248435561;-0.13543158579489167;-0.512074139750137;-0.45663323479222473
Abnormal central response of multifocal electroretinogram;Type 2 muscle fiber predominance;0.9653747901320457;0.86709684;0.5110237500993442;0.5424299285656927;0.9999003561294039;-0.03452556599735812;-0.13280351479410724;-0.48887660603005967;-0.45747042756371115
Abnormal central response of multifocal electroretinogram;Dependency on parenteral nutrition;0.9578420557081699;0.8517496;0.5134232686319645;0.5473641573812609;0.9999134918687169;-0.04207143616054698;-0.14816389288876697;-0.4864902232367524;-0.45254933448745605
Abnormal central response of multifocal electroretinogram;Limited shoulder flexion;0.939417626708746;0.8080492;0.5192957839525922;0.5614813929965099;1.0;-0.060582373291254044;-0.19195079803466797;-0.48070421604740776;-0.4385186070034901
Abnormal central response of multifocal electroretinogram;Paroxysmal vertigo;0.7200560569763184;0.66885805;0.5903158837915077;0.6074339088497415;0.9999134918687169;-0.27985743489239856;-0.3310554405686681;-0.40959760807720924;-0.39247958301897545
Abnormal central response of multifocal electroretinogram;Long hallux;1.0022027865052223;0.8874639;0.4992988307111911;0.535897394945883;0.9998836012415208;0.002319185263701562;-0.11241967397253882;-0.5005847705303297;-0.4639862062956378
Abnormal central response of multifocal electroretinogram;Broad medial eyebrow;0.7529116421937943;0.7060402;0.5794737935630043;0.5949731816598821;0.9999201345566091;-0.24700849236281486;-0.29387993098528953;-0.4204463409936048;-0.404946952896727
Abnormal central response of multifocal electroretinogram;Myxoid subcutaneous tumors;0.9288401082158089;0.79846305;0.5226700570849916;0.5645936127229505;0.9999201345566091;-0.07108002634080024;-0.20145708800585838;-0.4772500774716175;-0.4353265218336586
Abnormal central response of multifocal electroretinogram;Bulbous tips of toes;1.020220061764121;0.92775816;0.49356331578306045;0.5230153343561816;0.9999134918687169;0.020306569895404136;-0.07215533461545154;-0.5063501760856565;-0.4768981575125353
Abnormal central response of multifocal electroretinogram;Absent internal genitalia;0.965843565762043;0.8932133;0.5108744458612197;0.5340562076909601;1.0;-0.034156434237957;-0.10678672790527344;-0.48912555413878034;-0.46594379230903993
Abnormal central response of multifocal electroretinogram;Hyperphalangy of the 2nd finger;0.9670045971870422;0.86557525;0.5105046695686155;0.5429186503594411;0.9999201345566091;-0.03291553736956687;-0.13434488059313865;-0.4894154649879936;-0.457001484197168
Abnormal central response of multifocal electroretinogram;Renal interstitial hemosiderin;0.8843991905450821;0.772614;0.5368793334491153;0.573017911518287;1.0;-0.11560080945491791;-0.2273859977722168;-0.4631206665508847;-0.42698208848171304
Abnormal central response of multifocal electroretinogram;Abnormality of depressor anguli oris muscle;0.9151694849133492;0.7897979;0.5270348827702875;0.5674121997588835;1.0;-0.08483051508665085;-0.21020209789276123;-0.47296511722971246;-0.43258780024111654
Abnormal central response of multifocal electroretinogram;Paroxysmal dyspnea;0.9226882457733154;0.75859094;0.5246336770636997;0.5776095616945334;1.0;-0.07731175422668457;-0.2414090633392334;-0.4753663229363003;-0.42239043830546663
Abnormal central response of multifocal electroretinogram;Phenylpyruvic acidemia;0.9027557447552681;0.79249644;0.5310028020947136;0.5665338669527495;0.9999201345566091;-0.09716438980134101;-0.2074236917618093;-0.4689173324618955;-0.43338626760385957
Abnormal central response of multifocal electroretinogram;Lateral ventricle dilatation;0.7918116897344589;0.6984014;0.5667566871836189;0.5975202476716602;0.9998579617208769;-0.208046271986418;-0.30145657021468186;-0.433101274537258;-0.4023377140492167
Abnormal central response of multifocal electroretinogram;Neonatal unconjugated hyperbilirubinemia;0.9552730843424797;0.86669433;0.5142417705630278;0.5425591922306094;0.9999201345566091;-0.0446470502141294;-0.1332258033874807;-0.48567836399358133;-0.45736094232599966
Abnormal central response of multifocal electroretinogram;High maternal circulating alpha-fetoprotein concentration;0.8823151588439941;0.81497;0.5375472607895322;0.5592382153845205;1.0;-0.11768484115600586;-0.1850299835205078;-0.4624527392104678;-0.44076178461547955
Abnormal central response of multifocal electroretinogram;Prominent nasolabial fold;0.9431263357400894;0.83599484;0.5181132234416691;0.5524413727452688;0.9998944404568447;-0.05676810471675531;-0.1638996007885708;-0.4817812170151756;-0.4474530677115759
Abnormal central response of multifocal electroretinogram;Abnormality of inferior alveolar nerve;0.9010940566658974;0.7805306;0.5315342962289963;0.570432611792633;1.0;-0.09890594333410263;-0.21946942806243896;-0.4684657037710037;-0.42956738820736695
Abnormal central response of multifocal electroretinogram;Unilateral conductive hearing impairment;0.6779451370239258;0.6043743;0.6043735549921283;0.6294722326411628;0.9999201345566091;-0.3219749975326833;-0.39554584504397483;-0.3955465795644808;-0.3704479019154463
Abnormal central response of multifocal electroretinogram;Macular hypopigmented whorls, streaks, and patches;0.4783276915550232;0.5662189;0.6746916313040205;0.6428208772747512;0.9999201345566091;-0.5215924430015859;-0.43370122195513816;-0.32522850325258856;-0.3570992572818579
Abnormal central response of multifocal electroretinogram;Delayed ossification of pubic rami;1.030180161818862;0.87404114;0.49039189717230136;0.5402007386278538;0.9999134918687169;0.030266669950145042;-0.12587235178921863;-0.5095215946964156;-0.45971275324086314
Abnormal central response of multifocal electroretinogram;Hyperphenylalaninemia;0.936076432466507;0.8140476;0.5203613864535885;0.5595370376530948;0.9999028053808913;-0.06382637291438431;-0.18585523038394303;-0.47954141892730273;-0.44036576772779645
Abnormal central response of multifocal electroretinogram;Ureteropelvic junction obstruction;0.9048517420887947;0.76429284;0.530332516770969;0.5757406086583687;0.9998847295244674;-0.09503298743567268;-0.23559189333519737;-0.46955221275349834;-0.42414412086609865
Abnormal central response of multifocal electroretinogram;Cone-shaped epiphysis of the proximal phalanx of the 2nd toe;0.9393748715519905;0.7958286;0.5193094184031111;0.5654499848658248;1.0;-0.06062512844800949;-0.20417141914367676;-0.48069058159688893;-0.43455001513417524
Abnormal central response of multifocal electroretinogram;Difficulty walking;0.8648363202810287;0.79329824;0.5431560266490454;0.5662729895137872;0.9998344221996177;-0.13499810191858896;-0.20653617772329935;-0.4566783955505723;-0.4335614326858305
Abnormal central response of multifocal electroretinogram;Bilobate gallbladder;0.9315729588270187;0.8338828;0.5217980369885051;0.5531230029221017;0.9999134918687169;-0.06834053304169818;-0.16603068318341418;-0.4781154548802118;-0.4467904889466152
Abnormal central response of multifocal electroretinogram;Histidinuria;0.913352832198143;0.85320866;0.527615278594262;0.5468945858365339;0.9999090677057578;-0.08655623550761482;-0.1467004066263511;-0.4722937891114958;-0.4530144818692239
Abnormal central response of multifocal electroretinogram;Widened interpedicular distance;0.9129199162125587;0.73842555;0.5277536028699265;0.5842416933065268;1.0;-0.08708008378744125;-0.2615744471549988;-0.47224639713007355;-0.41575830669347325
Atypical or prolonged hepatitis;Cubitus varus;1.0067710969597101;0.96609807;0.49784467642774377;0.5107933805353677;0.9999201345566091;0.006850962403101013;-0.03382206441195579;-0.5020754581288653;-0.4891267540212414
Atypical or prolonged hepatitis;Nasal regurgitation;1.0618859231472015;0.94015086;0.4802885030963474;0.5190619580871392;0.8584874194359269;0.20339850371127466;0.08166343753581384;-0.37819891633957947;-0.3394254613487877
Atypical or prolonged hepatitis;Moon facies;0.9143581837415695;0.8984322;0.5272940712059898;0.5323858822400644;0.9999584729108851;-0.08560028916931561;-0.10152627772427014;-0.4726644017048953;-0.4675725906708207
Atypical or prolonged hepatitis;Intestinal pseudo-obstruction;0.792751669883728;0.6408992;0.5664508106256373;0.6169165703308541;0.8430783222418983;-0.05032665235817024;-0.20217914087593147;-0.276627511616261;-0.22616175191104415
Atypical or prolonged hepatitis;Bilateral renal atrophy;0.8335810750722885;0.7726461;0.5532204034725792;0.5730074101604892;0.9999600672783046;-0.16637899220601604;-0.22731393814698742;-0.4467396638057254;-0.4269526571178154
Atypical or prolonged hepatitis;Fractured left clavicle;0.9871665872633457;0.8723993;0.5040851142867793;0.5407276134118495;0.9999201345566091;-0.01275354729326339;-0.12752086402209373;-0.49583502026982984;-0.4591925211447596
Atypical or prolonged hepatitis;Positive urine norcotinine test;0.9657047353684902;0.9050056;0.5109186628537011;0.5302833229120892;0.9999201345566091;-0.03421539918811889;-0.09491456033022971;-0.489001471702908;-0.46963681164451987
Atypical or prolonged hepatitis;Long fibula;1.0195314809679985;0.8525668;0.4937825411686044;0.547101150828888;0.9999567459343585;0.019574735033640045;-0.1473899672745379;-0.506174204765754;-0.45285559510547047
Atypical or prolonged hepatitis;Fragmentation of the epiphysis of the distal phalanx of the hallux;1.1001694053411484;0.9383465;0.4680615240558256;0.5196373675611892;0.9999201345566091;0.10024927078453927;-0.06157362939150901;-0.5318586105007835;-0.48028276699541994
Atypical or prolonged hepatitis;Type II cryptotia;0.8357406407594681;0.7663866;0.5525233991858278;0.5750549895947854;0.9999201345566091;-0.16417949379714103;-0.23353350640566917;-0.4473967353707813;-0.4248651449618237
Atypical or prolonged hepatitis;Increased variability in muscle fiber diameter;0.950321014970541;0.80091333;0.5158198238514968;0.5637975172188284;0.9999473166570552;-0.04962630168651416;-0.1990339827642329;-0.48412749280555833;-0.43614979943822674
Atypical or prolonged hepatitis;Widened proximal tibial metaphyses;1.0550867654383183;0.84449744;0.48245645752458266;0.5496996846928954;0.9999600672783046;0.0551266981600137;-0.15546262503282116;-0.5175036097537219;-0.4502603825854091
Atypical or prolonged hepatitis;Wide anterior fontanel;1.0005093328654766;0.8475548;0.4998378743065507;0.5487147507410199;0.9999476714516888;0.0005616614137877729;-0.15239286855709655;-0.5001097971451381;-0.4512329207106689
Atypical or prolonged hepatitis;Increased circulating oleate level;0.7819271981716156;0.6817446;0.5699770252638865;0.6030969717585264;0.9999201345566091;-0.2179929363849935;-0.3181755590561208;-0.4299431092927226;-0.3968231627980827
Atypical or prolonged hepatitis;Lozenge-shaped umbilicus;0.9013242870569229;0.83322173;0.5314606513648936;0.5533364065926327;0.8584874194359269;0.04283686762099603;-0.025265685865828003;-0.32702676807103326;-0.30515101284329416
Atypical or prolonged hepatitis;Anti-myelin-associated glycoprotein antibody positivity;0.9103263020515442;0.78091145;0.5285824192065118;0.5703083517176721;0.5829152011936182;0.327411100857926;0.1979962444240576;-0.05433278198710634;-0.012606849475946036
Atypical or prolonged hepatitis;Fractured radius;1.0616541914641857;0.90060484;0.4803624067079999;0.531690781403436;0.9999600672783046;0.06169412418588116;-0.0993552231849818;-0.5195976605703047;-0.4682692858748686
Atypical or prolonged hepatitis;Abnormal manual kinetic perimetry test;0.9954130984842777;0.84640956;0.501460061219303;0.5490836517557963;0.9999201345566091;-0.004507036072331383;-0.15351057530673118;-0.49846007333730613;-0.4508364828008128
Atypical or prolonged hepatitis;Small radial epiphyses;1.0691670700907707;0.93862134;0.47796584504539275;0.5195497265378868;0.9999201345566091;0.06924693553416161;-0.061298792374449684;-0.5219542895112164;-0.48037040801872233
Atypical or prolonged hepatitis;Generalized keratosis follicularis;0.8353793621063232;0.72843516;0.5526399848235437;0.5875411403401976;0.9999600672783046;-0.1645807051719813;-0.27152490854875133;-0.44732008245476085;-0.412418926938107
Atypical or prolonged hepatitis;Hypoplasia of the calcaneus;1.0952393934130669;0.9732763;0.46963834155836826;0.508507416368092;0.9999584729108851;0.09528092050218173;-0.026682155791286744;-0.5303201313525169;-0.4914510565427931
Atypical or prolonged hepatitis;2-hydroxyadipic aciduria;0.8630062788724899;0.7863157;0.5437440164725242;0.5685463977674213;0.9999201345566091;-0.13691385568411918;-0.2136044550064382;-0.45617611808408487;-0.4313737367891878
Atypical or prolonged hepatitis;Potter facies;0.908181831240654;0.84620094;0.5292678536517336;0.549150854855157;0.9999552432134126;-0.09177341197275857;-0.1537543002202485;-0.470687389561679;-0.45080438835825554
Atypical or prolonged hepatitis;Increased heart rate variability;0.8186284750699997;0.6541326;0.5580536524869752;0.6124152988551339;0.9999600672783046;-0.18133159220830486;-0.34582746267930553;-0.4419064147913293;-0.38754476842317065
Atypical or prolonged hepatitis;Aplastic zygomatic arch;1.0257255360484123;0.7957238;0.4918104040621669;0.565484057053909;0.9999584729108851;0.02576706313752719;-0.20423467702007703;-0.5081480688487182;-0.4344744158569761
Atypical or prolonged hepatitis;Testicular torsion;0.9559819549322128;0.80583286;0.5140159075792371;0.5622004217629857;0.9999600672783046;-0.043978112346091724;-0.19412720442430065;-0.48594415969906746;-0.4377596455153189
Atypical or prolonged hepatitis;Abolished vibration sense;1.0408615991473198;0.96463203;0.48698972683415576;0.5112603215447509;0.9999584729108851;0.04090312623643466;-0.03532643860912732;-0.5129687460767294;-0.48869815136613426
Atypical or prolonged hepatitis;Fractured metatarsal bone of digit 5;1.0605077296495438;0.9182328;0.48072801952480826;0.5260564011217832;0.9999201345566091;0.060587595092934654;-0.08168733598025413;-0.5191921150318008;-0.4738637334348259
Atypical or prolonged hepatitis;Prolonged G2 phase of cell cycle;0.8090056329965591;0.7177577;0.5611712222264147;0.5910782097663818;0.9999567459343585;-0.19095111293779932;-0.28219904406057916;-0.43878552370794377;-0.40887853616797665
Atypical or prolonged hepatitis;Single naris;1.089282251894474;1.0807408;0.4715426837560599;0.4742714053821808;0.9999567459343585;0.08932550596011557;0.08078406350625433;-0.5284140621782986;-0.5256853405521776
Atypical or prolonged hepatitis;Perifoveal ring of hyperautofluorescence surrounded by normal autofluorescence;0.8369452953338623;0.746947;0.5521347050517293;0.5814347077536643;0.9999201345566091;-0.1629748392227468;-0.2529731440666494;-0.44778542950487976;-0.41848542680294476
Atypical or prolonged hepatitis;Asymmetry of the thorax;0.9542109370231628;0.7812467;0.5145802093586995;0.5701989865848669;0.9999567459343585;-0.04574580891119562;-0.2187100241898211;-0.48537653657565893;-0.42975775934949156
Atypical or prolonged hepatitis;Type 2 muscle fiber predominance;0.9598797298967838;0.8926399;0.5127741071183529;0.5342397760965591;0.9999556674707869;-0.04007593757400307;-0.1073157920587996;-0.487181560352434;-0.46571589137422775
Atypical or prolonged hepatitis;Dependency on parenteral nutrition;0.8149802684783936;0.7861821;0.5592349043901446;0.5685899119006449;0.8584874194359269;-0.043507150957533325;-0.07230531389469763;-0.2992525150457823;-0.289897507535282
Atypical or prolonged hepatitis;Limited shoulder flexion;0.9642102718353271;0.8744997;0.5113946577604028;0.5400535994332353;0.9999201345566091;-0.03570986272128196;-0.12542045594485374;-0.4885254767962063;-0.45986653512337383
Atypical or prolonged hepatitis;Paroxysmal vertigo;0.9731140211224556;0.7537823;0.5085591042541664;0.579187837927214;0.9999584729108851;-0.026844451788429535;-0.24617620057201794;-0.49139936865671874;-0.4207706349836712
Atypical or prolonged hepatitis;Long hallux;1.0036135595291853;0.8413669;0.4988497657742802;0.5507086958252073;0.9999526340597648;0.0036609254694205395;-0.15858574696717442;-0.5011028682854846;-0.44924393823455744
Atypical or prolonged hepatitis;Broad medial eyebrow;0.908304437994957;0.87462586;0.5292286613747564;0.5400131191383775;0.9999600672783046;-0.09165562928334758;-0.12533420563355968;-0.4707314059035481;-0.4599469481399271
Atypical or prolonged hepatitis;Myxoid subcutaneous tumors;0.9370364919304848;0.84662217;0.520055173134637;0.5490151548661197;0.9999600672783046;-0.06292357534781978;-0.1533378982605128;-0.47990489414366755;-0.4509449124121848
Atypical or prolonged hepatitis;Bulbous tips of toes;0.9677271023392677;0.8607397;0.5102745664696875;0.5444724711571807;0.9999584729108851;-0.0322313705716174;-0.1392187649641078;-0.48968390644119764;-0.45548600175370446
Atypical or prolonged hepatitis;Absent internal genitalia;1.1135893315076828;1.0004671;0.46376518589019855;0.4998513111638093;0.9999201345566091;0.11366919695107369;0.0005469274398508528;-0.5361549486664106;-0.5000688233927998
Atypical or prolonged hepatitis;Hyperphalangy of the 2nd finger;0.931696280837059;0.7866317;0.521758690316074;0.5684434343892721;0.9999600672783046;-0.06826378644124553;-0.21332836390153453;-0.47820137696223053;-0.4315166328890324
Atypical or prolonged hepatitis;Renal interstitial hemosiderin;0.7959743738174438;0.7650712;0.5654025893525997;0.5754856995217899;0.9999201345566091;-0.20394576073916526;-0.23484892131121726;-0.4345175452040094;-0.42443443503481926
Atypical or prolonged hepatitis;Abnormality of depressor anguli oris muscle;1.0585096329450607;0.8744707;0.4813651627194838;0.5400629128139376;0.9999201345566091;0.05858949838845162;-0.12544942380221458;-0.5185549718371253;-0.4598572217426715
Atypical or prolonged hepatitis;Paroxysmal dyspnea;0.8948517218232155;0.7089471;0.5335317198032992;0.5940055599952083;0.9999201345566091;-0.10506841273339362;-0.2909730124595937;-0.46638841475330994;-0.4059145745614008
Atypical or prolonged hepatitis;Phenylpyruvic acidemia;0.8320295959711075;0.71869457;0.55372130540785;0.5907674024530094;0.9999600672783046;-0.16793047130719707;-0.28126549959794567;-0.4462387618704545;-0.40919266482529515
Atypical or prolonged hepatitis;Lateral ventricle dilatation;0.8665918707847595;0.75876296;0.5425921098881314;0.5775531387550701;0.9999488789551968;-0.13335700817043727;-0.24118592328960842;-0.45735676906706535;-0.4223957402001267
Atypical or prolonged hepatitis;Neonatal unconjugated hyperbilirubinemia;0.6519805788993835;0.6537269;0.6131456767686376;0.6125529521393911;0.9999600672783046;-0.347979488378921;-0.3462331914962916;-0.3868143905096669;-0.38740711513891346
Atypical or prolonged hepatitis;High maternal circulating alpha-fetoprotein concentration;0.7757693231105804;0.6949845;0.571986907398311;0.5986616482673651;0.9999201345566091;-0.22415081144602866;-0.3049356389168081;-0.42793322715829807;-0.401258486289244
Atypical or prolonged hepatitis;Prominent nasolabial fold;1.0571462139487267;0.9285342;0.481799879969964;0.5227676713810663;0.9999545338528789;0.05719168009584774;-0.07142032412463795;-0.5181546538829149;-0.47718686247181263
Atypical or prolonged hepatitis;Abnormality of inferior alveolar nerve;1.0095630893483758;0.8308482;0.49695592771865715;0.5541028040761994;0.9999201345566091;0.009642954791766689;-0.16907191754611106;-0.502964206837952;-0.4458173304804097
Atypical or prolonged hepatitis;Unilateral conductive hearing impairment;1.0155775044113398;0.88805944;0.49504132578581594;0.5357066256953069;0.9999600672783046;0.015617437133035206;-0.11190063000337169;-0.5049187414924886;-0.46425344158299764
Atypical or prolonged hepatitis;Macular hypopigmented whorls, streaks, and patches;0.8274112492799759;0.7311808;0.5552131596339316;0.5866334179085844;0.9999600672783046;-0.17254881799832866;-0.26877928019181774;-0.44474690764437297;-0.4133266493697202
Atypical or prolonged hepatitis;Delayed ossification of pubic rami;1.0075541539117694;0.79019904;0.4975954152580586;0.5672815960994289;0.9999584729108851;0.007595681000884258;-0.20975943154430798;-0.5023630576528265;-0.4326768768114563
Atypical or prolonged hepatitis;Hyperphenylalaninemia;0.6635181307792664;0.5404266;0.6092370825744575;0.6519976695583893;0.9999561589935034;-0.3364380282142371;-0.45952954709317384;-0.3907190764190459;-0.3479584894351141
Atypical or prolonged hepatitis;Ureteropelvic junction obstruction;1.0120567623525858;0.85920006;0.49616212036141283;0.5449674377838607;0.9999528219730685;0.012103940379517342;-0.14075276160548422;-0.5037907016116556;-0.45498538418920775
Atypical or prolonged hepatitis;Cone-shaped epiphysis of the proximal phalanx of the 2nd toe;1.0792669206857681;0.95708674;0.4747420579523157;0.5136639162090479;0.9999201345566091;0.07934678612915902;-0.04283339263232322;-0.5251780766042934;-0.48625621834756116
Atypical or prolonged hepatitis;Difficulty walking;1.0298089534044266;0.9542759;0.490510109669422;0.5145595145030855;0.9999461221900431;0.02986283121438349;-0.04567021610407507;-0.5094360125206211;-0.4853866076869576
Atypical or prolonged hepatitis;Bilobate gallbladder;0.715410053730011;0.66714287;0.5918574403857836;0.6080126778046697;0.7152708671182011;0.0001391866118098939;-0.048127999076208905;-0.12341342673241751;-0.10725818931353137
Atypical or prolonged hepatitis;Histidinuria;0.8292684257030487;0.72776663;0.554613094693905;0.5877622695578459;0.9999574798349273;-0.17068905413187863;-0.2721908468011749;-0.44534438514102237;-0.4121952102770814
Atypical or prolonged hepatitis;Widened interpedicular distance;0.9475900493562222;0.77363896;0.5166902521848599;0.5726829209946724;0.9999201345566091;-0.052330085200386955;-0.2262811708572683;-0.48322988237174924;-0.42723721356193667
Cubitus varus;Nasal regurgitation;0.8817343935370445;0.7891298;0.5377334241959363;0.5676297412518115;0.9999134918687169;-0.1181790983316724;-0.2107836982247655;-0.46218006767278064;-0.4322837506169054
Cubitus varus;Moon facies;0.9074448943138123;0.9270203;0.5295034311153046;0.5232508314921951;0.9999134918687169;-0.09246859755490466;-0.0728931805131261;-0.4704100607534123;-0.47666266037652183
Cubitus varus;Intestinal pseudo-obstruction;0.9713460989296436;0.8746548;0.5091220685519882;0.5400038346272354;0.9998912449978579;-0.028545146068214233;-0.12523641549575215;-0.4907691764458697;-0.4598874103706224
Cubitus varus;Bilateral renal atrophy;0.888916939496994;0.8287356;0.5354319611991586;0.5547852321788538;0.9999201345566091;-0.11100319505961509;-0.17118454457553;-0.4644881733574505;-0.4451349023777553
Cubitus varus;Fractured left clavicle;0.7100992798805237;0.7280105;0.5936222909738111;0.5876816083563028;1.0;-0.2899007201194763;-0.27198952436447144;-0.40637770902618886;-0.4123183916436972
Cubitus varus;Positive urine norcotinine test;0.8836920261383057;0.8057137;0.5371059595736041;0.5622390748836048;1.0;-0.11630797386169434;-0.1942862868309021;-0.4628940404263959;-0.4377609251163952
Cubitus varus;Long fibula;0.8451623171567917;0.8882122;0.5494854584154145;0.5356577009533339;0.7078919860199948;0.13727033113679687;0.18032021795949738;-0.1584065276045803;-0.17223428506666094
Cubitus varus;Fragmentation of the epiphysis of the distal phalanx of the hallux;0.7304162383079529;0.78666663;0.586886109753717;0.5684320349210376;1.0;-0.2695837616920471;-0.2133333683013916;-0.413113890246283;-0.43156796507896245
Cubitus varus;Type II cryptotia;0.8472795486450195;0.75522834;0.5488034097695889;0.578712999520321;1.0;-0.15272045135498047;-0.24477165937423706;-0.45119659023041114;-0.42128700047967904
Cubitus varus;Increased variability in muscle fiber diameter;0.8002133369445801;0.7714639;0.564024910833022;0.5733939047482135;0.7712186293488323;0.028994707595747737;0.00024524165336492487;-0.20719371851581037;-0.19782472460061884
Cubitus varus;Widened proximal tibial metaphyses;0.7413308620452881;0.83396363;0.5832839341621443;0.5530969087588509;0.7527521012230838;-0.011421239177795695;0.08121153136053438;-0.16946816706093948;-0.1996551924642329
Cubitus varus;Wide anterior fontanel;1.0130656640976667;0.97314805;0.4958409516094795;0.5085482645301124;0.6617971500655027;0.3512685140321641;0.3113508978585391;-0.16595619845602316;-0.1532488855353903
Cubitus varus;Increased circulating oleate level;0.9402063153684139;0.8790113;0.519044280587283;0.5386064829637285;1.0;-0.059793684631586075;-0.12098872661590576;-0.480955719412717;-0.4613935170362715
Cubitus varus;Lozenge-shaped umbilicus;0.9939903886988759;0.96835095;0.5019129302037697;0.5100758961918501;0.9999134918687169;-0.005923103169841015;-0.03156254496548816;-0.4980005616649472;-0.4898375956768668
Cubitus varus;Anti-myelin-associated glycoprotein antibody positivity;1.0784204378724098;1.0709887;0.4750123432087834;0.47738457317664806;1.0;0.07842043787240982;0.07098865509033203;-0.5249876567912166;-0.5226154268233519
Cubitus varus;Fractured radius;0.7664604634046555;0.78600013;0.5750308282495074;0.5686492227609494;0.660589513309896;0.10587095009475944;0.12541061925083397;-0.08555868506038866;-0.09194029054894659
Cubitus varus;Abnormal manual kinetic perimetry test;0.7987306714057922;0.791057;0.5645066429385377;0.5670023268838537;1.0;-0.20126932859420776;-0.20894300937652588;-0.4354933570614623;-0.43299767311614634
Cubitus varus;Small radial epiphyses;0.7784927785396576;0.8172634;0.5710976377428678;0.5584955415239012;1.0;-0.2215072214603424;-0.1827365756034851;-0.4289023622571322;-0.44150445847609876
Cubitus varus;Generalized keratosis follicularis;0.9659882932901382;0.9520492;0.5108283508755805;0.515269074913398;0.9999201345566091;-0.033931841266470864;-0.047870938790160134;-0.48909178368102857;-0.4846510596432111
Cubitus varus;Hypoplasia of the calcaneus;0.5396521389484406;0.5351279;0.6522753145413898;0.6538997017078406;0.7321876298591573;-0.19253549091071676;-0.1970597516700704;-0.07991231531776755;-0.07828792815131669
Cubitus varus;2-hydroxyadipic aciduria;0.836289569735527;0.82893956;0.5523462718643622;0.554719349422208;1.0;-0.16371043026447296;-0.1710604429244995;-0.44765372813563775;-0.445280650577792
Cubitus varus;Potter facies;0.8480319976806641;0.88354826;0.5485610690734082;0.5371520397091127;0.9998981869165328;-0.1518661892358687;-0.11634992718142534;-0.4513371178431246;-0.46274614720742
Cubitus varus;Increased heart rate variability;0.851529598236084;0.8051973;0.5474349694447417;0.5624066518041664;0.9999201345566091;-0.14839053632052512;-0.1947228360298452;-0.4524851651118674;-0.43751348275244273
Cubitus varus;Aplastic zygomatic arch;0.9634957760572433;0.9290945;0.5116222375619899;0.522588883466768;0.8072246192530101;0.1562711568042332;0.1218698741361195;-0.29560238169102027;-0.28463573578624213
Cubitus varus;Testicular torsion;0.7930359691381454;0.7569263;0.5663583098026513;0.5781556792546569;0.9999201345566091;-0.20688416541846366;-0.24299383641512962;-0.43356182475395777;-0.42176445530195217
Cubitus varus;Abolished vibration sense;0.8287284672260284;0.86894464;0.5547875382386123;0.5418365542851367;0.9999134918687169;-0.17118502464268848;-0.1309688469407384;-0.44512595363010465;-0.45807693758358026
Cubitus varus;Fractured metatarsal bone of digit 5;0.7564899027347565;0.8729465;0.5782989010834882;0.5405519808715862;1.0;-0.24351009726524353;-0.12705349922180176;-0.42170109891651175;-0.4594480191284138
Cubitus varus;Prolonged G2 phase of cell cycle;0.9005551189184189;0.89893097;0.5317066953778482;0.5322262970681002;0.9999056439461368;-0.0993505250277179;-0.10097467709204133;-0.4681989485682886;-0.4676793468780366
Cubitus varus;Single naris;0.9669776521623135;0.9783151;0.5105132511128092;0.5069030466555823;0.9999056439461368;-0.03292799178382333;-0.021590528971161205;-0.4893923928333276;-0.4930025972905545
Cubitus varus;Perifoveal ring of hyperautofluorescence surrounded by normal autofluorescence;0.9565504044294357;0.9227532;0.5138347911932604;0.5246129371171887;1.0;-0.04344959557056427;-0.0772467851638794;-0.48616520880673963;-0.4753870628828113
Cubitus varus;Asymmetry of the thorax;0.7211560308933258;0.7451375;0.5899512294012175;0.5820302057446869;0.789736248610815;-0.06858021771748923;-0.04459873592694663;-0.19978501920959757;-0.20770604286612815
Cubitus varus;Type 2 muscle fiber predominance;0.8908012360334396;0.9200632;0.5348284994176871;0.5254718484294697;0.8527273749847077;0.038073861048731894;0.06733582262805471;-0.3178988755670207;-0.32725552655523804
Cubitus varus;Dependency on parenteral nutrition;1.009324511513114;0.9705879;0.49703187278909544;0.5093635072434075;0.9999134918687169;0.009411019644397056;-0.02932558264706775;-0.5028816190796215;-0.4905499846253094
Cubitus varus;Limited shoulder flexion;0.7044277191162109;0.79097664;0.5955103166836322;0.5670284602190518;1.0;-0.29557228088378906;-0.2090233564376831;-0.4044896833163678;-0.43297153978094816
Cubitus varus;Paroxysmal vertigo;0.9119815900921822;0.74959767;0.5280534326504059;0.5805628963995728;0.9999134918687169;-0.08793190177653476;-0.2503158232209508;-0.471860059218311;-0.4193505954691441
Cubitus varus;Long hallux;0.6690753102302551;0.7514086;0.6073606111019416;0.5799676319138232;0.6396520543512125;0.029423255879042598;0.1117565226141195;-0.03229144324927091;-0.05968442243738936
Cubitus varus;Broad medial eyebrow;0.9283911734819412;0.9360752;0.5228133229382783;0.5203617666862098;0.9999201345566091;-0.07152896107466789;-0.06384492398532005;-0.4771068116183308;-0.4795583678703993
Cubitus varus;Myxoid subcutaneous tumors;1.013175854459405;0.98737806;0.49580587390843933;0.5040178039013917;0.9999201345566091;0.013255719902795837;-0.012542073738890602;-0.5041142606481698;-0.4959023306552174
Cubitus varus;Bulbous tips of toes;0.8069099336862564;0.85777605;0.5618509562943087;0.5454253140702027;0.7321876298591573;0.0747223038270991;0.12558841594009806;-0.1703366735648486;-0.18676231578895464
Cubitus varus;Absent internal genitalia;0.9586925841867924;0.9456203;0.513152300936777;0.5173181463140981;1.0;-0.041307415813207626;-0.05437970161437988;-0.486847699063223;-0.4826818536859019
Cubitus varus;Hyperphalangy of the 2nd finger;0.8468397557735443;0.8892745;0.5489450667239277;0.5353174562873216;0.660589513309896;0.1862502424636483;0.22868496464878318;-0.11164444658596828;-0.12527205702257438
Cubitus varus;Renal interstitial hemosiderin;0.9948125341907144;0.957904;0.5016512290571002;0.513403537245064;1.0;-0.005187465809285641;-0.04209601879119873;-0.49834877094289975;-0.48659646275493595
Cubitus varus;Abnormality of depressor anguli oris muscle;0.7703726142644882;0.7832955;0.5737507521543417;0.5695308060654543;1.0;-0.22962738573551178;-0.21670448780059814;-0.4262492478456583;-0.43046919393454575
Cubitus varus;Paroxysmal dyspnea;0.9165473133325577;0.8469446;0.526594745515987;0.5489112954805114;1.0;-0.08345268666744232;-0.15305542945861816;-0.47340525448401305;-0.45108870451948857
Cubitus varus;Phenylpyruvic acidemia;0.8292628973722458;0.8237238;0.5546148806391102;0.5564051841833824;0.9999201345566091;-0.17065723718436332;-0.17619634152682395;-0.44530525391749887;-0.44351495037322675
Cubitus varus;Lateral ventricle dilatation;0.8955711498856544;0.7430521;0.5333014509938965;0.5827168700496922;0.9998579617208769;-0.10428681183522248;-0.2568058367437651;-0.46655651072698046;-0.41714109167118474
Cubitus varus;Neonatal unconjugated hyperbilirubinemia;0.9564476050436497;0.92780536;0.5138675442586511;0.5230002757345378;0.9999201345566091;-0.043472529512959435;-0.07211477042468162;-0.486052590297958;-0.47691985882207133
Cubitus varus;High maternal circulating alpha-fetoprotein concentration;1.0578818507492542;1.0463843;0.4815653312494058;0.4852301201297663;1.0;0.05788185074925423;0.046384334564208984;-0.5184346687505942;-0.5147698798702337
Cubitus varus;Prominent nasolabial fold;0.9336049258708954;0.9139592;0.5211497670489896;0.5274215381682559;0.9998944404568447;-0.06628951458594934;-0.08593523530624048;-0.4787446734078551;-0.47247290228858885
Cubitus varus;Abnormality of inferior alveolar nerve;1.0283658653497696;0.9257737;0.49096965334974163;0.5236487281554222;1.0;0.028365865349769592;-0.07422631978988647;-0.5090303466502584;-0.4763512718445778
Cubitus varus;Unilateral conductive hearing impairment;1.005837389267981;0.8992099;0.4981418907338493;0.5321370417181016;0.9999201345566091;0.005917254711371944;-0.10071021796496482;-0.5017782438227598;-0.4677830928385075
Cubitus varus;Macular hypopigmented whorls, streaks, and patches;1.0036122128367424;0.9811846;0.49885019444259626;0.5059894723966615;0.9999201345566091;0.003692078280133293;-0.018735532772856667;-0.5010699401140128;-0.49393066215994763
Cubitus varus;Delayed ossification of pubic rami;0.7681587189435959;0.7788305;0.5744749996234806;0.5709873894442233;0.8072246192530101;-0.03906590030941426;-0.0283940909937328;-0.23274961962952956;-0.2362372298087868
Cubitus varus;Hyperphenylalaninemia;0.9838843196630478;0.95262307;0.5051300024467336;0.5150861986303807;0.9999028053808913;-0.016018485717843478;-0.04727973609454483;-0.4947728029341577;-0.4848166067505105
Cubitus varus;Ureteropelvic junction obstruction;0.8716584146022797;0.7661174;0.5409653854298302;0.5751431459008872;0.9998847295244674;-0.12822631492218772;-0.23376733555397788;-0.4589193440946372;-0.42474158362358017
Cubitus varus;Cone-shaped epiphysis of the proximal phalanx of the 2nd toe;0.7266557812690735;0.74639493;0.5881298038053114;0.5816163587705163;1.0;-0.2733442187309265;-0.25360506772994995;-0.41187019619468856;-0.4183836412294837
Cubitus varus;Difficulty walking;0.8638462126255035;0.88015974;0.5434741283697047;0.5382382365705118;0.7552776988623575;0.10856851376314602;0.12488203681726895;-0.21180357049265286;-0.21703946229184568
Cubitus varus;Bilobate gallbladder;0.9614890739321709;0.8697138;0.5122614405742598;0.5415896317556113;0.9999134918687169;-0.03842441793654605;-0.13019970860455676;-0.4876520512944571;-0.45832386011310566
Cubitus varus;Histidinuria;0.9951241984963417;1.0038856;0.5015520219712093;0.4987631622796652;0.9999090677057578;-0.0047848692094161205;0.003976559087149889;-0.49835704573454853;-0.5011459054260926
Cubitus varus;Widened interpedicular distance;0.6015483736991882;0.74786055;0.6304523210380415;0.5811341566123003;1.0;-0.39845162630081177;-0.25213944911956787;-0.3695476789619585;-0.4188658433876997
Nasal regurgitation;Moon facies;0.9782105758786201;0.9609623;0.5069363380572178;0.5124292467258695;0.9999567459343585;-0.021746170055738312;-0.0389944504021319;-0.49302040787714063;-0.4875274992084889
Nasal regurgitation;Intestinal pseudo-obstruction;0.8541597127914429;0.75540763;0.5465885632252404;0.5786541403760417;0.7763545580080901;0.07780515478335281;-0.020946926610842742;-0.22976599478284965;-0.19770041763204838
Nasal regurgitation;Bilateral renal atrophy;0.8611264228820801;0.6874585;0.5443481681146134;0.60118031837451;0.9999584729108851;-0.13883205002880505;-0.3124999577436488;-0.45561030479627174;-0.3987781545363751
Nasal regurgitation;Fractured left clavicle;0.9461001381278038;0.828187;0.5171651771142698;0.5549624798825121;0.9999134918687169;-0.05381335374091312;-0.1717265030381505;-0.4827483147544471;-0.4449510119862048
Nasal regurgitation;Positive urine norcotinine test;0.7720506340265274;0.71752816;0.5732020686160865;0.5911543729449196;0.9999134918687169;-0.22786285784218951;-0.28238532748196765;-0.42671142325263045;-0.40875911892379735
Nasal regurgitation;Long fibula;1.022050255909562;0.9144603;0.49298061665256476;0.5272614511860128;0.9999548690865008;0.022095386823061336;-0.08549456768726982;-0.506974252433936;-0.472693417900488
Nasal regurgitation;Fragmentation of the epiphysis of the distal phalanx of the hallux;1.009431879967451;0.93774927;0.49699769484558165;0.5198278463111888;0.9999134918687169;0.009518388098734176;-0.062164225244266236;-0.5029157970231353;-0.4800856455575281
Nasal regurgitation;Type II cryptotia;1.01252799667418;0.9214947;0.49601211048288263;0.5250147551556174;0.9999134918687169;0.012614504805463111;-0.07841876950238391;-0.5039013813858343;-0.47489873671309957
Nasal regurgitation;Increased variability in muscle fiber diameter;1.0146191213279963;0.9385791;0.4953464233845427;0.5195631977037041;0.9999445057306702;0.01467461559732608;-0.0613654232416565;-0.5045980823461275;-0.4803813080269661
Nasal regurgitation;Widened proximal tibial metaphyses;1.0490419194102287;0.94735515;0.48438320792637424;0.5167651235875201;0.9999584729108851;0.0490834464993436;-0.052603321734432495;-0.5155752649845109;-0.483193349323365
Nasal regurgitation;Wide anterior fontanel;0.853450819849968;0.9000274;0.546816661589195;0.5318755214044941;0.9999448992541466;-0.1464940794041787;-0.09991750495940788;-0.4531282376649517;-0.4680693778496525
Nasal regurgitation;Increased circulating oleate level;1.0950902923941612;0.95728624;0.4696860182662004;0.5136003419003867;0.9999134918687169;0.0951768005254443;-0.0426272531983678;-0.5302274736025165;-0.4863131499683302
Nasal regurgitation;Lozenge-shaped umbilicus;0.9420695267617702;0.9074494;0.5184501717831447;0.529501987734349;0.8526023716255289;0.08946715513624137;0.05484705264128631;-0.3341521998423842;-0.3231003838911799
Nasal regurgitation;Anti-myelin-associated glycoprotein antibody positivity;0.9824042189866304;0.88318014;0.5056012001097097;0.5372700206488159;0.9999134918687169;-0.01750927288208648;-0.11673335041974231;-0.49431229175900726;-0.462643471219901
Nasal regurgitation;Fractured radius;0.9819934125989676;0.82787216;0.5057319845684035;0.5550642094920398;0.9999584729108851;-0.01796506031191758;-0.17208631581402234;-0.4942264883424816;-0.4448942634188453
Nasal regurgitation;Abnormal manual kinetic perimetry test;0.969601908698678;0.86006105;0.5096775037791981;0.5446906215013663;0.9999134918687169;-0.030311583170038903;-0.13985244240735217;-0.49023598808951885;-0.45522287036735065
Nasal regurgitation;Small radial epiphyses;1.050189521163702;0.9027585;0.4840174644662628;0.5310019228095127;0.9999134918687169;0.05027602929498509;-0.09715501275036975;-0.5158960274024541;-0.46891156905920417
Nasal regurgitation;Generalized keratosis follicularis;0.9741668216884136;0.9250525;0.5082238709254363;0.5238789039843044;0.9999584729108851;-0.025791651222471512;-0.07490594929790906;-0.4917346019854488;-0.47607956892658077
Nasal regurgitation;Hypoplasia of the calcaneus;0.9482211694121361;0.8555844;0.5164890872796497;0.546130214496821;0.9999567459343585;-0.05173557652222238;-0.1443723629234942;-0.48346765865470875;-0.4538265314375375
Nasal regurgitation;2-hydroxyadipic aciduria;0.9694945998489857;0.8792866;0.5097116770952301;0.5385182079583053;0.9999134918687169;-0.030418892019731247;-0.12062690463040515;-0.4902018147734868;-0.4613952839104116
Nasal regurgitation;Potter facies;0.9869903586804867;0.9649857;0.5041412142705907;0.5111476769736945;0.9999532306564473;-0.012962871975960577;-0.034967502392592276;-0.4958120163858566;-0.4888055536827528
Nasal regurgitation;Increased heart rate variability;0.8783570528030396;0.81920207;0.5388162845644913;0.5578680037518869;0.9999584729108851;-0.12160142010784558;-0.18075640744305066;-0.46114218834639387;-0.4420904691589982
Nasal regurgitation;Aplastic zygomatic arch;0.719612181186676;0.77067757;0.5904630683509074;0.5736510312243137;0.9999567459343585;-0.28034456474768243;-0.22927917940603815;-0.409493677583451;-0.42630571471004475
Nasal regurgitation;Testicular torsion;0.9783779215067625;0.8493302;0.5068830577365939;0.5481430240643533;0.9999584729108851;-0.021580551404122628;-0.15062828606701306;-0.4930754151742912;-0.4518154488465318
Nasal regurgitation;Abolished vibration sense;0.7618647962808609;0.76426;0.5765361370757226;0.5757513755378001;0.9999567459343585;-0.23809194965349756;-0.23569675190435968;-0.42342060885863586;-0.42420537039655837
Nasal regurgitation;Fractured metatarsal bone of digit 5;1.0662973448634148;0.9958894;0.4788814098356482;0.5013084319561201;0.9999134918687169;0.06638385299469785;-0.004024066591006958;-0.5210320820330687;-0.49860505991259685
Nasal regurgitation;Prolonged G2 phase of cell cycle;1.0467958003282547;0.9910484;0.4850989922578124;0.5028494186649448;0.9999548690865008;0.046840931241753925;-0.008906473452803265;-0.5148558768286884;-0.49710545042155596
Nasal regurgitation;Single naris;0.8450011759996414;0.8222922;0.5495373780494359;0.5568681765252472;0.9999548690865008;-0.15495369308685936;-0.17766266041493095;-0.45041749103706485;-0.44308669256125355
Nasal regurgitation;Perifoveal ring of hyperautofluorescence surrounded by normal autofluorescence;1.0282630417495966;0.8854065;0.4910023962459813;0.5365565464624701;0.9999134918687169;0.028349549880879676;-0.11450699772809192;-0.5089110956227356;-0.46335694540624683
Nasal regurgitation;Asymmetry of the thorax;0.8337396085262299;0.7687201;0.5531692277531194;0.5742913171382387;0.9999548690865008;-0.16621526056027092;-0.23123477869724907;-0.4467856413333814;-0.4256635519482621
Nasal regurgitation;Type 2 muscle fiber predominance;1.0266413316130638;0.9766794;0.4915187972941145;0.5074238500773716;0.9999536937290383;0.026687637884025506;-0.023274309020633765;-0.5084348964349238;-0.49252984365166674
Nasal regurgitation;Dependency on parenteral nutrition;0.9814126305282116;0.8499598;0.5059168841987314;0.5479403152911866;0.7017107679063793;0.2797018626218323;0.1482490228002552;-0.19579388370764794;-0.15377045261519273
Nasal regurgitation;Limited shoulder flexion;0.9441591873764992;0.8263457;0.5177839331884523;0.555557540190526;0.9999134918687169;-0.05575430449221774;-0.17356780972455188;-0.48212955868026464;-0.444355951678191
Nasal regurgitation;Paroxysmal vertigo;0.5869751274585724;0.59275967;0.6355277485693264;0.6335088567199317;0.9999567459343585;-0.41298161847578607;-0.4071970771073016;-0.3644289973650321;-0.3664478892144267
Nasal regurgitation;Long hallux;1.0102799572050571;0.9485759;0.4967277303561347;0.5163760227132559;0.9999503740898522;0.010329583115204932;-0.0513744601837548;-0.5032226437337175;-0.4835743513765963
Nasal regurgitation;Broad medial eyebrow;0.9592279382050037;0.9753031;0.5129817487704865;0.5078620648800427;0.9999584729108851;-0.040730534705881394;-0.02465535945034436;-0.4869767241403986;-0.4920964080308424
Nasal regurgitation;Myxoid subcutaneous tumors;0.9997844831086695;0.94991636;0.5000686011576811;0.515948790380145;0.9999584729108851;-0.00017398980221561278;-0.05004211014843396;-0.499889871753204;-0.48400968253074017
Nasal regurgitation;Bulbous tips of toes;1.0411047041416168;0.9806616;0.4869122790421838;0.5061560027944778;0.9999567459343585;0.04114795820725836;-0.01929517490851007;-0.5130444668921746;-0.49380074313988065
Nasal regurgitation;Absent internal genitalia;0.7871316373348236;0.7624201;0.5682805489125824;0.5763541496973397;0.9999134918687169;-0.2127818545338933;-0.2374933740136449;-0.4316329429561345;-0.42355934217137725
Nasal regurgitation;Hyperphalangy of the 2nd finger;1.0001762751489878;0.9501711;0.49994388987709804;0.515867593545472;0.9999584729108851;0.00021780223810263788;-0.04978735989666394;-0.5000145830337871;-0.4840908793654132
Nasal regurgitation;Renal interstitial hemosiderin;0.9318477809429169;0.75411576;0.5217103536985148;0.5790783086453869;0.9999134918687169;-0.06806571092580005;-0.24579773154233142;-0.4782031381702021;-0.42083518322333
Nasal regurgitation;Abnormality of depressor anguli oris muscle;0.7607140094041824;0.76940465;0.576913348849059;0.5740673515262457;0.9999134918687169;-0.23919948246453449;-0.23050884213421985;-0.42300014301965794;-0.42584614034247126
Nasal regurgitation;Paroxysmal dyspnea;0.5789477229118347;0.6023763;0.6383391109880543;0.6301650522735653;0.9999134918687169;-0.4209657689568822;-0.3975372096535985;-0.3615743808806626;-0.3697484395951516
Nasal regurgitation;Phenylpyruvic acidemia;0.9719226863235235;0.8517638;0.50893846120091;0.5473595914176106;0.9999584729108851;-0.02803578658736161;-0.14819468802547864;-0.4910200117099751;-0.45259888149327454
Nasal regurgitation;Lateral ventricle dilatation;0.8234897553920746;0.7306297;0.5564808722256138;0.5868155584257003;0.9999462364511621;-0.1764564810590875;-0.26931655391026854;-0.4434653642255483;-0.4131306780254618
Nasal regurgitation;Neonatal unconjugated hyperbilirubinemia;0.9695498906075954;0.8195666;0.5096940693203738;0.5577500261370856;0.9999584729108851;-0.03040858230328969;-0.18039186543560437;-0.4902644035905114;-0.44220844677379956
Nasal regurgitation;High maternal circulating alpha-fetoprotein concentration;1.0746136009693146;0.97611976;0.47622766075553125;0.5076020318720056;0.9999134918687169;0.07470010910059766;-0.02379373517010852;-0.5236858311131857;-0.49231145999671133
Nasal regurgitation;Prominent nasolabial fold;0.5788701176643372;0.61857706;0.6383663458475037;0.6245658362767819;0.9999524555142131;-0.4210823378498759;-0.3813753924305644;-0.36158610966670934;-0.3753866192374312
Nasal regurgitation;Abnormality of inferior alveolar nerve;0.7146011888980865;0.7587746;0.5921260495063976;0.5775493118214221;0.9999134918687169;-0.28531230297063037;-0.24113891329739734;-0.40778744236231934;-0.4223641800472948
Nasal regurgitation;Unilateral conductive hearing impairment;0.7278542518615723;0.72097325;0.5877332852781567;0.5900118139397212;0.9999584729108851;-0.27210422104931287;-0.27898521966076306;-0.4122251876327284;-0.4099466589711639
Nasal regurgitation;Macular hypopigmented whorls, streaks, and patches;0.9553003236651421;0.8948555;0.5142330913368939;0.5335305154726999;0.9999584729108851;-0.04465814924574307;-0.10510297364330701;-0.48572538157399126;-0.4664279574381852
Nasal regurgitation;Delayed ossification of pubic rami;0.9449977315962315;0.848635;0.5175166053946857;0.5483668704963011;0.9999567459343585;-0.054959014338127;-0.15132172806250177;-0.48244014053967277;-0.4515898754380574
Nasal regurgitation;Hyperphenylalaninemia;0.9636086076498032;0.83796954;0.5115862982710071;0.551804292848286;0.9999542297279059;-0.03634562207810277;-0.1619846881782233;-0.48836793145689883;-0.4481499368796199
Nasal regurgitation;Ureteropelvic junction obstruction;0.7078658938407898;0.54030603;0.5943653618091219;0.6520408977793135;0.9999505803237132;-0.2920846864829234;-0.4596445486197642;-0.4055852185145913;-0.3479096825443997
Nasal regurgitation;Cone-shaped epiphysis of the proximal phalanx of the 2nd toe;1.0430117100477219;0.9737409;0.4863047225276198;0.5083594985659119;0.9999134918687169;0.04309821817900494;-0.026172616147739136;-0.5136087693410971;-0.491553993302805
Nasal regurgitation;Difficulty walking;0.8748602569103241;0.7960612;0.5399379213184083;0.565374357210152;0.9999431787962207;-0.12508292188589665;-0.20388196101133915;-0.4600052574778124;-0.4345688215860688
Nasal regurgitation;Bilobate gallbladder;0.9024022221565247;0.77102196;0.5311158696665925;0.573538400209585;0.8526023716255289;0.04979985053099578;-0.08158040945969636;-0.32148650195893635;-0.27906397141594386
Nasal regurgitation;Histidinuria;0.9517955183982849;0.84451485;0.5153499116641438;0.5496940908413198;0.9999556674707869;-0.04816014907250199;-0.1554408206690291;-0.4846057558066431;-0.4502615766294671
Nasal regurgitation;Widened interpedicular distance;1.011071814224124;0.9425254;0.49647566006672694;0.5183048153454946;0.9999134918687169;0.011158322355407035;-0.057388105058414185;-0.50343783180199;-0.48160867652322237
Moon facies;Intestinal pseudo-obstruction;0.9422095715999603;0.87805104;0.5184055193194717;0.5389144260424175;0.9999518178785828;-0.057742246278622456;-0.12190077532182009;-0.48154629855911113;-0.4610373918361653
Moon facies;Bilateral renal atrophy;0.9227307587862015;0.88885945;0.5246201041495977;0.5354503792034099;0.9999584729108851;-0.07722771412468366;-0.11109902209377698;-0.47533836876128743;-0.46450809370747526
Moon facies;Fractured left clavicle;0.9967684939038008;0.94217545;0.5010286221279423;0.5184164065384795;0.9999134918687169;-0.003144997964916074;-0.0577380439278905;-0.4988848697407746;-0.4814970853302374
Moon facies;Positive urine norcotinine test;0.7987466752529144;0.820598;0.5645014423389493;0.5574162754397025;0.9999134918687169;-0.2011668166158025;-0.1793154856202428;-0.43541204952976764;-0.4424972164290144
Moon facies;Long fibula;1.0030445521697402;0.9227656;0.4990308874481999;0.5246089765819083;0.9999548690865008;0.003089683083239425;-0.07718925648426689;-0.5009239816383009;-0.47534589250459247
Moon facies;Fragmentation of the epiphysis of the distal phalanx of the hallux;0.9929510331712663;0.9788572;0.502243774410648;0.5067304617970487;0.9999134918687169;-0.006962458697450602;-0.021056272649509156;-0.49766971745806887;-0.4931830300716682
Moon facies;Type II cryptotia;0.7963924407958984;0.82672846;0.5652666612443185;0.5554338216808343;0.9999134918687169;-0.20352105107281848;-0.17318502869580432;-0.43464683062439846;-0.4444796701878826
Moon facies;Increased variability in muscle fiber diameter;0.9785336144268513;0.9227092;0.5068334876354568;0.5246269690984413;0.9999445057306702;-0.021410891303818902;-0.07723527912239381;-0.4931110180952134;-0.47531753663222887
Moon facies;Widened proximal tibial metaphyses;0.9278532937169075;0.78430486;0.522984979385462;0.5692017485306291;0.9999584729108851;-0.07210517919397763;-0.2156536156568568;-0.4769734935254232;-0.43075672438025603
Moon facies;Wide anterior fontanel;0.7779010236263275;0.819895;0.5712908108422239;0.5576437547725348;0.8751074957066792;-0.09720647208035171;-0.055212466638686064;-0.30381668486445534;-0.3174637409341444
Moon facies;Increased circulating oleate level;0.8807720392942429;0.8545058;0.5380419339169202;0.5464772102342877;0.9999134918687169;-0.11914145257447406;-0.14540771450970813;-0.4618715579517967;-0.4534362816344292
Moon facies;Lozenge-shaped umbilicus;0.9640789963304996;0.9709804;0.5114364709377397;0.5092385135993857;0.9999567459343585;-0.03587774960385881;-0.028976340126863342;-0.48852027499661876;-0.4907182323349728
Moon facies;Anti-myelin-associated glycoprotein antibody positivity;1.02941432595253;1.0053622;0.49063577859797125;0.4982931598598812;0.9999134918687169;0.029500834083812988;0.005448661184566772;-0.5092777132707457;-0.5016203320088357
Moon facies;Fractured radius;1.0228410698473454;0.96704614;0.4927288293172637;0.5104914312495525;0.9999584729108851;0.02288259693646022;-0.03291233128643445;-0.5072296435936214;-0.4894670416613326
Moon facies;Abnormal manual kinetic perimetry test;0.9757649004459381;0.977767;0.507715027130494;0.507077572800634;0.9999134918687169;-0.02414859142277881;-0.022146501207095826;-0.49219846473822293;-0.4928359190680829
Moon facies;Small radial epiphyses;0.89631637185812;0.8480687;0.533062944715269;0.5485492445573412;0.9999134918687169;-0.10359712001059695;-0.15184477772687122;-0.46685054715344787;-0.4513642473113757
Moon facies;Generalized keratosis follicularis;0.8169138729572296;0.8688385;0.5586087213569488;0.5418706485355149;0.9999584729108851;-0.18304459995365552;-0.1311199838552516;-0.4413497515539363;-0.4580878243753702
Moon facies;Hypoplasia of the calcaneus;0.9791513197124004;0.9624407;0.5066368219104193;0.5119582999500896;0.9999567459343585;-0.020805426221958023;-0.03751601679312311;-0.4933199240239392;-0.4879984459842689
Moon facies;2-hydroxyadipic aciduria;0.8394087553024292;0.8561699;0.5513400879601863;0.5459418837263041;0.9999134918687169;-0.16050473656628772;-0.143743612432224;-0.4485734039085306;-0.4539716081424128
Moon facies;Potter facies;0.5530824065208435;0.6369672;0.6474782847869218;0.6182587166342892;0.7002474829854209;-0.14716507646457744;-0.06328030082599712;-0.05276919819849912;-0.08198876635113173
Moon facies;Increased heart rate variability;0.9262507557868958;0.9017382;0.52349644578304;0.5313282421415432;0.9999584729108851;-0.07370771712398938;-0.09822024649715833;-0.47646202712784513;-0.46863023076934196
Moon facies;Aplastic zygomatic arch;0.8111234158277512;0.83678925;0.5604846122154044;0.5521850501211525;0.8846475303342614;-0.0735241145065102;-0.047858279960421024;-0.324162918118857;-0.33246248021310887
Moon facies;Testicular torsion;0.8815657272934914;0.81667036;0.5377874923223336;0.5586875642541527;0.9999584729108851;-0.11839274561739377;-0.18328811472988538;-0.46217098058855155;-0.44127090865673246
Moon facies;Abolished vibration sense;0.8531401455402374;0.9101853;0.5469166339588487;0.5286274858351137;0.9999567459343585;-0.14681660039412103;-0.08977146847235284;-0.45304011197550975;-0.4713292600992448
Moon facies;Fractured metatarsal bone of digit 5;1.0109477434307337;1.0032154;0.4965151554206668;0.49897649098001373;0.9999134918687169;0.011034251562016761;0.0033019402983363033;-0.5033983364480501;-0.5009370008887032
Moon facies;Prolonged G2 phase of cell cycle;0.907212883234024;0.89766157;0.5295776017087256;0.5326324705660322;0.9999548690865008;-0.09274198585247673;-0.10229330235218681;-0.4703772673777752;-0.46732239852046853
Moon facies;Single naris;0.7282835245132446;0.8452889;0.5875912928058258;0.5494446879816739;0.8796422427997362;-0.1513587182864916;-0.034353370080925205;-0.29205094999391046;-0.33019755481806234
Moon facies;Perifoveal ring of hyperautofluorescence surrounded by normal autofluorescence;0.761629581451416;0.8079661;0.5766132282633294;0.5615083423612104;0.9999134918687169;-0.2382839104173009;-0.19194737877820178;-0.42330026360538753;-0.43840514950750653
Moon facies;Asymmetry of the thorax;0.8797435760498047;0.830802;0.538371676441407;0.5541177326213558;0.9999548690865008;-0.12021129303669609;-0.16915284567570366;-0.46158319264509373;-0.445837136465145
Moon facies;Type 2 muscle fiber predominance;0.9419534876942635;0.8907213;0.5184871704249444;0.5348540807330053;0.9999536937290383;-0.05800020603477485;-0.10923237262308128;-0.4814665233040939;-0.465099612996033
Moon facies;Dependency on parenteral nutrition;0.8391951024532318;0.8174387;0.5514089912685765;0.5584388024488596;0.9999567459343585;-0.16076164348112665;-0.18251802427755914;-0.448547754665782;-0.4415179434854989
Moon facies;Limited shoulder flexion;0.9655984342098236;0.9480075;0.5109525195416187;0.5165571844469806;0.9999134918687169;-0.03431505765889331;-0.05190596785519763;-0.48896097232709823;-0.4833563074217363
Moon facies;Paroxysmal vertigo;1.0115872770547867;0.9353922;0.4963115726185934;0.5205796352737094;0.9999567459343585;0.011630531120428222;-0.0645645449875506;-0.5036451733157651;-0.47937711066064903
Moon facies;Long hallux;0.8593149036169052;0.8624396;0.5449305097257087;0.5439261239419739;0.9999503740898522;-0.140635470472947;-0.1375108012787255;-0.45501986436414354;-0.4560242501478783
Moon facies;Broad medial eyebrow;0.7478182911872864;0.78230083;0.581148067294813;0.5698551765714055;0.8892531322460213;-0.14143484105873494;-0.10695230235863118;-0.30810506495120826;-0.3193979556746158
Moon facies;Myxoid subcutaneous tumors;0.9127595573663712;0.87583065;0.5278048416754507;0.539626607300727;0.9999584729108851;-0.08719891554451398;-0.12412782258129529;-0.4721536312354344;-0.46033186561015815
Moon facies;Bulbous tips of toes;0.7697755992412567;0.79002553;0.5739460195177943;0.5673380888592849;0.9999567459343585;-0.23018114669310175;-0.20993121368872247;-0.4260107264165641;-0.4326186570750735
Moon facies;Absent internal genitalia;0.849272221326828;0.89109105;0.548161693009136;0.5347356956787537;0.9999134918687169;-0.15064127054188892;-0.10882244315121814;-0.45175179885958094;-0.46517779618996324
Moon facies;Hyperphalangy of the 2nd finger;0.9391215369105339;0.9448698;0.5193902065476954;0.5175573768446038;0.9999584729108851;-0.06083693600035123;-0.05508865660763196;-0.4805682663631897;-0.48240109606628134
Moon facies;Renal interstitial hemosiderin;0.982094306498766;0.96026134;0.5056998638639842;0.5126525442689824;0.9999134918687169;-0.017819185369950974;-0.03965214695904895;-0.4942136280047327;-0.4872609475997345
Moon facies;Abnormality of depressor anguli oris muscle;0.9329242333769798;0.96592116;0.5213669223062157;0.5108497265811568;0.7692950606685226;0.16362917270845723;0.19662610289043736;-0.24792813836230687;-0.2584453340873658
Moon facies;Paroxysmal dyspnea;1.0371061116456985;1.0095137;0.48818604573320146;0.4969716562491122;0.9999134918687169;0.03719261977698163;0.00960024390246228;-0.5117274461355155;-0.5029418356196047
Moon facies;Phenylpyruvic acidemia;1.023060567677021;0.9999863;0.4926589425794441;0.500004357506537;0.9999584729108851;0.023102094766135894;2.7818020816527955e-05;-0.507299530331441;-0.4999541154043481
Moon facies;Lateral ventricle dilatation;1.0020518228411674;0.9469606;0.4993468840466909;0.5168908799019821;0.9999462364511621;0.002105586390005354;-0.05298560841847777;-0.5005993524044712;-0.48305535654917997
Moon facies;Neonatal unconjugated hyperbilirubinemia;0.9919791938737035;0.9509825;0.5025531292608809;0.5156089979442551;0.9999584729108851;-0.007979279037181652;-0.04897596186733655;-0.4974053436500042;-0.48434947496663006
Moon facies;High maternal circulating alpha-fetoprotein concentration;0.8728113174438477;0.8676869;0.5405953725776819;0.5422404247666133;0.9999134918687169;-0.12710217442486926;-0.13222656455014392;-0.45931811929103505;-0.45767306710210365
Moon facies;Prominent nasolabial fold;0.7313604950904846;0.6617945;0.5865740305533385;0.6098199004773757;0.8732055871936235;-0.1418450921031389;-0.2114111035319719;-0.28663155664028506;-0.26338568671624785
Moon facies;Abnormality of inferior alveolar nerve;0.9285154715180397;0.9418291;0.5227736559881568;0.518526835945375;0.9999134918687169;-0.07139802035067722;-0.0580844065186803;-0.4771398358805601;-0.48138665592334196
Moon facies;Unilateral conductive hearing impairment;1.0982750803232193;1.0797071;0.4686674968257176;0.4746014851936068;0.9999584729108851;0.09831660741233417;0.07974867278003284;-0.5312909760851675;-0.5253569877172783
Moon facies;Macular hypopigmented whorls, streaks, and patches;0.7347405552864075;0.82229286;0.585457608945754;0.5568679740892966;0.9999584729108851;-0.26521791762447766;-0.17766560858822278;-0.4145008639651311;-0.4430904988215886
Moon facies;Delayed ossification of pubic rami;0.8864245936274529;0.82904726;0.5362303527301737;0.5546845482992373;0.9999567459343585;-0.11353215230690561;-0.17090948326574884;-0.46372639320418474;-0.44527219763512116
Moon facies;Hyperphenylalaninemia;0.9203125089406967;0.8814725;0.5253922385788494;0.5378173714148891;0.9999542297279059;-0.07964172078720921;-0.11848170174710149;-0.4745619911490565;-0.4621368583130169
Moon facies;Ureteropelvic junction obstruction;1.0600162968039513;1.0042353;0.48088473227033135;0.49865188738236843;0.9999505803237132;0.06006571648023806;0.004284687315446956;-0.5190658480533819;-0.5012986929413448
Moon facies;Cone-shaped epiphysis of the proximal phalanx of the 2nd toe;0.929485559463501;0.8729166;0.5224640861470462;0.5405616021542832;0.9999134918687169;-0.07042793240521594;-0.12699691262219592;-0.4774494057216707;-0.45935188971443375
Moon facies;Difficulty walking;0.958724457770586;1.0141816;0.5131421465997515;0.49548569749871907;0.9999431787962207;-0.04121872102563473;0.014238435125898397;-0.4868010321964692;-0.5044574812975017
Moon facies;Bilobate gallbladder;1.0190685875713825;0.97440386;0.4939299121640789;0.5081483883829;0.9999567459343585;0.019111841637024063;-0.025552887749544007;-0.5060268337702796;-0.49180835755145846
Moon facies;Histidinuria;0.8936985582113266;0.87401557;0.5339008520332351;0.5402089432963117;0.9999556674707869;-0.1062571092594603;-0.12594009778389725;-0.4660548154375518;-0.45974672417447515
Moon facies;Widened interpedicular distance;0.8606278598308563;0.81666076;0.5445084241336652;0.5586906715330341;0.9999134918687169;-0.1392856320378606;-0.183252730035526;-0.45540506773505174;-0.44122282033568283
Intestinal pseudo-obstruction;Bilateral renal atrophy;0.7718500792980194;0.69654787;0.5732676348722754;0.5981392489005461;0.9999539510871024;-0.22810387178908298;-0.30340608521948764;-0.426686316214827;-0.40181470218655624
Intestinal pseudo-obstruction;Fractured left clavicle;0.9705255031585693;0.8862471;0.5093833826987972;0.5362872197433333;0.9998912449978579;-0.02936574183928853;-0.11364414655196553;-0.4905078622990606;-0.4636040252545246
Intestinal pseudo-obstruction;Positive urine norcotinine test;0.8887101262807846;0.79536617;0.5354982026163921;0.5656003598108625;0.9998912449978579;-0.11118111871707326;-0.2045250769757021;-0.4643930423814657;-0.4342908851869953
Intestinal pseudo-obstruction;Long fibula;0.8874937891960144;0.81509465;0.5358878216879008;0.5591978564461995;0.9999494774285466;-0.11245568823253216;-0.18485482763682903;-0.46406165574064573;-0.4407516209823471
Intestinal pseudo-obstruction;Fragmentation of the epiphysis of the distal phalanx of the hallux;0.9710790477693081;0.8142853;0.5092071088211098;0.5594600185275707;0.9998912449978579;-0.028812197228549774;-0.18560596667754536;-0.4906841361767481;-0.4404312264702872
Intestinal pseudo-obstruction;Type II cryptotia;0.9265160635113716;0.77342355;0.5234117659424153;0.5727533126473371;0.9998912449978579;-0.07337518148648625;-0.2264676924847353;-0.4764794790554425;-0.4271379323505208
Intestinal pseudo-obstruction;Increased variability in muscle fiber diameter;0.8805387914180756;0.7950134;0.5381167134794365;0.5657150673940277;0.9999361236687703;-0.11939733225069471;-0.20492269593439527;-0.4618194101893338;-0.4342210562747426
Intestinal pseudo-obstruction;Widened proximal tibial metaphyses;0.9602133110165596;0.8422233;0.5126678400997278;0.5504326137405668;0.9999539510871024;-0.03974064007054279;-0.15773066445837924;-0.4872861109873746;-0.44952133734653554
Intestinal pseudo-obstruction;Wide anterior fontanel;0.9667547158896923;0.9224504;0.5105842529178813;0.5247095991502385;0.999936644490842;-0.03318192860114966;-0.07748622125018034;-0.4893523915729606;-0.47522704534060345
Intestinal pseudo-obstruction;Increased circulating oleate level;0.9594629555940628;0.8307654;0.5129068785138575;0.5541295475287259;0.9998912449978579;-0.04042828940379506;-0.16912581883895283;-0.48698436648400034;-0.44576169746913197
Intestinal pseudo-obstruction;Lozenge-shaped umbilicus;0.7254366278648376;0.7547098;0.5885333093909058;0.578883247654262;0.8358089506358302;-0.11037232277099251;-0.08109917041961312;-0.2472756412449244;-0.25692570298156814
Intestinal pseudo-obstruction;Anti-myelin-associated glycoprotein antibody positivity;0.874241054058075;0.7375518;0.5401365891821057;0.5845298827835514;0.9998912449978579;-0.1256501909397829;-0.2623394366406191;-0.45975465581575214;-0.4153613622143064
Intestinal pseudo-obstruction;Fractured radius;0.9388079084455967;0.8405237;0.5194902240607917;0.5509805402197319;0.9999539510871024;-0.06114604264150569;-0.15943023129950473;-0.4804637270263107;-0.4489734108673705
Intestinal pseudo-obstruction;Abnormal manual kinetic perimetry test;0.9945001490414143;0.8522717;0.5017506657585257;0.5471961344598123;0.9998912449978579;-0.005391095956443603;-0.14761956893432027;-0.4981405792393322;-0.45269511053804556
Intestinal pseudo-obstruction;Small radial epiphyses;0.9281436204910278;0.78059864;0.522892325020213;0.5704104084978943;0.9998912449978579;-0.07174762450683003;-0.21929260455596333;-0.4769989199776449;-0.4294808364999636
Intestinal pseudo-obstruction;Generalized keratosis follicularis;0.9450606517493725;0.8589566;0.5174965469587798;0.5450457178923022;0.9999539510871024;-0.054893299337729906;-0.14099737569342563;-0.4824574041283226;-0.4549082331948002
Intestinal pseudo-obstruction;Hypoplasia of the calcaneus;0.9229299873113632;0.8224314;0.5245564980655868;0.5568231688374314;0.9999518178785828;-0.07702183056721956;-0.17752043236146242;-0.475395319812996;-0.44312864904115135
Intestinal pseudo-obstruction;2-hydroxyadipic aciduria;0.747507780790329;0.6531589;0.5812502112619593;0.6127456975964356;0.9998912449978579;-0.2523834642075289;-0.3467323418759096;-0.41864103373589856;-0.38714554740142226
Intestinal pseudo-obstruction;Potter facies;0.9750792849808931;0.8776759;0.5079333312612566;0.5390347365013821;0.9999474151931498;-0.024868130212256645;-0.1222715242706034;-0.49201408393189316;-0.46091267869176766
Intestinal pseudo-obstruction;Increased heart rate variability;1.0032777525484562;0.884158;0.498956657091136;0.5369566307215607;0.9999539510871024;0.0033238014613538036;-0.11579593583594272;-0.5009972939959664;-0.46299732036554164
Intestinal pseudo-obstruction;Aplastic zygomatic arch;0.9622028768062592;0.7873284;0.5120340644984835;0.5682164424976412;0.9999518178785828;-0.03774894107232363;-0.21262339580903322;-0.48791775338009924;-0.43173537538094153
Intestinal pseudo-obstruction;Testicular torsion;0.81650111079216;0.64677936;0.558742371886991;0.6149135053439572;0.9999539510871024;-0.18345284029494235;-0.353174592700109;-0.44121157920011134;-0.3850404457431452
Intestinal pseudo-obstruction;Abolished vibration sense;1.0035376008599997;0.8889511;0.4988739443241884;0.5354210078169965;0.9999518178785828;0.003585782981416874;-0.11100069511781008;-0.5010778735543944;-0.46453081006158625
Intestinal pseudo-obstruction;Fractured metatarsal bone of digit 5;0.9589270241558552;0.8451471;0.5130776129908503;0.5494903747359055;0.9998912449978579;-0.040964220842002685;-0.15474417172896748;-0.48681363200700756;-0.4504008702619524
Intestinal pseudo-obstruction;Prolonged G2 phase of cell cycle;0.8561530560255051;0.83469504;0.545947299848857;0.5528608318518295;0.9999494774285466;-0.1437964214030415;-0.16525443624888958;-0.4540021775796895;-0.447088645576717
Intestinal pseudo-obstruction;Single naris;0.9975025653839111;0.9546945;0.5007949589547838;0.5144261187943941;0.9999494774285466;-0.0024469120446354298;-0.04525496792232098;-0.4991545184737628;-0.4855233586341524
Intestinal pseudo-obstruction;Perifoveal ring of hyperautofluorescence surrounded by normal autofluorescence;0.9676978439092636;0.74343896;0.5102838845754687;0.5825894659046087;0.9998912449978579;-0.03219340108859425;-0.25645228587615376;-0.48960736042238917;-0.41730177909324917
Intestinal pseudo-obstruction;Asymmetry of the thorax;0.8711117804050446;0.73918223;0.5411408417336308;0.5839921821620458;0.9999494774285466;-0.128837697023502;-0.26076724361812176;-0.4588086356949158;-0.4159572952665007
Intestinal pseudo-obstruction;Type 2 muscle fiber predominance;0.8950872346758842;0.84207386;0.533456336790252;0.5504807919212862;0.999947999865749;-0.10486076518986476;-0.15787414208147776;-0.46649166307549705;-0.4494672079444628
Intestinal pseudo-obstruction;Dependency on parenteral nutrition;0.6815452575683594;0.780879;0.6031638887277861;0.5703189445127068;0.7763545580080901;-0.09480930043973068;0.004524462682827912;-0.1731906692803039;-0.20603561349538324
Intestinal pseudo-obstruction;Limited shoulder flexion;0.9056147336959839;0.78545594;0.5300885510261567;0.5688265628447425;0.9998912449978579;-0.09427651130187398;-0.2144353028439272;-0.46980269397170116;-0.43106468215311533
Intestinal pseudo-obstruction;Paroxysmal vertigo;0.9948132913559675;0.7020536;0.5016509880406723;0.596301669051917;0.9999518178785828;-0.005138526522615261;-0.29789821136842043;-0.49830082983791046;-0.40365014882666583
Intestinal pseudo-obstruction;Long hallux;1.0467326864600182;0.9708979;0.48511910402922775;0.5092647859429473;0.9999437764344117;0.04678891002560648;-0.029045863455285703;-0.5148246724051839;-0.49067899049146435
Intestinal pseudo-obstruction;Broad medial eyebrow;1.0854764133691788;1.0782294;0.47275877193967464;0.47507332635463484;0.9999539510871024;0.08552246228207638;0.0782754762505441;-0.5271951791474278;-0.5248806247324675
Intestinal pseudo-obstruction;Myxoid subcutaneous tumors;0.8620269596576691;0.6989238;0.5440587319891124;0.5973458448713223;0.9999539510871024;-0.13792699142943332;-0.301030124869451;-0.45589521909799;-0.40260810621578014
Intestinal pseudo-obstruction;Bulbous tips of toes;1.0039741634391248;0.939726;0.4987349811580555;0.51919744755107;0.9999518178785828;0.00402234556054204;-0.060225822814801044;-0.5012168367205273;-0.4807543703275128
Intestinal pseudo-obstruction;Absent internal genitalia;0.8914986699819565;0.79793787;0.534605172323029;0.5647642978807791;0.9998912449978579;-0.10839257501590138;-0.2019533749722231;-0.4652860726748289;-0.4351269471170788
Intestinal pseudo-obstruction;Hyperphalangy of the 2nd finger;0.9586660414934158;0.84645754;0.513160756960473;0.5490681857547832;0.9999539510871024;-0.041287909593686556;-0.15349641009818027;-0.48679319412662936;-0.45088576533231917
Intestinal pseudo-obstruction;Renal interstitial hemosiderin;0.7838526964187622;0.7263551;0.5693491432352773;0.5882293252026412;0.9998912449978579;-0.21603854857909566;-0.2735361691616762;-0.43054210176258056;-0.4116619197952167
Intestinal pseudo-obstruction;Abnormality of depressor anguli oris muscle;0.8167341947555542;0.6295454;0.5586668990635004;0.6207980941575776;0.9998912449978579;-0.18315705024230367;-0.37034585439193135;-0.44122434593435744;-0.3790931508402803
Intestinal pseudo-obstruction;Paroxysmal dyspnea;0.827211782336235;0.60276383;0.5552776203605287;0.6300306184949473;0.9998912449978579;-0.17267946266162282;-0.39712741338240987;-0.4446136246373291;-0.3698606265029105
Intestinal pseudo-obstruction;Phenylpyruvic acidemia;0.8665815591812134;0.69123983;0.5425954217801736;0.5999140457263841;0.9999539510871024;-0.133372391905889;-0.3087141172553153;-0.4573585293069288;-0.4000399053607183
Intestinal pseudo-obstruction;Lateral ventricle dilatation;0.8893079608678818;0.7637946;0.5353067228804738;0.5759038198283857;0.9999384059522154;-0.11063044508433362;-0.23614380498862286;-0.46463168307174163;-0.4240345861238297
Intestinal pseudo-obstruction;Neonatal unconjugated hyperbilirubinemia;0.7419605851173401;0.66567314;0.5830764427965553;0.608508944752896;0.9999539510871024;-0.2579933659697623;-0.3342808143759818;-0.41687750829054704;-0.3914450063342064
Intestinal pseudo-obstruction;High maternal circulating alpha-fetoprotein concentration;0.9504509903490543;0.86763155;0.5157784003891777;0.5422582068555095;0.9998912449978579;-0.04944025464880353;-0.1322596903942812;-0.4841128446086802;-0.45763303814234835
Intestinal pseudo-obstruction;Prominent nasolabial fold;1.000257907435298;0.90452754;0.4999179055127142;0.5304361790862;0.9999464332748575;0.000311474160440417;-0.09541888829957679;-0.5000285277621433;-0.46951025418865755
Intestinal pseudo-obstruction;Abnormality of inferior alveolar nerve;0.8732714951038361;0.6564505;0.5404476985017121;0.6116293131594223;0.9998912449978579;-0.1266197498940218;-0.34344073497283345;-0.4594435464961457;-0.3882619318384356
Intestinal pseudo-obstruction;Unilateral conductive hearing impairment;1.0333780646324158;0.85122585;0.4893734582594258;0.5475327308148094;0.9999539510871024;0.03342411354531338;-0.1487280981207938;-0.5105804928276766;-0.45242122027229303
Intestinal pseudo-obstruction;Macular hypopigmented whorls, streaks, and patches;0.9512553736567497;0.7821425;0.5155220474372033;0.5699067928401972;0.9999539510871024;-0.04869857743035266;-0.2178114311362357;-0.4844319036498991;-0.4300471582469052
Intestinal pseudo-obstruction;Delayed ossification of pubic rami;0.8414289951324463;0.6876721;0.5506886775862272;0.6011087665681203;0.9999518178785828;-0.1585228227461365;-0.31227973926911623;-0.4492631402923556;-0.3988430513104625
Intestinal pseudo-obstruction;Hyperphenylalaninemia;0.9374509900808334;0.78491855;0.5199229736940955;0.5690016904782603;0.9999486748218075;-0.06249768474097406;-0.21503012814517175;-0.48002570112771203;-0.43094698434354717
Intestinal pseudo-obstruction;Ureteropelvic junction obstruction;0.5972364246845245;0.51989233;0.6319503165762267;0.659402411245221;0.9999440410039805;-0.40270761631945595;-0.48005170606593117;-0.3679937244277538;-0.34054162975875946
Intestinal pseudo-obstruction;Cone-shaped epiphysis of the proximal phalanx of the 2nd toe;0.9746842291206121;0.86021817;0.5080591211363192;0.5446401129013445;0.9998912449978579;-0.02520701587724572;-0.1396730776928652;-0.49183212386153863;-0.45525113209651336
Intestinal pseudo-obstruction;Difficulty walking;1.0554472208023071;1.0007468;0.48234154538770857;0.4997622689294694;0.999934359238598;0.05551286156370916;0.000812486960437675;-0.5175928138508894;-0.5001720903091286
Intestinal pseudo-obstruction;Bilobate gallbladder;0.4801498055458069;0.6126156;0.6740122409715407;0.6266213860414853;0.8358089506358302;-0.3556591450900233;-0.22319336530868172;-0.1617967096642895;-0.20918756459434484
Intestinal pseudo-obstruction;Histidinuria;0.8642501980066299;0.7751597;0.5433443307157045;0.5721860454747909;0.9999504758588345;-0.1357002778522045;-0.22479075925269432;-0.4566061451431299;-0.42776443038404355
Intestinal pseudo-obstruction;Widened interpedicular distance;0.929411306977272;0.80349696;0.5224877804906329;0.5629585684587459;0.9998912449978579;-0.07047993802058583;-0.19639428817260152;-0.47740346450722493;-0.43693267653911194
Bilateral renal atrophy;Fractured left clavicle;0.9481224082410336;0.799243;0.516520566244048;0.5643401839851585;0.9999201345566091;-0.051797726315575554;-0.2006771612289724;-0.48339956831256115;-0.4355799505714506
Bilateral renal atrophy;Positive urine norcotinine test;0.8029554486274719;0.8013157;0.5631343633696009;0.5636668309308586;0.9999201345566091;-0.19696468592913718;-0.19860440970690818;-0.43678577118700823;-0.43625330362575054
Bilateral renal atrophy;Long fibula;0.8649162799119949;0.7631704;0.5431303391209253;0.5761083091170266;0.9999567459343585;-0.13504046602236353;-0.23678632481085382;-0.4568264068134331;-0.42384843681733186
Bilateral renal atrophy;Fragmentation of the epiphysis of the distal phalanx of the hallux;0.8987554311752319;0.7643336;0.5322824598976561;0.5757272551173789;0.9999201345566091;-0.10116470338137717;-0.23558652879031272;-0.467637674658953;-0.42419287943923023
Bilateral renal atrophy;Type II cryptotia;0.9368389025330544;0.86989564;0.5201181932290405;0.5415312394016708;0.9999201345566091;-0.06308123202355476;-0.13002449752123924;-0.4798019413275686;-0.4583888951549383
Bilateral renal atrophy;Increased variability in muscle fiber diameter;0.8212020695209503;0.7548803;0.5572208360421107;0.578827252416263;0.9999473166570552;-0.17874524713610485;-0.24506700755213573;-0.44272648061494446;-0.4211200642407922
Bilateral renal atrophy;Widened proximal tibial metaphyses;0.88746677339077;0.74568915;0.5358964760453602;0.581848630035384;0.9999600672783046;-0.1124932938875346;-0.2542709136070399;-0.4640635912329444;-0.41811143724292055
Bilateral renal atrophy;Wide anterior fontanel;1.0440218895673752;0.8819683;0.4859828674911528;0.5376584380670244;0.9999476714516888;0.04407421811568635;-0.11797935203564269;-0.513964803960536;-0.46228923338466443
Bilateral renal atrophy;Increased circulating oleate level;0.9617859199643135;0.8120168;0.5121668819414847;0.5601950570129677;0.9999201345566091;-0.0381342145922956;-0.1879033494118032;-0.48775325261512437;-0.43972507754364143
Bilateral renal atrophy;Lozenge-shaped umbilicus;0.9614785462617874;0.95055693;0.5122647941242351;0.5157446337572579;0.9999584729108851;-0.03847992664909772;-0.04940153903103284;-0.48769367878665004;-0.48421383915362726
Bilateral renal atrophy;Anti-myelin-associated glycoprotein antibody positivity;0.8968019634485245;0.7756599;0.5329075424713742;0.5720226422760316;0.9999201345566091;-0.10311817110808463;-0.2242602157715139;-0.46701259208523493;-0.4278974922805775
Bilateral renal atrophy;Fractured radius;0.7954211384057999;0.6760775;0.5655824840201564;0.6050017147892524;0.9999600672783046;-0.2045389288725047;-0.32388258219377086;-0.4343775832581481;-0.3949583524890522
Bilateral renal atrophy;Abnormal manual kinetic perimetry test;0.7964075058698654;0.7048765;0.5652617632905346;0.5953608009329808;0.9999201345566091;-0.2035126286867437;-0.29504365206988425;-0.43465837126607454;-0.4045593336236283
Bilateral renal atrophy;Small radial epiphyses;0.7901760339736938;0.6958996;0.567289091150702;0.5983558314658831;0.9999201345566091;-0.20974410058291526;-0.3040205288055715;-0.4326310434059071;-0.401564303090726
Bilateral renal atrophy;Generalized keratosis follicularis;0.8990262299776077;0.7864766;0.532195817950625;0.5684939514194756;0.9999600672783046;-0.10093383730069683;-0.2134834551872401;-0.46776424932767957;-0.431466115858829
Bilateral renal atrophy;Hypoplasia of the calcaneus;0.8808961808681488;0.7370119;0.5380021348326041;0.5847080043660091;0.9999584729108851;-0.11906229204273633;-0.26294656342602185;-0.46195633807828107;-0.415250468544876
Bilateral renal atrophy;2-hydroxyadipic aciduria;0.6059182286262512;0.57116187;0.6289373266306204;0.6410769320615005;0.6288651353633673;-0.02294690673711608;-0.057703269175317984;7.219126725310776e-05;0.012211796698133215
Bilateral renal atrophy;Potter facies;0.9630034938454628;0.9019791;0.5117790417832143;0.531251213267891;0.9999552432134126;-0.03695174936794976;-0.0979761544301484;-0.48817620143019824;-0.4687040299455215
Bilateral renal atrophy;Increased heart rate variability;0.8943187147378922;0.8069142;0.5337023318221898;0.5618495785590618;0.9999600672783046;-0.1056413525404124;-0.1930458569587855;-0.4662577354561147;-0.43811048871924274
Bilateral renal atrophy;Aplastic zygomatic arch;0.9570626020431519;0.7375123;0.5136716013263845;0.5845429187468856;0.9999584729108851;-0.04289587086773328;-0.26244618243313245;-0.4862868715845007;-0.41541555416399956
Bilateral renal atrophy;Testicular torsion;0.782772108912468;0.6793386;0.569701476017021;0.6039051756218446;0.8586132879499475;-0.07584117903747956;-0.17927471354046265;-0.2889118119329265;-0.25470811232810286
Bilateral renal atrophy;Abolished vibration sense;0.9547680728137493;0.8205298;0.5144026835848521;0.5574383383522413;0.9999584729108851;-0.04519040009713582;-0.17942865437603406;-0.48555578932603305;-0.4425201345586438
Bilateral renal atrophy;Fractured metatarsal bone of digit 5;0.8736491054296494;0.8254912;0.5403265273723039;0.5558337412725716;0.9999201345566091;-0.12627102912695976;-0.17442894459994407;-0.4595936071843052;-0.44408639328403754
Bilateral renal atrophy;Prolonged G2 phase of cell cycle;0.8466080576181412;0.83114654;0.5490197004542505;0.5540064644290137;0.9999567459343585;-0.15334868831621729;-0.16881020767675958;-0.45093704548010793;-0.44595028150534477
Bilateral renal atrophy;Single naris;0.91368567943573;0.9253831;0.5275089316008159;0.5237733999319294;0.9999567459343585;-0.08627106649862848;-0.07457365496145807;-0.47244781433354255;-0.47618334600242906
Bilateral renal atrophy;Perifoveal ring of hyperautofluorescence surrounded by normal autofluorescence;0.8023941516876221;0.7096446;0.5633166131159706;0.5937735197732759;0.9999201345566091;-0.19752598286898704;-0.2902755189064321;-0.4366035214406385;-0.40614661478333325
Bilateral renal atrophy;Asymmetry of the thorax;0.8488184809684753;0.65718806;0.5483077973068897;0.6113793648594981;0.9999567459343585;-0.15113826496588312;-0.34276868803488336;-0.45164894862746874;-0.3885773810748604
Bilateral renal atrophy;Type 2 muscle fiber predominance;0.8200253993272781;0.7359633;0.5576015576137285;0.5850540117329882;0.9999556674707869;-0.17993026814350876;-0.26399238250145707;-0.44235410985705836;-0.4149016557377987
Bilateral renal atrophy;Dependency on parenteral nutrition;0.6987525820732117;0.7328192;0.5974030074598526;0.5860921025197785;0.9999584729108851;-0.30120589083767346;-0.2671392733488124;-0.4025554654510325;-0.41386637039110663
Bilateral renal atrophy;Limited shoulder flexion;0.8478383123874664;0.6820215;0.5486234464334675;0.6030039943311105;0.9999201345566091;-0.15208182216914268;-0.31789863587649436;-0.4512966881231416;-0.3969161402254986
Bilateral renal atrophy;Paroxysmal vertigo;1.0442819073796272;0.8159071;0.48590002046071;0.5589347312453194;0.9999584729108851;0.044323434468742096;-0.18405135220623425;-0.5140584524501751;-0.4410237416655657
Bilateral renal atrophy;Long hallux;0.9466467015445232;0.83749706;0.5169909498705043;0.5519567001990403;0.9999526340597648;-0.053305932515241516;-0.16245557852921666;-0.48296168418926044;-0.44799593386072445
Bilateral renal atrophy;Broad medial eyebrow;0.9438586533069611;0.8898258;0.5178797464595305;0.5351408756229561;0.9999600672783046;-0.056101413971343495;-0.11013424635545299;-0.48208032081877406;-0.46481919165534846
Bilateral renal atrophy;Myxoid subcutaneous tumors;0.9560863822698593;0.8745518;0.5139826351519994;0.5400369042805937;0.9999600672783046;-0.04387368500844524;-0.1254082942070155;-0.4859774321263052;-0.45992316299771085
Bilateral renal atrophy;Bulbous tips of toes;0.8471954613924026;0.7801569;0.5488304934565189;0.5705545343660448;0.9999584729108851;-0.15276301151848248;-0.21980156249142102;-0.4511279794543662;-0.4294039385448404
Bilateral renal atrophy;Absent internal genitalia;0.9396544918417931;0.83707476;0.5192202492392151;0.5520929473343086;0.717226575899895;0.22242791594189804;0.11984818072241943;-0.19800632666067997;-0.16513362856558644
Bilateral renal atrophy;Hyperphalangy of the 2nd finger;0.7991689294576645;0.68043894;0.5643642331934318;0.6035354555262098;0.9999600672783046;-0.20079113782064006;-0.3195211315216212;-0.4355958340848728;-0.39642461175209476
Bilateral renal atrophy;Renal interstitial hemosiderin;0.3814356327056885;0.5501275;0.7122854033024557;0.6485305754244594;0.4693866352828394;-0.08795100257715094;0.0807408709732641;0.2428987680196163;0.17914394014161994
Bilateral renal atrophy;Abnormality of depressor anguli oris muscle;0.9154141992330551;0.70574486;0.5269567068031541;0.5950715517910846;0.9999201345566091;-0.084505935323554;-0.2941752720001516;-0.472963427753455;-0.4048485827655245
Bilateral renal atrophy;Paroxysmal dyspnea;0.8468911647796631;0.6728419;0.5489285074178107;0.6060909655968412;0.9999201345566091;-0.15302896977694602;-0.3270782280090627;-0.45099162713879837;-0.39382916895976794
Bilateral renal atrophy;Phenylpyruvic acidemia;0.7611973881721497;0.6754879;0.576754890692625;0.605200120030978;0.9999600672783046;-0.2387626791061549;-0.324472191339889;-0.4232051765856796;-0.39475994724732655
Bilateral renal atrophy;Lateral ventricle dilatation;0.8649096935987473;0.6952678;0.5431324550042841;0.5985669730557447;0.9999488789551968;-0.13503918535644954;-0.30468108243877834;-0.4568164239509127;-0.4013819058994521
Bilateral renal atrophy;Neonatal unconjugated hyperbilirubinemia;0.7491391003131866;0.7401105;0.58071367572969;0.5836861267715262;0.9999600672783046;-0.2508209669651179;-0.2598495507301478;-0.41924639154861454;-0.41627394050677835
Bilateral renal atrophy;High maternal circulating alpha-fetoprotein concentration;0.8847797214984894;0.8237231;0.5367573918552435;0.5564054299342069;0.9999201345566091;-0.11514041305811973;-0.17619705678256126;-0.4631627427013656;-0.44351470462240217
Bilateral renal atrophy;Prominent nasolabial fold;0.97638238966465;0.7952717;0.507518417919897;0.5656310868908672;0.9999545338528789;-0.02357214418822895;-0.20468283919269215;-0.49243611593298187;-0.43432344696201175
Bilateral renal atrophy;Abnormality of inferior alveolar nerve;1.028383793309331;0.8435068;0.4909639444042869;0.5500189296513017;0.9999201345566091;0.028463658752721832;-0.1564133215072927;-0.5089561901523222;-0.4499012049053074
Bilateral renal atrophy;Unilateral conductive hearing impairment;1.0015244465321302;0.78956884;0.49951475340991713;0.5674867801437796;0.9999600672783046;0.0015643792538256873;-0.2103912258209376;-0.5004453138683874;-0.43247328713452493
Bilateral renal atrophy;Macular hypopigmented whorls, streaks, and patches;0.8002579808235168;0.7261734;0.5640104079239454;0.5882894506329558;0.9999600672783046;-0.1997020864547877;-0.2737866663993983;-0.43594965935435914;-0.41167061664534876
Bilateral renal atrophy;Delayed ossification of pubic rami;0.8751673102378845;0.7026719;0.5398394107353592;0.5960955318863481;0.9999584729108851;-0.12479116267300061;-0.29728658742046765;-0.4601190621755259;-0.403862941024537
Bilateral renal atrophy;Hyperphenylalaninemia;0.7798421084880829;0.68063575;0.5706572604911005;0.6034693431496677;0.9999561589935034;-0.22011405050542054;-0.31932040869977174;-0.4292988985024029;-0.3964868158438357
Bilateral renal atrophy;Ureteropelvic junction obstruction;0.5013890266418457;0.53359073;0.6661563622648574;0.6544525861730996;0.7198694509471423;-0.21848042430529657;-0.1862787169421679;-0.05371308868228486;-0.06541686477404263
Bilateral renal atrophy;Cone-shaped epiphysis of the proximal phalanx of the 2nd toe;0.8375480026006699;0.76256514;0.5519402648542532;0.5763066292392047;0.9999201345566091;-0.16237213195593925;-0.23735499860079856;-0.4479798697023559;-0.4236135053174044
Bilateral renal atrophy;Difficulty walking;0.8540808856487274;0.7595654;0.5466139260065749;0.577289952498662;0.9999461221900431;-0.14586523654131567;-0.24038070919184362;-0.4533321961834682;-0.4226561696913811
Bilateral renal atrophy;Bilobate gallbladder;0.6907325387001038;0.6905954;0.6000838325686126;0.600129740517742;0.9999584729108851;-0.3092259342107814;-0.30936308449840955;-0.3998746403422725;-0.3998287323931431
Bilateral renal atrophy;Histidinuria;0.6172606647014618;0.6682798;0.6250192608221854;0.6076289794960885;0.8024087134738423;-0.18514804877238056;-0.1341288868327596;-0.17738945265165695;-0.19477973397775383
Bilateral renal atrophy;Widened interpedicular distance;0.9456908851861954;0.7809968;0.517295637460401;0.5702805113712415;0.9999201345566091;-0.054229249370413735;-0.21892333508761497;-0.48262449709620814;-0.42963962318536764
Fractured left clavicle;Positive urine norcotinine test;0.9714308381080627;0.9118827;0.5090950841865138;0.5280850407391815;1.0;-0.028569161891937256;-0.08811730146408081;-0.49090491581348616;-0.4719149592608185
Fractured left clavicle;Long fibula;0.7202253043651581;0.75184476;0.5902597683589317;0.5798242978858472;0.6263392562858507;0.09388604807930734;0.1255055074699476;-0.03607948792691906;-0.046514958400003525
Fractured left clavicle;Fragmentation of the epiphysis of the distal phalanx of the hallux;0.6449301838874817;0.6276746;0.6155429072680771;0.6214394749346348;1.0;-0.3550698161125183;-0.37232542037963867;-0.38445709273192286;-0.3785605250653652
Fractured left clavicle;Type II cryptotia;0.8944718092679977;0.7920321;0.5336533262898386;0.5666849413764034;1.0;-0.10552819073200226;-0.2079678773880005;-0.46634667371016136;-0.43331505862359665
Fractured left clavicle;Increased variability in muscle fiber diameter;0.9697699882090092;0.93538785;0.5096239778100558;0.5205810303138796;0.7712186293488323;0.19855135886017683;0.16416922045890692;-0.2615946515387766;-0.25063759903495275
Fractured left clavicle;Widened proximal tibial metaphyses;0.6549677550792694;0.72593355;0.6121320229362888;0.5883688239146744;0.4693866352828394;0.18558111979643;0.25654691650549066;0.14274538765344935;0.11898218863183496
Fractured left clavicle;Wide anterior fontanel;0.9933872651308775;0.90754104;0.5021049142244509;0.5294726939014565;0.558799737971173;0.4345875271597045;0.34874129863466197;-0.05669482374672208;-0.029327044069716535
Fractured left clavicle;Increased circulating oleate level;0.9097517728805542;0.8311058;0.5287660420611424;0.5540196164524782;1.0;-0.0902482271194458;-0.16889417171478271;-0.4712339579388576;-0.4459803835475218
Fractured left clavicle;Lozenge-shaped umbilicus;0.8773557841777802;0.82169056;0.5391374026715456;0.5570628150014691;0.9999134918687169;-0.12255770769093677;-0.1782229324815099;-0.4607760891971713;-0.4428506768672478
Fractured left clavicle;Anti-myelin-associated glycoprotein antibody positivity;1.0919903740286827;0.95570886;0.4706770987386011;0.5141029208293753;1.0;0.09199037402868271;-0.044291138648986816;-0.5293229012613989;-0.48589707917062475
Fractured left clavicle;Fractured radius;0.3762178421020508;0.3956763;0.7144047600154171;0.7065566136836273;0.0;0.3762178421020508;0.39567631483078003;0.7144047600154171;0.7065566136836273
Fractured left clavicle;Abnormal manual kinetic perimetry test;1.0330268293619156;0.8914884;0.4894853215951921;0.5346084693315825;1.0;0.03302682936191559;-0.10851162672042847;-0.5105146784048079;-0.46539153066841754
Fractured left clavicle;Small radial epiphyses;0.5963309705257416;0.7042737;0.6322652696395974;0.5955616364336536;1.0;-0.4036690294742584;-0.29572629928588867;-0.3677347303604026;-0.40443836356634644
Fractured left clavicle;Generalized keratosis follicularis;0.9531122073531151;0.80780935;0.5149303219843107;0.5615592071206147;0.9999201345566091;-0.046807927203494026;-0.19211078168185325;-0.48498981257229845;-0.4383609274359944
Fractured left clavicle;Hypoplasia of the calcaneus;0.616847038269043;0.5945225;0.6251617868720285;0.6328947587027873;0.6574179255159834;-0.04057088724694047;-0.06289544931969437;-0.032256138643954935;-0.024523166813196107
Fractured left clavicle;2-hydroxyadipic aciduria;1.00689079426229;0.9418678;0.49780657470400214;0.5185144815670931;1.0;0.006890794262290001;-0.058132171630859375;-0.5021934252959979;-0.4814855184329069
Fractured left clavicle;Potter facies;1.0137879038229585;1.0124918;0.49561103483426117;0.4960236136113183;0.9998981869165328;0.013889716906425709;0.012593635326204056;-0.5042871520822716;-0.5038745733052145
Fractured left clavicle;Increased heart rate variability;1.0149478064849973;0.9466418;0.49524178821448095;0.5169925054800817;0.9999201345566091;0.015027671928388164;-0.053278331768828346;-0.5046783463421282;-0.4829276290765274
Fractured left clavicle;Aplastic zygomatic arch;0.917642630636692;0.7787488;0.5262448907801476;0.5710140667241335;0.7485161685812178;0.1691264620554742;0.03023264171007245;-0.22227127780107026;-0.17750210185708437
Fractured left clavicle;Testicular torsion;0.8378488421440125;0.80763316;0.5518432179273614;0.5616163472922057;0.9999201345566091;-0.16207129241259666;-0.1922869730118093;-0.44807691662924776;-0.43830378726440344
Fractured left clavicle;Abolished vibration sense;0.8253278583288193;0.7425473;0.5558865519426666;0.5828831636553324;0.9999134918687169;-0.17458563353989764;-0.25736621823285266;-0.44402693992605036;-0.4170303282133845
Fractured left clavicle;Fractured metatarsal bone of digit 5;0.5618047118186951;0.57173145;0.6443821667031786;0.6408762676732936;1.0;-0.43819528818130493;-0.42826855182647705;-0.3556178332968214;-0.35912373232670636
Fractured left clavicle;Prolonged G2 phase of cell cycle;0.8883643001317978;0.8852246;0.5356089727511726;0.5366148334963454;0.9999056439461368;-0.111541343814339;-0.11468106318136628;-0.4642966711949642;-0.46329081044979137
Fractured left clavicle;Single naris;1.0279067642986774;0.9348834;0.4911158476333203;0.5207419284016577;0.9999056439461368;0.028001120352540654;-0.06502222824713166;-0.5087897963128165;-0.4791637155444791
Fractured left clavicle;Perifoveal ring of hyperautofluorescence surrounded by normal autofluorescence;1.0216405540704727;0.91623014;0.49311105992814486;0.5266960590046275;1.0;0.021640554070472717;-0.08376985788345337;-0.5068889400718551;-0.47330394099537254
Fractured left clavicle;Asymmetry of the thorax;0.7132006287574768;0.70690084;0.5925913095484019;0.5946866007773275;0.3872114577231953;0.3259891710342815;0.3196893773140361;0.20537985182520657;0.20747514305413217
Fractured left clavicle;Type 2 muscle fiber predominance;1.0069260839372873;1.0034659;0.4977953413835028;0.49889678824537265;0.8527273749847077;0.1541987089525796;0.15073851589969167;-0.35493203360120495;-0.3538305867393351
Fractured left clavicle;Dependency on parenteral nutrition;0.9915432138368487;0.9537128;0.5026919107280576;0.5147389246005409;0.9999134918687169;-0.008370278031868184;-0.04620067086194202;-0.4972215811406593;-0.485174567268176
Fractured left clavicle;Limited shoulder flexion;0.6082403659820557;0.62058735;0.6281335186702641;0.6238739100926783;1.0;-0.39175963401794434;-0.3794126510620117;-0.3718664813297359;-0.37612608990732166
Fractured left clavicle;Paroxysmal vertigo;1.0645862966775894;0.8483017;0.4794272234699902;0.5484742103619746;0.9999134918687169;0.0646728048088725;-0.15161178317044421;-0.5204862683987267;-0.4514392815067423
Fractured left clavicle;Long hallux;0.8462561666965485;0.8581222;0.5491330554193963;0.5453140058437822;0.5390476299078587;0.30720853678868976;0.31907459966825213;0.010085425511537571;0.006266375935923496
Fractured left clavicle;Broad medial eyebrow;0.988484688103199;0.944121;0.5036655186317183;0.517796108987632;0.9999201345566091;-0.011435446453410103;-0.05579913140566917;-0.49625461592489084;-0.48212402556897715
Fractured left clavicle;Myxoid subcutaneous tumors;0.9999468512833118;0.9310659;0.5000169177619678;0.5219598106642499;0.9999201345566091;2.6716726702735727e-05;-0.06885421754153342;-0.49990321679464134;-0.4779603238923592
Fractured left clavicle;Bulbous tips of toes;0.8983860090374947;0.91255575;0.5324006602052713;0.5278699583527175;0.6574179255159834;0.24096808352151122;0.25513782866873946;-0.1250172653107121;-0.1295479671632659
Fractured left clavicle;Absent internal genitalia;0.9598202891647816;0.8537142;0.5127930429596437;0.5467318980241768;1.0;-0.04017971083521843;-0.1462857723236084;-0.4872069570403563;-0.45326810197582323
Fractured left clavicle;Hyperphalangy of the 2nd finger;0.7429533302783966;0.72857726;0.582749410338038;0.5874941441413759;0.683723727808895;0.0592296024695016;0.044853528393802744;-0.10097431747085706;-0.0962295836675191
Fractured left clavicle;Renal interstitial hemosiderin;1.0127271236851811;0.9334432;0.49594872133250123;0.5212013542228692;1.0;0.012727123685181141;-0.06655681133270264;-0.5040512786674988;-0.4787986457771308
Fractured left clavicle;Abnormality of depressor anguli oris muscle;0.9064432680606842;0.9008894;0.5298236481264822;0.5315997631946379;1.0;-0.0935567319393158;-0.09911060333251953;-0.4701763518735178;-0.46840023680536214
Fractured left clavicle;Paroxysmal dyspnea;0.9405403099954128;0.8310987;0.5189377772986957;0.5540219263674195;1.0;-0.05945969000458717;-0.16890132427215576;-0.4810622227013043;-0.44597807363258046
Fractured left clavicle;Phenylpyruvic acidemia;0.9214346781373024;0.83881706;0.5250339175271543;0.5515309163862273;0.9999201345566091;-0.07848545641930671;-0.1611030745628652;-0.47488621702945477;-0.4483892181703818
Fractured left clavicle;Lateral ventricle dilatation;0.9395908303558826;0.7452588;0.5192405503564179;0.5819902783305098;0.9998579617208769;-0.060267131364994286;-0.2545991535848906;-0.480617411364459;-0.4178676833903672
Fractured left clavicle;Neonatal unconjugated hyperbilirubinemia;0.9217136427760124;0.86075515;0.5249448459796864;0.5444675040775747;0.9999201345566091;-0.07820649178059669;-0.13916498900683494;-0.4749752885769227;-0.4554526304790344
Fractured left clavicle;High maternal circulating alpha-fetoprotein concentration;0.9350727871060371;0.86632144;0.520681521780307;0.5426789624420385;1.0;-0.06492721289396286;-0.13367855548858643;-0.479318478219693;-0.4573210375579615
Fractured left clavicle;Prominent nasolabial fold;0.9991858620196581;0.87088436;0.5002591481964886;0.5412138374364616;0.9998944404568447;-0.0007085784371866355;-0.12901008157394067;-0.4996352922603561;-0.45868060302038316
Fractured left clavicle;Abnormality of inferior alveolar nerve;1.0122773498296738;0.83340895;0.49609189998873704;0.5532759772877456;1.0;0.012277349829673767;-0.16659104824066162;-0.503908100011263;-0.4467240227122544
Fractured left clavicle;Unilateral conductive hearing impairment;1.0630682930350304;0.83226454;0.47991140635240315;0.5536454528734849;0.9999201345566091;0.06314815847842126;-0.16765559197695823;-0.520008728204206;-0.44627468168312423
Fractured left clavicle;Macular hypopigmented whorls, streaks, and patches;1.1150425523519516;1.0078535;0.46329955884208307;0.49750014107436646;0.9999201345566091;0.11512241779534249;0.00793337343899636;-0.536620575714526;-0.5024199934822426
Fractured left clavicle;Delayed ossification of pubic rami;0.7878830879926682;0.7542358;0.5680357645097225;0.5790388927759853;0.6574179255159834;0.13046516247668472;0.0968178785649797;-0.08938216100626095;-0.07837903273999813
Fractured left clavicle;Hyperphenylalaninemia;1.014060202986002;0.88292277;0.49552435091488234;0.5373525014726825;0.9999028053808913;0.0141573976051107;-0.1169800367880568;-0.5043784544660089;-0.4625503039082087
Fractured left clavicle;Ureteropelvic junction obstruction;0.8834178745746613;0.7185358;0.5371938224461097;0.5908200839343635;0.9998847295244674;-0.11646685494980613;-0.28134894861779014;-0.4626909070783577;-0.4090646455901039
Fractured left clavicle;Cone-shaped epiphysis of the proximal phalanx of the 2nd toe;0.6080549359321594;0.61662;0.6281976734684974;0.6252400287925837;1.0;-0.3919450640678406;-0.3833799958229065;-0.3718023265315026;-0.37475997120741633
Fractured left clavicle;Difficulty walking;0.9996054992079735;0.89556503;0.5001255735054666;0.5333034135464783;0.7552776988623575;0.24432780034561596;0.14028733409662686;-0.2551521253568909;-0.22197428531587926
Fractured left clavicle;Bilobate gallbladder;0.9340104833245277;0.8105353;0.5210203903632504;0.5606752585873758;0.9999134918687169;-0.06590300854418918;-0.18937818016980335;-0.4788931015054665;-0.43923823328134115
Fractured left clavicle;Histidinuria;1.0230375118553638;0.98799884;0.49266628342561336;0.5038201779700573;0.9999090677057578;0.02312844414960602;-0.011910224512703627;-0.5072427842801445;-0.49608888973570053
Fractured left clavicle;Widened interpedicular distance;0.7528452426195145;0.80700654;0.5794956057191567;0.561819616733273;1.0;-0.24715475738048553;-0.19299346208572388;-0.4205043942808433;-0.43818038326672704
Positive urine norcotinine test;Long fibula;0.9963006172329187;0.9377489;0.5011775527934369;0.5198279544283813;0.9999056439461368;-0.0036050267132180513;-0.06215673494955476;-0.4987280911526999;-0.48007768951775553
Positive urine norcotinine test;Fragmentation of the epiphysis of the distal phalanx of the hallux;0.9964723773300648;0.9720736;0.5011228794994496;0.5088903980206705;1.0;-0.0035276226699352264;-0.027926385402679443;-0.49887712050055044;-0.4911096019793295
Positive urine norcotinine test;Type II cryptotia;0.9045595228672028;0.8923347;0.5304259582780142;0.5343374829019873;1.0;-0.09544047713279724;-0.1076653003692627;-0.4695740417219858;-0.46566251709801265
Positive urine norcotinine test;Increased variability in muscle fiber diameter;0.8888671398162842;0.8992044;0.5354479116898381;0.5321388247502201;0.9998452077479463;-0.1109780679316621;-0.1006408343882661;-0.4643972960581082;-0.46770638299772616
Positive urine norcotinine test;Widened proximal tibial metaphyses;0.942833486944437;0.8216964;0.518206592016575;0.5570609061094374;0.9999201345566091;-0.05708664761217208;-0.1782237339142141;-0.48171354254003407;-0.44285922844717174
Positive urine norcotinine test;Wide anterior fontanel;0.9536967799067497;0.88411534;0.5147440444313083;0.5369702906048065;0.999848231156753;-0.046151451250003306;-0.11573289283125254;-0.48510418672544475;-0.46287794055194653
Positive urine norcotinine test;Increased circulating oleate level;0.9820147473365068;0.87270886;0.5057251924106057;0.5406282539921112;1.0;-0.017985252663493156;-0.12729114294052124;-0.49427480758939435;-0.45937174600788877
Positive urine norcotinine test;Lozenge-shaped umbilicus;0.8829943090677261;0.894245;0.5373295766135797;0.5337259142912524;0.9999134918687169;-0.11691918280099078;-0.10566846337292835;-0.4625839152551372;-0.46618757757746454
Positive urine norcotinine test;Anti-myelin-associated glycoprotein antibody positivity;0.8368813395500183;0.7433833;0.5521553390634343;0.5826078002738981;1.0;-0.1631186604499817;-0.2566167116165161;-0.4478446609365657;-0.41739219972610186
Positive urine norcotinine test;Fractured radius;0.9270780459046364;0.8496249;0.5232324001617015;0.5480481513619707;0.9999201345566091;-0.07284208865197273;-0.1502952623489675;-0.47668773439490764;-0.4518719831946384
Positive urine norcotinine test;Abnormal manual kinetic perimetry test;0.8800904154777527;0.80723524;0.5382604693110833;0.5617454155024666;1.0;-0.11990958452224731;-0.1927647590637207;-0.4617395306889167;-0.4382545844975334
Positive urine norcotinine test;Small radial epiphyses;0.9622502401471138;0.9374706;0.512018977511699;0.5199167099124336;1.0;-0.0377497598528862;-0.06252938508987427;-0.487981022488301;-0.48008329008756645
Positive urine norcotinine test;Generalized keratosis follicularis;0.9319743365049362;0.94373566;0.5216699761058532;0.5179189527660446;0.9999201345566091;-0.06794579805167289;-0.05618447543414207;-0.4782501584507559;-0.4820011817905645
Positive urine norcotinine test;Hypoplasia of the calcaneus;0.9847413338720798;0.8632804;0.5048571727710032;0.5436559367947771;0.9999134918687169;-0.01517215799663707;-0.13663307633374377;-0.49505631909771375;-0.45625755507393984
Positive urine norcotinine test;2-hydroxyadipic aciduria;0.7452074587345123;0.7970518;0.5820071811017695;0.5650522995803917;1.0;-0.25479254126548767;-0.2029482126235962;-0.4179928188982305;-0.4349477004196083
Positive urine norcotinine test;Potter facies;0.8249338418245316;0.8153086;0.5560139340360095;0.5591285795467726;0.9998981869165328;-0.1749643450920012;-0.18458961605471635;-0.44388425288052324;-0.4407696073697601
Positive urine norcotinine test;Increased heart rate variability;0.8826578557491302;0.85440767;0.5374374158922184;0.5465087850758215;0.9999201345566091;-0.11726227880747886;-0.1455124664429006;-0.4624827186643907;-0.45341134948078765
Positive urine norcotinine test;Aplastic zygomatic arch;0.9841784089803696;0.9647145;0.5050363789716423;0.5112340409290363;0.9999134918687169;-0.01573508288834735;-0.035198964738589966;-0.4948771128970746;-0.48867945093968057
Positive urine norcotinine test;Testicular torsion;0.8502991199493408;0.81478965;0.5478310695763073;0.5592966559855408;0.9999201345566091;-0.1496210146072683;-0.18513048173220725;-0.45208906498030177;-0.4406234785710683
Positive urine norcotinine test;Abolished vibration sense;0.8735826313495636;0.82136244;0.5403478577695998;0.5571689545929988;0.9999134918687169;-0.12633086051915332;-0.1785510560509984;-0.4595656340991171;-0.44274453727571816
Positive urine norcotinine test;Fractured metatarsal bone of digit 5;1.0069156773388386;1.018132;0.497798653986006;0.494228104484018;1.0;0.006915677338838577;0.01813197135925293;-0.502201346013994;-0.505771895515982
Positive urine norcotinine test;Prolonged G2 phase of cell cycle;0.896869346499443;0.9387065;0.5328859787229314;0.5195225585856076;0.6766288643064248;0.22024048219301828;0.2620776529131187;-0.14374288558349335;-0.15710630572081719
Positive urine norcotinine test;Single naris;0.7650668025016785;0.713018;0.5754871390514155;0.5926519929769336;0.9999056439461368;-0.23483884144445832;-0.2868876438202518;-0.4244185048947213;-0.4072536509692032
Positive urine norcotinine test;Perifoveal ring of hyperautofluorescence surrounded by normal autofluorescence;0.8910799622535706;0.8497002;0.534739245728639;0.5480238941189461;1.0;-0.10892003774642944;-0.1502997875213623;-0.46526075427136104;-0.45197610588105386
Positive urine norcotinine test;Asymmetry of the thorax;0.9818488582968712;0.8997348;0.5057780051533128;0.5319691265728715;0.9999056439461368;-0.018056785649265605;-0.10017084885260041;-0.49412763879282395;-0.46793651737326525
Positive urine norcotinine test;Type 2 muscle fiber predominance;0.9222047030925751;0.9104442;0.5247880584483304;0.5285447371262744;0.9999003561294039;-0.0776956530368288;-0.08945615609049395;-0.47511229768107344;-0.4713556190031295
Positive urine norcotinine test;Dependency on parenteral nutrition;0.8347009569406509;0.7415458;0.5528589273495663;0.5832131100420745;0.9999134918687169;-0.16521253492806598;-0.2583676954743688;-0.4470545645191506;-0.4167003818266424
Positive urine norcotinine test;Limited shoulder flexion;0.9304465651512146;0.8709943;0.5221574355770106;0.5411785518425065;1.0;-0.0695534348487854;-0.12900567054748535;-0.47784256442298945;-0.4588214481574935
Positive urine norcotinine test;Paroxysmal vertigo;0.8259404301643372;0.70109844;0.5556885307692179;0.5966202128159296;0.9999134918687169;-0.17397306170437976;-0.2988150497910802;-0.44422496109949905;-0.40329327905278733
Positive urine norcotinine test;Long hallux;0.9979846775531769;0.9164937;0.5006414974929154;0.5266118665202897;0.9998836012415208;-0.0018989236883438787;-0.08338988738577735;-0.49924210374860534;-0.4732717347212311
Positive urine norcotinine test;Broad medial eyebrow;0.942512758076191;0.9493527;0.5183088513559038;0.5161284401018176;0.9999201345566091;-0.05740737648041816;-0.050567452919798805;-0.48161128320070534;-0.48379169445479153
Positive urine norcotinine test;Myxoid subcutaneous tumors;0.8655242919921875;0.8489782;0.5429350206956747;0.5482563549505957;0.9999201345566091;-0.1343958425644216;-0.15094191314013572;-0.45698511386093443;-0.45166377960601345
Positive urine norcotinine test;Bulbous tips of toes;0.897617518901825;0.8728605;0.5326465606935828;0.5405795967308351;0.9999134918687169;-0.10229597296689197;-0.12705300059292957;-0.46726693117513407;-0.4593338951378818
Positive urine norcotinine test;Absent internal genitalia;0.8235608339309692;0.8445591;0.5564578864665262;0.5496798301909941;1.0;-0.17643916606903076;-0.15544092655181885;-0.44354211353347384;-0.4503201698090059
Positive urine norcotinine test;Hyperphalangy of the 2nd finger;0.9715168923139572;0.9739699;0.5090676811302659;0.5082865815297455;0.9999201345566091;-0.028403242242651894;-0.025950257790404274;-0.4908524534263432;-0.4916335530268636
Positive urine norcotinine test;Renal interstitial hemosiderin;0.8477801829576492;0.84270096;0.5486421676869299;0.5502786531108834;1.0;-0.15221981704235077;-0.15729904174804688;-0.45135783231307014;-0.4497213468891166
Positive urine norcotinine test;Abnormality of depressor anguli oris muscle;0.9106359481811523;0.8746273;0.5284834584669234;0.5400126697328276;1.0;-0.08936405181884766;-0.12537270784378052;-0.47151654153307665;-0.4599873302671724
Positive urine norcotinine test;Paroxysmal dyspnea;0.8101037442684174;0.7257261;0.5608151659207857;0.5884374897563895;1.0;-0.18989625573158264;-0.2742738723754883;-0.43918483407921427;-0.41156251024361046
Positive urine norcotinine test;Phenylpyruvic acidemia;0.7771084010601044;0.720416;0.5715495972498981;0.5901965419039341;0.726290173501319;0.0508182275587854;-0.005874164075202026;-0.1547405762514209;-0.13609363159738486
Positive urine norcotinine test;Lateral ventricle dilatation;0.904488667845726;0.9161809;0.5304486156365155;0.5267117929443643;0.9998579617208769;-0.09536929387515092;-0.08367705304091477;-0.46940934608436147;-0.4731461687765126
Positive urine norcotinine test;Neonatal unconjugated hyperbilirubinemia;0.8629932105541229;0.69791555;0.5437482158432723;0.5976824604503168;0.726290173501319;0.13670303705280396;-0.02837461945468811;-0.1825419576580467;-0.12860771305100216
Positive urine norcotinine test;High maternal circulating alpha-fetoprotein concentration;0.8879772424697876;0.8328576;0.5357329547167272;0.5534539659609932;1.0;-0.1120227575302124;-0.16714239120483398;-0.4642670452832728;-0.44654603403900683
Positive urine norcotinine test;Prominent nasolabial fold;0.9073368012905121;0.7606027;0.5295379866945416;0.5769498362019899;0.9998944404568447;-0.09255763916633264;-0.23929172782561914;-0.4703564537623032;-0.4229446042548548
Positive urine norcotinine test;Abnormality of inferior alveolar nerve;0.9421928338706493;0.8468248;0.518410856025811;0.5489498761474181;1.0;-0.05780716612935066;-0.15317517518997192;-0.48158914397418895;-0.4510501238525819
Positive urine norcotinine test;Unilateral conductive hearing impairment;0.9105461835861206;0.69272566;0.5285121463197762;0.5994169232995343;0.9999201345566091;-0.0893739509704885;-0.30719447613986106;-0.47140798823683294;-0.4005032112570748
Positive urine norcotinine test;Macular hypopigmented whorls, streaks, and patches;0.889366865158081;0.9308394;0.535287857190134;0.5220320748290856;0.9999201345566091;-0.11055326939852805;-0.06908071519167991;-0.46463227736647505;-0.47788805972752346
Positive urine norcotinine test;Delayed ossification of pubic rami;1.0163954347372055;0.95543647;0.4947809371940993;0.5141897167304936;0.9999134918687169;0.016481942868488586;-0.04447702374432727;-0.5051325546746176;-0.4857237751382233
Positive urine norcotinine test;Hyperphenylalaninemia;0.7354848682880402;0.677714;0.5852119102419071;0.6044512752196197;0.6669007119557334;0.06858415633230674;0.0108132782557534;-0.08168880171382631;-0.062449436736113695
Positive urine norcotinine test;Ureteropelvic junction obstruction;0.7550535202026367;0.7039962;0.5787703937453061;0.5956541038502825;0.9998847295244674;-0.24483120932183067;-0.2958885480364303;-0.42111433577916124;-0.4042306256741849
Positive urine norcotinine test;Cone-shaped epiphysis of the proximal phalanx of the 2nd toe;0.9336656928062439;0.8857054;0.5211303815961993;0.5364607688445491;1.0;-0.0663343071937561;-0.11429458856582642;-0.4788696184038007;-0.4635392311554509
Positive urine norcotinine test;Difficulty walking;0.9348113387823105;0.8706981;0.5207649200469144;0.5412736332599465;0.9998344221996177;-0.06502308341730723;-0.12913632783163675;-0.4790695021527033;-0.4585607889396712
Positive urine norcotinine test;Bilobate gallbladder;0.8591342270374298;0.8182008;0.5449885993496741;0.558192073692782;0.9999134918687169;-0.1407792648312871;-0.18171266522381946;-0.4549248925190428;-0.4417214181759349
Positive urine norcotinine test;Histidinuria;0.7767373025417328;0.7514206;0.5716707751652471;0.5799636948056401;0.6883625580296748;0.08837474451205796;0.06305805907390183;-0.11669178286442772;-0.10839886322403469
Positive urine norcotinine test;Widened interpedicular distance;1.003777552396059;0.8893705;0.4987975648669736;0.5352866950905875;1.0;0.0037775523960590363;-0.11062949895858765;-0.5012024351330264;-0.46471330490941254
Long fibula;Fragmentation of the epiphysis of the distal phalanx of the hallux;0.6231891512870789;0.7568127;0.6229793257921913;0.5781929697521151;0.6109530888848884;0.01223606240219044;0.14585960280364918;0.012026236907302867;-0.032760119132773324
Long fibula;Type II cryptotia;1.0632504150271416;1.0026942;0.4798533191480182;0.49914237621993873;0.9999056439461368;0.06334477108100478;0.0027886052070004164;-0.5200523247981186;-0.5007632677261981
Long fibula;Increased variability in muscle fiber diameter;0.7486055493354797;0.69711375;0.5808891329916966;0.5979502255778173;0.9133571980246588;-0.16475164868917902;-0.21624344565954645;-0.3324680650329621;-0.31540697244684146
Long fibula;Widened proximal tibial metaphyses;0.34246861934661865;0.44220018;0.728399291635564;0.6883543140022601;0.8216557397003772;-0.47918712035375854;-0.379455555831969;-0.09325644806481315;-0.1333014256981171
Long fibula;Wide anterior fontanel;0.9988146796822548;0.79030484;0.5003772992637827;0.5672471581595747;0.870344338586674;0.12847034109558075;-0.08003949897562057;-0.3699670393228913;-0.3030971804270993
Long fibula;Increased circulating oleate level;0.8503689467906952;0.73060006;0.5478085898041014;0.5868253498453246;0.9999056439461368;-0.1495366971554416;-0.2693055849136966;-0.4520970541420354;-0.41308029410081215
Long fibula;Lozenge-shaped umbilicus;0.9238387793302536;0.8512791;0.5242663677925208;0.5475156071401598;0.9999548690865008;-0.07611608975624717;-0.14867578917240776;-0.47568850129398;-0.452439261946341
Long fibula;Anti-myelin-associated glycoprotein antibody positivity;0.9563301801681519;0.8424513;0.5139049573528792;0.5503591334505803;0.9999056439461368;-0.043575463777984935;-0.15745436955114778;-0.48600068659325757;-0.4495465104955565
Long fibula;Fractured radius;0.6212472915649414;0.6754913;0.6236469107145494;0.6051989666811304;0.8216557397003772;-0.2004084481354358;-0.14616446629720947;-0.19800882898582783;-0.21645677301924682
Long fibula;Abnormal manual kinetic perimetry test;0.9669557735323906;0.8683688;0.5105202190997745;0.5420214613488841;0.9999056439461368;-0.032949870413746196;-0.13153683949133332;-0.48938542484636227;-0.4578841825972527
Long fibula;Small radial epiphyses;0.7743163853883743;0.8586844;0.5724615578159691;0.5451332335002177;0.6109530888848884;0.1633632965034859;0.2477313317007439;-0.03849153106891934;-0.06581985538467072
Long fibula;Generalized keratosis follicularis;0.9138450175523758;0.727109;0.5274580230612481;0.5879798332474115;0.9999567459343585;-0.08611172838198267;-0.2728477309464129;-0.47249872287311034;-0.4119769126869469
Long fibula;Hypoplasia of the calcaneus;0.7257798612117767;0.82731545;0.588419694037292;0.5552441184108488;0.6986638889529599;0.02711597225881679;0.1286515607617007;-0.11024419491566795;-0.1434197705421112
Long fibula;2-hydroxyadipic aciduria;0.9454575404524803;0.8862058;0.5173700236500425;0.5363004490158214;0.9999056439461368;-0.054448103493656475;-0.1136998515190738;-0.4825356202960943;-0.4636051949303154
Long fibula;Potter facies;0.9677470698952675;0.91770416;0.5102682072887263;0.5262252323140111;0.9999510285821799;-0.03220395868691239;-0.08224686360033784;-0.48968282129345353;-0.4737257962681688
Long fibula;Increased heart rate variability;0.9102361053228378;0.7475926;0.5286112459713697;0.581222299493253;0.9999567459343585;-0.08972064061152063;-0.2523641179321917;-0.4713454999629888;-0.41873444644110547
Long fibula;Aplastic zygomatic arch;0.9771301187574863;0.8931456;0.5072803440309199;0.5340778585240198;0.8994299275196795;0.0777001912378068;-0.006284306696773045;-0.3921495834887596;-0.36535206899565975
Long fibula;Testicular torsion;0.9462588988244534;0.8508853;0.5171145686644418;0.5476423783816302;0.9999567459343585;-0.053697847109905106;-0.14907147390829645;-0.48284217726991663;-0.45231436755272825
Long fibula;Abolished vibration sense;0.9852643683552742;0.92905736;0.5046906669964555;0.5226007190643993;0.9999548690865008;-0.014690500731226575;-0.0708975093910662;-0.4952642020900453;-0.47735415002210146
Long fibula;Fractured metatarsal bone of digit 5;0.5129318535327911;0.6198644;0.6619336712235964;0.6241226779154798;0.36999089714112543;0.1429409563916657;0.24987350706038214;0.29194277408247093;0.2541317807743544
Long fibula;Prolonged G2 phase of cell cycle;0.996907358057797;0.9037756;0.5009844200738709;0.5306766535506462;0.9999528219730685;-0.0030454639152714957;-0.09617724919627402;-0.49896840189919756;-0.46927616842242226
Long fibula;Single naris;0.9421356245875359;0.8523541;0.5184290968393097;0.5471695898353592;0.9999528219730685;-0.05781719738553259;-0.1475987126858065;-0.48152372513375874;-0.4527832321377092
Long fibula;Perifoveal ring of hyperautofluorescence surrounded by normal autofluorescence;0.9793895613402128;0.8160808;0.5065609709459205;0.5588784794215356;0.9999056439461368;-0.02051608260592397;-0.18382483530661042;-0.49334467300021634;-0.4410271645246012
Long fibula;Asymmetry of the thorax;0.8423663526773453;0.7098933;0.5503865069197078;0.5936908051512146;0.8948681243054075;-0.052501771628062244;-0.1849748380772276;-0.3444816173856997;-0.3011773191541929
Long fibula;Type 2 muscle fiber predominance;0.7899777442216873;0.80466753;0.5673536471833402;0.5625785844474235;0.9283707775802553;-0.138393033358568;-0.12370324513625508;-0.3610171303969151;-0.36579219313283184
Long fibula;Dependency on parenteral nutrition;0.9523242227733135;0.92727494;0.5151814261098866;0.523169549697062;0.9999548690865008;-0.04763064631318725;-0.07267992668842949;-0.4847734429766142;-0.4767853193894388
Long fibula;Limited shoulder flexion;0.767499715089798;0.7825724;0.5746906599811783;0.5697666104942484;0.8029485097445463;-0.03544879465474837;-0.02037612109555953;-0.22825784976336805;-0.23318189925029797
Long fibula;Paroxysmal vertigo;1.0665556490421295;0.9496814;0.4787990070604188;0.5160236670609553;0.9999548690865008;0.06660077995562874;-0.05027346783375419;-0.521155862026082;-0.4839312020255455
Long fibula;Long hallux;0.5394248366355896;0.5549421;0.6523568220673253;0.6468169170980496;0.7851314665573785;-0.24570662992178893;-0.23018939511954284;-0.13277464449005327;-0.13831454945932897
Long fibula;Broad medial eyebrow;0.9128151461482048;0.7897834;0.5277870795378744;0.5674169155032871;0.9999567459343585;-0.08714159978615366;-0.2101733277558001;-0.47216966639648406;-0.43253983043107136
Long fibula;Myxoid subcutaneous tumors;0.9544892609119415;0.92556417;0.5144915236581971;0.523715604741519;0.9999567459343585;-0.04546748502241693;-0.07439257605063043;-0.4854652222761614;-0.47624114119283945
Long fibula;Bulbous tips of toes;0.7939251512289047;0.79952693;0.5660690383719221;0.5642479124618818;0.8139171598024477;-0.019992008573542996;-0.01439022994710104;-0.2478481214305256;-0.24966924734056595
Long fibula;Absent internal genitalia;0.9584068171679974;0.8593384;0.5132433416477049;0.5449229641738011;0.9999056439461368;-0.04149882677813943;-0.14056724119802888;-0.4866623022984319;-0.45498267977233564
Long fibula;Hyperphalangy of the 2nd finger;0.8529694080352783;0.85306984;0.5469715778306852;0.5469392577354522;0.8216557397003772;0.031313668334901124;0.03141410216134766;-0.274684161869692;-0.27471648196492504
Long fibula;Renal interstitial hemosiderin;0.96586037799716;0.9094622;0.5108690912376816;0.5288585881659438;0.9999056439461368;-0.03404526594897683;-0.09044343042990144;-0.48903655270845514;-0.471047055780193
Long fibula;Abnormality of depressor anguli oris muscle;0.8780655339360237;0.85064185;0.5389097738317192;0.5477207358230265;0.8605427142144324;0.01752281972159131;-0.009900867557633086;-0.3216329403827132;-0.3128219783914059
Long fibula;Paroxysmal dyspnea;1.005240859463811;0.89221096;0.4983317749837626;0.534377100883199;0.9999056439461368;0.00533521551767413;-0.1076946835579532;-0.5015738689623742;-0.4655285430629378
Long fibula;Phenylpyruvic acidemia;0.9527089558541775;0.87620306;0.5150588234734421;0.5395071486109433;0.9999567459343585;-0.047247790080180985;-0.12375368578421198;-0.48489792246091634;-0.46044959732341517
Long fibula;Lateral ventricle dilatation;0.9662562012672424;0.7334043;0.5107430241387284;0.5858988466607601;0.9999433058680118;-0.0336871046007694;-0.26653902711282385;-0.4892002817292834;-0.41404445920725175
Long fibula;Neonatal unconjugated hyperbilirubinemia;0.9888133155182004;0.86697936;0.5035609065365831;0.542467658852994;0.9999567459343585;-0.011143430416158062;-0.13297738535391412;-0.4963958393977753;-0.4574890870813645
Long fibula;High maternal circulating alpha-fetoprotein concentration;0.7769592702388763;0.63865757;0.571598292920522;0.6176814564439239;0.9999056439461368;-0.22294637370726045;-0.3612480740608829;-0.4283073510256148;-0.3822241875022129
Long fibula;Prominent nasolabial fold;0.8621774911880493;0.6808589;0.5440103541353332;0.6033943866826311;0.9999501780647019;-0.13777268687665256;-0.3190912679809311;-0.4559398239293687;-0.39655579138207075
Long fibula;Abnormality of inferior alveolar nerve;0.9891951121389866;0.8853899;0.5034393695493595;0.5365618558672725;0.9999056439461368;-0.010710531807150203;-0.11451571989675935;-0.49646627439677726;-0.46334378807886434
Long fibula;Unilateral conductive hearing impairment;1.006518306210637;0.8499916;0.49792514399894794;0.5479300678667487;0.9999567459343585;0.006561560276278633;-0.14996512634741388;-0.5020316019354105;-0.45202667806760977
Long fibula;Macular hypopigmented whorls, streaks, and patches;1.0877865701913834;0.9607782;0.47202065099507484;0.512487892529205;0.9999567459343585;0.0878298242570249;-0.03917856914984308;-0.5279360949392836;-0.48746885340515345
Long fibula;Delayed ossification of pubic rami;0.7403169870376587;0.74088013;0.5836180782934868;0.5834324703327822;0.8212764310058089;-0.08095944396815025;-0.08039629928431236;-0.23765835271232216;-0.2378439606730267
Long fibula;Hyperphenylalaninemia;0.9568142481148243;0.79726756;0.5137507282337709;0.5649821698511965;0.9999521228478421;-0.04313787473301778;-0.20268456665735135;-0.4862013946140712;-0.43496995299664554
Long fibula;Ureteropelvic junction obstruction;0.9241928905248642;0.82875985;0.5241533238907101;0.5547774041145703;0.9999481150251853;-0.07575522450032113;-0.17118826595368264;-0.4757947911344752;-0.445170710910615
Long fibula;Cone-shaped epiphysis of the proximal phalanx of the 2nd toe;0.6730273962020874;0.82870555;0.6060284861436556;0.5547949523126302;0.6109530888848884;0.062074307317198985;0.2177524603552239;-0.004924602741232853;-0.05615813657225821
Long fibula;Difficulty walking;0.8781678751111031;0.8072913;0.538876952925627;0.5617272258432734;0.9111657437054939;-0.0329978685943908;-0.10387441479848092;-0.3722887907798669;-0.34943851786222047
Long fibula;Bilobate gallbladder;0.9129709899425507;0.7755298;0.5277372836415506;0.5720651486117638;0.9999548690865008;-0.08698387914395012;-0.22442506724095024;-0.4722175854449502;-0.42788972047473695
Long fibula;Histidinuria;0.9451439753174782;0.90693325;0.5174699841862312;0.5296669991839075;0.9999536937290383;-0.05480971841156013;-0.093020445685978;-0.48248370954280706;-0.47028669454513083
Long fibula;Widened interpedicular distance;0.6648119986057281;0.6707973;0.6087998367450232;0.6067799471306563;0.789736248610815;-0.12492425000508689;-0.11893896019299888;-0.1809364118657918;-0.18295630148015873
Fragmentation of the epiphysis of the distal phalanx of the hallux;Type II cryptotia;0.9197487384080887;0.7865058;0.525572268894695;0.5684844304881806;1.0;-0.08025126159191132;-0.2134941816329956;-0.474427731105305;-0.43151556951181935
Fragmentation of the epiphysis of the distal phalanx of the hallux;Increased variability in muscle fiber diameter;0.9077083021402359;0.8137631;0.5294192253822018;0.5596291949115874;0.7712186293488323;0.13648967279140356;0.04254445267860296;-0.24179940396663058;-0.21158943443724498
Fragmentation of the epiphysis of the distal phalanx of the hallux;Widened proximal tibial metaphyses;0.3831779360771179;0.5809288;0.7115801906866805;0.637644244822406;0.4693866352828394;-0.0862086992057215;0.11154216720739496;0.24219355540384113;0.1682576095395666
Fragmentation of the epiphysis of the distal phalanx of the hallux;Wide anterior fontanel;1.0585323423147202;0.9668677;0.48135792169278424;0.5105482833026944;0.6617971500655027;0.3967351922492175;0.3050705352524905;-0.18043922837271842;-0.15124886676280824
Fragmentation of the epiphysis of the distal phalanx of the hallux;Increased circulating oleate level;1.0148337623104453;0.9557984;0.4952780936280441;0.5140743982002679;1.0;0.014833762310445309;-0.04420161247253418;-0.5047219063719559;-0.4859256017997321
Fragmentation of the epiphysis of the distal phalanx of the hallux;Lozenge-shaped umbilicus;0.9575008153915405;0.89201885;0.5135319862375755;0.5344386209771173;0.9999134918687169;-0.04241267647717639;-0.10789463725064441;-0.48638150563114146;-0.46547487089159967
Fragmentation of the epiphysis of the distal phalanx of the hallux;Anti-myelin-associated glycoprotein antibody positivity;0.9841746743768454;0.905322;0.5050375678817152;0.5301821405542775;1.0;-0.01582532562315464;-0.09467798471450806;-0.49496243211828483;-0.4698178594457225
Fragmentation of the epiphysis of the distal phalanx of the hallux;Fractured radius;0.5652393698692322;0.59486634;0.6431670187879488;0.6327750195717372;0.4693866352828394;0.09585273458639276;0.12547970010915888;0.17378038350510938;0.1633883842888978
Fragmentation of the epiphysis of the distal phalanx of the hallux;Abnormal manual kinetic perimetry test;0.875943049788475;0.7501577;0.5395905506543357;0.5803787760557263;1.0;-0.12405695021152496;-0.24984228610992432;-0.4604094493456643;-0.4196212239442737
Fragmentation of the epiphysis of the distal phalanx of the hallux;Small radial epiphyses;0.5305107235908508;0.568232;0.6555619414968304;0.6421100794368544;1.0;-0.46948927640914917;-0.431768000125885;-0.34443805850316955;-0.3578899205631456
Fragmentation of the epiphysis of the distal phalanx of the hallux;Generalized keratosis follicularis;0.8590221107006073;0.8388685;0.545024646815655;0.5515143212424636;0.9999201345566091;-0.1408980238560018;-0.16105163575442405;-0.4548954877409541;-0.44840581331414553
Fragmentation of the epiphysis of the distal phalanx of the hallux;Hypoplasia of the calcaneus;0.374924898147583;0.48424983;0.7149316663441432;0.672486725377238;0.5863259809806012;-0.21140108283301817;-0.1020761507346295;0.128605685363542;0.08616074439663679
Fragmentation of the epiphysis of the distal phalanx of the hallux;2-hydroxyadipic aciduria;0.9249797314405441;0.787712;0.5239021493804596;0.5680914998575152;1.0;-0.07502026855945587;-0.2122880220413208;-0.47609785061954035;-0.43190850014248483
Fragmentation of the epiphysis of the distal phalanx of the hallux;Potter facies;0.9224739223718643;0.9188942;0.524702103693506;0.5258451731791633;0.9998981869165328;-0.07742426454466844;-0.08100401520175005;-0.47519608322302676;-0.4740530137373694
Fragmentation of the epiphysis of the distal phalanx of the hallux;Increased heart rate variability;1.0231872592121363;0.9656113;0.4926186046251899;0.5109484213748756;0.9999201345566091;0.02326712465552716;-0.0343088555458364;-0.5073015299314192;-0.4889717131817335
Fragmentation of the epiphysis of the distal phalanx of the hallux;Aplastic zygomatic arch;0.8160697519779205;0.7340008;0.5588820551233342;0.5857018443354636;0.8072246192530101;0.008845132724910387;-0.07322381721291005;-0.24834256412967592;-0.22152277491754657
Fragmentation of the epiphysis of the distal phalanx of the hallux;Testicular torsion;0.8924897313117981;0.8562713;0.534287851447032;0.5459092530695592;0.9999201345566091;-0.10743040324481101;-0.14364880801470847;-0.46563228310957716;-0.45401088148704993
Fragmentation of the epiphysis of the distal phalanx of the hallux;Abolished vibration sense;0.8680190145969391;0.7880225;0.5421337828662851;0.5679903400450204;0.9999134918687169;-0.13189447727177783;-0.21189097371075793;-0.4577797090024318;-0.43192315182369656
Fragmentation of the epiphysis of the distal phalanx of the hallux;Fractured metatarsal bone of digit 5;0.2635788321495056;0.42525154;0.7634857762907057;0.6949001019581541;1.0;-0.7364211678504944;-0.5747484564781189;-0.2365142237092943;-0.3050998980418459
Fragmentation of the epiphysis of the distal phalanx of the hallux;Prolonged G2 phase of cell cycle;0.9910465180873871;0.9399683;0.5028500198879813;0.5191201905474907;0.9999056439461368;-0.008859125858749706;-0.05993735600134309;-0.4970556240581555;-0.4807854533986461
Fragmentation of the epiphysis of the distal phalanx of the hallux;Single naris;1.0030865147709846;1.0054384;0.4990175302746107;0.49826886460573216;0.9999056439461368;0.003180870824847859;0.005532803052459401;-0.5008881136715261;-0.5016367793404046
Fragmentation of the epiphysis of the distal phalanx of the hallux;Perifoveal ring of hyperautofluorescence surrounded by normal autofluorescence;0.9202015250921249;0.81462544;0.5254276786956269;0.5593498421651952;1.0;-0.07979847490787506;-0.18537455797195435;-0.4745723213043731;-0.44065015783480477
Fragmentation of the epiphysis of the distal phalanx of the hallux;Asymmetry of the thorax;0.8696007579565048;0.76511335;0.5416259088218898;0.5754719045159749;0.789736248610815;0.07986450934568978;-0.024622894881566992;-0.24811033978892527;-0.2142643440948402
Fragmentation of the epiphysis of the distal phalanx of the hallux;Type 2 muscle fiber predominance;0.9390700235962868;0.93416893;0.519406634241017;0.5209698532811449;0.8527273749847077;0.08634264861157903;0.08144155983737478;-0.3333207407436908;-0.3317575217035629
Fragmentation of the epiphysis of the distal phalanx of the hallux;Dependency on parenteral nutrition;0.9796740524470806;0.8797284;0.5064703956386561;0.5383765474747126;0.9999134918687169;-0.020239439421636307;-0.12018511500332996;-0.4934430962300608;-0.4615369443940043
Fragmentation of the epiphysis of the distal phalanx of the hallux;Limited shoulder flexion;0.8410637825727463;0.8589595;0.5508064215569904;0.5450447788405454;1.0;-0.15893621742725372;-0.14104050397872925;-0.44919357844300956;-0.45495522115945464
Fragmentation of the epiphysis of the distal phalanx of the hallux;Paroxysmal vertigo;1.0785770788788795;0.8975531;0.47496232849295117;0.5326671834156402;0.9999134918687169;0.07866358701016263;-0.10236040558789417;-0.5249511633757658;-0.4672463084530767
Fragmentation of the epiphysis of the distal phalanx of the hallux;Long hallux;0.28240907192230225;0.44284362;0.7547552194864997;0.6881076109372772;0.0;0.28240907192230225;0.44284361600875854;0.7547552194864997;0.6881076109372772
Fragmentation of the epiphysis of the distal phalanx of the hallux;Broad medial eyebrow;0.9302596747875214;0.9372977;0.5222170694359324;0.5199718699519316;0.9999201345566091;-0.06966045976908775;-0.06262243272097678;-0.47770306512067673;-0.47994826460467754
Fragmentation of the epiphysis of the distal phalanx of the hallux;Myxoid subcutaneous tumors;0.9093957617878914;0.8821841;0.5288798300839068;0.5375892717508926;0.9999201345566091;-0.09052437276871772;-0.11773604632647605;-0.4710403044727023;-0.46233086280571656
Fragmentation of the epiphysis of the distal phalanx of the hallux;Bulbous tips of toes;0.5645478963851929;0.6807785;0.6434114745569424;0.6034213935492163;0.36317310279071235;0.20137479359448052;0.3176054006272564;0.28023837176623;0.24024829075850396
Fragmentation of the epiphysis of the distal phalanx of the hallux;Absent internal genitalia;0.8526278883218765;0.8040837;0.547081484192107;0.5627680983616286;1.0;-0.14737211167812347;-0.1959162950515747;-0.452918515807893;-0.43723190163837145
Fragmentation of the epiphysis of the distal phalanx of the hallux;Hyperphalangy of the 2nd finger;0.5568932890892029;0.5983764;0.6461237231318312;0.6315539848843668;0.6245600766986774;-0.06766678760947453;-0.026183683380501144;0.021563646433153782;0.006993908185689346
Fragmentation of the epiphysis of the distal phalanx of the hallux;Renal interstitial hemosiderin;0.9774817489087582;0.85645705;0.5071683878433254;0.5458495193287498;1.0;-0.022518251091241837;-0.14354294538497925;-0.4928316121566746;-0.4541504806712502
Fragmentation of the epiphysis of the distal phalanx of the hallux;Abnormality of depressor anguli oris muscle;0.8278064131736755;0.7575084;0.5550854632617646;0.5779646865173409;1.0;-0.17219358682632446;-0.24249160289764404;-0.44491453673823544;-0.4220353134826591
Fragmentation of the epiphysis of the distal phalanx of the hallux;Paroxysmal dyspnea;0.9016754478216171;0.73331517;0.5313483271930461;0.5859282763888839;1.0;-0.09832455217838287;-0.2666848301887512;-0.46865167280695386;-0.4140717236111161
Fragmentation of the epiphysis of the distal phalanx of the hallux;Phenylpyruvic acidemia;0.9398408718407154;0.8319764;0.5191608146608737;0.5537384875291734;0.9999201345566091;-0.0600792627158937;-0.16794372082980247;-0.4807593198957354;-0.4461816470274357
Fragmentation of the epiphysis of the distal phalanx of the hallux;Lateral ventricle dilatation;0.9696835521608591;0.72930574;0.5096515038749894;0.587253240471573;0.9998579617208769;-0.030174409560017823;-0.27055221754973435;-0.49020645784588757;-0.4126047212493039
Fragmentation of the epiphysis of the distal phalanx of the hallux;Neonatal unconjugated hyperbilirubinemia;1.0080865994095802;0.88509053;0.497425927407376;0.5366577969505353;0.9999201345566091;0.008166464852971123;-0.11482960463793845;-0.5024942071492331;-0.4632623376060738
Fragmentation of the epiphysis of the distal phalanx of the hallux;High maternal circulating alpha-fetoprotein concentration;1.0248145330697298;0.96149975;0.4921004779583861;0.5122580466786436;1.0;0.024814533069729805;-0.03850024938583374;-0.5078995220416139;-0.4877419533213564
Fragmentation of the epiphysis of the distal phalanx of the hallux;Prominent nasolabial fold;0.8566415309906006;0.8708823;0.5457901850071443;0.5412145118712357;0.9998944404568447;-0.14325290946624414;-0.1290121677365078;-0.45410425544970046;-0.458679928585609
Fragmentation of the epiphysis of the distal phalanx of the hallux;Abnormality of inferior alveolar nerve;0.8941519483923912;0.8093734;0.5337557146127424;0.5610519838215164;1.0;-0.1058480516076088;-0.1906266212463379;-0.4662442853872576;-0.43894801617848356
Fragmentation of the epiphysis of the distal phalanx of the hallux;Unilateral conductive hearing impairment;1.0176082216203213;0.8791035;0.4943948393085056;0.5385769222474037;0.9999201345566091;0.017688087063712166;-0.12081665278704734;-0.5055252952481035;-0.4613432123092054
Fragmentation of the epiphysis of the distal phalanx of the hallux;Macular hypopigmented whorls, streaks, and patches;0.9192417114973068;0.77758026;0.525734186121934;0.5713955222844878;0.9999201345566091;-0.08067842305930228;-0.22233987332614036;-0.4741859484346751;-0.42852461227212135
Fragmentation of the epiphysis of the distal phalanx of the hallux;Delayed ossification of pubic rami;0.6023752689361572;0.6166566;0.6301654037936901;0.6252274158772522;0.6574179255159834;-0.05504265657982621;-0.04076132408699784;-0.02725252172229331;-0.03219050963873127
Fragmentation of the epiphysis of the distal phalanx of the hallux;Hyperphenylalaninemia;0.9885259373113513;0.83495986;0.503652387733458;0.5527753764055647;0.9999028053808913;-0.01137686806953997;-0.16494294076449723;-0.4962504176474333;-0.44712742897532654
Fragmentation of the epiphysis of the distal phalanx of the hallux;Ureteropelvic junction obstruction;0.9389589391648769;0.81823194;0.519442059452438;0.5581820021114294;0.9998847295244674;-0.06092579035959045;-0.18165278925499717;-0.48044267007202934;-0.44170272741303795
Fragmentation of the epiphysis of the distal phalanx of the hallux;Cone-shaped epiphysis of the proximal phalanx of the 2nd toe;0.2101004719734192;0.3719269;0.7898673512457312;0.716156120670156;1.0;-0.7898995280265808;-0.6280730962753296;-0.21013264875426885;-0.283843879329844
Fragmentation of the epiphysis of the distal phalanx of the hallux;Difficulty walking;0.8836840987205505;0.8206049;0.5371085001929088;0.5574140286639944;0.7552776988623575;0.12840639985819302;0.06532722152491055;-0.21816919866944873;-0.19786367019836315
Fragmentation of the epiphysis of the distal phalanx of the hallux;Bilobate gallbladder;1.045744925737381;0.8888369;0.4854338546981023;0.5354575836870954;0.9999134918687169;0.04583143386866406;-0.11107657160733386;-0.5144796371706146;-0.4644559081816215
Fragmentation of the epiphysis of the distal phalanx of the hallux;Histidinuria;0.9057183787226677;0.79410326;0.5300554120112876;0.566011090887518;0.9999090677057578;-0.09419068898309013;-0.20580580289710304;-0.46985365569447024;-0.43389797681823983
Fragmentation of the epiphysis of the distal phalanx of the hallux;Widened interpedicular distance;0.6842458546161652;0.737018;0.6022574825414204;0.5847059788755467;1.0;-0.31575414538383484;-0.26298201084136963;-0.3977425174585796;-0.41529402112445335
Type II cryptotia;Increased variability in muscle fiber diameter;1.0066080316901207;0.8980237;0.49789658287663163;0.532516581102626;0.9998452077479463;0.006762823942174423;-0.10182148319197704;-0.5019486248713146;-0.46732862664532027
Type II cryptotia;Widened proximal tibial metaphyses;0.9999960949644446;0.9045823;0.5000012430114231;0.5304186679305632;0.9999201345566091;7.596040783552915e-05;-0.09533781291277976;-0.499918891545186;-0.46950146662604586
Type II cryptotia;Wide anterior fontanel;0.9662502110004425;0.9799837;0.5107449319865538;0.506371809784339;0.999848231156753;-0.033598020156310526;-0.01986454375593516;-0.48910329917019923;-0.493476421372414
Type II cryptotia;Increased circulating oleate level;0.9622107967734337;0.8883909;0.5120315416922986;0.5356004529194691;1.0;-0.037789203226566315;-0.11160910129547119;-0.4879684583077014;-0.4643995470805309
Type II cryptotia;Lozenge-shaped umbilicus;0.9650547243654728;0.91986716;0.5111256918916314;0.525534452999505;0.9999134918687169;-0.034858767503244126;-0.08004633393262073;-0.48878779997708555;-0.47437903886921196
Type II cryptotia;Anti-myelin-associated glycoprotein antibody positivity;0.9047528952360153;0.91002935;0.5303641242503601;0.5286773203000312;1.0;-0.09524710476398468;-0.0899706482887268;-0.46963587574963994;-0.47132267969996877
Type II cryptotia;Fractured radius;0.9222053363919258;0.8036738;0.5247878562500998;0.562901143501939;0.9999201345566091;-0.0777147981646833;-0.19624633075030418;-0.4751322783065093;-0.4370189910546701
Type II cryptotia;Abnormal manual kinetic perimetry test;0.9483283273875713;0.8260628;0.5164549321149663;0.5556489811692461;1.0;-0.051671672612428665;-0.17393720149993896;-0.4835450678850337;-0.4443510188307539
Type II cryptotia;Small radial epiphyses;0.8272965848445892;0.71129704;0.5552502148817582;0.5932240019101624;1.0;-0.17270341515541077;-0.28870296478271484;-0.4447497851182418;-0.40677599808983755
Type II cryptotia;Generalized keratosis follicularis;0.8641873002052307;0.8309842;0.543364538858528;0.5540588998344955;0.9999201345566091;-0.1357328343513784;-0.1689359593513784;-0.45655559569808113;-0.4458612347221136
Type II cryptotia;Hypoplasia of the calcaneus;0.8966068774461746;0.75692004;0.5329699742406862;0.5781577427704825;0.9999134918687169;-0.1033066144225423;-0.24299345221493884;-0.46694351762803077;-0.42175574909823443
Type II cryptotia;2-hydroxyadipic aciduria;0.8079432398080826;0.70517373;0.5615157709141484;0.595261787733733;1.0;-0.19205676019191742;-0.2948262691497803;-0.4384842290858516;-0.40473821226626705
Type II cryptotia;Potter facies;0.76866714656353;0.84099317;0.5743086394457713;0.5508291890502108;0.9998981869165328;-0.2312310403530028;-0.15890502094668413;-0.4255895474707615;-0.44906899786632193
Type II cryptotia;Increased heart rate variability;0.9910113755613565;0.9508755;0.5028612065516022;0.5156431081629365;0.9999201345566091;-0.008908758995252564;-0.04904461385043235;-0.49705892800500695;-0.48427702639367265
Type II cryptotia;Aplastic zygomatic arch;0.9434570707380772;0.8037828;0.5180077775369871;0.5628657636793725;0.9999134918687169;-0.056456421130639756;-0.1961306711671178;-0.4819057143317298;-0.43704772818934445
Type II cryptotia;Testicular torsion;0.8723832666873932;0.8320775;0.5407327448026619;0.5537058459641369;0.9999201345566091;-0.12753686786921592;-0.1678426313522634;-0.45918738975394724;-0.44621428859247225
Type II cryptotia;Abolished vibration sense;0.9038867801427841;0.8520112;0.5306410879296817;0.5472799668097361;0.9999134918687169;-0.0960267117259328;-0.14790228810284778;-0.46927240393903524;-0.4526335250589808
Type II cryptotia;Fractured metatarsal bone of digit 5;0.9758375491946936;0.9139884;0.5076918955418431;0.5274122021690015;1.0;-0.024162450805306435;-0.08601158857345581;-0.49230810445815687;-0.47258779783099847
Type II cryptotia;Prolonged G2 phase of cell cycle;0.8174394965171814;0.75076187;0.5584385419387754;0.5801801759703176;0.9999056439461368;-0.1824661474289554;-0.24914377737661775;-0.4414671020073614;-0.4197254679758192
Type II cryptotia;Single naris;0.9361173957586288;0.96408397;0.5203483207278161;0.5114348939963179;0.9999056439461368;-0.06378824818750795;-0.035821674353088695;-0.4795573232183207;-0.48847074994981887
Type II cryptotia;Perifoveal ring of hyperautofluorescence surrounded by normal autofluorescence;0.8275715112686157;0.77785516;0.5551613702322182;0.5713057844282093;1.0;-0.17242848873138428;-0.22214484214782715;-0.44483862976778177;-0.42869421557179066
Type II cryptotia;Asymmetry of the thorax;0.8384944498538971;0.7831402;0.551634969670123;0.5695814631579503;0.9999056439461368;-0.1614111940922397;-0.2167654614510196;-0.44827067427601375;-0.43032418078818646
Type II cryptotia;Type 2 muscle fiber predominance;0.9650101698935032;0.81469;0.5111398826989489;0.5593289275704665;0.9999003561294039;-0.03489018623590068;-0.18521036227106646;-0.4887604734304549;-0.4405714285589374
Type II cryptotia;Dependency on parenteral nutrition;0.9544414058327675;0.95989215;0.5145067722194345;0.5127701587946497;0.9999134918687169;-0.04547208603594943;-0.04002133812878772;-0.4854067196492824;-0.4871433330740672
Type II cryptotia;Limited shoulder flexion;0.9972871001809835;0.89875793;0.5008635438918767;0.5322816589266188;1.0;-0.0027128998190164566;-0.1012420654296875;-0.4991364561081233;-0.46771834107338117
Type II cryptotia;Paroxysmal vertigo;0.8984650894999504;0.7405905;0.5323753572438357;0.5835279227859198;0.6634698588464949;0.2349952306534555;0.07712065390603806;-0.13109450160265923;-0.07994193606057509
Type II cryptotia;Long hallux;0.9612930417060852;0.9400313;0.512323886129538;0.519100085902369;0.9998836012415208;-0.038590559535435554;-0.05985231118719947;-0.4875597151119827;-0.48078351533915176
Type II cryptotia;Broad medial eyebrow;0.9795748330652714;0.9728725;0.5065019847067922;0.5086360187759704;0.9999201345566091;-0.02034530149133773;-0.02704763890536399;-0.4934181498498169;-0.4912841157806387
Type II cryptotia;Myxoid subcutaneous tumors;0.8449969589710236;0.7691395;0.5495387367926663;0.5741540922044763;0.9999201345566091;-0.15492317558558555;-0.23078060628207298;-0.4503813977639428;-0.4257660423521328
Type II cryptotia;Bulbous tips of toes;0.8864737823605537;0.8748286;0.5362145935427112;0.539948085251517;0.9999134918687169;-0.11343970950816318;-0.12508491482709094;-0.46369889832600575;-0.45996540661719987
Type II cryptotia;Absent internal genitalia;0.9369123801589012;0.8793987;0.5200947578363846;0.5384822504069705;1.0;-0.06308761984109879;-0.12060129642486572;-0.4799052421636154;-0.4615177495930295
Type II cryptotia;Hyperphalangy of the 2nd finger;0.9016547352075577;0.7703811;0.5313549523324164;0.5737479889330109;0.9999201345566091;-0.09826539934905143;-0.2295390415314016;-0.46856518222419274;-0.4261721456235982
Type II cryptotia;Renal interstitial hemosiderin;0.8183221518993378;0.7622707;0.5581528054701862;0.5764031221945408;1.0;-0.18167784810066223;-0.23772931098937988;-0.4418471945298138;-0.4235968778054592
Type II cryptotia;Abnormality of depressor anguli oris muscle;1.0586701110005379;0.9279514;0.4813139930654464;0.5229536758926011;1.0;0.05867011100053787;-0.0720486044883728;-0.5186860069345536;-0.4770463241073989
Type II cryptotia;Paroxysmal dyspnea;0.8759218752384186;0.8065382;0.5395973432037137;0.561971548934286;1.0;-0.12407812476158142;-0.19346177577972412;-0.46040265679628634;-0.438028451065714
Type II cryptotia;Phenylpyruvic acidemia;0.8664722740650177;0.8227072;0.5426305223778437;0.5567339569485668;0.9999201345566091;-0.1334478604915914;-0.17721295834811301;-0.4572896121787654;-0.44318617760804235
Type II cryptotia;Lateral ventricle dilatation;0.9552383683621883;0.87798405;0.5142528320811677;0.5389359166403447;0.9998579617208769;-0.04461959335868859;-0.12187391478484177;-0.48560512963970925;-0.46092204508053225
Type II cryptotia;Neonatal unconjugated hyperbilirubinemia;0.9476843774318695;0.8838157;0.5166601853780233;0.5370663295626812;0.9999201345566091;-0.0522357571247396;-0.11610442878039451;-0.48325994917858583;-0.4628538049939279
Type II cryptotia;High maternal circulating alpha-fetoprotein concentration;0.9571898505091667;0.9281682;0.5136310596033877;0.5228844832408318;1.0;-0.04281014949083328;-0.07183182239532471;-0.48636894039661227;-0.4771155167591682
Type II cryptotia;Prominent nasolabial fold;0.9893566220998764;0.9407906;0.5033879563755121;0.5188579713108059;0.9998944404568447;-0.01053781835696832;-0.059103846832729734;-0.4965064840813326;-0.4810364691460388
Type II cryptotia;Abnormality of inferior alveolar nerve;1.0109524857252836;0.7895784;0.4965136458109207;0.5674836749785821;1.0;0.010952485725283623;-0.210421621799469;-0.5034863541890793;-0.4325163250214179
Type II cryptotia;Unilateral conductive hearing impairment;1.0025952272117138;0.88931525;0.4991739125943052;0.5353043986665151;0.5881001503332186;0.4144950768784952;0.30121509720248696;-0.0889262377389134;-0.05279575166670347
Type II cryptotia;Macular hypopigmented whorls, streaks, and patches;0.8754294067621231;0.855762;0.5397553264826531;0.5460730774887776;0.9999201345566091;-0.124490727794486;-0.1441581297043142;-0.460164808073956;-0.45384705706783146
Type II cryptotia;Delayed ossification of pubic rami;1.0295036677271128;0.9372628;0.49060732787995454;0.5199830075384307;0.9999134918687169;0.02959017585839585;-0.06265071835492297;-0.5093061639887624;-0.4799304843302862
Type II cryptotia;Hyperphenylalaninemia;0.8922760859131813;0.84453976;0.5343562541440381;0.549686057809426;0.9999028053808913;-0.10762671946770996;-0.15536304383761734;-0.4655465512368532;-0.45021674757146524
Type II cryptotia;Ureteropelvic junction obstruction;1.000585524365306;0.8789034;0.499813621795272;0.5386410899496334;0.9998847295244674;0.0007007948408385145;-0.1209813405474166;-0.5000711077291954;-0.46124363957483394
Type II cryptotia;Cone-shaped epiphysis of the proximal phalanx of the 2nd toe;0.834038183093071;0.615497;0.5530728495379778;0.6256271655235544;1.0;-0.16596181690692902;-0.38450300693511963;-0.44692715046202225;-0.37437283447644565
Type II cryptotia;Difficulty walking;0.920251227915287;0.9206164;0.5254118072133231;0.5252951962255783;0.9998344221996177;-0.0795831942843307;-0.07921803387869486;-0.47442261498629457;-0.4745392259740394
Type II cryptotia;Bilobate gallbladder;0.9714805111289024;0.86354405;0.5090792663275634;0.543571216847302;0.9999134918687169;-0.028432980739814484;-0.13636944498990222;-0.4908342255411535;-0.4563422750214149
Type II cryptotia;Histidinuria;0.8204547464847565;0.7989297;0.5574626290930358;0.5644419756434249;0.9999090677057578;-0.17945432122100136;-0.20097937639106056;-0.44244643861272204;-0.4354670920623329
Type II cryptotia;Widened interpedicular distance;0.9589092321693897;0.8598814;0.513083281141183;0.5447483743767388;1.0;-0.041090767830610275;-0.14011859893798828;-0.48691671885881704;-0.45525162562326116
Increased variability in muscle fiber diameter;Widened proximal tibial metaphyses;0.750028058886528;0.61662894;0.5804213989577539;0.6252369474423273;0.922134556158444;-0.17210649727191596;-0.30550561128463416;-0.34171315720069007;-0.2968976087161167
Increased variability in muscle fiber diameter;Wide anterior fontanel;0.9872820992022753;0.83849;0.5040483426936209;0.5516363971372242;0.8867374741530093;0.10054462504926598;-0.04824746484514797;-0.38268913145938843;-0.33510107701578506
Increased variability in muscle fiber diameter;Increased circulating oleate level;0.8367019295692444;0.71398044;0.552213223165982;0.5923322357846855;0.9998452077479463;-0.1631432781787019;-0.28586477142287303;-0.4476319845819643;-0.40751297196326075
Increased variability in muscle fiber diameter;Lozenge-shaped umbilicus;0.9783339872956276;0.928188;0.5068970457071602;0.5228781560905935;0.9999445057306702;-0.02161051843504258;-0.07175647977928468;-0.49304746002350996;-0.47706634964007666
Increased variability in muscle fiber diameter;Anti-myelin-associated glycoprotein antibody positivity;0.8236304372549057;0.71098506;0.556435378058691;0.5933277268954691;0.9998452077479463;-0.17621477049304057;-0.2888601432414155;-0.44340982968925524;-0.4065174808524772
Increased variability in muscle fiber diameter;Fractured radius;0.849630817770958;0.7955432;0.5480462322660478;0.5655427839428204;0.922134556158444;-0.07250373838748603;-0.1265913623413053;-0.3740883238923962;-0.35659177221562355
Increased variability in muscle fiber diameter;Abnormal manual kinetic perimetry test;0.8426275551319122;0.7018962;0.5503023127261479;0.5963541713740438;0.9998452077479463;-0.15721765261603404;-0.2979490171046357;-0.44954289502179834;-0.4034910363739025
Increased variability in muscle fiber diameter;Small radial epiphyses;0.8278048187494278;0.7503085;0.555085978478564;0.5803291989643952;0.7712186293488323;0.056586189400595455;-0.02091011570747492;-0.21613265087026834;-0.19088943038443718
Increased variability in muscle fiber diameter;Generalized keratosis follicularis;0.856663316488266;0.71080065;0.545783178103409;0.5933890471514346;0.9999473166570552;-0.14328400016878917;-0.28914666892145946;-0.4541641385536461;-0.4065582695056206
Increased variability in muscle fiber diameter;Hypoplasia of the calcaneus;0.8703748881816864;0.83685076;0.5413773861497171;0.5521651946223612;0.91798003561481;-0.04760514743312361;-0.08112927324756147;-0.3766026494650929;-0.36581484099244876
Increased variability in muscle fiber diameter;2-hydroxyadipic aciduria;0.7528603971004486;0.69310623;0.5794906274623328;0.5992896318885279;0.9998452077479463;-0.24698481064749767;-0.30673897367430736;-0.42035458028561346;-0.40055557585941837
Increased variability in muscle fiber diameter;Potter facies;1.0040045818313956;0.9461091;0.4987252986060239;0.5171623080594514;0.9999385832081533;0.004065998623242306;-0.053829467130730224;-0.5012132846021294;-0.4827762751487019
Increased variability in muscle fiber diameter;Increased heart rate variability;0.6697185635566711;0.5241801;0.6071436579021935;0.6578485896499287;0.9999473166570552;-0.330228753100384;-0.47576720238779857;-0.3928036587548617;-0.3420987270071265
Increased variability in muscle fiber diameter;Aplastic zygomatic arch;1.0233904346823692;0.8676383;0.49255391431884044;0.5422560486885633;0.91798003561481;0.10541039906755922;-0.05034174568637373;-0.4254261212959696;-0.37572398692624676
Increased variability in muscle fiber diameter;Testicular torsion;0.9121620953083038;0.81906307;0.5279957526504353;0.5579129997838157;0.9999473166570552;-0.08778522134875133;-0.1808842492208369;-0.47195156400661986;-0.44203431687323946
Increased variability in muscle fiber diameter;Abolished vibration sense;0.8899843990802765;0.8777205;0.5350900827470361;0.5390204471012823;0.9999445057306702;-0.10996010665039369;-0.1222240305338318;-0.4648544229836341;-0.4609240586293879
Increased variability in muscle fiber diameter;Fractured metatarsal bone of digit 5;0.9189903289079666;0.8433112;0.5258144667230744;0.5500819711757627;0.7712186293488323;0.14777169955913427;0.07209256125633123;-0.24540416262575793;-0.2211366581730696
Increased variability in muscle fiber diameter;Prolonged G2 phase of cell cycle;0.7581779956817627;0.67361975;0.5777450084131899;0.6058289998923019;0.9999413779434757;-0.241763382261713;-0.32632163078161047;-0.42219636953028583;-0.39411237805117383
Increased variability in muscle fiber diameter;Single naris;1.0208479724824429;1.0071886;0.49336340343993945;0.49771180792746383;0.9999413779434757;0.02090659453896715;0.007247180635015504;-0.5065779745035363;-0.5022295700160119
Increased variability in muscle fiber diameter;Perifoveal ring of hyperautofluorescence surrounded by normal autofluorescence;0.9124165624380112;0.8055356;0.5279144398670299;0.562296867723399;0.9998452077479463;-0.0874286453099351;-0.19430959325743724;-0.47193076788091637;-0.43754834002454723
Increased variability in muscle fiber diameter;Asymmetry of the thorax;0.8503926396369934;0.7538625;0.5478009622791398;0.5791614897359811;0.9133571980246588;-0.06296455838766535;-0.1594946978339239;-0.365556235745519;-0.3341957082886776
Increased variability in muscle fiber diameter;Type 2 muscle fiber predominance;0.3830655813217163;0.46894985;0.7116256302887867;0.6782024246079423;0.37463062526818536;0.008434956053530951;0.09431922910574653;0.3369950050206013;0.303571799339757
Increased variability in muscle fiber diameter;Dependency on parenteral nutrition;0.8864674642682076;0.82370126;0.5362166177411386;0.5564124748056223;0.9999445057306702;-0.11347704146246262;-0.17624324325661012;-0.4637278879895316;-0.4435320309250479
Increased variability in muscle fiber diameter;Limited shoulder flexion;0.8114775568246841;0.79139733;0.5603698234394634;0.5668915514639801;0.7712186293488323;0.0402589274758518;0.02017870379630926;-0.21084880590936894;-0.20432707788485227
Increased variability in muscle fiber diameter;Paroxysmal vertigo;1.0302647966891527;0.87230855;0.4903649447444015;0.5407567280984475;0.9999445057306702;0.030320290958482543;-0.12763595346550294;-0.5095795609862687;-0.4591877776322226
Increased variability in muscle fiber diameter;Long hallux;0.9153107851743698;0.8651853;0.5269897430608356;0.5430439150613566;0.9018040183019268;0.01350676687244301;-0.03661869792457695;-0.37481427524109123;-0.35876010324057017
Increased variability in muscle fiber diameter;Broad medial eyebrow;0.8986865282058716;0.76971745;0.5323045057524525;0.5739650482073899;0.9999473166570552;-0.10126078845118358;-0.23022986174677684;-0.4676428109046027;-0.42598226844966525
Increased variability in muscle fiber diameter;Myxoid subcutaneous tumors;0.7643111795186996;0.7081938;0.5757346102856126;0.594256237914565;0.9999473166570552;-0.23563613713835552;-0.29175353766535594;-0.4242127063714426;-0.4056910787424901
Increased variability in muscle fiber diameter;Bulbous tips of toes;0.9072712361812592;0.8174901;0.5295589469623082;0.5584221636527819;0.91798003561481;-0.010708799433550853;-0.1004899347542143;-0.3884210886525018;-0.35955787196202815
Increased variability in muscle fiber diameter;Absent internal genitalia;0.9873035056516528;0.9051662;0.5040415282589604;0.5302319666220507;0.9998452077479463;-0.012541702096293461;-0.0946789990038972;-0.49580367948898585;-0.46961324112589553
Increased variability in muscle fiber diameter;Hyperphalangy of the 2nd finger;0.9004823416471481;0.766594;0.531729976590761;0.5749871165048146;0.922134556158444;-0.021652214511295842;-0.15554056344833045;-0.39040457956768293;-0.3471474396536294
Increased variability in muscle fiber diameter;Renal interstitial hemosiderin;0.8945061042904854;0.81892514;0.5336423485689361;0.5579576207987065;0.9998452077479463;-0.10533910345746089;-0.18092006545973827;-0.46620285917901017;-0.4418875869492398
Increased variability in muscle fiber diameter;Abnormality of depressor anguli oris muscle;0.7064223289489746;0.5973922;0.5948459327074018;0.6318961346839098;0.3068593097210791;0.3995630192278955;0.2905328917025659;0.2879866229863227;0.3250368249628307
Increased variability in muscle fiber diameter;Paroxysmal dyspnea;0.8841817900538445;0.8197801;0.536949002132721;0.5576809234531888;0.9998452077479463;-0.11566341769410182;-0.18006509643508006;-0.46289620561522526;-0.4421642842947575
Increased variability in muscle fiber diameter;Phenylpyruvic acidemia;0.830375462770462;0.8097006;0.5542554976808736;0.5609458811598387;0.9999473166570552;-0.16957185388659313;-0.19024670840357616;-0.4456918189761816;-0.4390014354972165
Increased variability in muscle fiber diameter;Lateral ventricle dilatation;0.8856470137834549;0.7035554;0.5364794872351994;0.595801010193812;0.9999259293677907;-0.11427891558433578;-0.2963705242278676;-0.46344644213259123;-0.40412491917397864
Increased variability in muscle fiber diameter;Neonatal unconjugated hyperbilirubinemia;0.8921704143285751;0.8333133;0.5343900875294831;0.553306850734244;0.9999473166570552;-0.10777690232848003;-0.16663403035258129;-0.465557229127572;-0.44664046592281115
Increased variability in muscle fiber diameter;High maternal circulating alpha-fetoprotein concentration;0.9081002101302147;0.821362;0.5292939447706857;0.5571690943941339;0.9998452077479463;-0.09174499761773158;-0.1784831891627412;-0.4705512629772606;-0.4426761133538124
Increased variability in muscle fiber diameter;Prominent nasolabial fold;1.0250692442059517;0.896969;0.49201937565467846;0.5328540816292598;0.9999372395362296;0.025132004669722097;-0.10296821916956089;-0.5079178638815511;-0.46708315790696975
Increased variability in muscle fiber diameter;Abnormality of inferior alveolar nerve;0.8983232975006104;0.7234106;0.5324207258333671;0.5892041892255402;0.9998452077479463;-0.10152191024733592;-0.27643460136366893;-0.4674244819145792;-0.4106410185224061
Increased variability in muscle fiber diameter;Unilateral conductive hearing impairment;1.032857984304428;0.90020746;0.48953909583216737;0.5318179166656061;0.9999473166570552;0.03291066764737294;-0.09973985673044994;-0.5104082208248878;-0.4681293999914491
Increased variability in muscle fiber diameter;Macular hypopigmented whorls, streaks, and patches;0.9251394271850586;0.8182781;0.5238511733020761;0.558167082966272;0.9999473166570552;-0.07480788947199657;-0.1816692423925288;-0.4760961433549791;-0.4417802336907831
Increased variability in muscle fiber diameter;Delayed ossification of pubic rami;0.9013829901814461;0.78831005;0.5314418739943747;0.5678967096074661;0.91798003561481;-0.016597045433363933;-0.12966998465045454;-0.3865381616204353;-0.35008332600734393
Increased variability in muscle fiber diameter;Hyperphenylalaninemia;0.9653763696551323;0.84889567;0.5110232470198812;0.5482829420595519;0.9999402946117394;-0.034563924956607095;-0.15104462562827992;-0.48891704759185817;-0.45165735255218753
Increased variability in muscle fiber diameter;Ureteropelvic junction obstruction;0.899122916162014;0.8675674;0.5321648838324485;0.542278798067689;0.999933930251455;-0.10081101408944104;-0.1323665102456567;-0.4677690464190065;-0.4576551321837661
Increased variability in muscle fiber diameter;Cone-shaped epiphysis of the proximal phalanx of the 2nd toe;0.9177048951387405;0.833367;0.5262250038661379;0.5532895090118328;0.7712186293488323;0.1464862657899082;0.06214836074058416;-0.24499362548269443;-0.21792912033699952
Increased variability in muscle fiber diameter;Difficulty walking;0.8703629076480865;0.82434314;0.5413812321232079;0.5562049133632034;0.7732092081591891;0.0971536994888974;0.0511339367344571;-0.23182797603598126;-0.2170042947959857
Increased variability in muscle fiber diameter;Bilobate gallbladder;1.0070702470839024;0.9316937;0.49774945170495044;0.5217595128083545;0.9999445057306702;0.0071257413532321845;-0.06825083259682008;-0.5021950540257197;-0.47818499292231564
Increased variability in muscle fiber diameter;Histidinuria;0.8711837828159332;0.8247484;0.5411177299904553;0.5560738899042861;0.9999427179139311;-0.12875893509799785;-0.17519432104045696;-0.4588249879234758;-0.443868828009645
Increased variability in muscle fiber diameter;Widened interpedicular distance;0.7590465843677521;0.6191247;0.5774601030303167;0.6243772813284758;0.7712186293488323;-0.012172044981080266;-0.15209391878898737;-0.19375852631851564;-0.14684134802035653
Widened proximal tibial metaphyses;Wide anterior fontanel;0.9987359046936035;0.752031;0.5004023741402659;0.5797630999996544;0.8833906631088758;0.1153452415847277;-0.13135963483815438;-0.3829882889686099;-0.30362756310922145
Widened proximal tibial metaphyses;Increased circulating oleate level;0.7890951186418533;0.6212975;0.5676410325861754;0.6236296601190225;0.9999201345566091;-0.21082501591475578;-0.3786226558807668;-0.43227910197043373;-0.37629047443758656
Widened proximal tibial metaphyses;Lozenge-shaped umbilicus;1.0646831393241882;1.0001246;0.4793963329056966;0.4999603588151834;0.9999584729108851;0.0647246664133031;0.0001661007966954342;-0.5205621400051885;-0.4999981140957017
Widened proximal tibial metaphyses;Anti-myelin-associated glycoprotein antibody positivity;0.9724743813276291;0.80935395;0.5087627833189792;0.5610582844869108;0.9999201345566091;-0.02744575322898002;-0.19056618691714378;-0.49115735123762994;-0.43886185006969836
Widened proximal tibial metaphyses;Fractured radius;0.5701917409896851;0.62835395;0.64141884663845;0.6212064950641157;0.7346933176414197;-0.1645015766517346;-0.10633936427990842;-0.0932744710029697;-0.11348682257730391
Widened proximal tibial metaphyses;Abnormal manual kinetic perimetry test;0.9226118698716164;0.75357914;0.5246580613233971;0.5792545428276952;0.9999201345566091;-0.07730826468499274;-0.24634099484713645;-0.475262073233212;-0.42066559172891393
Widened proximal tibial metaphyses;Small radial epiphyses;0.562119722366333;0.6570738;0.6442706251931006;0.6114180825599165;0.4693866352828394;0.09273308708349359;0.18768716051260126;0.17488398991026122;0.14203144727707706
Widened proximal tibial metaphyses;Generalized keratosis follicularis;0.9049264788627625;0.7470269;0.5303086189807098;0.5814084096335694;0.9999600672783046;-0.0950335884155421;-0.25293314695970104;-0.46965144829759475;-0.4185516576447351
Widened proximal tibial metaphyses;Hypoplasia of the calcaneus;0.5102099776268005;0.72885716;0.6629265627252626;0.5874015768140282;0.8287763732556668;-0.31856639562886624;-0.09991921364110379;-0.16584981053040415;-0.24137479644163862
Widened proximal tibial metaphyses;2-hydroxyadipic aciduria;0.959805503487587;0.87424105;0.5127977531919261;0.540136593963251;0.9999201345566091;-0.04011463106902213;-0.12567908049853416;-0.487122381364683;-0.45978354059335813
Widened proximal tibial metaphyses;Potter facies;0.9012509286403656;0.74867904;0.5314841166785962;0.580864953817289;0.9999552432134126;-0.09870431457304696;-0.25127620135092477;-0.4684711265348164;-0.4190902893961236
Widened proximal tibial metaphyses;Increased heart rate variability;0.9092808812856674;0.650201;0.5289165489007814;0.6137501120520032;0.9999600672783046;-0.09067918599263713;-0.34975904465333507;-0.4710435183775231;-0.3862099552263013
Widened proximal tibial metaphyses;Aplastic zygomatic arch;0.901216447353363;0.7360364;0.531495146340963;0.5850298758957615;0.9074607173141833;-0.006244269960820281;-0.17142429744571408;-0.37596557097322036;-0.3224308414184218
Widened proximal tibial metaphyses;Testicular torsion;0.8446960598230362;0.7135781;0.5496356900339414;0.5924659034803388;0.9999600672783046;-0.15526400745526836;-0.2863819623054652;-0.45032437724436314;-0.40749416379796577
Widened proximal tibial metaphyses;Abolished vibration sense;0.9571087583899498;0.89887464;0.5136568957574736;0.5322443281825235;0.9999584729108851;-0.042849714520935334;-0.10108383244610242;-0.4863015771534115;-0.4677141447283616
Widened proximal tibial metaphyses;Fractured metatarsal bone of digit 5;0.41140496730804443;0.608902;0.7003187262387327;0.6279046601749869;0.4693866352828394;-0.05798166797479498;0.13951534225622308;0.2309320909558933;0.1585180248921475
Widened proximal tibial metaphyses;Prolonged G2 phase of cell cycle;0.9666245765984058;0.8369278;0.5106257005420108;0.5521403490954058;0.9999567459343585;-0.03333216933595262;-0.16302897436606012;-0.4893310453923476;-0.4478163968389527
Widened proximal tibial metaphyses;Single naris;0.9783011339604855;0.93253344;0.50690750570759;0.5214916043090034;0.9999567459343585;-0.021655611973873;-0.06742330296026788;-0.49304924022676844;-0.47846514162535503
Widened proximal tibial metaphyses;Perifoveal ring of hyperautofluorescence surrounded by normal autofluorescence;0.9967022780328989;0.8369496;0.5010496994065945;0.5521333108697228;0.9999201345566091;-0.0032178565237102053;-0.16297054768832298;-0.4988704351500146;-0.44778682368688627
Widened proximal tibial metaphyses;Asymmetry of the thorax;0.7608973681926727;0.5958897;0.5768532390497914;0.6324188152855681;0.9036123096265051;-0.14271494143383234;-0.3077226220883581;-0.3267590705767137;-0.271193494340937
Widened proximal tibial metaphyses;Type 2 muscle fiber predominance;0.7978611290454865;0.8081774;0.5647892351358424;0.5614398195468476;0.9344769737294281;-0.1366158446839416;-0.12629956217318417;-0.3696877385935856;-0.37303715418258043
Widened proximal tibial metaphyses;Dependency on parenteral nutrition;0.8992020189762115;0.8115071;0.5321395756263482;0.5603602508223862;0.9999584729108851;-0.10075645393467358;-0.1884513670835536;-0.46781889728453696;-0.43959822208849897
Widened proximal tibial metaphyses;Limited shoulder flexion;0.7901617884635925;0.81461644;0.5672937288842437;0.5593527527559288;0.8332104407109631;-0.043048652247370534;-0.018593998984278493;-0.2659167118267194;-0.2738576879550343
Widened proximal tibial metaphyses;Paroxysmal vertigo;1.0970870554447174;0.9049048;0.4690474740513094;0.5303155493460618;0.9999584729108851;0.09712858253383228;-0.09505369013882092;-0.5309109988595757;-0.4696429235648233
Widened proximal tibial metaphyses;Long hallux;0.4783155918121338;0.61477154;0.6746961457537549;0.6258773542379108;0.8047017442325175;-0.3263861524203837;-0.1899301992991984;-0.13000559847876259;-0.1788243899946067
Widened proximal tibial metaphyses;Broad medial eyebrow;0.8891249001026154;0.66312766;0.535365353831474;0.6093690789744228;0.9999600672783046;-0.1108351671756892;-0.3368324065269618;-0.46459471344683057;-0.3905909883038817
Widened proximal tibial metaphyses;Myxoid subcutaneous tumors;0.8911479264497757;0.77404535;0.5347174826550066;0.572550119251948;0.9999600672783046;-0.10881214082852886;-0.22591471911088512;-0.46524258462329793;-0.42740994802635657
Widened proximal tibial metaphyses;Bulbous tips of toes;0.634014219045639;0.6208843;0.6192681218983855;0.6237717660052566;0.8287763732556668;-0.19476215421002774;-0.2078920739774075;-0.20950825135728124;-0.20500460725041014
Widened proximal tibial metaphyses;Absent internal genitalia;0.9560039900243282;0.9040883;0.5140088867899839;0.530576638579003;0.9999201345566091;-0.043916144532280876;-0.0958318162086782;-0.4859112477666252;-0.46934349597760616
Widened proximal tibial metaphyses;Hyperphalangy of the 2nd finger;0.8298718184232712;0.7846124;0.5544181771411364;0.5691014828925756;0.8353502357086217;-0.005478417285350479;-0.05073781848755232;-0.28093205856748527;-0.2662487528160461
Widened proximal tibial metaphyses;Renal interstitial hemosiderin;1.0150635577738285;0.87122285;0.4952049392860075;0.541105198465891;0.9999201345566091;0.015143423217219398;-0.1286972808960256;-0.5047151952706016;-0.4588149360907181
Widened proximal tibial metaphyses;Abnormality of depressor anguli oris muscle;0.9724616520106792;0.9490294;0.5087668367229604;0.5162314837495088;0.8819596887815145;0.0905019632291647;0.06706969726203404;-0.3731928520585541;-0.36572820503200576
Widened proximal tibial metaphyses;Paroxysmal dyspnea;0.9677016101777554;0.80673695;0.5102826851091044;0.5619070673724934;0.9999201345566091;-0.03221852437885375;-0.19318318845065208;-0.48963744944750476;-0.4380130671841157
Widened proximal tibial metaphyses;Phenylpyruvic acidemia;0.9066082611680031;0.7544278;0.5297708982342977;0.5789758348515461;0.9999600672783046;-0.09335180611030147;-0.24553227663651989;-0.47018916904400687;-0.4209842324267584
Widened proximal tibial metaphyses;Lateral ventricle dilatation;0.9963472848758101;0.7415724;0.5011626979209686;0.5832043506131136;0.9999488789551968;-0.0036015940793866497;-0.2583764988892788;-0.4987861810342282;-0.4167445283420832
Widened proximal tibial metaphyses;Neonatal unconjugated hyperbilirubinemia;0.9876995654776692;0.88256264;0.5039154486520606;0.5374679454267244;0.9999600672783046;-0.012260501800635315;-0.11739742994920299;-0.49604461862624394;-0.4624921218515802
Widened proximal tibial metaphyses;High maternal circulating alpha-fetoprotein concentration;0.8819073736667633;0.64513826;0.5376779743341458;0.6154720597664858;0.9999201345566091;-0.1180127608898458;-0.35478187085421653;-0.46224216022246334;-0.38444807479012333
Widened proximal tibial metaphyses;Prominent nasolabial fold;0.8693384081125259;0.7270306;0.541710138010356;0.5880057867378377;0.9999545338528789;-0.13061612574035297;-0.27292395857745777;-0.45824439584252297;-0.41194874711504126
Widened proximal tibial metaphyses;Abnormality of inferior alveolar nerve;1.0041601276025176;0.92148495;0.4986757864366945;0.5250178620466801;0.9999201345566091;0.004239993045908497;-0.07843518735201926;-0.5012443481199146;-0.474902272509929
Widened proximal tibial metaphyses;Unilateral conductive hearing impairment;1.0616090893745422;0.88360655;0.480376790493123;0.5371333597050614;0.9999600672783046;0.06164902209623768;-0.1163535142006068;-0.5195832767851816;-0.4628267075732432
Widened proximal tibial metaphyses;Macular hypopigmented whorls, streaks, and patches;1.08570297062397;0.9080099;0.47268639092118026;0.5293228226655611;0.9999600672783046;0.08574290334566548;-0.09195018053666637;-0.5272736763571243;-0.4706372446127435
Widened proximal tibial metaphyses;Delayed ossification of pubic rami;0.5567641258239746;0.58664346;0.646169586864146;0.6356436816841019;0.8355479869321181;-0.27878386110814346;-0.24890452951939834;-0.18937840006797202;-0.19990430524801617
Widened proximal tibial metaphyses;Hyperphenylalaninemia;0.90937440097332;0.6641599;0.5288866575304374;0.6090201903360725;0.9999561589935034;-0.09058175802018342;-0.33579626500394044;-0.47106950146306603;-0.39093596865743097
Widened proximal tibial metaphyses;Ureteropelvic junction obstruction;0.9159851893782616;0.8016286;0.526774305716448;0.5635652301249845;0.9999528219730685;-0.08396763259480688;-0.1983242323429415;-0.47317851625662044;-0.43638759184808396
Widened proximal tibial metaphyses;Cone-shaped epiphysis of the proximal phalanx of the 2nd toe;0.4634547233581543;0.63514966;0.680270939314918;0.6188798489115079;0.4693866352828394;-0.005931911924685118;0.16576302244344843;0.21088430403207858;0.14949321362866852
Widened proximal tibial metaphyses;Difficulty walking;0.8797257393598557;0.7901398;0.5383773955466624;0.5673008941140527;0.9203691460904122;-0.04064340673055655;-0.1302293517407418;-0.3819917505437498;-0.3530682519763595
Widened proximal tibial metaphyses;Bilobate gallbladder;1.0437259003520012;0.9596609;0.48607717459543076;0.5128438208119884;0.9999584729108851;0.04376742744111606;-0.04029758519268445;-0.5138812983154544;-0.4871146520988967
Widened proximal tibial metaphyses;Histidinuria;0.9340874031186104;0.8190656;0.5209958526101983;0.5579121702643894;0.9999574798349273;-0.06587007671631695;-0.1808919090036285;-0.478961627224729;-0.4420453095705379
Widened proximal tibial metaphyses;Widened interpedicular distance;0.4984588027000427;0.43631107;0.6672334293503284;0.6906183221363826;0.822027235707794;-0.3235684330077513;-0.38571616955712873;-0.15479380635746565;-0.13140891357141138
Wide anterior fontanel;Increased circulating oleate level;0.8920176774263382;0.75774056;0.5344389907361302;0.5778885164652203;0.999848231156753;-0.10783055373041484;-0.24210767396299693;-0.4654092404206228;-0.4219597146915327
Wide anterior fontanel;Lozenge-shaped umbilicus;0.7609956562519073;0.76305354;0.5768210188080453;0.576146590036993;0.9999448992541466;-0.2389492430022393;-0.23689136283904655;-0.4231238804461014;-0.42379830921715367
Wide anterior fontanel;Anti-myelin-associated glycoprotein antibody positivity;0.9563689306378365;0.8515145;0.5138926109274747;0.547439828148333;0.999848231156753;-0.043479300518916575;-0.14833371289579722;-0.4859556202292783;-0.45240840300842
Wide anterior fontanel;Fractured radius;1.0450771301984787;0.92674345;0.4856466401362576;0.5233391916771665;0.8833906631088758;0.16168646708960288;0.04335278467173331;-0.39774402297261824;-0.36005147143170935
Wide anterior fontanel;Abnormal manual kinetic perimetry test;0.9747556336224079;0.8997987;0.5080363851112231;0.5319486824584893;0.999848231156753;-0.025092597534345118;-0.10004953988401744;-0.49181184604552997;-0.4678995486982638
Wide anterior fontanel;Small radial epiphyses;1.0089262537658215;0.9394779;0.49715864744668403;0.5192765589267504;0.6617971500655027;0.3471291037003188;0.2776807704667239;-0.16463850261881863;-0.14252059113875226
Wide anterior fontanel;Generalized keratosis follicularis;1.0150925405323505;0.88856924;0.49519571273856466;0.5355433253647286;0.9999476714516888;0.015144869080661705;-0.11137843564999206;-0.5047519587131242;-0.46440434608696024
Wide anterior fontanel;Hypoplasia of the calcaneus;1.0164927747100592;0.95151424;0.4947499487283501;0.5154395429384342;0.8772130769237713;0.1392796977862879;0.07430116715581858;-0.38246312819542116;-0.36177353398533707
Wide anterior fontanel;2-hydroxyadipic aciduria;0.9636331312358379;0.8896934;0.5115784870005377;0.5351832939820027;0.999848231156753;-0.036215099920915095;-0.11015485175459239;-0.4882697441562154;-0.4646649371747503
Wide anterior fontanel;Potter facies;0.7648699879646301;0.82770973;0.575551592553412;0.5551167039608423;0.8618831027018246;-0.09701311473719443;-0.0341733682619747;-0.2863315101484125;-0.3067663987409822
Wide anterior fontanel;Increased heart rate variability;0.8677026331424713;0.7334066;0.5422353811089209;0.5858980789387962;0.9999476714516888;-0.13224503830921752;-0.2665410681153546;-0.45771229034276795;-0.41404959251289264
Wide anterior fontanel;Aplastic zygomatic arch;0.6496769189834595;0.6455727;0.6139282081165591;0.6153241536917232;0.8080353522002968;-0.1583584332168373;-0.16246263024213636;-0.19410714408373764;-0.19271119850857354
Wide anterior fontanel;Testicular torsion;0.9598728679120541;0.86879045;0.5127762931162716;0.5418860738785234;0.9999476714516888;-0.040074803539634773;-0.13115722373974426;-0.48717137833541724;-0.45806159757316545
Wide anterior fontanel;Abolished vibration sense;0.8218636810779572;0.85171837;0.5570068024158032;0.5473742150059946;0.9999448992541466;-0.1780812181761895;-0.148226533108059;-0.4429380968383434;-0.45257068424815206
Wide anterior fontanel;Fractured metatarsal bone of digit 5;1.1232592016458511;1.0701498;0.46066534463335507;0.47765226301809793;0.6617971500655027;0.4614620515803485;0.4083526292542605;-0.2011318054321476;-0.18414488704740473
Wide anterior fontanel;Prolonged G2 phase of cell cycle;1.013047831133008;0.9078601;0.4958466285023455;0.5293706997715368;0.9999418169014338;0.013106014231574203;-0.09208171663211617;-0.5040951883990883;-0.47057111712989697
Wide anterior fontanel;Single naris;0.7653225213289261;0.8331915;0.5754034000808105;0.5533461624368384;0.8681209705070614;-0.1027984491781353;-0.03492945649186363;-0.2927175704262509;-0.31477480807022296
Wide anterior fontanel;Perifoveal ring of hyperautofluorescence surrounded by normal autofluorescence;0.9777433518320322;0.8752058;0.5070850961709331;0.5398270553524892;0.999848231156753;-0.022104879324720828;-0.12464241631834361;-0.4927631349858199;-0.4600211758042638
Wide anterior fontanel;Asymmetry of the thorax;0.7564060240983963;0.72781837;0.5783264294206205;0.5877451549405288;0.830858575555589;-0.07445255145719265;-0.10304020569017147;-0.25253214613496844;-0.24311342061506014
Wide anterior fontanel;Type 2 muscle fiber predominance;0.9928831188008189;0.9335174;0.5022653927684592;0.5211776902252627;0.911096795389366;0.08178632341145287;0.02242060106067667;-0.4088314026209069;-0.38991910516410333
Wide anterior fontanel;Dependency on parenteral nutrition;0.8696761280298233;0.8684296;0.541601711293349;0.5420019345746951;0.9999448992541466;-0.13026877122432334;-0.13151529806167228;-0.45834318796079765;-0.4579429646794515
Wide anterior fontanel;Limited shoulder flexion;0.9690605476498604;0.8663728;0.5098499054524459;0.5426624694482076;0.6830486703108347;0.28601187733902567;0.18332415340437525;-0.1731987648583888;-0.1403862008626271
Wide anterior fontanel;Paroxysmal vertigo;0.8374461233615875;0.91756004;0.5519731308764644;0.5262712767352917;0.9999448992541466;-0.16249877589255912;-0.0823848583033715;-0.44797176837768227;-0.4736736225188549
Wide anterior fontanel;Long hallux;0.8902414068579674;0.74083424;0.5350077761880561;0.5834475960582037;0.8532022824788488;0.037039124379118604;-0.11236804633382924;-0.3181945062907927;-0.26975468642064504
Wide anterior fontanel;Broad medial eyebrow;0.6985450387001038;0.6123174;0.5974722913525802;0.6267243426977274;0.8813910167023682;-0.18284597800226443;-0.26907363341303103;-0.283918725349788;-0.2546666740046408
Wide anterior fontanel;Myxoid subcutaneous tumors;1.0115038994699717;0.97778;0.49633811429720376;0.5070734410570166;0.9999476714516888;0.011556228018282821;-0.022167686977506706;-0.5036095571544851;-0.49287423039467226
Wide anterior fontanel;Bulbous tips of toes;0.8854359239339828;0.8572705;0.5365471237264916;0.5455878947983714;0.8772130769237713;0.008222847010211587;-0.019942597721500754;-0.34066595319727966;-0.3316251821253998
Wide anterior fontanel;Absent internal genitalia;0.7852505147457123;0.7371936;0.5688935031964872;0.5846480474021866;0.999848231156753;-0.21459771641104075;-0.26265464671461436;-0.4309547279602658;-0.41520018375456647
Wide anterior fontanel;Hyperphalangy of the 2nd finger;1.0214078687131405;0.9802259;0.4931851431409774;0.506294702912492;0.8833906631088758;0.13801720560426467;0.09683525756830924;-0.39020551996789843;-0.3770959601963838
Wide anterior fontanel;Renal interstitial hemosiderin;1.064084768295288;0.95189637;0.4795871963259525;0.5153177724910367;0.999848231156753;0.06423653713853505;-0.04795186169950816;-0.5202610348308006;-0.4845304586657163
Wide anterior fontanel;Abnormality of depressor anguli oris muscle;0.839446634054184;0.8273697;0.5513278722691983;0.5552265899671331;0.6559975620430308;0.18344907201115312;0.17137212789837541;-0.10466968977383251;-0.10077097207589769
Wide anterior fontanel;Paroxysmal dyspnea;0.9312586337327957;0.9303859;0.5218983259211054;0.5221767920087999;0.999848231156753;-0.06858959742395732;-0.06946234353391978;-0.4779499052356476;-0.4776714391479532
Wide anterior fontanel;Phenylpyruvic acidemia;1.0478428862988949;0.9456382;0.484765320651536;0.5173124341825286;0.9999476714516888;0.04789521484720605;-0.0543094916726361;-0.5151823508001528;-0.48263523726916024
Wide anterior fontanel;Lateral ventricle dilatation;0.7801880240440369;0.74310666;0.5705443871206617;0.5826989070114987;0.9999266287857647;-0.2197386047417278;-0.25681996555868336;-0.42938224166510297;-0.4172277217742659
Wide anterior fontanel;Neonatal unconjugated hyperbilirubinemia;0.8847228139638901;0.7876488;0.5367756275969664;0.5681120801960858;0.9999476714516888;-0.11522485748779876;-0.21229887441647155;-0.46317204385472244;-0.431835591255603
Wide anterior fontanel;High maternal circulating alpha-fetoprotein concentration;0.8244993388652802;0.70217913;0.5561544155572321;0.5962598122375731;0.999848231156753;-0.17534889229147288;-0.2976690972646937;-0.4436938155995209;-0.40358841891917996
Wide anterior fontanel;Prominent nasolabial fold;0.6157578229904175;0.58478546;0.625537231903055;0.6362934873560593;0.8588856025456406;-0.24312777955522313;-0.27410014111985936;-0.23334837064258562;-0.22259211518958133
Wide anterior fontanel;Abnormality of inferior alveolar nerve;0.794590175151825;0.7971751;0.565852726954468;0.5650122160617714;0.999848231156753;-0.20525805600492808;-0.20267312177030894;-0.43399550420228505;-0.4348360150949816
Wide anterior fontanel;Unilateral conductive hearing impairment;0.7718313485383987;0.7486186;0.573273758578217;0.5808848302986954;0.9999476714516888;-0.2281163229132901;-0.2513290686990033;-0.4266739128734718;-0.4190628411529934
Wide anterior fontanel;Macular hypopigmented whorls, streaks, and patches;1.0229801870882511;1.0114344;0.4926845352976864;0.49636023916203187;0.9999476714516888;0.02303251563656228;0.011486764392732551;-0.5072631361540024;-0.503587432289657
Wide anterior fontanel;Delayed ossification of pubic rami;0.9679076299071312;0.8546592;0.5102170729786817;0.5464278544921994;0.8772130769237713;0.09069455298335993;-0.022553877209110618;-0.3669960039450896;-0.3307852224315718
Wide anterior fontanel;Hyperphenylalaninemia;0.8329401314258575;0.68688047;0.5534273187828893;0.6013740491169643;0.9999407498804347;-0.16700061845457714;-0.3130602805582301;-0.4465134310975454;-0.39856670076347034
Wide anterior fontanel;Ureteropelvic junction obstruction;1.0754963234066963;0.9003421;0.47594588669526927;0.5317748377375248;0.9999344873001771;0.07556183610651923;-0.09959238048102426;-0.5239886006049078;-0.4681596495626523
Wide anterior fontanel;Cone-shaped epiphysis of the proximal phalanx of the 2nd toe;1.060274999588728;0.96329623;0.4808022352645105;0.511685791425656;0.6617971500655027;0.3984778495232253;0.3014990845421939;-0.18099491480099217;-0.1501113586398467
Wide anterior fontanel;Difficulty walking;0.8791183084249496;0.8695358;0.538572167908179;0.5416467625207031;0.8829632475843074;-0.0038449391593577964;-0.013427443789446603;-0.3443910796761285;-0.34131648506360435
Wide anterior fontanel;Bilobate gallbladder;1.0214566104114056;0.8917241;0.49316962461199176;0.5345329802206794;0.9999448992541466;0.021511711157258917;-0.10822078960448844;-0.5067752746421549;-0.46541191903346724
Wide anterior fontanel;Histidinuria;1.0183624289929867;0.9399648;0.494154728802211;0.5191213000828347;0.9999431371057684;0.018419291887218248;-0.05997836583501648;-0.5057884083035574;-0.4808218370229337
Wide anterior fontanel;Widened interpedicular distance;0.8445381820201874;0.6488642;0.5496865619736693;0.6142044492542071;0.558799737971173;0.2857384440490144;0.09006447168077403;-0.00911317599750372;0.05540471128303415
Increased circulating oleate level;Lozenge-shaped umbilicus;0.9721005335450172;0.8463283;0.5088818284860397;0.5491098127000129;0.9999134918687169;-0.027812958323699677;-0.15358517374966785;-0.49103166338267723;-0.450803679168704
Increased circulating oleate level;Anti-myelin-associated glycoprotein antibody positivity;0.9789766073226929;0.85958844;0.50669244678339;0.5448425660987422;1.0;-0.02102339267730713;-0.14041155576705933;-0.49330755321661;-0.45515743390125785
Increased circulating oleate level;Fractured radius;0.9461183585226536;0.8452924;0.5171593689422416;0.5494435453458798;0.9999201345566091;-0.05380177603395553;-0.15462774516375632;-0.48276076561436754;-0.4504765892107293
Increased circulating oleate level;Abnormal manual kinetic perimetry test;0.910902351140976;0.83130467;0.5283983201516781;0.5539554067786565;1.0;-0.08909764885902405;-0.168695330619812;-0.4716016798483219;-0.4460445932213435
Increased circulating oleate level;Small radial epiphyses;0.9574921727180481;0.9017816;0.5135347397743136;0.5313143628435242;1.0;-0.042507827281951904;-0.09821838140487671;-0.48646526022568637;-0.4686856371564758
Increased circulating oleate level;Generalized keratosis follicularis;0.9297619462013245;0.8699535;0.5223758908370177;0.5415126542226989;0.9999201345566091;-0.07015818835528465;-0.12996662141116233;-0.47754424371959137;-0.4584074803339102
Increased circulating oleate level;Hypoplasia of the calcaneus;0.8816693425178528;0.7994525;0.5377542770043191;0.5642721054887581;0.9999134918687169;-0.11824414935086414;-0.2004610082146947;-0.4621592148643978;-0.43564138637995886
Increased circulating oleate level;2-hydroxyadipic aciduria;0.8092488199472427;0.8046212;0.5610923635824034;0.5625936110547176;1.0;-0.19075118005275726;-0.19537878036499023;-0.43890763641759656;-0.4374063889452824
Increased circulating oleate level;Potter facies;0.9430194348096848;0.93589956;0.5181473063356468;0.5204178061636282;0.9998981869165328;-0.05687875210684801;-0.06399863123339677;-0.481750880580886;-0.47948038075290456
Increased circulating oleate level;Increased heart rate variability;0.8267011642456055;0.6325773;0.5554426446762961;0.6197597558975811;0.9999201345566091;-0.17321897031100364;-0.3673428344848928;-0.444477489880313;-0.38016037865902796
Increased circulating oleate level;Aplastic zygomatic arch;0.903308093547821;0.7710808;0.5308261515439294;0.5735191680149692;0.9999134918687169;-0.09660539832089587;-0.2288326999184911;-0.4690873403247875;-0.42639432385374776
Increased circulating oleate level;Testicular torsion;0.9592295959591866;0.84471196;0.5129812206518145;0.5496305620981174;0.9999201345566091;-0.040690538597422554;-0.15520817519457908;-0.4869389139047946;-0.45028957245849166
Increased circulating oleate level;Abolished vibration sense;1.0518914945423603;0.93187463;0.4834750023939064;0.5217017865643871;0.9999134918687169;0.051978002673643386;-0.06803885903332874;-0.5164384894748105;-0.47821170530432977
Increased circulating oleate level;Fractured metatarsal bone of digit 5;0.9722123462706804;0.8973385;0.5088462235857695;0.5327358521121721;1.0;-0.027787653729319572;-0.10266149044036865;-0.4911537764142305;-0.4672641478878279
Increased circulating oleate level;Prolonged G2 phase of cell cycle;0.8481364548206329;0.75391906;0.5485274288862996;0.5791429034364752;0.6766288643064248;0.17150759051420816;0.07729020069220194;-0.1281014354201252;-0.09748596086994954
Increased circulating oleate level;Single naris;1.052401039749384;1.0108157;0.48331258814385036;0.49655719173563606;0.9999056439461368;0.052495395803247136;0.010910095685516041;-0.5165930558022864;-0.5033484522105007
Increased circulating oleate level;Perifoveal ring of hyperautofluorescence surrounded by normal autofluorescence;0.9026441127061844;0.83424425;0.5310385050870211;0.5530063251242197;1.0;-0.09735588729381561;-0.1657557487487793;-0.4689614949129789;-0.44699367487578034
Increased circulating oleate level;Asymmetry of the thorax;0.9707731623202562;0.8409601;0.5093045163615437;0.5508398546468392;0.9999056439461368;-0.029132481625880557;-0.1589455585541385;-0.49060112758459307;-0.44906578929929764
Increased circulating oleate level;Type 2 muscle fiber predominance;0.924803614616394;0.8748122;0.5239583679027255;0.5399533441229144;0.9999003561294039;-0.07509674151300982;-0.12508817036509112;-0.4759419882266783;-0.45994701200648946
Increased circulating oleate level;Dependency on parenteral nutrition;0.8946304470300674;0.88352394;0.5336025472145296;0.5371598240770017;0.9999134918687169;-0.10528304483864948;-0.11638955082867786;-0.4663109446541873;-0.46275366779171523
Increased circulating oleate level;Limited shoulder flexion;1.0283569879829884;0.9631075;0.4909724802405139;0.5117458998551598;1.0;0.028356987982988358;-0.036892473697662354;-0.5090275197594861;-0.48825410014484016
Increased circulating oleate level;Paroxysmal vertigo;0.9746991209685802;0.8421227;0.5080543793950748;0.5504650606324062;0.9999134918687169;-0.025214370900136673;-0.15779081788037463;-0.4918591124736421;-0.44944843123631073
Increased circulating oleate level;Long hallux;0.9426419399678707;0.8540075;0.5182676635209903;0.5466375438664359;0.9998836012415208;-0.057241661273650046;-0.14587611871283424;-0.48161593772053046;-0.45324605737508483
Increased circulating oleate level;Broad medial eyebrow;0.8488002717494965;0.7760231;0.5483136608853387;0.5719040227778251;0.9999201345566091;-0.15111986280711265;-0.22389704467089744;-0.4516064736712704;-0.42801611177878396
Increased circulating oleate level;Myxoid subcutaneous tumors;1.054512545466423;0.96079683;0.48263951248491;0.5124819577953168;0.9999201345566091;0.054592410909813927;-0.03912330151827903;-0.5172806220716991;-0.4874381767612923
Increased circulating oleate level;Bulbous tips of toes;0.9169940277934074;0.8239254;0.5264520568157739;0.5563399987718719;0.9999134918687169;-0.08291946407530948;-0.1759881159303014;-0.473461435052943;-0.443573493096845
Increased circulating oleate level;Absent internal genitalia;1.0341432765126228;0.965171;0.48912974481715776;0.5110886653792363;1.0;0.03414327651262283;-0.034829020500183105;-0.5108702551828422;-0.48891133462076375
Increased circulating oleate level;Hyperphalangy of the 2nd finger;0.9986588177271187;0.90585387;0.5004269117046185;0.5300120990419424;0.9999201345566091;-0.0012613168294903776;-0.09406626702578635;-0.4994932228519906;-0.46990803551466676
Increased circulating oleate level;Renal interstitial hemosiderin;0.9923025202006102;0.8913899;0.5024502081155453;0.534639996269544;1.0;-0.007697479799389839;-0.10861009359359741;-0.4975497918844547;-0.46536000373045605
Increased circulating oleate level;Abnormality of depressor anguli oris muscle;1.0416013561189175;0.8805523;0.48675405446049236;0.5381123756051543;1.0;0.041601356118917465;-0.11944770812988281;-0.5132459455395076;-0.46188762439484565
Increased circulating oleate level;Paroxysmal dyspnea;1.0025440827012062;0.8621992;0.49919019245137475;0.5440033719479402;1.0;0.0025440827012062073;-0.13780081272125244;-0.5008098075486253;-0.45599662805205976
Increased circulating oleate level;Phenylpyruvic acidemia;0.8293201178312302;0.76134586;0.5545963954681673;0.5767062126331008;0.726290173501319;0.1030299443299112;0.03505568984096619;-0.17169377803315167;-0.14958396086821812
Increased circulating oleate level;Lateral ventricle dilatation;0.9055157899856567;0.726252;0.5301201871675385;0.5882634215270988;0.9998579617208769;-0.09434217173522019;-0.27360594231551194;-0.4697377745533384;-0.41159454019377817
Increased circulating oleate level;Neonatal unconjugated hyperbilirubinemia;0.7996284067630768;0.77492285;0.5642149423826281;0.5722634217165198;0.5415034547528017;0.2581249520102751;0.23341939299500103;0.022711487629826443;0.030759966963718077
Increased circulating oleate level;High maternal circulating alpha-fetoprotein concentration;0.747549831867218;0.6648496;0.5812363778468299;0.6087871400231613;1.0;-0.252450168132782;-0.33515042066574097;-0.4187636221531701;-0.39121285997683874
Increased circulating oleate level;Prominent nasolabial fold;0.9942138073965907;0.8883542;0.5018418125864481;0.5356122064755144;0.9998944404568447;-0.0056806330602540145;-0.11154025821349756;-0.4980526278703966;-0.4642822339813303
Increased circulating oleate level;Abnormality of inferior alveolar nerve;0.9609684087336063;0.7470568;0.5124272981625546;0.5813985847546166;1.0;-0.03903159126639366;-0.252943217754364;-0.4875727018374454;-0.4186014152453834
Increased circulating oleate level;Unilateral conductive hearing impairment;0.9708702452480793;0.80493844;0.5092736007426624;0.5624906668742635;0.9999201345566091;-0.029049889308529808;-0.1949816990021047;-0.49064653381394674;-0.4374294676823456
Increased circulating oleate level;Macular hypopigmented whorls, streaks, and patches;0.959809198975563;0.90754116;0.5127965759302816;0.52947266293811;0.9999201345566091;-0.04011093558104606;-0.0923789787414846;-0.4871235586263275;-0.4704474716184991
Increased circulating oleate level;Delayed ossification of pubic rami;0.863691657781601;0.7273232;0.5435237876737431;0.5879089769636058;0.9999134918687169;-0.13622183408711597;-0.2725903173920934;-0.4563897041949738;-0.41200451490511114
Increased circulating oleate level;Hyperphenylalaninemia;0.7243800759315491;0.6251027;0.5888831165966049;0.6223220309317936;0.4420190361951307;0.28236103973641835;0.18308366260781728;0.14686408040147414;0.1803029947366629
Increased circulating oleate level;Ureteropelvic junction obstruction;1.046488307416439;0.84438205;0.4851969769319012;0.5497368781974776;0.9998847295244674;0.04660357789197167;-0.15550268187126914;-0.5146877525925662;-0.45014785132698976
Increased circulating oleate level;Cone-shaped epiphysis of the proximal phalanx of the 2nd toe;0.9290143474936485;0.8647884;0.5226144543883946;0.5431714268550587;1.0;-0.07098565250635147;-0.13521158695220947;-0.4773855456116054;-0.4568285731449413
Increased circulating oleate level;Difficulty walking;0.9994654664769769;0.95196867;0.5001701473129775;0.5152947390382618;0.9998344221996177;-0.0003689557226408402;-0.04786575230826029;-0.4996642748866402;-0.48453968316135587
Increased circulating oleate level;Bilobate gallbladder;0.8831096366047859;0.81310356;0.5372926130759054;0.5598428850187847;0.9999134918687169;-0.116803855263931;-0.1868099352357213;-0.46262087879281155;-0.44007060684993227
Increased circulating oleate level;Histidinuria;0.91722721606493;0.906828;0.5263775743710493;0.5297006560402677;0.6883625580296748;0.22886465803525513;0.21846542821071213;-0.16198498365862557;-0.1586619019894071
Increased circulating oleate level;Widened interpedicular distance;0.7964541018009186;0.6511594;0.5652466141301042;0.6134245393014777;1.0;-0.20354589819908142;-0.348840594291687;-0.43475338586989576;-0.38657546069852233
Lozenge-shaped umbilicus;Anti-myelin-associated glycoprotein antibody positivity;1.0059598349034786;0.9619228;0.4981029143994561;0.5121232781052798;0.9999134918687169;0.006046343034761703;-0.03799066748593494;-0.5018105774692608;-0.4877902137634371
Lozenge-shaped umbilicus;Fractured radius;0.8784466832876205;0.8137755;0.5387875410010687;0.5596251879691514;0.9999584729108851;-0.12151178962326459;-0.18618299311733655;-0.4611709319098164;-0.44033328494173374
Lozenge-shaped umbilicus;Abnormal manual kinetic perimetry test;1.0926482677459717;1.0196061;0.47046678651211327;0.4937587922272485;0.9999134918687169;0.09273477587725476;0.01969262156512097;-0.5294467053566037;-0.5061546996414684
Lozenge-shaped umbilicus;Small radial epiphyses;0.9136225283145905;0.8519666;0.5275291085836173;0.5472943164765913;0.9999134918687169;-0.08629096355412647;-0.14794687237713977;-0.4723843832850996;-0.4526191753921256
Lozenge-shaped umbilicus;Generalized keratosis follicularis;0.870441734790802;0.9048592;0.5413559272598644;0.5303301415168711;0.9999584729108851;-0.12951673812008313;-0.0950992876920741;-0.45860254565102077;-0.46962833139401405
Lozenge-shaped umbilicus;Hypoplasia of the calcaneus;0.9615773297846317;0.9058859;0.5122333270564892;0.5300018652373151;0.9999567459343585;-0.03837941614972673;-0.09407087070929132;-0.4877234188778693;-0.4699548806970434
Lozenge-shaped umbilicus;2-hydroxyadipic aciduria;0.957951121032238;0.9557219;0.5133885212491;0.5140987581564729;0.9999134918687169;-0.04196237083647891;-0.044191577100497925;-0.48652497061961697;-0.48581473371224404
Lozenge-shaped umbilicus;Potter facies;0.9470177032053471;1.034637;0.516872689104459;0.48897249816096255;0.9999532306564473;-0.052935527451100195;0.03468374367826954;-0.4830805415519882;-0.5109807324954847
Lozenge-shaped umbilicus;Increased heart rate variability;0.9415803030133247;0.92319727;0.5186061607239631;0.5244711713566543;0.9999584729108851;-0.058378169897560395;-0.07676120347118787;-0.481352312186922;-0.4754873015542308
Lozenge-shaped umbilicus;Aplastic zygomatic arch;0.9291496947407722;0.88047075;0.5225712632727986;0.5381385319483791;0.9999567459343585;-0.07080705119358621;-0.119485993218294;-0.4773854826615599;-0.46181821398597933
Lozenge-shaped umbilicus;Testicular torsion;0.8501266241073608;0.8548151;0.5478866032238592;0.5463776848973219;0.9999584729108851;-0.1498318488035243;-0.14514334744549207;-0.45207186968702595;-0.4535807880135633
Lozenge-shaped umbilicus;Abolished vibration sense;0.9238917529582977;0.8917269;0.5242494566791585;0.5345320903850076;0.9999567459343585;-0.07606499297606073;-0.10822983486639581;-0.4757072892552;-0.46542465554935086
Lozenge-shaped umbilicus;Fractured metatarsal bone of digit 5;0.997266280464828;0.95152587;0.5008701710379315;0.5154358495819944;0.9999134918687169;-0.002647211403888905;-0.048387624883395874;-0.4990433208307854;-0.4844776422867225
Lozenge-shaped umbilicus;Prolonged G2 phase of cell cycle;0.9548918455839157;0.96122026;0.514363245234223;0.5123470751939431;0.9999548690865008;-0.045063023502585065;-0.03873460465168632;-0.4855916238522777;-0.4876077938925577
Lozenge-shaped umbilicus;Single naris;0.8449340313673019;0.86164963;0.5495590124225602;0.5441799971974297;0.9999548690865008;-0.15502083771919883;-0.13830523663258232;-0.45039585666394055;-0.45577487188907106
Lozenge-shaped umbilicus;Perifoveal ring of hyperautofluorescence surrounded by normal autofluorescence;1.0044714910909534;0.89951986;0.4985766754366928;0.5320378824094376;0.9999134918687169;0.004557999222236431;-0.1003936311242406;-0.5013368164320241;-0.4678756094592793
Lozenge-shaped umbilicus;Asymmetry of the thorax;0.9016704261302948;0.8688687;0.5313499334306206;0.5418609455478449;0.9999548690865008;-0.09828444295620598;-0.1310861604759661;-0.46860493565588013;-0.45809392353865586
Lozenge-shaped umbilicus;Type 2 muscle fiber predominance;0.978020491078496;0.9393489;0.506996858422643;0.5193177164632434;0.9999536937290383;-0.021933202650542327;-0.060604817252750465;-0.49295683530639534;-0.4806359772657949
Lozenge-shaped umbilicus;Dependency on parenteral nutrition;0.8580877929925919;0.9098742;0.5453250698107703;0.5287269078161918;0.8526023716255289;0.0054854213670629814;0.057271829195393975;-0.30727730181475854;-0.32387546380933707
Lozenge-shaped umbilicus;Limited shoulder flexion;0.9682086408138275;0.8810418;0.5101212093143676;0.5379554501352349;0.9999134918687169;-0.031704851054889405;-0.11887166705105945;-0.48979228255434937;-0.461958041733482
Lozenge-shaped umbilicus;Paroxysmal vertigo;0.9997110553085804;0.8837578;0.500091973953119;0.5370848801659054;0.9999567459343585;-0.0002456906257780611;-0.11619891626822076;-0.49986477198123946;-0.4628718657684531
Lozenge-shaped umbilicus;Long hallux;0.9226740524172783;0.8245372;0.5246382085145191;0.5561421731500042;0.9999503740898522;-0.07727632167257392;-0.1754131564728173;-0.47531216557533307;-0.44380820093984796
Lozenge-shaped umbilicus;Broad medial eyebrow;0.9048876017332077;0.9127599;0.5303210502891516;0.5278047416873003;0.9999584729108851;-0.09507087117767743;-0.08719857281780652;-0.4696374226217336;-0.47215373122358484
Lozenge-shaped umbilicus;Myxoid subcutaneous tumors;0.910314679145813;0.8692626;0.5285861338598576;0.5417344945043489;0.9999584729108851;-0.08964379376507214;-0.13069589680767468;-0.4713723390510275;-0.4582239784065363
Lozenge-shaped umbilicus;Bulbous tips of toes;0.8406451940536499;0.82494247;0.5509413824803773;0.5560111350204457;0.9999567459343585;-0.15931155188070856;-0.17501427633749567;-0.4490153634539812;-0.4439456109139127
Lozenge-shaped umbilicus;Absent internal genitalia;0.776631698012352;0.81435;0.5717052610295263;0.5594390639493174;0.9999134918687169;-0.22328179385636493;-0.18556348290417835;-0.4282082308391906;-0.4404744279193995
Lozenge-shaped umbilicus;Hyperphalangy of the 2nd finger;0.8520487397909164;0.8549343;0.5472678761395099;0.5463393669429748;0.9999584729108851;-0.1479097331199687;-0.14502419776058606;-0.45269059677137524;-0.45361910596791033
Lozenge-shaped umbilicus;Renal interstitial hemosiderin;0.860221192240715;0.828513;0.5446391500681989;0.5548571546880576;0.9999134918687169;-0.1396922996280019;-0.17140046563122913;-0.45527434180051807;-0.4450563371806593
Lozenge-shaped umbilicus;Abnormality of depressor anguli oris muscle;0.8491488844156265;0.8143177;0.5482014064547585;0.5594495291380308;0.9999134918687169;-0.1507646074530904;-0.1855957886216466;-0.45171208541395846;-0.4404639627306861
Lozenge-shaped umbilicus;Paroxysmal dyspnea;0.9478107914328575;0.9326655;0.516619891506652;0.5214494529899931;0.9999134918687169;-0.052102700435859406;-0.06724796500180408;-0.4832936003620649;-0.4784640388787238
Lozenge-shaped umbilicus;Phenylpyruvic acidemia;0.8923417776823044;0.9059614;0.5343352214870952;0.529977717297848;0.9999584729108851;-0.10761669522858075;-0.09399707860088757;-0.4656232514237899;-0.4699807556130371
Lozenge-shaped umbilicus;Lateral ventricle dilatation;0.7750189453363419;0.67845774;0.5722320228438399;0.6042012327045905;0.9999462364511621;-0.22492729111482024;-0.32148849948216796;-0.4277142136073222;-0.3957450037465716
Lozenge-shaped umbilicus;Neonatal unconjugated hyperbilirubinemia;0.6344131827354431;0.54670525;0.6191316716539008;0.6497515066013242;0.9999584729108851;-0.365545290175442;-0.45325322693920544;-0.3808268012569843;-0.35020696630956094
Lozenge-shaped umbilicus;High maternal circulating alpha-fetoprotein concentration;0.8654879331588745;0.9415375;0.5429467001866808;0.5186198112306476;0.9999134918687169;-0.1344255587098424;-0.05837599244092151;-0.45696679168203613;-0.4812936806380693
Lozenge-shaped umbilicus;Prominent nasolabial fold;0.9194962456822395;0.8253975;0.5256529007104765;0.5558640411021951;0.9999524555142131;-0.08045620983197355;-0.17455496405913495;-0.47429955480373653;-0.44408841441201796
Lozenge-shaped umbilicus;Abnormality of inferior alveolar nerve;0.9674454778432846;0.85564697;0.5103642574604867;0.5461100917456481;0.9999134918687169;-0.03246801402543231;-0.1442665239808385;-0.48954923440823017;-0.45380340012306886
Lozenge-shaped umbilicus;Unilateral conductive hearing impairment;0.9642840102314949;0.78715074;0.511371171083985;0.5682743255253833;0.9999584729108851;-0.03567446267939023;-0.212807732287411;-0.48858730182690013;-0.43168414738550187
Lozenge-shaped umbilicus;Macular hypopigmented whorls, streaks, and patches;0.9528637602925301;0.9609172;0.5150094926772357;0.512443612944575;0.9999584729108851;-0.04709471261835507;-0.03904129809475354;-0.4849489802336494;-0.48751485996631017
Lozenge-shaped umbilicus;Delayed ossification of pubic rami;0.9255880564451218;0.84456277;0.5237079707551402;0.5496786394072322;0.9999567459343585;-0.0743686894892367;-0.15539397699820123;-0.47624877517921826;-0.4502781065271263
Lozenge-shaped umbilicus;Hyperphenylalaninemia;0.9752873498946428;0.8932482;0.5078670817385087;0.5340450352837296;0.9999542297279059;-0.0246668798332631;-0.10670602931134099;-0.49208714798939723;-0.46590919444417633
Lozenge-shaped umbilicus;Ureteropelvic junction obstruction;0.7742227017879486;0.7045624;0.5724921682948373;0.5954654239318978;0.9999505803237132;-0.2257278785357646;-0.2953881547103099;-0.4274584120288759;-0.40448515639181537
Lozenge-shaped umbilicus;Cone-shaped epiphysis of the proximal phalanx of the 2nd toe;0.9124032631516457;0.8629412;0.5279186894943666;0.5437649272121419;0.9999134918687169;-0.08751022871707126;-0.13697228636716052;-0.4719948023743503;-0.45614856465657505
Lozenge-shaped umbilicus;Difficulty walking;1.0517527386546135;1.0462569;0.48351922919093693;0.485270723890011;0.9999431787962207;0.05180955985839275;0.046313721037458455;-0.5164239496052838;-0.5146724549062097
Lozenge-shaped umbilicus;Bilobate gallbladder;0.7838598638772964;0.71729904;0.5693468065262056;0.5912304030329216;0.8526023716255289;-0.06874250774823243;-0.1353033274932962;-0.28325556509932326;-0.26137196859260725
Lozenge-shaped umbilicus;Histidinuria;0.9064045548439026;0.88637066;0.5298360252352409;0.5362476325597493;0.9999556674707869;-0.09355111262688431;-0.11358500859627518;-0.47011964223554603;-0.4637080349110376
Lozenge-shaped umbilicus;Widened interpedicular distance;0.9884910471737385;0.90489906;0.5036634943425555;0.5303173885516623;0.9999134918687169;-0.01142244469497844;-0.09501443114255115;-0.4962499975261614;-0.4695961033170546
Anti-myelin-associated glycoprotein antibody positivity;Fractured radius;1.0722411572933197;0.95450175;0.47698487726857586;0.5144875459329608;0.9999201345566091;0.0723210227367106;-0.045418386471587135;-0.5229352572880333;-0.48543258862364835
Anti-myelin-associated glycoprotein antibody positivity;Abnormal manual kinetic perimetry test;0.8174654245376587;0.72687787;0.5584301477461442;0.5880563149364391;1.0;-0.1825345754623413;-0.2731221318244934;-0.4415698522538558;-0.41194368506356094
Anti-myelin-associated glycoprotein antibody positivity;Small radial epiphyses;1.0362057089805603;0.923255;0.48847284555768067;0.5244527275847402;1.0;0.0362057089805603;-0.07674497365951538;-0.5115271544423193;-0.47554727241525985
Anti-myelin-associated glycoprotein antibody positivity;Generalized keratosis follicularis;0.8082406669855118;0.6724991;0.561419303861036;0.6062064392846086;0.9999201345566091;-0.19167946757109733;-0.327421014321166;-0.4385008306955731;-0.3937136952720005
Anti-myelin-associated glycoprotein antibody positivity;Hypoplasia of the calcaneus;0.9989658901467919;0.91492194;0.5003291674483439;0.5271139696173288;0.9999134918687169;-0.0009476017219249844;-0.08499155249570056;-0.49958432442037304;-0.4727995222513881
Anti-myelin-associated glycoprotein antibody positivity;2-hydroxyadipic aciduria;0.8587282299995422;0.7837387;0.5451191376306239;0.5693863124801002;1.0;-0.14127177000045776;-0.21626132726669312;-0.4548808623693761;-0.4306136875198998
Anti-myelin-associated glycoprotein antibody positivity;Potter facies;0.9453109204769135;0.92352325;0.5174167640003634;0.5243670961835182;0.9998981869165328;-0.05458726643961931;-0.07637493967455888;-0.48248142291616936;-0.4755310907330146
Anti-myelin-associated glycoprotein antibody positivity;Increased heart rate variability;1.01228610239923;0.872258;0.49608911374917053;0.5407729498333856;0.9999201345566091;0.012365967842620895;-0.1276621270302114;-0.5038310208074386;-0.45914718472322347
Anti-myelin-associated glycoprotein antibody positivity;Aplastic zygomatic arch;0.9383867271244526;0.79414403;0.5196245436912537;0.5659978439826574;0.9999134918687169;-0.06152676474426433;-0.20576945748303577;-0.48028894817746326;-0.4339156478860595
Anti-myelin-associated glycoprotein antibody positivity;Testicular torsion;1.0138773936778307;0.9198986;0.4955825466031023;0.5255243935658881;0.9999201345566091;0.013957259121221588;-0.08002150536807151;-0.5043375879535068;-0.474395740990721
Anti-myelin-associated glycoprotein antibody positivity;Abolished vibration sense;1.033577211201191;0.95294446;0.4893100323853705;0.5149837691043084;0.9999134918687169;0.03366371933247403;-0.04696903433774158;-0.5106034594833464;-0.4849297227644085
Anti-myelin-associated glycoprotein antibody positivity;Fractured metatarsal bone of digit 5;0.9954454991966486;0.9028335;0.5014497476445028;0.5309779272317929;1.0;-0.004554500803351402;-0.09716647863388062;-0.4985502523554972;-0.46902207276820707
Anti-myelin-associated glycoprotein antibody positivity;Prolonged G2 phase of cell cycle;0.8379681408405304;0.7424938;0.5518047350650952;0.5829007760329552;0.9999056439461368;-0.1619375031056064;-0.25741183567663606;-0.4481009088810416;-0.4170048679131816
Anti-myelin-associated glycoprotein antibody positivity;Single naris;0.9467254467308521;0.9122732;0.5169658488004915;0.5279602480178248;0.9999056439461368;-0.053180197215284664;-0.08763241577764924;-0.48293979514564533;-0.471945395928312
Anti-myelin-associated glycoprotein antibody positivity;Perifoveal ring of hyperautofluorescence surrounded by normal autofluorescence;0.8361286520957947;0.70982987;0.5523981947544414;0.5937118995362982;1.0;-0.16387134790420532;-0.2901701331138611;-0.4476018052455586;-0.4062881004637018
Anti-myelin-associated glycoprotein antibody positivity;Asymmetry of the thorax;0.9986637085676193;0.8937953;0.5004253549003403;0.5338698839571361;0.9999056439461368;-0.001241935378517467;-0.10611033249517854;-0.49948028904579644;-0.4660357599890007
Anti-myelin-associated glycoprotein antibody positivity;Type 2 muscle fiber predominance;0.7631513625383377;0.66817486;0.5761145484251979;0.6076643965489065;0.9999003561294039;-0.23674899359106616;-0.33172549326777057;-0.42378580770420593;-0.3922359595804974
Anti-myelin-associated glycoprotein antibody positivity;Dependency on parenteral nutrition;0.8327232897281647;0.80074185;0.5534973267651417;0.5638532226449882;0.9999134918687169;-0.16719020214055225;-0.19917164053891345;-0.4464161651035752;-0.43606026922372876
Anti-myelin-associated glycoprotein antibody positivity;Limited shoulder flexion;0.9642236158251762;0.84718907;0.5113904075145761;0.5488325620639446;1.0;-0.03577638417482376;-0.1528109312057495;-0.4886095924854239;-0.4511674379360554
Anti-myelin-associated glycoprotein antibody positivity;Paroxysmal vertigo;0.8636091351509094;0.794503;0.5435503030760482;0.5658810891378122;0.9999134918687169;-0.1363043567178075;-0.20541051831219836;-0.4563631887926687;-0.4340324027309047
Anti-myelin-associated glycoprotein antibody positivity;Long hallux;0.9965853854082525;0.9297704;0.5010869076942178;0.522373187659908;0.9998836012415208;-0.003298215833268281;-0.07011319118063819;-0.49879669354730294;-0.4775104135816127
Anti-myelin-associated glycoprotein antibody positivity;Broad medial eyebrow;0.8779604285955429;0.77964836;0.5389434816408725;0.5707204791643876;0.9999201345566091;-0.1219597059610662;-0.22027177096636863;-0.46097665291573664;-0.4291996553922215
Anti-myelin-associated glycoprotein antibody positivity;Myxoid subcutaneous tumors;0.6886063814163208;0.61646366;0.6007957583264459;0.6252939133391224;0.9999201345566091;-0.3113137531402883;-0.38345647336276145;-0.39912437623016317;-0.3746262212174867
Anti-myelin-associated glycoprotein antibody positivity;Bulbous tips of toes;1.093811273574829;1.0439333;0.47009497083905094;0.4860111072884652;0.9999134918687169;0.09389778170611218;0.04401978049303845;-0.529818521029666;-0.5139023845802517
Anti-myelin-associated glycoprotein antibody positivity;Absent internal genitalia;0.9106961488723755;0.804064;0.528464219067425;0.5627744927873533;1.0;-0.08930385112762451;-0.19593602418899536;-0.471535780932575;-0.43722550721264675
Anti-myelin-associated glycoprotein antibody positivity;Hyperphalangy of the 2nd finger;0.9932263079099357;0.8836429;0.5021561496468481;0.5371216904388258;0.9999201345566091;-0.006693826646673395;-0.11627722264559837;-0.49776398490976104;-0.46279844411778326
Anti-myelin-associated glycoprotein antibody positivity;Renal interstitial hemosiderin;0.8619691729545593;0.7696756;0.5440773037634954;0.5739787349927794;1.0;-0.13803082704544067;-0.230324387550354;-0.4559226962365046;-0.4260212650072206
Anti-myelin-associated glycoprotein antibody positivity;Abnormality of depressor anguli oris muscle;0.924445278942585;0.7479788;0.5240727550976898;0.5810952683211363;1.0;-0.07555472105741501;-0.2520211935043335;-0.4759272449023102;-0.41890473167886366
Anti-myelin-associated glycoprotein antibody positivity;Paroxysmal dyspnea;0.8472923934459686;0.72824293;0.5487992726153843;0.5876047184316089;1.0;-0.15270760655403137;-0.2717570662498474;-0.4512007273846157;-0.4123952815683911
Anti-myelin-associated glycoprotein antibody positivity;Phenylpyruvic acidemia;0.8289650678634644;0.71169317;0.5547110979964842;0.5930923092476711;0.9999201345566091;-0.17095506669314475;-0.2882269668701467;-0.4452090365601249;-0.406827825308938
Anti-myelin-associated glycoprotein antibody positivity;Lateral ventricle dilatation;0.8318124711513519;0.8379475;0.553791415807863;0.5518114067831112;0.9998579617208769;-0.168045490569525;-0.1619104738897612;-0.446066545913014;-0.4480465549377657
Anti-myelin-associated glycoprotein antibody positivity;Neonatal unconjugated hyperbilirubinemia;0.9030700773000717;0.81863755;0.5309022720226035;0.5580507103490244;0.9999201345566091;-0.09685005725653739;-0.18128258467944236;-0.46901786253400557;-0.4418694242075847
Anti-myelin-associated glycoprotein antibody positivity;High maternal circulating alpha-fetoprotein concentration;0.7863494008779526;0.6684705;0.5685354053380154;0.6075646551330021;1.0;-0.21365059912204742;-0.33152949810028076;-0.4314645946619846;-0.39243534486699794
Anti-myelin-associated glycoprotein antibody positivity;Prominent nasolabial fold;0.9201302155852318;0.8470534;0.525450449898647;0.548876248082726;0.9998944404568447;-0.07976422487161294;-0.15284103183410302;-0.47444399055819775;-0.4510181923741188
Anti-myelin-associated glycoprotein antibody positivity;Abnormality of inferior alveolar nerve;0.8294002860784531;0.68990636;0.5545704972862086;0.6003604102102978;1.0;-0.17059971392154694;-0.31009364128112793;-0.44542950271379145;-0.39963958978970215
Anti-myelin-associated glycoprotein antibody positivity;Unilateral conductive hearing impairment;0.856050968170166;0.7598841;0.5459801371760895;0.5771854484936383;0.9999201345566091;-0.1438691663864431;-0.24003601552279563;-0.4539399973805196;-0.4227346860629708
Anti-myelin-associated glycoprotein antibody positivity;Macular hypopigmented whorls, streaks, and patches;0.788117453455925;0.7042277;0.5679594285276959;0.595576969301679;0.9999201345566091;-0.21180268110068412;-0.2956924486282644;-0.43196070602891323;-0.4043431652549301
Anti-myelin-associated glycoprotein antibody positivity;Delayed ossification of pubic rami;1.0454538315534592;0.9223028;0.4855266093376809;0.5247567416299962;0.9999134918687169;0.04554033968474225;-0.07761070933316394;-0.514386882531036;-0.4751567502387207
Anti-myelin-associated glycoprotein antibody positivity;Hyperphenylalaninemia;0.8485752046108246;0.7125054;0.5483861364636087;0.5928223370530388;0.9999028053808913;-0.15132760077006668;-0.2873974052000746;-0.4515166689172826;-0.4070804683278525
Anti-myelin-associated glycoprotein antibody positivity;Ureteropelvic junction obstruction;1.0243090279400349;0.8998102;0.4922614337985316;0.5319450021982441;0.9998847295244674;0.02442429841556748;-0.10007453455529014;-0.5076232957259358;-0.46793972732622324
Anti-myelin-associated glycoprotein antibody positivity;Cone-shaped epiphysis of the proximal phalanx of the 2nd toe;0.981770584359765;0.89739454;0.5058029246444301;0.5327179230502368;1.0;-0.018229415640234947;-0.10260546207427979;-0.4941970753555699;-0.4672820769497632
Anti-myelin-associated glycoprotein antibody positivity;Difficulty walking;0.8256826400756836;0.796366;0.5557718618409305;0.5652752654028632;0.9998344221996177;-0.17415178212393412;-0.20346844586599955;-0.4440625603586872;-0.4345591567967545
Anti-myelin-associated glycoprotein antibody positivity;Bilobate gallbladder;1.0128854550421238;0.8799592;0.49589831876303425;0.5383025273755282;0.9999134918687169;0.012971963173406875;-0.11995426621411487;-0.5040151731056827;-0.4616109644931887
Anti-myelin-associated glycoprotein antibody positivity;Histidinuria;0.7089812755584717;0.6630424;0.5939941967191338;0.6093978947134358;0.9999090677057578;-0.29092779214728615;-0.33686664159644386;-0.40591487098662404;-0.3905111729923221
Anti-myelin-associated glycoprotein antibody positivity;Widened interpedicular distance;0.8884506821632385;0.77358425;0.5355813036769141;0.5727007876165784;1.0;-0.11154931783676147;-0.226415753364563;-0.46441869632308586;-0.4272992123834216
Fractured radius;Abnormal manual kinetic perimetry test;0.8962744623422623;0.75942016;0.5330763572469364;0.577337587292235;0.9999201345566091;-0.10364567221434684;-0.24049997807772727;-0.46684377730967275;-0.42258254726437405
Fractured radius;Small radial epiphyses;0.4235825538635254;0.5485933;0.6955497631333756;0.6490776297167082;0.1542140045508552;0.2693685493126702;0.39437927814872975;0.5413357585825204;0.494863625165853
Fractured radius;Generalized keratosis follicularis;0.9457048363983631;0.7910213;0.5172911900897723;0.5670139384093715;0.9999600672783046;-0.05425523087994144;-0.2089387798370509;-0.48266887718853224;-0.432946128868933
Fractured radius;Hypoplasia of the calcaneus;0.6523981094360352;0.69698966;0.6130039221937607;0.5979916746553164;0.8287763732556668;-0.17637826381963162;-0.13178671776097683;-0.21577245106190612;-0.23078469860035034
Fractured radius;2-hydroxyadipic aciduria;0.8838027864694595;0.82274485;0.537070462785631;0.5567217732002541;0.9999201345566091;-0.11611734808714957;-0.17717528821261497;-0.46284967177097813;-0.44319836135635504
Fractured radius;Potter facies;1.0857077240943909;1.0638597;0.4726848722566672;0.47965898209012814;0.9999552432134126;0.08575248088097831;0.06390445794320365;-0.5272703709567453;-0.5202962611232844
Fractured radius;Increased heart rate variability;0.9672896191477776;0.85814863;0.5104138952602775;0.5453055054579083;0.9999600672783046;-0.032670448130527;-0.14181143284455822;-0.4895461720180271;-0.4546545618203962
Fractured radius;Aplastic zygomatic arch;0.9297114163637161;0.78184164;0.5223920148346793;0.5700049325689619;0.9074607173141833;0.022250699049532807;-0.1256190816101428;-0.385068702479504;-0.3374557847452214
Fractured radius;Testicular torsion;0.8531034290790558;0.7495393;0.5469284493138722;0.5805820820844816;0.9999600672783046;-0.14685663819924877;-0.25042075157777355;-0.45303161796443236;-0.41937798519382297
Fractured radius;Abolished vibration sense;0.8222964406013489;0.7197014;0.5568668173128819;0.5904334796351234;0.9999584729108851;-0.17766203230953626;-0.28025706357098035;-0.44309165559800323;-0.40952499327576175
Fractured radius;Fractured metatarsal bone of digit 5;0.4556697607040405;0.48698103;0.683216146695812;0.6714729532966031;0.0;0.4556697607040405;0.48698103427886963;0.683216146695812;0.6714729532966031
Fractured radius;Prolonged G2 phase of cell cycle;0.9199476838111877;0.89563483;0.5255087382067674;0.5332810648454314;0.9999567459343585;-0.08000906212317072;-0.1043219159363421;-0.4744480077275911;-0.4666756810889271
Fractured radius;Single naris;1.01974012888968;0.911775;0.49371611366499146;0.5281194585399969;0.9999567459343585;0.01978338295532145;-0.0881817529915484;-0.506240632269367;-0.4718372873943616
Fractured radius;Perifoveal ring of hyperautofluorescence surrounded by normal autofluorescence;0.910163938999176;0.7798601;0.5286343104101193;0.5706513914757001;0.9999201345566091;-0.08975619555743308;-0.22006005526812644;-0.4712858241464898;-0.429268743080909
Fractured radius;Asymmetry of the thorax;0.8149778544902802;0.75667834;0.5592356862861907;0.5782370586454747;0.9036123096265051;-0.08863445513622492;-0.1469339668072912;-0.3443766233403144;-0.3253752509810304
Fractured radius;Type 2 muscle fiber predominance;0.9741967245936394;0.9574554;0.5082143493611018;0.5135464660541869;0.9344769737294281;0.03971975086421131;0.022978422922793618;-0.4262626243683263;-0.4209305076752412
Fractured radius;Dependency on parenteral nutrition;0.8983275815844536;0.8463402;0.5324193550634044;0.5491059917412571;0.9999584729108851;-0.10163089132643155;-0.15361829346752576;-0.4675391178474807;-0.45085248116962806
Fractured radius;Limited shoulder flexion;0.6430785655975342;0.62901103;0.6161736149756387;0.6209812347136059;0.6115804491749721;0.03149811642256206;0.01743058579054302;0.004593165800666599;0.009400785538633771
Fractured radius;Paroxysmal vertigo;1.037178859114647;0.82265174;0.4881628735053305;0.5567518905379086;0.9999584729108851;0.03722038620376178;-0.17730672902203015;-0.5117955994055546;-0.4432065823729765
Fractured radius;Long hallux;0.8059777319431305;0.850161;0.5621534048835768;0.5478755309178092;0.8047017442325175;0.0012759877106129913;0.04545927175487874;-0.2425483393489407;-0.25682621331470834
Fractured radius;Broad medial eyebrow;0.9870181288570166;0.901384;0.5041323740023134;0.531441554644182;0.9999600672783046;-0.01294193842128799;-0.0985760712684779;-0.4958276932759912;-0.4685185126341226
Fractured radius;Myxoid subcutaneous tumors;0.9972881437279284;0.93265295;0.5008632117193457;0.5214534653476659;0.9999600672783046;-0.002671923550376154;-0.06730711699143932;-0.4990968555589589;-0.47850660193063865
Fractured radius;Bulbous tips of toes;0.7854700833559036;0.7455908;0.5688219445407497;0.5818809899118474;0.8287763732556668;-0.04330628989976315;-0.08318556724828152;-0.25995442871491703;-0.24689538334381933
Fractured radius;Absent internal genitalia;0.9444835036993027;0.86029136;0.5176805397060749;0.5446165930650095;0.9999201345566091;-0.055436630857306435;-0.13962877274783225;-0.48223959485053425;-0.4553035414915996
Fractured radius;Hyperphalangy of the 2nd finger;0.6856732666492462;0.67074937;0.6017787449667911;0.6067961018294146;0.830294756654948;-0.1446214900057018;-0.15954539037153126;-0.22851601168815694;-0.22349865482553344
Fractured radius;Renal interstitial hemosiderin;0.9127790331840515;0.830047;0.527798618608663;0.5543615873790918;0.9999201345566091;-0.0871411013725576;-0.16987312318118186;-0.47212151594794616;-0.4455585471775173
Fractured radius;Abnormality of depressor anguli oris muscle;0.8956008553504944;0.8641914;0.5332919434819388;0.5433632127087251;0.8819596887815145;0.013641166568979846;-0.017768275855794324;-0.3486677452995758;-0.3385964760727894
Fractured radius;Paroxysmal dyspnea;0.9238517135381699;0.78682923;0.5242622387154733;0.5683790586640886;0.9999201345566091;-0.07606842101843925;-0.21309090138705344;-0.4756578958411358;-0.43154107589252055
Fractured radius;Phenylpyruvic acidemia;0.9063685834407806;0.80727744;0.5298475257917814;0.5617317454445532;0.9999600672783046;-0.09359148383752391;-0.19268262625352428;-0.47011254148652315;-0.4382283218337514
Fractured radius;Lateral ventricle dilatation;0.9912329316139221;0.8204293;0.5027906802902231;0.5574708450136426;0.9999488789551968;-0.008715947341274677;-0.17951955385143703;-0.4971581986649737;-0.44247803394155416
Fractured radius;Neonatal unconjugated hyperbilirubinemia;0.8767195045948029;0.7816649;0.539341485472693;0.5700625763485819;0.9999600672783046;-0.1232405626835017;-0.21829515934602306;-0.46061858180561155;-0.4298974909297226
Fractured radius;High maternal circulating alpha-fetoprotein concentration;0.9474453553557396;0.8500377;0.5167363732772982;0.5479152245420187;0.9999201345566091;-0.052474779200869515;-0.14988244057925315;-0.48318376127931095;-0.4520049100145904
Fractured radius;Prominent nasolabial fold;0.9821623079478741;0.84249043;0.5056782148728622;0.5503465203588921;0.9999545338528789;-0.017792225905004844;-0.15746409920627247;-0.49427631898001667;-0.4496080134939868
Fractured radius;Abnormality of inferior alveolar nerve;0.9982415772974491;0.8518323;0.5005597236187611;0.547337548311015;0.9999201345566091;-0.0016785572591599962;-0.1480878639343557;-0.499360410937848;-0.4525825862455941
Fractured radius;Unilateral conductive hearing impairment;1.079232320189476;0.88136554;0.47475310638184365;0.5378516671025646;0.9999600672783046;0.07927225291117146;-0.11859452963487194;-0.5252069608964609;-0.46210840017573995
Fractured radius;Macular hypopigmented whorls, streaks, and patches;1.037777841091156;0.94656515;0.4879720775720744;0.5170169428536451;0.9999600672783046;0.03781777381285145;-0.053394916063704945;-0.5119879897062302;-0.4829431244246595
Fractured radius;Delayed ossification of pubic rami;0.6996076107025146;0.67308855;0.5971176247300773;0.6060078981660484;0.8355479869321181;-0.13594037622960342;-0.16245943636449112;-0.23843036220204072;-0.22954008876606968
Fractured radius;Hyperphenylalaninemia;1.0152619183063507;0.90207475;0.49514179190789265;0.5312206005022552;0.9999561589935034;0.015305759312847278;-0.09788140475537477;-0.5048143670856108;-0.46873555849124826
Fractured radius;Ureteropelvic junction obstruction;0.7996045649051666;0.65922695;0.5642226885939711;0.6106887733355655;0.9999528219730685;-0.20034825706790182;-0.34072586798976157;-0.4357301333790974;-0.38926404863750297
Fractured radius;Cone-shaped epiphysis of the proximal phalanx of the 2nd toe;0.5551689267158508;0.64086056;0.6467362855070542;0.6169297535955349;0.4693866352828394;0.08578229143301142;0.17147392227331293;0.17734965022421478;0.1475431183126955
Fractured radius;Difficulty walking;0.9450026601552963;0.8558013;0.517515034207407;0.5460604567388974;0.9203691460904122;0.02463351406488412;-0.0645678617772103;-0.40285411188300524;-0.37430868935151485
Fractured radius;Bilobate gallbladder;0.9530638009309769;0.85297954;0.5149457472098018;0.546968326618035;0.9999584729108851;-0.046894671979908265;-0.146978932085995;-0.48501272570108334;-0.45299014629285017
Fractured radius;Histidinuria;0.9263420701026917;0.87773055;0.5234673002633426;0.539017202128125;0.9999574798349273;-0.07361540973223568;-0.12222693145312191;-0.4764901795715847;-0.46094027770680235
Fractured radius;Widened interpedicular distance;0.7322254180908203;0.7425869;0.5862882462322934;0.582870106709084;0.822027235707794;-0.0898018176169737;-0.07944032498315412;-0.23573898947550065;-0.23915712899871
Abnormal manual kinetic perimetry test;Small radial epiphyses;0.8573570847511292;0.7762438;0.5455600519941102;0.5718319274124745;1.0;-0.14264291524887085;-0.22375619411468506;-0.4544399480058898;-0.42816807258752554
Abnormal manual kinetic perimetry test;Generalized keratosis follicularis;0.8693959563970566;0.82725954;0.5416916614938216;0.555262181552834;0.9999201345566091;-0.13052417815955253;-0.17266059399874778;-0.45822847306278747;-0.4446579530037751
Abnormal manual kinetic perimetry test;Hypoplasia of the calcaneus;0.9080893844366074;0.793675;0.5292974053419506;0.566150410957388;0.9999134918687169;-0.09182410743210956;-0.20623848643277332;-0.47061608652676634;-0.43376308091132887
Abnormal manual kinetic perimetry test;2-hydroxyadipic aciduria;0.8112432062625885;0.7189994;0.5604457832947116;0.5906662975471393;1.0;-0.1887567937374115;-0.28100061416625977;-0.4395542167052884;-0.4093337024528607
Abnormal manual kinetic perimetry test;Potter facies;0.9566562175750732;0.85534644;0.5138010780624316;0.5462067574254552;0.9998981869165328;-0.04324196934145952;-0.14455174564761186;-0.4860971088541012;-0.45369142949107755
Abnormal manual kinetic perimetry test;Increased heart rate variability;0.9258874729275703;0.80472744;0.5236123996323674;0.5625591472785851;0.9999201345566091;-0.07403266162903877;-0.1951926994446096;-0.4763077349242417;-0.43736098727802397
Abnormal manual kinetic perimetry test;Aplastic zygomatic arch;0.922167181968689;0.7920265;0.5248000381166844;0.5666867695303399;0.9999134918687169;-0.07774630990002795;-0.2078869720933263;-0.4751134537520325;-0.433226722338377
Abnormal manual kinetic perimetry test;Testicular torsion;0.8693034648895264;0.72437096;0.5417213569895409;0.5888861363978346;0.9999201345566091;-0.13061666966708274;-0.27554917813571067;-0.45819877756706817;-0.4110339981587745
Abnormal manual kinetic perimetry test;Abolished vibration sense;0.7789915204048157;0.7453432;0.5709348486013646;0.5819624868822137;0.9999134918687169;-0.22092197146390125;-0.25457028355572864;-0.42897864326735236;-0.41795100498650317
Abnormal manual kinetic perimetry test;Fractured metatarsal bone of digit 5;0.8739719390869141;0.76241416;0.5402229381511674;0.5763561077805575;1.0;-0.12602806091308594;-0.23758584260940552;-0.4597770618488326;-0.42364389221944254
Abnormal manual kinetic perimetry test;Prolonged G2 phase of cell cycle;0.8223868757486343;0.74342906;0.5568375655815645;0.5825927244551106;0.9999056439461368;-0.17751876819750245;-0.2564765791954654;-0.4430680783645723;-0.4173129194910262
Abnormal manual kinetic perimetry test;Single naris;0.882457435131073;0.9193392;0.5375016563193914;0.5257030689077355;0.9999056439461368;-0.11744820881506379;-0.08056646395346101;-0.4624039876267454;-0.47420257503840124
Abnormal manual kinetic perimetry test;Perifoveal ring of hyperautofluorescence surrounded by normal autofluorescence;0.5493935346603394;0.6806517;0.6487922266455489;0.6034639774784523;1.0;-0.45060646533966064;-0.3193482756614685;-0.3512077733544511;-0.39653602252154774
Abnormal manual kinetic perimetry test;Asymmetry of the thorax;0.9248327687382698;0.7577763;0.5239490615189815;0.5778767833573508;0.9999056439461368;-0.07507287520786698;-0.24212932396551545;-0.47595658242715533;-0.42202886058878597
Abnormal manual kinetic perimetry test;Type 2 muscle fiber predominance;0.9514169879257679;0.8475686;0.5154705429958542;0.5487103210091617;0.9999003561294039;-0.04848336820363597;-0.15233178456186847;-0.4844298131335497;-0.45119003512024214
Abnormal manual kinetic perimetry test;Dependency on parenteral nutrition;0.961954727768898;0.81581974;0.512113109645115;0.5589630098662203;0.9999134918687169;-0.03795876409981891;-0.18409375157330676;-0.4878003822236019;-0.44095048200249665
Abnormal manual kinetic perimetry test;Limited shoulder flexion;0.8185919523239136;0.70834845;0.5580654741442901;0.5942047645990403;1.0;-0.18140804767608643;-0.29165154695510864;-0.4419345258557099;-0.40579523540095974
Abnormal manual kinetic perimetry test;Paroxysmal vertigo;0.721768707036972;0.6774203;0.589748172615445;0.6045500281086438;0.9999134918687169;-0.2781447848317449;-0.32249317374203845;-0.41016531925327193;-0.39536346376007314
Abnormal manual kinetic perimetry test;Long hallux;0.9120018482208252;0.8258754;0.528046959169012;0.5557095558461922;0.9998836012415208;-0.08788175302069556;-0.17400819974463355;-0.47183664207250875;-0.44417404539532857
Abnormal manual kinetic perimetry test;Broad medial eyebrow;0.7692467868328094;0.7600229;0.5741190033309976;0.5771399349548978;0.9999201345566091;-0.23067334772379966;-0.23989725590975852;-0.4258011312256115;-0.4227801996017113
Abnormal manual kinetic perimetry test;Myxoid subcutaneous tumors;1.0136726535856724;0.91136926;0.4956477235826493;0.5282491115681041;0.9999201345566091;0.01375251902906327;-0.08855087043078513;-0.5042724109739598;-0.47167102298850505
Abnormal manual kinetic perimetry test;Bulbous tips of toes;0.9367373138666153;0.8617747;0.52015059470469;0.5441398157994668;0.9999134918687169;-0.06317617800210162;-0.1381388088700597;-0.47976289716402687;-0.4557736760692501
Abnormal manual kinetic perimetry test;Absent internal genitalia;0.9468406327068806;0.86270225;0.5169291319367857;0.543841705302561;1.0;-0.05315936729311943;-0.13729774951934814;-0.4830708680632143;-0.45615829469743896
Abnormal manual kinetic perimetry test;Hyperphalangy of the 2nd finger;0.802814707159996;0.68323183;0.5631800593066384;0.6025977200880566;0.9999201345566091;-0.19710542739661308;-0.3166883039596853;-0.4367400752499707;-0.39732241446855254
Abnormal manual kinetic perimetry test;Renal interstitial hemosiderin;0.9427155144512653;0.87132144;0.5182442054654421;0.5410735446940554;1.0;-0.057284485548734665;-0.128678560256958;-0.48175579453455786;-0.45892645530594456
Abnormal manual kinetic perimetry test;Abnormality of depressor anguli oris muscle;0.8372160941362381;0.72611666;0.5520473398638943;0.5883082207658972;1.0;-0.1627839058637619;-0.2738833427429199;-0.4479526601361057;-0.41169177923410283
Abnormal manual kinetic perimetry test;Paroxysmal dyspnea;0.8676789104938507;0.66338265;0.5422429992373654;0.6092828791388545;1.0;-0.1323210895061493;-0.3366173505783081;-0.4577570007626346;-0.3907171208611455
Abnormal manual kinetic perimetry test;Phenylpyruvic acidemia;0.7952629029750824;0.65109485;0.5656339410857532;0.613446464335841;0.9999201345566091;-0.2046572315815267;-0.34882528067858787;-0.43428619347085595;-0.38647367022076806
Abnormal manual kinetic perimetry test;Lateral ventricle dilatation;0.8819316402077675;0.7770509;0.537670195634667;0.5715683688203972;0.9998579617208769;-0.11792632151310944;-0.22280704934065843;-0.46218776608620993;-0.42828959290047974
Abnormal manual kinetic perimetry test;Neonatal unconjugated hyperbilirubinemia;0.9947566278278828;0.88062596;0.5016690248471221;0.538088765845797;0.9999201345566091;-0.005163506728726341;-0.11929417134554954;-0.49825110970948705;-0.4618313687108121
Abnormal manual kinetic perimetry test;High maternal circulating alpha-fetoprotein concentration;0.9091137796640396;0.80614364;0.5289699596438804;0.5620995624767515;1.0;-0.09088622033596039;-0.1938563585281372;-0.4710300403561196;-0.4379004375232485
Abnormal manual kinetic perimetry test;Prominent nasolabial fold;0.9847178868949413;0.9598314;0.5048646370459561;0.5127894957495283;0.9998944404568447;-0.015176553561903394;-0.04006302384994165;-0.49502980341088865;-0.48710494470731647
Abnormal manual kinetic perimetry test;Abnormality of inferior alveolar nerve;0.9444408044219017;0.8064599;0.5176941523181456;0.5619969690490793;1.0;-0.0555591955780983;-0.19354009628295898;-0.48230584768185436;-0.43800303095092075
Abnormal manual kinetic perimetry test;Unilateral conductive hearing impairment;0.6944537162780762;0.6998884;0.5988390703000421;0.5970239205989258;0.9999201345566091;-0.30546641827853294;-0.3000317263725576;-0.401081064256567;-0.40289621395768327
Abnormal manual kinetic perimetry test;Macular hypopigmented whorls, streaks, and patches;0.6079954504966736;0.6957692;0.6282182553132498;0.5983994085565203;0.9999201345566091;-0.3919246840599355;-0.30415094376834007;-0.3717018792433593;-0.4015207260000888
Abnormal manual kinetic perimetry test;Delayed ossification of pubic rami;1.0093914568424225;0.85571957;0.4970105624958272;0.5460867288795395;0.9999134918687169;0.009477964973705566;-0.14419392552350208;-0.5029029293728897;-0.45382676298917746
Abnormal manual kinetic perimetry test;Hyperphenylalaninemia;0.8674250394105911;0.75958294;0.5423245271783006;0.5772842108367995;0.9999028053808913;-0.13247776597030014;-0.24031986861712784;-0.45757827820259067;-0.4226185945440918
Abnormal manual kinetic perimetry test;Ureteropelvic junction obstruction;0.8993709981441498;0.81084275;0.5320855130035456;0.5605755997853616;0.9998847295244674;-0.1005137313803176;-0.18904197706780235;-0.4677992165209218;-0.43930912973910574
Abnormal manual kinetic perimetry test;Cone-shaped epiphysis of the proximal phalanx of the 2nd toe;0.7896512895822525;0.6775376;0.5674599352357295;0.6045105818222656;1.0;-0.2103487104177475;-0.32246237993240356;-0.43254006476427054;-0.3954894181777344
Abnormal manual kinetic perimetry test;Difficulty walking;0.7212347984313965;0.66433895;0.5899251216883212;0.6089596737854989;0.9998344221996177;-0.2785996237682212;-0.33549547585714945;-0.4099093005112965;-0.39087474841411884
Abnormal manual kinetic perimetry test;Bilobate gallbladder;1.0123665034770966;0.9445594;0.4960635193467672;0.5176563442052795;0.9999134918687169;0.012453011608379638;-0.05535409655545398;-0.5038499725219497;-0.4822571476634374
Abnormal manual kinetic perimetry test;Histidinuria;0.8811812028288841;0.7960549;0.537910760666457;0.5653764018063427;0.9999090677057578;-0.1187278648768737;-0.20385416801322243;-0.4619983070393008;-0.4345326658994151
Abnormal manual kinetic perimetry test;Widened interpedicular distance;0.7873613983392715;0.66782546;0.5682057001180407;0.6077823024872774;1.0;-0.21263860166072845;-0.33217453956604004;-0.4317942998819593;-0.3922176975127226
Small radial epiphyses;Generalized keratosis follicularis;0.8959488570690155;0.8450297;0.5331805644937615;0.5495281789495925;0.9999201345566091;-0.1039712774875936;-0.15489042283328147;-0.4667395700628476;-0.4503919556070166
Small radial epiphyses;Hypoplasia of the calcaneus;0.6240251064300537;0.6535455;0.6226921112796467;0.6126144856307825;0.6433114794007544;-0.019286372970700683;0.010234019447207032;-0.02061936812110765;-0.030696993769971925
Small radial epiphyses;2-hydroxyadipic aciduria;0.8091668784618378;0.73248553;0.5611189344622094;0.5862023141637829;1.0;-0.19083312153816223;-0.2675144672393799;-0.4388810655377906;-0.4137976858362171
Small radial epiphyses;Potter facies;0.8491045236587524;0.83522916;0.5482156904293367;0.5526884532693136;0.9998981869165328;-0.15079366325778032;-0.1646690285150435;-0.45168249648719605;-0.44720973364721917
Small radial epiphyses;Increased heart rate variability;1.0105026448145509;0.9333781;0.49665684286106715;0.5212221375654447;0.9999201345566091;0.010582510257941768;-0.06654203416140647;-0.503263291695542;-0.47869799699116444
Small radial epiphyses;Aplastic zygomatic arch;0.9925487972795963;0.83553624;0.5023718134375564;0.5525893537085957;0.8072246192530101;0.18532417802658618;0.028311622278361925;-0.3048528058154537;-0.2546352655444144
Small radial epiphyses;Testicular torsion;0.832644984126091;0.8032289;0.5535226086018094;0.5630455781667494;0.9999201345566091;-0.1672751504305181;-0.1966912198189077;-0.44639752595479976;-0.4368745563898597
Small radial epiphyses;Abolished vibration sense;0.994591262191534;0.9572719;0.5017216631106634;0.5136049351271506;0.9999134918687169;-0.005322229677182877;-0.04264161791775867;-0.49819182875805357;-0.48630855674156637
Small radial epiphyses;Fractured metatarsal bone of digit 5;0.5641326904296875;0.6115086;0.6435583054439711;0.6270036774131459;1.0;-0.4358673095703125;-0.3884913921356201;-0.3564416945560289;-0.3729963225868541
Small radial epiphyses;Prolonged G2 phase of cell cycle;0.934161439538002;0.91229796;0.520972234784383;0.5279523462430094;0.9999056439461368;-0.06574420440813478;-0.08760767985006745;-0.47893340916175375;-0.47195329770312744
Small radial epiphyses;Single naris;0.9763000495731831;0.83898747;0.5075446349233999;0.5514759506197036;0.9999056439461368;-0.02360559437295373;-0.16091817427298005;-0.49236100902273694;-0.44842969332643323
Small radial epiphyses;Perifoveal ring of hyperautofluorescence surrounded by normal autofluorescence;0.865080937743187;0.7481796;0.5430774426598852;0.5810292188986336;1.0;-0.13491906225681305;-0.2518203854560852;-0.4569225573401148;-0.41897078110136643
Small radial epiphyses;Asymmetry of the thorax;0.7899415791034698;0.75752175;0.5673654215521369;0.5779603107716642;0.789736248610815;0.0002053304926548094;-0.032214500068029395;-0.22237082705867817;-0.21177593783915083
Small radial epiphyses;Type 2 muscle fiber predominance;0.8871961459517479;0.82221544;0.5359831714568597;0.5568930184848315;0.8527273749847077;0.03446877096704015;-0.03051193709560862;-0.31674420352784804;-0.2958343564998762
Small radial epiphyses;Dependency on parenteral nutrition;0.9133151546120644;0.91262466;0.5276273170379686;0.5278479511086791;0.9999134918687169;-0.08659833725665256;-0.08728883471463367;-0.4722861748307483;-0.4720655407600378
Small radial epiphyses;Limited shoulder flexion;0.656576931476593;0.6758203;0.6115864649794848;0.6050882517680787;1.0;-0.343423068523407;-0.3241797089576721;-0.38841353502051523;-0.3949117482319213
Small radial epiphyses;Paroxysmal vertigo;1.1151427328586578;0.89262146;0.4632674570724893;0.5342456799191672;0.9999134918687169;0.11522924098994092;-0.10729203429196521;-0.5366460347962276;-0.46566781194954976
Small radial epiphyses;Long hallux;0.8302741050720215;0.92866075;0.5542882355360637;0.522727293920762;0.5200670694678955;0.310207035604126;0.40859368092120363;0.03422116606816816;0.002660224452866511
Small radial epiphyses;Broad medial eyebrow;0.9373520761728287;0.90645325;0.5199545208393958;0.5298204561927604;0.9999201345566091;-0.06256805838378043;-0.09346688271792503;-0.47996561371721336;-0.4700996783638487
Small radial epiphyses;Myxoid subcutaneous tumors;0.9059542715549469;0.79019797;0.5299799898695614;0.5672819599359948;0.9999201345566091;-0.09396586300166221;-0.20972216607363792;-0.4699401446870477;-0.43263817462061427
Small radial epiphyses;Bulbous tips of toes;0.6825742721557617;0.67987806;0.6028184169193513;0.6037238872014027;0.6433114794007544;0.039262792755007325;0.03656657664859253;-0.04049306248140305;-0.03958759219935171
Small radial epiphyses;Absent internal genitalia;0.9052374288439751;0.7964742;0.5302091916215951;0.5652400642357136;1.0;-0.09476257115602493;-0.20352578163146973;-0.4697908083784049;-0.4347599357642864
Small radial epiphyses;Hyperphalangy of the 2nd finger;0.709500789642334;0.7017524;0.5938213632060939;0.5964021145279303;0.660589513309896;0.04891127633243797;0.04116291093021629;-0.0667681501038021;-0.06418739878196567
Small radial epiphyses;Renal interstitial hemosiderin;0.8583608269691467;0.7543242;0.5452372735497484;0.5790098515833337;1.0;-0.14163917303085327;-0.24567580223083496;-0.4547627264502516;-0.42099014841666627
Small radial epiphyses;Abnormality of depressor anguli oris muscle;0.8878979831933975;0.81914425;0.5357583436484676;0.5578867254314397;1.0;-0.11210201680660248;-0.18085575103759766;-0.46424165635153236;-0.4421132745685603
Small radial epiphyses;Paroxysmal dyspnea;0.938617154955864;0.79581875;0.5195510571391759;0.5654531924256077;1.0;-0.06138284504413605;-0.2041812539100647;-0.48044894286082407;-0.43454680757439235
Small radial epiphyses;Phenylpyruvic acidemia;0.8714499771595001;0.7898116;0.5410322873083657;0.5674077363109392;0.9999201345566091;-0.12847015739710899;-0.210108523381072;-0.4588878472482434;-0.4325123982456699
Small radial epiphyses;Lateral ventricle dilatation;0.9778075478971004;0.8114494;0.507064656880345;0.5603789372791238;0.9998579617208769;-0.022050413823776482;-0.18840855318968797;-0.49279330484053196;-0.43947902444175313
Small radial epiphyses;Neonatal unconjugated hyperbilirubinemia;0.9351252019405365;0.8121135;0.5206648023708924;0.5601637152667427;0.9999201345566091;-0.06479493261607261;-0.18780661107333274;-0.4792553321857167;-0.4397564192898664
Small radial epiphyses;High maternal circulating alpha-fetoprotein concentration;0.9982547722756863;0.9258457;0.5005555235202954;0.5236257386045182;1.0;-0.001745227724313736;-0.0741543173789978;-0.4994444764797046;-0.4763742613954818
Small radial epiphyses;Prominent nasolabial fold;1.0386593043804169;0.88892174;0.4876912939441117;0.5354304315412977;0.9998944404568447;0.038764863923572146;-0.11097270278594629;-0.512203146512733;-0.46446400891554707
Small radial epiphyses;Abnormality of inferior alveolar nerve;1.0916955173015594;0.9095512;0.4707713529150057;0.5288301499165257;1.0;0.09169551730155945;-0.09044879674911499;-0.5292286470849943;-0.47116985008347434
Small radial epiphyses;Unilateral conductive hearing impairment;1.1261827796697617;0.94084734;0.459727417016617;0.5188398704141747;0.9999201345566091;0.12626264511315255;-0.059072797310667946;-0.5401927175399921;-0.48108026414243443
Small radial epiphyses;Macular hypopigmented whorls, streaks, and patches;0.9768902063369751;0.8268527;0.5073567307154659;0.5553936756682529;0.9999201345566091;-0.02302992821963401;-0.1730674553039846;-0.49256340384114317;-0.4445264588883562
Small radial epiphyses;Delayed ossification of pubic rami;0.6494821906089783;0.63798696;0.6139943884103987;0.6179104188631066;0.6574179255159834;-0.007935734907005165;-0.01943096748909745;-0.043423537105584775;-0.039507506652876834
Small radial epiphyses;Hyperphenylalaninemia;0.9696573428809643;0.89399016;0.5096598503876756;0.5338075099239314;0.9999028053808913;-0.03024546249992699;-0.10591264634616226;-0.4902429549932157;-0.4660952954569598
Small radial epiphyses;Ureteropelvic junction obstruction;0.8877003416419029;0.8157824;0.5358216546827043;0.5589750935706425;0.9998847295244674;-0.11218438788256446;-0.18410230173668662;-0.4640630748417631;-0.44090963595382493
Small radial epiphyses;Cone-shaped epiphysis of the proximal phalanx of the 2nd toe;0.4684275984764099;0.51626974;0.6783986519411115;0.6607184206836485;1.0;-0.5315724015235901;-0.4837302565574646;-0.3216013480588885;-0.3392815793163515
Small radial epiphyses;Difficulty walking;1.0341016575694084;0.96995133;0.48914300025742186;0.5095662299551508;0.7552776988623575;0.2788239587070509;0.21467363275309048;-0.26613469860493566;-0.24571146890720674
Small radial epiphyses;Bilobate gallbladder;1.0105752777308226;0.9095095;0.4966337218016901;0.5288434760009741;0.9999134918687169;0.010661785862105644;-0.09040401186917468;-0.5032797700670268;-0.4710700158677428
Small radial epiphyses;Histidinuria;0.838933140039444;0.8101103;0.551493477788225;0.5608130547346278;0.9999090677057578;-0.16097592766631386;-0.18979879672873756;-0.44841558991753283;-0.43909601297113
Small radial epiphyses;Widened interpedicular distance;0.7028056979179382;0.78945315;0.5960509115732155;0.5675244501985153;1.0;-0.29719430208206177;-0.2105468511581421;-0.40394908842678445;-0.4324755498014847
Generalized keratosis follicularis;Hypoplasia of the calcaneus;0.9601561799645424;0.9077699;0.5126860399097823;0.5293995187666147;0.9999584729108851;-0.03980229294634274;-0.09218855446911267;-0.4872724330011028;-0.4705589541442704
Generalized keratosis follicularis;2-hydroxyadipic aciduria;0.9091836735606194;0.8411089;0.5289476193366391;0.5507918599151844;0.9999201345566091;-0.09073646099598975;-0.15881121636660667;-0.47097251521996997;-0.4491282746414247
Generalized keratosis follicularis;Potter facies;0.7734257876873016;0.8171398;0.5727525821723053;0.5585355750368632;0.9999552432134126;-0.22652945552611092;-0.18281543885016183;-0.42720266104110727;-0.4414196681765493
Generalized keratosis follicularis;Increased heart rate variability;0.9142225161194801;0.83262444;0.5273374150498966;0.5535292526576839;0.9999600672783046;-0.08573755115882442;-0.16733563185349987;-0.47262265222840794;-0.4464308146206206
Generalized keratosis follicularis;Aplastic zygomatic arch;0.9429590590298176;0.8749076;0.5181665558513657;0.5399227376451035;0.9999584729108851;-0.05699941388106755;-0.125050860110287;-0.4817919170595194;-0.4600357352657817
Generalized keratosis follicularis;Testicular torsion;0.9090397506952286;0.90461165;0.5289936218074708;0.5304092905660029;0.9999600672783046;-0.09092031658307598;-0.09534842014924572;-0.47096644547083377;-0.4695507767123016
Generalized keratosis follicularis;Abolished vibration sense;0.9288704693317413;0.90928555;0.5226603682902717;0.5289150533736287;0.9999584729108851;-0.0710880035791438;-0.09067292756176404;-0.4772981046206134;-0.4710434195372565
Generalized keratosis follicularis;Fractured metatarsal bone of digit 5;0.9152432531118393;0.9144138;0.5270113167512189;0.5272763091600845;0.9999201345566091;-0.08467688144476981;-0.08550632478030296;-0.4729088178053902;-0.4726438253965246
Generalized keratosis follicularis;Prolonged G2 phase of cell cycle;0.8287056684494019;0.7542997;0.5547949041691955;0.579017905737277;0.9999567459343585;-0.1712510774849566;-0.2456570456741961;-0.44516184176516294;-0.4209388401970815
Generalized keratosis follicularis;Single naris;0.8470205068588257;0.9408007;0.5488868457538021;0.5188547426518487;0.9999567459343585;-0.15293623907553278;-0.05915601952063165;-0.45106990018055637;-0.48110200328250974
Generalized keratosis follicularis;Perifoveal ring of hyperautofluorescence surrounded by normal autofluorescence;0.5763666331768036;0.59159607;0.639245503363053;0.633914509640026;0.9999201345566091;-0.4235535013798055;-0.4083240676048574;-0.36067463119355614;-0.36600562491658306
Generalized keratosis follicularis;Asymmetry of the thorax;1.0041632084175944;0.8878942;0.4986748057743058;0.535759551287121;0.9999567459343585;0.004206462483235973;-0.11206253273474298;-0.5012819401600527;-0.4641971946472374
Generalized keratosis follicularis;Type 2 muscle fiber predominance;0.8479235172271729;0.7231438;0.5485960055382224;0.5892925622289367;0.9999556674707869;-0.15203215024361405;-0.2768118514765242;-0.4513596619325645;-0.41066310524185023
Generalized keratosis follicularis;Dependency on parenteral nutrition;0.9467854872345924;0.84390616;0.5169467101664966;0.549890216207511;0.9999584729108851;-0.053172985676292694;-0.1560523087415736;-0.4830117627443885;-0.45006825670337414
Generalized keratosis follicularis;Limited shoulder flexion;0.9580070748925209;0.80650556;0.5133706948366965;0.5619821559095451;0.9999201345566091;-0.041913059664088204;-0.19341457368167014;-0.4865494397199126;-0.43793797864706396
Generalized keratosis follicularis;Paroxysmal vertigo;0.9853688273578882;0.84926677;0.5046574130782036;0.5481634586748516;0.9999584729108851;-0.01458964555299691;-0.15069170540905408;-0.4953010598326816;-0.4517950142360335
Generalized keratosis follicularis;Long hallux;0.8843566626310349;0.9191277;0.5368929619068736;0.5257706024743564;0.9999526340597648;-0.1155959714287299;-0.08082493134675206;-0.4630596721528911;-0.4741820315854084
Generalized keratosis follicularis;Broad medial eyebrow;0.6455492377281189;0.7447923;0.6153321479484071;0.5821438540453198;0.8733283781844945;-0.2277791404563756;-0.12853609560316515;-0.2579962302360874;-0.2911845241391747
Generalized keratosis follicularis;Myxoid subcutaneous tumors;0.6860405802726746;0.715042;0.6016555908091464;0.5919796674394717;0.8434590184411804;-0.15741843816850587;-0.12841702339265748;-0.241803427632034;-0.2514793510017087
Generalized keratosis follicularis;Bulbous tips of toes;0.867919385433197;0.9103107;0.5421657758933695;0.528587407796359;0.9999584729108851;-0.1320390874776881;-0.0896477872762721;-0.4577926970175157;-0.4713710651145261
Generalized keratosis follicularis;Absent internal genitalia;0.7145203053951263;0.76332396;0.5921529131379721;0.5760580002916562;0.9999201345566091;-0.28539982916148277;-0.23659617186816306;-0.40776722141863697;-0.4238621342649529
Generalized keratosis follicularis;Hyperphalangy of the 2nd finger;0.7868311256170273;0.7714344;0.5683784518174537;0.5734035418469428;0.9999600672783046;-0.21312894166127727;-0.22852564097062633;-0.43158161546085083;-0.4265565254313618
Generalized keratosis follicularis;Renal interstitial hemosiderin;0.8134120404720306;0.7383772;0.5597429333073537;0.5842576451876509;0.9999201345566091;-0.18650809408457847;-0.26154292107852073;-0.4401772012492554;-0.4156624893689582
Generalized keratosis follicularis;Abnormality of depressor anguli oris muscle;0.9454206265509129;0.8907075;0.5173817912383337;0.534858525634843;0.9999201345566091;-0.05449950800569625;-0.10921264172823997;-0.4825383433182754;-0.46506160892176607
Generalized keratosis follicularis;Paroxysmal dyspnea;0.9939585365355015;0.86420953;0.5019230692463298;0.5433573910636771;0.9999201345566091;-0.005961598021107628;-0.13571060181887717;-0.4979970653102793;-0.456562743492932
Generalized keratosis follicularis;Phenylpyruvic acidemia;0.9078534916043282;0.8098721;0.529372812362394;0.560890271802471;0.9999600672783046;-0.0921065756739764;-0.19008797646180675;-0.4705872549159106;-0.4390697954758336
Generalized keratosis follicularis;Lateral ventricle dilatation;1.005655637010932;0.83428234;0.4981997452294392;0.5529940411377857;0.9999488789551968;0.005706758055735173;-0.16566654033596462;-0.5017491337257576;-0.4469548378174111
Generalized keratosis follicularis;Neonatal unconjugated hyperbilirubinemia;0.9365342706441879;0.82356346;0.5202153555086361;0.5564570479979207;0.9999600672783046;-0.06342579663411663;-0.1763966107429652;-0.4797447117696685;-0.4435030192803838
Generalized keratosis follicularis;High maternal circulating alpha-fetoprotein concentration;0.7959035187959671;0.70599294;0.5654256279814835;0.5949889127093122;0.9999201345566091;-0.204016615760642;-0.2939271974685964;-0.43449450657512556;-0.4049312218472969
Generalized keratosis follicularis;Prominent nasolabial fold;0.7907585799694061;0.80579746;0.5670994513047454;0.5622119005887114;0.9999545338528789;-0.20919595388347278;-0.1941570761578716;-0.43285508254813354;-0.4377426332641675
Generalized keratosis follicularis;Abnormality of inferior alveolar nerve;0.8778940886259079;0.8522252;0.5389647574273411;0.54721109742906;0.9999201345566091;-0.12202604593070121;-0.14769495011599632;-0.46095537712926804;-0.45270903712754906
Generalized keratosis follicularis;Unilateral conductive hearing impairment;0.9856153968721628;0.8516855;0.5045789193029064;0.5473847714864506;0.9999600672783046;-0.014344670406141735;-0.14827454329148815;-0.4953811479753981;-0.45257529579185396
Generalized keratosis follicularis;Macular hypopigmented whorls, streaks, and patches;0.5504080653190613;0.69088286;0.6484305884346566;0.6000335178546432;0.8284944252404275;-0.2780863599213662;-0.1376115636262002;-0.18006383680577087;-0.22846090738578428
Generalized keratosis follicularis;Delayed ossification of pubic rami;0.9519111067056656;0.9231037;0.5153130760439952;0.5245010326496856;0.9999584729108851;-0.048047366205219544;-0.07685478276348523;-0.4846453968668899;-0.4754574402611995
Generalized keratosis follicularis;Hyperphenylalaninemia;0.8839191049337387;0.82628965;0.5370331852097721;0.5555756594410433;0.9999561589935034;-0.11603705405976472;-0.17366650521542726;-0.4629229737837314;-0.4443804995524602
Generalized keratosis follicularis;Ureteropelvic junction obstruction;0.9663822129368782;0.88292825;0.5107028906083684;0.5373507534453226;0.9999528219730685;-0.033570609036190246;-0.11702456975291464;-0.4892499313647001;-0.4626020685277459
Generalized keratosis follicularis;Cone-shaped epiphysis of the proximal phalanx of the 2nd toe;0.8526037335395813;0.8382155;0.5470892577910992;0.5517249598229108;0.9999201345566091;-0.1473164010170278;-0.16170466424258323;-0.4528308767655099;-0.4481951747336983
Generalized keratosis follicularis;Difficulty walking;0.9381802082061768;0.8395027;0.5196904062573768;0.5513098035663204;0.9999461221900431;-0.06176591398386633;-0.16044342996744787;-0.48025571593266625;-0.44863631862372266
Generalized keratosis follicularis;Bilobate gallbladder;1.0254424512386322;0.9336946;0.4919005422604399;0.5211211500030659;0.9999584729108851;0.02548397832774707;-0.06626387185192517;-0.5080579306504452;-0.4788373229078192
Generalized keratosis follicularis;Histidinuria;0.7828359603881836;0.76650167;0.5696806544080286;0.5750173306737975;0.9999574798349273;-0.21712151944674374;-0.2334558147195709;-0.4302768254268987;-0.4249401491611299
Generalized keratosis follicularis;Widened interpedicular distance;0.9614075049757957;0.83136195;0.512287424095468;0.553936899328126;0.9999201345566091;-0.03851262958081336;-0.16855818511279197;-0.4876327104611411;-0.44598323522848315
Hypoplasia of the calcaneus;2-hydroxyadipic aciduria;0.8246957957744598;0.7033305;0.5560908966353747;0.5958759761925605;0.9999134918687169;-0.17521769609425708;-0.2965829750535314;-0.4438225952333422;-0.4040375156761564
Hypoplasia of the calcaneus;Potter facies;0.981363870203495;0.97259647;0.5059324077810397;0.508723902978767;0.9999532306564473;-0.01858936045295223;-0.027356764115156973;-0.4940208228754076;-0.49122932767768024
Hypoplasia of the calcaneus;Increased heart rate variability;1.0313481912016869;1.0006714;0.4900199257862248;0.4997862974757976;0.9999584729108851;0.03138971829080173;0.0007129138078648678;-0.5099385471246604;-0.5001721754350875
Hypoplasia of the calcaneus;Aplastic zygomatic arch;0.8074901252985001;0.68382186;0.5616627443479336;0.6023997325873122;0.9036123096265051;-0.09612218432800501;-0.21979045265094965;-0.34194956527857145;-0.3012125770391929
Hypoplasia of the calcaneus;Testicular torsion;0.974335178732872;0.9075674;0.5081702634395904;0.5294642742633144;0.9999584729108851;-0.025623294178013123;-0.09239109105205945;-0.49178820947129476;-0.4704941986475707
Hypoplasia of the calcaneus;Abolished vibration sense;0.8756084740161896;0.8166742;0.5396978807918162;0.5586863338890783;0.9999567459343585;-0.12434827191816888;-0.18328257305609308;-0.4602588651425422;-0.44127041204528017
Hypoplasia of the calcaneus;Fractured metatarsal bone of digit 5;0.4808088541030884;0.6601567;0.6737667266091838;0.6103740317508716;0.42239095481135847;0.05841789929172991;0.23776577202579974;0.25137577179782533;0.1879830769395131
Hypoplasia of the calcaneus;Prolonged G2 phase of cell cycle;1.0150707894936204;0.9694216;0.4952026370967677;0.5097349248133289;0.9999548690865008;0.01511592040711962;-0.030533243949171673;-0.5047522319897331;-0.49021994427317184
Hypoplasia of the calcaneus;Single naris;0.938528522849083;0.8916831;0.5195793229931258;0.5345461226241259;0.9999548690865008;-0.06142634623741783;-0.10827176743244804;-0.48037554609337496;-0.46540874646237484
Hypoplasia of the calcaneus;Perifoveal ring of hyperautofluorescence surrounded by normal autofluorescence;0.9990603039041162;0.8878901;0.5002991146013493;0.5357608782582532;0.9999134918687169;-0.0008531879646007656;-0.11202339138959094;-0.49961437726736757;-0.46415261361046367
Hypoplasia of the calcaneus;Asymmetry of the thorax;0.7993129342794418;0.7201118;0.564317442404755;0.5902974055968464;0.8994299275196795;-0.1001169932402377;-0.1793181402004962;-0.33511248511492453;-0.30913252192283314
Hypoplasia of the calcaneus;Type 2 muscle fiber predominance;0.8651618361473083;0.87572265;0.543051454420908;0.5396612447248693;0.9315598035443521;-0.06639796739704373;-0.05583715683109525;-0.3885083491234441;-0.39189855881948277
Hypoplasia of the calcaneus;Dependency on parenteral nutrition;0.9629791975021362;0.91782665;0.5117867808511798;0.5261861060537201;0.9999567459343585;-0.03697754843222223;-0.08213009340750299;-0.48816996508317867;-0.4737706398806384
Hypoplasia of the calcaneus;Limited shoulder flexion;0.7787618041038513;0.7592454;0.5710098255620453;0.5773948901658196;0.8193379704785829;-0.040576166374731604;-0.06009257481818253;-0.24832814491653765;-0.24194308031276335
Hypoplasia of the calcaneus;Paroxysmal vertigo;1.0647564604878426;0.9090593;0.47937294502117334;0.5289873752283516;0.9999567459343585;0.0647997145534841;-0.09089745981680475;-0.5205838009131851;-0.47096937070600686
Hypoplasia of the calcaneus;Long hallux;0.5222924947738647;0.67636794;0.6585321239303237;0.6049039968486452;0.7626934093495967;-0.24040091457573198;-0.08632547083107256;-0.10416128541927305;-0.15778941250095158
Hypoplasia of the calcaneus;Broad medial eyebrow;0.982012802734971;0.99060327;0.5057258114966456;0.5029911172593621;0.9999584729108851;-0.017945670175914086;-0.00935520476437024;-0.4942326614142395;-0.49696735565152306
Hypoplasia of the calcaneus;Myxoid subcutaneous tumors;0.8938840627670288;0.84435976;0.5338414682160207;0.5497440663317066;0.9999584729108851;-0.10607441014385632;-0.15559871739483289;-0.4661170046948644;-0.45021440657917855
Hypoplasia of the calcaneus;Bulbous tips of toes;0.691891610622406;0.76293045;0.5996959453857716;0.5761869324384247;0.7931629904903006;-0.10127137986789458;-0.030232537666661674;-0.19346704510452895;-0.21697605805187592
Hypoplasia of the calcaneus;Absent internal genitalia;0.900107316672802;0.8222469;0.5318499485658097;0.5568828290938952;0.9999134918687169;-0.09980617519591495;-0.1776665827271764;-0.4680635433029072;-0.4430306627748217
Hypoplasia of the calcaneus;Hyperphalangy of the 2nd finger;0.7115473747253418;0.6990017;0.5931407756281797;0.5973198412439591;0.8287763732556668;-0.11722899853032498;-0.12977464376729397;-0.2356355976274871;-0.23145653201170768
Hypoplasia of the calcaneus;Renal interstitial hemosiderin;1.0246114078909159;0.9292101;0.49216515446403375;0.5225519812346453;0.9999134918687169;0.02469791602219895;-0.07070336546872302;-0.5077483374046832;-0.4773615106340716
Hypoplasia of the calcaneus;Abnormality of depressor anguli oris muscle;0.7620039284229279;0.6822527;0.5764905389507845;0.6029263633562836;0.872141863789474;-0.11013793536654615;-0.18988915869227552;-0.2956513248386895;-0.2692155004331904
Hypoplasia of the calcaneus;Paroxysmal dyspnea;0.9219920039176941;0.77553993;0.5248559690756693;0.5720618339174967;0.9999134918687169;-0.07792148795102283;-0.22437355723355457;-0.4750575227930476;-0.42785165795122027
Hypoplasia of the calcaneus;Phenylpyruvic acidemia;0.8993013873696327;0.73994875;0.532107783926455;0.5837394621468182;0.9999584729108851;-0.10065708554125241;-0.2600097233686488;-0.46785068898443016;-0.416219010764067
Hypoplasia of the calcaneus;Lateral ventricle dilatation;0.983996756374836;0.80251247;0.5050942081136924;0.5632781999653416;0.9999462364511621;-0.015949480076326128;-0.19743376954366088;-0.49485202833746966;-0.43666803648582053
Hypoplasia of the calcaneus;Neonatal unconjugated hyperbilirubinemia;0.9421756900846958;0.8392163;0.5184163222058034;0.5514021575358251;0.9999584729108851;-0.057782782826189316;-0.16074218100643567;-0.4815421507050818;-0.44855631537506
Hypoplasia of the calcaneus;High maternal circulating alpha-fetoprotein concentration;0.9603717960417271;0.86513007;0.5126173529325646;0.5430616696935073;0.9999134918687169;-0.03954169582698985;-0.13478342499707385;-0.4872961389361523;-0.4568518221752096
Hypoplasia of the calcaneus;Prominent nasolabial fold;0.9120156541466713;0.87003905;0.5280425474945347;0.5414851952998188;0.9999524555142131;-0.08793680136754178;-0.12991340970351362;-0.47190990801967836;-0.4584672602143943
Hypoplasia of the calcaneus;Abnormality of inferior alveolar nerve;0.8877406790852547;0.7754466;0.5358087331686497;0.5720923235637116;0.9999134918687169;-0.11217281278346225;-0.22446689810727283;-0.4641047587000672;-0.4278211683050053
Hypoplasia of the calcaneus;Unilateral conductive hearing impairment;1.0026901634410024;0.8634237;0.499143693348431;0.5436098848405131;0.9999584729108851;0.0027316905301172367;-0.13653476780987195;-0.5008147795624541;-0.45634858807037204
Hypoplasia of the calcaneus;Macular hypopigmented whorls, streaks, and patches;1.0148000046610832;0.8885147;0.4952888402012873;0.5355608014345608;0.9999584729108851;0.01484153175019809;-0.11144377535915784;-0.5046696327095979;-0.4643976714763244
Hypoplasia of the calcaneus;Delayed ossification of pubic rami;0.5543268322944641;0.5761313;0.6470356438129485;0.6393282099828337;0.8287089627579918;-0.27438213046352766;-0.2525776785210838;-0.18167331894504324;-0.1893807527751581
Hypoplasia of the calcaneus;Hyperphenylalaninemia;1.0001247636973858;0.8484348;0.4999602864815822;0.5484313486083012;0.9999542297279059;0.000170533969479858;-0.15151942385784978;-0.49999394324632374;-0.4515228811196047
Hypoplasia of the calcaneus;Ureteropelvic junction obstruction;0.9027073904871941;0.7352143;0.5310182670683476;0.5853012214744333;0.9999505803237132;-0.09724318983651914;-0.2647362873206309;-0.46893231325536555;-0.4146493588492799
Hypoplasia of the calcaneus;Cone-shaped epiphysis of the proximal phalanx of the 2nd toe;0.4139057397842407;0.47903383;0.6993351786088828;0.674428237544399;0.5863259809806012;-0.17242024119636046;-0.10729215319892393;0.11300919762828165;0.08810225656379778
Hypoplasia of the calcaneus;Difficulty walking;0.8911401256918907;0.83839405;0.5347199805570642;0.551667359492952;0.9160188400246831;-0.02487871433279243;-0.0776247941949102;-0.381298859467619;-0.36435148053173116
Hypoplasia of the calcaneus;Bilobate gallbladder;0.9558067210018635;0.833637;0.5140717406044254;0.55320235063294;0.9999567459343585;-0.04415002493249498;-0.16631974680410944;-0.48588500532993306;-0.44675439530141847
Hypoplasia of the calcaneus;Histidinuria;1.017096672207117;0.9611991;0.49455769506616154;0.5123538013521046;0.9999556674707869;0.01714100473633018;-0.03875656268486771;-0.5053979724046254;-0.4876018661186823
Hypoplasia of the calcaneus;Widened interpedicular distance;0.7170924544334412;0.85504913;0.5912989612858923;0.5463024015203458;0.8072246192530101;-0.09013216481956898;0.047824514047771105;-0.21592565796711782;-0.26092221773266433
2-hydroxyadipic aciduria;Potter facies;0.7840096354484558;0.804065;0.5692979794053594;0.5627741542013839;0.9998981869165328;-0.21588855146807695;-0.19583319782656694;-0.43060020751117334;-0.4371240327151489
2-hydroxyadipic aciduria;Increased heart rate variability;0.9683062732219696;0.9097737;0.5100901162851862;0.5287590291076285;0.9999201345566091;-0.031613861334639504;-0.09014642716677757;-0.4898300182714229;-0.4711611054489806
2-hydroxyadipic aciduria;Aplastic zygomatic arch;0.9394758641719818;0.7893697;0.5192772123127422;0.5675516262166881;0.9999134918687169;-0.06043762769673511;-0.21054378952954456;-0.48063627955597477;-0.43236186565202883
2-hydroxyadipic aciduria;Testicular torsion;0.8791147470474243;0.7959;0.5385733099044497;0.5654267762881692;0.717226575899895;0.1618881711475293;0.07867341132086914;-0.1786532659954453;-0.15179979961172585
2-hydroxyadipic aciduria;Abolished vibration sense;1.0168431550264359;0.9618579;0.4946384037132989;0.5121439413943105;0.9999134918687169;0.016929663157718933;-0.03805557694409534;-0.505275088155418;-0.4877695504744064
2-hydroxyadipic aciduria;Fractured metatarsal bone of digit 5;0.9559248201549053;0.9093014;0.5140341118113272;0.5289099952578737;1.0;-0.04407517984509468;-0.09069859981536865;-0.4859658881886728;-0.47109000474212626
2-hydroxyadipic aciduria;Prolonged G2 phase of cell cycle;0.7300282716751099;0.66891205;0.5870143584971406;0.6074156919315342;0.6766288643064248;0.05339940736868509;-0.007716811198209439;-0.0896145058092842;-0.06921317237489055
2-hydroxyadipic aciduria;Single naris;0.9601223766803741;0.9860231;0.5126968083876141;0.5044491302856494;0.9999056439461368;-0.039783267265762645;-0.013882515913452464;-0.4872088355585227;-0.4954565136604874
2-hydroxyadipic aciduria;Perifoveal ring of hyperautofluorescence surrounded by normal autofluorescence;0.8427308797836304;0.7341208;0.550269008752064;0.5856622353535896;1.0;-0.15726912021636963;-0.26587921380996704;-0.44973099124793603;-0.41433776464641037
2-hydroxyadipic aciduria;Asymmetry of the thorax;0.9078491181135178;0.8084836;0.5293742104362;0.5613405153956662;0.9999056439461368;-0.09205652583261903;-0.1914220433296817;-0.47053143350993676;-0.4385651285504706
2-hydroxyadipic aciduria;Type 2 muscle fiber predominance;0.6905287504196167;0.5690624;0.6001520468525497;0.6418170920507646;0.9999003561294039;-0.30937160570978717;-0.43083794434427813;-0.3997483092768541;-0.3580832640786392
2-hydroxyadipic aciduria;Dependency on parenteral nutrition;0.7368589639663696;0.77478355;0.5847584559443092;0.5723089197092224;0.9999134918687169;-0.2630545279023473;-0.22512994017575427;-0.4151550359244077;-0.42760457215949454
2-hydroxyadipic aciduria;Limited shoulder flexion;0.8416407555341721;0.73481196;0.550620409561217;0.5854340353503429;1.0;-0.15835924446582794;-0.2651880383491516;-0.44937959043878295;-0.4145659646496571
2-hydroxyadipic aciduria;Paroxysmal vertigo;0.999979087151587;0.8327372;0.5000066567663985;0.5534928285102136;0.9999134918687169;6.559528287009009e-05;-0.1671762844559972;-0.49990683510231837;-0.4464206633585033
2-hydroxyadipic aciduria;Long hallux;0.9835525751113892;0.92861646;0.505235614016857;0.5227414195704866;0.9998836012415208;-0.0163310261301316;-0.07126713710348975;-0.49464798722466374;-0.47714218167103417
2-hydroxyadipic aciduria;Broad medial eyebrow;0.976765476167202;0.9600964;0.5073964442251311;0.5127050847215411;0.9999201345566091;-0.023154658389407112;-0.039823715699034645;-0.492523690331478;-0.487215049835068
2-hydroxyadipic aciduria;Myxoid subcutaneous tumors;0.8854948133230209;0.82401997;0.5365282544780734;0.5563094162266209;0.9999201345566091;-0.11442532123358817;-0.17590016604693504;-0.4633918800785357;-0.4436107183299882
2-hydroxyadipic aciduria;Bulbous tips of toes;0.9068776741623878;0.9019379;0.5296847660562036;0.5312643749874515;0.9999134918687169;-0.09303581770632907;-0.09797558989499255;-0.4702287258125133;-0.4686491168812654
2-hydroxyadipic aciduria;Absent internal genitalia;0.9076125174760818;0.8049532;0.5294498454095837;0.562485879159011;1.0;-0.09238748252391815;-0.1950467824935913;-0.47055015459041627;-0.43751412084098895
2-hydroxyadipic aciduria;Hyperphalangy of the 2nd finger;0.7808551490306854;0.61423284;0.5703267275208685;0.6260631936993192;0.9999201345566091;-0.21906498552592368;-0.38568729640277;-0.42959340703574056;-0.37385694085728993
2-hydroxyadipic aciduria;Renal interstitial hemosiderin;0.7646790444850922;0.7309591;0.5756141263987313;0.5867066764222475;1.0;-0.23532095551490784;-0.26904088258743286;-0.42438587360126867;-0.4132933235777525
2-hydroxyadipic aciduria;Abnormality of depressor anguli oris muscle;0.8336062133312225;0.628687;0.5532122885723139;0.6210923039657024;1.0;-0.16639378666877747;-0.3713129758834839;-0.44678771142768614;-0.37890769603429764
2-hydroxyadipic aciduria;Paroxysmal dyspnea;0.8498018085956573;0.7079153;0.5479911789508491;0.5943489260400528;1.0;-0.15019819140434265;-0.2920846939086914;-0.45200882104915086;-0.40565107395994715
2-hydroxyadipic aciduria;Phenylpyruvic acidemia;0.5139102041721344;0.5621297;0.661577208693416;0.6442671009183651;0.726290173501319;-0.21237996932918457;-0.16416049715930847;-0.064712964807903;-0.08202307258295383
2-hydroxyadipic aciduria;Lateral ventricle dilatation;0.9171712771058083;0.83492416;0.5263954416488177;0.5527868943195623;0.9998579617208769;-0.08268668461506867;-0.16493380028670335;-0.47346252007205925;-0.44707106740131464
2-hydroxyadipic aciduria;Neonatal unconjugated hyperbilirubinemia;0.6724774837493896;0.72235715;0.6062137284081489;0.5895531714907986;0.726290173501319;-0.05381268975192932;-0.00393301960880188;-0.12007644509317006;-0.13673700201052041
2-hydroxyadipic aciduria;High maternal circulating alpha-fetoprotein concentration;0.8103752881288528;0.7945171;0.560727131271909;0.565876494544416;1.0;-0.18962471187114716;-0.20548290014266968;-0.439272868728091;-0.434123505455584
2-hydroxyadipic aciduria;Prominent nasolabial fold;1.0400920733809471;0.9281101;0.48723487540422716;0.5229030248629243;0.9998944404568447;0.04019763292410239;-0.07178431777618066;-0.5126595650526176;-0.47699141559392044
2-hydroxyadipic aciduria;Abnormality of inferior alveolar nerve;0.9755913764238358;0.76648057;0.5077702778865802;0.5750242379812384;1.0;-0.024408623576164246;-0.23351943492889404;-0.49222972211341975;-0.42497576201876164
2-hydroxyadipic aciduria;Unilateral conductive hearing impairment;1.0058472943492234;0.87581795;0.49813873779475637;0.539630687188096;0.9999201345566091;0.005927159792614267;-0.12410218001635642;-0.5017813967618527;-0.46028944736851307
2-hydroxyadipic aciduria;Macular hypopigmented whorls, streaks, and patches;0.820921465754509;0.74391305;0.5573116202239818;0.5824333504810093;0.9999201345566091;-0.17899866880210014;-0.25600708009036155;-0.44260851433262727;-0.4174867840755998
2-hydroxyadipic aciduria;Delayed ossification of pubic rami;0.9132942855358124;0.7936355;0.5276339849768712;0.5661632762448447;0.9999134918687169;-0.08661920633290454;-0.2062780043122594;-0.4722795068918457;-0.43375021562387217
2-hydroxyadipic aciduria;Hyperphenylalaninemia;0.5901283621788025;0.6239537;0.6344265085893159;0.622716630477287;0.6669007119557334;-0.07677234977693093;-0.04294701189012062;-0.03247420336641749;-0.044184081478446435
2-hydroxyadipic aciduria;Ureteropelvic junction obstruction;0.8588913828134537;0.7754966;0.5450666789717613;0.5720759883502959;0.46433788485954575;0.39455349795390793;0.3111587171988649;0.08072879411221556;0.10773810349075019
2-hydroxyadipic aciduria;Cone-shaped epiphysis of the proximal phalanx of the 2nd toe;0.8062212467193604;0.64611995;0.5620743921557739;0.6151378826680229;1.0;-0.19377875328063965;-0.35388004779815674;-0.4379256078442261;-0.38486211733197706
2-hydroxyadipic aciduria;Difficulty walking;0.8838065341114998;0.85331476;0.5370692617386847;0.5468604351905488;0.9998344221996177;-0.11602788808811793;-0.14651966485251078;-0.46276516046093297;-0.4529739870090689
2-hydroxyadipic aciduria;Bilobate gallbladder;0.7919528484344482;0.7781501;0.5667107491036745;0.5712095145614906;0.9999134918687169;-0.20796064343426868;-0.22176341023419543;-0.43320274276504245;-0.4287039773072263
2-hydroxyadipic aciduria;Histidinuria;0.5119702219963074;0.5638963;0.6622842592213753;0.6436419163217347;0.250755027712249;0.26121519428405837;0.3131412706962593;0.41152923150912635;0.39288688860948573
2-hydroxyadipic aciduria;Widened interpedicular distance;0.8536545932292938;0.75491226;0.5467510915629807;0.5788167777426787;1.0;-0.14634540677070618;-0.24508774280548096;-0.45324890843701926;-0.4211832222573213
Potter facies;Increased heart rate variability;1.0276911463588476;0.95887613;0.4911845074900153;0.5130938246713961;0.9999552432134126;0.02773590314543506;-0.04107911024832467;-0.5087707357233973;-0.4868614185420165
Potter facies;Aplastic zygomatic arch;0.9081157818436623;0.9249175;0.5292889670796352;0.523922010572615;0.875272781796774;0.03284300004688823;0.04964473729578578;-0.3459838147171388;-0.35135077122415903
Potter facies;Testicular torsion;0.8817137479782104;0.84908915;0.5377400423356808;0.5482206421020773;0.9999552432134126;-0.11824149523520211;-0.15086609755301217;-0.4622152008777317;-0.45173460111133523
Potter facies;Abolished vibration sense;0.9320687428116798;1.0064023;0.5216398559708595;0.49796208826706545;0.9999532306564473;-0.06788448784476742;0.006449023448167002;-0.47831337468558777;-0.5019911423893818
Potter facies;Fractured metatarsal bone of digit 5;0.9963072827085853;1.0029179;0.5011754310921441;0.49907120204818767;0.9998981869165328;-0.0035909042079474984;0.003019698863801712;-0.49872275582438863;-0.5008269848683451
Potter facies;Prolonged G2 phase of cell cycle;0.9356075003743172;0.89744407;0.5205109603353044;0.5327020611624753;0.9999510285821799;-0.06434352820786271;-0.10250695919665131;-0.47944006824687546;-0.46724896741970456
Potter facies;Single naris;0.8412771672010422;0.8979854;0.5507376258286705;0.5325288397667685;0.8694001614694122;-0.02812299426837006;0.028585237299966426;-0.31866253564074176;-0.3368713217026438
Potter facies;Perifoveal ring of hyperautofluorescence surrounded by normal autofluorescence;0.8806556463241577;0.86188966;0.5380792493855854;0.5441028581589162;0.9998981869165328;-0.11924254059237505;-0.1380085265581038;-0.4618189375309474;-0.4557953287576165
Potter facies;Asymmetry of the thorax;0.8776301294565201;0.82954204;0.5390494130879354;0.5545247046092456;0.9999510285821799;-0.1223208991256598;-0.17040898775728974;-0.46090161549424447;-0.44542632397293425
Potter facies;Type 2 muscle fiber predominance;0.90143171697855;0.8507199;0.5314262878354377;0.5476955901303392;0.9999496416008017;-0.09851792462225173;-0.1492297128593466;-0.468523353765364;-0.4522540514704625
Potter facies;Dependency on parenteral nutrition;0.8673767149448395;0.8383754;0.5423400463718598;0.5516733722646627;0.9999532306564473;-0.13257651571160778;-0.161577841080489;-0.4576131842845874;-0.4482798583917845
Potter facies;Limited shoulder flexion;0.9498375281691551;0.9198984;0.5159739146046772;0.5255244839769564;0.9998981869165328;-0.05006065874737764;-0.07999979614657426;-0.48392427231185553;-0.47437370293957637
Potter facies;Paroxysmal vertigo;0.9582183547317982;0.83756137;0.5133033832985028;0.5519359529428269;0.9999532306564473;-0.041734875924649084;-0.16239186171418651;-0.4866498473579445;-0.4480172777136203
Potter facies;Long hallux;0.8448818325996399;0.84283626;0.5495758313146053;0.5502350425361107;0.9999456907727517;-0.15506385817311186;-0.1571094299771585;-0.45036985945814645;-0.4497106482366411
Potter facies;Broad medial eyebrow;0.7840346693992615;0.8476262;0.5692898182335014;0.5486917575125319;0.8806399863091361;-0.09660531690987462;-0.03301377705010289;-0.31135016807563465;-0.33194822879660424
Potter facies;Myxoid subcutaneous tumors;0.9198249727487564;0.92465997;0.5255479243056518;0.5240042127853164;0.9999552432134126;-0.08013027046465615;-0.07529527579092721;-0.4744073189077608;-0.47595103042809617
Potter facies;Bulbous tips of toes;0.7058239579200745;0.7367306;0.5950451990728027;0.5848008267290228;0.9999532306564473;-0.2941292727363728;-0.2632226550949238;-0.4049080315836445;-0.4151524039274245
Potter facies;Absent internal genitalia;0.8184604793787003;0.8820353;0.5581080298873516;0.5376369578908736;0.9998981869165328;-0.1814377075378325;-0.11786287187975908;-0.4417901570291811;-0.46226122902565914
Potter facies;Hyperphalangy of the 2nd finger;0.830236941576004;0.8019121;0.5543002392407075;0.5634731349613211;0.9999552432134126;-0.16971830163740853;-0.19804311428808907;-0.4456550039727051;-0.43648210825209144
Potter facies;Renal interstitial hemosiderin;0.9948124922811985;0.98484546;0.5016512423974928;0.5048240324423159;0.9998981869165328;-0.005085694635334259;-0.015052727455320603;-0.49824694451903995;-0.4950741544742169
Potter facies;Abnormality of depressor anguli oris muscle;0.9880175571888685;1.0187114;0.5038142212847672;0.4940436076694661;0.7284789198879239;0.2595386373009446;0.2902325278278354;-0.22466469860315674;-0.23443531221845781
Potter facies;Paroxysmal dyspnea;0.9332548752427101;0.8202311;0.5212614393421806;0.5575349922416037;0.9998981869165328;-0.06664331167382265;-0.17966710686129594;-0.47863674757435215;-0.442363194674929
Potter facies;Phenylpyruvic acidemia;0.7530465573072433;0.66529596;0.5794294753333598;0.6086363537892423;0.9999552432134126;-0.2469086859061692;-0.3346592846944306;-0.4205257678800528;-0.39131888942417026
Potter facies;Lateral ventricle dilatation;1.028298132121563;0.9432866;0.4909912221643119;0.518062123244541;0.9999406960247658;0.028357436096797195;-0.056654098296036515;-0.5089494738604539;-0.4818785727802247
Potter facies;Neonatal unconjugated hyperbilirubinemia;0.9988627368584275;0.96065086;0.5003620021791886;0.5125284520006793;0.9999552432134126;-0.0010925063549850345;-0.03930438195013741;-0.499593241034224;-0.48742679121273325
Potter facies;High maternal circulating alpha-fetoprotein concentration;0.8741698563098907;0.80017006;0.5401594335980722;0.5640389685210114;0.9998981869165328;-0.125728330606642;-0.19972812294405962;-0.4597387533184606;-0.43585921839552133
Potter facies;Prominent nasolabial fold;0.79339399933815;0.783571;0.5662418276516664;0.5694409725946457;0.8617867669399137;-0.06839276760176372;-0.07821576207236003;-0.2955449392882473;-0.2923457943452681
Potter facies;Abnormality of inferior alveolar nerve;0.9765581302344799;0.98574257;0.5074624624670689;0.5045384281962485;0.9998981869165328;-0.023340056682052857;-0.014155617946806198;-0.4924357244494638;-0.49535975872028426
Potter facies;Unilateral conductive hearing impairment;0.977867167443037;0.94843155;0.5070456747270353;0.5164220238851887;0.9999552432134126;-0.022088075770375526;-0.05152369175696114;-0.49290956848637724;-0.4835332193282239
Potter facies;Macular hypopigmented whorls, streaks, and patches;0.8311433345079422;0.8258834;0.5540074990707347;0.5557069692427212;0.9999552432134126;-0.16881190870547036;-0.17407185469412545;-0.4459477441426779;-0.44424827397069133
Potter facies;Delayed ossification of pubic rami;0.8820867240428925;0.8738394;0.5376204836629825;0.5402654634819899;0.9999532306564473;-0.1178665066135548;-0.12611385229951366;-0.4623327469934647;-0.45968776717445736
Potter facies;Hyperphenylalaninemia;0.7676693201065063;0.6988297;0.5746351530590816;0.5973772610127883;0.9999502748700689;-0.23228095476356259;-0.3011205643865179;-0.4253151218109873;-0.4025730138572806
Potter facies;Ureteropelvic junction obstruction;1.019744349643588;0.9531095;0.49371476989539875;0.5149311850077742;0.9999459376721075;0.01979841197148058;-0.04683643487974909;-0.5062311677767087;-0.48501475266433325
Potter facies;Cone-shaped epiphysis of the proximal phalanx of the 2nd toe;0.8661695420742035;0.8242667;0.5427277576825383;0.5562296448490018;0.9998981869165328;-0.13372864484232927;-0.17563151478213335;-0.4571704292339944;-0.4436685420675309
Potter facies;Difficulty walking;0.9169412106275558;0.96574533;0.5264689272981371;0.5109057383760099;0.999936953772814;-0.08299574314525815;-0.03419162391594144;-0.4734680264746769;-0.48903121539680405
Potter facies;Bilobate gallbladder;0.975570309907198;0.9273787;0.5077769855672709;0.5231364353258352;0.9999532306564473;-0.024382920749249304;-0.07257451657182201;-0.49217624508917635;-0.47681679533061205
Potter facies;Histidinuria;0.8341909348964691;0.8209472;0.5530235440020568;0.5573033038093385;0.999951967215123;-0.1657610323186539;-0.17900479695755467;-0.44692842321306625;-0.44264866340578457
Potter facies;Widened interpedicular distance;0.8519496321678162;0.78885007;0.5472997743632652;0.5677208216468134;0.9998981869165328;-0.1479485547487166;-0.21104811787051225;-0.4525984125532676;-0.4321773652697194
Increased heart rate variability;Aplastic zygomatic arch;0.901869885623455;0.81072927;0.5312861349568458;0.5606123884522274;0.9999584729108851;-0.09808858728743008;-0.18922920769787244;-0.4686723379540393;-0.43934608445865775
Increased heart rate variability;Testicular torsion;0.9373140409588814;0.8102436;0.5199666516672142;0.5607698122472551;0.9999600672783046;-0.06264602631942318;-0.18971646071092174;-0.4799934156110903;-0.43919025503104947
Increased heart rate variability;Abolished vibration sense;0.8656876683235168;0.86162317;0.5428825402905231;0.5441885124881092;0.9999584729108851;-0.1342708045873683;-0.13833530491924695;-0.45707593262036206;-0.45576996042277595
Increased heart rate variability;Fractured metatarsal bone of digit 5;1.012473065406084;0.95011663;0.496029597014885;0.5158849657271107;0.9999201345566091;0.012552930849474953;-0.049803500187712624;-0.5038905375417241;-0.4840351688294984
Increased heart rate variability;Prolonged G2 phase of cell cycle;0.7923835813999176;0.69632435;0.5665705819324014;0.5982139203702803;0.9999567459343585;-0.20757316453444086;-0.30363239748465143;-0.43338616400195706;-0.40174282556407814
Increased heart rate variability;Single naris;1.010240375995636;1.0256414;0.49674033010961327;0.49183718107064944;0.9999567459343585;0.010283630061277527;0.025684695410856384;-0.5032164158247452;-0.508119564863709
Increased heart rate variability;Perifoveal ring of hyperautofluorescence surrounded by normal autofluorescence;0.8912333995103836;0.76233125;0.5346901132326345;0.5763832624503369;0.9999201345566091;-0.1086867350462255;-0.2375888872268972;-0.4652300213239746;-0.4235368721062722
Increased heart rate variability;Asymmetry of the thorax;0.7555787563323975;0.6512525;0.5785979645446779;0.6133929180350607;0.9999567459343585;-0.244377989601961;-0.3487042377709063;-0.4213587813896805;-0.3865638278992978
Increased heart rate variability;Type 2 muscle fiber predominance;0.8986222594976425;0.8291868;0.5323250689920331;0.5546394700558486;0.9999556674707869;-0.10133340797314438;-0.1707688703287581;-0.46763059847875377;-0.44531619741493833
Increased heart rate variability;Dependency on parenteral nutrition;0.9862626753747463;0.89286613;0.5043728637821223;0.5341673496780913;0.9999584729108851;-0.01369579753613881;-0.10709233826733044;-0.4955856091287628;-0.4657911232327938
Increased heart rate variability;Limited shoulder flexion;1.019725888967514;0.8970058;0.4937206472557525;0.5328423223716491;0.9999201345566091;0.01980575441090493;-0.10291433812411399;-0.5061994873008566;-0.46707781218496003
Increased heart rate variability;Paroxysmal vertigo;0.942683719098568;0.78740025;0.5182543428965096;0.5681930549869318;0.9999584729108851;-0.05727475381231717;-0.21255822724438123;-0.4817041300143755;-0.4317654179239533
Increased heart rate variability;Long hallux;0.93867377191782;0.82859015;0.5195330013840601;0.5548322157108265;0.9999526340597648;-0.06127886214194478;-0.1713624794119376;-0.48041963267570464;-0.44512041834893823
Increased heart rate variability;Broad medial eyebrow;0.8533677160739899;0.76341987;0.5468434032264677;0.5760265857194047;0.9999600672783046;-0.14659235120431469;-0.2365402007164149;-0.4531166640518368;-0.42393348155889987
Increased heart rate variability;Myxoid subcutaneous tumors;0.9327970370650291;0.8943599;0.5214075017129048;0.5336891573926118;0.9999600672783046;-0.06716303021327541;-0.1056001806320338;-0.4785525655653997;-0.46627090988569275
Increased heart rate variability;Bulbous tips of toes;0.8809964656829834;0.81309354;0.5379699845258081;0.5598461296144945;0.9999584729108851;-0.11896200722790173;-0.1868649298582118;-0.461988488385077;-0.4401123432963906
Increased heart rate variability;Absent internal genitalia;1.0057675149291754;0.9645753;0.49816413280111727;0.511278397299266;0.9999201345566091;0.005847380372566269;-0.03534484387667747;-0.5017560017554918;-0.48864173725734306
Increased heart rate variability;Hyperphalangy of the 2nd finger;0.953560147434473;0.83882844;0.5147875827338613;0.5515272541963929;0.9999600672783046;-0.046399919843831516;-0.16113162279740856;-0.4851724845444433;-0.44843281308191163
Increased heart rate variability;Renal interstitial hemosiderin;0.9032574817538261;0.80798566;0.5308423376604293;0.5615020109603055;0.9999201345566091;-0.09666265280278297;-0.19193447114260764;-0.4690777968961798;-0.4384181235963036
Increased heart rate variability;Abnormality of depressor anguli oris muscle;0.9424531906843185;0.83724356;0.518327843686952;0.5520384896301245;0.9999201345566091;-0.057466943872290566;-0.16267657758029075;-0.48159229086965716;-0.44788164492648463
Increased heart rate variability;Paroxysmal dyspnea;0.753756195306778;0.75921494;0.5791963923996676;0.5774048888655641;0.9999201345566091;-0.24616393924983115;-0.24070519686968894;-0.4207237421569415;-0.42251524569104504
Increased heart rate variability;Phenylpyruvic acidemia;0.9448418915271759;0.8529353;0.5175662862481871;0.546982539920339;0.9999600672783046;-0.05511817575112865;-0.14702475309983776;-0.48239378103011743;-0.4529775273579656
Increased heart rate variability;Lateral ventricle dilatation;0.7982609272003174;0.71673566;0.5646592984887617;0.5914173759603678;0.9999488789551968;-0.2016879517548794;-0.2832132179253811;-0.43528958046643507;-0.408531502994829
Increased heart rate variability;Neonatal unconjugated hyperbilirubinemia;0.8734717965126038;0.82456243;0.5403834231814628;0.556134006773898;0.9999600672783046;-0.1264882707657008;-0.17539763689652965;-0.45957664409684174;-0.44382606050440654
Increased heart rate variability;High maternal circulating alpha-fetoprotein concentration;0.7760643661022186;0.6688921;0.5718905417203142;0.6074224176716492;0.9999201345566091;-0.22385576845439048;-0.33102804900439353;-0.42802959283629494;-0.39249771688495994
Increased heart rate variability;Prominent nasolabial fold;0.9314995557069778;0.8119103;0.5218214568796073;0.5602295867392444;0.9999545338528789;-0.06845497814590107;-0.18804426220828663;-0.47813307697327156;-0.4397249471136345
Increased heart rate variability;Abnormality of inferior alveolar nerve;0.9991144873201847;0.865461;0.5002818674771632;0.5429553449621589;0.9999201345566091;-0.0008056472364244005;-0.13445914269717307;-0.4996382670794459;-0.4569647895944502
Increased heart rate variability;Unilateral conductive hearing impairment;1.0253369882702827;0.90108716;0.49193412299135775;0.5315365055295662;0.9999600672783046;0.02537692099197819;-0.09887290239945934;-0.5080259442869468;-0.46842356174873834
Increased heart rate variability;Macular hypopigmented whorls, streaks, and patches;0.9261585175991058;0.86473787;0.5235258863826991;0.543187660132245;0.9999600672783046;-0.07380154967919872;-0.13522219896928356;-0.4764341808956054;-0.4567724071460596
Increased heart rate variability;Delayed ossification of pubic rami;0.9286917224526405;0.8091039;0.5227174100346309;0.5611393545657419;0.9999584729108851;-0.0712667504582446;-0.19085456675625256;-0.47724106287625423;-0.4388191183451432
Increased heart rate variability;Hyperphenylalaninemia;0.8591085374355316;0.69083863;0.5449968589782312;0.6000483207256662;0.9999561589935034;-0.1408476215579718;-0.3091175240256995;-0.4549593000152722;-0.39990783826783727
Increased heart rate variability;Ureteropelvic junction obstruction;0.9678467735648155;0.8906888;0.5102364541561298;0.5348645189861829;0.9999528219730685;-0.03210604840825293;-0.10926404500315878;-0.4897163678169386;-0.4650883029868855
Increased heart rate variability;Cone-shaped epiphysis of the proximal phalanx of the 2nd toe;1.0344639010727406;0.99999136;0.48902762674877975;0.5000027514930895;0.9999201345566091;0.03454376651613145;7.122276989846021e-05;-0.5108925078078294;-0.4999173830635196
Increased heart rate variability;Difficulty walking;0.9324418902397156;0.88309675;0.521520805960043;0.5372967466436565;0.9999461221900431;-0.06750423195032751;-0.11684936763910925;-0.47842531623000006;-0.46264937554638663
Increased heart rate variability;Bilobate gallbladder;1.018812021240592;0.9092711;0.4940115944163166;0.5289196780790923;0.9999584729108851;0.01885354832970687;-0.09068735188579968;-0.5059468784945685;-0.4710387948317928
Increased heart rate variability;Histidinuria;0.9122622981667519;0.8297623;0.5279637334702356;0.5544535604630121;0.9999574798349273;-0.08769518166817547;-0.17019519984759213;-0.4719937463646917;-0.44550391937191525
Increased heart rate variability;Widened interpedicular distance;0.8487501442432404;0.6257606;0.5483298026056324;0.6220961666609246;0.9999201345566091;-0.15116999031336875;-0.37415951968463035;-0.45159033195097675;-0.3778239678956845
Aplastic zygomatic arch;Testicular torsion;0.9155421629548073;0.8381335;0.5269158284073403;0.5517513909867531;0.9999584729108851;-0.08441630995607785;-0.16182495898342542;-0.47304264450354483;-0.44820708192413206
Aplastic zygomatic arch;Abolished vibration sense;0.8625799864530563;0.8675612;0.5438810051472022;0.5422807983390101;0.9999567459343585;-0.13737675948130212;-0.13239552481161676;-0.4560757407871563;-0.45767594759534835
Aplastic zygomatic arch;Fractured metatarsal bone of digit 5;0.7829445600509644;0.7279763;0.5696452413614796;0.587692905702828;0.8072246192530101;-0.02428005920204579;-0.07924829707893788;-0.2375793778915305;-0.2195317135501822
Aplastic zygomatic arch;Prolonged G2 phase of cell cycle;0.9759856462478638;0.8649459;0.507644741102968;0.5431208368177173;0.9999548690865008;-0.023969222838637005;-0.13500898056721367;-0.4923101279835328;-0.4568340322687835
Aplastic zygomatic arch;Single naris;0.920194610953331;0.95714575;0.5254298865758633;0.5136451123331527;0.8796422427997362;0.04055236815359475;0.07750350772287729;-0.3542123562238729;-0.36599713046658355
Aplastic zygomatic arch;Perifoveal ring of hyperautofluorescence surrounded by normal autofluorescence;0.9926702766679227;0.816959;0.5023331442912125;0.5585941024569663;0.9999134918687169;-0.007243215200794184;-0.18295446839306995;-0.49758034757750447;-0.44131938941175064
Aplastic zygomatic arch;Asymmetry of the thorax;0.8082567453384399;0.66736495;0.5614140891966858;0.607937723681923;0.8688019857338005;-0.06054524039536058;-0.20143703078537523;-0.30738789653711474;-0.2608642620518775
Aplastic zygomatic arch;Type 2 muscle fiber predominance;1.0748673900961876;0.9828876;0.4761466505831944;0.5054473020194029;0.9315598035443521;0.1433075865518355;0.05132782214992282;-0.4554131529611577;-0.42611250152494917
Aplastic zygomatic arch;Dependency on parenteral nutrition;0.9650422483682632;0.8875359;0.5111296655527535;0.5358743198932963;0.9999567459343585;-0.034914497566095215;-0.11242081625448785;-0.48882708038160494;-0.4640824260410622
Aplastic zygomatic arch;Limited shoulder flexion;1.1514829099178314;0.9812751;0.4515951492252577;0.5059606815158804;0.8193379704785829;0.3321449394392485;0.16193711115593856;-0.36774282125332525;-0.31337728896270256
Aplastic zygomatic arch;Paroxysmal vertigo;0.7748825699090958;0.78578115;0.5722765753793765;0.5687205738023736;0.9999567459343585;-0.2250741760252627;-0.21417560083853326;-0.427680170554982;-0.43123617213198484
Aplastic zygomatic arch;Long hallux;0.8640913218259811;0.8296574;0.5433953756457128;0.5544874474536978;0.8894132426424965;-0.02532192081651541;-0.05975586682996603;-0.3460178669967837;-0.3349257951887987
Aplastic zygomatic arch;Broad medial eyebrow;0.7111862897872925;0.73247826;0.5932608217252541;0.5862047163934648;0.8892531322460213;-0.17806684245872884;-0.1567748712520638;-0.29599231052076724;-0.3030484158525565
Aplastic zygomatic arch;Myxoid subcutaneous tumors;0.9272864162921906;0.87273955;0.5231658972594808;0.5406184124759559;0.9999584729108851;-0.07267205661869458;-0.12721891945934705;-0.4767925756514043;-0.45934006043492925
Aplastic zygomatic arch;Bulbous tips of toes;0.8774068653583527;0.85561824;0.5391210193962497;0.5461193430112491;0.9036123096265051;-0.02620544426815241;-0.04799407117740839;-0.3644912902302554;-0.357492966615256
Aplastic zygomatic arch;Absent internal genitalia;0.766592338681221;0.7296115;0.5749876579538347;0.5871521400747826;0.9999134918687169;-0.2333211531874959;-0.2703019758698766;-0.42492583391488226;-0.41276135179393436
Aplastic zygomatic arch;Hyperphalangy of the 2nd finger;0.8183131814002991;0.7257889;0.5581557091946019;0.588416705094562;0.9074607173141833;-0.08914753591388425;-0.1816718259987231;-0.34930500811958143;-0.3190440122196213
Aplastic zygomatic arch;Renal interstitial hemosiderin;1.1202772408723831;0.98883855;0.4616216488789817;0.503552873744475;0.9999134918687169;0.1203637490036662;-0.011074938440067017;-0.5382918429897352;-0.4963606181242419
Aplastic zygomatic arch;Abnormality of depressor anguli oris muscle;0.7005356848239899;0.7360734;0.5968079527866508;0.5850176901437724;0.7692950606685226;-0.06875937584453273;-0.03322168592029262;-0.17248710788187183;-0.18427737052475024
Aplastic zygomatic arch;Paroxysmal dyspnea;0.8672599196434021;0.74137205;0.5423775550968328;0.5832703621585011;0.9999134918687169;-0.13265357222531482;-0.25854144301388904;-0.4575359367718841;-0.4166431297102158
Aplastic zygomatic arch;Phenylpyruvic acidemia;0.9685709625482559;0.75317717;0.5100058210610396;0.579386573221571;0.9999584729108851;-0.03138751036262921;-0.2467813069257777;-0.4899526518498455;-0.4205718996893141
Aplastic zygomatic arch;Lateral ventricle dilatation;0.9021198749542236;0.83957744;0.5312061759514;0.5512856994074362;0.9999462364511621;-0.09782636149693846;-0.16036880000401854;-0.46874006049976213;-0.4486605370437259
Aplastic zygomatic arch;Neonatal unconjugated hyperbilirubinemia;1.0044423900544643;0.84912825;0.4985859386763103;0.5482080470273456;0.9999584729108851;0.004483917143579208;-0.15083022660351209;-0.5013725342345748;-0.45175042588353953
Aplastic zygomatic arch;High maternal circulating alpha-fetoprotein concentration;0.932649627327919;0.7829557;0.5214545302393752;0.5696416068118778;0.9999134918687169;-0.06726386454079791;-0.21695778574917957;-0.47845896162934176;-0.4302718850568391
Aplastic zygomatic arch;Prominent nasolabial fold;0.47821223735809326;0.68789536;0.6747347092009203;0.6010339548981393;0.8732055871936235;-0.39499334983553025;-0.18531022958482835;-0.19847087799270324;-0.27217163229548424
Aplastic zygomatic arch;Abnormality of inferior alveolar nerve;0.4347418546676636;0.61378264;0.6912234405630723;0.6262185230916879;0.9999134918687169;-0.5651716372010533;-0.38613084759686633;-0.30869005130564464;-0.373694968777029
Aplastic zygomatic arch;Unilateral conductive hearing impairment;0.8083306849002838;0.8203785;0.5613901087215214;0.5574873059006294;0.9999584729108851;-0.19162778801060132;-0.17957999056911877;-0.43856836418936374;-0.4424711670102557
Aplastic zygomatic arch;Macular hypopigmented whorls, streaks, and patches;0.9189349412918091;0.8306808;0.5258321553255497;0.5541568785134403;0.9999584729108851;-0.08102353161907605;-0.16927768534756116;-0.4741263175853354;-0.4458015943974448
Aplastic zygomatic arch;Delayed ossification of pubic rami;0.6832272410392761;0.65653336;0.6025992603075017;0.6116012222120752;0.9036123096265051;-0.22038506858722895;-0.24707894914524287;-0.3010130493190034;-0.2920110874144298
Aplastic zygomatic arch;Hyperphenylalaninemia;0.9526504576206207;0.7213923;0.5150774649222678;0.5898729377594012;0.9999542297279059;-0.0473037721072852;-0.27856195582501286;-0.4848767648056381;-0.41008129196850474
Aplastic zygomatic arch;Ureteropelvic junction obstruction;1.0056614503264427;0.8038983;0.4981978947640152;0.5628282805010563;0.9999505803237132;0.005710870002729518;-0.19605230542518415;-0.501752685559698;-0.43712229982265693
Aplastic zygomatic arch;Cone-shaped epiphysis of the proximal phalanx of the 2nd toe;0.7991193234920502;0.672715;0.5643803517458542;0.6061337118588845;0.8072246192530101;-0.008105295760959974;-0.13450961099419056;-0.24284426750715593;-0.2010909073941256
Aplastic zygomatic arch;Difficulty walking;0.958266481757164;0.9363364;0.5132880506169375;0.5202784702951622;0.9160188400246831;0.042247641732480856;0.02031755810001168;-0.40273078940774565;-0.395740369729521
Aplastic zygomatic arch;Bilobate gallbladder;1.0569057390093803;0.8877038;0.4818765502867184;0.5358205448717266;0.9999567459343585;0.05694899307502188;-0.11225296957480035;-0.5180801956476401;-0.46413620106263187
Aplastic zygomatic arch;Histidinuria;1.0681712478399277;0.97733897;0.47828357513197095;0.5072138391722805;0.9999556674707869;0.06821558036914077;-0.02261669776329789;-0.521672092338816;-0.49274182829850643
Aplastic zygomatic arch;Widened interpedicular distance;0.9301963299512863;0.79379463;0.522237281982239;0.5661114958268003;0.7485161685812178;0.18168016137006848;0.04527846337678998;-0.22627888659897888;-0.18240467275441752
Testicular torsion;Abolished vibration sense;0.8482181876897812;0.7862027;0.5485011073804591;0.5685831967915771;0.9999584729108851;-0.15174028522110394;-0.2137557441625636;-0.45145736553042604;-0.43137527611930804
Testicular torsion;Fractured metatarsal bone of digit 5;0.8654258549213409;0.84010696;0.5429666416160337;0.5511149364644917;0.9999201345566091;-0.13449427963526817;-0.15981317044528098;-0.4569534929405754;-0.4488051980921174
Testicular torsion;Prolonged G2 phase of cell cycle;0.8718869388103485;0.87783813;0.5408920384209666;0.5389827119951174;0.9999567459343585;-0.12806980712400995;-0.12211861116873346;-0.4590647075133919;-0.4609740339392411
Testicular torsion;Single naris;1.000806862488389;0.99941933;0.49974316766528737;0.5001848230320509;0.9999567459343585;0.0008501165540305555;-0.0005374143837603151;-0.5002135782690711;-0.49977192290230754
Testicular torsion;Perifoveal ring of hyperautofluorescence surrounded by normal autofluorescence;0.9816691502928734;0.90275586;0.5058352175067261;0.5310027568198601;0.9999201345566091;-0.018250984263735726;-0.09716427804263206;-0.494084917049883;-0.468917377736749
Testicular torsion;Asymmetry of the thorax;0.7060382962226868;0.5401157;0.5949738168521981;0.6521091056374801;0.9999567459343585;-0.2939184497116717;-0.4598410318611773;-0.4049829290821604;-0.3478476402968783
Testicular torsion;Type 2 muscle fiber predominance;0.9325707256793976;0.86157846;0.5214797026380036;0.5442028851066141;0.9999556674707869;-0.06738494179138932;-0.13837720296273026;-0.4784759648327833;-0.4557527823641728
Testicular torsion;Dependency on parenteral nutrition;0.9597115963697433;0.9148371;0.5128276689881799;0.5271410518983495;0.9999584729108851;-0.040246876541141785;-0.08512135094738416;-0.48713080392270525;-0.47281742101253565
Testicular torsion;Limited shoulder flexion;0.8324686884880066;0.74362624;0.5535795288619451;0.5825278004868005;0.9999201345566091;-0.16745144606860252;-0.25629389764102073;-0.44634060569466405;-0.4173923340698086
Testicular torsion;Paroxysmal vertigo;0.9330729469656944;0.7520547;0.5213194786892095;0.5797553201177705;0.9999584729108851;-0.0668855259451907;-0.24790378159618787;-0.47863899422167566;-0.4202031527931146
Testicular torsion;Long hallux;0.9578252844512463;0.9047123;0.5134286118410716;0.5303771061082925;0.9999526340597648;-0.042127349608518494;-0.09524031468568028;-0.4865240222186932;-0.4695755279514723
Testicular torsion;Broad medial eyebrow;0.9622631408274174;0.9654207;0.5120148681695798;0.5110091145323539;0.9999600672783046;-0.03769692645088718;-0.03453934431687877;-0.4879451991087248;-0.4889509527459507
Testicular torsion;Myxoid subcutaneous tumors;0.9644415974617004;0.8763863;0.5113209776274064;0.5394483629940078;0.9999600672783046;-0.035518469816604115;-0.12357378245011852;-0.4886390896508982;-0.4605117042842968
Testicular torsion;Bulbous tips of toes;0.8651332557201385;0.8376215;0.5430606357182438;0.5519165470569003;0.9999584729108851;-0.13482521719074658;-0.16233696288204602;-0.4568978371926413;-0.44804192585398483
Testicular torsion;Absent internal genitalia;0.6972097754478455;0.7950681;0.5979181544860808;0.5656972968683824;0.5291492300651881;0.16806054538265736;0.26591885512844593;0.06876892442089266;0.036548066803194335
Testicular torsion;Hyperphalangy of the 2nd finger;0.8960690051317215;0.85030013;0.5331421116953822;0.5478307385663945;0.9999600672783046;-0.10389106214658306;-0.14965993405000255;-0.4668179555829224;-0.45212932871191003
Testicular torsion;Renal interstitial hemosiderin;0.8640444576740265;0.8174374;0.5434104327260847;0.5584392173353714;0.717226575899895;0.14681788177413146;0.10021083445471923;-0.17381614317381033;-0.15878735856452364
Testicular torsion;Abnormality of depressor anguli oris muscle;0.8710022270679474;0.7558245;0.5411760072050078;0.5785172956471165;0.9999201345566091;-0.12891790748866172;-0.2440956282738027;-0.4587441273516013;-0.4214028389094926
Testicular torsion;Paroxysmal dyspnea;0.9525515548884869;0.81381357;0.5151089820638204;0.5596128340947546;0.9999201345566091;-0.047368579668122246;-0.18610656739504905;-0.4848111524927887;-0.4403073004618545
Testicular torsion;Phenylpyruvic acidemia;0.8785021975636482;0.81682354;0.5387697383100225;0.5586379643568848;0.9999600672783046;-0.12145786971465633;-0.18313652516023204;-0.46119032896828205;-0.4413221029214197
Testicular torsion;Lateral ventricle dilatation;0.8910679891705513;0.76348376;0.5347430796919563;0.5760056577357235;0.9999488789551968;-0.1088808897846455;-0.23646511621410793;-0.46520579926324046;-0.42394322121947325
Testicular torsion;Neonatal unconjugated hyperbilirubinemia;0.942845530807972;0.8463727;0.5182027520574205;0.5490955177426466;0.9999600672783046;-0.0571145364703326;-0.15358734369889782;-0.48175731522088405;-0.4508645495356579
Testicular torsion;High maternal circulating alpha-fetoprotein concentration;0.9518447890877724;0.91623265;0.5153342100819687;0.5266952664784594;0.9999201345566091;-0.04807534546883674;-0.08368748904498191;-0.48458592447464044;-0.4732248680781497
Testicular torsion;Prominent nasolabial fold;0.9678156524896622;0.889604;0.5102463654315944;0.5352119088922869;0.9999545338528789;-0.03213888136321674;-0.11035056141788135;-0.4897081684212845;-0.46474262496059204
Testicular torsion;Abnormality of inferior alveolar nerve;0.9950760155916214;0.87117857;0.5015673592502453;0.5411194040539322;0.9999201345566091;-0.004844118964987709;-0.12874156714709373;-0.4983527753063638;-0.4588007305026769
Testicular torsion;Unilateral conductive hearing impairment;1.0867475345730782;0.9590191;0.47235265292260875;0.5130482789549802;0.9999600672783046;0.0867874672947736;-0.0409409427704005;-0.5276074143556958;-0.4869117883233244
Testicular torsion;Macular hypopigmented whorls, streaks, and patches;0.948019839823246;0.8910008;0.5165532588948454;0.5347645924474586;0.9999600672783046;-0.05194022745505855;-0.10895925999299572;-0.4834068083834592;-0.465195474830846
Testicular torsion;Delayed ossification of pubic rami;0.629340410232544;0.60216415;0.6208683424338193;0.6302386477155526;0.9999584729108851;-0.3706180626783412;-0.39779432362652234;-0.37909013047706586;-0.36971982519533253
Testicular torsion;Hyperphenylalaninemia;0.9720000717788935;0.8438844;0.5089138189570824;0.5498972320137769;0.9999561589935034;-0.02795608721460996;-0.15607175051953492;-0.491042340036421;-0.4500589269797265
Testicular torsion;Ureteropelvic junction obstruction;0.6957538723945618;0.6639679;0.5984045271972183;0.6090850621078576;0.832960393740828;-0.1372065213462662;-0.16899248631208652;-0.23455586654360971;-0.22387533163297035
Testicular torsion;Cone-shaped epiphysis of the proximal phalanx of the 2nd toe;0.9008005261421204;0.86383104;0.5316281916570206;0.543479007114539;0.9999201345566091;-0.09911960841448875;-0.1360890913132009;-0.46829194289958853;-0.4564411274420701
Testicular torsion;Difficulty walking;1.1136666983366013;1.0206453;0.46374039872623884;0.49342793000664764;0.9999461221900431;0.11372057614655817;0.020699138620808966;-0.5362057234638042;-0.5065181921833954
Testicular torsion;Bilobate gallbladder;0.9019663110375404;0.8252386;0.5312552930854215;0.5559154219188266;0.9999584729108851;-0.0979921618733447;-0.1747198874387782;-0.4687031798254636;-0.44404305099205854
Testicular torsion;Histidinuria;0.8943224847316742;0.81854033;0.533701125038214;0.5580821818388944;0.8494521264714628;0.04487035826021135;-0.030911791769924757;-0.31575100143324886;-0.2913699446325685
Testicular torsion;Widened interpedicular distance;0.8013198375701904;0.7061696;0.5636654951817264;0.5949300788169287;0.9999201345566091;-0.19860029698641868;-0.29375052930148216;-0.43625463937488274;-0.4049900557396804
Abolished vibration sense;Fractured metatarsal bone of digit 5;0.8908694013953209;0.8219619;0.5348066712569828;0.5569750322148248;0.9999134918687169;-0.10904409047339603;-0.1779516121384923;-0.46510682061173414;-0.4429384596538921
Abolished vibration sense;Prolonged G2 phase of cell cycle;1.061721995472908;1.0164098;0.4803407828385172;0.4947763754132698;0.9999548690865008;0.061767126386407245;0.016454885666612018;-0.5196140862479836;-0.505178493673231
Abolished vibration sense;Single naris;0.8171981275081635;0.85715187;0.5585166870914311;0.5456260510327916;0.9999548690865008;-0.18275674157833732;-0.1428030031273333;-0.4414381819950697;-0.45432881805370917
Abolished vibration sense;Perifoveal ring of hyperautofluorescence surrounded by normal autofluorescence;0.8537619560956955;0.85934365;0.5467165452342522;0.5449212634338649;0.9999134918687169;-0.14615153577302142;-0.14056984391186877;-0.45319694663446475;-0.454992228434852
Abolished vibration sense;Asymmetry of the thorax;0.803838312625885;0.8239062;0.5628477451359168;0.5563462097862559;0.9999548690865008;-0.19611655646061577;-0.17604868584370292;-0.43710712395058393;-0.44360865930024485
Abolished vibration sense;Type 2 muscle fiber predominance;0.9966511316597462;0.9891392;0.5010659798927167;0.5034571611016679;0.9999536937290383;-0.0033025620692921365;-0.010814494472141334;-0.4988877138363216;-0.49649653262737037
Abolished vibration sense;Dependency on parenteral nutrition;1.032905027270317;0.89418083;0.48952411348945246;0.5337464632446689;0.9999567459343585;0.03294828133595862;-0.10577591164099298;-0.510432632444906;-0.46621028268968956
Abolished vibration sense;Limited shoulder flexion;0.7530223429203033;0.70128393;0.579437429395055;0.5965583529182161;0.9999134918687169;-0.24689114894841357;-0.2986295601365392;-0.42047606247366187;-0.4033551389505008
Abolished vibration sense;Paroxysmal vertigo;0.6836937069892883;0.6958308;0.6024427307246356;0.5983788147580165;0.9999567459343585;-0.31626303894507013;-0.30412592394339166;-0.39751401520972285;-0.401577931176342
Abolished vibration sense;Long hallux;0.8290407806634903;0.82910264;0.5546866375996501;0.5546666449215858;0.9999503740898522;-0.17090959342636192;-0.17084773870624625;-0.4452637364902021;-0.4452837291682664
Abolished vibration sense;Broad medial eyebrow;0.9502334371209145;0.9820434;0.5158477352716644;0.5057160834277994;0.9999584729108851;-0.04972503578997067;-0.017915087405208863;-0.48411073763922075;-0.49424238948308574
Abolished vibration sense;Myxoid subcutaneous tumors;0.930248849093914;0.8947284;0.5222205237732314;0.5335711815717615;0.9999584729108851;-0.0697096238169711;-0.10523005074596814;-0.4777379491376538;-0.4663872913391236
Abolished vibration sense;Bulbous tips of toes;0.7809319496154785;0.7967602;0.5703016723180814;0.5651470946052413;0.9999567459343585;-0.21902479631887994;-0.20319654448019586;-0.4296550736162771;-0.4348096513291172
Abolished vibration sense;Absent internal genitalia;0.7489247918128967;0.6901996;0.5807841476726693;0.6002622192780885;0.9999134918687169;-0.2509887000558202;-0.3097138782975499;-0.41912934419604764;-0.3996512725906284
Abolished vibration sense;Hyperphalangy of the 2nd finger;0.8328233510255814;0.8781315;0.5534650213554726;0.5388886203565053;0.9999584729108851;-0.16713512188530377;-0.12182696408367566;-0.44649345155541253;-0.4610698525543798
Abolished vibration sense;Renal interstitial hemosiderin;1.061896063387394;0.97354335;0.4802852691579106;0.5084223990698589;0.9999134918687169;0.06198257151867703;-0.02637014594052478;-0.5196282227108063;-0.49149109279885805
Abolished vibration sense;Abnormality of depressor anguli oris muscle;0.7430327534675598;0.7949735;0.5827232504286683;0.5657280695219168;0.9999134918687169;-0.2568807384011571;-0.20493999924634143;-0.41719024144004857;-0.43418542234680013
Abolished vibration sense;Paroxysmal dyspnea;0.7773788869380951;0.7775428;0.57146127987122;0.57140775307769;0.9999134918687169;-0.22253460493062183;-0.22237066235516711;-0.42845221199749695;-0.42850573879102694
Abolished vibration sense;Phenylpyruvic acidemia;0.991625877097249;0.9301216;0.5026655972632659;0.5222611296691321;0.9999584729108851;-0.008332595813636101;-0.06983687228298596;-0.49729287564761926;-0.47769734324175306
Abolished vibration sense;Lateral ventricle dilatation;0.9827295709401369;0.8644976;0.5054976216253342;0.5432648499310071;0.915698319803367;0.06703125113676989;-0.051200717817435626;-0.41020069817803284;-0.3724334698723599
Abolished vibration sense;Neonatal unconjugated hyperbilirubinemia;0.998578267171979;0.86382204;0.5004525517671301;0.5434818941489528;0.9999584729108851;-0.0013802057389061817;-0.136136429968838;-0.499505921143755;-0.4564765787619324
Abolished vibration sense;High maternal circulating alpha-fetoprotein concentration;1.0785395205020905;1.0391799;0.4749743207574314;0.48752545201230657;0.9999134918687169;0.07862602863337353;0.0392664292814906;-0.5249391711112855;-0.5123880398564103
Abolished vibration sense;Prominent nasolabial fold;0.8045963644981384;0.8001361;0.5626016878540747;0.5640499959557844;0.9999524555142131;-0.19535609101607465;-0.1998163661892619;-0.43735076766013836;-0.43590245955842866
Abolished vibration sense;Abnormality of inferior alveolar nerve;0.8362248092889786;0.7999919;0.5523671677856836;0.5640968464796122;0.8643545492165687;-0.02812973992759016;-0.06436264352732923;-0.3119873814308851;-0.3002577027369565
Abolished vibration sense;Unilateral conductive hearing impairment;0.6699459552764893;0.66912866;0.6070669767659007;0.6073426067592058;0.9999584729108851;-0.3300125176343959;-0.33082981652355603;-0.3928914961449844;-0.3926158661516793
Abolished vibration sense;Macular hypopigmented whorls, streaks, and patches;0.9098991751670837;0.9097469;0.5287189305226345;0.5287675946761733;0.9999584729108851;-0.09005929774380139;-0.09021158761120252;-0.4712395423882506;-0.47119087823471184
Abolished vibration sense;Delayed ossification of pubic rami;0.9630358815193176;0.88037676;0.5117687254099774;0.5381686634210412;0.9999567459343585;-0.03692086441504083;-0.1195799897431048;-0.48818802052438104;-0.46178808251331727
Abolished vibration sense;Hyperphenylalaninemia;1.0484860353171825;0.96740294;0.48456036208612363;0.510377811195746;0.9999542297279059;0.04853180558927661;-0.03255129469982976;-0.5153938676417823;-0.48957641853215994
Abolished vibration sense;Ureteropelvic junction obstruction;0.8881500065326691;0.76680416;0.5356776144144527;0.5749183201318933;0.9999505803237132;-0.11180057379104413;-0.23314642163612165;-0.4642729659092605;-0.42503226019181994
Abolished vibration sense;Cone-shaped epiphysis of the proximal phalanx of the 2nd toe;0.9172816425561905;0.8805035;0.5263601902655868;0.5381280287719863;0.9999134918687169;-0.08263184931252643;-0.11941001620267078;-0.47355330160313014;-0.46178546309673063
Abolished vibration sense;Difficulty walking;0.7277412116527557;0.745587;0.5877706790821331;0.5818822454807215;0.8934045521129487;-0.16566334046019293;-0.14781756080282904;-0.3056338730308156;-0.31152230663222713
Abolished vibration sense;Bilobate gallbladder;1.088920071721077;0.9610617;0.4716584296563613;0.5123975772895578;0.9999567459343585;0.0889633257867185;-0.038895029854646546;-0.5282983162779972;-0.48755916864480064
Abolished vibration sense;Histidinuria;1.0181667394936085;0.953776;0.4942170290969864;0.5147188073706106;0.9999556674707869;0.018211072022821573;-0.046179665540550086;-0.5057386383738005;-0.4852368601001763
Abolished vibration sense;Widened interpedicular distance;0.7802903205156326;0.79855084;0.5705110091778978;0.5645650903565183;0.9999134918687169;-0.2196231713530843;-0.20136264767621204;-0.42940248269081915;-0.43534840151219867
Fractured metatarsal bone of digit 5;Prolonged G2 phase of cell cycle;1.0066957101225853;0.9716234;0.49786867334729545;0.5090337619338496;0.9999056439461368;0.006790066176448506;-0.02828222323080476;-0.5020369705988413;-0.49087188201228715
Fractured metatarsal bone of digit 5;Single naris;0.9866231102496386;0.9523556;0.504258123252636;0.5151714125351685;0.9999056439461368;-0.013282533696498233;-0.04755002070089753;-0.4956475206935008;-0.4847342314109683
Fractured metatarsal bone of digit 5;Perifoveal ring of hyperautofluorescence surrounded by normal autofluorescence;0.9661928415298462;0.92440164;0.5107632036830557;0.5240866806043021;1.0;-0.03380715847015381;-0.07559835910797119;-0.4892367963169443;-0.4759133193956979
Fractured metatarsal bone of digit 5;Asymmetry of the thorax;0.8634136915206909;0.8271259;0.5436131024144457;0.5553053633516587;0.789736248610815;0.07367744290987588;0.03738965833345986;-0.24612314619636932;-0.23443088525915634
Fractured metatarsal bone of digit 5;Type 2 muscle fiber predominance;0.9900999329984188;1.0004315;0.5031513406797616;0.4998626378953269;0.8527273749847077;0.13737255801371107;0.14770416264346609;-0.3495760343049461;-0.3528647370893808
Fractured metatarsal bone of digit 5;Dependency on parenteral nutrition;0.9496925622224808;0.87879544;0.5160201170326142;0.5386756950053417;0.9999134918687169;-0.050220929646236145;-0.12111804690335437;-0.48389337483610273;-0.4612377968633752
Fractured metatarsal bone of digit 5;Limited shoulder flexion;0.7811404764652252;0.7917081;0.5702336453487098;0.5667904057496713;1.0;-0.21885952353477478;-0.2082918882369995;-0.4297663546512902;-0.4332095942503287
Fractured metatarsal bone of digit 5;Paroxysmal vertigo;1.071893148124218;0.90421456;0.4770959408175731;0.5305362684322963;0.9999134918687169;0.07197965625550107;-0.09569893088315173;-0.5228175510511438;-0.46937722343642063
Fractured metatarsal bone of digit 5;Long hallux;0.4986632466316223;0.69313246;0.6671582131572564;0.5992808606497728;0.44339171919682574;0.055271527434796575;0.24974074092051435;0.2237664939604307;0.15588914145294708
Fractured metatarsal bone of digit 5;Broad medial eyebrow;0.917793408036232;0.9047522;0.5261967335463054;0.5303643410510217;0.9999201345566091;-0.08212672652037711;-0.0951679396751699;-0.47372340101030375;-0.4695557935055874
Fractured metatarsal bone of digit 5;Myxoid subcutaneous tumors;0.8794766589999199;0.8413818;0.538457261262588;0.550703887009723;0.9999201345566091;-0.12044347555668922;-0.15853834630282493;-0.46146287329402114;-0.44921624754688616
Fractured metatarsal bone of digit 5;Bulbous tips of toes;0.5547132790088654;0.64877325;0.6468982474969415;0.6142353711610548;0.5863259809806012;-0.031612701971735824;0.062447271983418595;0.06057226651634029;0.027909390180453575
Fractured metatarsal bone of digit 5;Absent internal genitalia;0.8725055158138275;0.848212;0.5406935112144299;0.5485031084749956;1.0;-0.12749448418617249;-0.15178799629211426;-0.4593064887855701;-0.4514968915250044
Fractured metatarsal bone of digit 5;Hyperphalangy of the 2nd finger;0.4844588041305542;0.57930475;0.672409089634107;0.6382138278306266;0.6707004714172433;-0.18624166728668912;-0.09139571668320401;0.0017086182168636332;-0.03248664358661668
Fractured metatarsal bone of digit 5;Renal interstitial hemosiderin;1.0453632399439812;1.014595;0.4855554753178387;0.49535408504173906;1.0;0.04536323994398117;0.01459503173828125;-0.5144445246821613;-0.5046459149582609
Fractured metatarsal bone of digit 5;Abnormality of depressor anguli oris muscle;0.8632532954216003;0.86035347;0.543664641665482;0.5445966373228424;1.0;-0.13674670457839966;-0.1396465301513672;-0.456335358334518;-0.45540336267715764
Fractured metatarsal bone of digit 5;Paroxysmal dyspnea;0.9355252161622047;0.83080196;0.5205372067537231;0.5541177566842271;1.0;-0.06447478383779526;-0.16919803619384766;-0.47946279324627694;-0.44588224331577286
Fractured metatarsal bone of digit 5;Phenylpyruvic acidemia;0.9526031538844109;0.87842846;0.5150925390935338;0.5387933948182106;0.9999201345566091;-0.04731698067219825;-0.12149167538912864;-0.4848275954630753;-0.46112673973839846
Fractured metatarsal bone of digit 5;Lateral ventricle dilatation;1.0328622162342072;0.83542067;0.48953774803922045;0.5526266548945333;0.9998579617208769;0.03300425451333022;-0.16443729359572434;-0.5103202136816565;-0.4472313068263436
Fractured metatarsal bone of digit 5;Neonatal unconjugated hyperbilirubinemia;0.9952701590955257;0.9277671;0.5015055607335885;0.5230124833673262;0.9999201345566091;-0.004649975461083367;-0.07215303660662742;-0.49841457382302057;-0.4769076511892829
Fractured metatarsal bone of digit 5;High maternal circulating alpha-fetoprotein concentration;0.9677025005221367;0.8955928;0.5102824015557517;0.5332945093387623;1.0;-0.03229749947786331;-0.10440719127655029;-0.48971759844424834;-0.4667054906612377
Fractured metatarsal bone of digit 5;Prominent nasolabial fold;0.8813884258270264;0.8905957;0.5378443297611488;0.5348943213009114;0.9998944404568447;-0.11850601462981836;-0.10929876594207422;-0.4620501106956959;-0.4650001191559333
Fractured metatarsal bone of digit 5;Abnormality of inferior alveolar nerve;0.884418323636055;0.8100299;0.5368732020978377;0.5608391041592602;1.0;-0.11558167636394501;-0.18997007608413696;-0.46312679790216227;-0.4391608958407398
Fractured metatarsal bone of digit 5;Unilateral conductive hearing impairment;1.076717123389244;0.9637055;0.4755561636445004;0.5115554471750259;0.9999201345566091;0.07679698883263497;-0.03621465445788474;-0.5243639709121087;-0.48836468738158323
Fractured metatarsal bone of digit 5;Macular hypopigmented whorls, streaks, and patches;0.9356394037604332;0.8456538;0.5205007840632421;0.5493271198839471;0.9999201345566091;-0.06428073079617591;-0.15426636220248313;-0.47941935049336704;-0.450593014672662
Fractured metatarsal bone of digit 5;Delayed ossification of pubic rami;0.5970411896705627;0.62679946;0.6320182154917059;0.621739658606991;0.6574179255159834;-0.06037673584542069;-0.030618461290214394;-0.025399710024277544;-0.03567826690899245
Fractured metatarsal bone of digit 5;Hyperphenylalaninemia;0.9939947538077831;0.8812858;0.5019115407213772;0.5378772380864286;0.9999028053808913;-0.005908051573108142;-0.11861701875216812;-0.49799126465951404;-0.46202556729446265
Fractured metatarsal bone of digit 5;Ureteropelvic junction obstruction;0.906281128525734;0.84050465;0.5298754865042403;0.5509866998269713;0.9998847295244674;-0.09360360099873344;-0.15938008322319785;-0.47000924302022706;-0.44889802969749604
Fractured metatarsal bone of digit 5;Cone-shaped epiphysis of the proximal phalanx of the 2nd toe;0.29097628593444824;0.523918;0.7508640968907299;0.6579434672148197;1.0;-0.7090237140655518;-0.4760820269584656;-0.24913590310927014;-0.34205653278518033
Fractured metatarsal bone of digit 5;Difficulty walking;0.9365707114338875;0.9102326;0.5202037326269648;0.5286123675196759;0.7552776988623575;0.18129301257152997;0.15495490468759976;-0.23507396623539267;-0.22666533134268163
Fractured metatarsal bone of digit 5;Bilobate gallbladder;1.0202750600874424;0.9418156;0.4935458056834008;0.5185311405636955;0.9999134918687169;0.02036156821872548;-0.058097877168399537;-0.5063676861853161;-0.4813823513050214
Fractured metatarsal bone of digit 5;Histidinuria;0.9660543650388718;0.9458409;0.5108073074333952;0.517247819793415;0.9999090677057578;-0.03385470266688606;-0.05406817252982399;-0.48910176027236263;-0.4826612479123428
Fractured metatarsal bone of digit 5;Widened interpedicular distance;0.7549810856580734;0.85098493;0.5787941750540453;0.5476102831310203;1.0;-0.24501891434192657;-0.14901506900787354;-0.4212058249459547;-0.45238971686897966
Prolonged G2 phase of cell cycle;Single naris;1.1100806295871735;1.1395593;0.46488909149500734;0.4554314038851791;0.9999528219730685;0.11012780761410501;0.13960644697834756;-0.5350637304780611;-0.5445214180878893
Prolonged G2 phase of cell cycle;Perifoveal ring of hyperautofluorescence surrounded by normal autofluorescence;0.8715334236621857;0.8164925;0.5410055033808674;0.5587451608073739;0.9999056439461368;-0.12837222028395112;-0.1834131460251468;-0.4589001405652694;-0.4411604831387629
Prolonged G2 phase of cell cycle;Asymmetry of the thorax;0.8850877434015274;0.84523237;0.5366586898411702;0.5494628982262177;0.9999528219730685;-0.11486507857154105;-0.15472045445750449;-0.4632941321318983;-0.4504899237468507
Prolonged G2 phase of cell cycle;Type 2 muscle fiber predominance;0.710283100605011;0.5743939;0.5935611553579122;0.6399390656665653;0.9999515360511232;-0.2896684354461122;-0.4255576080001283;-0.406390380693211;-0.36001247038455786
Prolonged G2 phase of cell cycle;Dependency on parenteral nutrition;0.8144449591636658;0.8073425;0.5594083011118063;0.5617106121873001;0.9999548690865008;-0.185509909922835;-0.19261233978962577;-0.4405465679746945;-0.43824425689920066
Prolonged G2 phase of cell cycle;Limited shoulder flexion;0.920706570148468;0.83904684;0.5252664068211701;0.5514568088439342;0.9999056439461368;-0.07919907379766877;-0.16085880804678376;-0.4746392371249667;-0.44844883510220257
Prolonged G2 phase of cell cycle;Paroxysmal vertigo;1.0585780777037144;0.9134121;0.48134333864430967;0.5275963485370406;0.9999548690865008;0.058623208617213596;-0.08654277497028984;-0.5186115304421911;-0.47235852054946015
Prolonged G2 phase of cell cycle;Long hallux;1.02811442874372;0.9650449;0.49104972004060454;0.5111288171896033;0.9999478876548411;0.02816654108887895;-0.03490297197872416;-0.5088981676142366;-0.48881907046523776
Prolonged G2 phase of cell cycle;Broad medial eyebrow;0.8763371929526329;0.8305418;0.539464117416169;0.5542017765107734;0.9999567459343585;-0.12361955298172556;-0.1694149564026507;-0.4604926285181895;-0.44575496942358506
Prolonged G2 phase of cell cycle;Myxoid subcutaneous tumors;0.8464032709598541;0.83416414;0.5490856678166743;0.5530321823584186;0.9999567459343585;-0.15355347497450433;-0.16579260332571588;-0.4508710781176841;-0.4469245635759399
Prolonged G2 phase of cell cycle;Bulbous tips of toes;0.9868156146258116;0.95499426;0.5041968418019652;0.5143306038600006;0.9999548690865008;-0.013139254460689198;-0.04496060782169975;-0.49575802728453555;-0.48562426522650015
Prolonged G2 phase of cell cycle;Absent internal genitalia;1.044742912054062;0.99056226;0.4857531325232516;0.5030041616018286;0.9999056439461368;0.0448372681079251;-0.009343383795227367;-0.5141525114228852;-0.4969014823443082
Prolonged G2 phase of cell cycle;Hyperphalangy of the 2nd finger;0.8025449216365814;0.64006275;0.5632676569550974;0.6172019023362485;0.9999567459343585;-0.19741182429777704;-0.3598939965485247;-0.43668908897926106;-0.38275484359810996
Prolonged G2 phase of cell cycle;Renal interstitial hemosiderin;0.8342225849628448;0.8166102;0.5530133280902809;0.5587070427401937;0.9999056439461368;-0.16568305898329194;-0.1832954268517154;-0.44689231585585587;-0.4411986012059431
Prolonged G2 phase of cell cycle;Abnormality of depressor anguli oris muscle;1.0011380147188902;0.8923229;0.4996377585861661;0.5343412757853012;0.9999056439461368;0.0012323707727533995;-0.10758274603506501;-0.5002678853599707;-0.4655643681608356
Prolonged G2 phase of cell cycle;Paroxysmal dyspnea;0.8997287452220917;0.83854926;0.5319710596771601;0.5516173018475332;0.9999056439461368;-0.10017689872404512;-0.16135638762136872;-0.4679345842689767;-0.4482883420986036
Prolonged G2 phase of cell cycle;Phenylpyruvic acidemia;0.6627921462059021;0.71929616;0.6094825135985044;0.5905678706541244;0.851762385589393;-0.1889702393834909;-0.13246622822931609;-0.24227987199088863;-0.2611945149352686
Prolonged G2 phase of cell cycle;Lateral ventricle dilatation;0.9299253076314926;0.8413812;0.5223237628356339;0.5507040983859826;0.9999433058680118;-0.07001799823651922;-0.1585621136606754;-0.47761954303237797;-0.4492392074820293
Prolonged G2 phase of cell cycle;Neonatal unconjugated hyperbilirubinemia;0.828517347574234;0.917619;0.5548557488524977;0.5262524367450694;0.851762385589393;-0.02324503801515898;0.06585660435506502;-0.2969066367368953;-0.3255099488443236
Prolonged G2 phase of cell cycle;High maternal circulating alpha-fetoprotein concentration;0.7379579842090607;0.76976126;0.5843959039064581;0.573950708427075;0.9999056439461368;-0.2619476597370761;-0.23014437962194856;-0.41550974003967867;-0.42595493551906183
Prolonged G2 phase of cell cycle;Prominent nasolabial fold;1.0474141240119934;0.99383867;0.4849019549910816;0.5019612300812659;0.9999501780647019;0.04746394594729153;-0.006111510195134007;-0.5150482230736203;-0.49798894798343596
Prolonged G2 phase of cell cycle;Abnormality of inferior alveolar nerve;0.9993484765291214;0.87209314;0.5002073863765334;0.5408258577238103;0.9999056439461368;-0.0005571674170153917;-0.12781250286718782;-0.4996982575696034;-0.4590797862223265
Prolonged G2 phase of cell cycle;Unilateral conductive hearing impairment;1.084308698773384;1.0209892;0.4731318137007242;0.49331845012854725;0.9999567459343585;0.08435195283902563;0.021032433676847595;-0.5268249322336342;-0.5066382958058112
Prolonged G2 phase of cell cycle;Macular hypopigmented whorls, streaks, and patches;0.9070019423961639;0.8682836;0.5296450378476574;0.5420488019709169;0.9999567459343585;-0.09295480353819452;-0.13167311651693903;-0.4703117080867011;-0.4579079439634416
Prolonged G2 phase of cell cycle;Delayed ossification of pubic rami;0.9519103616476059;0.8886743;0.5153133134780425;0.5355096717640564;0.9999548690865008;-0.04804450743889488;-0.11128055029606498;-0.48464155560845823;-0.4644451973224444
Prolonged G2 phase of cell cycle;Hyperphenylalaninemia;0.8683016896247864;0.8137481;0.5420430122786826;0.5596340370487591;0.8359184341309926;0.03238325549379373;-0.02217031286939597;-0.2938754218523101;-0.2762843970822335
Prolonged G2 phase of cell cycle;Ureteropelvic junction obstruction;0.885994479060173;0.8757402;0.5363681575239081;0.5396556279424156;0.9999481150251853;-0.11395363596501229;-0.12420794454636452;-0.46357995750127723;-0.4602924870827697
Prolonged G2 phase of cell cycle;Cone-shaped epiphysis of the proximal phalanx of the 2nd toe;0.8431059420108795;0.69496554;0.5501481220034636;0.5986679835113007;0.9999056439461368;-0.15679970193525727;-0.30494010258337434;-0.44975752194267316;-0.4012376604348361
Prolonged G2 phase of cell cycle;Difficulty walking;0.9119344353675842;0.87218827;0.5280685009792971;0.5407953266289413;0.9999398952172014;-0.08800545984961716;-0.1277516251251909;-0.47187139423790425;-0.45914456858826014
Prolonged G2 phase of cell cycle;Bilobate gallbladder;0.88515954464674;0.852213;0.536635682481603;0.547214996450806;0.9999548690865008;-0.11479532443976082;-0.14774184399342216;-0.4633191866048978;-0.4527398726356948
Prolonged G2 phase of cell cycle;Histidinuria;0.8569778203964233;0.8695905;0.5456820262061295;0.5416292050243111;0.8413020594063172;0.015675760990106147;0.028288461452447455;-0.2956200332001877;-0.2996728543820061
Prolonged G2 phase of cell cycle;Widened interpedicular distance;0.7979423403739929;0.6504648;0.5647628401123662;0.6136605008473955;0.9999056439461368;-0.20196330357214387;-0.3494408707680362;-0.4351428038337706;-0.38624514309874125
Single naris;Perifoveal ring of hyperautofluorescence surrounded by normal autofluorescence;0.916465237736702;0.93044925;0.5266209625314436;0.5221565844854802;0.9999056439461368;-0.08344040620943483;-0.0694563965859073;-0.47328468141469315;-0.4777490594606566
Single naris;Asymmetry of the thorax;1.0093779675662518;0.95584697;0.49701485645488463;0.5140589250477179;0.9999528219730685;0.009425145593183304;-0.04410585666011069;-0.5029379655181838;-0.48589389692535057
Single naris;Type 2 muscle fiber predominance;1.0035324236378074;0.98286074;0.49887559229549194;0.5054558641346008;0.9999515360511232;0.0035808875866841783;-0.01709079205164199;-0.5010759437556312;-0.49449567191652244
Single naris;Dependency on parenteral nutrition;0.9508040621876717;0.9591817;0.5156658769022011;0.5129964755817453;0.9999548690865008;-0.049150806898829114;-0.04077314310764946;-0.48428899218429966;-0.48695839350475545
Single naris;Limited shoulder flexion;0.9471681639552116;0.8400803;0.5168247287889675;0.5511235230298425;0.9999056439461368;-0.05273747999092515;-0.15982532311102327;-0.48308091515716933;-0.4487821209162943
Single naris;Paroxysmal vertigo;0.9338626489043236;0.95404863;0.5210675505457109;0.514631921839682;0.9999548690865008;-0.0660922201821772;-0.04590623551106132;-0.4788873185407899;-0.4853229472468188
Single naris;Long hallux;0.8794303089380264;0.90012854;0.5384721233244295;0.5318431531710051;0.9999478876548411;-0.12051757871681468;-0.0998193442779185;-0.4614757643304116;-0.46810473448383605
Single naris;Broad medial eyebrow;0.7367368340492249;0.84885967;0.5847987519112049;0.5482945251436863;0.8846475303342614;-0.1479106962850365;-0.03578786255624622;-0.29984877842305646;-0.3363530051905751
Single naris;Myxoid subcutaneous tumors;0.9303213208913803;0.8883709;0.5221973990200688;0.5356068583031557;0.9999567459343585;-0.06963542504297815;-0.11158587439047418;-0.4777593469142897;-0.4643498876312028
Single naris;Bulbous tips of toes;0.8373824059963226;0.8431206;0.5519936862448498;0.5501434153964744;0.9999548690865008;-0.16257246309017814;-0.1568342941353289;-0.447961182841651;-0.4498114536900264
Single naris;Absent internal genitalia;0.7041853070259094;0.7371888;0.5955910908370899;0.5846496303523385;0.9999056439461368;-0.29572033692022737;-0.26271682787558015;-0.40431455310904685;-0.41525601359379827
Single naris;Hyperphalangy of the 2nd finger;1.0279154554009438;1.0533848;0.4911130800913379;0.4829990312842062;0.9999567459343585;0.027958709466585296;0.0534280349494306;-0.5088436658430205;-0.5169577146501523
Single naris;Renal interstitial hemosiderin;0.9544618874788284;0.9271325;0.5145002459356075;0.5232150199474725;0.9999056439461368;-0.04544375646730836;-0.07277315664907869;-0.4854053980105293;-0.47669062399866424
Single naris;Abnormality of depressor anguli oris muscle;0.9120928570628166;0.94243145;0.5280178774532354;0.5183347659862022;0.7483657621638067;0.16372709489900994;0.19406568772633004;-0.22034788471057132;-0.23003099617760447
Single naris;Paroxysmal dyspnea;1.0170291066169739;0.98387283;0.4945792049929256;0.5051336563613188;0.9999056439461368;0.017123462670837086;-0.016032813078369457;-0.5053264389532112;-0.494771987584818
Single naris;Phenylpyruvic acidemia;1.0042282547801733;0.9515831;0.4986541006917843;0.5154176143328424;0.9999567459343585;0.004271508845814842;-0.04837365849005304;-0.5013026452425742;-0.48453913160151607
Single naris;Lateral ventricle dilatation;1.0540393590927124;1.04245;0.48279035473246723;0.4864836851651594;0.9999433058680118;0.05409605322470057;0.042506645303863166;-0.5171529511355446;-0.5134596207028524
Single naris;Neonatal unconjugated hyperbilirubinemia;0.9059603661298752;0.7738724;0.5299780412702417;0.5726066508161105;0.9999567459343585;-0.09399637980448328;-0.2260843704460772;-0.46997870466411673;-0.42735009511824795
Single naris;High maternal circulating alpha-fetoprotein concentration;0.9006149768829346;0.8996849;0.5316875471367913;0.5319850753145436;0.9999056439461368;-0.09929066706320222;-0.10022073794027742;-0.46821809680934545;-0.46792056863159315
Single naris;Prominent nasolabial fold;0.6322787702083588;0.6233382;0.6198619338653686;0.6229281109548437;0.7703267171239124;-0.13804794691555367;-0.14698849462025032;-0.15046478325854384;-0.14739860616906875
Single naris;Abnormality of inferior alveolar nerve;0.8470405787229538;0.8004351;0.5488803805919893;0.5639528623276592;0.9999056439461368;-0.152865065223183;-0.19947051811834748;-0.4510252633541475;-0.4359527816184776
Single naris;Unilateral conductive hearing impairment;0.7840888798236847;0.66428196;0.569272145568773;0.6089789391354012;0.9999567459343585;-0.21586786611067377;-0.33567478163229547;-0.4306846003655854;-0.3909778067989572
Single naris;Macular hypopigmented whorls, streaks, and patches;0.8390150666236877;0.97798496;0.5514670549330443;0.5070081748474823;0.9999567459343585;-0.16094167931067072;-0.021971781086793762;-0.4484896910013142;-0.4929485710868762
Single naris;Delayed ossification of pubic rami;0.9948771223425865;0.95084596;0.5016306697366333;0.5156525312152406;0.9999548690865008;-0.005077746743914258;-0.04910891228413261;-0.4983241993498675;-0.4843023378712602
Single naris;Hyperphenylalaninemia;0.9842668138444424;0.9427444;0.5050082353263516;0.5182350039960117;0.9999521228478421;-0.015685309003399706;-0.057207748572634554;-0.49494388752149043;-0.48171711885183033
Single naris;Ureteropelvic junction obstruction;0.9272854700684547;0.8663243;0.5231661992512743;0.5426780387164701;0.9999481150251853;-0.07266264495673058;-0.13362380949082253;-0.47678191577391105;-0.4572700763087152
Single naris;Cone-shaped epiphysis of the proximal phalanx of the 2nd toe;0.9733694922178984;0.946452;0.5084777561506493;0.5170530154457658;0.9999056439461368;-0.026536151728238422;-0.05345362234732087;-0.4914278877954875;-0.48285262850037103
Single naris;Difficulty walking;0.8684084266424179;0.92751914;0.5420087385441217;0.5230916174235973;0.9999398952172014;-0.13153146857478348;-0.07242075258948533;-0.4579311566730797;-0.47684827779360406
Single naris;Bilobate gallbladder;1.012718465179205;0.9309543;0.49595147764364333;0.5219954338696057;0.9999548690865008;0.012763596092704166;-0.0690005915710894;-0.5040033914428574;-0.4779594352168951
Single naris;Histidinuria;0.8835190683603287;0.88815796;0.5371613905046493;0.5356750607868423;0.9999536937290383;-0.11643462536870963;-0.11179572997629172;-0.462792303224389;-0.46427863294219596
Single naris;Widened interpedicular distance;1.0747484266757965;1.0738456;0.47618462421956687;0.47647280091381805;0.9999056439461368;0.07484278272965972;0.07393998097756926;-0.5237210197265699;-0.5234328430323187
Perifoveal ring of hyperautofluorescence surrounded by normal autofluorescence;Asymmetry of the thorax;0.9850300960242748;0.8191127;0.5047652464223827;0.5578969206816042;0.9999056439461368;-0.014875547921861965;-0.18079292584082063;-0.49514039752375405;-0.44200872326453255
Perifoveal ring of hyperautofluorescence surrounded by normal autofluorescence;Type 2 muscle fiber predominance;0.967241644859314;0.82949924;0.5104291741387295;0.5545385390474125;0.9999003561294039;-0.0326587112700899;-0.17040111143946246;-0.4894711819906744;-0.4453618170819914
Perifoveal ring of hyperautofluorescence surrounded by normal autofluorescence;Dependency on parenteral nutrition;1.0143031682819128;0.96288675;0.4954470048806876;0.5118162337524322;0.9999134918687169;0.014389676413195884;-0.03702674117062732;-0.5044664869880293;-0.4880972581162847
Perifoveal ring of hyperautofluorescence surrounded by normal autofluorescence;Limited shoulder flexion;0.8732629865407944;0.7415189;0.5404504288767404;0.5832219677364916;1.0;-0.12673701345920563;-0.25848108530044556;-0.45954957112325956;-0.4167780322635084
Perifoveal ring of hyperautofluorescence surrounded by normal autofluorescence;Paroxysmal vertigo;0.9103908017277718;0.7914552;0.5285618053325442;0.566872704941287;0.9999134918687169;-0.08952269014094516;-0.2084582826134984;-0.47135168653617276;-0.43304078692742987
Perifoveal ring of hyperautofluorescence surrounded by normal autofluorescence;Long hallux;0.9166758209466934;0.8644746;0.5265536973059144;0.5432722368091012;0.9998836012415208;-0.08320778029482734;-0.13540900664847266;-0.47332990393560637;-0.45661136443241956
Perifoveal ring of hyperautofluorescence surrounded by normal autofluorescence;Broad medial eyebrow;0.7387106120586395;0.7895441;0.5841476867734321;0.5674948293445479;0.9999201345566091;-0.2612095224979696;-0.21037602902682395;-0.415772447783177;-0.43242530521206124
Perifoveal ring of hyperautofluorescence surrounded by normal autofluorescence;Myxoid subcutaneous tumors;0.9568784981966019;0.8621762;0.5137302577282162;0.5440107755574763;0.9999201345566091;-0.04304163636000724;-0.13774395467074485;-0.4861898768283929;-0.45590935899913276
Perifoveal ring of hyperautofluorescence surrounded by normal autofluorescence;Bulbous tips of toes;0.8676711320877075;0.83699834;0.5422454971465887;0.5521175999505238;0.9999134918687169;-0.1322423597810094;-0.16291514840100452;-0.45766799472212827;-0.44779589191819313
Perifoveal ring of hyperautofluorescence surrounded by normal autofluorescence;Absent internal genitalia;0.9421397522091866;0.8477928;0.5184277807715564;0.5486381076416601;1.0;-0.057860247790813446;-0.15220719575881958;-0.4815722192284436;-0.4513618923583399
Perifoveal ring of hyperautofluorescence surrounded by normal autofluorescence;Hyperphalangy of the 2nd finger;0.7934794425964355;0.70630914;0.566214030728357;0.5948836234443748;0.9999201345566091;-0.20644069196017356;-0.29361099482806297;-0.43370610382825214;-0.40503651111223427
Perifoveal ring of hyperautofluorescence surrounded by normal autofluorescence;Renal interstitial hemosiderin;0.7415770888328552;0.62662095;0.5832027990617917;0.6218009095217586;1.0;-0.2584229111671448;-0.37337905168533325;-0.41679720093820827;-0.3781990904782414
Perifoveal ring of hyperautofluorescence surrounded by normal autofluorescence;Abnormality of depressor anguli oris muscle;0.9962796624749899;0.8712456;0.5011842229459493;0.5410978804678187;1.0;-0.003720337525010109;-0.1287543773651123;-0.49881577705405067;-0.4589021195321813
Perifoveal ring of hyperautofluorescence surrounded by normal autofluorescence;Paroxysmal dyspnea;0.9871199708431959;0.8060849;0.5040999539806892;0.5621186507964475;1.0;-0.012880029156804085;-0.19391512870788574;-0.4959000460193108;-0.4378813492035525
Perifoveal ring of hyperautofluorescence surrounded by normal autofluorescence;Phenylpyruvic acidemia;0.8587923347949982;0.7227283;0.5450985258157917;0.5894302099586762;0.9999201345566091;-0.14112779976161094;-0.27719182254107566;-0.45482160874081745;-0.4104899245979329
Perifoveal ring of hyperautofluorescence surrounded by normal autofluorescence;Lateral ventricle dilatation;0.934955283999443;0.8146886;0.5207190034103057;0.559329366808079;0.9998579617208769;-0.06490267772143388;-0.18516933876936936;-0.4791389583105712;-0.44052859491279794
Perifoveal ring of hyperautofluorescence surrounded by normal autofluorescence;Neonatal unconjugated hyperbilirubinemia;0.9095119684934616;0.7831508;0.5288426877697653;0.5695779939694358;0.9999201345566091;-0.0904081660631475;-0.2167693424347219;-0.4710774467868438;-0.43034214058717335
Perifoveal ring of hyperautofluorescence surrounded by normal autofluorescence;High maternal circulating alpha-fetoprotein concentration;0.8222480118274689;0.73663735;0.5568824820579661;0.5848315757651171;1.0;-0.17775198817253113;-0.2633626461029053;-0.4431175179420339;-0.41516842423488287
Perifoveal ring of hyperautofluorescence surrounded by normal autofluorescence;Prominent nasolabial fold;0.9728657063096762;0.8609602;0.5086381741620514;0.5444016062838642;0.9998944404568447;-0.027028734147168554;-0.1389342549290432;-0.49125626629479335;-0.4554928341729805
Perifoveal ring of hyperautofluorescence surrounded by normal autofluorescence;Abnormality of inferior alveolar nerve;0.9936166107654572;0.85604507;0.5020319097001338;0.5459820400402511;1.0;-0.006383389234542847;-0.14395493268966675;-0.4979680902998662;-0.4540179599597489
Perifoveal ring of hyperautofluorescence surrounded by normal autofluorescence;Unilateral conductive hearing impairment;0.9011840671300888;0.8073573;0.531505503962507;0.5617058171224458;0.9999201345566091;-0.0987360674265203;-0.1925628233078298;-0.46841463059410215;-0.4382143174341633
Perifoveal ring of hyperautofluorescence surrounded by normal autofluorescence;Macular hypopigmented whorls, streaks, and patches;0.35369551181793213;0.5320813;0.7236864006309969;0.654995994785476;0.9999201345566091;-0.646224622738677;-0.46783882857592674;-0.27623373392561223;-0.3449241397711331
Perifoveal ring of hyperautofluorescence surrounded by normal autofluorescence;Delayed ossification of pubic rami;1.046265870332718;0.88004327;0.48526785712165643;0.5382755763109062;0.9999134918687169;0.046352378464000976;-0.11987022366498157;-0.5146456347470605;-0.46163791555781075
Perifoveal ring of hyperautofluorescence surrounded by normal autofluorescence;Hyperphenylalaninemia;0.7865950167179108;0.66470015;0.5684553777097245;0.608837635982947;0.9999028053808913;-0.2133077886629805;-0.33520265489108414;-0.43144742767116673;-0.3910651693979442
Perifoveal ring of hyperautofluorescence surrounded by normal autofluorescence;Ureteropelvic junction obstruction;0.9746667817234993;0.8669561;0.5080646765970362;0.5424751197964468;0.9998847295244674;-0.025217947800968088;-0.13292861475548545;-0.49182005292743114;-0.4574096097280206
Perifoveal ring of hyperautofluorescence surrounded by normal autofluorescence;Cone-shaped epiphysis of the proximal phalanx of the 2nd toe;0.8592635989189148;0.7662929;0.5449470046302374;0.5750856833827654;1.0;-0.1407364010810852;-0.23370707035064697;-0.4550529953697626;-0.42491431661723456
Perifoveal ring of hyperautofluorescence surrounded by normal autofluorescence;Difficulty walking;0.8943346738815308;0.92284715;0.5336972232656825;0.5245829346707972;0.9998344221996177;-0.10549974831808695;-0.07698727044333109;-0.46613719893393524;-0.4752514875288205
Perifoveal ring of hyperautofluorescence surrounded by normal autofluorescence;Bilobate gallbladder;0.9777788650244474;0.8780955;0.50707378917431;0.5389001707585996;0.9999134918687169;-0.022134626844269478;-0.12181798424695178;-0.4928397026944069;-0.4610133211101173
Perifoveal ring of hyperautofluorescence surrounded by normal autofluorescence;Histidinuria;0.8361709415912628;0.7426543;0.5523845491730706;0.582847900410869;0.9999090677057578;-0.163738126114495;-0.25725474412787697;-0.44752451853268727;-0.41706116729488885
Perifoveal ring of hyperautofluorescence surrounded by normal autofluorescence;Widened interpedicular distance;0.9291687607765198;0.78415465;0.5225651790794243;0.5692507132604379;1.0;-0.07083123922348022;-0.21584534645080566;-0.47743482092057565;-0.43074928673956214
Asymmetry of the thorax;Type 2 muscle fiber predominance;0.8691806495189667;0.80254185;0.5417607888857048;0.5632686488369554;0.9283707775802553;-0.05919012806128865;-0.12582892558287984;-0.38660998869455054;-0.36510212874329995
Asymmetry of the thorax;Dependency on parenteral nutrition;0.9621912240982056;0.92183965;0.5120377763238222;0.5249046166944074;0.9999548690865008;-0.03776364498829521;-0.07811521464085258;-0.4879170927626786;-0.4750502523920934
Asymmetry of the thorax;Limited shoulder flexion;0.6742388606071472;0.652676;0.6056205264336145;0.6129095940041733;0.8029485097445463;-0.12870964913739913;-0.15027252345456832;-0.19732798331093182;-0.19003891574037302
Asymmetry of the thorax;Paroxysmal vertigo;0.9035297483205795;0.77227175;0.5307552652534125;0.573129793021031;0.9999548690865008;-0.09642512076592125;-0.22768311672901786;-0.46919960383308823;-0.4268250760654698
Asymmetry of the thorax;Long hallux;0.8567768782377243;0.7450862;0.545746653421713;0.5820470992642186;0.8838724518653985;-0.02709557362767423;-0.13878625878068174;-0.3381257984436855;-0.30182535260117993
Asymmetry of the thorax;Broad medial eyebrow;0.8652453273534775;0.7987016;0.5430246335589983;0.5645160902548949;0.9999567459343585;-0.13471141858088098;-0.20125516159521661;-0.45693211237536013;-0.43544065567946355
Asymmetry of the thorax;Myxoid subcutaneous tumors;0.8922888040542603;0.8417389;0.5343521821412005;0.5505887767677495;0.9999567459343585;-0.1076679418800982;-0.15821786625372491;-0.46560456379315796;-0.4493679691666089
Asymmetry of the thorax;Bulbous tips of toes;0.91966462880373;0.8524003;0.5255991285355706;0.5471547374588734;0.8994299275196795;0.02023470128405047;-0.04702962463271665;-0.373830798984109;-0.3522751900608061
Asymmetry of the thorax;Absent internal genitalia;0.8955720365047455;0.82046795;0.5333011672227292;0.5574583572153384;0.9999056439461368;-0.10433360744139131;-0.17943769503256257;-0.46660447672340755;-0.44244728673079836
Asymmetry of the thorax;Hyperphalangy of the 2nd finger;0.8357236087322235;0.736228;0.5525288953091014;0.5849666470974823;0.9036123096265051;-0.06788870089428156;-0.16738432042972773;-0.35108341431740364;-0.3186456625290228
Asymmetry of the thorax;Renal interstitial hemosiderin;0.9591542780399323;0.8484;0.513005215077385;0.5484425678219212;0.9999056439461368;-0.04075136590620454;-0.15150564718862947;-0.48690042886875184;-0.45146307612421555
Asymmetry of the thorax;Abnormality of depressor anguli oris muscle;0.7640528678894043;0.71201503;0.5758192196484956;0.5929853185620438;0.8605427142144324;-0.0964898463250281;-0.1485276814461829;-0.2847234945659368;-0.26755739565238856
Asymmetry of the thorax;Paroxysmal dyspnea;0.6749450862407684;0.66372573;0.6053827886360426;0.6091669214848536;0.9999056439461368;-0.32496055770536836;-0.33617991018911775;-0.39452285531009423;-0.39073872246128316
Asymmetry of the thorax;Phenylpyruvic acidemia;0.8846901804208755;0.77831894;0.5367860849112494;0.57115437762958;0.9999567459343585;-0.11526656551348291;-0.2216378043411883;-0.4631706610231091;-0.42880236830477847
Asymmetry of the thorax;Lateral ventricle dilatation;0.8135424852371216;0.6885762;0.5597006697508045;0.6008058608751332;0.9999433058680118;-0.18640082063089025;-0.3113670844019474;-0.4402426361172074;-0.3991374449928786
Asymmetry of the thorax;Neonatal unconjugated hyperbilirubinemia;0.8472213447093964;0.788321;0.5488221566536928;0.5678931182623006;0.9999567459343585;-0.1527354012249621;-0.21163572771536432;-0.45113458928066563;-0.43206362767205786
Asymmetry of the thorax;High maternal circulating alpha-fetoprotein concentration;0.8586797416210175;0.74419814;0.5451347283767257;0.5823394672317979;0.9999056439461368;-0.14122590232511933;-0.25570750046392854;-0.45477091556941107;-0.41756617671433893
Asymmetry of the thorax;Prominent nasolabial fold;0.8208867609500885;0.6838609;0.5573228486517757;0.6023866335395072;0.9999501780647019;-0.17906341711461338;-0.3160892800468186;-0.44262732941292615;-0.3975635445251947
Asymmetry of the thorax;Abnormality of inferior alveolar nerve;0.9298472553491592;0.790095;0.522348668942551;0.567315472091999;0.9999056439461368;-0.07005838859697755;-0.20981067228933747;-0.47755697500358574;-0.43259017185413784
Asymmetry of the thorax;Unilateral conductive hearing impairment;0.9783844873309135;0.859267;0.5068809672812882;0.5449459171030204;0.9999567459343585;-0.021572258603444916;-0.14068974955069147;-0.4930757786530703;-0.45501082883133803
Asymmetry of the thorax;Macular hypopigmented whorls, streaks, and patches;1.0174722503870726;0.88038546;0.49443812695576694;0.5381658662007327;0.9999567459343585;0.017515504452714104;-0.11957128746496759;-0.5055186189785915;-0.46179087973362576
Asymmetry of the thorax;Delayed ossification of pubic rami;0.7607623040676117;0.64080864;0.5768975163258933;0.6169474603618322;0.8994299275196795;-0.13866762345206785;-0.25862128560912656;-0.3225324111937863;-0.2824824671578473
Asymmetry of the thorax;Hyperphenylalaninemia;0.8966282084584236;0.7062595;0.5329631477902853;0.5949001669154006;0.9999521228478421;-0.10332391438941846;-0.29369263378839383;-0.46698897505755677;-0.4050519559324415
Asymmetry of the thorax;Ureteropelvic junction obstruction;0.8941547572612762;0.753734;0.5337548154710476;0.5792036745137756;0.9999481150251853;-0.10579335776390908;-0.2462141224485862;-0.4661932995541377;-0.4207444405114097
Asymmetry of the thorax;Cone-shaped epiphysis of the proximal phalanx of the 2nd toe;0.9101420640945435;0.81651;0.5286413016841736;0.5587394912940835;0.789736248610815;0.12040581548372842;0.026773773075738916;-0.2610949469266415;-0.23099675731673153
Asymmetry of the thorax;Difficulty walking;0.9527768641710281;0.88927037;0.5150371834076748;0.5353187591891629;0.9111657437054939;0.04161112046553428;-0.02189537846730416;-0.39612856029781907;-0.3758469845163309
Asymmetry of the thorax;Bilobate gallbladder;0.9062672704458237;0.7815333;0.5298799171716622;0.5701055044982499;0.9999548690865008;-0.0936875986406771;-0.21842156820988334;-0.4700749519148386;-0.42984936458825085
Asymmetry of the thorax;Histidinuria;0.9698151275515556;0.8370528;0.509609602951115;0.5521000190646216;0.9999536937290383;-0.030138566177482673;-0.1629008716160012;-0.4903440907779233;-0.4478536746644167
Asymmetry of the thorax;Widened interpedicular distance;0.6382785439491272;0.60495245;0.6178108568252842;0.6292718854497242;0.7257018318265508;-0.0874232878774236;-0.12074937725959523;-0.10789097500126654;-0.09642994637682656
Type 2 muscle fiber predominance;Dependency on parenteral nutrition;0.8664998710155487;0.8478893;0.5426216586380392;0.5486070144860407;0.9999536937290383;-0.1334538227134896;-0.15206438956796653;-0.45733203509099907;-0.45134667924299765
Type 2 muscle fiber predominance;Limited shoulder flexion;0.7391499578952789;0.7187309;0.5840028144698236;0.5907553421244383;0.8527273749847077;-0.11357741708942881;-0.13399644847103587;-0.26872456051488414;-0.2619720328602695
Type 2 muscle fiber predominance;Paroxysmal vertigo;1.054613407701254;0.89984024;0.4826073591405743;0.5319353892070773;0.9999536937290383;0.054659713972215584;-0.10011345801889426;-0.517346334588464;-0.468018304521961
Type 2 muscle fiber predominance;Long hallux;0.9531679823994637;0.99740225;0.514912548711202;0.500826897307592;0.920652924919851;0.0325150574796127;0.0767493258469032;-0.405740376208649;-0.41982602761225896
Type 2 muscle fiber predominance;Broad medial eyebrow;0.951396394520998;0.88498473;0.5154771058332078;0.5366916911868453;0.9999556674707869;-0.0485592729497889;-0.11497093579659257;-0.4844785616375791;-0.46326397628394156
Type 2 muscle fiber predominance;Myxoid subcutaneous tumors;0.7167363166809082;0.6365072;0.5914171583471338;0.6184158646258175;0.9999556674707869;-0.2832193507898787;-0.36344845435509476;-0.4085385091236531;-0.38153980284496936
Type 2 muscle fiber predominance;Bulbous tips of toes;1.0210757665336132;1.0065019;0.49329087840578134;0.49793037199107115;0.9315598035443521;0.08951596298926112;0.07494210952632663;-0.43826892513857074;-0.43362943155328093
Type 2 muscle fiber predominance;Absent internal genitalia;0.9975050706416368;0.91969883;0.5007941615039978;0.525588195742714;0.9999003561294039;-0.0023952854877670182;-0.08020152171015338;-0.49910619462540606;-0.4743121603866899
Type 2 muscle fiber predominance;Hyperphalangy of the 2nd finger;0.8633957803249359;0.69172764;0.54361885766948;0.5997508199363984;0.9344769737294281;-0.07108119340449215;-0.24274933548479916;-0.390858116059948;-0.3347261537930296
Type 2 muscle fiber predominance;Renal interstitial hemosiderin;0.8690651953220367;0.75870335;0.541797857943685;0.5775726792663548;0.9999003561294039;-0.13083516080736712;-0.24119700510859088;-0.4581024981857189;-0.42232767686304906
Type 2 muscle fiber predominance;Abnormality of depressor anguli oris muscle;0.7565607875585556;0.7092004;0.5782756376838429;0.5939213001719561;0.5538069875543539;0.20275380000420173;0.15539339467831215;0.024468650129489067;0.04011431261760223
Type 2 muscle fiber predominance;Paroxysmal dyspnea;0.912283293902874;0.83754575;0.5279570244534912;0.5519409811035709;0.9999003561294039;-0.08761706222652987;-0.16235460360407428;-0.4719433316759126;-0.44795937502583294
Type 2 muscle fiber predominance;Phenylpyruvic acidemia;0.7710713744163513;0.7575284;0.5735222426139973;0.5779581155708371;0.9999556674707869;-0.22888429305443558;-0.2424272432077864;-0.4264334248567896;-0.4219975518999498
Type 2 muscle fiber predominance;Lateral ventricle dilatation;1.0248046964406967;0.876036;0.4921036100187205;0.5395607300951064;0.9999414386047084;0.024863257835988306;-0.12390545027386735;-0.5078378285859879;-0.460380708509602
Type 2 muscle fiber predominance;Neonatal unconjugated hyperbilirubinemia;0.9408553764224052;0.9352404;0.5188373117282351;0.5206280531432315;0.9999556674707869;-0.05910029104838166;-0.06471527955422196;-0.4811183557425518;-0.47932761432755544
Type 2 muscle fiber predominance;High maternal circulating alpha-fetoprotein concentration;0.9405842572450638;0.8678328;0.5189237636788051;0.5421935775406391;0.9999003561294039;-0.059316098884340085;-0.1320675762450655;-0.48097659245059876;-0.45770677858876474
Type 2 muscle fiber predominance;Prominent nasolabial fold;0.9875462744385004;0.8759677;0.5039642464432007;0.5395826467500564;0.9999487417813083;-0.012402467342807921;-0.12398106037337986;-0.4959844953381076;-0.4603660950312519
Type 2 muscle fiber predominance;Abnormality of inferior alveolar nerve;0.9400443136692047;0.8521222;0.5190959400118669;0.5472442465352962;0.9999003561294039;-0.059856042460199155;-0.14777816851496295;-0.480804416117537;-0.4526561095941076
Type 2 muscle fiber predominance;Unilateral conductive hearing impairment;1.0209292992949486;0.93351585;0.49333751066191955;0.5211781917410709;0.9999556674707869;0.020973631824161676;-0.06643982074150834;-0.5066181568088673;-0.47877747572971596
Type 2 muscle fiber predominance;Macular hypopigmented whorls, streaks, and patches;0.9554082676768303;0.8476704;0.5141986973960337;0.5486775326503052;0.9999556674707869;-0.04454739979395661;-0.15228529116997513;-0.48575697007475316;-0.45127813482048174
Type 2 muscle fiber predominance;Delayed ossification of pubic rami;0.9597772434353828;0.9284931;0.5128067559263827;0.5227807985333567;0.9315598035443521;0.02821743989103076;-0.0030667210210061358;-0.4187530476179694;-0.4087790050109954
Type 2 muscle fiber predominance;Hyperphenylalaninemia;0.973396323621273;0.90820324;0.5084692124226726;0.529261006403076;0.9999507979965523;-0.026554474375279247;-0.09174755378726274;-0.49148158557387966;-0.47068979159347624
Type 2 muscle fiber predominance;Ureteropelvic junction obstruction;0.9285485148429871;0.9196848;0.5227631110065026;0.5255926854409286;0.9999465554694025;-0.07139804062641542;-0.0802617281416742;-0.47718344446289984;-0.47435387002847385
Type 2 muscle fiber predominance;Cone-shaped epiphysis of the proximal phalanx of the 2nd toe;0.84939144551754;0.72782576;0.5481233045429209;0.5877427100164472;0.8527273749847077;-0.003335929467167764;-0.12490161414333811;-0.30460407044178683;-0.26498466496826056
Type 2 muscle fiber predominance;Difficulty walking;0.937762226909399;0.89761215;0.5198237105332729;0.5326482772617315;0.8236523433548952;0.1141098835545038;0.07395981112889993;-0.3038286328216223;-0.29100406609316376
Type 2 muscle fiber predominance;Bilobate gallbladder;0.954122893512249;0.8926073;0.5146082639608919;0.5342502240815926;0.9999536937290383;-0.045830800216789314;-0.10734642205774314;-0.48534542976814643;-0.4657034696474457
Type 2 muscle fiber predominance;Histidinuria;0.8965720385313034;0.8493595;0.5329811235860478;0.5481335769029986;0.9999524555142131;-0.10338041698290967;-0.15059294318511152;-0.4669713319281653;-0.4518188786112145
Type 2 muscle fiber predominance;Widened interpedicular distance;0.7860228717327118;0.7819194;0.5686418033084444;0.569979567129193;0.8527273749847077;-0.06670450325199595;-0.07080795521923533;-0.28408557167626336;-0.2827478078555148
Dependency on parenteral nutrition;Limited shoulder flexion;0.9893035674467683;0.9037037;0.5034048451575013;0.5306996438184661;0.9999134918687169;-0.010609924421948635;-0.0962098022935216;-0.49650864671121564;-0.4692138480502508
Dependency on parenteral nutrition;Paroxysmal vertigo;1.0306894034147263;0.8013845;0.49022972541081833;0.563644491159994;0.9999567459343585;0.030732657480367798;-0.19857223732458673;-0.5097270205235401;-0.4363122547743644
Dependency on parenteral nutrition;Long hallux;1.0543690137565136;0.9696638;0.48268526790242794;0.5096577932691571;0.9999503740898522;0.054418639666661384;-0.0302865752808007;-0.5172651061874243;-0.49029258082069516
Dependency on parenteral nutrition;Broad medial eyebrow;0.9664141163229942;0.92041385;0.5106927297072923;0.5253598821419061;0.9999584729108851;-0.0335443565878909;-0.07954462117290906;-0.48926574320359284;-0.47459859076897903
Dependency on parenteral nutrition;Myxoid subcutaneous tumors;0.9395700171589851;0.8895879;0.5192471875284117;0.5352170678149446;0.9999584729108851;-0.060388455751899994;-0.11037059372997693;-0.48071128538247343;-0.46474140509594053
Dependency on parenteral nutrition;Bulbous tips of toes;0.9422511793673038;0.8978466;0.5183922530002434;0.5325732688900235;0.9999567459343585;-0.05770556656705461;-0.10211016638266168;-0.4815644929341151;-0.4673834770443349
Dependency on parenteral nutrition;Absent internal genitalia;1.0064895413815975;0.9524423;0.497934300322069;0.5151438007891053;0.9999134918687169;0.0065760495128806;-0.047471203469974244;-0.5019791915466479;-0.48476969107961165
Dependency on parenteral nutrition;Hyperphalangy of the 2nd finger;0.9130413606762886;0.8092796;0.527714798697522;0.5610823760581928;0.9999584729108851;-0.08691711223459653;-0.1906788522634547;-0.4722436742133631;-0.43887609685269235
Dependency on parenteral nutrition;Renal interstitial hemosiderin;0.742069274187088;0.76464343;0.5830406338179162;0.575625785332008;0.9999134918687169;-0.2578442176816289;-0.23527006115887805;-0.41687285805080077;-0.4242877065367089
Dependency on parenteral nutrition;Abnormality of depressor anguli oris muscle;1.0824032127857208;0.9289764;0.473740467036016;0.5226265634774033;0.9999134918687169;0.0824897209170039;-0.07093707528088733;-0.5261730248327009;-0.4772869283913136
Dependency on parenteral nutrition;Paroxysmal dyspnea;0.8738680183887482;0.73697007;0.5402562832280171;0.5847217994260565;0.9999134918687169;-0.12604547347996875;-0.26294342484448596;-0.4596572086406998;-0.4151916924426604
Dependency on parenteral nutrition;Phenylpyruvic acidemia;0.7580613046884537;0.69720274;0.5777832890108727;0.5979205035442343;0.9999584729108851;-0.24189716822243146;-0.30275573081112317;-0.4221751839000124;-0.4020379693666508
Dependency on parenteral nutrition;Lateral ventricle dilatation;0.8707522451877594;0.8386617;0.5412562506578258;0.5515810246776565;0.9999462364511621;-0.1291939912634027;-0.16128456576634764;-0.4586899857933363;-0.44836521177350563
Dependency on parenteral nutrition;Neonatal unconjugated hyperbilirubinemia;0.6189736127853394;0.6813921;0.6244292996718177;0.6032153280434316;0.9999584729108851;-0.3809848601255458;-0.3185663992795985;-0.3755291732390674;-0.39674314486745355
Dependency on parenteral nutrition;High maternal circulating alpha-fetoprotein concentration;0.7874470502138138;0.7774404;0.5681777984540737;0.571441176675296;0.9999134918687169;-0.21246644165490314;-0.22247306313489124;-0.43173569341464324;-0.4284723151934209
Dependency on parenteral nutrition;Prominent nasolabial fold;0.9825548529624939;0.878935;0.5055532444649948;0.5386309646411034;0.9999524555142131;-0.017397602551719182;-0.12101747607543134;-0.49439921104921825;-0.4613214908731097
Dependency on parenteral nutrition;Abnormality of inferior alveolar nerve;0.984559141099453;0.8630645;0.5049151733651154;0.5437252941716422;0.9999134918687169;-0.015354350769263947;-0.13684896435712024;-0.49499831850360154;-0.45618819769707475
Dependency on parenteral nutrition;Unilateral conductive hearing impairment;1.0757433846592903;0.93281925;0.47586701883507676;0.5214004207334852;0.9999584729108851;0.07578491174840518;-0.06713922566509656;-0.5240914540758084;-0.4785580521773999
Dependency on parenteral nutrition;Macular hypopigmented whorls, streaks, and patches;0.978920029476285;0.9194907;0.5067104600631878;0.5256546756806082;0.9999584729108851;-0.02103844343460015;-0.08046777791119031;-0.49324801284769737;-0.47430379723027694
Dependency on parenteral nutrition;Delayed ossification of pubic rami;0.9380757249891758;0.8071913;0.5197237281400192;0.5617596754099665;0.9999567459343585;-0.06188102094518266;-0.19276543362127863;-0.48023301779433925;-0.43819707052439194
Dependency on parenteral nutrition;Hyperphenylalaninemia;0.7780217379331589;0.73813796;0.5712514025706015;0.5843365428601234;0.9999542297279059;-0.22193249179474706;-0.26181626929394597;-0.42870282715730446;-0.41561768686778255
Dependency on parenteral nutrition;Ureteropelvic junction obstruction;0.8273575305938721;0.7314739;0.5552305194057366;0.586536538336859;0.9999505803237132;-0.17259304972984113;-0.268476657594221;-0.44472006091797656;-0.41341404198685416
Dependency on parenteral nutrition;Cone-shaped epiphysis of the proximal phalanx of the 2nd toe;0.9276782274246216;0.8816811;0.5230408506699282;0.5377505081534617;0.9999134918687169;-0.07223526444409534;-0.11823240723584338;-0.4768726411987887;-0.4621629837152552
Dependency on parenteral nutrition;Difficulty walking;0.8304876089096069;0.73596257;0.5542192759071808;0.5850542477827696;0.9999431787962207;-0.1694555698866138;-0.2639806090826282;-0.44572390288903996;-0.41488893101345115
Dependency on parenteral nutrition;Bilobate gallbladder;0.7894061207771301;0.86800265;0.5675397630299844;0.542139032066756;0.8526023716255289;-0.06319625084839875;0.015400281496419366;-0.28506260859554444;-0.3104633395587729
Dependency on parenteral nutrition;Histidinuria;0.7551256716251373;0.751506;0.5787467058358768;0.5799356359263612;0.9999556674707869;-0.24482999584564957;-0.24844969651589188;-0.42120896163491006;-0.4200200315444257
Dependency on parenteral nutrition;Widened interpedicular distance;0.9594430327415466;0.8473301;0.5129132253742292;0.5487871251723379;0.9999134918687169;-0.04047045912717029;-0.15258339848492786;-0.4870002664944877;-0.45112636669637907
Limited shoulder flexion;Paroxysmal vertigo;0.9927052985876799;0.809788;0.5023219961698797;0.5609175399611014;0.9999134918687169;-0.007208193281037056;-0.1901255032059972;-0.4975914956988372;-0.43899595190761553
Limited shoulder flexion;Long hallux;0.8437924236059189;0.8718654;0.5499268801877881;0.5408989540667822;0.7569149208434753;0.08687750276244355;0.11495047088778687;-0.2069880406556872;-0.2160159667766931
Limited shoulder flexion;Broad medial eyebrow;0.8823503404855728;0.8290651;0.5375359837847462;0.5546787762581596;0.9999201345566091;-0.1175697940710363;-0.17085505009921165;-0.4623841507718629;-0.44524135829844946
Limited shoulder flexion;Myxoid subcutaneous tumors;0.9599345661699772;0.8385869;0.5127566381446897;0.551605142095488;0.9999201345566091;-0.03998556838663192;-0.161333208096343;-0.48716349641191936;-0.44831499246112105
Limited shoulder flexion;Bulbous tips of toes;0.9093182906508446;0.86132985;0.5289045918456934;0.5442827814700463;0.8193379704785829;0.08998032017226165;0.041991883056115564;-0.29043337863288954;-0.27505518900853665
Limited shoulder flexion;Absent internal genitalia;0.9308810755610466;0.80810565;0.5220187929526852;0.5614630999679031;1.0;-0.0691189244389534;-0.19189435243606567;-0.47798120704731484;-0.4385369000320969
Limited shoulder flexion;Hyperphalangy of the 2nd finger;0.6472453474998474;0.5937903;0.6147549712401368;0.633149754776002;0.8332104407109631;-0.18596509321111565;-0.2394201479710949;-0.21845546947082628;-0.20006068593496107
Limited shoulder flexion;Renal interstitial hemosiderin;0.9153729751706123;0.77543455;0.5269698760487762;0.5720962613720028;1.0;-0.08462702482938766;-0.22456544637680054;-0.4730301239512238;-0.42790373862799724
Limited shoulder flexion;Abnormality of depressor anguli oris muscle;0.6209551393985748;0.6408735;0.6237473981718415;0.6169253422098702;1.0;-0.37904486060142517;-0.3591265082359314;-0.37625260182815845;-0.38307465779012984
Limited shoulder flexion;Paroxysmal dyspnea;0.9175704419612885;0.7618338;0.526267947545014;0.576546290287351;1.0;-0.08242955803871155;-0.2381662130355835;-0.47373205245498595;-0.42345370971264895
Limited shoulder flexion;Phenylpyruvic acidemia;0.9106979891657829;0.7731137;0.5284636309339593;0.5728545797420852;0.9999201345566091;-0.08922214539082618;-0.22680640698702903;-0.4714565036226498;-0.4270655548145239
Limited shoulder flexion;Lateral ventricle dilatation;1.0301635712385178;0.8101702;0.49039718052341696;0.5607936193883529;0.9998579617208769;0.03030560951764083;-0.1896877880758574;-0.50946078119746;-0.439064342332524
Limited shoulder flexion;Neonatal unconjugated hyperbilirubinemia;1.0085174459964037;0.8642575;0.49728877995187226;0.5433419752648685;0.9999201345566091;0.008597311439794586;-0.13566262007983299;-0.5026313546047368;-0.4565781592917406
Limited shoulder flexion;High maternal circulating alpha-fetoprotein concentration;0.9376662410795689;0.8302053;0.5198543232107539;0.5543104621845738;1.0;-0.06233375892043114;-0.16979467868804932;-0.48014567678924613;-0.4456895378154262
Limited shoulder flexion;Prominent nasolabial fold;0.9749527052044868;0.8492608;0.5079736354364114;0.5481653634843768;0.9998944404568447;-0.024941735252357877;-0.1506336334194912;-0.49192080502043334;-0.4517290769724679
Limited shoulder flexion;Abnormality of inferior alveolar nerve;1.0114032961428165;0.8605653;0.49637013943150965;0.5445285371658146;1.0;0.011403296142816544;-0.13943469524383545;-0.5036298605684904;-0.4554714628341854
Limited shoulder flexion;Unilateral conductive hearing impairment;0.9633750058710575;0.76277936;0.5116607056301723;0.576236425964572;0.9999201345566091;-0.0365451286855516;-0.2371407795074758;-0.4882594289264368;-0.4236837085920371
Limited shoulder flexion;Macular hypopigmented whorls, streaks, and patches;1.0060435682535172;0.88868266;0.49807626076628586;0.5355070037393073;0.9999201345566091;0.006123433696908043;-0.11123747111590476;-0.5018438737903232;-0.46441313081730184
Limited shoulder flexion;Delayed ossification of pubic rami;0.8760337084531784;0.8423795;0.5395614686139972;0.5503822608612753;0.8193379704785829;0.056695737974595484;0.02304153992409652;-0.2797765018645857;-0.26895570961730764
Limited shoulder flexion;Hyperphenylalaninemia;0.9652315303683281;0.85844135;0.5110693785721286;0.5452113708889932;0.9999028053808913;-0.034671275012563174;-0.141461452536653;-0.48883342680876263;-0.4546914344918981
Limited shoulder flexion;Ureteropelvic junction obstruction;0.8428169041872025;0.7182937;0.5502412814796375;0.5909003715163941;0.9998847295244674;-0.15706782533726493;-0.281591003080223;-0.4496434480448299;-0.4089843580080733
Limited shoulder flexion;Cone-shaped epiphysis of the proximal phalanx of the 2nd toe;0.755476787686348;0.73214567;0.5786314378777707;0.5863145942484077;1.0;-0.24452321231365204;-0.26785433292388916;-0.4213685621222293;-0.4136854057515923
Limited shoulder flexion;Difficulty walking;0.9393103271722794;0.80691004;0.5193300014179203;0.5618509321235048;0.7552776988623575;0.18403262830992184;0.05163233913202725;-0.23594769744443722;-0.19342676673885273
Limited shoulder flexion;Bilobate gallbladder;1.0161716807633638;0.92450964;0.4948521697406272;0.524052198708324;0.9999134918687169;0.01625818889464692;-0.0754038473603551;-0.5050613221280897;-0.47586129316039294
Limited shoulder flexion;Histidinuria;0.9469991400837898;0.8829595;0.5168786062433907;0.5373407476820733;0.9999090677057578;-0.052909927621968;-0.11694958265174171;-0.48303046146236717;-0.46256832002368453
Limited shoulder flexion;Widened interpedicular distance;0.5546305477619171;0.67336;0.6469276590792027;0.6059164573752405;1.0;-0.4453694522380829;-0.3266400098800659;-0.3530723409207973;-0.39408354262475953
Paroxysmal vertigo;Long hallux;1.0651580914855003;0.9671832;0.4792448313329274;0.5104477940437584;0.9999503740898522;0.06520771739564812;-0.032767201387062905;-0.5207055427569248;-0.4895025800460938
Paroxysmal vertigo;Broad medial eyebrow;1.0229891017079353;1.0482788;0.49268169693626584;0.4846263839333155;0.9999584729108851;0.0230306287970502;0.04832033568286487;-0.5072767759746193;-0.5153320889775697
Paroxysmal vertigo;Myxoid subcutaneous tumors;0.9564591832458973;0.8296859;0.5138638553030557;0.5544782151123413;0.9999584729108851;-0.04349928966498784;-0.1702725464735072;-0.48609461760782946;-0.44548025779854383
Paroxysmal vertigo;Bulbous tips of toes;0.9975561909377575;0.8947444;0.5007778893587441;0.5335660684688058;0.9999567459343585;-0.0024005549966009676;-0.10521234972464166;-0.49917885657561434;-0.4663906774655526
Paroxysmal vertigo;Absent internal genitalia;0.9128959476947784;0.8507927;0.5277612613864122;0.5476721668180276;0.9999134918687169;-0.08701754417393848;-0.1491207858559911;-0.4721522304823047;-0.45224132505068937
Paroxysmal vertigo;Hyperphalangy of the 2nd finger;0.9937020819634199;0.8075255;0.5020047028259134;0.5616512549232596;0.9999584729108851;-0.006256390947465218;-0.19243295735454968;-0.49795377008497177;-0.4383072179876255
Paroxysmal vertigo;Renal interstitial hemosiderin;1.1071702390909195;0.9092785;0.4658210123132498;0.5289173085716663;0.9999134918687169;0.10725674722220258;-0.09063497986767932;-0.5340924795554671;-0.4709961832970506
Paroxysmal vertigo;Abnormality of depressor anguli oris muscle;0.8886840641498566;0.8291718;0.5355065503185346;0.5546443273229624;0.9999134918687169;-0.11122942771886035;-0.1707417150971715;-0.46440694155018236;-0.4452691645457545
Paroxysmal vertigo;Paroxysmal dyspnea;0.5402839779853821;0.33609676;0.6520488024527391;0.7311013311022702;0.9999134918687169;-0.45962951388333484;-0.6638167282578771;-0.3478646894159778;-0.26881216076644676
Paroxysmal vertigo;Phenylpyruvic acidemia;0.9076440557837486;0.6206269;0.5294397633495568;0.6238603044586317;0.9999584729108851;-0.0923144171271365;-0.379331546488766;-0.47051870956132835;-0.3760981684522534
Paroxysmal vertigo;Lateral ventricle dilatation;0.7433197498321533;0.6733718;0.5826287261386581;0.6059125028411743;0.9999462364511621;-0.2566264866190088;-0.3265744446115625;-0.41731751031250397;-0.39403373360998784
Paroxysmal vertigo;Neonatal unconjugated hyperbilirubinemia;1.0027579069137573;0.8039639;0.4991221298513199;0.5628069683532775;0.9999584729108851;0.002799434002872192;-0.19599457329845837;-0.5008363430595653;-0.43715150455760765
Paroxysmal vertigo;High maternal circulating alpha-fetoprotein concentration;1.0007834199350327;0.88639396;0.4997506296641372;0.5362401706392483;0.9999134918687169;0.000869928066315806;-0.11351952757809802;-0.5001628622045797;-0.4636733212294686
Paroxysmal vertigo;Prominent nasolabial fold;0.7844823151826859;0.8281561;0.5691438916575084;0.5549724657734469;0.9999524555142131;-0.21547014033152723;-0.17179634188964032;-0.43080856385670463;-0.44497998974076614
Paroxysmal vertigo;Abnormality of inferior alveolar nerve;0.7303167581558228;0.70138943;0.5869189931722034;0.5965231551929879;0.9999134918687169;-0.26959673371289417;-0.29852405991528674;-0.4129944986965135;-0.403390336675729
Paroxysmal vertigo;Unilateral conductive hearing impairment;0.3578999638557434;0.5536277;0.7219366263510247;0.6472842762011739;0.7730659511922591;-0.41516598733651566;-0.21943822177636552;-0.051129324841234336;-0.12578167499108517
Paroxysmal vertigo;Macular hypopigmented whorls, streaks, and patches;0.910026915371418;0.83605886;0.5286781037316375;0.5524207068103941;0.9999584729108851;-0.08993155753946713;-0.16389961785412244;-0.47128036917924765;-0.447537766100491
Paroxysmal vertigo;Delayed ossification of pubic rami;1.0460798367857933;0.83283967;0.48532713666259275;0.5534597534374509;0.9999567459343585;0.046123090851434845;-0.16711707813726984;-0.5146296092717657;-0.44649699249690755
Paroxysmal vertigo;Hyperphenylalaninemia;0.9273685738444328;0.76292014;0.5231396763665996;0.5761903012782306;0.9999542297279059;-0.0725856558834731;-0.23703408850781316;-0.4768145533613063;-0.42376392844967536
Paroxysmal vertigo;Ureteropelvic junction obstruction;0.9747375436127186;0.70640355;0.5080421451771384;0.5948521846305485;0.9999505803237132;-0.02521303671099462;-0.29354702683784284;-0.4919084351465748;-0.40509839569316475
Paroxysmal vertigo;Cone-shaped epiphysis of the proximal phalanx of the 2nd toe;1.0597611963748932;0.8731781;0.4809660792722351;0.5404776706282697;0.9999134918687169;0.05984770450617627;-0.1267353674409215;-0.5189474125964818;-0.45943582124044724
Paroxysmal vertigo;Difficulty walking;0.8624448627233505;0.8107096;0.5439244287387688;0.5606187454004876;0.9999431787962207;-0.13749831607287022;-0.18923358311598393;-0.45601875005745196;-0.4393244333957331
Paroxysmal vertigo;Bilobate gallbladder;1.0069017708301544;0.830005;0.49780308067084766;0.5543751558641807;0.9999567459343585;0.006945024895795959;-0.16995175583349786;-0.5021536652635108;-0.4455815900701777
Paroxysmal vertigo;Histidinuria;0.9912813846021891;0.85937136;0.5027752566355588;0.5449123573266593;0.9999556674707869;-0.008674282868597838;-0.1405843033541182;-0.4971804108352281;-0.4550433101441276
Paroxysmal vertigo;Widened interpedicular distance;1.031997736543417;0.8791733;0.4898130652939361;0.5385545387026767;0.9999134918687169;0.03208424467470006;-0.12074021306012317;-0.5101004265747808;-0.46135895316604025
Long hallux;Broad medial eyebrow;0.7681790292263031;0.7170827;0.5744683535956405;0.5913022053503596;0.9999526340597648;-0.23177360483346165;-0.28286995478806676;-0.42548428046412423;-0.40865042870940516
Long hallux;Myxoid subcutaneous tumors;0.9964709021151066;1.0156485;0.5011233490778779;0.49501874605671403;0.9999526340597648;-0.003481731944658173;0.01569585017027675;-0.49882928498188683;-0.5049338880030507
Long hallux;Bulbous tips of toes;0.5019848346710205;0.6024333;0.6659376169206521;0.6301452743681222;0.6346804177612032;-0.1326955830901827;-0.03224709390103475;0.03125719915944891;-0.004535143393081031
Long hallux;Absent internal genitalia;0.8655428886413574;0.86114794;0.5429290469457069;0.5443412567358565;0.9998836012415208;-0.13434071260016334;-0.13873566108267676;-0.4569545542958139;-0.4555423445056642
Long hallux;Hyperphalangy of the 2nd finger;0.7021238803863525;0.7676525;0.5962782361792793;0.5746406636587147;0.7773371784594012;-0.07521329807304866;-0.009684666862721514;-0.18105894228012187;-0.2026965148006865
Long hallux;Renal interstitial hemosiderin;1.016876731067896;0.9451068;0.4946277146080247;0.5174818398584959;0.9998836012415208;0.01699312982637513;-0.05477679687064063;-0.5052558866334961;-0.4824017613830248
Long hallux;Abnormality of depressor anguli oris muscle;0.8246356844902039;0.82825017;0.5561103317210683;0.5549420653092427;0.8279638214854832;-0.0033281369952793405;0.0002863482685451224;-0.2718534897644149;-0.27302175617624047
Long hallux;Paroxysmal dyspnea;1.0117997005581856;0.93447447;0.4962439514939406;0.5208723837814375;0.9998836012415208;0.011916099316664819;-0.06540913301031959;-0.5036396497475801;-0.47901121746008324
Long hallux;Phenylpyruvic acidemia;1.0483563132584095;0.9834309;0.4846017023918062;0.5052743497882546;0.9999526340597648;0.048403679198644745;-0.016521712028362168;-0.5153509316679585;-0.49467828427151017
Long hallux;Lateral ventricle dilatation;0.9666773751378059;0.71205306;0.5106088848915153;0.5929726785252389;0.9999360266643673;-0.03325865152656138;-0.2878829661327511;-0.48932714177285197;-0.4069633481391284
Long hallux;Neonatal unconjugated hyperbilirubinemia;1.048936389386654;0.8964209;0.4844168395573276;0.5330294959062458;0.9999526340597648;0.048983755326889145;-0.10353173800645055;-0.5155357945024371;-0.46692313815351894
Long hallux;High maternal circulating alpha-fetoprotein concentration;0.9825235437601805;0.87039256;0.505563212013187;0.541371717655087;0.9998836012415208;-0.017360057481340285;-0.12949104028265845;-0.49432038922833377;-0.4585118835864338
Long hallux;Prominent nasolabial fold;0.7006580233573914;0.6607518;0.596767138956841;0.6101726533363292;0.9999446427564167;-0.29928661939902534;-0.339192823145821;-0.40317750379957573;-0.3897719894200875
Long hallux;Abnormality of inferior alveolar nerve;0.8946128860116005;0.8648708;0.5336081683577019;0.543144963648027;0.9998836012415208;-0.10527071522992026;-0.13501281457465064;-0.4662754328838189;-0.45673863759349376
Long hallux;Unilateral conductive hearing impairment;0.9153594747185707;0.7954435;0.5269741888499176;0.5655752155287745;0.9999526340597648;-0.08459315934119405;-0.2045091588133353;-0.4729784452098471;-0.4343774185309902
Long hallux;Macular hypopigmented whorls, streaks, and patches;0.9357834979891777;0.9084873;0.5204548223670598;0.5291701929248789;0.9999526340597648;-0.06416913607058705;-0.0914653141134757;-0.479497811692705;-0.4707824411348859
Long hallux;Delayed ossification of pubic rami;0.7038678228855133;0.7398197;0.595696889357044;0.5837820024934175;0.803475731189364;-0.09960790830385069;-0.06365602570306639;-0.20777884183231998;-0.2196937286959465
Long hallux;Hyperphenylalaninemia;0.9343990981578827;0.73091507;0.520896421797499;0.5867212341332536;0.9999470333157194;-0.06554793515783675;-0.2690319637356413;-0.4790506115182205;-0.4132257991824658
Long hallux;Ureteropelvic junction obstruction;1.0402080044150352;0.95187676;0.48719794363045166;0.5153240170137581;0.999942084065247;0.040265920349788265;-0.048065324536133214;-0.5127441404347953;-0.4846180670514889
Long hallux;Cone-shaped epiphysis of the proximal phalanx of the 2nd toe;0.48840463161468506;0.67535716;0.6709453054077399;0.6052440988319188;0.1431341874814257;0.34527044413325936;0.5322229754709974;0.5278111179263142;0.46210991135049306
Long hallux;Difficulty walking;0.7589381635189056;0.74089247;0.5774956626411534;0.5834284040992264;0.8989796451888926;-0.14004148166998698;-0.15808717530592753;-0.32148398254773924;-0.31555124108966626
Long hallux;Bilobate gallbladder;1.0359408631920815;0.88132656;0.4885572034953143;0.537864161170209;0.9999503740898522;0.03599048910222924;-0.1186238178841027;-0.5113931705945379;-0.46208621291964325
Long hallux;Histidinuria;0.9374658018350601;0.84914845;0.5199182497184387;0.5482015503975817;0.9999489492479948;-0.0624831474129347;-0.15080049696604292;-0.4800306995295561;-0.45174739885041315
Long hallux;Widened interpedicular distance;0.5824959874153137;0.62306195;0.6370950297967974;0.6230230366869316;0.7406161172192745;-0.15812012980396073;-0.11755416224414628;-0.10352108742247701;-0.11759308053234285
Broad medial eyebrow;Myxoid subcutaneous tumors;0.9148267954587936;0.92746735;0.5271443604344872;0.5231081458739123;0.8733283781844945;0.04149841727429915;0.05413896800691176;-0.3461840177500073;-0.3502202323105822
Broad medial eyebrow;Bulbous tips of toes;0.8103433102369308;0.8172822;0.5607374982752984;0.5584894579399038;0.9999584729108851;-0.18961516267395429;-0.182676273051266;-0.43922097463558674;-0.44146901497098134
Broad medial eyebrow;Absent internal genitalia;0.8417314141988754;0.901644;0.5505911834363733;0.5313583935972361;0.9999201345566091;-0.15818872035773368;-0.0982761430862722;-0.44932895112023585;-0.468561740959373
Broad medial eyebrow;Hyperphalangy of the 2nd finger;0.761711597442627;0.78585136;0.5765863471669241;0.5686977026294393;0.9999600672783046;-0.2382484698356776;-0.21410870791093395;-0.4233737201113804;-0.43126236464886525
Broad medial eyebrow;Renal interstitial hemosiderin;0.9686699286103249;0.9333437;0.5099743036640327;0.5212330925911478;0.9999201345566091;-0.03125020594628425;-0.06657642604144187;-0.4899458308925764;-0.4786870419654613
Broad medial eyebrow;Abnormality of depressor anguli oris muscle;0.770242303609848;0.8375781;0.5737933708087092;0.5519305498477685;0.7870101688836642;-0.01676786527381613;0.050567948963778475;-0.21321679807495497;-0.2350796190358957
Broad medial eyebrow;Paroxysmal dyspnea;1.071531467139721;1.0234067;0.4772113646262004;0.49254870843169496;0.9999201345566091;0.07161133258311181;0.02348660944668679;-0.5227087699304087;-0.5073714261249141
Broad medial eyebrow;Phenylpyruvic acidemia;1.0402377620339394;1.0001343;0.4871884638144567;0.49995723068338105;0.9999600672783046;0.04027769475563481;0.0001742815910191764;-0.5127716034638479;-0.5000028365949235
Broad medial eyebrow;Lateral ventricle dilatation;0.9012373611330986;0.807891;0.5314884565649882;0.5615327160681838;0.9999488789551968;-0.0987115178220982;-0.19205786771709865;-0.4684604223902086;-0.438416162887013
Broad medial eyebrow;Neonatal unconjugated hyperbilirubinemia;0.9856341294944286;0.95612115;0.5045729559078531;0.5139715609940692;0.9999600672783046;-0.01432593778387592;-0.043838920599379994;-0.49538711137045144;-0.4859885062842354
Broad medial eyebrow;High maternal circulating alpha-fetoprotein concentration;0.8519321084022522;0.7741082;0.5473054145139493;0.5725295814878792;0.9999201345566091;-0.1479880261543569;-0.2258119630935964;-0.4526147200426598;-0.42739055306872986
Broad medial eyebrow;Prominent nasolabial fold;0.5791510939598083;0.66006976;0.6382677448894549;0.6104034652742487;0.8787482221886792;-0.29959712822887086;-0.2186784585282483;-0.24048047729922428;-0.2683447569144305
Broad medial eyebrow;Abnormality of inferior alveolar nerve;0.7971835732460022;0.9102771;0.5650094695918875;0.5285981398366657;0.9999201345566091;-0.2027365613106069;-0.08964300633700462;-0.43491066496472164;-0.4713219947199434
Broad medial eyebrow;Unilateral conductive hearing impairment;0.8715414851903915;0.8577632;0.5410029158776246;0.5454294638585708;0.9999600672783046;-0.128418582087913;-0.14219689608232067;-0.45895715140067994;-0.4545306034197337
Broad medial eyebrow;Macular hypopigmented whorls, streaks, and patches;0.7187224328517914;0.7962121;0.5907581594842866;0.5653252974118106;0.8733283781844945;-0.1546059453327031;-0.07711630104368639;-0.28257021870020793;-0.3080030807726839
Broad medial eyebrow;Delayed ossification of pubic rami;0.951236866414547;0.9784245;0.515527945489193;0.5068682371561762;0.9999584729108851;-0.048721606496338166;-0.021533983412746704;-0.4844305274216921;-0.4930902357547089
Broad medial eyebrow;Hyperphenylalaninemia;0.8099143207073212;0.7649104;0.5608765799175309;0.5755383531717668;0.9999561589935034;-0.19004183828618226;-0.2350457590797156;-0.4390795790759725;-0.4244178058217366
Broad medial eyebrow;Ureteropelvic junction obstruction;1.0895103365182877;1.0633074;0.4714697903097931;0.4798351519067138;0.9999528219730685;0.08955751454521921;0.06335458254505899;-0.5284830316632754;-0.5201176700663547
Broad medial eyebrow;Cone-shaped epiphysis of the proximal phalanx of the 2nd toe;0.8569052517414093;0.8409797;0.5457053655897629;0.5508335321510796;0.9999201345566091;-0.1430148828151998;-0.1589404392364797;-0.4542147689668462;-0.44908660240552956
Broad medial eyebrow;Difficulty walking;0.9063034728169441;0.86380315;0.5298683426607684;0.5434879650721989;0.9999461221900431;-0.09364264937309896;-0.13614297392038976;-0.47007777952927465;-0.4564581571178442
Broad medial eyebrow;Bilobate gallbladder;1.0496231690049171;0.96507734;0.48419796488110867;0.5111184944555074;0.9999584729108851;0.04966469609403201;-0.034881132308010376;-0.5157605080297765;-0.48883997845537774
Broad medial eyebrow;Histidinuria;0.9065165147185326;0.8819839;0.5298002303602409;0.5376534537146045;0.9999574798349273;-0.09344096511639477;-0.11797360360659481;-0.4701572494746864;-0.46230402612032284
Broad medial eyebrow;Widened interpedicular distance;0.7946177423000336;0.64071035;0.565843760892712;0.6169809843136361;0.9999201345566091;-0.20530239225657554;-0.35920978070529075;-0.43407637366389706;-0.382939150242973
Myxoid subcutaneous tumors;Bulbous tips of toes;0.9400071650743484;0.921618;0.5191077861007296;0.524975395857958;0.9999584729108851;-0.05995130783653668;-0.07834048813915662;-0.4808506868101555;-0.4749830770529271
Myxoid subcutaneous tumors;Absent internal genitalia;0.9342866688966751;0.93299824;0.5209322865302144;0.521343312154288;0.9999201345566091;-0.065633465659934;-0.06692189456256004;-0.4789878480263947;-0.47857682240232113
Myxoid subcutaneous tumors;Hyperphalangy of the 2nd finger;0.9311267733573914;0.9096997;0.5219403980945596;0.5287826874635745;0.9999600672783046;-0.0688332939209132;-0.09026038885728405;-0.47801966918374494;-0.47117737981473007
Myxoid subcutaneous tumors;Renal interstitial hemosiderin;0.8646394908428192;0.7394354;0.5432192605338932;0.5839087091041915;0.9999201345566091;-0.1352806437137899;-0.2604847598198232;-0.45670087402271586;-0.41601142545241765
Myxoid subcutaneous tumors;Abnormality of depressor anguli oris muscle;0.8609338700771332;0.7790375;0.5444100601384618;0.5709198449354911;0.9999201345566091;-0.13898626447947593;-0.2208826589706716;-0.4555100744181473;-0.429000289621118
Myxoid subcutaneous tumors;Paroxysmal dyspnea;0.841081976890564;0.78172445;0.5508005555709345;0.5700431589799331;0.9999201345566091;-0.15883815766604514;-0.218195681584197;-0.44911957898567456;-0.42987697557667603
Myxoid subcutaneous tumors;Phenylpyruvic acidemia;0.9607356525957584;0.89222705;0.512501443580536;0.5343719434543783;0.9999600672783046;-0.039224414682546116;-0.1077330136360316;-0.4874586236977686;-0.4655881238239262
Myxoid subcutaneous tumors;Lateral ventricle dilatation;0.9939050879329443;0.91407937;0.501940082778175;0.5273831469385655;0.9999488789551968;-0.006043791022252498;-0.08586951084072536;-0.49800879617702176;-0.4725657320166313
Myxoid subcutaneous tumors;Neonatal unconjugated hyperbilirubinemia;0.975956816226244;0.92082906;0.5076539206342983;0.5252272996221374;0.9999600672783046;-0.02400325105206058;-0.07913100958482311;-0.4923061466440063;-0.4747327676561671
Myxoid subcutaneous tumors;High maternal circulating alpha-fetoprotein concentration;0.9602609761059284;0.91179407;0.5126526558219909;0.5281133539751974;0.9999201345566091;-0.03965915845068069;-0.08812606812747092;-0.4872674787346182;-0.4718067805814117
Myxoid subcutaneous tumors;Prominent nasolabial fold;0.8812287598848343;0.8575638;0.5378955148265485;0.5454935757227937;0.9999545338528789;-0.11872577396804462;-0.1423907401936687;-0.4620590190263304;-0.45446095813008525
Myxoid subcutaneous tumors;Abnormality of inferior alveolar nerve;0.8484528511762619;0.78245187;0.5484255374825695;0.5698059142021814;0.9999201345566091;-0.1514672833803472;-0.21746826649935813;-0.4514945970740396;-0.4301142203544277
Myxoid subcutaneous tumors;Unilateral conductive hearing impairment;0.9785561487078667;0.8491535;0.5068263130995425;0.548199914248076;0.9999600672783046;-0.021403918570437885;-0.15080654860154674;-0.49313375417876204;-0.45176015303022854
Myxoid subcutaneous tumors;Macular hypopigmented whorls, streaks, and patches;0.7762738913297653;0.7121778;0.5718221115588702;0.5929312131317384;0.8434590184411804;-0.06718512711141511;-0.13128120538804933;-0.27163690688231024;-0.2505278053094421
Myxoid subcutaneous tumors;Delayed ossification of pubic rami;0.9432636611163616;0.87359995;0.518069440720444;0.5403423063978297;0.9999584729108851;-0.056694811794523514;-0.12635852641201428;-0.4818890321904411;-0.4596161665130555
Myxoid subcutaneous tumors;Hyperphenylalaninemia;1.0226381700485945;0.9763792;0.49279343103384254;0.5075194314659548;0.9999561589935034;0.022682011055091045;-0.023576943276187756;-0.5071627279596609;-0.49243672752754863
Myxoid subcutaneous tumors;Ureteropelvic junction obstruction;1.0014718361198902;0.88499594;0.49953149984304435;0.5366881076460223;0.9999528219730685;0.0015190141468217622;-0.11495688462565634;-0.5004213221300241;-0.4632647143270462
Myxoid subcutaneous tumors;Cone-shaped epiphysis of the proximal phalanx of the 2nd toe;0.9057546555995941;0.851337;0.530043813075963;0.547496958320995;0.9999201345566091;-0.09416547895701499;-0.1485831189277944;-0.46987632148064606;-0.4524231762356141
Myxoid subcutaneous tumors;Difficulty walking;0.9601976089179516;0.90920126;0.5126728421951906;0.528941999156074;0.9999461221900431;-0.0397485132720915;-0.0907448578086344;-0.4872732799948525;-0.4710041230339691
Myxoid subcutaneous tumors;Bilobate gallbladder;1.0516646578907967;0.9816791;0.483547303726673;0.5058320520836723;0.9999584729108851;0.05170618497991153;-0.01827939099407605;-0.5164111691842121;-0.4941264208272128
Myxoid subcutaneous tumors;Histidinuria;0.8339405357837677;0.79801065;0.5531043690072751;0.5647406395835435;0.9999574798349273;-0.16601694405115963;-0.20194683253802181;-0.4468531108276522;-0.43521684025138385
Myxoid subcutaneous tumors;Widened interpedicular distance;1.0181332938373089;0.9373722;0.49422767693400327;0.5199481096907941;0.9999201345566091;0.018213159280699776;-0.06254792691500755;-0.5056924576226058;-0.47997202486581503
Bulbous tips of toes;Absent internal genitalia;0.8259431272745132;0.8315434;0.5556876589442941;0.5538783080515484;0.9999134918687169;-0.17397036459420367;-0.1683701058862035;-0.44422583292442286;-0.44603518381716856
Bulbous tips of toes;Hyperphalangy of the 2nd finger;0.5172017216682434;0.61456364;0.660379566838631;0.625949069163745;0.8047850673551408;-0.28758334568689736;-0.19022142342279824;-0.1444055005165098;-0.17883599819139573
Bulbous tips of toes;Renal interstitial hemosiderin;0.9514180794358253;0.91131246;0.5154701951466629;0.5282672664618031;0.9999134918687169;-0.04849541243289157;-0.08860103096936389;-0.484443296722054;-0.4716462254069138
Bulbous tips of toes;Abnormality of depressor anguli oris muscle;0.9651313722133636;0.94439566;0.5111012792460068;0.5177085511763585;0.872141863789474;0.09298950842388964;0.07225379756459094;-0.3610405845434672;-0.3544333126131155
Bulbous tips of toes;Paroxysmal dyspnea;0.9520007185637951;0.89476335;0.5152845187260918;0.5335599990551727;0.9999134918687169;-0.04791277330492183;-0.10515014138196155;-0.4846289731426251;-0.4663534928135442
Bulbous tips of toes;Phenylpyruvic acidemia;0.9220626726746559;0.91226363;0.5248334058177846;0.5279633168346954;0.9999584729108851;-0.07789580023622922;-0.08769484109020642;-0.47512506709310054;-0.4719951560761897
Bulbous tips of toes;Lateral ventricle dilatation;0.988008706830442;0.80779326;0.5038170386437639;0.5615644270833392;0.9999462364511621;-0.011937529620720144;-0.1921529768304956;-0.49612919780739817;-0.4383818093678229
Bulbous tips of toes;Neonatal unconjugated hyperbilirubinemia;0.8947397395968437;0.7923634;0.5335675637643398;0.5665771472783662;0.9999584729108851;-0.10521873331404141;-0.207595067683224;-0.46639090914654535;-0.43338132563251897
Bulbous tips of toes;High maternal circulating alpha-fetoprotein concentration;0.9756968840956688;0.9469369;0.5077366837859227;0.5168984500164413;0.9999134918687169;-0.024216607773048127;-0.0529765864846532;-0.4921768080827942;-0.4830150418522756
Bulbous tips of toes;Prominent nasolabial fold;0.8519855886697769;0.81271183;0.5472882015499005;0.559969824865141;0.9999524555142131;-0.14796686684443616;-0.18724062060668134;-0.45266425396431254;-0.43998263064907206
Bulbous tips of toes;Abnormality of inferior alveolar nerve;1.0128783518448472;0.9285939;0.49590057996857473;0.5227486452820738;0.9999134918687169;0.012964859976130283;-0.07131961789105579;-0.5040129119001422;-0.47716484658664315
Bulbous tips of toes;Unilateral conductive hearing impairment;0.9588280990719795;0.8735068;0.5131091284815406;0.5403721959706381;0.9999584729108851;-0.04113037383890561;-0.12645168847179822;-0.4868493444293446;-0.459586276940247
Bulbous tips of toes;Macular hypopigmented whorls, streaks, and patches;0.881461426615715;0.8395486;0.537820927789603;0.551295002731844;0.9999584729108851;-0.1184970462951701;-0.16040988511181287;-0.46213754512128213;-0.4486634701790412
Bulbous tips of toes;Delayed ossification of pubic rami;0.7459883987903595;0.6910547;0.5817501432321451;0.5999760042404916;0.8287089627579918;-0.08272056396763228;-0.13765426095287703;-0.24695881952584664;-0.2287329585175002
Bulbous tips of toes;Hyperphenylalaninemia;0.8418916165828705;0.75391084;0.5505395391774348;0.5791456096393526;0.9999542297279059;-0.15806261314503545;-0.24604339017025822;-0.4494146905504711;-0.42080862008855335
Bulbous tips of toes;Ureteropelvic junction obstruction;0.9026045352220535;0.82875025;0.531051163146429;0.5547805093390181;0.9999505803237132;-0.09734604510165967;-0.17120032760001935;-0.46889941717728423;-0.4451700709846951
Bulbous tips of toes;Cone-shaped epiphysis of the proximal phalanx of the 2nd toe;0.46193742752075195;0.59537643;0.6808435939070421;0.63259744517675;0.36317310279071235;0.0987643247300396;0.23220332915127373;0.3176704911163297;0.26942434238603763
Bulbous tips of toes;Difficulty walking;0.8221035897731781;0.84144515;0.556929197564739;0.5506834652869632;0.9160188400246831;-0.09391525025150504;-0.07457369203350273;-0.3590896424599441;-0.36533537473771993
Bulbous tips of toes;Bilobate gallbladder;1.0207130778580904;0.90781045;0.4934063510065265;0.529386562097617;0.9999567459343585;0.02075633192373194;-0.09214629633413873;-0.5065503949278319;-0.47057018383674143
Bulbous tips of toes;Histidinuria;0.8728372156620026;0.87098527;0.5405870614339907;0.5411814600028884;0.9999556674707869;-0.12711845180878434;-0.1289703979242781;-0.4593686060367962;-0.45877420746789854
Bulbous tips of toes;Widened interpedicular distance;0.7489010691642761;0.7224552;0.5807919487372137;0.5895206944104194;0.8072246192530101;-0.05832355008873402;-0.08476941571983754;-0.2264326705157964;-0.2177039248425907
Absent internal genitalia;Hyperphalangy of the 2nd finger;0.9278397634625435;0.91713077;0.5229892974540555;0.5264083781049349;0.9999201345566091;-0.07208037109406562;-0.08278936625750632;-0.4769308371025536;-0.4735117564516742
Absent internal genitalia;Renal interstitial hemosiderin;0.9233968332409859;0.863544;0.5244074557756679;0.543571235999194;1.0;-0.07660316675901413;-0.13645601272583008;-0.47559254422433206;-0.456428764000806
Absent internal genitalia;Abnormality of depressor anguli oris muscle;0.837539553642273;0.78568685;0.5519429904487106;0.5687513023490449;1.0;-0.16246044635772705;-0.21431314945220947;-0.44805700955128935;-0.4312486976509551
Absent internal genitalia;Paroxysmal dyspnea;0.9581630751490593;0.8958951;0.5133209947354671;0.5331977570530473;1.0;-0.041836924850940704;-0.10410487651824951;-0.4866790052645329;-0.4668022429469527
Absent internal genitalia;Phenylpyruvic acidemia;1.030414255335927;0.9323498;0.49031734866868915;0.521550193201523;0.9999201345566091;0.0304941207793179;-0.06757033349307151;-0.50960278588792;-0.47836994135508615
Absent internal genitalia;Lateral ventricle dilatation;0.9751054868102074;0.9029945;0.5079249883716286;0.5309264481391699;0.9998579617208769;-0.024752474910669564;-0.09686344820921922;-0.49193297334924835;-0.46893151358170704
Absent internal genitalia;Neonatal unconjugated hyperbilirubinemia;1.021665470674634;0.80222064;0.4931031268667724;0.5633729547392732;0.9999201345566091;0.02174533611802487;-0.1976994919899282;-0.5068170076898367;-0.43654717981733593
Absent internal genitalia;High maternal circulating alpha-fetoprotein concentration;0.969224575906992;0.93853575;0.5097976687612005;0.5195770122490142;1.0;-0.03077542409300804;-0.06146425008773804;-0.4902023312387995;-0.4804229877509858
Absent internal genitalia;Prominent nasolabial fold;0.7115035057067871;0.7201016;0.5931553595694046;0.5903007850080091;0.9998944404568447;-0.2883909347500576;-0.27979284553191797;-0.40673908088744015;-0.40959365544883564
Absent internal genitalia;Abnormality of inferior alveolar nerve;0.8160625696182251;0.75529766;0.558884381022466;0.5786902323680043;1.0;-0.1839374303817749;-0.24470233917236328;-0.44111561897753404;-0.4213097676319957
Absent internal genitalia;Unilateral conductive hearing impairment;0.9089217633008957;0.76634717;0.5290313349035682;0.5750679168027725;0.9999201345566091;-0.09099837125571342;-0.23357296468051048;-0.47088879965304087;-0.42485221775383664
Absent internal genitalia;Macular hypopigmented whorls, streaks, and patches;0.8636467307806015;0.86788243;0.5435382231611328;0.5421776477792257;0.9999201345566091;-0.1362734037760076;-0.13203770400317283;-0.45638191139547635;-0.4577424867773834
Absent internal genitalia;Delayed ossification of pubic rami;0.7704552263021469;0.7533815;0.5737237342330448;0.579319450156542;0.9999134918687169;-0.22945826556657;-0.24653200116131946;-0.42618975763567213;-0.42059404171217496
Absent internal genitalia;Hyperphenylalaninemia;1.0019575292244554;0.8700531;0.49937689869741586;0.54148067943701;0.9999028053808913;0.002054723843564088;-0.1298496928740248;-0.5005259066834754;-0.4584221259438813
Absent internal genitalia;Ureteropelvic junction obstruction;0.7813118696212769;0.73721063;0.5701777348132018;0.5846424235220931;0.5918707055256804;0.18944116409559641;0.145339925844864;-0.021692970712478665;-0.007228282003587383
Absent internal genitalia;Cone-shaped epiphysis of the proximal phalanx of the 2nd toe;0.8723400235176086;0.82888114;0.5407466230443725;0.5547382209671989;1.0;-0.12765997648239136;-0.1711188554763794;-0.4592533769556275;-0.44526177903280106
Absent internal genitalia;Difficulty walking;0.943529948592186;0.91063964;0.5179845426716071;0.5284822869559517;0.9998344221996177;-0.05630447360743174;-0.0891947785304893;-0.4818498795280106;-0.47135213524366604
Absent internal genitalia;Bilobate gallbladder;1.05129000172019;0.9271468;0.48366671881530443;0.5232104686208492;0.9999134918687169;0.05137650985147313;-0.07276669945691272;-0.5162467730534125;-0.47670302324786773
Absent internal genitalia;Histidinuria;0.9092821031808853;0.8493107;0.5289161583490428;0.5481493046030914;0.6780430294702215;0.23123907371066377;0.17126766665480897;-0.14912687112117873;-0.12989372486713013
Absent internal genitalia;Widened interpedicular distance;0.9440048933029175;0.86286426;0.5178331234822664;0.5437896640916093;1.0;-0.05599510669708252;-0.13713574409484863;-0.4821668765177336;-0.45621033590839066
Hyperphalangy of the 2nd finger;Renal interstitial hemosiderin;0.9222112447023392;0.8295623;0.524785969860031;0.5545181677049209;0.9999201345566091;-0.07770888985426994;-0.17035782815249534;-0.4751341646965781;-0.4454019668516882
Hyperphalangy of the 2nd finger;Abnormality of depressor anguli oris muscle;0.7616031467914581;0.7455317;0.5766218924563694;0.581900470994389;0.8819596887815145;-0.12035654199005641;-0.13642801058174647;-0.3053377963251451;-0.3000592177871255
Hyperphalangy of the 2nd finger;Paroxysmal dyspnea;0.8394156098365784;0.69483924;0.5513378774046309;0.5987101995800674;0.9999201345566091;-0.16050452472003074;-0.3050808954361257;-0.4485822571519782;-0.40120993497654167
Hyperphalangy of the 2nd finger;Phenylpyruvic acidemia;0.8030007630586624;0.6787855;0.5631196509615604;0.6040910468108054;0.9999600672783046;-0.19695930421964214;-0.32117456436769054;-0.4368404163167442;-0.39586902046749917
Hyperphalangy of the 2nd finger;Lateral ventricle dilatation;1.02827806212008;0.83989817;0.4909976132018181;0.5511822605640959;0.9999488789551968;0.028329183164883198;-0.16005070991451686;-0.5089512657533787;-0.4487666183911009
Hyperphalangy of the 2nd finger;Neonatal unconjugated hyperbilirubinemia;0.8981439471244812;0.8681977;0.5324781127655351;0.5420764060761565;0.9999600672783046;-0.10181612015382335;-0.13176238775865123;-0.4674819545127694;-0.4578836612021481
Hyperphalangy of the 2nd finger;High maternal circulating alpha-fetoprotein concentration;0.9401884377002716;0.81841743;0.519049981429039;0.5581219645530362;0.9999201345566091;-0.0597316968563375;-0.18150270463259788;-0.4808701531275701;-0.4417981700035729
Hyperphalangy of the 2nd finger;Prominent nasolabial fold;0.853921115398407;0.8811486;0.5466653332994587;0.5379212247660052;0.9999545338528789;-0.14603341845447193;-0.11880595711642872;-0.45328920055342026;-0.4620333090868737
Hyperphalangy of the 2nd finger;Abnormality of inferior alveolar nerve;0.8498019129037857;0.8101673;0.5479911453675692;0.5607945469462716;0.9999201345566091;-0.1501182216528234;-0.1897528219345388;-0.4519289891890399;-0.4391255876103375
Hyperphalangy of the 2nd finger;Unilateral conductive hearing impairment;1.028288135305047;0.9308039;0.49099440552423645;0.5220434144962225;0.9999600672783046;0.02832806802674248;-0.06915617228166149;-0.5089656617540681;-0.47791665278208206
Hyperphalangy of the 2nd finger;Macular hypopigmented whorls, streaks, and patches;0.8437747657299042;0.8005669;0.549932570727889;0.5639100627122902;0.9999600672783046;-0.15618530154840038;-0.19939315558091686;-0.4500274965504155;-0.4360500045660144
Hyperphalangy of the 2nd finger;Delayed ossification of pubic rami;0.8377870321273804;0.794209;0.5518631566382743;0.5659767063698666;0.8355479869321181;0.0022390451952623014;-0.04133898348363174;-0.2836848302938437;-0.26957128056225144
Hyperphalangy of the 2nd finger;Hyperphenylalaninemia;0.8245477974414825;0.67647433;0.5561387476036224;0.6048682149575186;0.9999561589935034;-0.17540836155202089;-0.3234818261840552;-0.44381741138988107;-0.3950879440359848
Hyperphalangy of the 2nd finger;Ureteropelvic junction obstruction;0.8995586335659027;0.8022493;0.5320254826501476;0.5633636449747167;0.9999528219730685;-0.10039418840716574;-0.19770350957225058;-0.46792733932292085;-0.43658917699835176
Hyperphalangy of the 2nd finger;Cone-shaped epiphysis of the proximal phalanx of the 2nd toe;0.34831178188323975;0.34299862;0.7259389307980895;0.7281754426143038;0.6245600766986774;-0.27624829481543767;-0.281561452850716;0.10137885409941205;0.10361536591562637
Hyperphalangy of the 2nd finger;Difficulty walking;0.9282784834504128;0.8705026;0.5228492857589568;0.5413363915111377;0.9203691460904122;0.007909337360000546;-0.04986655495729453;-0.39751986033145537;-0.37903275457927454
Hyperphalangy of the 2nd finger;Bilobate gallbladder;0.9661690518260002;0.8627087;0.510770780515138;0.5438396462333546;0.9999584729108851;-0.03378942108488492;-0.13724978512859753;-0.4891876923957471;-0.45611882667753056
Hyperphalangy of the 2nd finger;Histidinuria;0.8684645444154739;0.82135284;0.5419907190722876;0.557172068786443;0.9999574798349273;-0.1314929354194534;-0.17860464036501766;-0.45796676076263976;-0.44278541104848435
Hyperphalangy of the 2nd finger;Widened interpedicular distance;0.8011239767074585;0.72656757;0.5637291090762881;0.5881589955686428;0.822027235707794;-0.020903259000335517;-0.0954596693129881;-0.25829812663150586;-0.2338682401391512
Renal interstitial hemosiderin;Abnormality of depressor anguli oris muscle;1.0466827787458897;0.90069425;0.4851350075051143;0.5316621879306315;1.0;0.046682778745889664;-0.09930574893951416;-0.5148649924948857;-0.46833781206936853
Renal interstitial hemosiderin;Paroxysmal dyspnea;1.0077851563692093;0.8839282;0.49752188272920306;0.5370302721744855;1.0;0.0077851563692092896;-0.11607182025909424;-0.5024781172707969;-0.4629697278255145
Renal interstitial hemosiderin;Phenylpyruvic acidemia;0.8661559820175171;0.82111573;0.5427321131675138;0.5572487780352369;0.9999201345566091;-0.13376415253909202;-0.17880440236361594;-0.4571880213890953;-0.44267135652137224
Renal interstitial hemosiderin;Lateral ventricle dilatation;0.8990132361650467;0.80623376;0.5321999752600055;0.5620703212341523;0.9998579617208769;-0.10084472555583024;-0.19362419802611375;-0.4676579864608714;-0.4377876404867246
Renal interstitial hemosiderin;Neonatal unconjugated hyperbilirubinemia;0.7648389786481857;0.7578105;0.575561747878929;0.5778655685626717;0.9999201345566091;-0.23508115590842338;-0.24210966111453147;-0.4243583866776801;-0.4220545659939374
Renal interstitial hemosiderin;High maternal circulating alpha-fetoprotein concentration;0.8712572157382965;0.8466254;0.541094159298092;0.5490141228702179;1.0;-0.1287427842617035;-0.15337461233139038;-0.458905840701908;-0.4509858771297821
Renal interstitial hemosiderin;Prominent nasolabial fold;1.0802126973867416;0.9241687;0.474440046174157;0.5241610395487876;0.9998944404568447;0.08031825692989691;-0.07572573451659814;-0.5254543942826877;-0.47573340090805716
Renal interstitial hemosiderin;Abnormality of inferior alveolar nerve;1.1155513152480125;0.896565;0.46313652733519384;0.5329833672894129;1.0;0.11555131524801254;-0.1034349799156189;-0.5368634726648062;-0.46701663271058713
Renal interstitial hemosiderin;Unilateral conductive hearing impairment;1.0567387454211712;0.85704017;0.4819297920189092;0.5456619650773031;0.9999201345566091;0.05681861086456208;-0.1428799677017507;-0.5179903425376999;-0.454258169479306
Renal interstitial hemosiderin;Macular hypopigmented whorls, streaks, and patches;0.7873887866735458;0.7328484;0.5681967781293443;0.5860824453535125;0.9999201345566091;-0.21253134788306327;-0.2670717287185964;-0.4317233564272648;-0.4138376892030966
Renal interstitial hemosiderin;Delayed ossification of pubic rami;0.9837563037872314;0.8519459;0.5051707565003165;0.5473009925578094;0.9999134918687169;-0.016157188081485474;-0.1479676147935216;-0.4947427353684004;-0.4526124993109075
Renal interstitial hemosiderin;Hyperphenylalaninemia;0.8384399563074112;0.77605236;0.551652546332964;0.571894454620244;0.9999028053808913;-0.16146284907348007;-0.22385044961459488;-0.44825025904792726;-0.42800835076064725
Renal interstitial hemosiderin;Ureteropelvic junction obstruction;0.5617356896400452;0.60566324;0.6444066091849759;0.6290256439173434;0.31555464056675586;0.2461810490732893;0.29010859938914624;0.3288519686182201;0.31347100335058753
Renal interstitial hemosiderin;Cone-shaped epiphysis of the proximal phalanx of the 2nd toe;0.9365043193101883;0.8475575;0.5202249085822716;0.5487138916698513;1.0;-0.0634956806898117;-0.15244251489639282;-0.47977509141772845;-0.4512861083301487
Renal interstitial hemosiderin;Difficulty walking;0.9303635954856873;0.8787328;0.5221839098330354;0.5386957835416772;0.9998344221996177;-0.06947082671393046;-0.1211016217159141;-0.4776505123665823;-0.46113863865794047
Renal interstitial hemosiderin;Bilobate gallbladder;0.7083392441272736;0.7566148;0.5942078291242155;0.5782579055577713;0.9999134918687169;-0.29157424774144336;-0.24329868760083362;-0.40570566274450137;-0.4216555863109456
Renal interstitial hemosiderin;Histidinuria;0.5299091339111328;0.5230764;0.655778861168026;0.6582481583952673;0.5774374587829405;-0.04752832487180769;-0.05436104372098982;0.07834140238508547;0.08081069961232679
Renal interstitial hemosiderin;Widened interpedicular distance;1.0166427865624428;0.8671783;0.4947021919177812;0.5424037512580877;1.0;0.01664278656244278;-0.1328216791152954;-0.5052978080822188;-0.4575962487419123
Abnormality of depressor anguli oris muscle;Paroxysmal dyspnea;0.88756462931633;0.77461886;0.5358651285902668;0.5723627198854205;1.0;-0.11243537068367004;-0.22538113594055176;-0.4641348714097332;-0.42763728011457947
Abnormality of depressor anguli oris muscle;Phenylpyruvic acidemia;1.0098600341007113;0.8708384;0.4968614028103544;0.5412285937291685;0.9999201345566091;0.009939899544102238;-0.12908173085482688;-0.5030587317462547;-0.45869154082744057
Abnormality of depressor anguli oris muscle;Lateral ventricle dilatation;0.9513784423470497;0.7470777;0.5154828269516778;0.5813916916982463;0.9998579617208769;-0.04847951937382722;-0.2527802582449248;-0.48437513476919913;-0.4184662700226306
Abnormality of depressor anguli oris muscle;Neonatal unconjugated hyperbilirubinemia;0.9952373076230288;0.83741605;0.5015160177998446;0.5519828364826906;0.9999201345566091;-0.004682826933580353;-0.16250408173831077;-0.49840411675676455;-0.44793729807391847
Abnormality of depressor anguli oris muscle;High maternal circulating alpha-fetoprotein concentration;1.0483013838529587;0.91134006;0.4846192074196074;0.5282584449576809;1.0;0.04830138385295868;-0.08865994215011597;-0.5153807925803926;-0.47174155504231907
Abnormality of depressor anguli oris muscle;Prominent nasolabial fold;0.7026585042476654;0.78677404;0.5960999830954459;0.5683970408581445;0.7184876422794455;-0.0158291380317801;0.06828639698904815;-0.12238765918399963;-0.15009060142130104
Abnormality of depressor anguli oris muscle;Abnormality of inferior alveolar nerve;0.5920137166976929;0.5203726;0.6337688827201579;0.6592281655117478;1.0;-0.40798628330230713;-0.4796273708343506;-0.36623111727984214;-0.3407718344882522
Abnormality of depressor anguli oris muscle;Unilateral conductive hearing impairment;0.8871410191059113;0.79107416;0.536000831652315;0.5669967200142092;0.9999201345566091;-0.11277911545069785;-0.20884597779543967;-0.46391930290429406;-0.4329234145423999
Abnormality of depressor anguli oris muscle;Macular hypopigmented whorls, streaks, and patches;0.9529829621315002;0.8337699;0.5149715074384391;0.5531594343437838;0.9999201345566091;-0.046937172425108864;-0.16615021706851096;-0.48494862711817;-0.4467607002128253
Abnormality of depressor anguli oris muscle;Delayed ossification of pubic rami;0.76669642329216;0.70488775;0.5749535861196198;0.5953570578565781;0.872141863789474;-0.10544544049731397;-0.1672541160248866;-0.29718827766985423;-0.2767848059328959
Abnormality of depressor anguli oris muscle;Hyperphenylalaninemia;1.1016693338751793;0.9141812;0.4675816318905952;0.5273506213481216;0.9999028053808913;0.10176652849428802;-0.08572163253314347;-0.5323211734902961;-0.47255218403276966
Abnormality of depressor anguli oris muscle;Ureteropelvic junction obstruction;0.9050033167004585;0.77357554;0.5302840495340997;0.5727036314939541;0.9998847295244674;-0.09488141282400886;-0.22630918516716758;-0.4696006799903677;-0.4271810980305133
Abnormality of depressor anguli oris muscle;Cone-shaped epiphysis of the proximal phalanx of the 2nd toe;0.9127635359764099;0.8803946;0.527803570397743;0.5381629447688497;1.0;-0.08723646402359009;-0.1196054220199585;-0.47219642960225705;-0.46183705523115026
Abnormality of depressor anguli oris muscle;Difficulty walking;0.9685792997479439;0.88708085;0.5100031659366346;0.5360201030886818;0.5306161845308115;0.4379631152171324;0.356464663686199;-0.020613018594176857;0.0054039185578702575
Abnormality of depressor anguli oris muscle;Bilobate gallbladder;0.9827891066670418;0.8193449;0.5054786679977752;0.5578217791424576;0.9999134918687169;-0.01712438520167514;-0.1805686136720006;-0.49443482387094173;-0.44209171272625936
Abnormality of depressor anguli oris muscle;Histidinuria;0.9653519466519356;0.82742023;0.5110310257705056;0.555210251105867;0.9999090677057578;-0.03455712105382225;-0.17248883302558204;-0.4888780419352522;-0.44469881659989086
Abnormality of depressor anguli oris muscle;Widened interpedicular distance;0.7564587593078613;0.79073536;0.5783091220520149;0.5671070084945995;1.0;-0.24354124069213867;-0.2092646360397339;-0.4216908779479851;-0.4328929915054005
Paroxysmal dyspnea;Phenylpyruvic acidemia;0.6992241144180298;0.4634229;0.5972456142253519;0.6802829453707544;0.9999201345566091;-0.3006960201385793;-0.5364972400787649;-0.40267452033125717;-0.3196371891858547
Paroxysmal dyspnea;Lateral ventricle dilatation;0.8223431706428528;0.728475;0.5568517021708235;0.5875279618881364;0.9998579617208769;-0.17751479107802415;-0.27138298708861375;-0.44300625955005346;-0.41232999983274055
Paroxysmal dyspnea;Neonatal unconjugated hyperbilirubinemia;0.8210082948207855;0.75022495;0.557283527775182;0.5803566642603777;0.9999201345566091;-0.17891183973582359;-0.24969518662722678;-0.44263660678142713;-0.4195634702962314
Paroxysmal dyspnea;High maternal circulating alpha-fetoprotein concentration;0.9391098544001579;0.8196253;0.5193939321178098;0.5577310310638117;1.0;-0.06089014559984207;-0.18037468194961548;-0.4806060678821902;-0.4422689689361883
Paroxysmal dyspnea;Prominent nasolabial fold;0.9006884023547173;0.8593422;0.53166405888021;0.5449217377245906;0.9998944404568447;-0.09920603810212747;-0.1405522230114712;-0.46823038157663477;-0.4549727027322541
Paroxysmal dyspnea;Abnormality of inferior alveolar nerve;0.9170001596212387;0.80448955;0.5264500982358933;0.5626363556818675;1.0;-0.08299984037876129;-0.19551044702529907;-0.4735499017641067;-0.43736364431813246
Paroxysmal dyspnea;Unilateral conductive hearing impairment;0.8273514807224274;0.7038243;0.5552324744972288;0.595711409820477;0.9999201345566091;-0.17256865383418174;-0.2960958528641042;-0.4446876600593803;-0.4042087247361321
Paroxysmal dyspnea;Macular hypopigmented whorls, streaks, and patches;0.9017421305179596;0.7165083;0.5313269981498258;0.5914928310533425;0.9999201345566091;-0.09817800403864951;-0.2834118056419668;-0.46859313640678335;-0.4084273035032666
Paroxysmal dyspnea;Delayed ossification of pubic rami;1.0064261015504599;0.83878464;0.4979544942685843;0.5515413695249862;0.9999134918687169;0.006512609681742942;-0.16112885680173084;-0.5019589976001326;-0.4483721223437307
Paroxysmal dyspnea;Hyperphenylalaninemia;0.9052136093378067;0.6841764;0.5302168078884741;0.6022807878221863;0.9999028053808913;-0.09468919604308457;-0.3157264199782118;-0.46968599749241713;-0.39762201755870497
Paroxysmal dyspnea;Ureteropelvic junction obstruction;0.8241496980190277;0.6459895;0.556267467870468;0.6151822987219275;0.9998847295244674;-0.17573503150543968;-0.35389525189003745;-0.4436172616539994;-0.38470243080253985
Paroxysmal dyspnea;Cone-shaped epiphysis of the proximal phalanx of the 2nd toe;0.9111714214086533;0.7617273;0.5283123314732521;0.5765812044625039;1.0;-0.08882857859134674;-0.23827272653579712;-0.4716876685267479;-0.42341879553749606
Paroxysmal dyspnea;Difficulty walking;0.8047288656234741;0.7331041;0.5625586829947848;0.5859979855250759;0.9998344221996177;-0.1951055565761436;-0.2667303124355186;-0.43727573920483287;-0.41383643667454184
Paroxysmal dyspnea;Bilobate gallbladder;0.9044727832078934;0.7416698;0.5304536950992098;0.5831722692640691;0.9999134918687169;-0.09544070866082355;-0.25824371781323596;-0.4694597967695071;-0.41674122260464785
Paroxysmal dyspnea;Histidinuria;0.9951485879719257;0.8850704;0.5015442584681897;0.5366642477337755;0.9999090677057578;-0.00476047973383209;-0.11483868415702125;-0.4983648092375681;-0.4632448199719823
Paroxysmal dyspnea;Widened interpedicular distance;0.9495160803198814;0.8193778;0.5160763644388823;0.5578111454865993;1.0;-0.05048391968011856;-0.18062222003936768;-0.4839236355611177;-0.44218885451340073
Phenylpyruvic acidemia;Lateral ventricle dilatation;0.9497283175587654;0.8364723;0.5160087213363829;0.5522873308220817;0.9999488789551968;-0.050220561396431385;-0.163476606082272;-0.4839401576188139;-0.4476615481331151
Phenylpyruvic acidemia;Neonatal unconjugated hyperbilirubinemia;0.6376383006572723;0.70253354;0.6180294838307808;0.596141644570501;0.8631450867506595;-0.22550678609338715;-0.16061154364076569;-0.24511560291987866;-0.2670034421801585
Phenylpyruvic acidemia;High maternal circulating alpha-fetoprotein concentration;0.735970139503479;0.6417699;0.5850517495916797;0.6166196721305721;0.9999201345566091;-0.2639499950531301;-0.3581502485397634;-0.4148683849649294;-0.383300462426037
Phenylpyruvic acidemia;Prominent nasolabial fold;1.091350495815277;0.9288744;0.4708816395427582;0.5226591247974048;0.9999545338528789;0.09139596196239819;-0.07108016041690479;-0.5290728943101207;-0.4772954090554741
Phenylpyruvic acidemia;Abnormality of inferior alveolar nerve;1.109960213303566;0.9036834;0.4649276552967957;0.5307061175294524;0.9999201345566091;0.11004007874695687;-0.09623671056063743;-0.5349924792598134;-0.4692140170271567
Phenylpyruvic acidemia;Unilateral conductive hearing impairment;0.9759848043322563;0.8025993;0.5076450091703388;0.563249996723789;0.9999600672783046;-0.023975262946048237;-0.1973607564033656;-0.4923150581079657;-0.4367100705545156
Phenylpyruvic acidemia;Macular hypopigmented whorls, streaks, and patches;0.9028372168540955;0.77377;0.5309767453290537;0.572640113146535;0.9999600672783046;-0.0971228504242091;-0.22619009256974743;-0.46898332194925085;-0.4273199541317696
Phenylpyruvic acidemia;Delayed ossification of pubic rami;0.9770490862429142;0.83761966;0.5073061442533983;0.5519171431228287;0.9999584729108851;-0.022909386667970932;-0.16233881062603406;-0.49265232865748687;-0.44804132978805644
Phenylpyruvic acidemia;Hyperphenylalaninemia;0.5727351903915405;0.467407;0.6405227939263585;0.6787823454853732;0.8497508587917271;-0.27701566840018654;-0.38234387064780617;-0.2092280648653686;-0.17096851330635388
Phenylpyruvic acidemia;Ureteropelvic junction obstruction;0.8154645264148712;0.6347019;0.5590780594871375;0.6190329386930162;0.9999528219730685;-0.18448829555819724;-0.36525091433833334;-0.44087476248593094;-0.3809198832800522
Phenylpyruvic acidemia;Cone-shaped epiphysis of the proximal phalanx of the 2nd toe;0.8206216990947723;0.70462894;0.5574086094143147;0.5954432612780893;0.9999201345566091;-0.17929843546183677;-0.29529119015963645;-0.4425115251422944;-0.4044768732785198
Phenylpyruvic acidemia;Difficulty walking;0.8847489878535271;0.8529608;0.536767240286721;0.546974330336109;0.9999461221900431;-0.11519713433651602;-0.14698529722361242;-0.4631788819033221;-0.4529717918539341
Phenylpyruvic acidemia;Bilobate gallbladder;0.8187290132045746;0.7403505;0.5580211107909593;0.5836070466942886;0.9999584729108851;-0.18122945970631055;-0.25960798806286267;-0.44193736211992585;-0.4163514262165965
Phenylpyruvic acidemia;Histidinuria;0.7344183325767517;0.74193126;0.585563991263276;0.5830861046301443;0.8542775634790427;-0.119859230902291;-0.11234630384693212;-0.26871357221576675;-0.2711914588488984
Phenylpyruvic acidemia;Widened interpedicular distance;0.8517122864723206;0.7572006;0.5473761670636219;0.5780656848634198;0.9999201345566091;-0.14820784808428855;-0.24271953583987327;-0.4525439674929872;-0.4218544496931893
Lateral ventricle dilatation;Neonatal unconjugated hyperbilirubinemia;0.7965031713247299;0.73620445;0.5652306609230016;0.5849744263458687;0.9999488789551968;-0.20344570763046688;-0.26374443359310573;-0.43471821803219524;-0.4149744526093281
Lateral ventricle dilatation;High maternal circulating alpha-fetoprotein concentration;0.8166550993919373;0.8189471;0.5586925098482034;0.5579505214854257;0.9998579617208769;-0.18320286232893968;-0.18091088492339158;-0.44116545187267353;-0.44190744023545125
Lateral ventricle dilatation;Prominent nasolabial fold;0.9610610343515873;0.8240416;0.5123977920816636;0.5563024199469541;0.9999394441529541;-0.03887840980136681;-0.17589783915722657;-0.4875416520712905;-0.44363702420600004
Lateral ventricle dilatation;Abnormality of inferior alveolar nerve;0.9443777203559875;0.80271447;0.5177142636994392;0.5632126157451721;0.596292991364175;0.34808472899181253;0.20642147568447;-0.07857872766473584;-0.0330803756190029
Lateral ventricle dilatation;Unilateral conductive hearing impairment;0.8591059148311615;0.73613226;0.5449977021902868;0.5849982463147348;0.9999488789551968;-0.1408429641240353;-0.26381661481792873;-0.45495117676491004;-0.41495063264046195
Lateral ventricle dilatation;Macular hypopigmented whorls, streaks, and patches;0.8957019746303558;0.7869246;0.5332595795337055;0.5683480078594102;0.9999488789551968;-0.10424690432484096;-0.2130242783540005;-0.4666892994214913;-0.4316008710957866
Lateral ventricle dilatation;Delayed ossification of pubic rami;0.9533879831433296;0.74764097;0.5148424437398001;0.5812063978156807;0.9999462364511621;-0.046558253307832476;-0.2523052690820825;-0.48510379271136195;-0.41873983863548137
Lateral ventricle dilatation;Hyperphenylalaninemia;0.8099903613328934;0.7055316;0.5608519261158106;0.5951425734786524;0.9999422932358373;-0.1899519319029439;-0.2944106960983861;-0.4390903671200267;-0.4047997197571849
Lateral ventricle dilatation;Ureteropelvic junction obstruction;0.9770207423716784;0.7416347;0.5073151687678821;0.5831838074519464;0.9999363689743077;-0.022915626602629358;-0.2583016424499547;-0.49262120020642564;-0.4167525615223613
Lateral ventricle dilatation;Cone-shaped epiphysis of the proximal phalanx of the 2nd toe;1.0295230634510517;0.8447921;0.49060115133868554;0.5496047353602906;0.9998579617208769;0.02966510173017478;-0.155065834111624;-0.5092568103821914;-0.4502532263605863
Lateral ventricle dilatation;Difficulty walking;0.9274915903806686;0.8147862;0.5231004154687965;0.5592977709522388;0.8801199872450469;0.04737160313562172;-0.06533379149004204;-0.35701957177625043;-0.32082221629280816
Lateral ventricle dilatation;Bilobate gallbladder;0.9232191741466522;0.8052384;0.5244641734649733;0.5623933098059224;0.9999462364511621;-0.07672706230450987;-0.19470781071950316;-0.4754820629861888;-0.4375529266452397
Lateral ventricle dilatation;Histidinuria;0.9199585244059563;0.8223703;0.5255052764297796;0.5568429300495875;0.9999445600944175;-0.07998603568846119;-0.17757426933819187;-0.47443928366463783;-0.44310163004482994
Lateral ventricle dilatation;Widened interpedicular distance;0.9484810940921307;0.68944913;0.5164062401085281;0.6005135083998158;0.9998579617208769;-0.05137686762874627;-0.3104088302320769;-0.48345172161234884;-0.39934445332106117
Neonatal unconjugated hyperbilirubinemia;High maternal circulating alpha-fetoprotein concentration;0.7459151744842529;0.7627013;0.5817742418922437;0.5762620108067342;0.9999201345566091;-0.2540049600723562;-0.23721886159213157;-0.4181458926643654;-0.4236581237498749
Neonatal unconjugated hyperbilirubinemia;Prominent nasolabial fold;1.0083421766757965;0.79124606;0.49734457189180836;0.566940783429044;0.9999545338528789;0.008387642822917596;-0.20870847729617725;-0.5026099619610706;-0.43301375042383494
Neonatal unconjugated hyperbilirubinemia;Abnormality of inferior alveolar nerve;1.031882282346487;0.82151777;0.4898498342662213;0.5571187088585494;0.9999201345566091;0.03196214778987794;-0.17840236903460593;-0.5100703002903878;-0.4428014256980597
Neonatal unconjugated hyperbilirubinemia;Unilateral conductive hearing impairment;0.9733743406832218;0.680023;0.5084762122887656;0.6036751837162457;0.9999600672783046;-0.026585726595082737;-0.3199370527328639;-0.49148385498953895;-0.3962848835620588
Neonatal unconjugated hyperbilirubinemia;Macular hypopigmented whorls, streaks, and patches;0.8815856277942657;0.85956335;0.5377811129047511;0.5448506335624212;0.9999600672783046;-0.11837443948403881;-0.14039671660081432;-0.4621789543735535;-0.4551094337158833
Neonatal unconjugated hyperbilirubinemia;Delayed ossification of pubic rami;0.960800539702177;0.7626246;0.5124807734598196;0.57628712740759;0.9999584729108851;-0.039157933208708084;-0.23733385151958875;-0.48747769945106556;-0.4236713455032951
Neonatal unconjugated hyperbilirubinemia;Hyperphenylalaninemia;0.6590778231620789;0.63145316;0.6107392667699572;0.6201445846881579;0.5721925110198667;0.08688531214221218;0.05926064545138576;0.03854675575009048;0.04795207366829124
Neonatal unconjugated hyperbilirubinemia;Ureteropelvic junction obstruction;0.8770093023777008;0.70646584;0.5392485325881564;0.5948314343450407;0.9999528219730685;-0.12294351959536765;-0.2934869816334078;-0.46070428938491204;-0.40512138762802774
Neonatal unconjugated hyperbilirubinemia;Cone-shaped epiphysis of the proximal phalanx of the 2nd toe;0.9984911940991879;0.94551575;0.5004802680167824;0.5173514703597364;0.9999201345566091;-0.0014289404574212572;-0.054404382717925026;-0.49943986653982675;-0.4825686641968727
Neonatal unconjugated hyperbilirubinemia;Difficulty walking;0.9776239823549986;0.9596888;0.5071231021206197;0.5128349402717052;0.9999461221900431;-0.022322139835044497;-0.04025733949808752;-0.49282302006942336;-0.4871111819183379
Neonatal unconjugated hyperbilirubinemia;Bilobate gallbladder;0.6229954361915588;0.59776795;0.6230458967780031;0.6317654950666787;0.9999584729108851;-0.3769630367193263;-0.40219052380657605;-0.376912576132882;-0.36819297784420646
Neonatal unconjugated hyperbilirubinemia;Histidinuria;0.6798137724399567;0.67495215;0.6037454861605445;0.6053804112655621;0.8542775634790427;-0.17446379103908605;-0.1793254140878684;-0.25053207731849825;-0.24889715221348063
Neonatal unconjugated hyperbilirubinemia;Widened interpedicular distance;0.9605319947004318;0.85659206;0.5125663201911281;0.5458061015931142;0.9999201345566091;-0.039388139856177284;-0.1433280754211721;-0.487353814365481;-0.45411403296349495
High maternal circulating alpha-fetoprotein concentration;Prominent nasolabial fold;1.004810782149434;0.8246019;0.49846867457478305;0.5561212682652961;0.9998944404568447;0.0049163416925893655;-0.1752925518002285;-0.5014257658820617;-0.44377317219154866
High maternal circulating alpha-fetoprotein concentration;Abnormality of inferior alveolar nerve;0.9945045299828053;0.8484312;0.5017492712404958;0.5484325002784206;1.0;-0.005495470017194748;-0.15156877040863037;-0.49825072875950416;-0.4515674997215794
High maternal circulating alpha-fetoprotein concentration;Unilateral conductive hearing impairment;1.0064957267604768;0.8965759;0.4979323314133224;0.5329798789394067;0.9999201345566091;0.0065755922038677195;-0.10334420682223411;-0.5019878031432867;-0.4669402556172024
High maternal circulating alpha-fetoprotein concentration;Macular hypopigmented whorls, streaks, and patches;0.908244676887989;0.8926045;0.5292477644581035;0.5342511209879701;0.9999201345566091;-0.09167545766862006;-0.10731566430361839;-0.4706723700985056;-0.465669013568639
High maternal circulating alpha-fetoprotein concentration;Delayed ossification of pubic rami;0.9976881388574839;0.8982435;0.5007358889126658;0.5324462627921311;0.9999134918687169;-0.0022253530112330555;-0.10167000498746082;-0.49917760295605107;-0.4674672290765858
High maternal circulating alpha-fetoprotein concentration;Hyperphenylalaninemia;0.6877486705780029;0.5411917;0.6010831030776872;0.6517235342490464;0.9999028053808913;-0.31215413480288834;-0.45871110826022476;-0.39881970230320407;-0.3481792711318449
High maternal circulating alpha-fetoprotein concentration;Ureteropelvic junction obstruction;1.0281079597771168;0.9007379;0.49105177999071536;0.5316482404531968;0.9998847295244674;0.02822323025264939;-0.09914684786400596;-0.508832949533752;-0.4682364890712706
High maternal circulating alpha-fetoprotein concentration;Cone-shaped epiphysis of the proximal phalanx of the 2nd toe;0.9468835145235062;0.8798599;0.5169154629187855;0.5383343616156762;1.0;-0.053116485476493835;-0.12014007568359375;-0.48308453708121446;-0.46166563838432384
High maternal circulating alpha-fetoprotein concentration;Difficulty walking;0.9390918090939522;0.8906055;0.5193996867983037;0.5348911814380568;0.9998344221996177;-0.06074261310566553;-0.10922891291845926;-0.480434735401314;-0.4649432407615609
High maternal circulating alpha-fetoprotein concentration;Bilobate gallbladder;0.9967349953949451;0.95764863;0.5010392850907375;0.5134848819261956;0.9999134918687169;-0.0031784964737717747;-0.04226485695813342;-0.49887420677797945;-0.48642860994252135
High maternal circulating alpha-fetoprotein concentration;Histidinuria;0.9000537693500519;0.8522208;0.5318670789364704;0.5472125074065799;0.9999090677057578;-0.09985529835570595;-0.1476882940088584;-0.4680419887692874;-0.45269656029917793
High maternal circulating alpha-fetoprotein concentration;Widened interpedicular distance;0.9551911875605583;0.7959364;0.5142678652804984;0.5654149395649034;1.0;-0.04480881243944168;-0.20406359434127808;-0.4857321347195016;-0.4345850604350966
Prominent nasolabial fold;Abnormality of inferior alveolar nerve;0.4135923385620117;0.66449976;0.6994583178213925;0.608905324172451;0.9998944404568447;-0.586302101894833;-0.33539468078277246;-0.3004361226354523;-0.3909891162843937
Prominent nasolabial fold;Unilateral conductive hearing impairment;0.7462675869464874;0.75494015;0.5816582647421122;0.5788076240941393;0.9999545338528789;-0.2536869469063915;-0.245014381684605;-0.41829626911076667;-0.4211469097587396
Prominent nasolabial fold;Macular hypopigmented whorls, streaks, and patches;0.8668900281190872;0.88573945;0.5424963493958073;0.5364498806768494;0.9999545338528789;-0.1330645057337917;-0.11421508816653858;-0.45745818445707165;-0.4635046531760295
Prominent nasolabial fold;Delayed ossification of pubic rami;0.785973995923996;0.75096565;0.5686577299285102;0.5801132059641895;0.9999524555142131;-0.2139784595902171;-0.24898680066420698;-0.4312947255857029;-0.4198392495500236
Prominent nasolabial fold;Hyperphenylalaninemia;0.9545701369643211;0.75000894;0.5144657533567063;0.5804276938106974;0.9999493977362748;-0.045379260771953644;-0.24994045703955847;-0.4854836443795685;-0.4195217039255774
Prominent nasolabial fold;Ureteropelvic junction obstruction;0.9753581490367651;0.78994834;0.5078445388066406;0.5673632287083362;0.9999448992541466;-0.024586750217381548;-0.2099965550234948;-0.49210036044750605;-0.4325816705458104
Prominent nasolabial fold;Cone-shaped epiphysis of the proximal phalanx of the 2nd toe;0.9123942852020264;0.9013542;0.5279215582932324;0.5314510803497765;0.9998944404568447;-0.08750015525481836;-0.09854024676940576;-0.47197288216361233;-0.4684433601070682
Prominent nasolabial fold;Difficulty walking;0.9205826222896576;0.8788035;0.5253059854657425;0.5386731098838176;0.9999355370354486;-0.07935291474579098;-0.12113204544304135;-0.4746295515697061;-0.461262427151631
Prominent nasolabial fold;Bilobate gallbladder;1.017887406051159;0.821276;0.49430595814459777;0.5571969102210921;0.9999524555142131;0.017934950536945826;-0.1786764464314189;-0.5056464973696153;-0.442755545293121
Prominent nasolabial fold;Histidinuria;1.0152785312384367;0.88965976;0.495136503230729;0.5351940555600183;0.9999511492611326;0.0153273819773041;-0.11029138687862527;-0.5048146460304036;-0.4647570937011143
Prominent nasolabial fold;Widened interpedicular distance;0.8806633949279785;0.7657323;0.5380767651746936;0.5752692219186593;0.9998944404568447;-0.11923104552886621;-0.23416215209624902;-0.4618176752821511;-0.42462521853818547
Abnormality of inferior alveolar nerve;Unilateral conductive hearing impairment;0.7054203152656555;0.6227784;0.5951796397056095;0.6231204834970094;0.9999201345566091;-0.2944998192909536;-0.37714171887667747;-0.4047404948509996;-0.37679965105959967
Abnormality of inferior alveolar nerve;Macular hypopigmented whorls, streaks, and patches;0.9091651439666748;0.8838933;0.5289535419689173;0.5370414587245242;0.9999201345566091;-0.0907549905899343;-0.11602682353289695;-0.4709665925876918;-0.46287867583208486
Abnormality of inferior alveolar nerve;Delayed ossification of pubic rami;0.7815785109996796;0.68467844;0.5700907575217457;0.6021123647011879;0.9999134918687169;-0.21833498086903735;-0.31523505654309436;-0.42982273434697127;-0.397801127167529
Abnormality of inferior alveolar nerve;Hyperphenylalaninemia;1.0436325818300247;0.8252251;0.48610690718013594;0.5559197767828631;0.9999028053808913;0.04372977644913345;-0.17467769055850357;-0.5137958982007553;-0.4439830285980282
Abnormality of inferior alveolar nerve;Ureteropelvic junction obstruction;0.99633071385324;0.75887597;0.5011679726766256;0.5775160673438422;0.9998847295244674;-0.003554015671227373;-0.24100876345238487;-0.4987167568478418;-0.4223686621806252
Abnormality of inferior alveolar nerve;Cone-shaped epiphysis of the proximal phalanx of the 2nd toe;0.9403781034052372;0.8384695;0.5189895010244581;0.5516430106011698;1.0;-0.0596218965947628;-0.1615304946899414;-0.48101049897554193;-0.4483569893988302
Abnormality of inferior alveolar nerve;Difficulty walking;0.9412572756409645;0.8863545;0.5187091604174591;0.5362528148585994;0.7403726674076037;0.20088460823336085;0.14598183860817393;-0.2216635069901446;-0.20411985254900422
Abnormality of inferior alveolar nerve;Bilobate gallbladder;0.9930725656449795;0.8303094;0.5022050884781246;0.5542768287197716;0.9999134918687169;-0.006840926223737442;-0.1696041008469884;-0.4977084033905923;-0.44563666314894534
Abnormality of inferior alveolar nerve;Histidinuria;1.0449232161045074;0.8730571;0.4856956821946704;0.5405164895633637;0.9999090677057578;0.04501414839874962;-0.12685194070685646;-0.5142133855110874;-0.4593925781423941
Abnormality of inferior alveolar nerve;Widened interpedicular distance;0.9820784404873848;0.82688403;0.5057049149827733;0.5553835429862133;1.0;-0.017921559512615204;-0.17311596870422363;-0.49429508501722674;-0.4446164570137867
Unilateral conductive hearing impairment;Macular hypopigmented whorls, streaks, and patches;0.9037575423717499;0.84992194;0.5306824171854612;0.5479525009640637;0.9999600672783046;-0.09620252490655468;-0.1500381255211024;-0.4692776500928434;-0.4520075663142409
Unilateral conductive hearing impairment;Delayed ossification of pubic rami;1.0520976334810257;0.89730585;0.4834092974570743;0.532746287732508;0.9999584729108851;0.052139160570140564;-0.1026526266965907;-0.5165491754538108;-0.46721218517837715
Unilateral conductive hearing impairment;Hyperphenylalaninemia;0.9372294098138809;0.77784073;0.5199936437544218;0.5713104935033654;0.9999561589935034;-0.06272674917962251;-0.22211542546536622;-0.4799625152390816;-0.42864566549013805
Unilateral conductive hearing impairment;Ureteropelvic junction obstruction;1.0184544511139393;0.76348317;0.4941254322870685;0.5760058432400558;0.9999528219730685;0.018501629140870834;-0.23646965527842734;-0.5058273896859999;-0.4239469787330127
Unilateral conductive hearing impairment;Cone-shaped epiphysis of the proximal phalanx of the 2nd toe;1.012518560513854;0.8758016;0.49601511434156254;0.5396359191094782;0.9999201345566091;0.012598425957244919;-0.12411851168902488;-0.5039050202150466;-0.46028421544713094
Unilateral conductive hearing impairment;Difficulty walking;0.7574183642864227;0.67336065;0.5779942268608917;0.6059162466001538;0.9999461221900431;-0.24252775790362036;-0.3265854764190165;-0.42195189532915134;-0.39402987558988933
Unilateral conductive hearing impairment;Bilobate gallbladder;0.9889893168583512;0.79319364;0.5035048801191639;0.5663070171805736;0.9999584729108851;-0.010969156052533902;-0.20676483458614758;-0.4964535927917212;-0.4336514557303115
Unilateral conductive hearing impairment;Histidinuria;0.9551073238253593;0.79508805;0.5142945868264295;0.5656907934991383;0.9999574798349273;-0.04485015600956799;-0.20486942708529354;-0.48566289300849785;-0.434266686335789
Unilateral conductive hearing impairment;Widened interpedicular distance;0.9688822515308857;0.8520352;0.5099066862099613;0.5472722212911502;0.9999201345566091;-0.03103788302572341;-0.14788491011889549;-0.49001344834664784;-0.45264791326545895
Macular hypopigmented whorls, streaks, and patches;Delayed ossification of pubic rami;1.034359872341156;0.90494883;0.48906075974599883;0.5303014694508059;0.9999584729108851;0.034401399430270874;-0.09500964230633191;-0.5108977131648863;-0.4696570034600792
Macular hypopigmented whorls, streaks, and patches;Hyperphenylalaninemia;0.8571865558624268;0.77692986;0.5456148945071374;0.571607907694837;0.9999561589935034;-0.14276960313107667;-0.22302630364682374;-0.454341264486366;-0.4283482512986664
Macular hypopigmented whorls, streaks, and patches;Ureteropelvic junction obstruction;0.9866636395454407;0.89101124;0.5042452212261926;0.5347612570890987;0.9999528219730685;-0.013289182427627777;-0.10894158387492392;-0.4957076007468758;-0.46519156488396973
Macular hypopigmented whorls, streaks, and patches;Cone-shaped epiphysis of the proximal phalanx of the 2nd toe;0.927625298500061;0.8425921;0.523057742736682;0.5503137439845548;0.9999201345566091;-0.07229483605654807;-0.15732801438601585;-0.47686239181992707;-0.4496063905720543
Macular hypopigmented whorls, streaks, and patches;Difficulty walking;0.8585851490497589;0.80839396;0.5451651435818166;0.5613695984942783;0.9999461221900431;-0.14136097314028417;-0.1915521669593302;-0.4547809786082265;-0.43857652369576483
Macular hypopigmented whorls, streaks, and patches;Bilobate gallbladder;0.9561310857534409;0.8134049;0.5139683918651716;0.5597452507367451;0.9999584729108851;-0.043827387157444275;-0.18655355519390515;-0.4859900810457135;-0.44021322217414005
Macular hypopigmented whorls, streaks, and patches;Histidinuria;0.8092246204614639;0.7702729;0.5611002106204361;0.5737833605429193;0.9999574798349273;-0.1907328593734634;-0.22968456923998715;-0.4388572692144912;-0.426174119292008
Macular hypopigmented whorls, streaks, and patches;Widened interpedicular distance;1.080776147544384;0.9340048;0.4742601105356703;0.521022213349313;0.9999201345566091;0.0808560129877749;-0.06591535092623801;-0.5256600240209388;-0.47889792120729613
Delayed ossification of pubic rami;Hyperphenylalaninemia;0.9845646396279335;0.8046473;0.5049134229205319;0.5625851473866248;0.9999542297279059;-0.015389590099972428;-0.19530690325848454;-0.49504080680737406;-0.43736908234128113
Delayed ossification of pubic rami;Ureteropelvic junction obstruction;0.8134991824626923;0.65452635;0.5597146995498975;0.6122817312335579;0.9999505803237132;-0.18645139786102094;-0.34542422744132795;-0.4402358807738157;-0.3876688490901553
Delayed ossification of pubic rami;Cone-shaped epiphysis of the proximal phalanx of the 2nd toe;0.6897210478782654;0.7208456;0.6004224568861538;0.5900541253312449;0.6574179255159834;0.032303122362281944;0.06342765458502975;-0.056995468629829626;-0.06736380018473853
Delayed ossification of pubic rami;Difficulty walking;1.1008137166500092;0.99146795;0.4678553899233576;0.5027158661685422;0.9160188400246831;0.184794876625326;0.07544911270358834;-0.4481634501013255;-0.4133029738561409
Delayed ossification of pubic rami;Bilobate gallbladder;0.9271467477083206;0.7973454;0.5232104733766739;0.5649568565077282;0.9999567459343585;-0.07280999822603784;-0.20261134607779108;-0.47674627255768454;-0.43499988942663026
Delayed ossification of pubic rami;Histidinuria;0.9699715673923492;0.86713076;0.5095597840198259;0.5424190269023406;0.9999556674707869;-0.02998410007843766;-0.13282491109261307;-0.49039588345096097;-0.45753664056844634
Delayed ossification of pubic rami;Widened interpedicular distance;0.6645014882087708;0.6508203;0.6089047501808367;0.6135397178097317;0.8072246192530101;-0.1427231310442394;-0.15640430436882435;-0.19831986907217347;-0.19368490144327843
Hyperphenylalaninemia;Ureteropelvic junction obstruction;0.9691519737243652;0.7779064;0.5098207897313902;0.5712890400973759;0.999947268185474;-0.030795294461108735;-0.22204085033879428;-0.49012647845408375;-0.42865822808809806
Hyperphenylalaninemia;Cone-shaped epiphysis of the proximal phalanx of the 2nd toe;0.9122728034853935;0.7726233;0.5279603765795344;0.5730148624144145;0.9999028053808913;-0.08763000189549774;-0.2272795048285231;-0.47194242880135684;-0.4268879429664768
Hyperphenylalaninemia;Difficulty walking;0.9136260598897934;0.8646432;0.5275279802312516;0.5432180541480209;0.9999387558585022;-0.08631269596870883;-0.13529553972538455;-0.47241077562725065;-0.4567207017104813
Hyperphenylalaninemia;Bilobate gallbladder;0.7308355271816254;0.67004776;0.586747523190918;0.6070326482220759;0.9999542297279059;-0.26911870254628056;-0.3299064697181403;-0.4132067065369879;-0.39292158150583
Hyperphenylalaninemia;Histidinuria;0.596393883228302;0.60431266;0.6322433816516999;0.6294936038717291;0.8389944217294671;-0.24260053850116514;-0.23468176341953062;-0.20675104007776723;-0.209500817857738
Hyperphenylalaninemia;Widened interpedicular distance;0.8754828423261642;0.68231326;0.539738183944278;0.6029060336739641;0.9999028053808913;-0.12441996305472702;-0.317589541964601;-0.4601646214366133;-0.39699677170692715
Ureteropelvic junction obstruction;Cone-shaped epiphysis of the proximal phalanx of the 2nd toe;0.8770919069647789;0.75244254;0.5392220377132682;0.5796279014856327;0.9998847295244674;-0.12279282255968849;-0.24744219078621665;-0.46066269181119923;-0.4202568280388347
Ureteropelvic junction obstruction;Difficulty walking;0.971360594034195;0.84178704;0.5091174527225737;0.5505732511831634;0.999932040772814;-0.028571446738619;-0.15814500053920189;-0.49081458805024025;-0.4493587895896506
Ureteropelvic junction obstruction;Bilobate gallbladder;0.6707583665847778;0.6537752;0.6067930677783674;0.6125365405793728;0.9999505803237132;-0.32919221373893537;-0.3461753651747874;-0.3931575125453458;-0.3874140397443404
Ureteropelvic junction obstruction;Histidinuria;0.8247917890548706;0.8149047;0.5560598606773293;0.5592593798385224;0.7637811309637142;0.061010658091156356;0.05112355882510411;-0.20772127028638498;-0.2045217511251919
Ureteropelvic junction obstruction;Widened interpedicular distance;0.928695909678936;0.77705204;0.5227160737976797;0.5715680087619721;0.9998847295244674;-0.07118881984553138;-0.22283268465599815;-0.4771686557267877;-0.4283167207624953
Cone-shaped epiphysis of the proximal phalanx of the 2nd toe;Difficulty walking;0.8859449923038483;0.84814495;0.5363840130690205;0.5485246935456036;0.7552776988623575;0.13066729344149075;0.09286724962015591;-0.218893685793337;-0.2067530053167539
Cone-shaped epiphysis of the proximal phalanx of the 2nd toe;Bilobate gallbladder;1.0459074787795544;0.9467323;0.4853820580415614;0.5169636792693124;0.9999134918687169;0.04599398691083745;-0.053181209230167115;-0.5145314338271555;-0.4829498125994045
Cone-shaped epiphysis of the proximal phalanx of the 2nd toe;Histidinuria;0.9099550098180771;0.89650035;0.52870108526336;0.5330040661862478;0.9999090677057578;-0.08995405788768074;-0.10340871866095802;-0.4712079824423978;-0.46690500151951
Cone-shaped epiphysis of the proximal phalanx of the 2nd toe;Widened interpedicular distance;0.6875791549682617;0.6963055;0.6011399031869926;0.5982202129411331;1.0;-0.3124208450317383;-0.303694486618042;-0.3988600968130074;-0.40177978705886686
Difficulty walking;Bilobate gallbladder;1.0672761648893356;0.9895275;0.4785691445284934;0.5033335501748224;0.9999431787962207;0.06733298609311489;-0.010415655278612101;-0.5213740342677273;-0.49660962862139835
Difficulty walking;Histidinuria;0.9023387134075165;0.8770838;0.531136182165596;0.5392246448905156;0.9999413030146577;-0.09760258960714119;-0.12285752463331001;-0.4688051208490617;-0.4607166581241421
Difficulty walking;Widened interpedicular distance;0.8337004631757736;0.77103007;0.5531818640198971;0.5735357446204645;0.7552776988623575;0.0784227643134161;0.015752369535164457;-0.2020958348424604;-0.181741954241893
Bilobate gallbladder;Histidinuria;0.8327444642782211;0.8085122;0.5534904903841044;0.5613312270842594;0.9999556674707869;-0.16721120319256577;-0.19144345662483964;-0.44646517708668254;-0.4386244403865275
Bilobate gallbladder;Widened interpedicular distance;1.0187604390084743;0.92033046;0.4940280164488605;0.5253865071878885;0.9999134918687169;0.01884694713975743;-0.07958302702878162;-0.5058854754198564;-0.47452698468082843
Histidinuria;Widened interpedicular distance;0.9094101786613464;0.8292232;0.5288752221008421;0.5546277000218321;0.9999090677057578;-0.09049888904441139;-0.17068585212577125;-0.4710338456049157;-0.4452813676839257
